,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-36,"October 01, 2012 -  September 30, 2013",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI","Tao  Deng|Takashi  Furusawa|Jamie Elyse Kugler|Fenfei  Leng|Yuri  Postnikov; MD, PhD|Shaofei  Zhang","Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Jefferey  Hayes (University of Rochester medical Center)|Eran  Meshorer (Hebrew University)|Joseph  Orly (Hebrew University)",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Rafael Cristian Casellas; PhD (NIAMS) |David  Landsman; PhD (NLM),"1. Barkess G, Postnikov Y, Campos CD, Mishra S, Mohan G, Verma S, Bustin M, West KL (2012). The chromatin-binding protein HMGN3 stimulates histone acetylation and transcription across the Glyt1 gene. Biochem J  442, 495-505.   https://doi.org/10.1042/BJ20111502|2. Masaoka A, Gassman NR, Kedar PS, Prasad R, Hou EW, Horton JK, Bustin M, Wilson SH (2012). HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts. J Biol Chem  287, 27648-58.   https://doi.org/10.1074/jbc.M112.370759|3. Postnikov YV, Kurahashi T, Zhou M, Bustin M (2012). The nucleosome binding protein HMGN1 interacts with PCNA and facilitates its binding to chromatin. Mol Cell Biol  32, 1844-54.   https://doi.org/10.1128/MCB.06429-11",https://intramural.nih.gov/search/searchview.taf?ipid=78194
1,BC004504-41,"October 01, 2012 -  September 30, 2013",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Christophe  Cataisson|Luowei  Li|Francesca  Mascia|Derek T Schloemann|Mary Ann A Stepp|Show all 9,"Mary Ann Stepp; PhD (Anatomy and Cell Biology, George Washington University)|Philip  Dennis (Johns Hopkins Cancer Center)|Ronald  Wolf",Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Elise C Kohn; MD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),Maria Irene Morasso; PhD (NIAMS) |Robert  Langenbach; PhD (NIEHS),"1. Cataisson C, Salcedo R, Hakim S, Moffitt BA, Wright L, Yi M, Stephens R, Dai RM, Lyakh L, Schenten D, Yuspa HS, Trinchieri G (2012). IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J Exp Med  209, 1689-702.   https://doi.org/10.1084/jem.20101355|2. Hattinger E, Zwicker S, Ruzicka T, Yuspa SH, Wolf R (2013). Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis. Curr Opin Pharmacol  13, 588-94.   https://doi.org/10.1016/j.coph.2013.04.007|3. Lao HC, Akunda JK, Chun KS, Flake GP, Yuspa SH, Langenbach R (2012). Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation. Carcinogenesis  33, 2293-300.   https://doi.org/10.1093/carcin/bgs267|4. Mascia F, Lam G, Keith C, Garber C, Steinberg S, Kohn E, Yuspa S (2013) Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy. Sci Transl Med 5:199ra110|5. Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G (2013). MyD88 and its divergent toll in carcinogenesis. Trends Immunol  34, 379-89.   https://doi.org/10.1016/j.it.2013.03.008",https://intramural.nih.gov/search/searchview.taf?ipid=78195
2,BC004517-37,"October 01, 2012 -  September 30, 2013",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",John  Digiovanna|Elizabeth Rose Heller|Sikandar  Khan|Christiane  Kuschal|Taro  Masaki|Deborah E Schmidt|Show all 7,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Engin  Gozukara (Malatya Univ)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|Show all 14","Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Michael  Bustin; PhD (Protein Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark  Raffeld; MD (Laboratory of Pathology)","Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD) |Suvimol  Hill; MD (CC)","1. Kraemer K, Ruenger T (2012) Genome instability, DNA repair and cancer, in Fitzpatrick's Dermatology in General Medicine. Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds., pp. 1227-39.|2. Ruenger T, DiGiovanna J, Kraemer K (2012) Hereditary diseases of genome instability and DNA repair, in Fitzpatrick's Dermatology in General Medicine. Wolff K, Katz S, Goldsmith L, Gilchrist B, Leffell D, Paller A, eds., pp. 1654-71.|3. DiGiovanna JJ, Kraemer KH (2012). Shining a light on xeroderma pigmentosum. J Invest Dermatol  132, 785-96.   https://doi.org/10.1038/jid.2011.426|4. Imoto K, Nadem C, Moriwaki S, Nishigori C, Oh KS, Khan SG, Goldstein AM, Kraemer KH (2013). Ancient origin of a Japanese xeroderma pigmentosum founder mutation. J Dermatol Sci  69, 175-6.   https://doi.org/10.1016/j.jdermsci.2012.10.008|5. Lai J, Liu Y, Alimchandani M, Liu Q, Aung P, Matsuda K, Lee C, Tsokos M, Hewitt S, Rushing E, Tamura D, Levens D, DiGiovanna J, Fine H, Patronas N, Khan S, Kleiner D, Oberholtzer J, Quezado M, Kraemer K (2013) The influence of DNA repair on neurologic degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathologica Communications 1:4|6. Moriwaki S, Takigawa M, Igarashi N, Nagai Y, Amano H, Ishikawa O, Khan SG, Kraemer KH (2012). Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities. Exp Dermatol  21, 304-7.   https://doi.org/10.1111/j.1600-0625.2012.01446.x|7. Tamura D, Khan SG, Merideth M, DiGiovanna JJ, Tucker MA, Goldstein AM, Oh KS, Ueda T, Boyle J, Sarihan M, Kraemer KH (2012). Effect of mutations in XPD(ERCC2) on pregnancy and prenatal development in mothers of patients with trichothiodystrophy or xeroderma pigmentosum. Eur J Hum Genet  20, 1308-10.   https://doi.org/10.1038/ejhg.2012.90|8. Yuspa SH, Kraemer KH, Dlugosz AA, Roop DR, Kulesz-Martin M, Bickenbach JR (2012). Montagna Symposium 2011: 60th Anniversary--Advances in Science and Medicine Catalyzed by Pioneering Skin Research. J Invest Dermatol  132, 1317-20.   https://doi.org/10.1038/jid.2011.480|9. Zhou X, Khan SG, Tamura D, Ueda T, Boyle J, Compe E, Egly JM, DiGiovanna JJ, Kraemer KH (2013). Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum. Eur J Hum Genet  21, 831-7.   https://doi.org/10.1038/ejhg.2012.246",https://intramural.nih.gov/search/searchview.taf?ipid=78196
3,BC005093-35,"October 01, 2012 -  September 30, 2013",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Michael David Hall|Caroline Amanda Murray|Nirmala D Sharma|Shunsuke  Tanigawa|Fang  Tian|Yili D Yang|Show all 8,Frank  Costantini; PhD (Columbia University)|Harold  Lovvorn (Vanderbilt University)|Thomas C Carroll|Seppo  Vainio (University of Oulu)|Emilio  Casanova (Ludwig Boltzmann Institute)|Ryuichi  Nishnakamura (Kumamoto University - Institute of Molecular Embryology and Genetics),Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|James  Lautenberger; PhD (Office of the Director)|George  Nelson (Office of the Director),Lothar  Hennighausen; PhD (NIDDK),"1. Hall M, Perantoni A (2013) Wilms TumorNephroblastoma:  a metanephric caricature, in Stem Cell Handbook., in press.|2. Murphy AJ, de Caestecker C, Pierce J, Boyle SC, Ayers GD, Zhao Z, Libes JM, Correa H, Walter T, Huppert SS, Perantoni AO, de Caestecker MP, Lovvorn HN (2012). CITED1 expression in liver development and hepatoblastoma. Neoplasia  14, 1153-63.   https://doi.org/10.1593/neo.12958|3. Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, de Caestecker MP, Lovvorn HN (2012). SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor. J Pediatr Surg  47, 1239-49.   https://doi.org/10.1016/j.jpedsurg.2012.03.034",https://intramural.nih.gov/search/searchview.taf?ipid=78197
4,BC005148-34,"October 01, 2012 -  September 30, 2013",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sharon A Bargo|David M Mccurdy|Ahmed M Raafat|Arun  Vaidyanath|Gilbert  Smith; PhD,NULL,Robert H Stephens (Business Operations Branch),NULL,"1. Baljinnyam B, Klauzinska M, Saffo S, Callahan R, Rubin JS (2012). Recombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cells. PLoS One  7, e29455.   https://doi.org/10.1371/journal.pone.0029455|2. Callahan R, Mudunur U, Bargo S, Raafat A, McCurdy D, Boulanger C, Lowther W, Stephens R, Luke BT, Stewart C, Wu X, Munroe D, Smith GH (2012). Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors. Oncotarget  3, 1320-34.   https://doi.org/10.18632/oncotarget.682|3. Raafat A, Strizzi L, Lashin K, Ginsburg E, McCurdy D, Salomon D, Smith GH, Medina D, Callahan R (2012). Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice. PLoS One  7, e43624.   https://doi.org/10.1371/journal.pone.0043624",https://intramural.nih.gov/search/searchview.taf?ipid=78198
5,BC005177-33,"October 01, 2012 -  September 30, 2013",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathyayini Venkataseshasai Divi|Elena Estela Hernandez-Ramon|Ofelia  Olivero; PhD|Andrea V Rivera|Nancy N Si,NULL,Qing  Lan (Occupational and Environmental Epidemiology Branch),NULL,"1. Poirier M, Weisburger E (2012) Chemical Carcinogenesis, in Cancer the Outlaw Cell., pp. 179-188.|2. Suastegui W, HuertaChagoya A, Pratt M, John K, Poirier M, Petrosyan P, Rubio J, Gonsebatt M (2012) PAH-DNA adducts in non-smoking inhabitants of Mexico City, in Polycyclic Aromatic Hydrocarbons: Chemistry, Occurrence and Health Issues., pp. 100-110.|3. Georgiadis P, Kovács K, Kaila S, Makedonopoulou P, Anna L, Poirier MC, Knudsen LE, Schoket B, Kyrtopoulos SA (2012). Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo[a]pyrene and other polycyclic aromatic hydrocarbons. Mutagenesis  27, 589-97.   https://doi.org/10.1093/mutage/ges024|4. John K, Pratt MM, Beland FA, Churchwell MI, McMullen G, Olivero OA, Pogribny IP, Poirier MC (2012). Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days. Carcinogenesis  33, 2236-41.   https://doi.org/10.1093/carcin/bgs247",https://intramural.nih.gov/search/searchview.taf?ipid=78199
6,BC005258-34,"October 01, 2012 -  September 30, 2013",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Yikang  Rong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78200
7,BC005263-32,"October 01, 2012 -  September 30, 2013",Eukaryotic Chromatin Structure and Gene Regulation,Carl  Wu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Anand  Ranjan|Feng  Wang|Debbie  Wei|Jan  Wisniewski|Hua  Xiao; PhD|Yawen  Bai; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78201
8,BC005268-26,"October 01, 2012 -  September 30, 2013",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jianhong  Chen; PhD|Hardeep  Kaur; PhD|Darpan Kaustuv Medhi|Robert A Shroff,Alastair  Goldman (University of Sheffield)|Galina  Petukhova (USUHS)|Alain  Nicolas,NULL,"Rafael  Camerini-Otero; MD, PhD (NIDDK)","1. De Muyt A, Jessop L, Kolar E, Sourirajan A, Chen J, Dayani Y, Lichten M (2012). BLM helicase ortholog Sgs1 is a central regulator of meiotic recombination intermediate metabolism. Mol Cell  46, 43-53.   https://doi.org/10.1016/j.molcel.2012.02.020",https://intramural.nih.gov/search/searchview.taf?ipid=78202
9,BC005270-32,"October 01, 2012 -  September 30, 2013",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Agnes  Czikora|Timothy E Esch|Tamas  Geczy|Noemi  Kedei|Jessica S Kelsey|Nancy E Lewin|Show all 9,"James  Stone (Dept. of Cardiology, University of Alberta)|Gary  Keck (Dept. of Chemistry, University of Utah)|Raz  Jelinek|Said  El Kazzouli|Julieta  Comin (University of Buenos Aires)|Raymond C Merritt|Show all 12",Victor  Marquez; PhD (Chemical Biology Laboratory)|Megan L Peach (Chemical Biology Laboratory)|Susan H Garfield (Laboratory of Experimental Carcinogenesis),NULL,"1. Bhondwe RS, Kang DW, Kim MS, Kim HS, Park SG, Son K, Choi S, Kuhs KA, Pavlyukovets VA, Pearce LV, Blumberg PM, Lee J (2012). Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism. Bioorg Med Chem Lett  22, 3656-60.   https://doi.org/10.1016/j.bmcl.2012.04.034|2. Cho Y, Kim MS, Kim HS, Ann J, Lee J, Pearce LV, Pavlyukovets VA, Morgan MA, Blumberg PM, Lee J (2012). The SAR analysis of TRPV1 agonists with the α-methylated B-region. Bioorg Med Chem Lett  22, 5227-31.   https://doi.org/10.1016/j.bmcl.2012.06.059|3. Geczy T, Peach ML, El Kazzouli S, Sigano DM, Kang JH, Valle CJ, Selezneva J, Woo W, Kedei N, Lewin NE, Garfield SH, Lim L, Mannan P, Marquez VE, Blumberg PM (2012). Molecular basis for failure of ""atypical"" C1 domain of Vav1 to bind diacylglycerol/phorbol ester. J Biol Chem  287, 13137-58.   https://doi.org/10.1074/jbc.M111.320010|4. Keck GE, Poudel YB, Rudra A, Stephens JC, Kedei N, Lewin NE, Blumberg PM (2012). Role of the C8 gem-dimethyl group of bryostatin 1 on its unique pattern of biological activity. Bioorg Med Chem Lett  22, 4084-8.   https://doi.org/10.1016/j.bmcl.2012.04.073|5. Kedei N, Telek A, Michalowski AM, Kraft MB, Li W, Poudel YB, Rudra A, Petersen ME, Keck GE, Blumberg PM (2013). Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. Biochem Pharmacol  85, 313-24.   https://doi.org/10.1016/j.bcp.2012.10.028|6. Kim MS, Ryu H, Kang DW, Cho SH, Seo S, Park YS, Kim MY, Kwak EJ, Kim YS, Bhondwe RS, Kim HS, Park SG, Son K, Choi S, DeAndrea-Lazarus IA, Pearce LV, Blumberg PM, Frank R, Bahrenberg G, Stockhausen H, Kögel BY, Schiene K, Christoph T, Lee J (2012). 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region. J Med Chem  55, 8392-408.   https://doi.org/10.1021/jm300780p|7. Kim YS, Kil MJ, Kang SU, Ryu H, Kim MS, Cho Y, Bhondwe RS, Thorat SA, Sun W, Liu K, Lee JH, Choi S, Pearce LV, Pavlyukovets VA, Morgan MA, Tran R, Lazar J, Blumberg PM, Lee J (2012). N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the A-region. Bioorg Med Chem  20, 215-24.   https://doi.org/10.1016/j.bmc.2011.11.008|8. Kortum RL, Rouquette-Jazdanian AK, Miyaji M, Merrill RK, Markegard E, Pinski JM, Wesselink A, Nath NN, Alexander CP, Li W, Kedei N, Roose JP, Blumberg PM, Samelson LE, Sommers CL (2013). A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice. J Immunol  190, 147-58.   https://doi.org/10.4049/jimmunol.1201458|9. Song X, LopezCampistrous A, Sung L, Dower N, Kedei N, Yang J, Kelsey J, Lewin N, Esch T, Blumberg P, Stone J (2013) RasGRPs are targets of the anti-cancer agent ingenol 3-angelate. PLOS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78203
10,BC005271-22,"October 01, 2012 -  September 30, 2013",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",NULL,NULL,Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Michael  Bustin; PhD (Protein Section)|Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,"1. Chatterjee R, Vinson C (2012). CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim Biophys Acta  1819, 763-70.   https://doi.org/10.1016/j.bbagrm.2012.02.014|2. Chatterjee R, Zhao J, He X, Shlyakhtenko A, Mann I, Waterfall JJ, Meltzer P, Sathyanarayana BK, FitzGerald PC, Vinson C (2012). Overlapping ETS and CRE Motifs ((G/C)CGGAAGTGACGTCA) preferentially bound by GABPα and CREB proteins. G3 (Bethesda)  2, 1243-56.   https://doi.org/10.1534/g3.112.004002|3. Kimura S, Paiz J, Yoneda M, Kido T, Vinson C, Ward JM (2012). Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse. Mol Cancer  11, 90.   https://doi.org/10.1186/1476-4598-11-90|4. Rios-Doria E, Chatterjee R, Zhao J, Rishi V, Vinson C (2012). Ubiquitin tagged dominant negative induces degradation of B-ZIP proteins. Biochem Biophys Res Commun  424, 624-8.   https://doi.org/10.1016/j.bbrc.2012.07.007|5. Vinson C, Chatterjee R (2012). CG methylation. Epigenomics  4, 655-63.   https://doi.org/10.2217/epi.12.55|6. Warren CL, Zhao J, Glass K, Rishi V, Ansari AZ, Vinson C (2012). Fabrication of duplex DNA microarrays incorporating methyl-5-cytosine. Lab Chip  12, 376-80.   https://doi.org/10.1039/c1lc20698b|7. Zhao J, Stagno JR, Varticovski L, Nimako E, Rishi V, McKinnon K, Akee R, Shoemaker RH, Ji X, Vinson C (2012). P6981, an arylstibonic acid, is a novel low nanomolar inhibitor of cAMP response element-binding protein binding to DNA. Mol Pharmacol  82, 814-23.   https://doi.org/10.1124/mol.112.080820",https://intramural.nih.gov/search/searchview.taf?ipid=78204
11,BC005317-30,"October 01, 2012 -  September 30, 2013",Role of Selenium in Development and Health,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Fang  Chen|Ryuta  Tobe|Petra Akiko Tsuji|Min-Hyuk  Yoo,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Marcus  Conrad (Institute of Clinical Molecular Biology and Tumor Genetics)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Frank Jess Gonzalez; PhD (Nucleic Acids Section),Cindy D Davis (OD),"1. Carlson B, Yoo M, Tsuji P, Tobe R, NaranjoSuarez S, Chen F, Feigenbaum L, Tessarollo L, Lee B, Gladyshev V, Hatfield D (2012) Mouse models that target removal or over-expression of the selenocysteine tRNA[Ser]Sec gene to elucidate the role of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health. Hatfield D, Berry M, Gladyshev V, eds., pp. 561-572.|2. Yoo M, Carlson B, Tsuji P, Tobe R, NaranjoSuarez S, Lee B, Davis C, Gladyshev V, Hatfield D (2012) Selenoproteins harboring a split personality in both preventing and promoting cancer, in Selenium: Its molecular biology and role in human health. Hatfield D, Berry M, Gladyshev V, eds., pp. 325-334.|3. Carlson BA, Yoo MH, Tobe R, Mueller C, Naranjo-Suarez S, Hoffmann VJ, Gladyshev VN, Hatfield DL (2012). Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis  33, 1806-13.   https://doi.org/10.1093/carcin/bgs230|4. Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE (2012). Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis  33, 1225-30.   https://doi.org/10.1093/carcin/bgs129|5. Kasaikina MV, Hatfield DL, Gladyshev VN (2012). Understanding selenoprotein function and regulation through the use of rodent models. Biochim Biophys Acta  1823, 1633-42.   https://doi.org/10.1016/j.bbamcr.2012.02.018|6. Malinouski M, Kehr S, Finney L, Vogt S, Carlson BA, Seravalli J, Jin R, Handy DE, Park TJ, Loscalzo J, Hatfield DL, Gladyshev VN (2012). High-resolution imaging of selenium in kidneys: a localized selenium pool associated with glutathione peroxidase 3. Antioxid Redox Signal  16, 185-92.   https://doi.org/10.1089/ars.2011.3997|7. Naranjo-Suarez S, Carlson BA, Tsuji PA, Yoo MH, Gladyshev VN, Hatfield DL (2012). HIF-independent regulation of thioredoxin reductase 1 contributes to the high levels of reactive oxygen species induced by hypoxia. PLoS One  7, e30470.   https://doi.org/10.1371/journal.pone.0030470|8. Tobe R, Yoo MH, Fradejas N, Carlson BA, Calvo S, Gladyshev VN, Hatfield DL (2012). Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J  445, 423-30.   https://doi.org/10.1042/BJ20120618|9. Tsuji PA, Carlson BA, Naranjo-Suarez S, Yoo MH, Xu XM, Fomenko DE, Gladyshev VN, Hatfield DL, Davis CD (2012). Knockout of the 15 kDa selenoprotein protects against chemically-induced aberrant crypt formation in mice. PLoS One  7, e50574.   https://doi.org/10.1371/journal.pone.0050574",https://intramural.nih.gov/search/searchview.taf?ipid=78205
12,BC005445-29,"October 01, 2012 -  September 30, 2013",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Christophe  Cataisson|Brittany M Flowers|Alan Yu Lang|Luowei  Li|Ulrike F Lichti; PhD|Show all 12,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention),John J O'Shea; MD (NIAMS),"1. Ansbro MR, Shukla S, Ambudkar SV, Yuspa SH, Li L (2013). Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference. PLoS One  8, e60334.   https://doi.org/10.1371/journal.pone.0060334|2. Mascia F, Lam G, Keith C, Garber C, Steinberg SM, Kohn E, Yuspa SH (2013). Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy. Sci Transl Med  5, 199ra110.   https://doi.org/10.1126/scitranslmed.3005773|3. Okano J, Levy C, Lichti U, Sun HW, Yuspa SH, Sakai Y, Morasso MI (2012). Cutaneous retinoic acid levels determine hair follicle development and downgrowth. J Biol Chem  287, 39304-15.   https://doi.org/10.1074/jbc.M112.397273|4. Sengupta A, Lichti UF, Carlson BA, Cataisson C, Ryscavage AO, Mikulec C, Conrad M, Fischer SM, Hatfield DL, Yuspa SH (2013). Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J Invest Dermatol  133, 1731-41.   https://doi.org/10.1038/jid.2013.52|5. Shukla A, Edwards R, Yang Y, Hahn A, Folkers K, Ding J, Padmakumar VC, Cataisson C, Suh KS, Yuspa SH (2014). CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma. Oncogene  33, 842-50.   https://doi.org/10.1038/onc.2013.18",https://intramural.nih.gov/search/searchview.taf?ipid=78206
13,BC005450-30,"October 01, 2012 -  September 30, 2013",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Songjoon  Baek|Ido  Goldstein; PhD|Lars  Grontved|Michael Joseph Guertin|Cynthia  Haggerty|Thomas A Johnson|Show all 15,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Fahri  Saatcioglu (Department of Biology, University of Oslo)|John  Stamatoyanopolus (Genome Sciences, University of Washington)|Michael  Stallcup (Univ of Southern California)|Susanne  Mandrup (University of Southern Denmark)|Michael J Garabedian; PhD (Microbiology and Kaplan Cancer Center, New York University Medical Center)|Show all 12","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Charles  Vinson; PhD (Laboratory of Metabolism)|David  Levens; PhD (Laboratory of Pathology)|John Carl Oberholtzer (Laboratory of Pathology)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)","Greti  Aguilera Harwood; MD (NICHD) |Rafael Cristian Casellas; PhD (NIAMS) |Jay H Chung; MD, PhD (NHLBI) |Iain  Fraser (NIAID) |John J O'Shea; MD (NIAMS)","1. Baek S, Sung MH, Hager GL (2012). Quantitative analysis of genome-wide chromatin remodeling. Methods Mol Biol  833, 433-41.   https://doi.org/10.1007/978-1-61779-477-3_26|2. Grøntved L, Bandle R, John S, Baek S, Chung HJ, Liu Y, Aguilera G, Oberholtzer C, Hager GL, Levens D (2012). Rapid genome-scale mapping of chromatin accessibility in tissue. Epigenetics Chromatin  5, 10.   https://doi.org/10.1186/1756-8935-5-10|3. Khozoie C, Borland MG, Zhu B, Baek S, John S, Hager GL, Shah YM, Gonzalez FJ, Peters JM (2012). Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4. BMC Genomics  13, 665.   https://doi.org/10.1186/1471-2164-13-665|4. Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC, Potter M, Nussenzweig MC, Casellas R (2012). Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. Proc Natl Acad Sci U S A  109, 10972-7.   https://doi.org/10.1073/pnas.1200106109|5. Mandrup S, Hager GL (2012). Modulation of chromatin access during adipocyte differentiation. Nucleus  3, 12-5.   https://doi.org/10.4161/nucl.18928|6. Miranda TB, Voss TC, Hager GL (2013). High-throughput fluorescence-based screen to identify factors involved in nuclear receptor recruitment to response elements. Methods Mol Biol  1042, 3-12.   https://doi.org/10.1007/978-1-62703-526-2_1|7. Nakahashi H, Kieffer Kwon KR, Resch W, Vian L, Dose M, Stavreva D, Hakim O, Pruett N, Nelson S, Yamane A, Qian J, Dubois W, Welsh S, Phair RD, Pugh BF, Lobanenkov V, Hager GL, Casellas R (2013). A genome-wide map of CTCF multivalency redefines the CTCF code. Cell Rep  3, 1678-1689.   https://doi.org/10.1016/j.celrep.2013.04.024|8. Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M (2012). The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med  4, 603-16.   https://doi.org/10.1002/emmm.201200236|9. Stavreva DA, Varticovski L, Hager GL (2012). Complex dynamics of transcription regulation. Biochim Biophys Acta  1819, 657-66.   https://doi.org/10.1016/j.bbagrm.2012.03.004",https://intramural.nih.gov/search/searchview.taf?ipid=78207
14,BC005522-26,"October 01, 2012 -  September 30, 2013",Thyroid StemProgenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Shigetoshi  Yokoyama,NULL,NULL,"Jerrold M Ward; DVM, PhD (NIAID)","1. Kimura S, Paiz J, Yoneda M, Kido T, Vinson C, Ward JM (2012). Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse. Mol Cancer  11, 90.   https://doi.org/10.1186/1476-4598-11-90|2. Ozaki T, Matsubara T, Seo D, Okamoto M, Nagashima K, Sasaki Y, Hayase S, Murata T, Liao XH, Hanson J, Rodriguez-Canales J, Thorgeirsson SS, Kakudo K, Refetoff S, Kimura S (2012). Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology  153, 2514-25.   https://doi.org/10.1210/en.2011-1365",https://intramural.nih.gov/search/searchview.taf?ipid=78210
15,BC005562-26,"October 01, 2012 -  September 30, 2013",Xenobiotic-Metabolizing Enzymes,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Linda G Byrd|Zhong-Ze  Fang|Srujana  Golla|Haiping  Hao|Kristopher W Krausz|Fei  Li|Show all 9,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Tami  Nakajima (Nagoya University)|Jeffrey  Idle (University of Bern)|Xiaochao  Ma (NCI)|Andrew  Patterson (Pennsylvania State University)|Bart  Staels (University of Lille Nord de France)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section),Byoungjoon  Song; PhD (NIAAA),"1. Bi H, Krausz KW, Manna SK, Li F, Johnson CH, Gonzalez FJ (2013). Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells. Anal Bioanal Chem  405, 5279-89.   https://doi.org/10.1007/s00216-013-6927-9|2. Bi H, Li F, Krausz KW, Qu A, Johnson CH, Gonzalez FJ (2013). Targeted Metabolomics of Serum Acylcarnitines Evaluates Hepatoprotective Effect of Wuzhi Tablet (Schisandra sphenanthera Extract) against Acute Acetaminophen Toxicity. Evid Based Complement Alternat Med  2013, 985257.   https://doi.org/10.1155/2013/985257|3. Cheng J, Chen C, Kristopher KW, Manna SK, Scerba M, Friedman FK, Luecke H, Idle JR, Gonzalez FJ (2013). Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping. Toxicol Sci  135, 37-47.   https://doi.org/10.1093/toxsci/kft143|4. Cheng J, Krausz KW, Li F, Ma X, Gonzalez FJ (2013). CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol Appl Pharmacol  266, 245-53.   https://doi.org/10.1016/j.taap.2012.10.024|5. Cheng J, Krausz KW, Tanaka N, Gonzalez FJ (2012). Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice. Toxicol Sci  129, 456-68.   https://doi.org/10.1093/toxsci/kfs211|6. Cheng J, Zhen Y, Miksys S, Beyoğlu D, Krausz KW, Tyndale RF, Yu A, Idle JR, Gonzalez FJ (2013). Potential role of CYP2D6 in the central nervous system. Xenobiotica  43, 973-84.   https://doi.org/10.3109/00498254.2013.791410|7. Fang ZZ, Krausz KW, Tanaka N, Li F, Qu A, Idle JR, Gonzalez FJ (2013). Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum. Arch Toxicol  87, 1975-1987.   https://doi.org/10.1007/s00204-013-1053-1|8. Holmstock N, Gonzalez FJ, Baes M, Annaert P, Augustijns P (2013). PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein. Mol Pharm  10, 1056-62.   https://doi.org/10.1021/mp300512r|9. Ito Y, Nakamura T, Yanagiba Y, Ramdhan DH, Yamagishi N, Naito H, Kamijima M, Gonzalez FJ, Nakajima T (2012). Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor α Less Than That of a Mouse but May Activate Constitutive Androstane Receptor in Liver. PPAR Res  2012, 201284.   https://doi.org/10.1155/2012/201284|10. Jennings BL, Estes AM, Anderson LJ, Fang XR, Yaghini FA, Fan Z, Gonzalez FJ, Campbell WB, Malik KU (2012). Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice. Hypertension  60, 1510-6.   https://doi.org/10.1161/HYPERTENSIONAHA.112.202606|11. Johnson CH, Slanař O, Krausz KW, Kang DW, Patterson AD, Kim JH, Luecke H, Gonzalez FJ, Idle JR (2012). Novel metabolites and roles for α-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics. Am J Clin Nutr  96, 818-30.   https://doi.org/10.3945/ajcn.112.042929|12. Kim JH, Qu A, Reddy JK, Gao B, Gonzalez FJ (2014). Hepatic oxidative stress activates the Gadd45b gene by way of degradation of the transcriptional repressor STAT3. Hepatology  59, 695-704.   https://doi.org/10.1002/hep.26683|13. Konstandi M, Cheng J, Gonzalez FJ (2013). Sex steroid hormones regulate constitutive expression of Cyp2e1 in female mouse liver. Am J Physiol Endocrinol Metab  304, E1118-28.   https://doi.org/10.1152/ajpendo.00585.2012|14. Li F, Pang X, Krausz KW, Jiang C, Chen C, Cook JA, Krishna MC, Mitchell JB, Gonzalez FJ, Patterson AD (2013). Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology. J Proteome Res  12, 1369-76.   https://doi.org/10.1021/pr301023x|15. Li F, Patterson AD, Krausz KW, Jiang C, Bi H, Sowers AL, Cook JA, Mitchell JB, Gonzalez FJ (2013). Metabolomics reveals that tumor xenografts induce liver dysfunction. Mol Cell Proteomics  12, 2126-35.   https://doi.org/10.1074/mcp.M113.028324|16. Montanez JE, Peters JM, Correll JB, Gonzalez FJ, Patterson AD (2013). Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha. Toxicol Pathol  41, 410-8.   https://doi.org/10.1177/0192623312466960|17. Nakashima R, Hayashi Y, Md K, Jia X, Wang D, Naito H, Ito Y, Kamijima M, Gonzalez FJ, Nakajima T (2013). Exposure to DEHP decreased four fatty acid levels in plasma of prepartum mice. Toxicology  309, 52-60.   https://doi.org/10.1016/j.tox.2013.04.010|18. Patterson AD, Carlson BA, Li F, Bonzo JA, Yoo MH, Krausz KW, Conrad M, Chen C, Gonzalez FJ, Hatfield DL (2013). Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity. Chem Res Toxicol  26, 1088-96.   https://doi.org/10.1021/tx4001013",https://intramural.nih.gov/search/searchview.taf?ipid=78211
16,BC005597-24,"October 01, 2012 -  September 30, 2013",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Poorva  Dharkar|Ramatoulaye Kane Deme|Germaine Yeku Noukelak|Serhiy Volodymirovych Surkov; PhD|Yang  Zhang,"Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Sun-Shin  Cha (Korea Ocean Research and Development Institute)|Anuradha  Janakiraman (The City College of CUNY)|Alfred  Goldberg (Department Cell Biology, Harvard University Medical School)","Di S Xia; PhD, MS, BS (Crystallography Section)",Alasdair C Steven; PhD (NIAMS) |Grzegorz  Piszczek; PhD (NHLBI),"1. Derrien B, Majeran W, Effantin G, Ebenezer J, Friso G, van Wijk KJ, Steven AC, Maurizi MR, Vallon O (2012). The purification of the Chlamydomonas reinhardtii chloroplast ClpP complex: additional subunits and structural features. Plant Mol Biol  80, 189-202.   https://doi.org/10.1007/s11103-012-9939-5|2. Kang JH, Chang YC, Maurizi MR (2012). 4-O-carboxymethyl ascochlorin causes ER stress and induced autophagy in human hepatocellular carcinoma cells. J Biol Chem  287, 15661-71.   https://doi.org/10.1074/jbc.M112.358473",https://intramural.nih.gov/search/searchview.taf?ipid=78212
17,BC005598-24,"October 01, 2012 -  September 30, 2013",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Joshua  Bakhsheshian|Carol O Cardarelli|King Leung Fung|Matthew David Hall|Alexandra Diana Troy Kwit|James Patrick Madigan|Show all 11,"Gergely  Szakcs (Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences)|JeanPierre  Gillet (University of Namur)","Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Susan  Bates; MD (Medical Oncology Branch)","Chava  Kimchi-Sarfaty (OD) |Christopher P Austin; AB, MD (NCATS) |Robert  Innis; MD (NIMH) |Yardena Rachel Samuels; PhD (NHGRI) |Kevin G Chen; MD (NINDS) |Teresa M Przytycka (NLM)","1. Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM (2012). Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clin Cancer Res  18, 3197-206.   https://doi.org/10.1158/1078-0432.CCR-12-0056|2. Gillet JP, Gottesman MM (2012). Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1. Drug Resist Updat  15, 2-4.   https://doi.org/10.1016/j.drup.2012.03.001|3. Padmanabhan R, Chen KG, Gillet JP, Handley M, Mallon BS, Hamilton RS, Park K, Varma S, Mehaffey MG, Robey PG, McKay RD, Gottesman MM (2012). Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells  30, 2175-87.   https://doi.org/10.1002/stem.1195|4. Patel C, Stenke L, Varma S, Lindberg ML, Björkholm M, Sjöberg J, Viktorsson K, Lewensohn R, Landgren O, Gottesman MM, Gillet JP (2013). Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity. Cancer  119, 3076-83.   https://doi.org/10.1002/cncr.28098|5. Pluchino KM, Hall MD, Goldsborough AS, Callaghan R, Gottesman MM (2012). Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Updat  15, 98-105.   https://doi.org/10.1016/j.drup.2012.03.002|6. Shaffer BC, Gillet JP, Patel C, Baer MR, Bates SE, Gottesman MM (2012). Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updat  15, 62-9.   https://doi.org/10.1016/j.drup.2012.02.001",https://intramural.nih.gov/search/searchview.taf?ipid=78213
18,BC005599-23,"October 01, 2012 -  September 30, 2013","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI","Subrata  Debnath; PhD|Sharlyn  Mazur; PhD|Hiroyasu  Sakai; MD, PhD|Harichandra Dnyaneshwar Tagad; PhD","Donald  Hunt (Department of Chemistry, University of Minnesota)|Yang  Xu (University of California)|Tatiana  Kutateladze (University of Colorado Denver School of Medicine)",Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Jenkins LM, Durell SR, Mazur SJ, Appella E (2012). p53 N-terminal phosphorylation: a defining layer of complex regulation. Carcinogenesis  33, 1441-9.   https://doi.org/10.1093/carcin/bgs145|2. Karamychev VN, Wang D, Mazur SJ, Appella E, Neumann RD, Zhurkin VB, Panyutin IG (2012). Radioprobing the conformation of DNA in a p53-DNA complex. Int J Radiat Biol  88, 1039-45.   https://doi.org/10.3109/09553002.2012.698030",https://intramural.nih.gov/search/searchview.taf?ipid=78214
19,BC005645-24,"October 01, 2012 -  September 30, 2013",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Maria Fernanda  Amarante|Dustin  Edwards|Cynthia  Masison|Robyn M Washington Parks|Claudio  Fenizia,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)|Jacek  Skowronski (Case School of Medicine)",Kathryn  Jones; PhD (Laboratory of Experimental Immunology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|John  Schiller; PhD (Laboratory of Cellular Oncology),Steven J Jacobson; PhD (NINDS) |Klaus  Strebel; PhD (NIAID),"1. Mendoza D, Migueles SA, Rood JE, Peterson B, Johnson S, Doria-Rose N, Schneider D, Rakasz E, Trivett MT, Trubey CM, Coalter V, Hallahan CW, Watkins D, Franchini G, Lifson JD, Connors M (2013). Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques. PLoS Pathog  9, e1003195.   https://doi.org/10.1371/journal.ppat.1003195",https://intramural.nih.gov/search/searchview.taf?ipid=78215
20,BC005657-24,"October 01, 2012 -  September 30, 2013",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Charlotte A Hanson|Monika  Kaczmarek|Jami A Wolfe,NULL,Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78216
21,BC005673-23,"October 01, 2012 -  September 30, 2013",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",Zhao  Cao|Kenyatta Meticeo Cosby; MD|Ryan John Holland; PhD|Joseph A. Hrabie; PhD|Youseung  Kim|Anna E Maciag|Show all 8,"Melina  Kibbe (Division of Vascular Surgery, Northwestern University)|Jeffrey  Deschamps (Naval Research Laboratory)|Sonia  Donzelli|Paul  Shami (Medical Oncology, U of Utah)|Astrid  Weyerbrock (UNIVERSITTSKLINIKUM FREIBURG)","Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|David Anderson Wink (Radiation Biology Branch)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology)",NULL,"1. Biswas D, Cao Z, Keefer LK, Saavedra JE (2012). Nitrous oxide as a primary product in base-mediated β-elimination reactions of diazeniumdiolated benzylamine derivatives. Chem Commun (Camb)  48, 5931-3.   https://doi.org/10.1039/c2cc32284f|2. Kaczmarek MZ, Holland RJ, Lavanier SA, Troxler JA, Fesenkova VI, Hanson CA, Cmarik JL, Saavedra JE, Keefer LK, Ruscetti SK (2014). Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cells. Leuk Res  38, 377-82.   https://doi.org/10.1016/j.leukres.2013.12.002|3. Nandurdikar RS, Maciag AE, Cao Z, Keefer LK, Saavedra JE (2012). Diazeniumdiolated carbamates: a novel class of nitric oxide donors. Bioorg Med Chem  20, 2025-9.   https://doi.org/10.1016/j.bmc.2012.01.046|4. Nandurdikar RS, Maciag AE, Holland RJ, Cao Z, Shami PJ, Anderson LM, Keefer LK, Saavedra JE (2012). Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugs. Bioorg Med Chem  20, 3094-9.   https://doi.org/10.1016/j.bmc.2012.02.045|5. Hrabie JA, Keefer LA (submitted in 2012) Nitric Oxide-releasing Diazeniumdiolated Polyvinylpyrrolidone-based Polymers, And Compositions, Medical Devices, And Uses Thereof. Patents issued: 9,540,471 (US in 2017); 2013292695 (AU in 2017). Patents pending: 13819293.5 (EP application); PCT/US2013/050793 (PC application); 2,879,843 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=78217
22,BC005708-22,"October 01, 2012 -  September 30, 2013",Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Chad Nicholas Brocker|Linda G Byrd|Srujana  Golla|Haiping  Hao|Changtao  Jiang|Jung Hwan  Kim|Show all 12,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Tami  Nakajima (Nagoya University)|Jeffrey  Idle (University of Bern)|Bart  Staels (University of Lille Nord de France)|Masahiko  Kurabayashi (Gunma University Graduate School of Health Sciences)|Show all 9",Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention),Oksana  Gavrilova; PhD (NIDDK) |Lothar  Hennighausen; PhD (NIDDK) |Byoungjoon  Song; PhD (NIAAA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78219
23,BC005740-21,"October 01, 2012 -  September 30, 2013",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Olga  Aprelikova; PhD|Constance Emmanuelle Brignatz-Guittard|Chang Hee  Han|Dong Joon Min|Tinghu  Qiu|Aleksandra M Michalowska|Show all 8,Alfonso  Calvo (University of Pamplona)|Tamaro  Hudson (Howard University),Melinda  Hollingshead (Biological Testing Branch)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Young S Kim (Nutritional Science Research Group),"Chuxia  Deng; PhD (NIDDK) |Mark  Hoenerhoff; DVM, PhD (NIEHS)","1. Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE (2012). Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Res  14, R109.   https://doi.org/10.1186/bcr3230|2. Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE (2012). Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis  33, 1225-30.   https://doi.org/10.1093/carcin/bgs129",https://intramural.nih.gov/search/searchview.taf?ipid=78220
24,BC005785-19,"October 01, 2012 -  September 30, 2013",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathleen C Flanders; PhD|Nellie  Moshkovich; BS|Yoshiko  Nagano|Binwu  Tang|Asaf  Raviv|Jeffrey E Green; MD|Show all 7,NULL,Miriam R Anver (Office Of The Director)|Dominic  Esposito; PhD (Office Of The Director)|Maxwell P Lee; PhD (Office of the Director)|Jinqiu  Chen (Pigment Cell Biology Section)|Ashish Kumar Lal (Cancer Genetics Branch)|Ana  Robles (Laboratory of Human Carcinogenesis),Rea  Ravin; PhD (NIBIB),"1. Kohn EA, Yang YA, Du Z, Nagano Y, Van Schyndle CM, Herrmann MA, Heldman M, Chen JQ, Stuelten CH, Flanders KC, Wakefield LM (2012). Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. Mol Cancer Res  10, 1389-99.   https://doi.org/10.1158/1541-7786.MCR-12-0136-T",https://intramural.nih.gov/search/searchview.taf?ipid=78221
25,BC005793-19,"October 01, 2012 -  September 30, 2013",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78222
26,BC006140-37,"October 01, 2012 -  September 30, 2013",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Allison  Burrell|Daisuke  Maeda|Christophe  Redon|Urbain Sossou  Weyemi|Yves  Pommier; PhD|Mirit I Aladjem; PhD,"David  Brenner (Columbia University)|Igor  Koturbash (Department of Biological Sciences, University of Lethbridge)|Alexandros  Georgakilas (East Carolina University)|Alexey  Kondratiev (Georgetown University)|Valeria  Audoshina (Georgetown University)|Ashutosh  Rao|Show all 16","Jiuping  Ji (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",Daman  Kumari; PhD (NIDDK),"1. Dickey JS, Baird BJ, Redon CE, Avdoshina V, Palchik G, Wu J, Kondratyev A, Bonner WM, Martin OA (2012). Susceptibility to bystander DNA damage is influenced by replication and transcriptional activity. Nucleic Acids Res  40, 10274-86.   https://doi.org/10.1093/nar/gks795|2. Dickey JS, Gonzalez Y, Aryal B, Mog S, Nakamura AJ, Redon CE, Baxa U, Rosen E, Cheng G, Zielonka J, Parekh P, Mason KP, Joseph J, Kalyanaraman B, Bonner W, Herman E, Shacter E, Rao VA (2013). Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. PLoS One  8, e70575.   https://doi.org/10.1371/journal.pone.0070575|3. Moroni M, Maeda D, Whitnall MH, Bonner WM, Redon CE (2013). Evaluation of the gamma-H2AX assay for radiation biodosimetry in a swine model. Int J Mol Sci  14, 14119-35.   https://doi.org/10.3390/ijms140714119|4. Redon CE, Weyemi U, Parekh PR, Huang D, Burrell AS, Bonner WM (2012). γ-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta  1819, 743-56.   https://doi.org/10.1016/j.bbagrm.2012.02.021|5. Weyemi U, Parekh PR, Redon CE, Bonner WM (2012). SOD2 deficiency promotes aging phenotypes in mouse skin. Aging (Albany NY)  4, 116-8.   https://doi.org/10.18632/aging.100433|6. Weyemi U, Redon CE, Parekh PR, Dupuy C, Bonner WM (2013). NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy. Anticancer Agents Med Chem  13, 502-14.",https://intramural.nih.gov/search/searchview.taf?ipid=78224
27,BC006150-32,"October 01, 2012 -  September 30, 2013","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Sheena Margie-Ann Aris|Andrea Simone Baechler|Adel  Chergui|Benu Brata  Das|Rui  Gao|Show all 21,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yoshi  Shiloh (Tel Aviv University)|Show all 8",Robert  Shoemaker (Screening Technologies Branch)|Robert J Fisher (Office Of The Director)|Marc C Nicklaus (Chemical Biology Laboratory)|Joseph E Tomaszewski (Office of the Director)|Melinda  Hollingshead (Biological Testing Branch)|Susan  Bates; MD (Medical Oncology Branch),"Christopher P Austin; AB, MD (NCATS) |Weidong  Wang; PhD (NIA)","1. Conda-Sheridan M, Reddy PV, Morrell A, Cobb BT, Marchand C, Agama K, Chergui A, Renaud A, Stephen AG, Bindu LK, Pommier Y, Cushman M (2013). Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1). J Med Chem  56, 182-200.   https://doi.org/10.1021/jm3014458|2. Cunningham L, Finckbeiner S, Hyde RK, Southall N, Marugan J, Yedavalli VR, Dehdashti SJ, Reinhold WC, Alemu L, Zhao L, Yeh JR, Sood R, Pommier Y, Austin CP, Jeang KT, Zheng W, Liu P (2012). Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction. Proc Natl Acad Sci U S A  109, 14592-7.   https://doi.org/10.1073/pnas.1200037109|3. Frontini M, Kukalev A, Leo E, Ng YM, Cervantes M, Cheng CW, Holic R, Dormann D, Tse E, Pommier Y, Yu V (2012). The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment. Dev Cell  23, 356-70.   https://doi.org/10.1016/j.devcel.2012.06.018|4. Gao R, Huang SY, Marchand C, Pommier Y (2012). Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes. J Biol Chem  287, 30842-52.   https://doi.org/10.1074/jbc.M112.393983|5. Kohn KW, Zeeberg BR, Reinhold WC, Sunshine M, Luna A, Pommier Y (2012). Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes. PLoS One  7, e35716.   https://doi.org/10.1371/journal.pone.0035716|6. Murai J, Huang SY, Das BB, Dexheimer TS, Takeda S, Pommier Y (2012). Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells. J Biol Chem  287, 12848-57.   https://doi.org/10.1074/jbc.M111.333963|7. Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y (2012). Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res  72, 5588-99.   https://doi.org/10.1158/0008-5472.CAN-12-2753|8. Nguyen TX, Morrell A, Conda-Sheridan M, Marchand C, Agama K, Bermingham A, Bermingam A, Stephen AG, Chergui A, Naumova A, Fisher R, O'Keefe BR, Pommier Y, Cushman M (2012). Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors. J Med Chem  55, 4457-78.   https://doi.org/10.1021/jm300335n|9. Nguyen TX, Morrell A, Conda-Sheridan M, Marchand C, Agama K, Bermingham A, Stephen AG, Chergui A, Naumova A, Fisher R, O'Keefe BR, Pommier Y, Cushman M (2012). Correction to Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I (Top1) Inhibitors. J Med Chem  55, 7297.   https://doi.org/10.1021/jm301167v|10. Pfister TD, Hollingshead M, Kinders RJ, Zhang Y, Evrard YA, Ji J, Khin SA, Borgel S, Stotler H, Carter J, Divelbiss R, Kummar S, Pommier Y, Parchment RE, Tomaszewski JE, Doroshow JH (2012). Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues. PLoS One  7, e50494.   https://doi.org/10.1371/journal.pone.0050494|11. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012). CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res  72, 3499-511.   https://doi.org/10.1158/0008-5472.CAN-12-1370|12. Ruan X, Kocher JP, Pommier Y, Liu H, Reinhold WC (2012). Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location. PLoS One  7, e31628.   https://doi.org/10.1371/journal.pone.0031628|13. Shi K, Kurahashi K, Gao R, Tsutakawa SE, Tainer JA, Pommier Y, Aihara H (2012). Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2. Nat Struct Mol Biol  19, 1372-7.   https://doi.org/10.1038/nsmb.2423|14. Solier S, Kohn KW, Scroggins B, Xu W, Trepel J, Neckers L, Pommier Y (2012). Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A  109, 12866-72.   https://doi.org/10.1073/pnas.1203617109|15. Zeeberg BR, Kohn KW, Kahn A, Larionov V, Weinstein JN, Reinhold W, Pommier Y (2012). Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples. PLoS One  7, e40062.   https://doi.org/10.1371/journal.pone.0040062|16. Zeeberg BR, Reinhold W, Snajder R, Thallinger GG, Weinstein JN, Kohn KW, Pommier Y (2012). Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines. PLoS One  7, e30317.   https://doi.org/10.1371/journal.pone.0030317|17. Zeng Z, Sharma A, Ju L, Murai J, Umans L, Vermeire L, Pommier Y, Takeda S, Huylebroeck D, Caldecott KW, El-Khamisy SF (2012). TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1. Nucleic Acids Res  40, 8371-80.   https://doi.org/10.1093/nar/gks622|18. Zhang YW, Ghosh AK, Pommier Y (2012). Lasonolide A, a potent and reversible inducer of chromosome condensation. Cell Cycle  11, 4424-35.   https://doi.org/10.4161/cc.22768|19. Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, Ballestrero A, Doroshow JH, Pommier Y (2012). Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc Natl Acad Sci U S A  109, 15030-5.   https://doi.org/10.1073/pnas.1205943109",https://intramural.nih.gov/search/searchview.taf?ipid=78225
28,BC006161-30,"October 01, 2012 -  September 30, 2013",DNA Topoisomerases as Target of Action of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Ilaria  Dalla Rosa|Shar-Yin Naomi Huang|Salim  Khiati|Hongliang  Zhang|Kurt  Kohn; PhD|Show all 9,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch)|Joseph E Tomaszewski (Office of the Director)|Susan  Bates; MD (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch),NULL,"1. Balaña-Fouce R, Prada CF, Requena JM, Cushman M, Pommier Y, Álvarez-Velilla R, Escudero-Martínez JM, Calvo-Álvarez E, Pérez-Pertejo Y, Reguera RM (2012). Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis. Antimicrob Agents Chemother  56, 5264-70.   https://doi.org/10.1128/AAC.00499-12|2. Cinelli MA, Reddy PV, Lv PC, Liang JH, Chen L, Agama K, Pommier Y, van Breemen RB, Cushman M (2012). Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons. J Med Chem  55, 10844-62.   https://doi.org/10.1021/jm300519w|3. Douarre C, Sourbier C, Dalla Rosa I, Brata Das B, Redon CE, Zhang H, Neckers L, Pommier Y (2012). Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLoS One  7, e41094.   https://doi.org/10.1371/journal.pone.0041094|4. Kiselev E, Agama K, Pommier Y, Cushman M (2012). Azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents: a systematic study of structure-activity relationships. J Med Chem  55, 1682-97.   https://doi.org/10.1021/jm201512x|5. Kiselev E, Empey N, Agama K, Pommier Y, Cushman M (2012). Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation. J Org Chem  77, 5167-72.   https://doi.org/10.1021/jo3006039|6. Mancini G, D'Annessa I, Coletta A, Chillemi G, Pommier Y, Cushman M, Desideri A (2012). Binding of an Indenoisoquinoline to the topoisomerase-DNA complex induces reduction of linker mobility and strengthening of protein-DNA interaction. PLoS One  7, e51354.   https://doi.org/10.1371/journal.pone.0051354|7. Pfister TD, Hollingshead M, Kinders RJ, Zhang Y, Evrard YA, Ji J, Khin SA, Borgel S, Stotler H, Carter J, Divelbiss R, Kummar S, Pommier Y, Parchment RE, Tomaszewski JE, Doroshow JH (2012). Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues. PLoS One  7, e50494.   https://doi.org/10.1371/journal.pone.0050494|8. Seol Y, Zhang H, Pommier Y, Neuman KC (2012). A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity. Proc Natl Acad Sci U S A  109, 16125-30.   https://doi.org/10.1073/pnas.1206480109|9. Solier S, Ryan MC, Martin SE, Varma S, Kohn KW, Liu H, Zeeberg BR, Pommier Y (2013). Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p. Cancer Res  73, 4830-9.   https://doi.org/10.1158/0008-5472.CAN-12-3504|10. Zhang F, Rothermund K, Gangadharan SB, Pommier Y, Prochownik EV, Lazo JS (2012). Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target. Oncotarget  3, 998-1010.   https://doi.org/10.18632/oncotarget.632|11. Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, Ballestrero A, Doroshow JH, Pommier Y (2012). Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc Natl Acad Sci U S A  109, 15030-5.   https://doi.org/10.1073/pnas.1205943109",https://intramural.nih.gov/search/searchview.taf?ipid=78226
29,BC006192-25,"October 01, 2012 -  September 30, 2013",Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Mirit I Aladjem; PhD|Geoffrey B Mcfadden,Evrim Itir Karac|Martijn  van Iersel (Netherlands Consortium for Systems Biology),NULL,NULL,"1. Chandan K, van Iersel MP, Aladjem MI, Kohn KW, Luna A (2012). PathVisio-Validator: a rule-based validation plugin for graphical pathway notations. Bioinformatics  28, 889-90.   https://doi.org/10.1093/bioinformatics/btr694|2. Fried JY, van Iersel MP, Aladjem MI, Kohn KW, Luna A (2013). PathVisio-Faceted Search: an exploration tool for multi-dimensional navigation of large pathways. Bioinformatics  29, 1465-6.   https://doi.org/10.1093/bioinformatics/btt146|3. Kohn KW, Zeeberg BR, Reinhold WC, Sunshine M, Luna A, Pommier Y (2012). Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes. PLoS One  7, e35716.   https://doi.org/10.1371/journal.pone.0035716|4. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012). CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res  72, 3499-511.   https://doi.org/10.1158/0008-5472.CAN-12-1370|5. Zeeberg BR, Kohn KW, Kahn A, Larionov V, Weinstein JN, Reinhold W, Pommier Y (2012). Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples. PLoS One  7, e40062.   https://doi.org/10.1371/journal.pone.0040062|6. Zeeberg BR, Reinhold W, Snajder R, Thallinger GG, Weinstein JN, Kohn KW, Pommier Y (2012). Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines. PLoS One  7, e30317.   https://doi.org/10.1371/journal.pone.0030317",https://intramural.nih.gov/search/searchview.taf?ipid=78227
30,BC006198-24,"October 01, 2012 -  September 30, 2013",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Medhanit  Bahta|Christopher George Nelson; PhD|Wen-Jian  Qian; PhD,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Michael  Yaffe (Massachusetts Institute of Technology)",David S Waugh; PhD (Protein Engineering Section)|Kyung  Lee; PhD (Chemistry Section),NULL,"1. Bahta M, Burke Jr T (2012) Yersinia pestis and approaches to targeting its outer protein H protein-tyrosine phosphatase (YopH). Curr Med Chem 19:5726-5734|2. Bahta M, Liu F, Kim SE, Stephen AG, Fisher RJ, Burke TR (2012). Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors. Nat Protoc  7, 686-702.   https://doi.org/10.1038/nprot.2012.007|3. Cui H, Thomas JD, Burke TR, Rader C (2012). Chemically programmed bispecific antibodies that recruit and activate T cells. J Biol Chem  287, 28206-14.   https://doi.org/10.1074/jbc.M112.384594|4. Liu F, Park JE, Qian WJ, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR (2012). Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification. ACS Chem Biol  7, 805-10.   https://doi.org/10.1021/cb200469a|5. Liu F, Park JE, Qian WJ, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR (2012). Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. Chembiochem  13, 1291-6.   https://doi.org/10.1002/cbic.201200206|6. Métifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y (2013). Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem Biol  8, 209-17.   https://doi.org/10.1021/cb300471n|7. Qian W, Lai C, Kelley J, Burke T (2013) Design and synthesis of N-FMoc-Thr[PO(OH)(OPOM)] for the preparation of peptides prodrugs containing phosphothreonine in fully protected form. Chem Biodiver, in press.|8. Qian W, Park J, Lim D, Park S, Lee K, Yaffe M, Lee K, Burke T (2013) Peptides Containing Mono-anionic Phosphothreonine Esters That Exhibit High Plk1 Polo-box Domain-binding Affinities and Potent Antiproliferative Effects in HeLa Cells. Chemistry Biology, in press.|9. Qian W, Park JE, Liu F, Lee KS, Burke TR (2013). Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position. Bioorg Med Chem  21, 3996-4003.   https://doi.org/10.1016/j.bmc.2012.05.036|10. Qian WJ, Park JE, Lee KS, Burke TR (2012). Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1). Bioorg Med Chem Lett  22, 7306-8.   https://doi.org/10.1016/j.bmcl.2012.10.093|11. Thomas JD, Cui H, North PJ, Hofer T, Rader C, Burke TR (2012). Application of strain-promoted azide-alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates. Bioconjug Chem  23, 2007-13.   https://doi.org/10.1021/bc300052u|12. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chem Biol Drug Des  79, 157-65.   https://doi.org/10.1111/j.1747-0285.2011.01270.x|13. Zhao XZ, Maddali K, Smith SJ, Métifiot M, Johnson BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  22, 7309-13.   https://doi.org/10.1016/j.bmcl.2012.10.088",https://intramural.nih.gov/search/searchview.taf?ipid=78228
31,BC007333-22,"October 01, 2012 -  September 30, 2013",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Christophe R Marchand|Mathieu Albert Metifiot,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Agrawal A, DeSoto J, Fullagar JL, Maddali K, Rostami S, Richman DD, Pommier Y, Cohen SM (2012). Probing chelation motifs in HIV integrase inhibitors. Proc Natl Acad Sci U S A  109, 2251-6.   https://doi.org/10.1073/pnas.1112389109|2. Johnson BC, Métifiot M, Pommier Y, Hughes SH (2012). Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity. Antimicrob Agents Chemother  56, 411-9.   https://doi.org/10.1128/AAC.05292-11|3. Métifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y (2013). Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem Biol  8, 209-17.   https://doi.org/10.1021/cb300471n|4. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chem Biol Drug Des  79, 157-65.   https://doi.org/10.1111/j.1747-0285.2011.01270.x|5. Zhao XZ, Maddali K, Smith SJ, Métifiot M, Johnson BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  22, 7309-13.   https://doi.org/10.1016/j.bmcl.2012.10.088",https://intramural.nih.gov/search/searchview.taf?ipid=78229
32,BC007363-19,"October 01, 2012 -  September 30, 2013",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Xue Zhi  Zhao,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Métifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y (2013). Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem Biol  8, 209-17.   https://doi.org/10.1021/cb300471n|2. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chem Biol Drug Des  79, 157-65.   https://doi.org/10.1111/j.1747-0285.2011.01270.x|3. Zhao XZ, Maddali K, Smith SJ, Métifiot M, Johnson BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  22, 7309-13.   https://doi.org/10.1016/j.bmcl.2012.10.088",https://intramural.nih.gov/search/searchview.taf?ipid=78230
33,BC007365-19,"October 01, 2012 -  September 30, 2013",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Pei-Wen  Chen|Xiaoying  Jian; PhD|Ruibai  Luo|Yoko  Shiba|Peng  Zhai; PhD,Richard  Kahn (Emory University)|Elizabeth  Sztul (University of Alabama)|Sylvain  Bourgain (University of Laval),Lino  Tessarollo (Mouse Cancer Genetics Program)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory),"J Silvio  Gutkind; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |Kenneth Manao Yamada; MD, PhD (NIDCR)","1. Jian X, Gruschus JM, Sztul E, Randazzo PA (2012). The pleckstrin homology (PH) domain of the Arf exchange factor Brag2 is an allosteric binding site. J Biol Chem  287, 24273-83.   https://doi.org/10.1074/jbc.M112.368084|2. Luo R, Akpan IO, Hayashi R, Sramko M, Barr V, Shiba Y, Randazzo PA (2012). GTP-binding protein-like domain of AGAP1 is protein binding site that allosterically regulates ArfGAP protein catalytic activity. J Biol Chem  287, 17176-85.   https://doi.org/10.1074/jbc.M111.334458|3. Northup JK, Jian X, Randazzo PA (2012). Nucleotide exchange factors: Kinetic analyses and the rationale for studying kinetics of GEFs. Cell Logist  2, 140-146.   https://doi.org/10.4161/cl.21627",https://intramural.nih.gov/search/searchview.taf?ipid=78231
34,BC008303-41,"October 01, 2012 -  September 30, 2013",Mechanisms of Viral Fusion and Inactivation,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Anu  Puri; PhD|Mathias  Viard|Dimiter Stanchev Dimitrov; PhD,"Yechiel  Shai (Biological Chemistry, Weizmann  Institute, Israel)|Assaf  Friedler (Hebrew University)|Mark  Tomkins (University of Georgia)|Jeeseong  Hwang (NIST)|Richard  Wyatt (The Scripps Research Institute)","Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Stephen J Lockett; PhD (Office Of The Director)","Bernard  Moss; MD, PhD (NIAID) |Alasdair C Steven; PhD (NIAMS)","1. Ashkenazi A, Viard M, Unger L, Blumenthal R, Shai Y (2012). Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. FASEB J  26, 4628-36.   https://doi.org/10.1096/fj.12-215111|2. Belanger JM, Raviv Y, Viard M, Baxa U, Blumenthal R (2012). Orthogonal inactivation of influenza and the creation of detergent resistant viral aggregates: towards a novel vaccine strategy. Virol J  9, 72.   https://doi.org/10.1186/1743-422X-9-72|3. Blumenthal R, Durell S, Viard M (2012). HIV entry and envelope glycoprotein-mediated fusion. J Biol Chem  287, 40841-9.   https://doi.org/10.1074/jbc.R112.406272|4. Reuven EM, Dadon Y, Viard M, Manukovsky N, Blumenthal R, Shai Y (2012). HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry  51, 2867-78.   https://doi.org/10.1021/bi201721r|5. Yavlovich A, Viard M, Zhou M, Veenstra TD, Wang JM, Gong W, Heldman E, Blumenthal R, Raviv Y (2012). Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells. Blood  120, 1246-53.   https://doi.org/10.1182/blood-2011-12-399063",https://intramural.nih.gov/search/searchview.taf?ipid=78232
35,BC008382-30,"October 01, 2012 -  September 30, 2013",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Eckart  Bindewald|Anish A Dalal|Adrian K Davey|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Arti  Santhanam|Show all 7,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luiz  Penalva (Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)|Gregory  Chirikjian (Mechanical Engineering, Johns Hopkins University)|Show all 11",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Kasprzak W, Shapiro B (2012) Computational prediction and modeling aid in the discovery of a conformational switch controlling replication and translation in a plus-strand RNA virus, in RNA 3D Structure Analysis and Prediction (Nucleic Acids and Molecular Biology). Leontis N, Westhof E, eds., pp. 119-142.|2. Gao F, Kasprzak W, Stupina VA, Shapiro BA, Simon AE (2012). A ribosome-binding, 3' translational enhancer has a T-shaped structure and engages in a long-distance RNA-RNA interaction. J Virol  86, 9828-42.   https://doi.org/10.1128/JVI.00677-12|3. Hua L, Wang JT, Ji X, Malhotra A, Khaladkar M, Shapiro BA, Zhang K (2012). A method for discovering common patterns from two RNA secondary structures and its application to structural repeat detection. J Bioinform Comput Biol  10, 1250001.   https://doi.org/10.1142/S0219720012500011|4. Wolfe KC, Hastings WA, Dutta S, Long A, Shapiro BA, Woolf TB, Guthold M, Chirikjian GS (2012). Multiscale modeling of double-helical DNA and RNA: a unification through Lie groups. J Phys Chem B  116, 8556-72.   https://doi.org/10.1021/jp2126015",https://intramural.nih.gov/search/searchview.taf?ipid=78233
36,BC008710-36,"October 01, 2012 -  September 30, 2013",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Shannon M Doyle|Olivier Patrick Genest|Joel R Hoskins|Monica  Markovski|Shankar  Shastry,George  Stan (University of Cincinnati)|David  Agard (UCSF)|Michal  Zolkiewski; PhD (Kansas State University),Susan  Gottesman; PhD (Biochemical Genetics Section)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Jane Beth Trepel (Medical Oncology Branch),"Daniel C Masison; PhD (NIDDK) |Kenneth Manao Yamada; MD, PhD (NIDCR)","1. Doyle SM, Hoskins JR, Wickner S (2012). DnaK chaperone-dependent disaggregation by caseinolytic peptidase B (ClpB) mutants reveals functional overlap in the N-terminal domain and nucleotide-binding domain-1 pore tyrosine. J Biol Chem  287, 28470-9.   https://doi.org/10.1074/jbc.M112.383091|2. Genest O, Reidy M, Street TO, Hoskins JR, Camberg JL, Agard DA, Masison DC, Wickner S (2013). Uncovering a region of heat shock protein 90 important for client binding in E. coli and chaperone function in yeast. Mol Cell  49, 464-73.   https://doi.org/10.1016/j.molcel.2012.11.017|3. Zhang T, Ploetz EA, Nagy M, Doyle SM, Wickner S, Smith PE, Zolkiewski M (2012). Flexible connection of the N-terminal domain in ClpB modulates substrate binding and the aggregate reactivation efficiency. Proteins  80, 2758-68.   https://doi.org/10.1002/prot.24159",https://intramural.nih.gov/search/searchview.taf?ipid=78190
37,BC008714-36,"October 01, 2012 -  September 30, 2013",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Suanur  Cureoglu|Nicholas  de Lay|Ricardo A Francis|Hyun-Jung  Lee|Nadim  Majdalani|Ashley S Parker|Show all 8,"Linda  Kenney (Microbiology, U. of Illinois School of Medicine)|Maude  Guillier|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Christian  Raetz (Duke University)|Ben  Luisi (University of Cambridge)",Peter C Fitzgerald (Office of the Director),"Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC)","1. De Lay N, Gottesman S (2012). RNase E finds some sRNAs stimulating. Mol Cell  47, 825-6.   https://doi.org/10.1016/j.molcel.2012.09.007|2. Thomason MK, Fontaine F, De Lay N, Storz G (2012). A small RNA that regulates motility and biofilm formation in response to changes in nutrient availability in Escherichia coli. Mol Microbiol  84, 17-35.   https://doi.org/10.1111/j.1365-2958.2012.07965.x",https://intramural.nih.gov/search/searchview.taf?ipid=78234
38,BC008751-33,"October 01, 2012 -  September 30, 2013",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Amlanjyoti  Dhar|Phuoc  Le|Dale  Lewis; PhD|Francisco Jesus Malagon Bautista|Zhong  Qian|Andrei  Trostel,Laura  Finzi (University of Milan)|Michal  Hammel (Lawrence Berkeley National Laboratory)|Szabolcs  Semsey,Victor  Zhurkin; PhD (Laboratory of Cell Biology)|Peter C Fitzgerald (Office of the Director),NULL,"1. Adhya S, Biswas B, Merril C (2013) Therapeutic and prophylactic applications of bacteriophage and its components in modern medicine, in Bacterial Pathogenesis. Maloy S, Cossart P, eds., pp. In Press.|2. Macvanin M, Edgar R, Cui F, Trostel A, Zhurkin V, Adhya S (2012). Noncoding RNAs binding to the nucleoid protein HU in Escherichia coli. J Bacteriol  194, 6046-55.   https://doi.org/10.1128/JB.00961-12",https://intramural.nih.gov/search/searchview.taf?ipid=78235
39,BC008752-33,"October 01, 2012 -  September 30, 2013",Thyroid Hormone Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Dong Wook  Kim; PhD|Jeong-Won  Park|Mark Cauthen Willingham|Li  Zhao|Xuguang  Zhu,"Anthony  Hollenberg (Harvard University)|James  Lechleiter (University of Texas Health Science Center at San Antonio)|G.R.  Williams (Imperial College London, Imperial College London)|Anneke  Alkemade (University of Amsterdam Medical Center)|Frances  Carr (University of Vermont College of Medicine)|MARK  WILLINGHAM (Wake Forest University)","Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Douglas  Forrest; PhD (NIDDK),"1. Chocron ES, Sayre NL, Holstein D, Saelim N, Ibdah JA, Dong LQ, Zhu X, Cheng SY, Lechleiter JD (2012). The trifunctional protein mediates thyroid hormone receptor-dependent stimulation of mitochondria metabolism. Mol Endocrinol  26, 1117-28.   https://doi.org/10.1210/me.2011-1348|2. Cordas EA, Ng L, Hernandez A, Kaneshige M, Cheng SY, Forrest D (2012). Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones. Endocrinology  153, 1548-60.   https://doi.org/10.1210/en.2011-1834|3. O'Shea PJ, Kim DW, Logan JG, Davis S, Walker RL, Meltzer PS, Cheng SY, Williams GR (2012). Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J Biol Chem  287, 17812-22.   https://doi.org/10.1074/jbc.M111.311464|4. Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu X, Privalsky ML, Cheng SY, Stevens RD, Summers SA, Newgard CB, Lazar MA, Yen PM (2012). Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest  122, 2428-38.   https://doi.org/10.1172/JCI60580",https://intramural.nih.gov/search/searchview.taf?ipid=78236
40,BC008753-31,"October 01, 2012 -  September 30, 2013",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Fatima Ghazanfar Ali-Rahmani|Prince K Awuah|Richard A Beers|Tapan K Bera|Kevin  Hollevoet|Xiaobo  Hu|Show all 17,"Itai  Benhar (Tel Aviv University)|DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Ulrich  Brinkmann (NCI)|Iekuni  Ichikawa (Vanderbilt University School of Medicine)|Taiji  Matsusaka (Tokyo Medical & Dental University)|Satoshi  Nagata (Sanford Research/USD)|Show all 14","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Oleg Y Chertov (Office Of The Director)|David J Fitzgerald; PhD (Biotherapy Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Mitchell  Ho (Laboratory of Molecular Biology)",Chang Hum  Paik; PhD (CC),"1. Baskar S, Wiestner A, Wilson WH, Pastan I, Rader C (2012). Targeting malignant B cells with an immunotoxin against ROR1. MAbs  4, 349-61.   https://doi.org/10.4161/mabs.19870|2. Biberacher V, Decker T, Oelsner M, Wagner M, Bogner C, Schmidt B, Kreitman RJ, Peschel C, Pastan I, Meyer Zum Büschenfelde C, Ringshausen I (2012). The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion. Haematologica  97, 771-9.   https://doi.org/10.3324/haematol.2011.049155|3. Chandramohan V, Sampson JH, Pastan I, Bigner DD (2012). Toxin-based targeted therapy for malignant brain tumors. Clin Dev Immunol  2012, 480429.   https://doi.org/10.1155/2012/480429|4. Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I (2012). A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity. Protein Eng Des Sel  25, 1-6.   https://doi.org/10.1093/protein/gzr053|5. Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I (2012). Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci U S A  109, 11782-7.   https://doi.org/10.1073/pnas.1209292109|6. Ma J, Tang WK, Esser L, Pastan I, Xia D (2012). Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009. Acta Crystallogr Sect F Struct Biol Cryst Commun  68, 950-3.   https://doi.org/10.1107/S1744309112028229|7. Ma J, Tang WK, Esser L, Pastan I, Xia D (2012). Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights. J Biol Chem  287, 33123-31.   https://doi.org/10.1074/jbc.M112.381756|8. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I (2012). Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol  23, 1181-9.   https://doi.org/10.1681/ASN.2011121159|9. Mazor R, Vassall AN, Eberle JA, Beers R, Weldon JE, Venzon DJ, Tsang KY, Benhar I, Pastan I (2012). Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A. Proc Natl Acad Sci U S A  109, E3597-603.   https://doi.org/10.1073/pnas.1218138109|10. Pak Y, Zhang Y, Pastan I, Lee B (2012). Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors. Cancer Res  72, 3143-52.   https://doi.org/10.1158/0008-5472.CAN-11-3925|11. Pastan I, Zhang Y (2012). Modulating mesothelin shedding to improve therapy. Oncotarget  3, 114-5.   https://doi.org/10.18632/oncotarget.445|12. Tortorella LL, Pipalia NH, Mukherjee S, Pastan I, Fitzgerald D, Maxfield FR (2012). Efficiency of immunotoxin cytotoxicity is modulated by the intracellular itinerary. PLoS One  7, e47320.   https://doi.org/10.1371/journal.pone.0047320|13. Wang S, Shin IS, Hancock H, Jang BS, Kim HS, Lee SM, Zderic V, Frenkel V, Pastan I, Paik CH, Dreher MR (2012). Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors. J Control Release  162, 218-24.   https://doi.org/10.1016/j.jconrel.2012.06.025|14. Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I (2013). A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity. Mol Cancer Ther  12, 48-57.   https://doi.org/10.1158/1535-7163.MCT-12-0336|15. Zhang J, Qiu S, Zhang Y, Merino M, Fetsch P, Avital I, Filie A, Pastan I, Hassan R (2012). Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P. Anticancer Res  32, 5151-8.",https://intramural.nih.gov/search/searchview.taf?ipid=78237
41,BC008756-26,"October 01, 2012 -  September 30, 2013",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kavita  Bhatnagar|Chi-Ping  Day|Prasun J Mishra|Pravin J Mishra|Jennifer D Rieker|Willie  Wilson|Show all 8,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Scott  Lowe (Cold Spring Harbor Laboratory)|Norman  Sharpless (University of North Carolina)|Show all 14","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Miriam R Anver (Office Of The Director)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Margaret Anne Tucker (Human Genetics Program)","Heinz  Arnheiter; MD (NINDS) |Francis S Collins; MD, PhD (OD) |J Silvio  Gutkind; PhD (NIDCR) |William James Pavan; PhD (NHGRI)","1. Debbache J, Zaidi MR, Davis S, Guo T, Bismuth K, Wang X, Skuntz S, Maric D, Pickel J, Meltzer P, Merlino G, Arnheiter H (2012). In vivo role of alternative splicing and serine phosphorylation of the microphthalmia-associated transcription factor. Genetics  191, 133-44.   https://doi.org/10.1534/genetics.111.135996|2. Jarrett SG, Novak M, Harris N, Merlino G, Slominski A, Kaetzel DM (2013). NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma. Clin Exp Metastasis  30, 25-36.   https://doi.org/10.1007/s10585-012-9495-z|3. Merlino G (2012). Unraveling the melanoma pathogenome. Pigment Cell Melanoma Res  25, 121.   https://doi.org/10.1111/j.1755-148X.2012.00974.x|4. Noonan FP, Zaidi MR, Wolnicka-Glubisz A, Anver MR, Bahn J, Wielgus A, Cadet J, Douki T, Mouret S, Tucker MA, Popratiloff A, Merlino G, De Fabo EC (2012). Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment. Nat Commun  3, 884.   https://doi.org/10.1038/ncomms1893|5. Van Dyke T, Merlino G (2012). β-catenin in metastatic melanoma--the smoking gun reloaded. Pigment Cell Melanoma Res  25, 125-6.   https://doi.org/10.1111/j.1755-148X.2011.00964.x|6. Wilson W, Merlino G (2013). Flipping the phenotypic switch on a novel antimelanoma differentiation strategy. Pigment Cell Melanoma Res  26, 791-3.   https://doi.org/10.1111/pcmr.12160|7. Zaidi MR, De Fabo EC, Noonan FP, Merlino G (2012). Shedding light on melanocyte pathobiology in vivo. Cancer Res  72, 1591-5.   https://doi.org/10.1158/0008-5472.CAN-11-2586",https://intramural.nih.gov/search/searchview.taf?ipid=78238
42,BC008757-26,"October 01, 2012 -  September 30, 2013",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD|Christopher S Choo|Abid Rasheed Mattoo; PhD|Matteo  Pasetto|Robert J Sarnovsky|Emily C Weiss",NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director)|Alan S Wayne; MD (Pediatric Oncology Branch),Scott E Martin (NCATS) |Craig Joseph Thomas (NCATS),"1. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, Fitzgerald DJ, Lechleider R, Pastan I (2012). Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. J Clin Oncol  30, 1822-8.   https://doi.org/10.1200/JCO.2011.38.1756|2. Mattoo AR, FitzGerald DJ (2013). Combination treatments with ABT-263 and an immunotoxin produce synergistic killing of ABT-263-resistant small cell lung cancer cell lines. Int J Cancer  132, 978-87.   https://doi.org/10.1002/ijc.27732|3. Wei H, Xiang L, Wayne AS, Chertov O, FitzGerald DJ, Bera TK, Pastan I (2012). Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proc Natl Acad Sci U S A  109, 6898-903.   https://doi.org/10.1073/pnas.1204523109",https://intramural.nih.gov/search/searchview.taf?ipid=78239
43,BC008905-32,"October 01, 2012 -  September 30, 2013",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman|Xiao-Li  Du|Xi  Liu|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Brajendra  Tripathi; MS, PhD|Show all 7",Igor  Barsukov (University of Liverpool)|Steven J Carr|Pierre  Lavigne (University of Liverpool),Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Nicolae C Popescu; PhD (Molecular Cytogenetics Section),NULL,"1. Du X, Qian X, Papageorge A, Schetter AJ, Vass WC, Liu X, Braverman R, Robles AI, Lowy DR (2012). Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells. Cancer Res  72, 4405-16.   https://doi.org/10.1158/0008-5472.CAN-12-0777|2. Durkin ME, Qian X, Popescu NC, Lowy DR (2013). Isolation of Mouse Embryo Fibroblasts. Bio Protoc  3.   https://doi.org/10.21769/bioprotoc.908",https://intramural.nih.gov/search/searchview.taf?ipid=78240
44,BC009003-31,"October 01, 2012 -  September 30, 2013",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Laboratory of Cancer Prevention, NCI",NULL,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78241
45,BC009052-24,"October 01, 2012 -  September 30, 2013",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Nicolas  Cuburu; PhD|Patricia  Day; PhD|Alessandra  Handisurya|Yuk Ying S Pang|Cynthia D Thompson|Christopher  Buck,Denise  NardelliHaefliger (Universitaire Vaudois)|Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Reinhard  Glueck (Etna Biotech),Ligia  Pinto (Infection & Immunoepidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Genoveffa  Franchini; MD (Vaccine Branch),"Barney S Graham; MD, PhD (NIAID)","1. Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT (2012). Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest  122, 4606-20.   https://doi.org/10.1172/JCI63287|2. Day PM, Pang YY, Kines RC, Thompson CD, Lowy DR, Schiller JT (2012). A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies. Clin Vaccine Immunol  19, 1075-82.   https://doi.org/10.1128/CVI.00139-12|3. Domingos-Pereira S, Decrausaz L, Derré L, Bobst M, Romero P, Schiller JT, Jichlinski P, Nardelli-Haefliger D (2013). Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol  6, 393-404.   https://doi.org/10.1038/mi.2012.83|4. Handisurya A, Day PM, Thompson CD, Buck CB, Kwak K, Roden RB, Lowy DR, Schiller JT (2012). Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species. Virology  433, 385-94.   https://doi.org/10.1016/j.virol.2012.08.035|5. Kemp TJ, Safaeian M, Hildesheim A, Pan Y, Penrose KJ, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA (2012). Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®). Vaccine  31, 165-70.   https://doi.org/10.1016/j.vaccine.2012.10.067|6. Lowy DR, Schiller JT (2012). Reducing HPV-associated cancer globally. Cancer Prev Res (Phila)  5, 18-23.   https://doi.org/10.1158/1940-6207.CAPR-11-0542|7. Schelhaas M, Shah B, Holzer M, Blattmann P, Kühling L, Day PM, Schiller JT, Helenius A (2012). Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog  8, e1002657.   https://doi.org/10.1371/journal.ppat.1002657|8. Schiller J, Lowy D (2013) Virus Infection and Cancer: an Overview. Recent Results in Cancer Research 193:1-10|9. Schiller JT, Castellsagué X, Garland SM (2012). A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine  30 Suppl 5, F123-38.   https://doi.org/10.1016/j.vaccine.2012.04.108|10. Schiller JT, Lowy DR (2012). Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol  10, 681-92.   https://doi.org/10.1038/nrmicro2872",https://intramural.nih.gov/search/searchview.taf?ipid=78242
46,BC009262-31,"October 01, 2012 -  September 30, 2013",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Qun  Jiang|John R Ortaldo; PhD|Anthony J Scarzello|Jeffrey J Subleski|Jonathan  Weiss|Show all 9,"Bruce  Blazar (University of Minnesota)|Bill  Murphy (Clinical Research, University of Nevada at Reno)|Sylvie  Guichard (AstraZeneca)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|William Marston Linehan; MD (Urologic Oncology Branch)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)|David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Chan T, Back TC, Subleski JJ, Weiss JM, Ortaldo JR, Wiltrout RH (2012). Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities. PLoS One  7, e33303.   https://doi.org/10.1371/journal.pone.0033303|2. Jiang Q, Weiss JM, Wiltrout RH (2012). A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatment. Oncoimmunology  1, 115-117.   https://doi.org/10.4161/onci.1.1.18036|3. Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy WJ (2012). Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood  119, 3073-83.   https://doi.org/10.1182/blood-2011-07-369736|4. Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y (2013). The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell  23, 527-40.   https://doi.org/10.1016/j.ccr.2013.03.009",https://intramural.nih.gov/search/searchview.taf?ipid=78245
47,BC009264-30,"October 01, 2012 -  September 30, 2013",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Yi  Huang|Kathryn  Jones; PhD|Sadowski  Cari,"Steven  Bartelmez (stem cell biology, Betastem Therapeutics)|Pat  Iversen (AVI-Biopharma)",NULL,NULL,"1. Akel S, Bertolette D, Ruscetti FW (2013). Crosstalk between the Smad and the Mitogen-Activated Protein Kinase Pathways is Essential for Erythroid Differentiation of Erythroleukemia Cells Induced by TGF-β, Activin, Hydroxyurea and Butyrate. J Leuk (Los Angel)  1.   https://doi.org/10.4172/2329-6917.1000109",https://intramural.nih.gov/search/searchview.taf?ipid=78246
48,BC009265-31,"October 01, 2012 -  September 30, 2013",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Steven Edward Bowen|Chiharu  Fujihara|Karen  Hathcock|Hyein  Jeon|Joy A Williams,"Ferenc  Livak (School of Medicine, University of Maryland)|Gail  Bishop (University of Iowa)|Yousuke  Takahama (Tokushima)",Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),Ranjan  Sen; PhD (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78247
49,BC009273-26,"October 01, 2012 -  September 30, 2013",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Arlene  Sharpe (Dept of Pathology, Harvard Medical School)|Sophia D Sarafova (NCI)|Show all 8","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Molecular Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD) |Lothar  Hennighausen; PhD (NIDDK)","1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78248
50,BC009279-28,"October 01, 2012 -  September 30, 2013",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Zohar Sara Barbash|John A Campbell|Natalia  Komissarova; PhD|Jie  Mu|Jocelyn D Weissman,NULL,Brian  Lewis (Lymphoid Malignancies Branch)|Susan  Sharrow (Experimental Immunology Branch)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression)|Maxwell P Lee; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78249
51,BC009281-27,"October 01, 2012 -  September 30, 2013",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Yungping  Chiang|Masashi  Watanabe|Chiharu  Fujihara,NULL,Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78250
52,BC009283-29,"October 01, 2012 -  September 30, 2013",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Deborah L Hodge|Saebyeokbyeol Esther Kim|Fan Ching  Lin|Brittany Deborah Reichelt|Della A Reynolds|Michael E Sanford|Show all 9,Rivkah  Gonsky (UCLA)|Ram  Savan|Andrew  Welcher (Amgen)|Monika  Wolkers (Sanquin),Lino  Tessarollo (Mouse Cancer Genetics Program)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention),"Ronald N Germain; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78251
53,BC009285-27,"October 01, 2012 -  September 30, 2013",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Devaiah Nanjappa Ballachanda,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78252
54,BC009287-29,"October 01, 2012 -  September 30, 2013",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Julie  Hixon|Wenqing  Li|Emilee Rose Senkevitch|Arthur A Hurwitz,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Alan S Wayne; MD (Pediatric Oncology Branch),NULL,"1. Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM (2013). Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest  123, 1694-704.   https://doi.org/10.1172/JCI65569|2. Kibe R, Zhang S, Guo D, Marrero L, Tsien F, Rodriguez P, Khan S, Zieske A, Huang J, Li W, Durum SK, Iwakuma T, Cui Y (2012). IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis. Cell Death Differ  19, 1139-51.   https://doi.org/10.1038/cdd.2011.203|3. Mazzucchelli RI, Riva A, Durum SK (2012). The human IL-7 receptor gene: deletions, polymorphisms and mutations. Semin Immunol  24, 225-30.   https://doi.org/10.1016/j.smim.2012.02.007|4. Patel ES, Okada S, Hachey K, Yang LJ, Durum SK, Moreb JS, Chang LJ (2012). Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation. BMC Immunol  13, 46.   https://doi.org/10.1186/1471-2172-13-46|5. Ruppert SM, Li W, Zhang G, Carlson AL, Limaye A, Durum SK, Khaled AR (2012). The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes. Biochim Biophys Acta  1823, 1877-93.   https://doi.org/10.1016/j.bbamcr.2012.06.017",https://intramural.nih.gov/search/searchview.taf?ipid=78253
55,BC009297-22,"October 01, 2012 -  September 30, 2013",Ubiquitin And SUMO Post-Translational Modifications In Development And Disease,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Margaret M O'Toole-Lualdi|Prashant  Sharma|Allan M Weissman; MD,NULL,Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Sharma P, Yamada S, Lualdi M, Dasso M, Kuehn MR (2013). Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo. Cell Rep  3, 1640-50.   https://doi.org/10.1016/j.celrep.2013.04.016",https://intramural.nih.gov/search/searchview.taf?ipid=78254
56,BC009304-19,"October 01, 2012 -  September 30, 2013",Structure-Function Studies and Design of Novel Glycosyltransferases,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Gabriella Suad Balaa|Natalia  Mercer|Boopathy  Ramakrishna,NULL,NULL,NULL,"1. Ramakrishnan B, Qasba P (2012) In vitro Folding of beta-1,4Galactosyltransferase and Polypeptide-alpha-N-acetylgalactosaminyltransferase from the Inclusion Bodies, in Methods in Molecular Biology -Glycosyltransferases: Methods and Protocols., in press.|2. Ramakrishnan B, Qasba P (2013) UDP-Gal:betaGlcNAc beta 1,4-galactosyl-transferase, polypeptide 1 (B4GALT1), in Handbook of Glycosyltransferases and Related Genes. Taniguchi N, Honke K, Fukuda M, Narimatsu H, Yamaguchi Y, Angata T, eds., in press.|3. Mercer N, Ramakrishnan B, Boeggeman E, Verdi L, Qasba PK (2013). Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface. Bioconjug Chem  24, 144-52.   https://doi.org/10.1021/bc300542z|4. Ramakrishnan B, Boeggeman E, Qasba PK (2012). Binding of N-acetylglucosamine (GlcNAc) β1-6-branched oligosaccharide acceptors to β4-galactosyltransferase I reveals a new ligand binding mode. J Biol Chem  287, 28666-74.   https://doi.org/10.1074/jbc.M112.373514|5. Ramakrishnan B, Moncrief A, Davis T, Holland L, Qasba P (2013) Investigations on Beta1,4-galactosyltransferase I using 6-sulfo-GlcNAc as an acceptor sugar substrate. Glycoconjugate Journal, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78255
57,BC009322-25,"October 01, 2012 -  September 30, 2013",Mechanisms Used by NKT Cells in the Control of Liver Tumors,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|John R Ortaldo; PhD|Jeffrey J Subleski|Howard A Young; PhD,NULL,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"1. Chan T, Back TC, Subleski JJ, Weiss JM, Ortaldo JR, Wiltrout RH (2012). Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities. PLoS One  7, e33303.   https://doi.org/10.1371/journal.pone.0033303",https://intramural.nih.gov/search/searchview.taf?ipid=78256
58,BC009369-23,"October 01, 2012 -  September 30, 2013",Studies of Chemokine-Receptor Interactions with Chemokines and alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|Poonam  Tewary|Anna Lee  Trivett|De  Yang,Robert  Goldman (Peprotech)|Yana  Li|Gonzalo  De La Rosa|Folkert Watze Werner Steinhagen,"Michael  Bustin; PhD (Protein Section)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)|Takashi  Furusawa (Laboratory of Metabolism)|Yuri  Postnikov; MD, PhD (Laboratory of Metabolism)|Sergey G Tarasov (Structural Biophysics Laboratory)|Luis G Rodriguez (Office Of The Director)",NULL,"1. Tewary P, de la Rosa G, Sharma N, Rodriguez LG, Tarasov SG, Howard OM, Shirota H, Steinhagen F, Klinman DM, Yang D, Oppenheim JJ (2013) Beta Defensin 2 and 3 Promote the uptake of self or CpG DNA, Enhance IFN-alpha Production by Human Plasmacytoid Dendritic Cells and Promote Inflammation. J Immunol, in press.|2. Yang D, Wei F, Tewary P, Howard OM, Oppenheim JJ (2013). Alarmin-induced cell migration. Eur J Immunol  43, 1412-8.   https://doi.org/10.1002/eji.201243138",https://intramural.nih.gov/search/searchview.taf?ipid=78257
59,BC009392-21,"October 01, 2012 -  September 30, 2013",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Ventzislava Alexandrova Hristova; PhD|Meredith Boyle Metzger; PhD|Daniel Kenneth Stringer|Yien-Che  Tsai|Mei  Yang; MD|Jennifer B Mariano,Michael  Glickman (Technion)|Joseph  Roitelman,Robert Andrew Byrd (Structural Biophysics Laboratory)|Chand  Khanna; MD (Pediatric Oncology Branch)|Xinhua  Ji; PhD (Biomolecular Structure Section),Juan S Bonifacino; PhD (NICHD),"1. Byrd RA, Weissman AM (2013). Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase. EMBO J  32, 2087-9.   https://doi.org/10.1038/emboj.2013.158|2. Leboucher GP, Tsai YC, Yang M, Shaw KC, Zhou M, Veenstra TD, Glickman MH, Weissman AM (2012). Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol Cell  47, 547-57.   https://doi.org/10.1016/j.molcel.2012.05.041|3. Metzger MB, Hristova VA, Weissman AM (2012). HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci  125, 531-7.   https://doi.org/10.1242/jcs.091777|4. Tsai YC, Leichner GS, Pearce MM, Wilson GL, Wojcikiewicz RJ, Roitelman J, Weissman AM (2012). Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system. Mol Biol Cell  23, 4484-94.   https://doi.org/10.1091/mbc.E12-08-0631|5. Tsai YC, Weissman AM (2012). A ubiquitin-binding rhomboid protease aimed at ERADication. Dev Cell  23, 454-6.   https://doi.org/10.1016/j.devcel.2012.08.015|6. Weissman AM (2013). Ubiquitin and drug discovery: challenges and opportunities. Cell Biochem Biophys  67, 1-2.   https://doi.org/10.1007/s12013-013-9620-x",https://intramural.nih.gov/search/searchview.taf?ipid=78183
60,BC009404-19,"October 01, 2012 -  September 30, 2013",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Kazuyuki  Furuta|Erica Lynn Heipertz|Sanjay  Khandelwal|Sharad Kumar Mittal; PhD,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)|Elizabeth D Mellins; MD (Department of Pediatrics, Stanford University)",Lionel  Feigenbaum (Office Of The Director),NULL,"1. Furuta K, Ishido S, Roche PA (2012). Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells. Proc Natl Acad Sci U S A  109, 19380-5.   https://doi.org/10.1073/pnas.1213868109|2. Hunt D, Wilson JE, Weih KA, Ishido S, Harton JA, Roche PA, Drake JR (2012). Francisella tularensis elicits IL-10 via a PGE₂-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS One  7, e37330.   https://doi.org/10.1371/journal.pone.0037330",https://intramural.nih.gov/search/searchview.taf?ipid=78258
61,BC009405-19,"October 01, 2012 -  September 30, 2013",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Yungping  Chiang|Karen  Hathcock|Daniel Augustus Triner|Masashi  Watanabe,NULL,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Karl Thomas Ried; MD (Cancer Genetics Branch),Herbert Carpenter Morse; MD (NIAID),"1. Chiang YJ, Difilippantonio MJ, Tessarollo L, Morse HC, Hodes RJ (2012). Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas. PLoS One  7, e49305.   https://doi.org/10.1371/journal.pone.0049305",https://intramural.nih.gov/search/searchview.taf?ipid=78259
62,BC010001-18,"October 01, 2012 -  September 30, 2013",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Laboratory of Cancer Prevention, NCI",Wonil  Kim|Kimberly D Klarmann|Lei  Sun|Emily  Bowers|Bjorg  Gudmundsdottir|Peter F Johnson; PhD,NULL,Laura  Schmidt (Urologic Oncology Branch)|Serguei V Kozlov (Office of the Director)|Masaya  Baba (Urologic Oncology Branch)|Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program)|Shyam K Sharan (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78260
63,BC010006-18,"October 01, 2012 -  September 30, 2013",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Hee Jun  Cho; PhD|Yoo-Seok  Hwang|Yon Ju  Ji|Kathleen T Soria|Emily Frances Winterbottom,Sally  Moody (George Washington University Medical Center)|Aykut  Uren (Georgetown University Medical Center),NULL,NULL,"1. Klein SL, Neilson KM, Orban J, Yaklichkin S, Hoffbauer J, Mood K, Daar IO, Moody SA (2013). Conserved structural domains in FoxD4L1, a neural forkhead box transcription factor, are required to repress or activate target genes. PLoS One  8, e61845.   https://doi.org/10.1371/journal.pone.0061845|2. Neilson KM, Klein SL, Mhaske P, Mood K, Daar IO, Moody SA (2012). Specific domains of FoxD4/5 activate and repress neural transcription factor genes to control the progression of immature neural ectoderm to differentiating neural plate. Dev Biol  365, 363-75.   https://doi.org/10.1016/j.ydbio.2012.03.004",https://intramural.nih.gov/search/searchview.taf?ipid=78261
64,BC010008-18,"October 01, 2012 -  September 30, 2013",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Joy Michelle Gary|John K Simmons|Dena Hoa Tran|Shuling  Zhang; MD, PhD|Ke  Zhang|Robert Mark Simpson; DVM, PhD",NULL,NULL,"Rafael Cristian Casellas; PhD (NIAMS) |Alasdair M Gilfillan; PhD (NIAID) |Toren  Finkel; MD, PhD (NHLBI)","1. Simmons JK, Amlin-Van Schaick JC, Geiger TR, Reilly K, Hunter K, Mock BA (2012). Mouse genetics 2011: meeting report. Mamm Genome  23, 225-31.   https://doi.org/10.1007/s00335-012-9390-6",https://intramural.nih.gov/search/searchview.taf?ipid=78262
65,BC010012-18,"October 01, 2012 -  September 30, 2013",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks|Robert  Wiltrout; PhD,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Hyam  Levitsky (Department of Oncology, Johns Hopkins University)|Linda A Sherman",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78263
66,BC010013-18,"October 01, 2012 -  September 30, 2013",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Andrew Robert Huehn|Hong-Chuan  Li|Paul  Wright|Mary  Carrington; MS, PhD|Daniel  McVicar; PhD|Michael  Dean; PhD","Jeffrey  Miller (University of Minnesota Cancer Center)|Andrew  Makrigiannis (ICRM)|Colin  Brooks (School of Biosciences, University of Newcastle)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)|William  Murphy (UC Davis)",NULL,NULL,"1. Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ (2012). CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood  120, 3455-65.   https://doi.org/10.1182/blood-2012-03-416867|2. Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF, Chanock SJ, Anderson SK, Dean M (2012). Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts. Hum Genet  131, 1453-1466.   https://doi.org/10.1007/s00439-012-1182-2|3. Zhang Q, Rahim MM, Allan DS, Tu MM, Belanger S, Abou-Samra E, Ma J, Sekhon HS, Fairhead T, Zein HS, Carlyle JR, Anderson SK, Makrigiannis AP (2012). Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance. PLoS One  7, e50561.   https://doi.org/10.1371/journal.pone.0050561",https://intramural.nih.gov/search/searchview.taf?ipid=78264
67,BC010014-18,"October 01, 2012 -  September 30, 2013",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI",Yixing  Han; PhD|Jianke  Ren|Minoru  Terashima; PhD|Weishi  Yu,NULL,Robert M Leighty (Office Of The Director)|Carl E Mcintosh (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78265
68,BC010015-18,"October 01, 2012 -  September 30, 2013",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,Philip M Murphy; MD (NIAID),"1. Arroyo DS, Soria JA, Gaviglio EA, Garcia-Keller C, Cancela LM, Rodriguez-Galan MC, Wang JM, Iribarren P (2013). Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J  27, 299-312.   https://doi.org/10.1096/fj.12-214312|2. Bena S, Brancaleone V, Wang JM, Perretti M, Flower RJ (2012). Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J Biol Chem  287, 24690-7.   https://doi.org/10.1074/jbc.M112.377101|3. Chen K, Liu M, Liu Y, Wang C, Yoshimura T, Gong W, Le Y, Tessarollo L, Wang JM (2013). Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation. J Biol Chem  288, 16262-73.   https://doi.org/10.1074/jbc.M113.450635|4. Liu Y, Chen K, Wang C, Gong W, Yoshimura T, Liu M, Wang JM (2013). Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. Cancer Res  73, 550-60.   https://doi.org/10.1158/0008-5472.CAN-12-2290|5. Madenspacher JH, Azzam KM, Gong W, Gowdy KM, Vitek MP, Laskowitz DT, Remaley AT, Wang JM, Fessler MB (2012). Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem  287, 43730-40.   https://doi.org/10.1074/jbc.M112.377192|6. Yavlovich A, Viard M, Zhou M, Veenstra TD, Wang JM, Gong W, Heldman E, Blumenthal R, Raviv Y (2012). Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells. Blood  120, 1246-53.   https://doi.org/10.1182/blood-2011-12-399063",https://intramural.nih.gov/search/searchview.taf?ipid=78266
69,BC010017-18,"October 01, 2012 -  September 30, 2013","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Phuoc  Le|Francisco Jesus Malagon Bautista|Andrei  Trostel|Brian P Peddie,NULL,NULL,NULL,"1. Csiszovszki Z, Lewis D, Le P, Sneppen K, Semsey S (2012) Specific contacts of the -35 region of the galP1 promoter by RNA polymerase inhibit GalR mediated DNA looping repression. Nucleic Acids Res 40:10064-72|2. Qian Z, Dimitriadis EK, Edgar R, Eswaramoorthy P, Adhya S (2012). Galactose repressor mediated intersegmental chromosomal connections in Escherichia coli. Proc Natl Acad Sci U S A  109, 11336-41.   https://doi.org/10.1073/pnas.1208595109",https://intramural.nih.gov/search/searchview.taf?ipid=78267
70,BC010020-18,"October 01, 2012 -  September 30, 2013",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Barbara  Debrah|Sonya C Duke|Natasha L Kormanik|Elizabeth J Maestri|Yvonne D Mallory|Joan  Aaron|Show all 11,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Ramy A Ibrahim|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)","Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)",NULL,"1. Kelly RJ, Sharon E, Pastan I, Hassan R (2012). Mesothelin-targeted agents in clinical trials and in preclinical development. Mol Cancer Ther  11, 517-25.   https://doi.org/10.1158/1535-7163.MCT-11-0454|2. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, Fitzgerald DJ, Lechleider R, Pastan I (2012). Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. J Clin Oncol  30, 1822-8.   https://doi.org/10.1200/JCO.2011.38.1756|3. Sharon E, Zhang J, Hollevoet K, Steinberg SM, Pastan I, Onda M, Gaedcke J, Ghadimi BM, Ried T, Hassan R (2012). Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers. Clin Chem Lab Med  50, 721-5.   https://doi.org/10.1515/CCLM.2011.816",https://intramural.nih.gov/search/searchview.taf?ipid=78268
71,BC010021-18,"October 01, 2012 -  September 30, 2013",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Robert  Callahan; PhD,"Cathrin  Brisken (ISREC/EPFL)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)",David  Salomon; PhD (Laboratory of Cancer Prevention),NULL,"1. Boulanger CA, Bruno RD, Rosu-Myles M, Smith GH (2012). The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate. Stem Cells Dev  21, 948-54.   https://doi.org/10.1089/scd.2011.0148|2. Bruno RD, Smith GH (2012). Reprogramming non-mammary and cancer cells in the developing mouse mammary gland. Semin Cell Dev Biol  23, 591-8.   https://doi.org/10.1016/j.semcdb.2012.03.007|3. Bussard KM, Smith GH (2012). Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo. PLoS One  7, e49221.   https://doi.org/10.1371/journal.pone.0049221|4. Callahan R, Mudunur U, Bargo S, Raafat A, McCurdy D, Boulanger C, Lowther W, Stephens R, Luke BT, Stewart C, Wu X, Munroe D, Smith GH (2012). Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors. Oncotarget  3, 1320-34.   https://doi.org/10.18632/oncotarget.682|5. Raafat A, Strizzi L, Lashin K, Ginsburg E, McCurdy D, Salomon D, Smith GH, Medina D, Callahan R (2012). Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice. PLoS One  7, e43624.   https://doi.org/10.1371/journal.pone.0043624",https://intramural.nih.gov/search/searchview.taf?ipid=78269
72,BC010022-18,"October 01, 2012 -  September 30, 2013",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Harrison Lee Boyce|Victor A David|Levi Timothy Hooper|Sophie Mh Limou|Show all 7,"Gregory D Kirk|David  Gasser (Department of Genetics, University of Pennsylvania)|Barry  Freedman (Wake Forest University)|Linda  Kao (Dept. of Epidemiology, Johns Hopkins University)|Rulan  Parekh (Johns Hopkins University)|Martin R Pollak (Division of Nephrology, Beth Israel Deaconess Medical Center)|Show all 9",George  Nelson (Office of the Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB (2012). HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int  82, 338-43.   https://doi.org/10.1038/ki.2012.111|2. Kopp JB, Winkler CA (2012). Genetic risk prediction for CKD: a journey of a thousand miles. Am J Kidney Dis  59, 4-8.   https://doi.org/10.1053/j.ajkd.2011.11.011|3. Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB, SK Investigators (2013). Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int  83, 114-20.   https://doi.org/10.1038/ki.2012.263",https://intramural.nih.gov/search/searchview.taf?ipid=78270
73,BC010025-18,"October 01, 2012 -  September 30, 2013",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Matthew R Young; PhD,"Myung  Cho (Laboratory of Toxicology, Seoul National University)|Powel  Brown (Baylor Breast Center, Baylor College of Medicine)",James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|John A Beutler (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Camalier CE, Yi M, Yu LR, Hood BL, Conrads KA, Lee YJ, Lin Y, Garneys LM, Bouloux GF, Young MR, Veenstra TD, Stephens RM, Colburn NH, Conrads TP, Beck GR (2013). An integrated understanding of the physiological response to elevated extracellular phosphate. J Cell Physiol  228, 1536-50.   https://doi.org/10.1002/jcp.24312|2. Kang MI, Baker AR, Dextras CR, Cabarcas SM, Young MR, Colburn NH (2012). Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis. Genes Cancer  3, 37-50.   https://doi.org/10.1177/1947601912448820|3. Wei Q, Jiang H, Baker A, Dodge LK, Gerard M, Young MR, Toledano MB, Colburn NH (2013). Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. Carcinogenesis  34, 1403-10.   https://doi.org/10.1093/carcin/bgt059",https://intramural.nih.gov/search/searchview.taf?ipid=78271
74,BC010026-18,"October 01, 2012 -  September 30, 2013","The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression",Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Glenn  Hegamyer|Soon-Kyung  Hwang|Matthew R Young; PhD,"Myung  Cho (Laboratory of Toxicology, Seoul National University)|Heike  Allgayer (University of Munich)|Michele  Pagano (New York Univ)|Nahum  Sonenberg (McGill University)|Arti  Gaur (Dartmouth Med Sch)|Tobias  Schmid",Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|James  McMahon; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,"1. Blees JS, Bokesch HR, Rübsamen D, Schulz K, Milke L, Bajer MM, Gustafson KR, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B (2012). Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1. PLoS One  7, e46567.   https://doi.org/10.1371/journal.pone.0046567|2. Narasimhan M, Rathinam M, Riar A, Patel D, Mummidi S, Yang HS, Colburn NH, Henderson GI, Mahimainathan L (2013). Programmed cell death 4 (PDCD4): a novel player in ethanol-mediated suppression of protein translation in primary cortical neurons and developing cerebral cortex. Alcohol Clin Exp Res  37, 96-109.   https://doi.org/10.1111/j.1530-0277.2012.01850.x",https://intramural.nih.gov/search/searchview.taf?ipid=78272
75,BC010027-19,"October 01, 2012 -  September 30, 2013",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Songjoon  Baek|Ofir  Hakim|Thomas A Johnson|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD|Diana  Stavreva|Show all 9,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Paolo  SassoneCorsi (University of California)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression),John J O'Shea; MD (NIAMS) |Rafael Cristian Casellas; PhD (NIAMS),"1. Hager GL, Varticovski L (2012). Chromatin in time and space. Biochim Biophys Acta  1819, 631.   https://doi.org/10.1016/j.bbagrm.2012.05.002|2. Hakim O, Resch W, Yamane A, Klein I, Kieffer-Kwon KR, Jankovic M, Oliveira T, Bothmer A, Voss TC, Ansarah-Sobrinho C, Mathe E, Liang G, Cobell J, Nakahashi H, Robbiani DF, Nussenzweig A, Hager GL, Nussenzweig MC, Casellas R (2012). DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature  484, 69-74.   https://doi.org/10.1038/nature10909|3. Miranda TB, Voss TC, Hager GL (2013). High-throughput fluorescence-based screen to identify factors involved in nuclear receptor recruitment to response elements. Methods Mol Biol  1042, 3-12.   https://doi.org/10.1007/978-1-62703-526-2_1|4. Nakahashi H, Kieffer Kwon KR, Resch W, Vian L, Dose M, Stavreva D, Hakim O, Pruett N, Nelson S, Yamane A, Qian J, Dubois W, Welsh S, Phair RD, Pugh BF, Lobanenkov V, Hager GL, Casellas R (2013). A genome-wide map of CTCF multivalency redefines the CTCF code. Cell Rep  3, 1678-1689.   https://doi.org/10.1016/j.celrep.2013.04.024|5. Sung MH, Hager GL (2012). Nonlinear dependencies of biochemical reactions for context-specific signaling dynamics. Sci Rep  2, 616.   https://doi.org/10.1038/srep00616",https://intramural.nih.gov/search/searchview.taf?ipid=78273
76,BC010030-18,"October 01, 2012 -  September 30, 2013",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Joseph Michael Ahearn|Eduardo Emilio Chufan; PhD|John E Golin|Khyati  Kapoor; PhD|Rajendra Prasad Nagarajan; PhD|Suneet  Shukla|Show all 7,"Rajendra  Prasad (Jawaharlal Nehru University)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Bjorn  Bauer|Jack  Freed (Cornell University)|Liwu  Fu (Sun Yat-Sen University)|John E Golin","Di S Xia; PhD, MS, BS (Crystallography Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Susan  Bates; MD (Medical Oncology Branch)|Stewart  Durell (Laboratory of Cell Biology)",Craig Joseph Thomas (NCATS),"1. Downes MT, Mehla J, Ananthaswamy N, Wakschlag A, Lamonde M, Dine E, Ambudkar SV, Golin J (2013). The transmission interface of the Saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in drug resistance. Antimicrob Agents Chemother  57, 1025-34.   https://doi.org/10.1128/AAC.02133-12|2. Duveau DY, Hu X, Walsh MJ, Shukla S, Skoumbourdis AP, Boxer MB, Ambudkar SV, Shen M, Thomas CJ (2013). Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors. Bioorg Med Chem Lett  23, 682-6.   https://doi.org/10.1016/j.bmcl.2012.11.111|3. Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM (2012). Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clin Cancer Res  18, 3197-206.   https://doi.org/10.1158/1078-0432.CCR-12-0056|4. Gupta V, Bhinge KN, Hosain SB, Xiong K, Gu X, Shi R, Ho MY, Khoo KH, Li SC, Li YT, Ambudkar SV, Jazwinski SM, Liu YY (2012). Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells. J Biol Chem  287, 37195-205.   https://doi.org/10.1074/jbc.M112.396390|5. Kuang YH, Patel JP, Sodani K, Wu CP, Liao LQ, Patel A, Tiwari AK, Dai CL, Chen X, Fu LW, Ambudkar SV, Korlipara VL, Chen ZS (2012). OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance. Biochem Pharmacol  84, 766-74.   https://doi.org/10.1016/j.bcp.2012.06.019|6. Liu KJ, He JH, Su XD, Sim HM, Xie JD, Chen XG, Wang F, Liang YJ, Singh S, Sodani K, Talele TT, Ambudkar SV, Chen ZS, Wu HY, Fu LW (2013). Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo. Int J Cancer  132, 224-35.   https://doi.org/10.1002/ijc.27649|7. Natarajan K, Bhullar J, Shukla S, Burcu M, Chen ZS, Ambudkar SV, Baer MR (2013). The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms. Biochem Pharmacol  85, 514-24.   https://doi.org/10.1016/j.bcp.2012.12.006|8. Sen R, Natarajan K, Bhullar J, Shukla S, Fang HB, Cai L, Chen ZS, Ambudkar SV, Baer MR (2012). The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2. Mol Cancer Ther  11, 2033-44.   https://doi.org/10.1158/1535-7163.MCT-12-0302|9. Shukla S, Chen ZS, Ambudkar SV (2012). Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance. Drug Resist Updat  15, 70-80.   https://doi.org/10.1016/j.drup.2012.01.005|10. Shukla S, Schwartz C, Kapoor K, Kouanda A, Ambudkar SV (2012). Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells. Drug Metab Dispos  40, 304-12.   https://doi.org/10.1124/dmd.111.042721|11. Wu CP, Hsiao SH, Sim HM, Luo SY, Tuo WC, Cheng HW, Li YQ, Huang YH, Ambudkar SV (2013). Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1. Biochem Pharmacol  86, 904-13.   https://doi.org/10.1016/j.bcp.2013.08.004|12. Wu CP, Sim HM, Huang YH, Liu YC, Hsiao SH, Cheng HW, Li YQ, Ambudkar SV, Hsu SC (2013). Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells. Biochem Pharmacol  85, 325-34.   https://doi.org/10.1016/j.bcp.2012.11.003|13. Zhao XQ, Xie JD, Chen XG, Sim HM, Zhang X, Liang YJ, Singh S, Talele TT, Sun Y, Ambudkar SV, Chen ZS, Fu LW (2012). Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo. Mol Pharmacol  82, 47-58.   https://doi.org/10.1124/mol.111.076299",https://intramural.nih.gov/search/searchview.taf?ipid=78274
77,BC010251-18,"October 01, 2012 -  September 30, 2013",Wnt Signaling and Secreted Frizzled-Related Proteins,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Jacomijn Petronella Dijksterhuis; MSC|Aykut  Uren|Charles Peter Xavier,"Ernest  Arenas (CEDB, Karolinska Institute)|Abbot  Clark (Alcon Labs, Alcon Research, Ltd.)",Robert  Callahan; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Olga  Aprelikova; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J (2013). Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene  32, 3246-53.   https://doi.org/10.1038/onc.2012.351|2. Baljinnyam B, Klauzinska M, Saffo S, Callahan R, Rubin JS (2012). Recombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cells. PLoS One  7, e29455.   https://doi.org/10.1371/journal.pone.0029455|3. Mao W, Millar JC, Wang WH, Silverman SM, Liu Y, Wordinger RJ, Rubin JS, Pang IH, Clark AF (2012). Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol Vis Sci  53, 7043-51.   https://doi.org/10.1167/iovs.12-9664|4. Nagaoka T, Karasawa H, Turbyville T, Rangel MC, Castro NP, Gonzales M, Baker A, Seno M, Lockett S, Greer YE, Rubin JS, Salomon DS, Bianco C (2013). Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors. Cell Signal  25, 178-89.   https://doi.org/10.1016/j.cellsig.2012.09.024",https://intramural.nih.gov/search/searchview.taf?ipid=78277
78,BC010252-18,"October 01, 2012 -  September 30, 2013",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Daniel C Bertolette|Yi  Huang|Kathryn  Jones; PhD|Sadowski  Cari,Claudine  Pique (Inserm)|Pat  Green (Ohio State University)|Judy  Mikovits (whittemore peterson inst),Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program)|Gene  Shearer; PhD (Cell Mediated Immunity Section)|Genoveffa  Franchini; MD (Vaccine Branch)|Sandra  Ruscetti; PhD (Laboratory of Cancer Prevention),Steven J Jacobson; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78278
79,BC010256-18,"October 01, 2012 -  September 30, 2013",The Nodal Signaling Pathway In Embryonic Development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Oyvind  Dahle|Margaret M O'Toole-Lualdi|Acong  Yang,Luca  Brunelli (University of Utah)|Chin  Chiang; PhD (Vanderbilt U),NULL,Amit  Kumar; PhD (NIDDK),"1. Dahle O, Kuehn MR (2013). Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming. Stem Cells  31, 1488-97.   https://doi.org/10.1002/stem.1417|2. Liu J, Li Q, Kuehn MR, Litingtung Y, Vokes SA, Chiang C (2013). Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning. Dev Biol  375, 160-71.   https://doi.org/10.1016/j.ydbio.2012.12.018",https://intramural.nih.gov/search/searchview.taf?ipid=78280
80,BC010277-16,"October 01, 2012 -  September 30, 2013",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jonghwan  Baek|Papri  Banerjee|Reema  Deb Ray Choudhuri; PhD|Jyoti Krishna Jha|Shanmuga  Sozhamannan; PhD,"Petra  Levin; PhD (Biology, Washington U)|Rajagopala  Venkatappa (J Craig Ventor Institute)|Malanie  Blokesch (Global Health Institute)",Peter C Fitzgerald (Office of the Director),Emilios K Dimitriadis; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Hill NS, Kadoya R, Chattoraj DK, Levin PA (2012). Cell size and the initiation of DNA replication in bacteria. PLoS Genet  8, e1002549.   https://doi.org/10.1371/journal.pgen.1002549|2. Jha JK, Baek JH, Venkova-Canova T, Chattoraj DK (2012). Chromosome dynamics in multichromosome bacteria. Biochim Biophys Acta  1819, 826-9.   https://doi.org/10.1016/j.bbagrm.2012.01.012|3. Jha JK, Demarre G, Venkova-Canova T, Chattoraj DK (2012). Replication regulation of Vibrio cholerae chromosome II involves initiator binding to the origin both as monomer and as dimer. Nucleic Acids Res  40, 6026-38.   https://doi.org/10.1093/nar/gks260|4. Kadoya R, Chattoraj DK (2012). Insensitivity of chromosome I and the cell cycle to blockage of replication and segregation of Vibrio cholerae chromosome II. MBio  3.   https://doi.org/10.1128/mBio.00067-12|5. Venkova-Canova T, Baek JH, Fitzgerald PC, Blokesch M, Chattoraj DK (2013). Evidence for two different regulatory mechanisms linking replication and segregation of vibrio cholerae chromosome II. PLoS Genet  9, e1003579.   https://doi.org/10.1371/journal.pgen.1003579|6. Venkova-Canova T, Saha A, Chattoraj DK (2012). A 29-mer site regulates transcription of the initiator gene as well as function of the replication origin of Vibrio cholerae chromosome II. Plasmid  67, 102-10.   https://doi.org/10.1016/j.plasmid.2011.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=78282
81,BC010278-16,"October 01, 2012 -  September 30, 2013",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Pinaki  Bose|Moez M Dawood|Lesley Ann Earl; PhD|Andrei Radu Florescu|Tushar  Govil|Carlos Manuel Guardia|Show all 11,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|John Henry  Scott (NIST)|Chris  Szakal (NIST)",Vincent J. Hearing; PhD (Pigment Cell Biology Section),Donald F Bliss (NLM) |Terry S Yoo; PhD (NLM),"1. Kuybeda O, Frank GA, Bartesaghi A, Borgnia M, Subramaniam S, Sapiro G (2013). A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol  181, 116-27.   https://doi.org/10.1016/j.jsb.2012.10.010|2. Narayan K, Prosa TJ, Fu J, Kelly TF, Subramaniam S (2012). Chemical mapping of mammalian cells by atom probe tomography. J Struct Biol  178, 98-107.   https://doi.org/10.1016/j.jsb.2011.12.016|3. Patwardhan A, Carazo JM, Carragher B, Henderson R, Heymann JB, Hill E, Jensen GJ, Lagerstedt I, Lawson CL, Ludtke SJ, Mastronarde D, Moore WJ, Roseman A, Rosenthal P, Sorzano CO, Sanz-García E, Scheres SH, Subramaniam S, Westbrook J, Winn M, Swedlow JR, Kleywegt GJ (2012). Data management challenges in three-dimensional EM. Nat Struct Mol Biol  19, 1203-7.   https://doi.org/10.1038/nsmb.2426",https://intramural.nih.gov/search/searchview.taf?ipid=78283
82,BC010283-16,"October 01, 2012 -  September 30, 2013",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Jacqueline H Barlow|Maria Elsa  Callen Moreu|Arnab  Ray Chaudhuri|Hua Tang  Chen|Aysegul  Ergen|Babak  Faryabi|Show all 13,NULL,NULL,NULL,"1. Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A (2013). Identification of early replicating fragile sites that contribute to genome instability. Cell  152, 620-32.   https://doi.org/10.1016/j.cell.2013.01.006|2. Bothmer A, Rommel PC, Gazumyan A, Polato F, Reczek CR, Muellenbeck MF, Schaetzlein S, Edelmann W, Chen PL, Brosh RM, Casellas R, Ludwig T, Baer R, Nussenzweig A, Nussenzweig MC, Robbiani DF (2013). Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J Exp Med  210, 115-23.   https://doi.org/10.1084/jem.20121975|3. Bowman-Colin C, Xia B, Bunting S, Klijn C, Drost R, Bouwman P, Fineman L, Chen X, Culhane AC, Cai H, Rodig SJ, Bronson RT, Jonkers J, Nussenzweig A, Kanellopoulou C, Livingston DM (2013). Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer. Proc Natl Acad Sci U S A  110, 8632-7.   https://doi.org/10.1073/pnas.1305362110|4. Bunting SF, Callén E, Kozak ML, Kim JM, Wong N, López-Contreras AJ, Ludwig T, Baer R, Faryabi RB, Malhowski A, Chen HT, Fernandez-Capetillo O, D'Andrea A, Nussenzweig A (2012). BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell  46, 125-35.   https://doi.org/10.1016/j.molcel.2012.02.015|5. Bunting SF, Nussenzweig A (2013). End-joining, translocations and cancer. Nat Rev Cancer  13, 443-54.   https://doi.org/10.1038/nrc3537|6. Callen E, Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen HT, Faryabi RB, Polato F, Santos M, Starnes LM, Wesemann DR, Lee JE, Tubbs A, Sleckman BP, Daniel JA, Ge K, Alt FW, Fernandez-Capetillo O, Nussenzweig MC, Nussenzweig A (2013). 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell  153, 1266-80.   https://doi.org/10.1016/j.cell.2013.05.023|7. Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A (2012). The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration. Immunity  37, 971-85.   https://doi.org/10.1016/j.immuni.2012.10.007|8. Daniel JA, Nussenzweig A (2012). Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination. Biochim Biophys Acta  1819, 733-8.   https://doi.org/10.1016/j.bbagrm.2012.01.019|9. Daniel JA, Nussenzweig A (2013). The AID-induced DNA damage response in chromatin. Mol Cell  50, 309-21.   https://doi.org/10.1016/j.molcel.2013.04.017|10. Daniel JA, Pellegrini M, Lee BS, Guo Z, Filsuf D, Belkina NV, You Z, Paull TT, Sleckman BP, Feigenbaum L, Nussenzweig A (2012). Loss of ATM kinase activity leads to embryonic lethality in mice. J Cell Biol  198, 295-304.   https://doi.org/10.1083/jcb.201204035|11. Di Virgilio M, Callen E, Yamane A, Zhang W, Jankovic M, Gitlin AD, Feldhahn N, Resch W, Oliveira TY, Chait BT, Nussenzweig A, Casellas R, Robbiani DF, Nussenzweig MC (2013). Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science  339, 711-5.   https://doi.org/10.1126/science.1230624|12. Feldhahn N, Ferretti E, Robbiani DF, Callen E, Deroubaix S, Selleri L, Nussenzweig A, Nussenzweig MC (2012). The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo. EMBO J  31, 4045-56.   https://doi.org/10.1038/emboj.2012.247|13. Hakim O, Resch W, Yamane A, Klein I, Kieffer-Kwon KR, Jankovic M, Oliveira T, Bothmer A, Voss TC, Ansarah-Sobrinho C, Mathe E, Liang G, Cobell J, Nakahashi H, Robbiani DF, Nussenzweig A, Hager GL, Nussenzweig MC, Casellas R (2012). DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature  484, 69-74.   https://doi.org/10.1038/nature10909|14. Lee BS, Gapud EJ, Zhang S, Dorsett Y, Bredemeyer A, George R, Callen E, Daniel JA, Osipovich O, Oltz EM, Bassing CH, Nussenzweig A, Lees-Miller S, Hammel M, Chen BP, Sleckman BP (2013). Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination. Mol Cell Biol  33, 3568-79.   https://doi.org/10.1128/MCB.00308-13|15. Muñoz MC, Laulier C, Gunn A, Cheng A, Robbiani DF, Nussenzweig A, Stark JM (2012). RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1. J Biol Chem  287, 40618-28.   https://doi.org/10.1074/jbc.M112.410951|16. Sin HS, Barski A, Zhang F, Kartashov AV, Nussenzweig A, Chen J, Andreassen PR, Namekawa SH (2012). RNF8 regulates active epigenetic modifications and escape gene activation from inactive sex chromosomes in post-meiotic spermatids. Genes Dev  26, 2737-48.   https://doi.org/10.1101/gad.202713.112|17. Yamane A, Robbiani DF, Resch W, Bothmer A, Nakahashi H, Oliveira T, Rommel PC, Brown EJ, Nussenzweig A, Nussenzweig MC, Casellas R (2013). RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. Cell Rep  3, 138-47.   https://doi.org/10.1016/j.celrep.2012.12.006",https://intramural.nih.gov/search/searchview.taf?ipid=78284
83,BC010292-16,"October 01, 2012 -  September 30, 2013",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Ventzislava Alexandrova Hristova; PhD|Jennifer B Mariano|Meredith Boyle Metzger; PhD|Daniel Kenneth Stringer|Yien-Che  Tsai|Mei  Yang; MD,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Hristova VA, Stringer DK, Weissman AM (2012). Cullin RING ligases: glommed by glomulin. Mol Cell  47, 331-2.   https://doi.org/10.1016/j.molcel.2012.07.025|2. Metzger MB, Hristova VA, Weissman AM (2012). HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci  125, 531-7.   https://doi.org/10.1242/jcs.091777|3. Metzger MB, Pruneda JN, Klevit RE, Weissman AM (2014). RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta  1843, 47-60.   https://doi.org/10.1016/j.bbamcr.2013.05.026",https://intramural.nih.gov/search/searchview.taf?ipid=78184
84,BC010297-16,"October 01, 2012 -  September 30, 2013",Identification of Gene Polymorphisms Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Harrison Lee Boyce|Victor A David|Levi Timothy Hooper|Sophie Mh Limou|Show all 8,"Sharyne  Donfield (Hemophilia Growth and Development Study, Rho, Inc.)|John P Phair|Gregory D Kirk|Jean-Francois  Zagury (Conservatoire National des Arts et MÃ©tiers)|Tara  Oleksyk (Uiversity of Puerto Rico)|Martin R Pollak (Division of Nephrology, Beth Israel Deaconess Medical Center)|Show all 10",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)|George  Nelson (Office of the Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, Lucas GM, Nelson GW, Warner AC, Winkler CA, Kopp JB (2012). HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int  82, 338-43.   https://doi.org/10.1038/ki.2012.111|2. Limou S, Delaneau O, van Manen D, An P, Sezgin E, Le Clerc S, Coulonges C, Troyer JL, Veldink JH, van den Berg LH, Spadoni JL, Taing L, Labib T, Montes M, Delfraissy JF, Schachter F, O'Brien SJ, Buchbinder S, van Natta ML, Jabs DA, Froguel P, Schuitemaker H, Winkler CA, Zagury JF (2012). Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. J Infect Dis  205, 1155-62.   https://doi.org/10.1093/infdis/jis028|3. Tang M, Lautenberger JA, Gao X, Sezgin E, Hendrickson SL, Troyer JL, David VA, Guan L, McIntosh CE, Guo X, Zheng Y, Liao J, Deng H, Malasky M, Kessing B, Winkler CA, Carrington M, Dé The G, Zeng Y, O'Brien SJ (2012). The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet  8, e1003103.   https://doi.org/10.1371/journal.pgen.1003103|4. Wester CW, Eden SK, Shepherd BE, Bussmann H, Novitsky V, Samuels DC, Hendrickson SL, Winkler CA, O'Brien SJ, Essex M, D'Aquila RT, DeGruttola V, Marlink RG (2012). Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses  28, 759-65.   https://doi.org/10.1089/AID.2011.0303|5. Zhao K, Ishida Y, Oleksyk TK, Winkler CA, Roca AL (2012). Evidence for selection at HIV host susceptibility genes in a West Central African human population. BMC Evol Biol  12, 237.   https://doi.org/10.1186/1471-2148-12-237",https://intramural.nih.gov/search/searchview.taf?ipid=78285
85,BC010298-16,"October 01, 2012 -  September 30, 2013",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera,Sandra  Kleiman (Tel Aviv University)|Daniel  Wreschner (Tel Aviv University),NULL,NULL,"1. Bera TK, Walker DA, Sherins RJ, Pastan I (2012). POTE protein, a cancer-testis antigen, is highly expressed in spermatids in human testis and is associated with apoptotic cells. Biochem Biophys Res Commun  417, 1271-4.   https://doi.org/10.1016/j.bbrc.2011.12.125|2. Liu XF, Bera TK, Kahue C, Escobar T, Fei Z, Raciti GA, Pastan I (2012). ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. PLoS One  7, e38130.   https://doi.org/10.1371/journal.pone.0038130|3. Margalit M, Yogev L, Yavetz H, Lehavi O, Hauser R, Botchan A, Barda S, Levitin F, Weiss M, Pastan I, Wreschner DH, Paz G, Kleiman SE (2012). Involvement of the prostate and testis expression (PATE)-like proteins in sperm-oocyte interaction. Hum Reprod  27, 1238-48.   https://doi.org/10.1093/humrep/des064",https://intramural.nih.gov/search/searchview.taf?ipid=78286
86,BC010300-16,"October 01, 2012 -  September 30, 2013",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Walter A Baseler; PhD|Kimberly Covington Boelte|Geraldine Martina O'Connor|Laura Ann R Quigley|Giorgio  Trinchieri,"Weiguo  Zhang (NICHHD)|Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Neil  Gow (Unversity of Aberdeen)|Show all 9",Oleg Y Chertov (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),"Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Igal  Gery; PhD (NEI) |Suk See De Ravin; MD, PhD (NIAID) |Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI)","1. Derive M, Bouazza Y, Sennoun N, Marchionni S, Quigley L, Washington V, Massin F, Max JP, Ford J, Alauzet C, Levy B, McVicar DW, Gibot S (2012). Soluble TREM-like transcript-1 regulates leukocyte activation and controls microbial sepsis. J Immunol  188, 5585-92.   https://doi.org/10.4049/jimmunol.1102674",https://intramural.nih.gov/search/searchview.taf?ipid=78287
87,BC010301-16,"October 01, 2012 -  September 30, 2013",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Barbara  Debrah|Sonya C Duke|Natasha L Kormanik|Elizabeth J Maestri|Laura M Roth|Show all 12,Arthur  Frankel (Texas A&M)|Michael  Grever (Ohio State Universithy)|Ramy A Ibrahim|Farhad  Ravandi (MD Anderson)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Jan  Burger (MD Anderson)|Show all 9,"Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Biberacher V, Decker T, Oelsner M, Wagner M, Bogner C, Schmidt B, Kreitman RJ, Peschel C, Pastan I, Meyer Zum Büschenfelde C, Ringshausen I (2012). The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion. Haematologica  97, 771-9.   https://doi.org/10.3324/haematol.2011.049155|2. Kreitman RJ (2012). Immunoconjugates and new molecular targets in hairy cell leukemia. Hematology Am Soc Hematol Educ Program  2012, 660-6.   https://doi.org/10.1182/asheducation-2012.1.660|3. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, Fitzgerald DJ, Lechleider R, Pastan I (2012). Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. J Clin Oncol  30, 1822-8.   https://doi.org/10.1200/JCO.2011.38.1756|4. Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I (2012). Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci U S A  109, 11782-7.   https://doi.org/10.1073/pnas.1209292109|5. Simone CB, Morris JC, Stewart DM, Urquhart NE, Janik JE, Kreitman RJ, Lita E, Conlon K, Wharfe G, Waldmann TA, Kaushal A (2012). Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma. Blood  120, 1816-9.   https://doi.org/10.1182/blood-2012-01-401349|6. Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ (2012). Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood  119, 3330-2.   https://doi.org/10.1182/blood-2011-09-379339",https://intramural.nih.gov/search/searchview.taf?ipid=78288
88,BC010304-15,"October 01, 2012 -  September 30, 2013",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Isha  Agarwal|Lakshmi  Balagopalan|Nathan  Coussens|Ellen  Dinerman|Geoffrey  Guittard; PhD|Robert L Kortum|Show all 15,"Carl  June (University of Pennsylvania)|Wolfgang  Losert (University of Maryland)|Jeroen  Roose (University of California, San Francisco)",Ettore  Appella; MD (Chemical Immunology Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling),"Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID)","1. Balagopalan L, Barr VA, Kortum RL, Park AK, Samelson LE (2013). Cutting edge: cell surface linker for activation of T cells is recruited to microclusters and is active in signaling. J Immunol  190, 3849-53.   https://doi.org/10.4049/jimmunol.1202760|2. Coussens NP, Hayashi R, Brown PH, Balagopalan L, Balbo A, Akpan I, Houtman JC, Barr VA, Schuck P, Appella E, Samelson LE (2013). Multipoint binding of the SLP-76 SH2 domain to ADAP is critical for oligomerization of SLP-76 signaling complexes in stimulated T cells. Mol Cell Biol  33, 4140-51.   https://doi.org/10.1128/MCB.00410-13|3. Kortum RL, Balagopalan L, Alexander CP, Garcia J, Pinski JM, Merrill RK, Nguyen PH, Li W, Agarwal I, Akpan IO, Sommers CL, Samelson LE (2013). The ability of Sos1 to oligomerize the adaptor protein LAT is separable from its guanine nucleotide exchange activity in vivo. Sci Signal  6, ra99.   https://doi.org/10.1126/scisignal.2004494|4. Kortum RL, Rouquette-Jazdanian AK, Miyaji M, Merrill RK, Markegard E, Pinski JM, Wesselink A, Nath NN, Alexander CP, Li W, Kedei N, Roose JP, Blumberg PM, Samelson LE, Sommers CL (2013). A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice. J Immunol  190, 147-58.   https://doi.org/10.4049/jimmunol.1201458|5. Kortum RL, Rouquette-Jazdanian AK, Samelson LE (2013). Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. Trends Immunol  34, 259-68.   https://doi.org/10.1016/j.it.2013.02.004|6. Kortum RL, Sommers CL, Pinski JM, Alexander CP, Merrill RK, Li W, Love PE, Samelson LE (2012). Deconstructing Ras signaling in the thymus. Mol Cell Biol  32, 2748-59.   https://doi.org/10.1128/MCB.00317-12|7. Kunii N, Zhao Y, Jiang S, Liu X, Scholler J, Balagopalan L, Samelson LE, Milone MC, June CH (2013). Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation. Hum Gene Ther  24, 27-37.   https://doi.org/10.1089/hum.2012.130|8. Lesourne R, Zvezdova E, Song KD, El-Khoury D, Uehara S, Barr VA, Samelson LE, Love PE (2012). Interchangeability of Themis1 and Themis2 in thymocyte development reveals two related proteins with conserved molecular function. J Immunol  189, 1154-61.   https://doi.org/10.4049/jimmunol.1200123|9. Rouquette-Jazdanian AK, Sommers CL, Kortum RL, Morrison DK, Samelson LE (2012). LAT-independent Erk activation via Bam32-PLC-γ1-Pak1 complexes: GTPase-independent Pak1 activation. Mol Cell  48, 298-312.   https://doi.org/10.1016/j.molcel.2012.08.011|10. Sherman E, Barr V, Samelson LE (2013). Super-resolution characterization of TCR-dependent signaling clusters. Immunol Rev  251, 21-35.   https://doi.org/10.1111/imr.12010|11. Sherman E, Barr VA, Samelson LE (2013). Resolving multi-molecular protein interactions by photoactivated localization microscopy. Methods  59, 261-9.   https://doi.org/10.1016/j.ymeth.2012.12.002|12. Sommers CL, Rouquette-Jazdanian AK, Robles AI, Kortum RL, Merrill RK, Li W, Nath N, Wohlfert E, Sixt KM, Belkaid Y, Samelson LE (2013). miRNA signature of mouse helper T cell hyper-proliferation. PLoS One  8, e66709.   https://doi.org/10.1371/journal.pone.0066709",https://intramural.nih.gov/search/searchview.taf?ipid=78289
89,BC010307-14,"October 01, 2012 -  September 30, 2013",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Balamurugan  Kuppusamy|Daniel Yazmany Mendoza Villanueva; PhD|Shikha  Sharan,Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Snehalata Anil Pawar|Fiona  Yull (Vanderbilt University),Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,"1. Balamurugan K, Sterneck E (2013) The Many Faces of CEBPdelta and their Relevance for Inflammation and Cancer. Int J Biol Sci, in press.|2. Ko CY, Chang LH, Lee YC, Sterneck E, Cheng CP, Chen SH, Huang AM, Tseng JT, Wang JM (2012). CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells. Neurobiol Aging  33, 422.e11-25.   https://doi.org/10.1016/j.neurobiolaging.2010.09.017|3. Sarkar TR, Sharan S, Wang J, Pawar SA, Cantwell CA, Johnson PF, Morrison DK, Wang JM, Sterneck E (2012). Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells. Mol Cell Biol  32, 320-32.   https://doi.org/10.1128/MCB.05790-11",https://intramural.nih.gov/search/searchview.taf?ipid=78192
90,BC010308-15,"October 01, 2012 -  September 30, 2013",In vivo Imaging Analysis of SteroidNuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Cynthia  Haggerty|Rodney Louis Schiltz; PhD|Diana  Stavreva,NULL,James  McMahon; PhD (Molecular Targets Laboratory),NULL,"1. Stavreva DA, George AA, Klausmeyer P, Varticovski L, Sack D, Voss TC, Schiltz RL, Blazer VS, Iwanowicz LR, Hager GL (2012). Prevalent glucocorticoid and androgen activity in US water sources. Sci Rep  2, 937.   https://doi.org/10.1038/srep00937",https://intramural.nih.gov/search/searchview.taf?ipid=78292
91,BC010309-15,"October 01, 2012 -  September 30, 2013",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rebecca Catherine Burgess; PhD|Bharat  Burman|Travis  Dittmer|Patricia  Fernandez Ferri; PhD|Saadia  Iftikhar; PhD|Leonard Pieter Kubben|Show all 17,Miroslav  Dundr|Angus  Lamond (Wellcome Trust)|Poulikos  Poulikakos (Mount Sinai Medical School),Stephen J Lockett; PhD (Office Of The Director),"Christopher P Austin; AB, MD (NCATS) |James  Inglese (NCATS)","1. Burgess RC, Misteli T, Oberdoerffer P (2012). DNA damage, chromatin, and transcription: the trinity of aging. Curr Opin Cell Biol  24, 724-30.   https://doi.org/10.1016/j.ceb.2012.07.005|2. Cukierski WJ, Nandy K, Gudla P, Meaburn KJ, Misteli T, Foran DJ, Lockett SJ (2012). Ranked retrieval of segmented nuclei for objective assessment of cancer gene repositioning. BMC Bioinformatics  13, 232.   https://doi.org/10.1186/1471-2105-13-232|3. Hakim O, Misteli T (2012). SnapShot: Chromosome confirmation capture. Cell  148, 1068.e1-2.   https://doi.org/10.1016/j.cell.2012.02.019|4. Kubben N, Adriaens M, Meuleman W, Voncken JW, van Steensel B, Misteli T (2012). Mapping of lamin A- and progerin-interacting genome regions. Chromosoma  121, 447-64.   https://doi.org/10.1007/s00412-012-0376-7|5. Misteli T (2012). Parallel genome universes. Nat Biotechnol  30, 55-6.   https://doi.org/10.1038/nbt.2085|6. Nandy K, Gudla PR, Amundsen R, Meaburn KJ, Misteli T, Lockett SJ (2012). Automatic segmentation and supervised learning-based selection of nuclei in cancer tissue images. Cytometry A  81, 743-54.   https://doi.org/10.1002/cyto.a.22097|7. Pegoraro G, Voss TC, Martin SE, Tuzmen P, Guha R, Misteli T (2012). Identification of mammalian protein quality control factors by high-throughput cellular imaging. PLoS One  7, e31684.   https://doi.org/10.1371/journal.pone.0031684",https://intramural.nih.gov/search/searchview.taf?ipid=78293
92,BC010313-15,"October 01, 2012 -  September 30, 2013",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Hien Thi-Thu Dang|Marshonna J Forgues|Junfang  Ji|Juling  Ji|Bahadir  Ozdemir|Show all 9,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Masao  Omata (University of Tokyo)|Show all 12,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Budhu A, Wang XW (2012). At the cancer steering wheel: defining key genomic drivers of liver cancer with next generation sequencing. J Hepatol  56, 1412-4.   https://doi.org/10.1016/j.jhep.2011.12.024|2. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, Qin LX, Yamashita T, Woo HG, Kim YJ, Kaneko S, Tang ZY, Thorgeirsson SS, Wang XW (2012). Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology  56, 1792-803.   https://doi.org/10.1002/hep.25890|3. Wang XW, Heegaard NH, Orum H (2012). MicroRNAs in liver disease. Gastroenterology  142, 1431-43.   https://doi.org/10.1053/j.gastro.2012.04.007|4. Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, Li P, Cai H, Yu L, Liu F, Hang D, Yang H, Wang XW, Ke Y, Harris CC (2013). microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer  132, 2901-9.   https://doi.org/10.1002/ijc.27954",https://intramural.nih.gov/search/searchview.taf?ipid=78295
93,BC010319-15,"October 01, 2012 -  September 30, 2013",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao|Elizabeth B Bou|Lothar  Esser|Wai-Kwan  Tang|Yumei  Xiao|Fei  Zhou,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section),NULL,"1. Su T, Esser L, Xia D, Yu CA, Yu L (2012). Generation, characterization and crystallization of a cytochrome c(1)-subunit IV fused cytochrome bc(1) complex from Rhodobacter sphaeroides. Biochim Biophys Acta  1817, 298-305.   https://doi.org/10.1016/j.bbabio.2011.10.005|2. Xia D, Esser L, Tang WK, Zhou F, Zhou Y, Yu L, Yu CA (2013). Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function. Biochim Biophys Acta  1827, 1278-94.   https://doi.org/10.1016/j.bbabio.2012.11.008",https://intramural.nih.gov/search/searchview.taf?ipid=78297
94,BC010326-14,"October 01, 2012 -  September 30, 2013","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Smita  Kakar; PhD|Vandana  Kumari; PhD|Gary X Shaw|Genbin  Shi,Honggao  Yan|Jorge  CruzReyes (Texas A&M University)|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University),Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Larry K Keefer; PhD (Chemical Biology Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Shi G, Shaw G, Li Y, Wu Y, Yan H, Ji X (2012). Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode. Bioorg Med Chem  20, 4303-9.   https://doi.org/10.1016/j.bmc.2012.05.060|2. Stagno JR, Ma B, Li J, Altieri AS, Byrd RA, Ji X (2012). Crystal structure of a plectonemic RNA supercoil. Nat Commun  3, 901.   https://doi.org/10.1038/ncomms1903|3. Zhao J, Stagno JR, Varticovski L, Nimako E, Rishi V, McKinnon K, Akee R, Shoemaker RH, Ji X, Vinson C (2012). P6981, an arylstibonic acid, is a novel low nanomolar inhibitor of cAMP response element-binding protein binding to DNA. Mol Pharmacol  82, 814-23.   https://doi.org/10.1124/mol.112.080820",https://intramural.nih.gov/search/searchview.taf?ipid=78298
95,BC010328-14,"October 01, 2012 -  September 30, 2013",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Mesfin Ademe Gonit|Christopher Jack  Huggins|Sook  Lee|Nancy C Martin|Jacqueline  Salotti; PhD|Karen Lynn Saylor|Show all 7,Robert  Smart (North Carolina State University)|Hongwei  Gao (Harvard Medical School)|Warren  Tourtellotte (Northwestern University),Alexander  Wlodawer; PhD (Protein Structure Section)|Maria  Miller (Protein Structure Section)|William Gregory Alvord (Office Of The Director)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Yan C, Wu M, Cao J, Tang H, Zhu M, Johnson PF, Gao H (2012). Critical role for CCAAT/enhancer-binding protein β in immune complex-induced acute lung injury. J Immunol  189, 1480-90.   https://doi.org/10.4049/jimmunol.1200877|2. Yan C, Zhu M, Staiger J, Johnson PF, Gao H (2012). C5a-regulated CCAAT/enhancer-binding proteins β and δ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages. J Biol Chem  287, 3217-30.   https://doi.org/10.1074/jbc.M111.280834",https://intramural.nih.gov/search/searchview.taf?ipid=78299
96,BC010329-14,"October 01, 2012 -  September 30, 2013",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Alyson Kara Freeman|Jeremy Scott Logue; PhD|Daniel A Ritt|Elizabeth Mclean Terrell,"Premkumar  Reddy (Mount Sinai School of Medicine)|Robert  Rottapel (University of Toronto)|Rebecca  Page (Brown Medical School)|John Fickes Brognard; MS|Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)|Wolfgang  Peti (Brown University)",Udayan  Guha (Medical Oncology Branch)|Peter F Johnson; PhD (Laboratory of Cancer Prevention)|Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology),NULL,"1. Koveal D, Schuh-Nuhfer N, Ritt D, Page R, Morrison DK, Peti W (2012). A CC-SAM, for coiled coil-sterile α motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane. Sci Signal  5, ra94.   https://doi.org/10.1126/scisignal.2003289|2. Logue JS, Morrison DK (2012). Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev  26, 641-50.   https://doi.org/10.1101/gad.186965.112|3. Morrison DK (2012). MAP kinase pathways. Cold Spring Harb Perspect Biol  4.   https://doi.org/10.1101/cshperspect.a011254|4. Rouquette-Jazdanian AK, Sommers CL, Kortum RL, Morrison DK, Samelson LE (2012). LAT-independent Erk activation via Bam32-PLC-γ1-Pak1 complexes: GTPase-independent Pak1 activation. Mol Cell  48, 298-312.   https://doi.org/10.1016/j.molcel.2012.08.011",https://intramural.nih.gov/search/searchview.taf?ipid=78300
97,BC010331-14,"October 01, 2012 -  September 30, 2013",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Kunduri  Govind; PhD|Katherine M Nyswaner,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78301
98,BC010333-14,"October 01, 2012 -  September 30, 2013",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI",NULL,"Flemming  Hansen (BioCentrum, Technical University of Denmank)|Alba  Guarne; PhD|Suckjoon  Jun (Harvard University)",Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78302
99,BC010334-14,"October 01, 2012 -  September 30, 2013",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Rachel Elizabeth Kelly Beach|Jenifer L Bear|Natalie Susan Coleman|Guy Robert Pilkington|Cristina  Bergamaschi|George N Pavlakis; MD, PhD",NULL,"Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Bergamaschi C, Bear J, Rosati M, Beach RK, Alicea C, Sowder R, Chertova E, Rosenberg SA, Felber BK, Pavlakis GN (2012). Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood  120, e1-8.   https://doi.org/10.1182/blood-2011-10-384362|2. Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, Felber BK (2012). Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol  86, 13089-94.   https://doi.org/10.1128/JVI.00606-12",https://intramural.nih.gov/search/searchview.taf?ipid=78303
100,BC010336-14,"October 01, 2012 -  September 30, 2013",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Nina C Costantino|Marina  Hoashi|Xintian  Li|Michelle  Miron|James A Sawitzke|Lynn C Thomason|Show all 8,"David  Friedman (University of Michigan School of Medicine)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|JeanHerve  Alix (CNRS at University of Paris)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Sankar  Adhya; PhD (Developmental Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Stuart J Austin (Cell Cycle Regulation Section),Michael B Strader; PhD (OD),"1. Feiss M, Court D (2012) #955;-like phages - Siphoviridae, in The Springer Index of viruses. Tidona C, Darai G, eds., pp. 1781-1790.|2. Bubunenko M, Court DL, Al Refaii A, Saxena S, Korepanov A, Friedman DI, Gottesman ME, Alix JH (2013). Nus transcription elongation factors and RNase III modulate small ribosome subunit biogenesis in Escherichia coli. Mol Microbiol  87, 382-93.   https://doi.org/10.1111/mmi.12105|3. Court D, Gan j, Liang Y, Shaw G, Tropea J, Costantino N, Waugh D, Ji X (2013) RNASE III: GENETICS AND FUNCTION; STRUCTURE AND MECHANISM. Annual Review of Genetics, in press.|4. Sawitzke JA, Youngren B, Thomason LC, Baker T, Sengupta M, Court D, Austin S (2012). The segregation of Escherichia coli minichromosomes constructed in vivo by recombineering. Plasmid  67, 148-54.   https://doi.org/10.1016/j.plasmid.2012.01.002",https://intramural.nih.gov/search/searchview.taf?ipid=78304
101,BC010338-14,"October 01, 2012 -  September 30, 2013",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Naiche L Adler|Matthew J Anderson|Cynthia M Elder|Irene Hwang Hung|Maria  Kaltcheva,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)|Thomas  Schimmang (University of Valladolid)|Gary C Schoenwolf",Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),NULL,"1. Williams M, Burdsal C, Periasamy A, Lewandoski M, Sutherland A (2012). Mouse primitive streak forms in situ by initiation of epithelial to mesenchymal transition without migration of a cell population. Dev Dyn  241, 270-83.   https://doi.org/10.1002/dvdy.23711",https://intramural.nih.gov/search/searchview.taf?ipid=78305
102,BC010341-14,"October 01, 2012 -  September 30, 2013",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Brian P Austin|Shawn Michael Hess|Danielle  Needle|Sreejith  Raran Kurussi; PhD,Jozsef  Tozser|James  Williams (Nature Technology Corp.),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78306
103,BC010342-14,"October 01, 2012 -  September 30, 2013",Structural Proteomics of the Yersinia Yop Virulon,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Brian P Austin|Shawn Michael Hess|George T Lountos|Danielle  Needle|Sreejith  Raran Kurussi; PhD,"Gregory  Plano; PhD (Microbiology and Immunology, University of Miami School of Medicine)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Alexander  Wlodawer; PhD (Protein Structure Section),NULL,"1. Hogan M, Bahta M, Cherry S, Lountos GT, Tropea JE, Zhao BM, Burke TR, Waugh DS, Ulrich RG (2013). Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase. Chem Biol Drug Des  81, 323-33.   https://doi.org/10.1111/cbdd.12097|2. Lountos GT, Tropea JE, Waugh DS (2012). Structure of the cytoplasmic domain of Yersinia pestis YscD, an essential component of the type III secretion system. Acta Crystallogr D Biol Crystallogr  68, 201-9.   https://doi.org/10.1107/S0907444911054308",https://intramural.nih.gov/search/searchview.taf?ipid=78307
104,BC010345-14,"October 01, 2012 -  September 30, 2013",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Lauren Cynthia Canizales|Ravindra Babu  Chalamalasetty|Robert John Garriock|Mark William Lorne Kennedy; PhD|Sara E Parkin,NULL,NULL,Benjamin  Feldman; PhD (NICHD),"1. Miyoshi H, Ajima R, Luo CT, Yamaguchi TP, Stappenbeck TS (2012). Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science  338, 108-13.   https://doi.org/10.1126/science.1223821|2. Tsukiyama T, Yamaguchi TP (2012). Mice lacking Wnt2b are viable and display a postnatal olfactory bulb phenotype. Neurosci Lett  512, 48-52.   https://doi.org/10.1016/j.neulet.2012.01.062",https://intramural.nih.gov/search/searchview.taf?ipid=78308
105,BC010348-14,"October 01, 2012 -  September 30, 2013",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Protein Structure Section, NCI",Jamaine S Davis|Alla E Gustchina|Maria  Miller|Di  Zhang|Dongwen  Zhou,"Ben  Dunn (Biochem. & Mol. Biol., University of Florida)|Kohei  Oda (Dept. Applied Biology, Kyoto Inst. of Technology)|Mariusz  Jaskolski (Adam Mickiewicz University)|Yoshiaki  Kiso (Kyoto Pharmaceutical University)|David  Baker (University of Washington)",Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Acchione M, Lee YC, DeSantis ME, Lipschultz CA, Wlodawer A, Li M, Shanmuganathan A, Walter RL, Smith-Gill S, Barchi JJ (2012). Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics. Biochemistry  51, 6017-27.   https://doi.org/10.1021/bi300455t|2. Matúz K, Mótyán J, Li M, Wlodawer A, Tőzsér J (2012). Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin. FEBS J  279, 3276-86.   https://doi.org/10.1111/j.1742-4658.2012.08714.x|3. Oeemig JS, Zhou D, Kajander T, Wlodawer A, Iwaï H (2012). NMR and crystal structures of the Pyrococcus horikoshii RadA intein guide a strategy for engineering a highly efficient and promiscuous intein. J Mol Biol  421, 85-99.   https://doi.org/10.1016/j.jmb.2012.04.029|4. Pletnev S, Pletneva NV, Souslova EA, Chudakov DM, Lukyanov S, Wlodawer A, Dauter Z, Pletnev V (2012). Structural basis for bathochromic shift of fluorescence in far-red fluorescent proteins eqFP650 and eqFP670. Acta Crystallogr D Biol Crystallogr  68, 1088-97.   https://doi.org/10.1107/S0907444912020598|5. Pletnev S, Subach FV, Dauter Z, Wlodawer A, Verkhusha VV (2012). A structural basis for reversible photoswitching of absorbance spectra in red fluorescent protein rsTagRFP. J Mol Biol  417, 144-51.   https://doi.org/10.1016/j.jmb.2012.01.044|6. Zhou D, Chung S, Miller M, Grice SF, Wlodawer A (2012). Crystal structures of the reverse transcriptase-associated ribonuclease H domain of xenotropic murine leukemia-virus related virus. J Struct Biol  177, 638-45.   https://doi.org/10.1016/j.jsb.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=78310
106,BC010350-14,"October 01, 2012 -  September 30, 2013",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Candido  Alicea; PhD|Rachel Elizabeth Kelly Beach|Jenifer L Bear|Cristina  Bergamaschi|Xintao  Hu|Viraj M Kulkarni|Show all 10,"Ruth  Ruprecht (Dana-Farber Cancer Institute)|David  Weiner (University of Pennsylvania)|Amitinder  Kaur (New England Primate Research Center)|Koen  Van Rompay (California National Primate Research Center)|Bette  Korber; PhD (Los Alamos National Laboratory)|James  Mullins; PhD (Microbiology, University of Washington)|Show all 9",NULL,NULL,"1. Bergamaschi C, Bear J, Rosati M, Beach RK, Alicea C, Sowder R, Chertova E, Rosenberg SA, Felber BK, Pavlakis GN (2012). Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood  120, e1-8.   https://doi.org/10.1182/blood-2011-10-384362|2. Chertova E, Bergamaschi C, Chertov O, Sowder R, Bear J, Roser JD, Beach RK, Lifson JD, Felber BK, Pavlakis GN (2013). Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer. J Biol Chem  288, 18093-103.   https://doi.org/10.1074/jbc.M113.461756|3. Jalah R, Patel V, Kulkarni V, Rosati M, Alicea C, Ganneru B, von Gegerfelt A, Huang W, Guan Y, Broderick KE, Sardesai NY, LaBranche C, Montefiori DC, Pavlakis GN, Felber BK (2012). IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Hum Vaccin Immunother  8, 1620-9.   https://doi.org/10.4161/hv.21407|4. Jalah R, Rosati M, Ganneru B, Pilkington GR, Valentin A, Kulkarni V, Bergamaschi C, Chowdhury B, Zhang GM, Beach RK, Alicea C, Broderick KE, Sardesai NY, Pavlakis GN, Felber BK (2013). The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem  288, 6763-76.   https://doi.org/10.1074/jbc.M112.436675|5. Lai L, Kwa SF, Kozlowski PA, Montefiori DC, Nolen TL, Hudgens MG, Johnson WE, Ferrari G, Hirsch VM, Felber BK, Pavlakis GN, Earl PL, Moss B, Amara RR, Robinson HL (2012). SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine  30, 1737-45.   https://doi.org/10.1016/j.vaccine.2011.12.026|6. Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, Walker BD, Weiner D, Paredes R, Clotet B, Felber BK, Pavlakis GN, Mullins JI, Brander C (2012). CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One  7, e29717.   https://doi.org/10.1371/journal.pone.0029717|7. Pavlakis GN, Felber BN, Mullins JN (submitted in 2012) Method Of Altering The Immunodominance Hierarchy Of Hiv Gag By Dna Vaccine Expressing Conserved Regions. Patent issued: 9,415,099 (US in 2016). Patents pending: 15/235,430 (US application); 13710247.1 (EP application); PCT/US2013/028932 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=78311
107,BC010378-14,"October 01, 2012 -  September 30, 2013",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Miroslawa  Dauter|Dorothee Claudia Liebschner|Zhipu  Luo|Sergei V Pletnev,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Alexander  Wlodawer; PhD (Protein Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78312
108,BC010379-14,"October 01, 2012 -  September 30, 2013",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI","Xianyang  Fang|Yu  Liu|Jinbu  Wang|Ping  Yu; MD, PhD",NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),Adrian Riu Ferre-D'Amare (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78313
109,BC010380-14,"October 01, 2012 -  September 30, 2013",Recombination and Regulation,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",Deanna R Gotte|Alison J Rattray|Brenda K Shafer|Hui  Yang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78314
110,BC010381-14,"October 01, 2012 -  September 30, 2013",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78315
111,BC010385-14,"October 01, 2012 -  September 30, 2013",Studies on mat1 imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78316
112,BC010387-14,"October 01, 2012 -  September 30, 2013",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Kajal  Biswas|Xia  Ding|Suzanne A Hartford|Betty K Martin|Thirthagiri  Eswary,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, Burkett SS, Martin BK, Southon E, Sizemore SC, Pruss D, Bowles KR, Roa BB, Hunter N, Tessarollo L, Wenstrup RJ, Byrd RA, Sharan SK (2012). Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet  21, 3993-4006.   https://doi.org/10.1093/hmg/dds222|2. Chang S, Sharan SK (2012). Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1. Oncotarget  3, 5-6.   https://doi.org/10.18632/oncotarget.433",https://intramural.nih.gov/search/searchview.taf?ipid=78317
113,BC010390-14,"October 01, 2012 -  September 30, 2013",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Erkan  Kiris|Mary Ellen  Palko|Francesco  Tomassoni Ardori; PhD|Show all 8,"Susan  Dorsey (University of Maryland)|Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)",NULL,NULL,"1. Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW (2013). ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A  110, E736-45.   https://doi.org/10.1073/pnas.1222809110|2. Di Lieto A, Rantamäki T, Vesa L, Yanpallewar S, Antila H, Lindholm J, Rios M, Tessarollo L, Castrén E (2012). The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development. PLoS One  7, e32869.   https://doi.org/10.1371/journal.pone.0032869|3. Liu Y, Rutlin M, Huang S, Barrick CA, Wang F, Jones KR, Tessarollo L, Ginty DD (2012). Sexually dimorphic BDNF signaling directs sensory innervation of the mammary gland. Science  338, 1357-60.   https://doi.org/10.1126/science.1228258|4. Waldron-Roby E, Ratovitski T, Wang X, Jiang M, Watkin E, Arbez N, Graham RK, Hayden MR, Hou Z, Mori S, Swing D, Pletnikov M, Duan W, Tessarollo L, Ross CA (2012). Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci  32, 183-93.   https://doi.org/10.1523/JNEUROSCI.1305-11.2012|5. Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L (2012). Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One  7, e39946.   https://doi.org/10.1371/journal.pone.0039946|6. Yanpallewar SU, Barrick CA, Palko ME, Fulgenzi G, Tessarollo L (2012). Tamalin is a critical mediator of electroconvulsive shock-induced adult neuroplasticity. J Neurosci  32, 2252-62.   https://doi.org/10.1523/JNEUROSCI.5493-11.2012",https://intramural.nih.gov/search/searchview.taf?ipid=78318
114,BC010391-14,"October 01, 2012 -  September 30, 2013",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Gianluca  Fulgenzi|Erkan  Kiris|Mary Ellen  Palko|Sandrine Solange Marie Puverel; PhD|Francesco  Tomassoni Ardori; PhD,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)",NULL,"1. Liu Y, Rutlin M, Huang S, Barrick CA, Wang F, Jones KR, Tessarollo L, Ginty DD (2012). Sexually dimorphic BDNF signaling directs sensory innervation of the mammary gland. Science  338, 1357-60.   https://doi.org/10.1126/science.1228258|2. Siao CJ, Lorentz CU, Kermani P, Marinic T, Carter J, McGrath K, Padow VA, Mark W, Falcone DJ, Cohen-Gould L, Parrish DC, Habecker BA, Nykjaer A, Ellenson LH, Tessarollo L, Hempstead BL (2012). ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. J Exp Med  209, 2291-305.   https://doi.org/10.1084/jem.20111749",https://intramural.nih.gov/search/searchview.taf?ipid=78319
115,BC010411-14,"October 01, 2012 -  September 30, 2013",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Amy Louise Conner|Haiqing  Fu|Catherine J Redmond|Chiimei (Cindy) L Tseng|Koichi  Utani|Ya  Zhang|Show all 7,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Elsa  Bronze Da Rocha (University Do Porto)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Aladjem MI (2012). Rif1 choreographs DNA replication timing. EMBO J  31, 3650-2.   https://doi.org/10.1038/emboj.2012.238|2. Conner AL, Aladjem MI (2012). The chromatin backdrop of DNA replication: lessons from genetics and genome-scale analyses. Biochim Biophys Acta  1819, 794-801.   https://doi.org/10.1016/j.bbagrm.2012.01.017|3. Fu H, Maunakea AK, Martin MM, Huang L, Zhang Y, Ryan M, Kim R, Lin CM, Zhao K, Aladjem MI (2013). Methylation of histone H3 on lysine 79 associates with a group of replication origins and helps limit DNA replication once per cell cycle. PLoS Genet  9, e1003542.   https://doi.org/10.1371/journal.pgen.1003542|4. Kouprina N, Samoshkin A, Erliandri I, Fu H, Aladjem M, Earnshaw W, Larionov V (2012) Organization of Synthetic Alphoid DNA Array in Human Artificial Chromosome (HAC) with a Conditional Centromere. ACS Synth Biol 1:590â601|5. Kouprina N, Samoshkin A, Erliandri I, Nakano M, Lee HS, Fu H, Iida Y, Aladjem M, Oshimura M, Masumoto H, Earnshaw WC, Larionov V (2012). Organization of synthetic alphoid DNA array in human artificial chromosome (HAC) with a conditional centromere. ACS Synth Biol  1, 590-601.   https://doi.org/10.1021/sb3000436|6. Lee KY, Fu H, Aladjem MI, Myung K (2013). ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin. J Cell Biol  200, 31-44.   https://doi.org/10.1083/jcb.201206084",https://intramural.nih.gov/search/searchview.taf?ipid=78320
116,BC010412-14,"October 01, 2012 -  September 30, 2013",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Alan Anthony Merk|Sriram  Subramaniam; PhD,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,"1. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S (2012). Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog  8, e1002797.   https://doi.org/10.1371/journal.ppat.1002797",https://intramural.nih.gov/search/searchview.taf?ipid=78321
117,BC010413-13,"October 01, 2012 -  September 30, 2013",Study of hereditary prostate cancer and human artificial chromosomes,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Indri  Erliandri|Jung-Hyun  Kim|Artem Vadimovich  Kononenko|Natalay  Kouprina|Nicholas Cheng Ooi Lee; PhD|Hee-Sheung  Lee|Show all 8,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Johanna  Schleutker (Institute of Medical Technology)|Hiroshi  Masumoto (NCI)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78193
118,BC010418-14,"October 01, 2012 -  September 30, 2013",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sonia Tara Ammu|Satarupa  Das|Paul W Kriebel|Wolfgang  Losert; PhD|Weiye  Wang|Chenlu  Wang,NULL,NULL,Alan Robert Kimmel; PhD (NIDDK) |Tian  Jin; PhD (NIAID),"1. Driscoll MK, McCann C, Kopace R, Homan T, Fourkas JT, Parent C, Losert W (2012). Cell shape dynamics: from waves to migration. PLoS Comput Biol  8, e1002392.   https://doi.org/10.1371/journal.pcbi.1002392",https://intramural.nih.gov/search/searchview.taf?ipid=78322
119,BC010419-14,"October 01, 2012 -  September 30, 2013",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Mary E Heller|Yi  Tang|Liuya  Tang|Veenu  Tripathi; PhD|Xuan  Xu,NULL,Ming  Zhou (Nucleic Acids Section)|Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),"Sushil Gopal Rane; MS, PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78323
120,BC010425-14,"October 01, 2012 -  September 30, 2013",Strategies for Therapeutic Cancer Vaccine Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Benedetto Paolo Farsaci; PhD|Romaine Ingrid Fernando|Italia  Grenga|Diane J Poole|Kwong Yok Tsang|Show all 9,"Philip  Kantoff (Dana-Farber Cancer Institute)|David  Apelian (GlobeImmune, Inc.)|James  Breitmeyer (BN ImmunoTherapeutics)","William Laurence Dahut; MD (Medical Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors, in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation. Lattime E, Gerson SL, eds., in press.|3. Bot A, Ahn M, Bosch M, Brockstedt D, Butterfield LH, Cornforth A, Harrop R, Kast WM, Koya R, Marincola F, Margolin K, McCoy C, Pawelec G, Rothman J, Ramirez-Montagut T, Schlom J, Srivastava P, Wallis S, Walter S, Wang E, Waslif J (2012). A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies. J Transl Med  10, 218.   https://doi.org/10.1186/1479-5876-10-218|4. Gulley JL, Leitman SF, Dahut W, Schlom J (2012). Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J Natl Cancer Inst  104, 1106; author reply 1109-12.   https://doi.org/10.1093/jnci/djs280|5. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|6. Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL (2012). Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol  39, 296-304.   https://doi.org/10.1053/j.seminoncol.2012.02.010|7. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2|8. Schlom J (2012). Recent advances in therapeutic cancer vaccines. Cancer Biother Radiopharm  27, 2-5.   https://doi.org/10.1089/cbr.2012.1200|9. Schlom J (2012). Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst  104, 599-613.   https://doi.org/10.1093/jnci/djs033|10. Schlom J, Hodge JW (2012). Introduction: Therapeutic cancer vaccines. Semin Oncol  39, 243-4.   https://doi.org/10.1053/j.seminoncol.2012.02.009",https://intramural.nih.gov/search/searchview.taf?ipid=78324
121,BC010440-12,"October 01, 2012 -  September 30, 2013","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Hyunbum  Jang|Buyong  Ma|Chung  Tsai|Robert  Blumenthal; PhD,"Carlos  Aleman (Engineering, Univ. Barcelona)|Turkan  Haliloglu|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Ratnesh  Lal (Medical School, University of Chicago)|David  Zanuy (Institute Polytechnical)|Bruce  Kagan (UCLA)|Show all 18",NULL,NULL,"1. Capone R, Jang H, Kotler SA, Connelly L, Teran Arce F, Ramachandran S, Kagan BL, Nussinov R, Lal R (2012). All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers. J Chem Theory Comput  8, 1143-1152.   https://doi.org/10.1021/ct200885r|2. Capone R, Jang H, Kotler SA, Kagan BL, Nussinov R, Lal R (2012). Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions. Biochemistry  51, 776-85.   https://doi.org/10.1021/bi2017427|3. Connelly L, Jang H, Arce FT, Capone R, Kotler SA, Ramachandran S, Kagan BL, Nussinov R, Lal R (2012). Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology. J Phys Chem B  116, 1728-35.   https://doi.org/10.1021/jp2108126|4. Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R (2013). Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther  138, 333-408.   https://doi.org/10.1016/j.pharmthera.2013.01.016|5. Liu J, Nussinov R (2013). The role of allostery in the ubiquitin-proteasome system. Crit Rev Biochem Mol Biol  48, 89-97.   https://doi.org/10.3109/10409238.2012.742856|6. Ma B, Nussinov R (2012). Selective molecular recognition in amyloid growth and transmission and cross-species barriers. J Mol Biol  421, 172-84.   https://doi.org/10.1016/j.jmb.2011.11.023|7. Miller Y, Ma B, Nussinov R (2012) Metal binding sites in amyloid oligomers: Complexes and mechanisms. Coordination Chemistry Reviews 254 (19-20):2245-52|8. Nussinov R (2012). Allosteric modulators can restore function in an amino acid neurotransmitter receptor by slightly altering intra-molecular communication pathways. Br J Pharmacol  165, 2110-2.   https://doi.org/10.1111/j.1476-5381.2011.01793.x|9. Nussinov R, Ma B (2012). Protein dynamics and conformational selection in bidirectional signal transduction. BMC Biol  10, 2.   https://doi.org/10.1186/1741-7007-10-2|10. Siddiqua A, Luo Y, Meyer V, Swanson MA, Yu X, Wei G, Zheng J, Eaton GR, Ma B, Nussinov R, Eaton SS, Margittai M (2012). Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau. J Am Chem Soc  134, 10271-8.   https://doi.org/10.1021/ja303498q|11. Yu X, Luo Y, Dinkel P, Zheng J, Wei G, Margittai M, Nussinov R, Ma B (2012). Cross-seeding and conformational selection between three- and four-repeat human Tau proteins. J Biol Chem  287, 14950-9.   https://doi.org/10.1074/jbc.M112.340794|12. Zhao J, Luo Y, Jang H, Yu X, Wei G, Nussinov R, Zheng J (2012). Probing ion channel activity of human islet amyloid polypeptide (amylin). Biochim Biophys Acta  1818, 3121-30.   https://doi.org/10.1016/j.bbamem.2012.08.012",https://intramural.nih.gov/search/searchview.taf?ipid=78290
122,BC010441-12,"October 01, 2012 -  September 30, 2013",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Ozlem Z Keskin|Jin  Liu|Buyong  Ma|Ruxi  Qi|Chung  Tsai|David  Zanuy Gomara,"Carlos  Aleman (Engineering, Univ. Barcelona)|Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Carlos  Cativiela (Chemistry, Univ. Zaragoza)|Haim  Wolfson (Tel Aviv Univ)|Show all 12",NULL,NULL,"1. Acuner Ozbabacan SE, Keskin O, Nussinov R, Gursoy A (2012). Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes. J Struct Biol  179, 338-46.   https://doi.org/10.1016/j.jsb.2012.02.002|2. Engin HB, Keskin O, Nussinov R, Gursoy A (2012). A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model  52, 2273-86.   https://doi.org/10.1021/ci300072q|3. Huang Q, Yu L, Levine AJ, Nussinov R, Ma B (2014). Dipeptide analysis of p53 mutations and evolution of p53 family proteins. Biochim Biophys Acta  1844, 198-206.   https://doi.org/10.1016/j.bbapap.2013.04.002|4. Kar G, Keskin O, Nussinov R, Gursoy A (2012). Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. J Proteome Res  11, 1196-207.   https://doi.org/10.1021/pr2009143|5. Korkmaz EN, Nussinov R, Haliloğlu T (2012). Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB. PLoS Comput Biol  8, e1002420.   https://doi.org/10.1371/journal.pcbi.1002420|6. Liu J, Nussinov R (2013). The role of allostery in the ubiquitin-proteasome system. Crit Rev Biochem Mol Biol  48, 89-97.   https://doi.org/10.3109/10409238.2012.742856|7. Nussinov R (2012). Allosteric modulators can restore function in an amino acid neurotransmitter receptor by slightly altering intra-molecular communication pathways. Br J Pharmacol  165, 2110-2.   https://doi.org/10.1111/j.1476-5381.2011.01793.x|8. Nussinov R, Ma B (2012). Protein dynamics and conformational selection in bidirectional signal transduction. BMC Biol  10, 2.   https://doi.org/10.1186/1741-7007-10-2|9. Xu Y, Ma B, Nussinov R (2012). Structural and functional consequences of phosphate-arsenate substitutions in selected nucleotides: DNA, RNA, and ATP. J Phys Chem B  116, 4801-11.   https://doi.org/10.1021/jp300307u|10. Xu Y, Wang H, Nussinov R, Ma B (2013). Protein charge and mass contribute to the spatio-temporal dynamics of protein-protein interactions in a minimal proteome. Proteomics  13, 1339-51.   https://doi.org/10.1002/pmic.201100540|11. Zanuy D, Kotla R, Nussinov R, Teesalu T, Sugahara KN, Alemán C, Haspel N (2013). Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. J Struct Biol  182, 78-86.   https://doi.org/10.1016/j.jsb.2013.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=78291
123,BC010442-12,"October 01, 2012 -  September 30, 2013",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Ozlem Z Keskin|Buyong  Ma|Chung  Tsai,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)",NULL,NULL,"1. Engin HB, Keskin O, Nussinov R, Gursoy A (2012). A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model  52, 2273-86.   https://doi.org/10.1021/ci300072q|2. Xu Y, Ma B, Nussinov R (2012). Structural and functional consequences of phosphate-arsenate substitutions in selected nucleotides: DNA, RNA, and ATP. J Phys Chem B  116, 4801-11.   https://doi.org/10.1021/jp300307u",https://intramural.nih.gov/search/searchview.taf?ipid=78294
124,BC010446-12,"October 01, 2012 -  September 30, 2013",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jinguo  Cao|Yingzi  Huang|Natalia  Wesolowska|Yi  Zhang|Liang  Zhang,NULL,NULL,NULL,"1. Beaucher M, Zheng XF, Amariei F, Rong YS (2012). Multiple pathways suppress telomere addition to DNA breaks in the Drosophila germline. Genetics  191, 407-17.   https://doi.org/10.1534/genetics.112.138818|2. Kane DP, Shusterman M, Rong Y, McVey M (2012). Competition between replicative and translesion polymerases during homologous recombination repair in Drosophila. PLoS Genet  8, e1002659.   https://doi.org/10.1371/journal.pgen.1002659|3. Morciano P, Zhang Y, Cenci G, Rong YS (2013). A hypomorphic mutation reveals a stringent requirement for the ATM checkpoint protein in telomere protection during early cell division in Drosophila. G3 (Bethesda)  3, 1043-8.   https://doi.org/10.1534/g3.113.006312|4. Wesolowska N, Amariei FL, Rong YS (2013). Clustering and protein dynamics of Drosophila melanogaster telomeres. Genetics  195, 381-91.   https://doi.org/10.1534/genetics.113.155408|5. Wesolowska N, Rong YS (2013). Long-range targeted manipulation of the Drosophila genome by site-specific integration and recombinational resolution. Genetics  193, 411-9.   https://doi.org/10.1534/genetics.112.145631|6. Yamanaka S, Mehta S, Reyes-Turcu FE, Zhuang F, Fuchs RT, Rong Y, Robb GB, Grewal SI (2013). RNAi triggered by specialized machinery silences developmental genes and retrotransposons. Nature  493, 557-60.   https://doi.org/10.1038/nature11716|7. Yu Z, Ren M, Wang Z, Zhang B, Rong YS, Jiao R, Gao G (2013). Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics  195, 289-91.   https://doi.org/10.1534/genetics.113.153825|8. Zhang L, Rong YS (2012). Retrotransposons at Drosophila telomeres: host domestication of a selfish element for the maintenance of genome integrity. Biochim Biophys Acta  1819, 771-5.   https://doi.org/10.1016/j.bbagrm.2012.01.018",https://intramural.nih.gov/search/searchview.taf?ipid=78296
125,BC010448-12,"October 01, 2012 -  September 30, 2013",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kathleen L Decicco|Monika  Deshpande|Zhihong  Shan|Robert Mark Simpson; DVM, PhD",NULL,NULL,NULL,"1. Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest JS (2013). TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One  8, e66114.   https://doi.org/10.1371/journal.pone.0066114",https://intramural.nih.gov/search/searchview.taf?ipid=78325
126,BC010449-12,"October 01, 2012 -  September 30, 2013",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yan  Cai|Miyuki  Murata|Shigetoshi  Yokoyama|Mitsuhiro  Yoneda,NULL,NULL,"Jerrold M Ward; DVM, PhD (NIAID)","1. Cai Y, Kimura S (2013) Non-invasive intratracheal intubation to study the pathology and physiology of mouse lung. J Vis Exp In Press|2. Guha A, Vasconcelos M, Cai Y, Yoneda M, Hinds A, Qian J, Li G, Dickel L, Johnson JE, Kimura S, Guo J, McMahon J, McMahon AP, Cardoso WV (2012). Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airways. Proc Natl Acad Sci U S A  109, 12592-7.   https://doi.org/10.1073/pnas.1204710109",https://intramural.nih.gov/search/searchview.taf?ipid=78326
127,BC010451-12,"October 01, 2012 -  September 30, 2013",Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Souvik  Biswas|Loren Joy Kozar|Jeffrey  Gildersleeve,kate  RittenhouseOlson (University of Buffalo)|Lugang  Yu (University of Liverpool),Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Briñas RP, Maetani M, Barchi JJ (2013). A survey of place-exchange reaction for the preparation of water-soluble gold nanoparticles. J Colloid Interface Sci  392, 415-421.   https://doi.org/10.1016/j.jcis.2012.06.042|2. Brinãs RP, Sundgren A, Sahoo P, Morey S, Rittenhouse-Olson K, Wilding GE, Deng W, Barchi JJ (2012). Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines. Bioconjug Chem  23, 1513-23.   https://doi.org/10.1021/bc200606s|3. Jayasekara PS, Phan K, Tosh DK, Kumar TS, Moss SM, Zhang G, Barchi JJ, Gao ZG, Jacobson KA (2013). Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles. Purinergic Signal  9, 183-98.   https://doi.org/10.1007/s11302-012-9338-z|4. Luo M, Velikovsky CA, Yang X, Siddiqui MA, Hong X, Barchi JJ, Gildersleeve JC, Pancer Z, Mariuzza RA (2013). Recognition of the Thomsen-Friedenreich pancarcinoma carbohydrate antigen by a lamprey variable lymphocyte receptor. J Biol Chem  288, 23597-606.   https://doi.org/10.1074/jbc.M113.480467",https://intramural.nih.gov/search/searchview.taf?ipid=78413
128,BC010453-12,"October 01, 2012 -  September 30, 2013",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Elena Valerie Fernandez|Douglas K Price|Kelie M Reece; PhD|Shandiz  Shahbazi|William Laurence Dahut; MD|Show all 8,Romano  Danesi|Alan  Kristal (Fred Hutchinson Cancer Research Center)|Robin  Leach (UT Health Science Center San Antonio)|Jeanny  AragonChing (George Washington University)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Show all 15,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Ann  Hsing; PhD (Infection & Immunoepidemiology Branch)|Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)",NULL,"1. Campbell TJ, Tindall DJ, Figg WD (2012). Dihydrotestosterone synthesis from adrenal precursors does not involve testosterone in castration-resistant prostate cancer. Cancer Biol Ther  13, 237-8.   https://doi.org/10.4161/cbt.19608|2. Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman SM, Hsing AW (2012). Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev  21, 1823-32.   https://doi.org/10.1158/1055-9965.EPI-12-0695|3. Troutman SM, Sissung TM, Cropp CD, Venzon DJ, Spencer SD, Adesunloye BA, Huang X, Karzai FH, Price DK, Figg WD (2012). Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis. Oncologist  17, 312-20.   https://doi.org/10.1634/theoncologist.2011-0315",https://intramural.nih.gov/search/searchview.taf?ipid=78328
129,BC010476-11,"October 01, 2012 -  September 30, 2013",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Janusz W Koscielniak|Shingo  Matsumoto|Masayuki  Matsuo|Peter  Riesz; PhD|Keita  Saito|Show all 8,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Calvin A Johnson; PhD (CIT) |Anthony R Fletcher; PhD (CIT) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78342
130,BC010477-11,"October 01, 2012 -  September 30, 2013",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Nallathamby  Devasahayam|Shingo  Matsumoto|Masayuki  Matsuo|Keita  Saito|Sankaran  Subramanian; MD|James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Jang H, Subramanian S, Devasahayam N, Saito K, Matsumoto S, Krishna MC, McMillan AB (2013). Single acquisition quantitative single-point electron paramagnetic resonance imaging. Magn Reson Med  70, 1173-81.   https://doi.org/10.1002/mrm.24886",https://intramural.nih.gov/search/searchview.taf?ipid=78340
131,BC010481-11,"October 01, 2012 -  September 30, 2013",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Patrick K Clark|Carolyn Ana Crisp|Linda L Dunn|Andrea L Ferris|Barry  Johnson|Show all 7,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Dwight V Nissley (Office Of The Director)|Gary T Pauly (Chemical Biology Laboratory)|Jeffrey N Strathern (Genome Recombination and Regulation Section)|William Gregory Alvord (Office Of The Director)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics),Craig Joseph Thomas (NCATS),"1. Boyer PL, Clark PK, Hughes SH (2012). HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors. J Virol  86, 5885-94.   https://doi.org/10.1128/JVI.06597-11|2. Chung S, Miller JT, Johnson BC, Hughes SH, Le Grice SF (2012). Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J Biol Chem  287, 4066-75.   https://doi.org/10.1074/jbc.M111.314781|3. Elleder D, Baiga TJ, Russell RL, Naughton JA, Hughes SH, Noel JP, Young JA (2012). Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase. Virol J  9, 305.   https://doi.org/10.1186/1743-422X-9-305|4. Hu WS, Hughes SH (2012). HIV-1 reverse transcription. Cold Spring Harb Perspect Med  2.   https://doi.org/10.1101/cshperspect.a006882|5. Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH (2012). A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology  9, 99.   https://doi.org/10.1186/1742-4690-9-99",https://intramural.nih.gov/search/searchview.taf?ipid=78337
132,BC010483-11,"October 01, 2012 -  September 30, 2013",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman|Lihong  Xu; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78351
133,BC010484-11,"October 01, 2012 -  September 30, 2013",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Emily  Hsiao|Ekaterina  Posokhova|Steven  Seaman|Christopher S Szot|Suresh R Volate,NULL,NULL,NULL,"1. Chaudhary A, Hilton MB, Seaman S, Haines DC, Stevenson S, Lemotte PK, Tschantz WR, Zhang XM, Saha S, Fleming T, St Croix B (2012). TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell  21, 212-26.   https://doi.org/10.1016/j.ccr.2012.01.004",https://intramural.nih.gov/search/searchview.taf?ipid=78352
134,BC010486-11,"October 01, 2012 -  September 30, 2013",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78353
135,BC010487-11,"October 01, 2012 -  September 30, 2013",Cytoplasmic-Nuclear Trafficking of HIV-1,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Christopher Lee Case; PhD|Laura Minji Choi|Kyeongeun  Lee|Hyun Jae  Yu|Wendy  Yuen|Guangai  Xue; PhD|Show all 8,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Sara  Sawyer (University of Texas, Austin)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Xiaolin  Wu; PhD (Office Of The Director),NULL,"1. Ambrose Z, Lee K, Ndjomou J, Xu H, Oztop I, Matous J, Takemura T, Unutmaz D, Engelman A, Hughes SH, KewalRamani VN (2012). Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J Virol  86, 4708-14.   https://doi.org/10.1128/JVI.05887-11|2. Lee K, Mulky A, Yuen W, Martin TD, Meyerson NR, Choi L, Yu H, Sawyer SL, Kewalramani VN (2012). HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J Virol  86, 3851-60.   https://doi.org/10.1128/JVI.06607-11|3. Price AJ, Fletcher AJ, Schaller T, Elliott T, Lee K, KewalRamani VN, Chin JW, Towers GJ, James LC (2012). CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog  8, e1002896.   https://doi.org/10.1371/journal.ppat.1002896",https://intramural.nih.gov/search/searchview.taf?ipid=78338
136,BC010488-11,"October 01, 2012 -  September 30, 2013",Animal Models for HIV-1 Replication and Pathogenesis,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kyeongeun  Lee|Guangai  Xue; PhD|Wendy  Yuen,"Paul  Bieniasz (Rockefeller University, Aaron Diamond AIDS Research Center)|Theodora  Hatziioannou (Aaron Diamond AIDS Research Center)",Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Boltz VF, Ambrose Z, Kearney MF, Shao W, Kewalramani VN, Maldarelli F, Mellors JW, Coffin JM (2012). Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase. J Virol  86, 12525-30.   https://doi.org/10.1128/JVI.01963-12|2. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, Roser JD, Estes JD, Hao XP, Trubey CM, Lara A, Lee K, Chaipan C, Bess JW, Nagashima K, Keele BF, Macallister R, Smedley J, Pathak VK, Kewalramani VN, Coffin JM, Lifson JD (2012). Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques. J Virol  86, 3152-66.   https://doi.org/10.1128/JVI.06886-11",https://intramural.nih.gov/search/searchview.taf?ipid=78339
137,BC010493-11,"October 01, 2012 -  September 30, 2013",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jennifer T Miller|Brian Makori Omwena Ogendi|Jason William Rausch|Casey Marie Silver|Joanna  Sztuba-Solinska; PhD|Humeyra  Taskent; PhD,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Xiaowei  Zhuang (Chemistry and Biology, Harvard University)|John  Marino (Center for Advanced Research in Biotechnology)|Marie-Louise  Hammarskjold (University of Virginia)|Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|David  Garfinkel (University of Georgia)|Show all 12",Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Barbara K Felber (Vaccine Branch)|Yun Xing M Wang (Structural Biophysics Laboratory)|John Stephen Schneekloth (Chemical Biology Laboratory)|Alexander  Wlodawer; PhD (Protein Structure Section),NULL,"1. Legrice S, Nowotny M (2013) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., in press.|2. Miller J, Legrice S (2013) Reverse transcriptase-catalyzed HIV-1 DNA synthesis, in Encyclopedia of AIDS., in press.|3. SztubaSolinska J, Legrice S (2013) Insights into secondary and tertiary interactions of dengue virus RNA by SHAPE, in Dengue: Protocols and Methods  (R Padebanemabhan, ed.),, Methods in Molecular Biology., in press.|4. Kenyon J, Prestwood L, Legrice S, Lever A (2013) In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res, in press.|5. Le Grice SF (2012). Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J Biol Chem  287, 40850-7.   https://doi.org/10.1074/jbc.R112.389056|6. Lusvarghi S, SztubaSolinska J, Purzycka K, Rausch J, Legrice S (2013) RNA secondary structure prediction using high-throughput SHAPE. J Vis Exp, in press.|7. Sztuba-Solinska J, Le Grice SF (2012). Probing Retroviral and Retrotransposon Genome Structures: The ""SHAPE"" of Things to Come. Mol Biol Int  2012, 530754.   https://doi.org/10.1155/2012/530754",https://intramural.nih.gov/search/searchview.taf?ipid=78345
138,BC010494-11,"October 01, 2012 -  September 30, 2013",HIV-1 RNase H  as  a Therapeutic Target,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Suhman  Chung|Takashi  Masaoka|Jennifer T Miller|Jason William Rausch|Joanna  Sztuba-Solinska; PhD|Show all 8,"Matthias  Goette (McGill University)|James  Cowan (Ohio State University)|Graziella  Tocco (University of Cagliari)|Marcin  Nowotny (International Institute of Molecular and Cell Biology)|Angela Maria Gronenborn; PhD (Department of Structural Biology, University of Pittsburgh)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|Show all 9",John A Beutler (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Barry R O'Keefe (Molecular Targets Laboratory),Craig Joseph Thomas (NCATS) |Wei  Yang; PhD (NIDDK),"1. Legrice S (2013) Conformational dynamics of reverse transcription, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. (Le Grice S, Goette M, eds., in press.|2. Legrice S, Nowotny M (2013) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., in press.|3. Barrioluengo V, Wang Y, Le Grice SF, Menéndez-Arias L (2012). Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase. FEBS J  279, 1433-44.   https://doi.org/10.1111/j.1742-4658.2012.08532.x|4. Chung S, Miller JT, Johnson BC, Hughes SH, Le Grice SF (2012). Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J Biol Chem  287, 4066-75.   https://doi.org/10.1074/jbc.M111.314781|5. Corona A, Masaoka T, Tocco G, Tramontano E, Legrice S (2013) Active site and allosteric inhibitors of the ribonuclease H activity of human immunodeficiency virus reverse transcriptase. Future Med Chem, in press.|6. Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM (2012). Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS One  7, e30889.   https://doi.org/10.1371/journal.pone.0030889|7. Kessl JJ, Jena N, Koh Y, Taskent-Sezgin H, Slaughter A, Feng L, de Silva S, Wu L, Le Grice SF, Engelman A, Fuchs JR, Kvaratskhelia M (2012). Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors. J Biol Chem  287, 16801-11.   https://doi.org/10.1074/jbc.M112.354373|8. Lapkouski M, Tian L, Miller JT, Le Grice SFJ, Yang W (2013). Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation. Nat Struct Mol Biol  20, 230-236.   https://doi.org/10.1038/nsmb.2485|9. Le Grice SF (2012). Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J Biol Chem  287, 40850-7.   https://doi.org/10.1074/jbc.R112.389056|10. Nair GR, Dash C, Le Grice SF, DeStefano JJ (2012). Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract. PLoS One  7, e41712.   https://doi.org/10.1371/journal.pone.0041712|11. Zhou D, Chung S, Miller M, Grice SF, Wlodawer A (2012). Crystal structures of the reverse transcriptase-associated ribonuclease H domain of xenotropic murine leukemia-virus related virus. J Struct Biol  177, 638-45.   https://doi.org/10.1016/j.jsb.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=78343
139,BC010495-11,"October 01, 2012 -  September 30, 2013",Unnatural Amino Acids as Probes of Protein Structure and Function,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Vineet Narain KewalRamani; PhD,NULL,Deb  Chatterjee (Office Of The Director),NULL,"1. Legrice S, Nowotny M (2013) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78344
140,BC010499-11,"October 01, 2012 -  September 30, 2013",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Adrienne Michelle Starks,"Carlo  Croce (Ohio State University)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Feng  WangJohanning (University of Texas MD Anderson Cancer Center)|Sharon  Glynn",Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S (2013). MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene  32, 4139-47.   https://doi.org/10.1038/onc.2012.424|2. Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs S (2012). MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res  40, 3689-703.   https://doi.org/10.1093/nar/gkr1222",https://intramural.nih.gov/search/searchview.taf?ipid=78329
141,BC010504-11,"October 01, 2012 -  September 30, 2013",Elucidating the Mechanisms of Reverse Transcription and Recombination,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Malika  Kuzembayeva|Olga A Nikolaitchik|Vinay K Pathak; PhD|John Miller Coffin; PhD,NULL,Frank  Maldarelli (Host Virus Interaction Branch)|Mary  Kearney (Host Virus Interaction Branch),NULL,"1. Cingöz O, Paprotka T, Delviks-Frankenberry KA, Wildt S, Hu WS, Pathak VK, Coffin JM (2012). Characterization, mapping, and distribution of the two XMRV parental proviruses. J Virol  86, 328-38.   https://doi.org/10.1128/JVI.06022-11|2. Delviks-Frankenberry K, Paprotka T, CingÃ¶z O, Wildt S, Hu WS, Coffin JM, Pathak VK (2013) Generation of multiple replication competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2. J Virol, in press.|3. Hu WS, Hughes SH (2012). HIV-1 reverse transcription. Cold Spring Harb Perspect Med  2.   https://doi.org/10.1101/cshperspect.a006882",https://intramural.nih.gov/search/searchview.taf?ipid=78336
142,BC010506-11,"October 01, 2012 -  September 30, 2013",Understanding Retroviral Gag and RNA Targeting and Virus Assembly,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Kari Ann Dilley|Malika  Kuzembayeva|Luca  Sardo|Vinay K Pathak; PhD|Alan  Rein; PhD|Show all 7,David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|WE  Moerner (Stanford University),Kunio  Nagashima (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Hatch SC, Sardo L, Chen J, Burdick R, Gorelick R, Fivash MJ, Pathak VK, Hu WS (2013) Gag-dependent enrichment of HIV-1 RNA near the uropod membrane of polarized T cells. J Virol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78335
143,BC010511-11,"October 01, 2012 -  September 30, 2013",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Siddhartha  Datta; PhD|Demetria P Harvin|Jane  Mirro|Ina  O'Carroll,"Susan  Krueger (National Institute of Standards and Technology)|Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Walther  Mothes (Yale University)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|Show all 10",Robert J Fisher (Office Of The Director)|Raul Eduardo Cachau (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory)|Robert  Gorelick (Office Of The Director),NULL,"1. O'Carroll IP, Crist RM, Mirro J, Harvin D, Soheilian F, Kamata A, Nagashima K, Rein A (2012). Functional redundancy in HIV-1 viral particle assembly. J Virol  86, 12991-6.   https://doi.org/10.1128/JVI.06287-11",https://intramural.nih.gov/search/searchview.taf?ipid=78349
144,BC010512-11,"October 01, 2012 -  September 30, 2013",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Mauricio  Comas Garcia; PhD|Demetria P Harvin|Jane  Mirro|Smita  Nair; PhD|Ina  O'Carroll|Wei-Shau  Hu; PhD,Kevin  Weeks (University of North Carolina)|Karin  MusierForsyth (Ohio State University)|Mark  Williams (Northeastern University),Robert J Fisher (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory),Judith Goldstein Levin; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78350
145,BC010516-11,"October 01, 2012 -  September 30, 2013",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|Hu-Chen  Xie|Ying  Zhuge,"Alan  Huston (Naval Research Laboratory)|Brian  Justus (Optical Sciences Division, Naval Research Lab (NRL))",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78356
146,BC010518-11,"October 01, 2012 -  September 30, 2013",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder|Maria  Kaltcheva|Ying  Zhang,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78359
147,BC010523-11,"October 01, 2012 -  September 30, 2013",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Venkata Raghavendra Chalamcharla; PhD|Jothy  Dhakshnamoorthy|Pamela S Gallagher|Namhoon  Lee|Sameet Satish Mehta; PhD|Deborah Ruth Smith|Show all 7,NULL,Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),NULL,"1. Aygün O, Mehta S, Grewal SI (2013). HDAC-mediated suppression of histone turnover promotes epigenetic stability of heterochromatin. Nat Struct Mol Biol  20, 547-54.   https://doi.org/10.1038/nsmb.2565|2. Lee NN, Chalamcharla VR, Reyes-Turcu F, Mehta S, Zofall M, Balachandran V, Dhakshnamoorthy J, Taneja N, Yamanaka S, Zhou M, Grewal SI (2013). Mtr4-like protein coordinates nuclear RNA processing for heterochromatin assembly and for telomere maintenance. Cell  155, 1061-74.   https://doi.org/10.1016/j.cell.2013.10.027|3. Reyes-Turcu FE, Grewal SI (2012). Different means, same end-heterochromatin formation by RNAi and RNAi-independent RNA processing factors in fission yeast. Curr Opin Genet Dev  22, 156-63.   https://doi.org/10.1016/j.gde.2011.12.004|4. Yamanaka S, Mehta S, Reyes-Turcu FE, Zhuang F, Fuchs RT, Rong Y, Robb GB, Grewal SI (2013). RNAi triggered by specialized machinery silences developmental genes and retrotransposons. Nature  493, 557-60.   https://doi.org/10.1038/nature11716|5. Zofall M, Yamanaka S, Reyes-Turcu FE, Zhang K, Rubin C, Grewal SI (2012). RNA elimination machinery targeting meiotic mRNAs promotes facultative heterochromatin formation. Science  335, 96-100.   https://doi.org/10.1126/science.1211651",https://intramural.nih.gov/search/searchview.taf?ipid=78185
148,BC010524-11,"October 01, 2012 -  September 30, 2013",HIV Integrase Modeling and Computer-Aided Inhibitor Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Chenzhong  Liao|Alexey Vladimirovich Zakharov; PhD|Terrence R Burke; PhD,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Karen  Buckheit (ImQuest Biosciences)",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Lagunin A, Filimonov D, Gloriozova T, Tarasova O, Zakharov A, GuaschPamies L, Nicklaus M, Poroikov V (2013) Virtual Screening of Potential Anti-HIV Agents in Libraries of Commercially Available Organic Compounds (Russ.). Chem Pharm J (Moscow) 47:3-21",https://intramural.nih.gov/search/searchview.taf?ipid=78357
149,BC010525-11,"October 01, 2012 -  September 30, 2013",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Nataliya Prokopenko Buxbaum|Don Eugene Farthing|Philip J Lucas; PhD|Jiun  Wang,NULL,Alfred  Singer; MD (Lymphocyte Development Section)|Richard J Hodes; MD (Immune Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Joy A Williams (Lymphocyte Development Section),NULL,"1. El-Kassar N, Flomerfelt FA, Choudhury B, Hugar LA, Chua KS, Kapoor V, Lucas PJ, Gress RE (2012). High levels of IL-7 cause dysregulation of thymocyte development. Int Immunol  24, 661-71.   https://doi.org/10.1093/intimm/dxs067|2. Foglietta M, Neelapu SS, Kwak LW, Jiang Y, Nattamai D, Lee ST, Fowler DH, Sportes C, Gress RE, Steinberg SM, Vence LM, Radvanyi L, Dwyer KC, Qazilbash MH, Bryant RN, Bishop MR (2013). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplant  48, 269-77.   https://doi.org/10.1038/bmt.2012.132|3. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH (2012). An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol  188, 5859-66.   https://doi.org/10.4049/jimmunol.1102328",https://intramural.nih.gov/search/searchview.taf?ipid=78332
150,BC010538-11,"October 01, 2012 -  September 30, 2013",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Brunilde M Gril|Emily  Hua|Ladawn Tiffany Reed|Stephan  Woditschka; PhD,"Andreas  Stark (University of Schleswig-Holstein Medical Center)|George  Sledge Jr (Indiana University)|Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Paul  Lockman (Texas Tech University)|Fernando  VidalVanaclocha (CEU-San Pablo University School of Medicine)|Renata  Duchnowska (Military Institute of Medicine,)|Show all 8",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|James B Mitchell; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78354
151,BC010539-11,"October 01, 2012 -  September 30, 2013",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Georgette Nicole Jones; PhD|Min-Hyung  Lee; PhD|Jimmy  Stauffer|Robert  Tuskan|Melissa Anne Whitman|Carrie Antoinette Williams,Karl  Broman (University of Michigan)|David  Gutmann (Washington University)|Joshua  Rubin (Washington University)|Keiko  Akagi (NCI)|Melissa  Bondy (MD Anderson)|Yanhong  Liu (MD Anderson),"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Uma  Shankavaram; PhD (Radiation Oncology Branch)","Thanh truc B Huynh (NICHD) |Karel  Pacak; MD, PhD (NICHD)","1. Amlin-Van Schaick JC, Kim S, DiFabio C, Lee MH, Broman KW, Reilly KM (2012). Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. Neuro Oncol  14, 160-74.   https://doi.org/10.1093/neuonc/nor206",https://intramural.nih.gov/search/searchview.taf?ipid=78347
152,BC010540-11,"October 01, 2012 -  September 30, 2013",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Robert  Tuskan|Carrie Antoinette Williams|Min-Hyung  Lee; PhD|Melissa Anne Whitman,David  Gutmann (Washington University)|Joshua  Rubin (Washington University),NULL,NULL,"1. Amlin-Van Schaick JC, Kim S, DiFabio C, Lee MH, Broman KW, Reilly KM (2012). Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. Neuro Oncol  14, 160-74.   https://doi.org/10.1093/neuonc/nor206|2. Zemp FJ, McKenzie BA, Lun X, Maxwell L, Reilly KM, McFadden G, Yong VW, Forsyth PA (2013). Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon. PLoS One  8, e65801.   https://doi.org/10.1371/journal.pone.0065801",https://intramural.nih.gov/search/searchview.taf?ipid=78348
153,BC010541-11,"October 01, 2012 -  September 30, 2013",Development of Mouse Astrocytoma Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Robert  Tuskan|Carrie Antoinette Williams,"David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|Christophe  Echeverri (Cenix BioScience)",Brigitte  Widemann; MD (Pediatric Oncology Branch)|John A Beutler (Molecular Targets Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Thomas J Turbyville (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory)|James  McMahon; PhD (Molecular Targets Laboratory),NULL,"1. Devkota K, Willson J, Henrich C, McMahon J, Reilly K, Beutler J (2013) Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells. Phytochemistry Letters, in press.|2. Devkota KP, Wilson J, Henrich CJ, McMahon JB, Reilly KM, Beutler JA (2013). Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth. J Nat Prod  76, 59-63.   https://doi.org/10.1021/np300696g",https://intramural.nih.gov/search/searchview.taf?ipid=78346
154,BC010547-11,"October 01, 2012 -  September 30, 2013",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Bamidele  Adesunloye|Cindy Huong-Bich Chau|Elena Valerie Fernandez|Xuan  Huang; MD, PhD|Fatima Hafiz Karzai; MD|Kelie M Reece; PhD|Show all 10",Jeanny  AragonChing (George Washington University)|Romano  Danesi|Min Hee Kang|Mark  Ratain (University of Chicago)|Christopher  Schofield (University of Oxford)|Ian Abban Thompson; MD|Show all 8,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|John J Wright (Investigational Drug Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)",Clara Chi Chen; MD (CC),"1. Chau C, Figg W (2012) Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer, in Emerging Cancer Therapeutics:  Prostate Cancer. Abraham J, Gulley J, eds., pp. 513-23.|2. Gordon MS, Rosen LS, Mendelson D, Ramanathan RK, Goldman J, Liu L, Xu Y, Gerson SL, Anthony SP, Figg WD, Spencer S, Adams BJ, Theuer CP, Leigh BR, Weiss GJ (2013) A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Invest New Drugs 31:714-23|3. Huang X, Chau CH, Figg WD (2012). Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures. J Hematol Oncol  5, 35.   https://doi.org/10.1186/1756-8722-5-35|4. Richardson ED, Price DK, Figg WD (2012). Significant addition to treatment options for bone metastasis in prostate cancer. Cancer Biol Ther  13, 69-70.   https://doi.org/10.4161/cbt.13.2.18441|5. Spencer S, Marini BL, Figg WD (2012). Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer. Anticancer Res  32, 2391-8.",https://intramural.nih.gov/search/searchview.taf?ipid=78331
155,BC010549-11,"October 01, 2012 -  September 30, 2013",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Heather R Shive,NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)","1. English MA, Lei L, Blake T, Wincovitch SM, Sood R, Azuma M, Hickstein D, Liu PP (2012). Incomplete splicing, cell division defects, and hematopoietic blockage in dhx8 mutant zebrafish. Dev Dyn  241, 879-89.   https://doi.org/10.1002/dvdy.23774",https://intramural.nih.gov/search/searchview.taf?ipid=78186
156,BC010561-10,"October 01, 2012 -  September 30, 2013",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Sourav  Ganguly|Tatsuya  Morisaki|Waltraud  Mueller|Ronit  Salomon,David  Auble (Univ. Virginia)|Jason  Lieb (University North Carolina),NULL,NULL,"1. Lickwar CR, Mueller F, Hanlon SE, McNally JG, Lieb JD (2012). Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function. Nature  484, 251-5.   https://doi.org/10.1038/nature10985|2. Mazza D, Abernathy A, Golob N, Morisaki T, McNally JG (2012). A benchmark for chromatin binding measurements in live cells. Nucleic Acids Res  40, e119.   https://doi.org/10.1093/nar/gks701|3. Mueller F, Morisaki T, Mazza D, McNally JG (2012). Minimizing the impact of photoswitching of fluorescent proteins on FRAP analysis. Biophys J  102, 1656-65.   https://doi.org/10.1016/j.bpj.2012.02.029|4. Quénet D, McNally JG, Dalal Y (2012). Through thick and thin: the conundrum of chromatin fibre folding in vivo. EMBO Rep  13, 943-4.   https://doi.org/10.1038/embor.2012.143|5. Rieder D, Trajanoski Z, McNally JG (2012). Transcription factories. Front Genet  3, 221.   https://doi.org/10.3389/fgene.2012.00221",https://intramural.nih.gov/search/searchview.taf?ipid=78381
157,BC010562-10,"October 01, 2012 -  September 30, 2013",Molecular Interaction Maps and Analysis of Bioregulatory Networks,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Geoffrey B Mcfadden|Yves  Pommier; PhD|Kurt  Kohn; PhD,NULL,NULL,NULL,"1. Chandan K, van Iersel MP, Aladjem MI, Kohn KW, Luna A (2012). PathVisio-Validator: a rule-based validation plugin for graphical pathway notations. Bioinformatics  28, 889-90.   https://doi.org/10.1093/bioinformatics/btr694|2. Fried JY, van Iersel MP, Aladjem MI, Kohn KW, Luna A (2013). PathVisio-Faceted Search: an exploration tool for multi-dimensional navigation of large pathways. Bioinformatics  29, 1465-6.   https://doi.org/10.1093/bioinformatics/btt146|3. van Iersel MP, Villéger AC, Czauderna T, Boyd SE, Bergmann FT, Luna A, Demir E, Sorokin A, Dogrusoz U, Matsuoka Y, Funahashi A, Aladjem MI, Mi H, Moodie SL, Kitano H, Le Novère N, Schreiber F (2012). Software support for SBGN maps: SBGN-ML and LibSBGN. Bioinformatics  28, 2016-21.   https://doi.org/10.1093/bioinformatics/bts270",https://intramural.nih.gov/search/searchview.taf?ipid=78365
158,BC010566-10,"October 01, 2012 -  September 30, 2013",Tumor and Metastasis Biology,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Allyson E Koyen|Michael Mark Lizardo; PhD|Ling  Ren|Lee Jay Helman; MD|Javed  Khan; MD,"Aykut  Uren (Georgetown University Medical Center)|Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Danny  Welch (Department of Pathology, University of Alabama, Birmingham)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)","Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, Rahim S, Bulut G, Zhou M, Veenstra TD, Chen Q, Wei JS, Khan J, Uren A, Khanna C (2012). The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia  14, 297-310.   https://doi.org/10.1593/neo.11518|2. Hong SH, Ren L, Mendoza A, Eleswarapu A, Khanna C (2012). Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells. Neoplasia  14, 249-58.   https://doi.org/10.1593/neo.111498|3. Ren L, Hong SH, Chen QR, Briggs J, Cassavaugh J, Srinivasan S, Lizardo MM, Mendoza A, Xia AY, Avadhani N, Khan J, Khanna C (2012). Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer Res  72, 1001-12.   https://doi.org/10.1158/0008-5472.CAN-11-0210",https://intramural.nih.gov/search/searchview.taf?ipid=78377
159,BC010578-10,"October 01, 2012 -  September 30, 2013",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Steven  Seaman|Christopher S Szot|Enrique  Zudaire Ubani; PhD,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Chaudhary A, Hilton MB, Seaman S, Haines DC, Stevenson S, Lemotte PK, Tschantz WR, Zhang XM, Saha S, Fleming T, St Croix B (2012). TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell  21, 212-26.   https://doi.org/10.1016/j.ccr.2012.01.004|2. Chaudhary A, St Croix B (2012). Selective blockade of tumor angiogenesis. Cell Cycle  11, 2253-9.   https://doi.org/10.4161/cc.20374|3. Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, St Croix B, Qian M, Dimitrov DS, Ho M (2013). A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Mol Cancer Ther  12, 416-26.   https://doi.org/10.1158/1535-7163.MCT-12-0731",https://intramural.nih.gov/search/searchview.taf?ipid=78189
160,BC010579-10,"October 01, 2012 -  September 30, 2013",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Alexander G Papageorge|William C Vass|John  Schiller; PhD|Christopher  Buck,NULL,Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,"1. Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT (2012). Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest  122, 4606-20.   https://doi.org/10.1172/JCI63287|2. Castro FA, Quint W, Gonzalez P, Katki HA, Herrero R, van Doorn LJ, Schiffman M, Struijk L, Rodriguez AC, DelVecchio C, Lowy DR, Porras C, Jimenez S, Schiller J, Solomon D, Wacholder S, Hildesheim A, Kreimer AR, Costa Rica Vaccine Trial Group (2012). Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis  206, 1103-10.   https://doi.org/10.1093/infdis/jis458|3. Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE (2012). Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine  30, 6016-9.   https://doi.org/10.1016/j.vaccine.2012.07.056|4. Day PM, Pang YY, Kines RC, Thompson CD, Lowy DR, Schiller JT (2012). A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies. Clin Vaccine Immunol  19, 1075-82.   https://doi.org/10.1128/CVI.00139-12|5. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT (2013). Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol  87, 3862-70.   https://doi.org/10.1128/JVI.03222-12|6. Handisurya A, Day PM, Thompson CD, Buck CB, Kwak K, Roden RB, Lowy DR, Schiller JT (2012). Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species. Virology  433, 385-94.   https://doi.org/10.1016/j.virol.2012.08.035|7. Jagu S, Kwak K, Schiller JT, Lowy DR, Kleanthous H, Kalnin K, Wang C, Wang HK, Chow LT, Huh WK, Jaganathan KS, Chivukula SV, Roden RB (2013). Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine. J Virol  87, 6127-36.   https://doi.org/10.1128/JVI.03218-12|8. Kemp TJ, Safaeian M, Hildesheim A, Pan Y, Penrose KJ, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA (2012). Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®). Vaccine  31, 165-70.   https://doi.org/10.1016/j.vaccine.2012.10.067|9. Lowy DR, Schiller JT (2012). Reducing HPV-associated cancer globally. Cancer Prev Res (Phila)  5, 18-23.   https://doi.org/10.1158/1940-6207.CAPR-11-0542|10. Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Pinto LA (2013). Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Hum Vaccin Immunother  9, 1399-406.   https://doi.org/10.4161/hv.24340|11. Schiller JT, Lowy DR (2012). Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol  10, 681-92.   https://doi.org/10.1038/nrmicro2872",https://intramural.nih.gov/search/searchview.taf?ipid=78379
161,BC010580-10,"October 01, 2012 -  September 30, 2013",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Pamela  Wolters|Nalini M Jayaprakash,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Ko C, Kaushal A, Hammoud DA, Steffen-Smith EA, Bent R, Citrin D, Camphausen K, Warren KE (2012). Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  83, 1252-1256.   https://doi.org/10.1016/j.ijrobp.2011.09.046|2. Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE (2012). Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  84, 774-9.   https://doi.org/10.1016/j.ijrobp.2012.01.032|3. Warren KE (2012). Diffuse intrinsic pontine glioma: poised for progress. Front Oncol  2, 205.   https://doi.org/10.3389/fonc.2012.00205",https://intramural.nih.gov/search/searchview.taf?ipid=78363
162,BC010589-10,"October 01, 2012 -  September 30, 2013",Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Jennifer D Rabb|Laurie  Steffen,NULL,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Joelle  Sarlls; PhD (NINDS)","1. Hipp SJ, Steffen-Smith EA, Patronas N, Herscovitch P, Solomon JM, Bent RS, Steinberg SM, Warren KE (2012). Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI. J Neurooncol  109, 521-7.   https://doi.org/10.1007/s11060-012-0918-0|2. Ko C, Kaushal A, Hammoud DA, Steffen-Smith EA, Bent R, Citrin D, Camphausen K, Warren KE (2012). Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  83, 1252-1256.   https://doi.org/10.1016/j.ijrobp.2011.09.046|3. Steffen-Smith EA, Baker EH, Venzon D, Shandilya S, Bent RS, Warren KE (2014). Measurements of the pons as a biomarker of progression for pediatric DIPG. J Neurooncol  116, 127-33.   https://doi.org/10.1007/s11060-013-1266-4|4. Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE (2012). Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  84, 774-9.   https://doi.org/10.1016/j.ijrobp.2012.01.032",https://intramural.nih.gov/search/searchview.taf?ipid=78361
163,BC010591-10,"October 01, 2012 -  September 30, 2013",Characterization of Xenograft Models of Childhood Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Carol J Thiele|Chand  Khanna; MD,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78375
164,BC010592-10,"October 01, 2012 -  September 30, 2013",Comparative Genomic Hybridization of Neuroblastoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78376
165,BC010595-10,"October 01, 2012 -  September 30, 2013",Structure and Function of APOBEC3 Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Belete Ayele Desimmie|Dongfei  Qi|Ryan C Burdick|Hibiki  Doi|Wei-Shau  Hu; PhD,Jean L Mbisa (NCI)|Yoshio  Koyanagi|Kei  Sato (Kyoto University)|Joseph  Wedekind (University of Rochester Medical Center)|Yong  Xiong (Yale University),Robert  Gorelick (Office Of The Director),James  Inglese (NCATS),"1. Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK (2014). Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol  426, 1220-45.   https://doi.org/10.1016/j.jmb.2013.10.033",https://intramural.nih.gov/search/searchview.taf?ipid=78383
166,BC010598-10,"October 01, 2012 -  September 30, 2013",Human Immune Responses to Tumor Antigens for Cancer Vaccine Development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Benedetto Paolo Farsaci; PhD|Italia  Grenga|Diane J Poole|Kwong Yok Tsang|Claudia Mercedes Palena|Show all 7,"Douglas  McNeel (University of Wisconsin)|David  Apelian (GlobeImmune, Inc.)|James  Breitmeyer (BN ImmunoTherapeutics)",NULL,NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors, in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation. Lattime E, Gerson SL, eds., in press.|3. Bot A, Ahn M, Bosch M, Brockstedt D, Butterfield LH, Cornforth A, Harrop R, Kast WM, Koya R, Marincola F, Margolin K, McCoy C, Pawelec G, Rothman J, Ramirez-Montagut T, Schlom J, Srivastava P, Wallis S, Walter S, Wang E, Waslif J (2012). A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies. J Transl Med  10, 218.   https://doi.org/10.1186/1479-5876-10-218|4. Gulley JL, Leitman SF, Dahut W, Schlom J (2012). Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J Natl Cancer Inst  104, 1106; author reply 1109-12.   https://doi.org/10.1093/jnci/djs280|5. Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J (2012). Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood  120, 3030-8.   https://doi.org/10.1182/blood-2012-05-427799|6. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|7. Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL (2012). Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol  39, 296-304.   https://doi.org/10.1053/j.seminoncol.2012.02.010|8. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2|9. Schlom J (2012). Recent advances in therapeutic cancer vaccines. Cancer Biother Radiopharm  27, 2-5.   https://doi.org/10.1089/cbr.2012.1200|10. Schlom J (2012). Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst  104, 599-613.   https://doi.org/10.1093/jnci/djs033|11. Schlom J, Hodge JW (2012). Introduction: Therapeutic cancer vaccines. Semin Oncol  39, 243-4.   https://doi.org/10.1053/j.seminoncol.2012.02.009|12. Tucker J, Jochems C, Gulley J, Schlom J, Tsang K (2012) Shifting the balance of cell-mediated immunity and suppression in human prostate cancer [review]. Cancers 4:1333-1348|13. Schlom J, Tsang K (submitted in 2012) Native And Agonist Ctl Epitopes Of The Muc1 Tumor Antigen. Patents issued: 2013206896 (AU in 2017); 602013031592 (EP in 2018). Patents pending: 551304/2014 (JP application); PCT/US2013/020058 (PC application); 14/370,595 (US application); 2860599 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=78187
167,BC010600-10,"October 01, 2012 -  September 30, 2013",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),NULL,"1. Tang W, Xia D (2012) IBMPFD and p97, the structural and molecular basis for functional disruption, in Neuromuscular Disorders., pp. 155-174.|2. Ma J, Tang WK, Esser L, Pastan I, Xia D (2012). Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009. Acta Crystallogr Sect F Struct Biol Cryst Commun  68, 950-3.   https://doi.org/10.1107/S1744309112028229|3. Ma J, Tang WK, Esser L, Pastan I, Xia D (2012). Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights. J Biol Chem  287, 33123-31.   https://doi.org/10.1074/jbc.M112.381756|4. Tang WK, Xia D (2012). Structural and functional deviations in disease-associated p97 mutants. J Struct Biol  179, 83-92.   https://doi.org/10.1016/j.jsb.2012.04.024",https://intramural.nih.gov/search/searchview.taf?ipid=78364
168,BC010607-10,"October 01, 2012 -  September 30, 2013",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin|Amir Hossein Ameri,NULL,Peter L Choyke; MD (Molecular Imaging Program),Alan Paul Koretsky; PhD (NINDS),"1. Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K, Ren G, Tao Q (2012) The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. PLoS One 7:e29783|2. Yin X, Xiang T, Li L, Su X, Shu X, Luo X, Huang J, Yuan Y, Peng W, Oberst M, Kelly K, Ren G, Tao Q (2013). DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Res  15, R23.   https://doi.org/10.1186/bcr3399",https://intramural.nih.gov/search/searchview.taf?ipid=78374
169,BC010612-10,"October 01, 2012 -  September 30, 2013",The Role of miRNA-mediated RNAI in the Biology of Cancer,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sirisha  Chakka|Konrad  Huppi; MD, PhD|Suntae  Kim|Ashish Kumar Lal",Siegfried  Janz (University of Iowa)|Patrick  Grohar,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,"1. Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C (2012). p53-Dependent induction of PVT1 and miR-1204. J Biol Chem  287, 2509-19.   https://doi.org/10.1074/jbc.M111.322875|2. Huppi K, Pitt JJ, Wahlberg BM, Caplen NJ (2012). The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front Genet  3, 69.   https://doi.org/10.3389/fgene.2012.00069",https://intramural.nih.gov/search/searchview.taf?ipid=78391
170,BC010613-10,"October 01, 2012 -  September 30, 2013",The Induction of Gene-specific RNAi Against Cancer-associated Genes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sirisha  Chakka|Konrad  Huppi; MD, PhD|Tamara L Jones|Suntae  Kim|Karl Thomas Ried; MD",NULL,"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Christina M Annunziata (Medical Oncology Branch)",NULL,"1. Hummon AB, Pitt JJ, Camps J, Emons G, Skube SB, Huppi K, Jones TL, Beissbarth T, Kramer F, Grade M, Difilippantonio MJ, Ried T, Caplen NJ (2012). Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. Mol Cancer  11, 1.   https://doi.org/10.1186/1476-4598-11-1",https://intramural.nih.gov/search/searchview.taf?ipid=78392
171,BC010615-10,"October 01, 2012 -  September 30, 2013",RNAi Screening for the Systematic Discovery of Cancer Gene Function,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sirisha  Chakka|Konrad  Huppi; MD, PhD|Tamara L Jones|Karl Thomas Ried; MD",NULL,"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Christina M Annunziata (Medical Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)","Christopher P Austin; AB, MD (NCATS) |Scott E Martin (NCATS)","1. Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE (2012). Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Res  14, R109.   https://doi.org/10.1186/bcr3230|2. Hummon AB, Pitt JJ, Camps J, Emons G, Skube SB, Huppi K, Jones TL, Beissbarth T, Kramer F, Grade M, Difilippantonio MJ, Ried T, Caplen NJ (2012). Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. Mol Cancer  11, 1.   https://doi.org/10.1186/1476-4598-11-1",https://intramural.nih.gov/search/searchview.taf?ipid=78393
172,BC010620-10,"October 01, 2012 -  September 30, 2013",Clinical Studies to Circumvent Drug Resistance,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey|Antonio  Fojo; MD, PhD|William D Figg; PharmD","Thomas  Litman (University of Copenhagen)|Wilfred  Stein (Hebrew University, Jerusalem)|Alex  Sparreboom",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Jo Anne N Zujewski (Clinical Investigations Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch),Clara Chi Chen; MD (CC) |Robert  Innis; MD (NIMH),"1. Amiri-Kordestani L, Basseville A, Kurdziel K, Fojo AT, Bates SE (2012). Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist Updat  15, 50-61.   https://doi.org/10.1016/j.drup.2012.02.002|2. Fojo AT, Bates SE, Chabner BA (2013). Clinical trial results: Sharing results, speeding discoveries. Oncologist  18, 779.   https://doi.org/10.1634/theoncologist.2013-0247|3. Kelly RJ, Robey RW, Chen CC, Draper D, Luchenko V, Barnett D, Oldham RK, Caluag Z, Frye AR, Steinberg SM, Fojo T, Bates SE (2012). A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors. Oncologist  17, 512.   https://doi.org/10.1634/theoncologist.2012-0080|4. Shaffer BC, Gillet JP, Patel C, Baer MR, Bates SE, Gottesman MM (2012). Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updat  15, 62-9.   https://doi.org/10.1016/j.drup.2012.02.001|5. Sissung TM, Troutman SM, Campbell TJ, Pressler HM, Sung H, Bates SE, Figg WD (2012). Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. Discov Med  13, 19-34.|6. Stein WD, Wilkerson J, Kim ST, Huang X, Motzer RJ, Fojo AT, Bates SE (2012). Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth. Clin Cancer Res  18, 2374-81.   https://doi.org/10.1158/1078-0432.CCR-11-2275",https://intramural.nih.gov/search/searchview.taf?ipid=78368
173,BC010621-10,"October 01, 2012 -  September 30, 2013",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Agnes Marie Therese Basseville|Victoria  Luchenko|Robert W Robey|Wilfred D Stein|Zhirong  Zhan|Antonio  Fojo; MD, PhD|Show all 7","Stefania  Scala (Clinical Immunology, National Cancer Institute, G. Pascale Foundation)|Thomas  Litman (University of Copenhagen)|Giuseppe  Giaccone; MD|Owen  O'Connor (Columbia University Medical Center)|Louise  Showe (University of Pennsylvania)","Patricia A Fetsch (Laboratory of Pathology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Maria L Turner; MD (Dermatology Branch)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)","Danny L Sackett; PhD (NICHD) |Douglas R Rosing; MD (NHLBI) |Alexander  Ling (CC) |David Theodore George; MD (NIAAA) |Markus Alexander Heilig; MD, PhD (NIAAA)","1. Akilov OE, Grant C, Frye R, Bates S, Piekarz R, Geskin LJ (2012). Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions. Br J Dermatol  167, 194-7.   https://doi.org/10.1111/j.1365-2133.2012.10905.x|2. Basseville A, Tamaki A, Ierano C, Trostel S, Ward Y, Robey RW, Hegde RS, Bates SE (2012). Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter. Cancer Res  72, 3642-51.   https://doi.org/10.1158/0008-5472.CAN-11-2008|3. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, Ge K, Thiele CJ (2012). EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res  72, 315-24.   https://doi.org/10.1158/0008-5472.CAN-11-0961",https://intramural.nih.gov/search/searchview.taf?ipid=78366
174,BC010622-10,"October 01, 2012 -  September 30, 2013",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI",Agnes Marie Therese Basseville|Robert W Robey|William D Figg; PharmD,"Thomas  Litman (University of Copenhagen)|Hendrik  van Veen (Department of Pharmacology, University of Cambridge)|Alex  Sparreboom","Michael  Dean; PhD (Laboratory of Experimental Immunology)|Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Patricia A Fetsch (Laboratory of Pathology)|Curtis  Henrich (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",NULL,"1. Basseville A, Tamaki A, Ierano C, Trostel S, Ward Y, Robey RW, Hegde RS, Bates SE (2012). Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter. Cancer Res  72, 3642-51.   https://doi.org/10.1158/0008-5472.CAN-11-2008|2. Sissung TM, Troutman SM, Campbell TJ, Pressler HM, Sung H, Bates SE, Figg WD (2012). Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. Discov Med  13, 19-34.|3. Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, Wiegand G, Avital I, Fetsch P, Mani H, Zlott D, Robey R, Bates SE, Li X, Rao M, Schrump DS (2012). Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res  72, 4178-92.   https://doi.org/10.1158/0008-5472.CAN-11-3983",https://intramural.nih.gov/search/searchview.taf?ipid=78367
175,BC010624-10,"October 01, 2012 -  September 30, 2013",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Atsushi  Terunuma,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Johns Hopkins University)|Feng  WangJohanning (University of Texas MD Anderson Cancer Center)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Bernhard  KwabiAddo (Howard University)",NULL,NULL,"1. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL (2012). Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst  104, 189-210.   https://doi.org/10.1093/jnci/djr540",https://intramural.nih.gov/search/searchview.taf?ipid=78386
176,BC010625-10,"October 01, 2012 -  September 30, 2013",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Marianne  Poruchynsky|Shana Y Trostel|Susan  Bates; MD|William D Figg; PharmD,NULL,Yvona  Ward; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),Danny L Sackett; PhD (NICHD),"1. Blagoev KB, Wilkerson J, Stein WD, Motzer RJ, Bates SE, Fojo AT (2013). Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma. Cell Rep  3, 277-81.   https://doi.org/10.1016/j.celrep.2013.01.015|2. Komlodi-Pasztor E, Sackett DL, Fojo AT (2012). Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale. Clin Cancer Res  18, 51-63.   https://doi.org/10.1158/1078-0432.CCR-11-0999",https://intramural.nih.gov/search/searchview.taf?ipid=78370
177,BC010626-10,"October 01, 2012 -  September 30, 2013","Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer","Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn Ann J Mickley|Julia  Wilkerson|Susan  Bates; MD|Samuel A Wells,NULL,Electron  Kebebew; MD (Endocrine Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David  Schrump; MD (Surgery Branch),"Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC) |Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD)","1. Jain M, Zhang L, He M, Patterson EE, Nilubol N, Fojo AT, Joshi B, Puri R, Kebebew E (2012). Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma. Cancer  118, 5698-708.   https://doi.org/10.1002/cncr.27629",https://intramural.nih.gov/search/searchview.taf?ipid=78494
178,BC010627-10,"October 01, 2012 -  September 30, 2013",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Tessa J Campbell|Alesia J Holly|Linda Marie Johnson|Timothy James Martin|Cody John Peer|Tristan  Sissung|Show all 7,Romano  Danesi|Alex  Sparreboom|John F Deeken|Michael  Pacanowski (FDA),Susan  Bates; MD (Medical Oncology Branch)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Heidi H Kong (Dermatology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch),NULL,"1. Sissung T, Figg W (2013) Pharmacogenetics of Membrane Transporters: A Review of Current Approaches, in Pharmacogenomics in Drug Discovery and Development. Qing Y, ed., in press.|2. Gao R, Reece KM, Sissung T, Fu SH, Venzon DJ, Reed E, Spencer SD, Price DK, Figg WD (2013). Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N? BMJ Open  3.   https://doi.org/10.1136/bmjopen-2012-002030|3. Lancaster CS, Bruun GH, Peer CJ, Mikkelsen TS, Corydon TJ, Gibson AA, Hu S, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A (2012). OATP1B1 polymorphism as a determinant of erythromycin disposition. Clin Pharmacol Ther  92, 642-50.   https://doi.org/10.1038/clpt.2012.106|4. Moriyama B, Jarosinski PF, Figg WD, Henning SA, Danner RL, Penzak SR, Wayne AS, Walsh TJ (2013). Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype. Pharmacotherapy  33, e19-22.   https://doi.org/10.1002/phar.1192|5. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484|6. Sissung TM, Troutman SM, Campbell TJ, Pressler HM, Sung H, Bates SE, Figg WD (2012). Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy. Discov Med  13, 19-34.",https://intramural.nih.gov/search/searchview.taf?ipid=78369
179,BC010632-10,"October 01, 2012 -  September 30, 2013",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Cedric Nicolas Lionel Cagliero|Carolyn B McGill|Yan Ning H Zhou|Thomas Dana Schneider; PhD,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Jeffrey N Strathern (Genome Recombination and Regulation Section)|Stephen J Lockett; PhD (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory),NULL,"1. Hansen AM, Jin DJ (2012). SspA up-regulates gene expression of the LEE pathogenicity island by decreasing H-NS levels in enterohemorrhagic Escherichia coli. BMC Microbiol  12, 231.   https://doi.org/10.1186/1471-2180-12-231|2. Jin D, Cagliero C, Zhou Y (2013) Role of RNA Polymerase and Transcription in the Organization of the Bacterial Nucleoid. Chemical Reviews In Press",https://intramural.nih.gov/search/searchview.taf?ipid=78373
180,BC010638-10,"October 01, 2012 -  September 30, 2013",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Jesper B Andersen; PhD|Valentina  Factor|Tanya N Hoang|Kosuke  Kaji|Akira  Tomokuni; MD, PhD|Phuongnga  Ton|Show all 8",Aranzazu  Sanchezmunoz (Complutense University of Madrid)|Jens Uwe Marquardt,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,"1. Clavijo-Cornejo D, Enriquez-Cortina C, López-Reyes A, Domínguez-Pérez M, Nuño N, Domínguez-Meraz M, Bucio L, Souza V, Factor VM, Thorgeirsson SS, Gutiérrez-Ruiz MC, Gómez-Quiroz LE (2013). Biphasic regulation of the NADPH oxidase by HGF/c-Met signaling pathway in primary mouse hepatocytes. Biochimie  95, 1177-84.   https://doi.org/10.1016/j.biochi.2013.01.005|2. Coulouarn C, Corlu A, Glaise D, Guénon I, Thorgeirsson SS, Clément B (2012). Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma. Cancer Res  72, 2533-42.   https://doi.org/10.1158/0008-5472.CAN-11-3317|3. Marquardt JU, Seo D, Gómez-Quiroz LE, Uchida K, Gillen MC, Kitade M, Kaposi-Novak P, Conner EA, Factor VM, Thorgeirsson SS (2012). Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways. Biochim Biophys Acta  1822, 942-51.   https://doi.org/10.1016/j.bbadis.2012.02.012|4. Thorgeirsson SS (2012). The central role of the c-Met pathway in rebuilding the liver. Gut  61, 1105-6.   https://doi.org/10.1136/gutjnl-2012-302234",https://intramural.nih.gov/search/searchview.taf?ipid=78360
181,BC010646-10,"October 01, 2012 -  September 30, 2013",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Songjoon  Baek|Cynthia  Haggerty|Mary  Hawkins|Qizong  Lao; PhD|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD|Show all 7,"Dafna  Benayahu (Sackler School of Medicine Tel Aviv University)|Montse  SanchezCespedes (PEBC Bellvitge Biomedical Research)|Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Michael  Stallcup (Univ of Southern California)|Fyodor  Urnov; PhD",Charles  Vinson; PhD (Laboratory of Metabolism),Greti  Aguilera Harwood; MD (NICHD),"1. Hager GL, Varticovski L (2012). Chromatin in time and space. Biochim Biophys Acta  1819, 631.   https://doi.org/10.1016/j.bbagrm.2012.05.002|2. Miranda TB, Morris SA, Hager GL (2013). Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor. Mol Cell Endocrinol  380, 16-24.   https://doi.org/10.1016/j.mce.2013.03.002|3. Morris SA, Baek S, Sung MH, John S, Wiench M, Johnson TA, Schiltz RL, Hager GL (2014). Overlapping chromatin-remodeling systems collaborate genome wide at dynamic chromatin transitions. Nat Struct Mol Biol  21, 73-81.   https://doi.org/10.1038/nsmb.2718|4. Stavreva DA, Varticovski L, Hager GL (2012). Complex dynamics of transcription regulation. Biochim Biophys Acta  1819, 657-66.   https://doi.org/10.1016/j.bbagrm.2012.03.004",https://intramural.nih.gov/search/searchview.taf?ipid=78371
182,BC010649-09,"October 01, 2012 -  September 30, 2013",Immunotherapy Strategies for Gastrointestinal and Hepatocellular Cancer,Udai S Kammula,NULL,"Surgery Branch, NCI",Biman  Paria|Luke Daniel Rothermel,NULL,"Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)",Francesco M. Marincola; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78401
183,BC010652-09,"October 01, 2012 -  September 30, 2013",Lipid-based Nanocapsules and Triggered Chemotherapy,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Cheongweon  Cho|Sophie Allende Dean|Sai Janani  Ganesan|Patrick J Hall|Anu  Puri; PhD|Yossef  Raviv|Show all 12,Paul  Wang|Angela  Hight Walker|Sara  Grinberg (Ben Gurion University)|Jeeseong  Hwang (NIST)|Michael  Nantz (University of Louisville),Joseph John Barchi (Chemical Biology Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Stephen J Lockett; PhD (Office Of The Director)|Scott E McNeil (Office Of The Director)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Howard A Young; PhD (Laboratory of Experimental Immunology),Bradford J Wood; MD (CC),"1. Lee JH, Oh H, Baxa U, Raghavan SR, Blumenthal R (2012). Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules  13, 3388-94.   https://doi.org/10.1021/bm301143d|2. Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP (2012). Anticancer β-hairpin peptides: membrane-induced folding triggers activity. J Am Chem Soc  134, 6210-7.   https://doi.org/10.1021/ja210569f",https://intramural.nih.gov/search/searchview.taf?ipid=78390
184,BC010654-09,"October 01, 2012 -  September 30, 2013",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Harsh Kumar Agarwal|Marcelino  Bernardo|Ismail Baris Turkbey,"Laureen  Sena (Dept of Radiology, Boston Childrens Hospital)|Steven  Fishman (Boston Childrens Hospital)",Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Bouchelouche K, Turkbey B, Choyke PL (2012). PET/CT and MRI in Bladder Cancer. J Cancer Sci Ther  S14.   https://doi.org/10.4172/1948-5956.S14-001|2. Kosaka N, Bernardo M, Mitsunaga M, Choyke PL, Kobayashi H (2012). MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals. Contrast Media Mol Imaging  7, 247-53.   https://doi.org/10.1002/cmmi.489|3. Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H (2013). In vivo real-time lymphatic draining using quantum-dot optical imaging in mice. Contrast Media Mol Imaging  8, 96-100.   https://doi.org/10.1002/cmmi.1487|4. Lim J, Turkbey B, Bernardo M, Bryant LH, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H (2012). Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. Bioconjug Chem  23, 2291-9.   https://doi.org/10.1021/bc300461r",https://intramural.nih.gov/search/searchview.taf?ipid=78395
185,BC010655-09,"October 01, 2012 -  September 30, 2013",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Harsh Kumar Agarwal|Marcelino  Bernardo|Dagane  Daar|Philip Charles Eclarinal|Karen A Kurdziel; MD|Show all 15,Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital),William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology),Bradford J Wood; MD (CC),"1. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ, European Society of Urogenital Radiology (2012). ESUR prostate MR guidelines 2012. Eur Radiol  22, 746-57.   https://doi.org/10.1007/s00330-011-2377-y|2. Gulley JL, Emberton M, Kurhanewicz J, Choyke P (2012). Progress in prostate cancer imaging. Urol Oncol  30, 938-9.   https://doi.org/10.1016/j.urolonc.2012.09.008|3. Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL (2012). The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med  53, 1175-84.   https://doi.org/10.2967/jnumed.111.100883|4. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|5. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA (2012). Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int  110, E694-700.   https://doi.org/10.1111/j.1464-410X.2012.11503.x|6. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|7. Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M (2012). Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys  39, 4093-103.   https://doi.org/10.1118/1.4722753|8. Tahmasebi AM, Sharifi R, Agarwal HK, Turkbey B, Bernardo M, Choyke P, Pinto P, Wood B, Kruecker J (2012). A statistical model-based technique for accounting for prostate gland deformation in endorectal coil-based MR imaging. Conf Proc IEEE Eng Med Biol Soc  2012, 5412-5.   https://doi.org/10.1109/EMBC.2012.6347218|9. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|10. Turkbey B, Choyke PL (2012). Multiparametric MRI and prostate cancer diagnosis and risk stratification. Curr Opin Urol  22, 310-5.   https://doi.org/10.1097/MOU.0b013e32835481c2|11. Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL (2012). Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int  110, 1642-7.   https://doi.org/10.1111/j.1464-410X.2012.11469.x|12. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology  268, 144-52.   https://doi.org/10.1148/radiol.13121325|13. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA (2012). Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol  188, 1157-1163.   https://doi.org/10.1016/j.juro.2012.06.011|14. Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M (2012). Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol  198, 1277-88.   https://doi.org/10.2214/AJR.12.8510|15. Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol  188, 2152-2157.   https://doi.org/10.1016/j.juro.2012.08.025|16. Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013). Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol  190, 2020-2025.   https://doi.org/10.1016/j.juro.2013.05.118|17. Wang S, Liu P, Turkbey B, Choyke P, Pinto P, Summers RM (2012). Gaussian process inference for estimating pharmacokinetic parameters of dynamic contrast-enhanced MR images. Med Image Comput Comput Assist Interv  15, 582-9.   https://doi.org/10.1007/978-3-642-33454-2_72|18. Wood BJ, Choyke P, Turkbey B, Pinto P (2013). Editorial comment. J Urol  189, 92.   https://doi.org/10.1016/j.juro.2012.08.261|19. Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int  110, E783-8.   https://doi.org/10.1111/j.1464-410X.2012.11646.x",https://intramural.nih.gov/search/searchview.taf?ipid=78396
186,BC010656-09,"October 01, 2012 -  September 30, 2013",Growth Factor Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Philip Charles Eclarinal|Michael  Green|Elaine Marie Jagoda; MS|Karen A Kurdziel; MD|Gideon K Kwarteng|Show all 17,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)",NULL,"1. Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013). Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics  12, 1621-31.   https://doi.org/10.1074/mcp.M112.026427|2. Jagoda EM, Lang L, Bhadrasetty V, Histed S, Williams M, Kramer-Marek G, Mena E, Rosenblum L, Marik J, Tinianow JN, Merchant M, Szajek L, Paik C, Cecchi F, Raffensperger K, Jose-Dizon JM, Bottaro DP, Choyke P (2012). Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. J Nucl Med  53, 1592-600.   https://doi.org/10.2967/jnumed.111.102293|3. Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC (2013). Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatr Blood Cancer  60, 396-401.   https://doi.org/10.1002/pbc.24281|4. Kramer-Marek G, Longmire MR, Choyke PL, Kobayashi H (2012). Recent advances in optical cancer imaging of EGF receptors. Curr Med Chem  19, 4759-66.   https://doi.org/10.2174/092986712803341584|5. Mitsunaga M, Nakajima T, Sano K, Kramer-Marek G, Choyke PL, Kobayashi H (2012). Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer  12, 345.   https://doi.org/10.1186/1471-2407-12-345|6. Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H (2012). Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Cancer Res  72, 4622-8.   https://doi.org/10.1158/0008-5472.CAN-12-1298|7. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2013). Acute cytotoxic effects of photoimmunotherapy assessed by 18F-FDG PET. J Nucl Med  54, 770-5.   https://doi.org/10.2967/jnumed.112.112110|8. Sano K, Nakajima T, Choyke PL, Kobayashi H (2013). Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano  7, 717-24.   https://doi.org/10.1021/nn305011p",https://intramural.nih.gov/search/searchview.taf?ipid=78397
187,BC010657-09,"October 01, 2012 -  September 30, 2013",Intracellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Marcelino  Bernardo|Philip Charles Eclarinal|Gideon K Kwarteng|Noriko  Sato; PhD|Mark  Williams|Show all 7,NULL,NULL,Richard  Childs; MD (NHLBI) |Joshua  Farber; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78398
188,BC010661-09,"October 01, 2012 -  September 30, 2013",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Anna Ruth Kwilas; PhD|Andressa  Ardiani|Marion G Taylor|Jeffrey  Schlom; PhD,NULL,NULL,NULL,"1. Ardiani A, Farsaci B, Rogers CJ, Protter A, Guo Z, King TH, Apelian D, Hodge JW (2013). Combination therapy with a second-generation androgen receptor antagonist and a metastasis vaccine improves survival in a spontaneous prostate cancer model. Clin Cancer Res  19, 6205-18.   https://doi.org/10.1158/1078-0432.CCR-13-1026|2. Gameiro SR, Caballero JA, Hodge JW (2012). Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing. Cancer Biother Radiopharm  27, 23-35.   https://doi.org/10.1089/cbr.2012.1203|3. Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang KY, Ferrone S, Gameiro SR (2013). Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Int J Cancer  133, 624-36.   https://doi.org/10.1002/ijc.28070",https://intramural.nih.gov/search/searchview.taf?ipid=78412
189,BC010666-09,"October 01, 2012 -  September 30, 2013",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Philip M Arlen; MD|Bonnie L Casey|Christopher Ryan Heery; MD|Joseph Woong Kim; MD|Jennifer L Marte|Sheri A Mcmahon|Show all 13,"Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Douglas  McNeel (University of Wisconsin)|Carsten Goessl  Goessl (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Ravi  Madan (Medical Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch),NULL,"1. Gulley J (2012) Prostate-specific antigen, in Encyclopedia of Cancer Therapeutic Targets. Marshall J, Weiner L, eds, in press.|2. Remondo C, Gulley J (2012) Immunotherapy for prostate cancer, in Targeted Therapies for Castration-Resistant Prostate Cancer. Cardino PT, ed., in press.|3. Bilusic M, Gulley JL (2012). Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines. Cancer Immunol Immunother  61, 109-17.   https://doi.org/10.1007/s00262-011-1141-0|4. Gulley J, Heery C, Madan R, Walter B, Merino M, Dahut W, Tsang K, Schlom J, Pinto P (2013) Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunology, Immunotherapy, in press.|5. Gulley JL, Madan RA, Heery CR (2013). Therapeutic vaccines and immunotherapy in castration-resistant prostate cancer: current progress and clinical applications. Am Soc Clin Oncol Educ Book  .  https://doi.org/10.1200/EdBook_AM.2013.33.e166|6. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013) Soluble CD27-pool in humans may contribute to T-cell activation and tumor immunity. J Immunol, in press.|7. Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J (2012). Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood  120, 3030-8.   https://doi.org/10.1182/blood-2012-05-427799|8. Kim JW, Gulley JL (2012). Poxviral vectors for cancer immunotherapy. Expert Opin Biol Ther  12, 463-78.   https://doi.org/10.1517/14712598.2012.668516|9. Madan R, Gulley J, Kantoff P (2013) Demystifying immunotherapy in prostate cancer: Understanding current and future treatment strategies. Cancer Journal (United States) 19(1):50-58|10. Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL (2012). Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol  39, 296-304.   https://doi.org/10.1053/j.seminoncol.2012.02.010|11. Madan RA, Schwaab T, Gulley JL (2012). Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer. J Natl Compr Canc Netw  10, 1505-12.   https://doi.org/10.6004/jnccn.2012.0156|12. Tucker J, Jochems C, Gulley J, Schlom J, Tsang K (2012) Shifting the balance of cell-mediated immunity and suppression in human prostate cancer [review]. Cancers 4:1333-1348",https://intramural.nih.gov/search/searchview.taf?ipid=78411
190,BC010668-09,"October 01, 2012 -  September 30, 2013",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Dagane  Daar|Philip Charles Eclarinal|Michael  Green|Elaine Marie Jagoda; MS|Karen A Kurdziel; MD|Show all 11,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL (2012). The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med  53, 1175-84.   https://doi.org/10.2967/jnumed.111.100883",https://intramural.nih.gov/search/searchview.taf?ipid=78394
191,BC010670-09,"October 01, 2012 -  September 30, 2013",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Molykutty J Aryankalayil|Adeola Yetunde Makinde|Adilakshmi  Tadepalli; PhD,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University),James B Mitchell; PhD (Radiation Biology Branch)|Sunghan  Yoo (Molecular Radiation Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78385
192,BC010671-09,"October 01, 2012 -  September 30, 2013",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Andrea Christine Bohrer|Thomas  Ciucci|Sugata  Manna|Melanie S Vacchio; PhD|Linus  Williams|Qi  Xiao,Albert  Bendelac (University of Chicago)|Marc  Jenkins,Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),"Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |John J O'Shea; MD (NIAMS) |Jinfang  Zhu; PhD (NIAID)","1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Carpenter AC, Grainger JR, Xiong Y, Kanno Y, Chu HH, Wang L, Naik S, dos Santos L, Wei L, Jenkins MK, O'Shea JJ, Belkaid Y, Bosselut R (2012). The transcription factors Thpok and LRF are necessary and partly redundant for T helper cell differentiation. Immunity  37, 622-33.   https://doi.org/10.1016/j.immuni.2012.06.019|3. Xiong Y, Bosselut R (2012). CD4-CD8 differentiation in the thymus: connecting circuits and building memories. Curr Opin Immunol  24, 139-45.   https://doi.org/10.1016/j.coi.2012.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=78384
193,BC010675-09,"October 01, 2012 -  September 30, 2013",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD|Sudipa  Chowdhury|David W Farnsworth|Saddam Musleh Muthana; PhD|Whitney Shea Wright|Yalong  Zhang|Show all 7",NULL,Luis G Rodriguez (Office Of The Director),NULL,"1. Zhang Y, Muthana SM, Barchi JJ, Gildersleeve JC (2012). Divergent behavior of glycosylated threonine and serine derivatives in solid phase peptide synthesis. Org Lett  14, 3958-61.   https://doi.org/10.1021/ol301723e|2. Zhang Y, Muthana SM, Farnsworth D, Ludek O, Adams K, Barchi JJ, Gildersleeve JC (2012). Enhanced epimerization of glycosylated amino acids during solid-phase peptide synthesis. J Am Chem Soc  134, 6316-25.   https://doi.org/10.1021/ja212188r",https://intramural.nih.gov/search/searchview.taf?ipid=78400
194,BC010677-09,"October 01, 2012 -  September 30, 2013",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS",NULL,NULL,NULL,"1. Doroshow JH, Juhasz A, Ge Y, Holbeck S, Lu J, Antony S, Wu Y, Jiang G, Roy K (2012). Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel. Biochem Pharmacol  83, 1195-207.   https://doi.org/10.1016/j.bcp.2012.01.022",https://intramural.nih.gov/search/searchview.taf?ipid=78399
195,BC010681-09,"October 01, 2012 -  September 30, 2013",Development of anti-polo-box therapeutic agents,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Sunho  Choi|Jung Eun  Park|Sang Gwon  Seo,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Terrence R Burke; PhD (Chemical Biology Laboratory),NULL,"1. He L, Lee J, Jang JH, Sakchaisri K, Hwang J, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, Soung NK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY (2013). Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast. Cell Signal  25, 552-60.   https://doi.org/10.1016/j.cellsig.2012.11.015|2. Liu F, Park JE, Qian WJ, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR (2012). Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification. ACS Chem Biol  7, 805-10.   https://doi.org/10.1021/cb200469a|3. Liu F, Park JE, Qian WJ, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR (2012). Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. Chembiochem  13, 1291-6.   https://doi.org/10.1002/cbic.201200206|4. Qian W, Park JE, Liu F, Lee KS, Burke TR (2013). Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position. Bioorg Med Chem  21, 3996-4003.   https://doi.org/10.1016/j.bmc.2012.05.036",https://intramural.nih.gov/search/searchview.taf?ipid=78406
196,BC010683-09,"October 01, 2012 -  September 30, 2013",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI","Kristin  Eckfeld|Naoto  Miyajima; MD, PhD|Harvey Grant Schwartz|Soichiro  Yoshida|Abbey Dyanne Zuehlke|William Marston Linehan; MD",Sunil  Sudarshan|YunJin  Jung (Pusan National University),NULL,NULL,"1. Douarre C, Sourbier C, Dalla Rosa I, Brata Das B, Redon CE, Zhang H, Neckers L, Pommier Y (2012). Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLoS One  7, e41094.   https://doi.org/10.1371/journal.pone.0041094",https://intramural.nih.gov/search/searchview.taf?ipid=78408
197,BC010692-09,"October 01, 2012 -  September 30, 2013",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Shannon I Skarshaug|Valerie M Zgonc,NULL,Blanche P Alter (Clinical Genetics Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),Irina  Maric; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78388
198,BC010696-09,"October 01, 2012 -  September 30, 2013",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","David D Roberts; PhD|Michael R Emmert-Buck; MD, PhD",NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|2. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM (2012). Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis  1, e14.   https://doi.org/10.1038/oncsis.2012.14|3. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013). An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer  132, 2640-7.   https://doi.org/10.1002/ijc.27934|4. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|5. Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM (2013). Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol  189, 430-5.   https://doi.org/10.1016/j.juro.2012.07.139|6. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001|7. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D (2012). Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol  36, 654-62.   https://doi.org/10.1097/PAS.0b013e31824f24a6",https://intramural.nih.gov/search/searchview.taf?ipid=78407
199,BC010701-08,"October 01, 2012 -  September 30, 2013",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Weizao  Chen|Yang  Feng|Dontcho Videv Jelev; PhD|Jinyu  Li|John  Owens|Prabakaran  Ponraj|Show all 10,Kurt  Ghelsen (RCT)|Philip  Low (Perdue University)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Rui  Gong; PhD|Yuxian  He (Chinese Academy of Medical Sciences)|Nancy  Ip (Hong University of Science and Technology)|Show all 12,Ira H Pastan; MD (Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Bradley D St Croix (Mouse Cancer Genetics Program)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Jeffrey  Baron; MD (NICHD) |Peter D Kwong; PhD (NIAID),"1. Adler MJ, Dimitrov DS (2012). Therapeutic antibodies against cancer. Hematol Oncol Clin North Am  26, 447-81, vii.   https://doi.org/10.1016/j.hoc.2012.02.013|2. Chen W, Feng Y, Zhao Q, Zhu Z, Dimitrov DS (2012). Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics. Mol Cancer Ther  11, 1400-10.   https://doi.org/10.1158/1535-7163.MCT-12-0172|3. Chen W, Ying T, Dimitrov DS (2013). Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design. Expert Opin Biol Ther  13, 657-71.   https://doi.org/10.1517/14712598.2013.761969|4. Feng Y, Dimitrov DS (2012). Antibody-based therapeutics against components of the IGF system. Oncoimmunology  1, 1390-1391.   https://doi.org/10.4161/onci.20925|5. Gehlsen K, Gong R, Bramhill D, Wiersma D, Kirkpatrick S, Wang Y, Feng Y, Dimitrov DS (2012). Pharmacokinetics of engineered human monomeric and dimeric CH2 domains. MAbs  4, 466-74.   https://doi.org/10.4161/mabs.20652|6. Gong R, Chen W, Dimitrov DS (2012). Expression, purification, and characterization of engineered antibody CH2 and VH domains. Methods Mol Biol  899, 85-102.   https://doi.org/10.1007/978-1-61779-921-1_6|7. Varewijck AJ, Brugts MP, Frystyk J, Goudzwaard JA, Uitterlinden P, Waaijers AM, Feng Y, Dimitrov DS, Lamberts SW, Hofland LJ, Janssen JA (2013). Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling. Mol Cell Endocrinol  365, 17-24.   https://doi.org/10.1016/j.mce.2012.08.021|8. Ying T, Chen W, Gong R, Feng Y, Dimitrov DS (2012). Soluble monomeric IgG1 Fc. J Biol Chem  287, 19399-408.   https://doi.org/10.1074/jbc.M112.368647|9. Zhao Q, Zhu Z, Dimitrov DS (2012). Yeast display of engineered antibody domains. Methods Mol Biol  899, 73-84.   https://doi.org/10.1007/978-1-61779-921-1_5|10. Dimitrov DS, Ying TS (submitted in 2012) Soluble Engineered Monomeric Fc. Patents issued: 2825557 (FR in 2017); 2825557 (GB in 2017); 9,676,857 (US in 2017); 602013022827 (DE in 2017); 2825557 (EP in 2017). Patents pending: PCT/US13/31593 (PC application); 15/590,981 (US application).|11. Ho M, Dimitrov D, Feng M, Gao W, Pastan I, Tang Z (submitted in 2012) Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity. Patents issued: 9,416,190 (US in 2016); 2900695 (EP in 2018); 2013324049 (AU in 2018). Patents pending: 201380060415.1 (CN application); 13766859.6 (DE application); 13766859.6 (ES application); 13766859.6 (FR application); 13766859.6 (GB application); 16100885.0 (HK application); 13766859.6 (IT application); 2015-534544 (JP application); PCT/US2013/059883 (PC application); 2885761 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=78415
200,BC010707-08,"October 01, 2012 -  September 30, 2013",Role of T regulatory suppression in autoimmunity and cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Xin  Chen|Ola Mae Zack Howard|Anna Lee  Trivett,NULL,Yinling  Hu (Laboratory of Experimental Immunology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Chen X, Wu X, Zhou Q, Howard OM, Netea MG, Oppenheim JJ (2013). TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment. J Immunol  190, 1076-84.   https://doi.org/10.4049/jimmunol.1202659|2. Zhou Q, Hu Y, Howard OM, Oppenheim JJ, Chen X (2014). In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo. Cytokine  65, 56-64.   https://doi.org/10.1016/j.cyto.2013.09.008",https://intramural.nih.gov/search/searchview.taf?ipid=78418
201,BC010708-08,"October 01, 2012 -  September 30, 2013",Consequences of receptor cross talk on inflammation and algesia,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Ola Mae Zack Howard|Anna Lee  Trivett|Zhizheng  Zhao,NULL,"Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78419
202,BC010709-08,"October 01, 2012 -  September 30, 2013",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen|Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch),"Carlo  Pierpaoli; MD, PhD (NICHD)","1. Ko C, Kaushal A, Hammoud DA, Steffen-Smith EA, Bent R, Citrin D, Camphausen K, Warren KE (2012). Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  83, 1252-1256.   https://doi.org/10.1016/j.ijrobp.2011.09.046|2. Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE (2012). Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  84, 774-9.   https://doi.org/10.1016/j.ijrobp.2012.01.032",https://intramural.nih.gov/search/searchview.taf?ipid=78441
203,BC010714-08,"October 01, 2012 -  September 30, 2013",Angiogenesis imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Harsh Kumar Agarwal|Marcelino  Bernardo|Philip Charles Eclarinal|Elaine Marie Jagoda; MS|Gideon K Kwarteng|Show all 15,Frederick  Giesel (University of Heidelberg)|Michael  Knopp (Ohio State University)|Anwar  Padhani (Mt Vernon Hospital),William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Ola Anders Landgren (Lymphoid Malignancies Branch),David M Thomasson; PhD (NIAID) |Thomas J Pohida; MS (CIT) |Chang Hum  Paik; PhD (CC),"1. Choyke PL (2012). Science to practice: imaging of cellular microparticles--magic dust or just dirt? Radiology  263, 1-2.   https://doi.org/10.1148/radiol.12120076|2. Gulley JL, Emberton M, Kurhanewicz J, Choyke P (2012). Progress in prostate cancer imaging. Urol Oncol  30, 938-9.   https://doi.org/10.1016/j.urolonc.2012.09.008|3. Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H (2013). In vivo real-time lymphatic draining using quantum-dot optical imaging in mice. Contrast Media Mol Imaging  8, 96-100.   https://doi.org/10.1002/cmmi.1487|4. Kramer-Marek G, Longmire MR, Choyke PL, Kobayashi H (2012). Recent advances in optical cancer imaging of EGF receptors. Curr Med Chem  19, 4759-66.   https://doi.org/10.2174/092986712803341584|5. Lim J, Turkbey B, Bernardo M, Bryant LH, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H (2012). Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. Bioconjug Chem  23, 2291-9.   https://doi.org/10.1021/bc300461r|6. Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H (2012). Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Cancer Res  72, 4622-8.   https://doi.org/10.1158/0008-5472.CAN-12-1298|7. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA (2012). Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int  110, E694-700.   https://doi.org/10.1111/j.1464-410X.2012.11503.x|8. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|9. Sano K, Nakajima T, Choyke PL, Kobayashi H (2013). Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano  7, 717-24.   https://doi.org/10.1021/nn305011p|10. Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyke PL, Harisinghani M (2012). Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol  198, 1277-88.   https://doi.org/10.2214/AJR.12.8510|11. Wang S, Liu P, Turkbey B, Choyke P, Pinto P, Summers RM (2012). Gaussian process inference for estimating pharmacokinetic parameters of dynamic contrast-enhanced MR images. Med Image Comput Comput Assist Interv  15, 582-9.   https://doi.org/10.1007/978-3-642-33454-2_72|12. Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int  110, E783-8.   https://doi.org/10.1111/j.1464-410X.2012.11646.x",https://intramural.nih.gov/search/searchview.taf?ipid=78428
204,BC010715-08,"October 01, 2012 -  September 30, 2013",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78442
205,BC010716-08,"October 01, 2012 -  September 30, 2013",Phase I and II Study of BCL Family Inhibitors in Lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Louis  Staudt; MD,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78443
206,BC010717-08,"October 01, 2012 -  September 30, 2013",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78444
207,BC010719-08,"October 01, 2012 -  September 30, 2013",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78445
208,BC010725-08,"October 01, 2012 -  September 30, 2013",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Gert  SchmidSchonbein (UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",Jonathan  Keller; PhD (Laboratory of Cancer Prevention),"Philip M Murphy; MD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Ronald N Germain; MD, PhD (NIAID)","1. Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM (2013). Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest  123, 1694-704.   https://doi.org/10.1172/JCI65569|2. Lämmermann T, Afonso PV, Angermann BR, Wang JM, Kastenmüller W, Parent CA, Germain RN (2013). Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature  498, 371-5.   https://doi.org/10.1038/nature12175|3. Liu Y, Chen K, Wang C, Gong W, Yoshimura T, Liu M, Wang JM (2013). Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. Cancer Res  73, 550-60.   https://doi.org/10.1158/0008-5472.CAN-12-2290|4. Madenspacher JH, Azzam KM, Gong W, Gowdy KM, Vitek MP, Laskowitz DT, Remaley AT, Wang JM, Fessler MB (2012). Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem  287, 43730-40.   https://doi.org/10.1074/jbc.M112.377192|5. Yavlovich A, Viard M, Zhou M, Veenstra TD, Wang JM, Gong W, Heldman E, Blumenthal R, Raviv Y (2012). Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells. Blood  120, 1246-53.   https://doi.org/10.1182/blood-2011-12-399063|6. Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, Liu Y, Liu M, Oppenheim JJ, Wang JM (2013) Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One 8:e58791",https://intramural.nih.gov/search/searchview.taf?ipid=78425
209,BC010728-08,"October 01, 2012 -  September 30, 2013",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78446
210,BC010729-08,"October 01, 2012 -  September 30, 2013",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Adele R Blackler; PhD|Qiang  Du; PhD|Jeffrey C Hanson|Michael  Tangrea,"Benjamin  Shapiro (Engineering, University of Maryland)|Elisabeth  Smela (Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"1. Hipp J, Monaco J, Kunju LP, Cheng J, Yagi Y, Rodriguez-Canales J, Emmert-Buck MR, Hewitt S, Feldman MD, Tomaszewski JE, Toner M, Tompkins RG, Flotte T, Lucas D, Gilbertson JR, Madabhushi A, Balis U (2012). Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification. Anal Cell Pathol (Amst)  35, 251-65.   https://doi.org/10.3233/ACP-2012-0054|2. Rodriguez-Canales J, Hanson JC, Hipp JD, Balis UJ, Tangrea MA, Emmert-Buck MR, Bova GS (2013). Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications. Methods Mol Biol  980, 61-120.   https://doi.org/10.1007/978-1-62703-287-2_5|3. Yan W, Shih J, Rodriguez-Canales J, Tangrea MA, Player A, Diao L, Hu N, Goldstein AM, Wang J, Taylor PR, Lippman SM, Wistuba II, Emmert-Buck MR, Erickson HS (2013). Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma. Am J Pathol  182, 529-39.   https://doi.org/10.1016/j.ajpath.2012.10.028|4. Yan W, Shih JH, Rodriguez-Canales J, Tangrea MA, Ylaya K, Hipp J, Player A, Hu N, Goldstein AM, Taylor PR, Emmert-Buck MR, Erickson HS (2012). Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma. BMC Res Notes  5, 73.   https://doi.org/10.1186/1756-0500-5-73",https://intramural.nih.gov/search/searchview.taf?ipid=78416
211,BC010735-08,"October 01, 2012 -  September 30, 2013",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao,NULL,NULL,NULL,"1. Bao R, Esser L, Sadhukhan A, Nair MK, Schifferli DM, Xia D (2012). Crystallization and preliminary X-ray diffraction analysis of PsaA, the adhesive pilin subunit that forms the pH 6 antigen on the surface of Yersinia pestis. Acta Crystallogr Sect F Struct Biol Cryst Commun  68, 1243-6.   https://doi.org/10.1107/S1744309112033076",https://intramural.nih.gov/search/searchview.taf?ipid=78427
212,BC010736-08,"October 01, 2012 -  September 30, 2013",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Steven  Seaman,Zissis  Chroneos (The Pennsylvania State University College of Medicine)|Joanna  Floros (The Pennsylvania State University College of Medicine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78440
213,BC010738-08,"October 01, 2012 -  September 30, 2013","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Ying  Liu|Hyunhee  Shin|Shree Ram  Singh|Xiankun  Zeng|Jiangsha  Zhao; PhD|Lino  Tessarollo,Neal  Copeland (Institute of Molecular and Cell Biology)|Nancy  Jenkins (Institute of Molecular and Cell Biology)|Xinhua  Lin (Children's Hospital Medical Center),NULL,NULL,"1. Zeng X, Hou SX (2012). Broad relays hormone signals to regulate stem cell differentiation in Drosophila midgut during metamorphosis. Development  139, 3917-25.   https://doi.org/10.1242/dev.083030",https://intramural.nih.gov/search/searchview.taf?ipid=78433
214,BC010740-08,"October 01, 2012 -  September 30, 2013",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sudipa  Chowdhury|Whitney Shea Wright,"Lara  Mahal (Chemistry, University of Texas at Austin)|Cristina  Voss (Department of Chemistry, German Cancer Research Center)|Mai  Xu; PhD|Matthew  Zimmt (Brown University)|Mohamed  Shoreibah (Abeome Corp.)|Zeev  Pancer (University of Maryland School of Medicine)|Show all 7",Miriam R Anver (Office Of The Director),NULL,"1. Bayer H, Essig K, Stanzel S, Frank M, Gildersleeve JC, Berger MR, Voss C (2012). Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. J Biol Chem  287, 35873-86.   https://doi.org/10.1074/jbc.M112.368548|2. Gildersleeve JC, Wang B, Achilefu S, Tu Z, Xu M (2012). Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies. Bioorg Med Chem Lett  22, 6839-43.   https://doi.org/10.1016/j.bmcl.2012.09.055",https://intramural.nih.gov/search/searchview.taf?ipid=78429
215,BC010742-08,"October 01, 2012 -  September 30, 2013",Utilizing Glycosyltransferases for Bioconjugation,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Natalia  Mercer|Boopathy  Ramakrishna,NULL,"Gary Leonard Griffiths; BSc, PhD (Molecular Imaging Program)",NULL,"1. Ramakrishnan B, Qasba P (2012) In vitro Folding of beta-1,4Galactosyltransferase and Polypeptide-alpha-N-acetylgalactosaminyltransferase from the Inclusion Bodies, in Methods in Molecular Biology -Glycosyltransferases: Methods and Protocols., in press.|2. Ramakrishnan B, Qasba P (2013) UDP-Gal:betaGlcNAc beta 1,4-galactosyl-transferase, polypeptide 1 (B4GALT1), in Handbook of Glycosyltransferases and Related Genes. Taniguchi N, Honke K, Fukuda M, Narimatsu H, Yamaguchi Y, Angata T, eds., in press.|3. Mercer N, Ramakrishnan B, Boeggeman E, Verdi L, Qasba PK (2013). Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface. Bioconjug Chem  24, 144-52.   https://doi.org/10.1021/bc300542z|4. Ramakrishnan B, Boeggeman E, Qasba PK (2012). Binding of N-acetylglucosamine (GlcNAc) β1-6-branched oligosaccharide acceptors to β4-galactosyltransferase I reveals a new ligand binding mode. J Biol Chem  287, 28666-74.   https://doi.org/10.1074/jbc.M112.373514|5. Ramakrishnan B, Moncrief A, Davis T, Holland L, Qasba P (2013) Investigations on Beta1,4-galactosyltransferase I using 6-sulfo-GlcNAc as an acceptor sugar substrate. Glycoconjugate Journal, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78438
216,BC010743-08,"October 01, 2012 -  September 30, 2013",Metabolic Mechanisms for Programmed Cell Death,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Joseph William Fischer|Chad Nathaniel Hancock; PhD|Wei  Liu|Akriti  Trehan,"Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Andrew  Lane (U. of Louisville)",Michael L Nickerson (Laboratory of Experimental Immunology),NULL,"1. Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A, Phang JM (2012). Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res  72, 3677-86.   https://doi.org/10.1158/0008-5472.CAN-12-0080|2. Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM (2012). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A  109, 8983-8.   https://doi.org/10.1073/pnas.1203244109|3. Liu W, Phang JM (2012). Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy  8, 1407-9.   https://doi.org/10.4161/auto.21152|4. Phang JM, Liu W, Hancock C (2013). Bridging epigenetics and metabolism: role of non-essential amino acids. Epigenetics  8, 231-6.   https://doi.org/10.4161/epi.24042|5. Phang JM, Liu W, Hancock C, Christian KJ (2012). The proline regulatory axis and cancer. Front Oncol  2, 60.   https://doi.org/10.3389/fonc.2012.00060",https://intramural.nih.gov/search/searchview.taf?ipid=78422
217,BC010744-08,"October 01, 2012 -  September 30, 2013",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Joseph William Fischer|Chad Nathaniel Hancock; PhD|Meredith Paige Harman|Wei  Liu|Akriti  Trehan,David  Valle (Johns Hopkins University School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Kristine  Glunde (Johns Hopkins),NULL,NULL,"1. Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A, Phang JM (2012). Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res  72, 3677-86.   https://doi.org/10.1158/0008-5472.CAN-12-0080|2. Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM (2012). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A  109, 8983-8.   https://doi.org/10.1073/pnas.1203244109|3. Liu W, Phang JM (2012). Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy  8, 1407-9.   https://doi.org/10.4161/auto.21152|4. Phang JM, Liu W, Hancock C (2013). Bridging epigenetics and metabolism: role of non-essential amino acids. Epigenetics  8, 231-6.   https://doi.org/10.4161/epi.24042|5. Phang JM, Liu W, Hancock C, Christian KJ (2012). The proline regulatory axis and cancer. Front Oncol  2, 60.   https://doi.org/10.3389/fonc.2012.00060",https://intramural.nih.gov/search/searchview.taf?ipid=78423
218,BC010746-08,"October 01, 2012 -  September 30, 2013",Extracellular Matrix and Stress Substrates: the Role of Prolidase,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Wei  Liu,Antonella  Forlino (University of Pavia)|Teresa  Gunn (McLaughlin Research Institute),NULL,NULL,"1. Phang JM, Liu W, Hancock C, Christian KJ (2012). The proline regulatory axis and cancer. Front Oncol  2, 60.   https://doi.org/10.3389/fonc.2012.00060",https://intramural.nih.gov/search/searchview.taf?ipid=78424
219,BC010747-08,"October 01, 2012 -  September 30, 2013",Charaterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Geraldine Martina O'Connor|Laura Ann R Quigley|Jonathan  Shakesprere|Mary  Carrington; MS, PhD|Stephen K Anderson; PhD","Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|Simon  Kollnberger (University of Oxford)|David  Price (Cardiff University)|Alain  Rook (University of Pennsylvania)",NULL,"Suk See De Ravin; MD, PhD (NIAID) |Robert A Colbert; MD, PhD (NIAMS) |Michael  Ward; MD (NIAMS)","1. O'Connor GM, McVicar D (2013). The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. Crit Rev Immunol  33, 203-18.   https://doi.org/10.1615/critrevimmunol.2013007409|2. O'Connor GM, Seich Al Basatena NK, Olavarria V, MacNamara A, Vine A, Ying Q, Hisada M, Galvão-Castro B, Asquith B, McVicar DW (2012). In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Hum Immunol  73, 783-7.   https://doi.org/10.1016/j.humimm.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78417
220,BC010749-08,"October 01, 2012 -  September 30, 2013",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Bhabadeb S Chowdhury; PhD|Jinyao  Li; PhD|Margherita  Rosati|Antonio L Valentin|Marjorie  Robert-Guroff; PhD|Show all 10,"Rama  Amara (Emory Vaccine Center)|Dan  Barouch (Harvard University)|Christian  Brander (AIDS Research Center, Massachusetts General Hospital)|Michael  Egan (Profectus Biosciences, Inc.)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Show all 27",Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director),Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID) |Adrian Bernard McDermott; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78420
221,BC010750-08,"October 01, 2012 -  September 30, 2013",Cytokines in AIDS and Cancer,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Barbara K Felber|Jay Arthur Berzofsky; MD, PhD|Lauren V Wood; MD",David  Weiner (University of Pennsylvania)|Dirk  Daelemans|Karen  Gaensler (University of California)|Peter  Katsikis (Drexel University College of Medicine)|Amitinder  Kaur (New England Primate Research Center),Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Elena  Chertova (Office Of The Director)|Stephen  Creekmore; PhD (Biological Resources Branch),"Tomoshige  Kino; MD, PhD (NICHD) |Richard A Koup; MD (NIAID) |Konstantinos  Petrovas (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78421
222,BC010759-08,"October 01, 2012 -  September 30, 2013",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Violet Maria Fernandes|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Yuan  Jiang; MD|Show all 15",Charles  Keller (University of Texas)|Heinrich  Kovar (St. Anna's Children's Hospital)|Jeffrey  Trent (TGen),Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P (2013). Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol  37, 234-40.   https://doi.org/10.1097/PAS.0b013e3182671178|2. Zhang H, Meltzer P, Davis S (2013). RCircos: an R package for Circos 2D track plots. BMC Bioinformatics  14, 244.   https://doi.org/10.1186/1471-2105-14-244|3. Zhu Y, Stephens RM, Meltzer PS, Davis SR (2013). SRAdb: query and use public next-generation sequencing data from within R. BMC Bioinformatics  14, 19.   https://doi.org/10.1186/1471-2105-14-19",https://intramural.nih.gov/search/searchview.taf?ipid=78437
223,BC010763-08,"October 01, 2012 -  September 30, 2013",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Erica Lynne Braverman|Zulmarie  Franco; MSc|Sidharth  Kerkar|Anthony J Leonardi|Douglas  Palmer|Rahul  Roychoudhuri|Show all 13,Ton  Schumacher (Netherlands Cancer Institute)|Paul  Antony (Univeristy of Maryland)|Carl  June (Univesity of Pennsylvania)|Vincenzo  Bronte|Christopher  Touloukian (Indianna University),Giorgio  Trinchieri (Laboratory of Experimental Immunology),Robert L Danner; MD (CC) |Mario  Roederer; PhD (NIAID),"1. Chinnasamy D, Tran E, Yu Z, Morgan RA, Restifo NP, Rosenberg SA (2013). Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice. Cancer Res  73, 3371-80.   https://doi.org/10.1158/0008-5472.CAN-12-3913|2. Chinnasamy D, Yu Z, Kerkar SP, Zhang L, Morgan RA, Restifo NP, Rosenberg SA (2012). Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clin Cancer Res  18, 1672-83.   https://doi.org/10.1158/1078-0432.CCR-11-3050|3. Crompton JG, Rao M, Restifo NP (2013). Memoirs of a reincarnated T cell. Cell Stem Cell  12, 6-8.   https://doi.org/10.1016/j.stem.2012.12.009|4. Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P (2013). MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity  38, 742-53.   https://doi.org/10.1016/j.immuni.2012.12.006|5. Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013). Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol  31, 2152-9.   https://doi.org/10.1200/JCO.2012.46.6441|6. Gattinoni L, Klebanoff CA, Restifo NP (2012). Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer  12, 671-84.   https://doi.org/10.1038/nrc3322|7. Hanada K, Restifo NP (2013). Double or nothing on cancer immunotherapy. Nat Biotechnol  31, 33-4.   https://doi.org/10.1038/nbt.2471|8. Jensen SM, Twitty CG, Maston LD, Antony PA, Lim M, Hu HM, Petrausch U, Restifo NP, Fox BA (2012). Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence. J Immunol  189, 767-76.   https://doi.org/10.4049/jimmunol.1103822|9. Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP (2013). Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther  21, 1369-77.   https://doi.org/10.1038/mt.2013.58|10. Kerkar SP, Restifo NP (2012). Cellular constituents of immune escape within the tumor microenvironment. Cancer Res  72, 3125-30.   https://doi.org/10.1158/0008-5472.CAN-11-4094|11. Klebanoff CA, Gattinoni L, Restifo NP (2012). Sorting through subsets:  which T-cell populations mediate highly effective adoptive immunotherapy? J Immunother  35, 651-60.   https://doi.org/10.1097/CJI.0b013e31827806e6|12. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M (2013). Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest  123, 594-9.   https://doi.org/10.1172/JCI66327|13. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M (2013). Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc  8, 33-42.   https://doi.org/10.1038/nprot.2012.143|14. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath A, Wang T, Bielekova B, Wuest SC, Akula N, et al. [6 more authors] (2013). Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother  36, 133-51.   https://doi.org/10.1097/CJI.0b013e3182829903|15. Restifo NP, Dudley ME, Rosenberg SA (2012). Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol  12, 269-81.   https://doi.org/10.1038/nri3191|16. Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, Gattinoni L, Heath JR, Kalos M, Marincola FM, Miller JS, Mostoslavsky G, Powell DJ, Rao M, Restifo NP, Rosenberg SA, O'Shea J, Melief CJ (2012). New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med  10, 48.   https://doi.org/10.1186/1479-5876-10-48|17. Wang A, Chandran S, Shah SA, Chiu Y, Paria BC, Aghamolla T, Alvarez-Downing MM, Lee CC, Singh S, Li T, Dudley ME, Restifo NP, Rosenberg SA, Kammula US (2012). The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci Transl Med  4, 149ra120.   https://doi.org/10.1126/scitranslmed.3004306|18. Yang S, Ji Y, Gattinoni L, Zhang L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA (2013). Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol Immunother  62, 727-36.   https://doi.org/10.1007/s00262-012-1378-2|19. Zhang L, Yu Z, Muranski P, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2013). Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy. Gene Ther  20, 575-80.   https://doi.org/10.1038/gt.2012.75|20. Zhong S, Malecek K, Johnson LA, Yu Z, Vega-Saenz de Miera E, Darvishian F, McGary K, Huang K, Boyer J, Corse E, Shao Y, Rosenberg SA, Restifo NP, Osman I, Krogsgaard M (2013). T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy. Proc Natl Acad Sci U S A  110, 6973-8.   https://doi.org/10.1073/pnas.1221609110",https://intramural.nih.gov/search/searchview.taf?ipid=78439
224,BC010766-07,"October 01, 2012 -  September 30, 2013",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",Smita Sarat Chandran|Biman  Paria|Abhishek Kumar Srivastava|Daniel Jordan Stephens; MD,NULL,NULL,NULL,"1. Wang A, Chandran S, Shah SA, Chiu Y, Paria BC, Aghamolla T, Alvarez-Downing MM, Lee CC, Singh S, Li T, Dudley ME, Restifo NP, Rosenberg SA, Kammula US (2012). The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci Transl Med  4, 149ra120.   https://doi.org/10.1126/scitranslmed.3004306",https://intramural.nih.gov/search/searchview.taf?ipid=78504
225,BC010767-07,"October 01, 2012 -  September 30, 2013",Biosynthesis of Selenocysteine and Its Incorporation into Protein,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Bradley A Carlson|Fang  Chen|Ryuta  Tobe|Petra Akiko Tsuji|Min-Hyuk  Yoo,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Byeong Jae  Lee (Seoul National University)|Michael  Howard (University of Utah)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",Harold  Seifried; PhD (Nutritional Science Research Group),NULL,"1. Xu X, Turanov A, Carlson B, Yoo M, Gladyshev V, Hatfield D (2012) Selenocysteine biosynthesis and the replacement of selenocysteine with cysteine in the pathway, in Selenium: Its molecular biology and role in human health. Hatfield D, Berry M, Gladyshev V, eds., pp. 23-32.",https://intramural.nih.gov/search/searchview.taf?ipid=78505
226,BC010770-07,"October 01, 2012 -  September 30, 2013",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathyayini Venkataseshasai Divi|Yongmin  Liu|Ofelia  Olivero; PhD|Michael O Ongele|Andrea V Rivera|Eunwoo  Shim|Show all 7,"Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Vernon  Walker (University of Vermont)",NULL,NULL,"1. Herman E, Kanpton A, Liu Y, Lipshultz S, Estis J, Todd J, Woodward R, Cochran T, Zhang J, Poirier M (2013) The influence of age on serum concentrations of Cardiac Troponin I Results in Monkeys, Rats and Commercial Sera. Toxicologic Pathology in press",https://intramural.nih.gov/search/searchview.taf?ipid=78507
227,BC010773-07,"October 01, 2012 -  September 30, 2013",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Demetria P Harvin|Jane  Mirro|Smita  Nair; PhD,"John  Coffin (Tufts University)|Hung  Fan (University of California, Irvine)|Susan R Ross",NULL,NULL,"1. Sanchez-Martinez S, Aloia AL, Harvin D, Mirro J, Gorelick RJ, Jern P, Coffin JM, Rein A (2012). Studies on the restriction of murine leukemia viruses by mouse APOBEC3. PLoS One  7, e38190.   https://doi.org/10.1371/journal.pone.0038190",https://intramural.nih.gov/search/searchview.taf?ipid=78506
228,BC010774-07,"October 01, 2012 -  September 30, 2013",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong|Matthias Martin Gaida|Maria Letizia  Giardino Torchia,Al  Fornace (Georgetown University)|Oded  Livnah (Hebrew University of Jerusalem),Ettore  Appella; MD (Chemical Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78447
229,BC010775-07,"October 01, 2012 -  September 30, 2013","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly",Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Muthukumar  Balasubramaniam|Lillian Susanna Kuo; PhD|Scott William Macdonald|Angelica Nascimento Martins; PhD|Megan Amanda Mounts|Show all 12,"Michael  Summers (University of Maryland, Baltimore County)|Tatyana  Polenova; PhD (University of Delaware)|Scott  Morham (Myriad Pharmaceuticals)|Anjali  Joshi|Alok  Mulky|Simon  Cocklin (Drexel University)",Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program),Judith Goldstein Levin; PhD (NICHD) |Jennifer A Lippincott Schwartz; PhD (NICHD),"1. Matreyek KA, Oztop I, Freed EO, Engelman A (2012). Viral latency and potential eradication of HIV-1. Expert Rev Anti Infect Ther  10, 855-7.   https://doi.org/10.1586/eri.12.68|2. Tedbury P, Ablan S, Freed E (2013) Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog, in press.|3. Waheed AA, Freed EO (2012). HIV type 1 Gag as a target for antiviral therapy. AIDS Res Hum Retroviruses  28, 54-75.   https://doi.org/10.1089/AID.2011.0230",https://intramural.nih.gov/search/searchview.taf?ipid=78458
230,BC010776-07,"October 01, 2012 -  September 30, 2013",Retrovirus Budding and Endosomal Sorting,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Muthukumar  Balasubramaniam|Lillian Susanna Kuo; PhD|Scott William Macdonald|Angelica Nascimento Martins; PhD|Megan Amanda Mounts|Show all 10,"Michael  Summers (University of Maryland, Baltimore County)|Scott  Morham (Myriad Pharmaceuticals)|Jeffrey  Aube; PhD (University of North Carolina)|Gali  Prag",NULL,James H Hurley; PhD (NIDDK) |Anton  Simeonov (NCATS),"1. Kuo L, Freed EO (2012). ARRDC1 as a mediator of microvesicle budding. Proc Natl Acad Sci U S A  109, 4025-6.   https://doi.org/10.1073/pnas.1201441109|2. Luttge BG, Panchal P, Puri V, Checkley MA, Freed EO (2014) Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission. Biochim Biophys Acta 1838:1143-52|3. Waheed AA, Freed EO (2012). HIV type 1 Gag as a target for antiviral therapy. AIDS Res Hum Retroviruses  28, 54-75.   https://doi.org/10.1089/AID.2011.0230",https://intramural.nih.gov/search/searchview.taf?ipid=78459
231,BC010778-07,"October 01, 2012 -  September 30, 2013",Inhibition of HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Emiko  Urano; PhD|Abdul Latheef Abdul Waheed|Alan  Rein; PhD,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Tatyana  Polenova; PhD (University of Delaware)|Catherine  Adamson (University of St. Andrews)|Feng  Li; PhD",Elena  Chertova (Office Of The Director),Alasdair C Steven; PhD (NIAMS),"1. Waheed AA, Freed EO (2012). HIV type 1 Gag as a target for antiviral therapy. AIDS Res Hum Retroviruses  28, 54-75.   https://doi.org/10.1089/AID.2011.0230|2. Waki K, Durell SR, Soheilian F, Nagashima K, Butler SL, Freed EO (2012). Structural and functional insights into the HIV-1 maturation inhibitor binding pocket. PLoS Pathog  8, e1002997.   https://doi.org/10.1371/journal.ppat.1002997",https://intramural.nih.gov/search/searchview.taf?ipid=78457
232,BC010779-07,"October 01, 2012 -  September 30, 2013",Regulation and Consequences of Ubiquitination,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Maria Letizia  Giardino Torchia,NULL,NULL,Dragana  Jankovic; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78448
233,BC010780-07,"October 01, 2012 -  September 30, 2013",Structural studies of molecular cancer targets and drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Brian P Austin|Shawn Michael Hess|George T Lountos|Danielle  Needle|Sreejith  Raran Kurussi; PhD,"Julius  Rebek (The Scripps Research Institute)|Kamal  Saikh (USAMRIID)|Christopher  Self (Provide Pharma)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Screening Technologies Branch)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,"1. Kissner TL, Ruthel G, Alam S, Mann E, Ajami D, Rebek M, Larkin E, Fernandez S, Ulrich RG, Ping S, Waugh DS, Rebek J, Saikh KU (2012). Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One  7, e40773.   https://doi.org/10.1371/journal.pone.0040773|2. Lountos GT, Tropea JE, Waugh DS (2013). Structure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas' disease. Mol Biochem Parasitol  187, 1-8.   https://doi.org/10.1016/j.molbiopara.2012.10.006|3. Raran-Kurussi S, Tözsér J, Cherry S, Tropea JE, Waugh DS (2013). Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases. Anal Biochem  436, 142-4.   https://doi.org/10.1016/j.ab.2013.01.031|4. Raran-Kurussi S, Waugh DS (2012). The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated. PLoS One  7, e49589.   https://doi.org/10.1371/journal.pone.0049589",https://intramural.nih.gov/search/searchview.taf?ipid=78463
234,BC010782-07,"October 01, 2012 -  September 30, 2013",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Inn-Inn  Chen|Michael Joseph Diprima|Hyeong Il  Kwak|Arianna  Caprioli|Nicole Sarah Mills|Hidetaka  Ohnuki|Show all 8,"James  Stone (Dept. of Cardiology, University of Alberta)|Catherine  Porcher (Oxford Univ)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Maria  Cid (Univ. of Barcelona Medical School)|Elena  Pasquale (Burnham Inst)|Show all 7",Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),"Dragan  Maric; PhD (NINDS) |William E Paul; MD (NIAID) |Jinfang  Zhu; PhD (NIAID) |Joshua  Farber; MD (NIAID) |Yosuke  Mukoyama; PhD (NHLBI) |Roberto  Weigert; MSc Chemistry, PhD (NIDCR)","1. Salvucci O, Jiang K, Gasperini P, Maric D, Zhu J, Sakakibara S, Espigol-Frigole G, Wang S, Tosato G (2012). MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. Haematologica  97, 818-26.   https://doi.org/10.3324/haematol.2011.056945|2. Salvucci O, Tosato G (2012). Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res  114, 21-57.   https://doi.org/10.1016/B978-0-12-386503-8.00002-8",https://intramural.nih.gov/search/searchview.taf?ipid=78464
235,BC010783-07,"October 01, 2012 -  September 30, 2013","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Swati Suresh Choksi|Huijuan  Cui|Elena  Pobezinskaya|Yan  Zhang|Ilona  Linnoila; MD,NULL,NULL,J Silvio  Gutkind; PhD (NIDCR),"1. Zhang Y, Morgan MJ, Chen K, Choksi S, Liu ZG (2012). Induction of autophagy is essential for monocyte-macrophage differentiation. Blood  119, 2895-905.   https://doi.org/10.1182/blood-2011-08-372383",https://intramural.nih.gov/search/searchview.taf?ipid=78465
236,BC010784-07,"October 01, 2012 -  September 30, 2013",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Sergio  Coelho|Lanlan  Yin,"Janusz  Beer (Center for Devices & Radiological Health, Food & Drug Administration)|Shosuke  Ito (Department of Chemistry, Fujita Health University)|Yuji  Yamaguchi|Ludger  Kolbe (Beiersdorf AG)",NULL,NULL,"1. Coelho SG, Zmudzka BZ, Yin L, Miller SA, Yamaguchi Y, Tadokoro T, Hearing VJ, Beer JZ (2013). Non-invasive diffuse reflectance measurements of cutaneous melanin content can predict human sensitivity to ultraviolet radiation. Exp Dermatol  22, 266-71.   https://doi.org/10.1111/exd.12116|2. Kornhauser A, Coelho SG, Hearing VJ (2012). Effects of cosmetic formulations containing hydroxyacids on sun-exposed skin: current applications and future developments. Dermatol Res Pract  2012, 710893.   https://doi.org/10.1155/2012/710893|3. Miller SA, Coelho SG, Miller SW, Yamaguchi Y, Hearing VJ, Beer JZ (2012). Evidence for a new paradigm for ultraviolet exposure: a universal schedule that is skin phototype independent. Photodermatol Photoimmunol Photomed  28, 187-95.   https://doi.org/10.1111/j.1600-0781.2012.00666.x",https://intramural.nih.gov/search/searchview.taf?ipid=78466
237,BC010785-07,"October 01, 2012 -  September 30, 2013",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Dominik David Ebsen; PhD|Julio C Valencia; MD|Lanlan  Yin,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Takeshi  Namiki|Thierry  Passeron",Michael Marc Gottesman; MD (Multidrug Resistence Section)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Kevin G Chen; MD (NINDS) |David R Adams (NHGRI) |Joseph A Mindell; BS, MD, PhD (NINDS)","1. Spritz R, Hearing V (2013) Abnormalities of Pigmentation, in Emery and Rimoin's Principles and Practice of Medical Genetics. Rimoin D, Connor J, Pyeritz R, Korf B, eds., pp. 4053-4096.|2. Choi W, Kolbe L, Hearing VJ (2012). Characterization of the bioactive motif of neuregulin-1, a fibroblast-derived paracrine factor that regulates the constitutive color and the function of melanocytes in human skin. Pigment Cell Melanoma Res  25, 477-81.   https://doi.org/10.1111/j.1755-148X.2012.01002.x|3. Kawaguchi M, Valencia JC, Namiki T, Suzuki T, Hearing VJ (2012). Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes. J Invest Dermatol  132, 2791-9.   https://doi.org/10.1038/jid.2012.261",https://intramural.nih.gov/search/searchview.taf?ipid=78467
238,BC010786-07,"October 01, 2012 -  September 30, 2013",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Dominik David Ebsen; PhD|Julio C Valencia; MD|Lanlan  Yin,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Ludger  Kolbe (Beiersdorf AG)|Takeshi  Namiki|Thierry  Passeron",NULL,NULL,"1. Spritz R, Hearing V (2013) Abnormalities of Pigmentation, in Emery and Rimoin's Principles and Practice of Medical Genetics. Rimoin D, Connor J, Pyeritz R, Korf B, eds., pp. 4053-4096.|2. Valencia J, Hearing V (2012) The role of glycosylation in the control of processing and cellular transport of the functional amyloid Pmel17, in Glycosylation. Petrescu S, ed., pp. 327-350.|3. Choi W, Kolbe L, Hearing VJ (2012). Characterization of the bioactive motif of neuregulin-1, a fibroblast-derived paracrine factor that regulates the constitutive color and the function of melanocytes in human skin. Pigment Cell Melanoma Res  25, 477-81.   https://doi.org/10.1111/j.1755-148X.2012.01002.x|4. Kawaguchi M, Valencia JC, Namiki T, Suzuki T, Hearing VJ (2012). Diacylglycerol kinase regulates tyrosinase expression and function in human melanocytes. J Invest Dermatol  132, 2791-9.   https://doi.org/10.1038/jid.2012.261",https://intramural.nih.gov/search/searchview.taf?ipid=78468
239,BC010788-07,"October 01, 2012 -  September 30, 2013",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Nancy Z Ding|Shiwei  He|Zhihui  Liu|Doo-Yi  Oh|Luke Allister Wylie|Javed  Khan; MD|Show all 7,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)",Lino  Tessarollo (Mouse Cancer Genetics Program)|Susan  Bates; MD (Medical Oncology Branch),Kai  Ge; PhD (NIDDK) |Yosuke  Mukoyama; PhD (NHLBI),"1. Liu Z, Thiele CJ (2012). ALK and MYCN: when two oncogenes are better than one. Cancer Cell  21, 325-6.   https://doi.org/10.1016/j.ccr.2012.03.004|2. Virden RA, Thiele CJ, Liu Z (2012). Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression. Mol Cell Biol  32, 1518-28.   https://doi.org/10.1128/MCB.06039-11|3. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, Marquez VE, Bates SE, Jin Q, Khan J, Ge K, Thiele CJ (2012). EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res  72, 315-24.   https://doi.org/10.1158/0008-5472.CAN-11-0961",https://intramural.nih.gov/search/searchview.taf?ipid=78470
240,BC010789-07,"October 01, 2012 -  September 30, 2013",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Shuang  Yan|Javed  Khan; MD|Chand  Khanna; MD,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)",Susan  Bates; MD (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Li Z, Yan S, Attayan N, Ramalingam S, Thiele CJ (2012). Combination of an allosteric Akt Inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma. Clin Cancer Res  18, 3603-15.   https://doi.org/10.1158/1078-0432.CCR-11-3321",https://intramural.nih.gov/search/searchview.taf?ipid=78471
241,BC010791-07,"October 01, 2012 -  September 30, 2013","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Danillo  Gardenal Augusto; PhD|Smita V Kulkarni; PhD|Show all 11,"Amalio  Telenti (University Hospital of Lausanne)|Howard  Strickler (Albert Einstein College of Medicine)|Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Show all 24",Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),NULL,"1. Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, Busch MP, Deeks SG, Carrington M, O'Doherty U, Kostman J, Montaner LJ (2013). Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis  207, 213-22.   https://doi.org/10.1093/infdis/jis663|2. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, Chui CK, Cotton LA, Knapp DJ, Riddler SA, Haubrich R, Nelson G, Pfeifer N, Deziel CE, Heckerman D, Apps R, Carrington M, Mallal S, Harrigan PR, John M, Brumme ZL, International HIV Adaptation Collaborative (2012). Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol  86, 13202-16.   https://doi.org/10.1128/JVI.01998-12|3. Carrington M, Alter G (2012). Innate immune control of HIV. Cold Spring Harb Perspect Med  2, a007070.   https://doi.org/10.1101/cshperspect.a007070|4. Carrington M, Walker BD (2012). Immunogenetics of spontaneous control of HIV. Annu Rev Med  63, 131-45.   https://doi.org/10.1146/annurev-med-062909-130018|5. Chen H, Hayashi G, Lai OY, Dilthey A, Kuebler PJ, Wong TV, Martin MP, Fernandez Vina MA, McVean G, Wabl M, Leslie KS, Maurer T, Martin JN, Deeks SG, Carrington M, Bowcock AM, Nixon DF, Liao W (2012). Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet  8, e1002514.   https://doi.org/10.1371/journal.pgen.1002514|6. Fadda L, Körner C, Kumar S, van Teijlingen NH, Piechocka-Trocha A, Carrington M, Altfeld M (2012). HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog  8, e1002805.   https://doi.org/10.1371/journal.ppat.1002805|7. Kløverpris HN, Harndahl M, Leslie AJ, Carlson JM, Ismail N, van der Stok M, Huang KH, Chen F, Riddell L, Steyn D, Goedhals D, van Vuuren C, Frater J, Walker BD, Carrington M, Ndung'u T, Buus S, Goulder P (2012). HIV control through a single nucleotide on the HLA-B locus. J Virol  86, 11493-500.   https://doi.org/10.1128/JVI.01020-12|8. Li JZ, Brumme CJ, Lederman MM, Brumme ZL, Wang H, Spritzler J, Carrington M, Medvik K, Walker BD, Schooley RT, Kuritzkes DR, AIDS Clinical Trials Group A5197 Study Team (2012). Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial. PLoS One  7, e34134.   https://doi.org/10.1371/journal.pone.0034134|9. Naruto T, Gatanaga H, Nelson G, Sakai K, Carrington M, Oka S, Takiguchi M (2012). HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent. J Virol  86, 10870-2.   https://doi.org/10.1128/JVI.00689-12|10. Sips M, Sciaranghella G, Diefenbach T, Dugast AS, Berger CT, Liu Q, Kwon D, Ghebremichael M, Estes JD, Carrington M, Martin JN, Deeks SG, Hunt PW, Alter G (2012). Altered distribution of mucosal NK cells during HIV infection. Mucosal Immunol  5, 30-40.   https://doi.org/10.1038/mi.2011.40|11. Tang M, Lautenberger JA, Gao X, Sezgin E, Hendrickson SL, Troyer JL, David VA, Guan L, McIntosh CE, Guo X, Zheng Y, Liao J, Deng H, Malasky M, Kessing B, Winkler CA, Carrington M, Dé The G, Zeng Y, O'Brien SJ (2012). The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet  8, e1003103.   https://doi.org/10.1371/journal.pgen.1003103|12. Thobakgale CF, Fadda L, Lane K, Toth I, Pereyra F, Bazner S, Ndung'u T, Walker BD, Rosenberg ES, Alter G, Carrington M, Allen TM, Altfeld M (2012). Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection. J Virol  86, 6986-93.   https://doi.org/10.1128/JVI.00569-12|13. Thomas R, Thio CL, Apps R, Qi Y, Gao X, Marti D, Stein JL, Soderberg KA, Moody MA, Goedert JJ, Kirk GD, Hoots WK, Wolinsky S, Carrington M (2012). A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol  86, 6979-85.   https://doi.org/10.1128/JVI.00406-12|14. Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ (2012). Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS  26, 1869-78.   https://doi.org/10.1097/QAD.0b013e32835861b0",https://intramural.nih.gov/search/searchview.taf?ipid=78452
242,BC010792-07,"October 01, 2012 -  September 30, 2013",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Darlene M Marti|Maureen P Martin|Show all 10,"John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Bruce  Walker (Harvard Medical School)|Diogo  Meyer (Genetics and evolutionary biology, University of Sao Paulo)|Ashley  Moffett (Pathology, University of Cambridge)|Maria  PetzlErler (Federal University of Parana)|Show all 11",NULL,NULL,"1. Deng Z, Gao X, Kirk GD, Wolinsky S, Carrington M (2012). Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts. Hum Immunol  73, 715-9.   https://doi.org/10.1016/j.humimm.2012.04.021",https://intramural.nih.gov/search/searchview.taf?ipid=78451
243,BC010793-07,"October 01, 2012 -  September 30, 2013","Role of inflammation, innate resistance, and immunity in carcinogenesis.",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Sarah Delia Cramer|Ren Ming  Dai|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Hiu  Kiu|Rosalba  Salcedo|Show all 11,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Mario  Colombo (Experimental Oncology, National Institute of Surgery and Cure of Tumors)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Dominique  Kaiserlian (U404, INSERM)|Sergey  Grivennikov (Fox Chase Cancer Center)",Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|David Anderson Wink (Radiation Biology Branch)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Alan  Sher; PhD (NIAID) |Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID),"1. Berezhnoy A, Stewart CA, Mcnamara JO, Thiel W, Giangrande P, Trinchieri G, Gilboa E (2012). Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing. Mol Ther  20, 1242-50.   https://doi.org/10.1038/mt.2012.18|2. Cataisson C, Salcedo R, Hakim S, Moffitt BA, Wright L, Yi M, Stephens R, Dai RM, Lyakh L, Schenten D, Yuspa HS, Trinchieri G (2012). IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J Exp Med  209, 1689-702.   https://doi.org/10.1084/jem.20101355|3. Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA (2012). The immune score as a new possible approach for the classification of cancer. J Transl Med  10, 1.   https://doi.org/10.1186/1479-5876-10-1|4. Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, Kelsall B, Trinchieri G, Sher A (2012). NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity  36, 1047-59.   https://doi.org/10.1016/j.immuni.2012.03.026|5. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012). Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature  491, 254-8.   https://doi.org/10.1038/nature11465|6. Ridnour LA, Cheng RY, Switzer CH, Heinecke JL, Ambs S, Glynn S, Young HA, Trinchieri G, Wink DA (2013). Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity. Clin Cancer Res  19, 1340-6.   https://doi.org/10.1158/1078-0432.CCR-12-0408|7. Stewart C, Gabrysova L, Steinhagen F, Hanson M, Metheny H, Roers A, O'Garra A, Muller W, Karp C, Trinchieri G (2013) IL-10 from tumor Treg is induced by type I interferon and limit the local TH17 response. J Clin Inv In press|8. Trinchieri G (2012). Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol  30, 677-706.   https://doi.org/10.1146/annurev-immunol-020711-075008|9. Trinchieri G (2012). Lymphocyte choriomeningitis virus plays hide-and-seek with type 1 interferon. Cell Host Microbe  11, 553-5.   https://doi.org/10.1016/j.chom.2012.05.007|10. Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A (2012). The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res  72, 3977-86.   https://doi.org/10.1158/0008-5472.CAN-12-0938",https://intramural.nih.gov/search/searchview.taf?ipid=78472
244,BC010795-07,"October 01, 2012 -  September 30, 2013",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Masahiko  Imashimizu|Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,"Zachary  Burton (Department of Biochemistry and Molecular Biology, Michigan State University)|Jianhua  Fu (Cornell University)|Charles  Turnbough (Unversity of Alabama)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Benoit  Coulombe (Institut de recherches cliniques de Montreal)|Carlos  Bustamante (University of California - Berkeley)|Show all 7",Jeffrey N Strathern (Genome Recombination and Regulation Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section)|Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Afonin KA, Kireeva M, Grabow WW, Kashlev M, Jaeger L, Shapiro BA (2012). Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs. Nano Lett  12, 5192-5.   https://doi.org/10.1021/nl302302e|2. Arnold JJ, Sharma SD, Feng JY, Ray AS, Smidansky ED, Kireeva ML, Cho A, Perry J, Vela JE, Park Y, Xu Y, Tian Y, Babusis D, Barauskus O, Peterson BR, Gnatt A, Kashlev M, Zhong W, Cameron CE (2012). Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathog  8, e1003030.   https://doi.org/10.1371/journal.ppat.1003030|3. Bintu L, Ishibashi T, Dangkulwanich M, Wu YY, Lubkowska L, Kashlev M, Bustamante C (2012). Nucleosomal elements that control the topography of the barrier to transcription. Cell  151, 738-749.   https://doi.org/10.1016/j.cell.2012.10.009|4. Kireeva ML, Opron K, Seibold SA, Domecq C, Cukier RI, Coulombe B, Kashlev M, Burton ZF (2012). Molecular dynamics and mutational analysis of the catalytic and translocation cycle of RNA polymerase. BMC Biophys  5, 11.   https://doi.org/10.1186/2046-1682-5-11|5. Zhou YN, Lubkowska L, Hui M, Court C, Chen S, Court DL, Strathern J, Jin DJ, Kashlev M (2013). Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J Biol Chem  288, 2700-10.   https://doi.org/10.1074/jbc.M112.429464",https://intramural.nih.gov/search/searchview.taf?ipid=78473
245,BC010800-07,"October 01, 2012 -  September 30, 2013",Convection enhanced delivery of agents into the brainstem of glioma patients,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen,NULL,NULL,"Russell R Lonser; MD (NINDS) |Carlo  Pierpaoli; MD, PhD (NICHD) |Joelle  Sarlls; PhD (NINDS) |John D Heiss; MD (NINDS)","1. Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE (2012). Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys  84, 774-9.   https://doi.org/10.1016/j.ijrobp.2012.01.032|2. Warren K (2013) Novel therapeutic delivery approaches in development for pediatric gliomas. Futur Oncology, in press.|3. Warren KE (2012). Diffuse intrinsic pontine glioma: poised for progress. Front Oncol  2, 205.   https://doi.org/10.3389/fonc.2012.00205",https://intramural.nih.gov/search/searchview.taf?ipid=78474
246,BC010801-07,"October 01, 2012 -  September 30, 2013",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Srivandana  Akshintala|Andrea Maria Baldwin|Diane  Cole|Eva  Dombi|Nalini M Jayaprakash|Robert F Murphy|Show all 9,"David  Viskochil (University of Utah)|John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Larry  Baker (SARC)|Susan  Blaney (Texas Children's Cancer Center)|Roger  Packer (Children's National Medical Center)|David  Gutmann (Washington University)|Show all 22","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Thomas J Hornyak (Dermatology Branch)|Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Ann M Cohen-Berger; MD (CC) |Nicholas  Patronas; MD (CC) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI)","1. Dagalakis U, Lodish M, Dombi E, Sinaii N, Sabo J, Baldwin A, Steinberg SM, Stratakis CA, Widemann BC (2014). Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I. J Pediatr  164, 620-4.   https://doi.org/10.1016/j.jpeds.2013.10.081|2. Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N (2013). MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J Clin Invest  123, 340-7.   https://doi.org/10.1172/JCI60578|3. Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC (2013). Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatr Blood Cancer  60, 396-401.   https://doi.org/10.1002/pbc.24281|4. Lodish MB, Dagalakis U, Sinaii N, Bornstein E, Kim A, Lokie KB, Baldwin AM, Reynolds JC, Dombi E, Stratakis CA, Widemann BC (2012). Bone mineral density in children and young adults with neurofibromatosis type 1. Endocr Relat Cancer  19, 817-25.   https://doi.org/10.1530/ERC-12-0293|5. Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B (2012). Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables. J Pediatr Psychol  37, 713-24.   https://doi.org/10.1093/jpepsy/jsr124|6. Meany H, Dombi E, Reynolds J, Whatley M, Kurwa A, Tsokos M, Salzer W, Gillespie A, Baldwin A, Derdak J, Widemann B (2013). 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Pediatr Blood Cancer  60, 59-64.   https://doi.org/10.1002/pbc.24212|7. Nguyen R, Dombi E, Widemann BC, Solomon J, Fuensterer C, Kluwe L, Friedman JM, Mautner VF (2012). Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis  7, 75.   https://doi.org/10.1186/1750-1172-7-75",https://intramural.nih.gov/search/searchview.taf?ipid=78475
247,BC010802-07,"October 01, 2012 -  September 30, 2013",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Amir Hossein Ameri|Paul Gerard Hynes|Keith Henry Jansson|Heather  Sheppard,NULL,NULL,NULL,"1. Hynes PG, Kelly K (2012). Prostate cancer stem cells: The case for model systems. J Carcinog  11, 6.   https://doi.org/10.4103/1477-3163.93701|2. Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K (2012). Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol  32, 941-53.   https://doi.org/10.1128/MCB.06306-11",https://intramural.nih.gov/search/searchview.taf?ipid=78476
248,BC010803-07,"October 01, 2012 -  September 30, 2013",Characterizing a novel tumor recognition mechanism,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Qiong J Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78477
249,BC010804-07,"October 01, 2012 -  September 30, 2013",Using Glycosyltransferases for the Development of Targeted Drug Delivery System,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,"1. Mercer N, Ramakrishnan B, Boeggeman E, Verdi L, Qasba PK (2013). Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface. Bioconjug Chem  24, 144-52.   https://doi.org/10.1021/bc300542z",https://intramural.nih.gov/search/searchview.taf?ipid=78478
250,BC010806-07,"October 01, 2012 -  September 30, 2013",Targeting High-risk Neuroblastoma using high through put siRNA screening,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Carol J Thiele|Lee Jay Helman; MD,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)",Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78479
251,BC010808-07,"October 01, 2012 -  September 30, 2013",Nucleosome Dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Jingjun  Hong|Hongwei  Wu|Bing-Rui  Zhou|Carl  Wu; PhD,NULL,NULL,Rodolfo  Ghirlando; PhD (NIDDK) |Tsan  Xiao; PhD (NIAID),"1. Chu X, Wang Y, Gan L, Bai Y, Han W, Wang E, Wang J (2012). Importance of electrostatic interactions in the association of intrinsically disordered histone chaperone Chz1 and histone H2A.Z-H2B. PLoS Comput Biol  8, e1002608.   https://doi.org/10.1371/journal.pcbi.1002608|2. Hong J, Feng H, Zhou Z, Ghirlando R, Bai Y (2013). Identification of functionally conserved regions in the structure of the chaperone/CenH3/H4 complex. J Mol Biol  425, 536-45.   https://doi.org/10.1016/j.jmb.2012.11.021|3. Kato H, Jiang J, Zhou BR, Rozendaal M, Feng H, Ghirlando R, Xiao TS, Straight AF, Bai Y (2013). A conserved mechanism for centromeric nucleosome recognition by centromere protein CENP-C. Science  340, 1110-3.   https://doi.org/10.1126/science.1235532",https://intramural.nih.gov/search/searchview.taf?ipid=78449
252,BC010814-07,"October 01, 2012 -  September 30, 2013",Regulation of Retroviral RNA Packaging and Dynamics of HIV-1 RNA Export,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kari Ann Dilley|Malika  Kuzembayeva|Louis M Levine|Edward D Liang|Olga A Nikolaitchik|Eduardo  Paredes; PhD|Show all 9,William W Fu|Roger  Ptak (Southern Research Institute)|David  Grnwald (Technical University of Delft)|Andrea  Galli|Dmitriy  Mazurov (Institute of Immunology)|WE  Moerner (Stanford University),Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78480
253,BC010816-07,"October 01, 2012 -  September 30, 2013",Immunotherapy for Malignant Mesothelioma,Raffit  Hassan|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Lisa Ann Bengtson|Sonya C Duke|Neetu  Kalra|Yvonne D Mallory|Jeannette Christine Nashed|Anish  Thomas; MD|Show all 12,NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Markku Martti Miettinen (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,"1. Kalra N, Ashai A, Xi L, Zhang J, Avital I, Raffeld M, Hassan R (2012). Patients with peritoneal mesothelioma lack epidermal growth factor receptor             tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep  27, 1794-800.   https://doi.org/10.3892/or.2012.1725|2. Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R (2012). Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell. Int J Cancer  131, 2143-52.   https://doi.org/10.1002/ijc.27471|3. Kelly RJ, Sharon E, Pastan I, Hassan R (2012). Mesothelin-targeted agents in clinical trials and in preclinical development. Mol Cancer Ther  11, 517-25.   https://doi.org/10.1158/1535-7163.MCT-11-0454|4. Le DT, Brockstedt DG, Nir-Paz R, Hampl J, Mathur S, Nemunaitis J, Sterman DH, Hassan R, Lutz E, Moyer B, Giedlin M, Louis JL, Sugar EA, Pons A, Cox AL, Levine J, Murphy AL, Illei P, Dubensky TW, Eiden JE, Jaffee EM, Laheru DA (2012). A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res  18, 858-68.   https://doi.org/10.1158/1078-0432.CCR-11-2121|5. Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I (2012). Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci U S A  109, 11782-7.   https://doi.org/10.1073/pnas.1209292109|6. Miller AC, Hassan R (2012). Clinical and pathological features are still the best determinants of prognosis in mesothelioma. Oncology (Williston Park)  26, 1176, 1178, 1180.|7. Sharon E, Zhang J, Hollevoet K, Steinberg SM, Pastan I, Onda M, Gaedcke J, Ghadimi BM, Ried T, Hassan R (2012). Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers. Clin Chem Lab Med  50, 721-5.   https://doi.org/10.1515/CCLM.2011.816|8. Thomas A, Hassan R (2012). Immunotherapies for non-small-cell lung cancer and mesothelioma. Lancet Oncol  13, e301-10.   https://doi.org/10.1016/S1470-2045(12)70126-2|9. Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I (2013). A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity. Mol Cancer Ther  12, 48-57.   https://doi.org/10.1158/1535-7163.MCT-12-0336|10. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP (2012). DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One  7, e31507.   https://doi.org/10.1371/journal.pone.0031507|11. Zhang J, Qiu S, Zhang Y, Merino M, Fetsch P, Avital I, Filie A, Pastan I, Hassan R (2012). Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P. Anticancer Res  32, 5151-8.",https://intramural.nih.gov/search/searchview.taf?ipid=78481
254,BC010819-07,"October 01, 2012 -  September 30, 2013",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Shawn A Hill|Shiva Rattan Ambardar|Zehava  Grossman; PhD,John W Mellors|Deborah  Persaud (Johns Hopkins University)|Deborah  McMahon (University of Pittsburgh)|Helene  Mens (Copenhagen University)|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|Show all 8,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Paul L Boyer (Retroviral Replication Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Michael  Polis; MD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joseph A Kovacs; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78482
255,BC010822-07,"October 01, 2012 -  September 30, 2013",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Lars  Bockmann|Prashant  Mishra|Lauren Elizabeth Dittman|Kentaro  Ohkuni|Tejaswini Arun Pachpor|Show all 8,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Melissa  Gardner (Univ of Minnesota)|Show all 8",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Choy JS, Mishra PK, Au WC, Basrai MA (2012). Insights into assembly and regulation of centromeric chromatin in Saccharomyces cerevisiae. Biochim Biophys Acta  1819, 776-83.   https://doi.org/10.1016/j.bbagrm.2012.02.008|2. Stirling PC, Crisp MJ, Basrai MA, Tucker CM, Dunham MJ, Spencer FA, Hieter P (2012). Mutability and mutational spectrum of chromosome transmission fidelity genes. Chromosoma  121, 263-75.   https://doi.org/10.1007/s00412-011-0356-3",https://intramural.nih.gov/search/searchview.taf?ipid=78450
256,BC010824-07,"October 01, 2012 -  September 30, 2013",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Gabriel Abraham Frank|Katherine Elizabeth Klymko|Joel Reuben Meyerson|Prashant Arkalgud Rao|Madhvi Jayalakshmi Venkatesh|Lisa M. Hartnell|Show all 7,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NICHD)","1. Kuybeda O, Frank GA, Bartesaghi A, Borgnia M, Subramaniam S, Sapiro G (2013). A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol  181, 116-27.   https://doi.org/10.1016/j.jsb.2012.10.010|2. Milne JL, Borgnia MJ, Bartesaghi A, Tran EE, Earl LA, Schauder DM, Lengyel J, Pierson J, Patwardhan A, Subramaniam S (2013). Cryo-electron microscopy--a primer for the non-microscopist. FEBS J  280, 28-45.   https://doi.org/10.1111/febs.12078",https://intramural.nih.gov/search/searchview.taf?ipid=78483
257,BC010825-07,"October 01, 2012 -  September 30, 2013",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Thao Phuong Do|Gabriel Abraham Frank|Giovanna  Grandinetti|Audray  Harris; PhD|Joel Reuben Meyerson|Show all 8,NULL,Jeffrey D Lifson; MD (Office Of The Director)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Alexander  Wlodawer; PhD (Protein Structure Section),"G. Marius  Clore; PhD, MD (NIDDK) |Avindra  Nath; MD (NINDS) |Kanta  Subbarao; MD, MPH (NIAID)","1. Frank GA, Bartesaghi A, Kuybeda O, Borgnia MJ, White TA, Sapiro G, Subramaniam S (2012). Computational separation of conformational heterogeneity using cryo-electron tomography and 3D sub-volume averaging. J Struct Biol  178, 165-76.   https://doi.org/10.1016/j.jsb.2012.01.004|2. Gopinath A, Xu G, Ress D, Öktem O, Subramaniam S, Bajaj C (2012). Shape-based regularization of electron tomographic reconstruction. IEEE Trans Med Imaging  31, 2241-52.   https://doi.org/10.1109/TMI.2012.2214229|3. Narayan K, Danielson CM, Lagarec K, Lowekamp BC, Coffman P, Laquerre A, Phaneuf MW, Hope TJ, Subramaniam S (2014). Multi-resolution correlative focused ion beam scanning electron microscopy: applications to cell biology. J Struct Biol  185, 278-84.   https://doi.org/10.1016/j.jsb.2013.11.008|4. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S (2012). Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog  8, e1002797.   https://doi.org/10.1371/journal.ppat.1002797",https://intramural.nih.gov/search/searchview.taf?ipid=78484
258,BC010826-07,"October 01, 2012 -  September 30, 2013",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Pinaki  Bose|Moez M Dawood|Lesley Ann Earl; PhD|Andrei Radu Florescu|Tushar  Govil|Show all 15,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Alexander  Wlodawer; PhD (Protein Structure Section),"Bernard R Brooks; PhD (NHLBI) |G. Marius  Clore; PhD, MD (NIDDK) |Mark Lee Mayer; BSc, PhD (NICHD)","1. Bartesaghi A, Lecumberry F, Sapiro G, Subramaniam S (2012). Protein secondary structure determination by constrained single-particle cryo-electron tomography. Structure  20, 2003-13.   https://doi.org/10.1016/j.str.2012.10.016|2. Earl LA, Lifson JD, Subramaniam S (2013). Catching HIV 'in the act' with 3D electron microscopy. Trends Microbiol  21, 397-404.   https://doi.org/10.1016/j.tim.2013.06.004|3. Frank GA, Bartesaghi A, Kuybeda O, Borgnia MJ, White TA, Sapiro G, Subramaniam S (2012). Computational separation of conformational heterogeneity using cryo-electron tomography and 3D sub-volume averaging. J Struct Biol  178, 165-76.   https://doi.org/10.1016/j.jsb.2012.01.004|4. Kuybeda O, Frank GA, Bartesaghi A, Borgnia M, Subramaniam S, Sapiro G (2013). A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol  181, 116-27.   https://doi.org/10.1016/j.jsb.2012.10.010|5. Milne JL, Borgnia MJ, Bartesaghi A, Tran EE, Earl LA, Schauder DM, Lengyel J, Pierson J, Patwardhan A, Subramaniam S (2013). Cryo-electron microscopy--a primer for the non-microscopist. FEBS J  280, 28-45.   https://doi.org/10.1111/febs.12078|6. Narayan K, Prosa TJ, Fu J, Kelly TF, Subramaniam S (2012). Chemical mapping of mammalian cells by atom probe tomography. J Struct Biol  178, 98-107.   https://doi.org/10.1016/j.jsb.2011.12.016|7. Patwardhan A, Carazo JM, Carragher B, Henderson R, Heymann JB, Hill E, Jensen GJ, Lagerstedt I, Lawson CL, Ludtke SJ, Mastronarde D, Moore WJ, Roseman A, Rosenthal P, Sorzano CO, Sanz-García E, Scheres SH, Subramaniam S, Westbrook J, Winn M, Swedlow JR, Kleywegt GJ (2012). Data management challenges in three-dimensional EM. Nat Struct Mol Biol  19, 1203-7.   https://doi.org/10.1038/nsmb.2426",https://intramural.nih.gov/search/searchview.taf?ipid=78485
259,BC010827-07,"October 01, 2012 -  September 30, 2013",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk|Mario J Borgnia; PhD|Sriram  Subramaniam; PhD,NULL,Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Milne JL, Borgnia MJ, Bartesaghi A, Tran EE, Earl LA, Schauder DM, Lengyel J, Pierson J, Patwardhan A, Subramaniam S (2013). Cryo-electron microscopy--a primer for the non-microscopist. FEBS J  280, 28-45.   https://doi.org/10.1111/febs.12078|2. Tran EE, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, Frank GA, Sapiro G, Milne JL, Subramaniam S (2012). Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog  8, e1002797.   https://doi.org/10.1371/journal.ppat.1002797",https://intramural.nih.gov/search/searchview.taf?ipid=78486
260,BC010830-07,"October 01, 2012 -  September 30, 2013",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Carol O Cardarelli|James Martin Greene|Matthew David Hall|Ashley A Jaeger; BS|Orit  Lavi; PhD|Tobie D Lee|Show all 9,Jacob  Hochman (Hebrew University)|Ram  Ganapathy (Cleveland Clinic)|Piet  Borst (Netherlands Cancer Institute)|JeanPierre  Gillet (University of Namur)|Doron  Levy (University of Maryland),Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Vincent J. Hearing; PhD (Pigment Cell Biology Section)|Ola Anders Landgren (Lymphoid Malignancies Branch),"Kevin G Chen; MD (NINDS) |Joshua  Zimmerberg; PhD, MD (NICHD) |Chava  Kimchi-Sarfaty (OD) |Thomas J Pohida; MS (CIT)","1. Gottesman MM (2013). The role of the NIH in nurturing clinician-scientists. N Engl J Med  368, 2249-51.   https://doi.org/10.1056/NEJMp1302969|2. Hochman J, Shen D, Gottesman MM, Chan CC (2013). Anti-LFA-1 antibodies enhance metastasis of ocular lymphoma to the brain and contralateral eye. Clin Exp Metastasis  30, 91-102.   https://doi.org/10.1007/s10585-012-9512-2|3. Kimchi-Sarfaty C, Gottesman MM (2012). SV40 in vitro packaging: a pseudovirion gene delivery system. Cold Spring Harb Protoc  2012, 1019-23.   https://doi.org/10.1101/pdb.prot071043|4. Lavi O, Gottesman MM, Levy D (2012). The dynamics of drug resistance: a mathematical perspective. Drug Resist Updat  15, 90-7.   https://doi.org/10.1016/j.drup.2012.01.003|5. Pouliot LM, Chen YC, Bai J, Guha R, Martin SE, Gottesman MM, Hall MD (2012). Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Res  72, 5945-55.   https://doi.org/10.1158/0008-5472.CAN-12-1400|6. Pouliot LM, Shen DW, Suzuki T, Hall MD, Gottesman MM (2013). Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells. Exp Cell Res  319, 566-74.   https://doi.org/10.1016/j.yexcr.2012.10.012|7. Rottenberg S, Vollebergh MA, de Hoon B, de Ronde J, Schouten PC, Kersbergen A, Zander SA, Pajic M, Jaspers JE, Jonkers M, Lodén M, Sol W, van der Burg E, Wesseling J, Gillet JP, Gottesman MM, Gribnau J, Wessels L, Linn SC, Jonkers J, Borst P (2012). Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. Cancer Res  72, 2350-61.   https://doi.org/10.1158/0008-5472.CAN-11-4201|8. Shen DW, Gottesman MM (2012). RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm Res  29, 643-50.   https://doi.org/10.1007/s11095-011-0562-y|9. Shen DW, Pouliot LM, Gillet JP, Ma W, Johnson AC, Hall MD, Gottesman MM (2012). The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin. Mol Pharm  9, 1822-33.   https://doi.org/10.1021/mp300153z|10. Shen DW, Pouliot LM, Hall MD, Gottesman MM (2012). Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev  64, 706-21.   https://doi.org/10.1124/pr.111.005637",https://intramural.nih.gov/search/searchview.taf?ipid=78487
261,BC010832-07,"October 01, 2012 -  September 30, 2013",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Megan L Peach|Markus  Sitzmann,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Iwona Elzbieta Weidlich,Raul Eduardo Cachau (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78488
262,BC010833-07,"October 01, 2012 -  September 30, 2013",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Jordi  Camps Polo|Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Turid A Knutsen|Nicole E Mcneil|Show all 11,NULL,NULL,NULL,"1. Hummon AB, Pitt JJ, Camps J, Emons G, Skube SB, Huppi K, Jones TL, Beissbarth T, Kramer F, Grade M, Difilippantonio MJ, Ried T, Caplen NJ (2012). Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. Mol Cancer  11, 1.   https://doi.org/10.1186/1476-4598-11-1",https://intramural.nih.gov/search/searchview.taf?ipid=78489
263,BC010834-07,"October 01, 2012 -  September 30, 2013","Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Amanda Iris Bradley|Bernard N Chen|Chi Chung  Cheng|Kerstin  Heselmeyer|Yue  Hu|Yueh Hwa Chien Tong|Show all 10,NULL,NULL,NULL,"1. Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ, Christensen R, Prindiville SA, Calzone KA, Soballe PW, Hu Y, Chowdhury SA, Schwartz R, Schäffer AA, Ried T (2012). Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol  181, 1807-22.   https://doi.org/10.1016/j.ajpath.2012.07.012|2. Ried T, Gaiser T (2012). A recurrent fusion gene in high-grade endometrial stromal sarcoma: a new tool for diagnosis and therapy? Genome Med  4, 20.   https://doi.org/10.1186/gm319",https://intramural.nih.gov/search/searchview.taf?ipid=78490
264,BC010835-07,"October 01, 2012 -  September 30, 2013",Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Jordi  Camps Polo|Eric  Cardin|Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Nicole E Mcneil|Show all 9,Yuri  Lazebnik (Cold Spring Harbor Laboratories)|Thomas  Cremer (University of Munich),Yamini Praful Dalal (Laboratory of Receptor Biology and Gene Expression),Danny L Sackett; PhD (NICHD),"1. Calado RT, Cooper JN, Padilla-Nash HM, Sloand EM, Wu CO, Scheinberg P, Ried T, Young NS (2012). Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia  26, 700-7.   https://doi.org/10.1038/leu.2011.272|2. Hirsch D, Kemmerling R, Davis S, Camps J, Meltzer PS, Ried T, Gaiser T (2013). Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res  73, 1454-60.   https://doi.org/10.1158/0008-5472.CAN-12-0928|3. Ried T, Hu Y, Difilippantonio MJ, Ghadimi BM, Grade M, Camps J (2012). The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. Biochim Biophys Acta  1819, 784-93.   https://doi.org/10.1016/j.bbagrm.2012.02.020|4. Tang J, Li Y, Lyon K, Camps J, Dalton S, Ried T, Zhao S (2014). Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer. Oncogene  33, 814-22.   https://doi.org/10.1038/onc.2013.17",https://intramural.nih.gov/search/searchview.taf?ipid=78491
265,BC010837-07,"October 01, 2012 -  September 30, 2013",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Damrong M Wangsa|Darawalee  Wangsa|Natasha  Caplen,NULL,NULL,NULL,"1. Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T (2012). The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res  18, 4919-30.   https://doi.org/10.1158/1078-0432.CCR-12-0016|2. Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP (2013). Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res  19, 4983-93.   https://doi.org/10.1158/1078-0432.CCR-13-0209",https://intramural.nih.gov/search/searchview.taf?ipid=78493
266,BC010839-07,"October 01, 2012 -  September 30, 2013",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Rolanda  Bailey|Mehmet  Baysan|Galina Ivanovna Belova|Margaret  Cam; PhD|Emely  Castro-Rivera|Show all 17,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78454
267,BC010844-07,"October 01, 2012 -  September 30, 2013",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)",Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78495
268,BC010845-07,"October 01, 2012 -  September 30, 2013",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Ettore  Appella; MD (Chemical Immunology Section),Ronald D Neumann; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78462
269,BC010846-07,"October 01, 2012 -  September 30, 2013",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Jung Shin  Byun|Jesse F Quintero|Paul S Meltzer; MD, PhD",NULL,William D Figg; PharmD (Medical Oncology Branch),Dan L Longo; MD (NIA),"1. Byun JS, Fufa TD, Wakano C, Fernandez A, Haggerty CM, Sung MH, Gardner K (2012). ELL facilitates RNA polymerase II pause site entry and release. Nat Commun  3, 633.   https://doi.org/10.1038/ncomms1652|2. Li X, Li L, Pandey R, Byun JS, Gardner K, Qin Z, Dou Y (2012). The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell  11, 163-78.   https://doi.org/10.1016/j.stem.2012.04.023|3. Wakano C, Byun JS, Di LJ, Gardner K (2012). The dual lives of bidirectional promoters. Biochim Biophys Acta  1819, 688-93.   https://doi.org/10.1016/j.bbagrm.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=78460
270,BC010847-07,"October 01, 2012 -  September 30, 2013",Gene-specific Mechanisms of BRCA1 transcriptional Control,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Jung Shin  Byun|Natnael Debela Kenea; BSc|Jesse F Quintero|Paul S Meltzer; MD, PhD",NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Kevin A Camphausen; MD (Radiation Oncology Branch),Dan L Longo; MD (NIA),"1. Li X, Li L, Pandey R, Byun JS, Gardner K, Qin Z, Dou Y (2012). The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell  11, 163-78.   https://doi.org/10.1016/j.stem.2012.04.023",https://intramural.nih.gov/search/searchview.taf?ipid=78461
271,BC010850-07,"October 01, 2012 -  September 30, 2013",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Luz Marina Giordano|Kathryn Elizabeth Hudak|Ayla Oksuz White,David  Gaffney (University of Utah)|Radaition  Oncology (Unniversity of Pennsylvania),James B Mitchell; PhD (Radiation Biology Branch),Pamela Gehron Robey; PhD (NIDCR),"1. Baum BJ, Alevizos I, Zheng C, Cotrim AP, Liu S, McCullagh L, Goldsmith CM, Burbelo PD, Citrin DE, Mitchell JB, Nottingham LK, Rudy SF, Van Waes C, Whatley MA, Brahim JS, Chiorini JA, Danielides S, Turner RJ, Patronas NJ, Chen CC, Nikolov NP, Illei GG (2012). Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A  109, 19403-7.   https://doi.org/10.1073/pnas.1210662109|2. Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, Gaffney D (2012). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol  7, 64.   https://doi.org/10.1186/1748-717X-7-64|3. Saligan LN, Hsiao CP, Wang D, Wang XM, St John L, Kaushal A, Citrin D, Barb JJ, Munson PJ, Dionne RA (2013). Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain Behav Immun  27, 63-70.   https://doi.org/10.1016/j.bbi.2012.09.009",https://intramural.nih.gov/search/searchview.taf?ipid=78497
272,BC010852-07,"October 01, 2012 -  September 30, 2013",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Christian Hans Bode; MD|Takashi  Sato|Debra  Tross|Yan  Wang; PhD, MD|Jing  Wang|Gan  Zhao|Show all 8","Ihsan  Gursel|Jay  Hooper (USAMRIID)|Yoshiaki  Ishigatsubo; MD, PhD (Yokohama City Univ Medical School)|Sven  Klaschik","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)",Igal  Gery; PhD (NEI),"1. Kinjo T, Tomaru K, Haines DC, Klinman DM (2012). The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy. Respir Res  13, 47.   https://doi.org/10.1186/1465-9921-13-47|2. Shirota H, Klinman DM (2012). Effect of CpG ODN on monocytic myeloid derived suppressor cells. Oncoimmunology  1, 780-782.   https://doi.org/10.4161/onci.19731|3. Shirota Y, Shirota H, Klinman DM (2012). Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol  188, 1592-9.   https://doi.org/10.4049/jimmunol.1101304|4. Steinhagen F, Meyer C, Tross D, Gursel M, Maeda T, Klaschik S, Klinman DM (2012). Activation of type I interferon-dependent genes characterizes the ""core response"" induced by CpG DNA. J Leukoc Biol  92, 775-85.   https://doi.org/10.1189/jlb.1011522|5. Yang D, Postnikov YV, Li Y, Tewary P, de la Rosa G, Wei F, Klinman D, Gioannini T, Weiss JP, Furusawa T, Bustin M, Oppenheim JJ (2012). High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med  209, 157-71.   https://doi.org/10.1084/jem.20101354|6. Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters RC, Kirk J, Eppler B, Klinman DM, Sui Y, Gagnon S, Belyakov IM, Mumper RJ, Berzofsky JA (2012). Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med  18, 1291-6.   https://doi.org/10.1038/nm.2866",https://intramural.nih.gov/search/searchview.taf?ipid=78502
273,BC010853-07,"October 01, 2012 -  September 30, 2013",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Takashi  Sato|Debra  Tross|Jing  Wang|Gan  Zhao|Giorgio  Trinchieri,NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Igal  Gery; PhD (NEI),"1. Steinhagen F, McFarland AP, Rodriguez LG, Tewary P, Jarret A, Savan R, Klinman DM (2013). IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. Eur J Immunol  43, 1896-906.   https://doi.org/10.1002/eji.201242792",https://intramural.nih.gov/search/searchview.taf?ipid=78503
274,BC010870-06,"October 01, 2012 -  September 30, 2013",Hematopoietic Stem Cell Transplant for Immunodeficiency with MDS,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert R West,NULL,NULL,Steven M Holland; MD (NIAID),"1. Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC, Hickstein DD, Pavletic S, Fahle G, Nath A (2013). Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology  80, 1494-500.   https://doi.org/10.1212/WNL.0b013e31828cf8a2|2. Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong CE, Babic M, Bardy PG, Shimamura A, Zhang MY, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, Harvey NL (2012). Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood  119, 1283-91.   https://doi.org/10.1182/blood-2011-08-374363",https://intramural.nih.gov/search/searchview.taf?ipid=78565
275,BC010871-06,"October 01, 2012 -  September 30, 2013",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Miriam R Anver (Office Of The Director)|Melinda  Hollingshead (Biological Testing Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78678
276,BC010872-06,"October 01, 2012 -  September 30, 2013",High throughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Pavol  Cekan; PhD,NULL,NULL,Min  Shen (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78643
277,BC010876-06,"October 01, 2012 -  September 30, 2013",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Satish Babu  Agadkar|Anuradha Samantha Budhu|Marshonna J Forgues|Junfang  Ji|Sonya Teresa Parpart|Atsushi  Takai; MD, PhD|Show all 8",Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute)|Show all 7,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Mitchell  Ho (Laboratory of Molecular Biology)",NULL,"1. Ji J, Wang XW (2012). Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol  39, 461-72.   https://doi.org/10.1053/j.seminoncol.2012.05.011|2. Ji J, Wang XW (2012). Identification of cancer stem cell-related microRNAs in hepatocellular carcinoma. Methods Mol Biol  826, 163-75.   https://doi.org/10.1007/978-1-61779-468-1_14|3. Zhu WW, Guo JJ, Guo L, Jia HL, Zhu M, Zhang JB, Loffredo CA, Forgues M, Huang H, Xing XJ, Ren N, Dong QZ, Zhou HJ, Ren ZG, Zhao NQ, Wang XW, Tang ZY, Qin LX, Ye QH (2013). Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma. Clin Cancer Res  19, 3944-54.   https://doi.org/10.1158/1078-0432.CCR-12-3363",https://intramural.nih.gov/search/searchview.taf?ipid=78622
278,BC010877-06,"October 01, 2012 -  September 30, 2013",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Stephanie  Roessler|Zhipeng  Yu,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78621
279,BC010880-06,"October 01, 2012 -  September 30, 2013",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Philip L Martin (Office of the Director)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78616
280,BC010881-06,"October 01, 2012 -  September 30, 2013",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kathleen C Flanders; PhD|Dror  Luger; PhD|Asaf  Raviv|Yu-an  Yang|Jeffrey E Green; MD|Robert Mark Simpson; DVM, PhD|Show all 8","Scott  Lonning (Gene Therapy, Genzyme Corp.)|John  McPherson (Genzyme Corp.)|Amer  Mirza (XOMA (US) LLC)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Miriam R Anver (Office Of The Director)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jane Beth Trepel (Medical Oncology Branch)|Jinqiu  Chen (Pigment Cell Biology Section)",NULL,"1. Luger D, Wakefield L (2012) Inflammation and beyond:  complex roles for TGF-beta in the tumor microenvironment, in The Inflammatory Milieu of Tumors:  Cytokines and Chemokines that Affect Tumor Growth and Metastasis. Ben-Baruch A, ed., in press.|2. Luger D, Yang Y, Raviv A, Weinberg D, Banerjee S, Lee M, Trepel J, Yang L, Wakefield L (2013) Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLOS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78619
281,BC010885-06,"October 01, 2012 -  September 30, 2013",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI","Karen O Aleman|David A Davis; MD|Duosha  Hu; MD, PhD|Suraj  Mishra|Thomas S Uldrick|Ravindra P Veeranna|Show all 10",NULL,"Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)",NULL,"1. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM (2012). Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol  86, 11663-74.   https://doi.org/10.1128/JVI.01147-12|2. Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G (2012). Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res  72, 1157-69.   https://doi.org/10.1158/0008-5472.CAN-11-3067|3. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R (2012). Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front Microbiol  3, 73.   https://doi.org/10.3389/fmicb.2012.00073|4. Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Whitby D (2012). Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. J Infect Dis  205, 1665-76.   https://doi.org/10.1093/infdis/jis249|5. Sakakibara S, Espigol-Frigole G, Gasperini P, Uldrick TS, Yarchoan R, Tosato G (2013). A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein. Oncogene  32, 1223-32.   https://doi.org/10.1038/onc.2012.145|6. Veeranna RP, Haque M, Davis DA, Yang M, Yarchoan R (2012). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. J Virol  86, 1097-108.   https://doi.org/10.1128/JVI.05167-11",https://intramural.nih.gov/search/searchview.taf?ipid=78635
282,BC010886-06,"October 01, 2012 -  September 30, 2013",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Adrienne Michelle Starks,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S (2013). MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene  32, 4139-47.   https://doi.org/10.1038/onc.2012.424|2. Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs S (2012). MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res  40, 3689-703.   https://doi.org/10.1093/nar/gkr1222",https://intramural.nih.gov/search/searchview.taf?ipid=78508
283,BC010887-06,"October 01, 2012 -  September 30, 2013",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Prachi  Mishra|Adrienne Michelle Starks|Atsushi  Terunuma,"Feng  WangJohanning (University of Texas MD Anderson Cancer Center)|Arun  Sreekumar (Baylor College of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Bernhard  KwabiAddo (Howard University)|Olufunmilayo  Olopade (University of Chicago)",David Anderson Wink (Radiation Biology Branch),NULL,"1. Ambs S (2012). Analysis of stromal gene expression for the identification of prognostic and predictive molecular markers in cancer therapy. Int J Cancer  131, 2213-4.   https://doi.org/10.1002/ijc.27568|2. Hou N, Zheng Y, Gamazon ER, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, Pierce B, Cox NJ, Olopade OI, Huo D (2012). Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiol Biomarkers Prev  21, 552-6.   https://doi.org/10.1158/1055-9965.EPI-11-0979|3. Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, Cox NJ, Olopade OI (2012). Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis  33, 835-40.   https://doi.org/10.1093/carcin/bgs093|4. Ridnour LA, Barasch KM, Windhausen AN, Dorsey TH, Lizardo MM, Yfantis HG, Lee DH, Switzer CH, Cheng RY, Heinecke JL, Brueggemann E, Hines HB, Khanna C, Glynn SA, Ambs S, Wink DA (2012). Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. PLoS One  7, e44081.   https://doi.org/10.1371/journal.pone.0044081|5. Switzer CH, Cheng RY, Ridnour LA, Glynn SA, Ambs S, Wink DA (2012). Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. Breast Cancer Res  14, R125.   https://doi.org/10.1186/bcr3319|6. Switzer CH, Cheng RY, Ridnour LA, Murray MC, Tazzari V, Sparatore A, Del Soldato P, Hines HB, Glynn SA, Ambs S, Wink DA (2012). Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Res  72, 2394-404.   https://doi.org/10.1158/0008-5472.CAN-11-3115|7. Switzer CH, Glynn SA, Cheng RY, Ridnour LA, Green JE, Ambs S, Wink DA (2012). S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol Cancer Res  10, 1203-15.   https://doi.org/10.1158/1541-7786.MCR-12-0124|8. Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B (2012). Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One  7, e37928.   https://doi.org/10.1371/journal.pone.0037928|9. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL (2012). Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst  104, 189-210.   https://doi.org/10.1093/jnci/djr540|10. Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, Cox NJ, Olopade OI, Huo D (2012). Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Res Treat  132, 341-5.   https://doi.org/10.1007/s10549-011-1890-7",https://intramural.nih.gov/search/searchview.taf?ipid=78509
284,BC010888-06,"October 01, 2012 -  September 30, 2013",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Karen O Aleman|Thomas S Uldrick|Victoria Y Wang|Kathleen M Wyvill|Joseph M Ziegelbauer,NULL,"Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)",Amir Hossein Gandjbakhche; PhD (NICHD) |Moinuddin  Hassan; PhD (NICHD) |H. Clifford  Lane; MD (NIAID) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID),"1. O'Mahony D, Little R, Yarchoan R (2012) AIDS and cancer, in Cancer - The Outlaw Cell. LaFond R, ed., pp. 165-178.|2. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484|3. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R (2012). Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front Microbiol  3, 73.   https://doi.org/10.3389/fmicb.2012.00073|4. Uldrick TS, Polizzotto MN, Yarchoan R (2012). Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol  24, 495-505.   https://doi.org/10.1097/CCO.0b013e328355e0f3|5. Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R (2012). Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol  30, 1476-83.   https://doi.org/10.1200/JCO.2011.39.6853",https://intramural.nih.gov/search/searchview.taf?ipid=78634
285,BC010891-06,"October 01, 2012 -  September 30, 2013",Antibody Therapy of Cancer,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Mingqian  Feng|Wei  Gao|Zhewei  Tang|Yifan  Zhang|Raffit  Hassan,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|William D Figg; PharmD (Medical Oncology Branch)|Tim Friedrich Greten (Medical Oncology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Gauthier A, Ho M (2013). Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol Res  43, 147-54.   https://doi.org/10.1111/j.1872-034X.2012.01113.x|2. Ho M, Royston I, Beck A (2012). 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA. MAbs  4, 562-70.   https://doi.org/10.4161/mabs.21521|3. Kim H, Phung Y, Ho M (2012). Changes in global gene expression associated with 3D structure of tumors: an ex vivo matrix-free mesothelioma spheroid model. PLoS One  7, e39556.   https://doi.org/10.1371/journal.pone.0039556|4. Phung Y, Gao W, Man YG, Nagata S, Ho M (2012). High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening. MAbs  4, 592-9.   https://doi.org/10.4161/mabs.20933|5. Tang Z, Qian M, Ho M (2013). The role of mesothelin in tumor progression and targeted therapy. Anticancer Agents Med Chem  13, 276-80.   https://doi.org/10.2174/1871520611313020014|6. Ho M, Dimitrov D, Feng M, Gao W, Pastan I, Tang Z (submitted in 2012) Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity. Patents issued: 9,416,190 (US in 2016); 2900695 (EP in 2018); 2013324049 (AU in 2018). Patents pending: 201380060415.1 (CN application); 13766859.6 (DE application); 13766859.6 (ES application); 13766859.6 (FR application); 13766859.6 (GB application); 16100885.0 (HK application); 13766859.6 (IT application); 2015-534544 (JP application); PCT/US2013/059883 (PC application); 2885761 (CA application).|7. Ho M, Gao W, Hassan R, Pastan I, Phung Y, Zhang Y (submitted in 2012) Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof. Patents issued: 9,409,992 (US in 2016); 2888282 (EP in 2018); 9,803,022 (US in 2018). Patents pending: 2,882,753 (CA application); 201380053870.9 (CN application); 13753475.6 (DE application); 2013306076 (AU application); 17210140.4 (EP application); 13753475.6 (FR application); 13753475.6 (GB application); PCT/US2013/055273 (PC application). Tracking number: E-198-2012-0-AU-13 (AU application).|8. Ho M, Gao W, Phung Y, Zhang Y (submitted in 2012) High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof. Patents issued: 9,409,994 (US in 2016); 11201407972R (SG in 2018). Patents pending: 10-2014-7037046 (KR application); PCT/US2013/043633 (PC application); 201380039993.7 (CN application); 2015-515243 (JP application).",https://intramural.nih.gov/search/searchview.taf?ipid=78566
286,BC010892-06,"October 01, 2012 -  September 30, 2013",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Qun  Jiang|John R Ortaldo; PhD|Anthony J Scarzello|Jeffrey J Subleski|Howard A Young; PhD,"Bill  Murphy (Clinical Research, University of Nevada at Reno)|Jon Marc Wigginton; MD (NCI)",David Anderson Wink (Radiation Biology Branch)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis),NULL,"1. Jiang Q, Weiss JM, Wiltrout RH (2012). A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatment. Oncoimmunology  1, 115-117.   https://doi.org/10.4161/onci.1.1.18036|2. Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC (2013). NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer  132, 9-18.   https://doi.org/10.1002/ijc.27644|3. Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH (2012). Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology  56, 1567-74.   https://doi.org/10.1002/hep.25674",https://intramural.nih.gov/search/searchview.taf?ipid=78627
287,BC010893-06,"October 01, 2012 -  September 30, 2013",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Qun  Jiang|John R Ortaldo; PhD|Anthony J Scarzello|Jeffrey J Subleski|Jonathan  Weiss|Show all 7,NULL,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)",NULL,"1. Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC (2013). NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression. Int J Cancer  132, 9-18.   https://doi.org/10.1002/ijc.27644|2. Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH (2012). Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology  56, 1567-74.   https://doi.org/10.1002/hep.25674",https://intramural.nih.gov/search/searchview.taf?ipid=78628
288,BC010898-06,"October 01, 2012 -  September 30, 2013",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Julie Lynn Heinecke; PhD|Lisa Ann Ridnour|Christopher H Switzer|Murali  Krishna; PhD,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Ridnour LA, Barasch KM, Windhausen AN, Dorsey TH, Lizardo MM, Yfantis HG, Lee DH, Switzer CH, Cheng RY, Heinecke JL, Brueggemann E, Hines HB, Khanna C, Glynn SA, Ambs S, Wink DA (2012). Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. PLoS One  7, e44081.   https://doi.org/10.1371/journal.pone.0044081|2. Ridnour LA, Cheng RY, Switzer CH, Heinecke JL, Ambs S, Glynn S, Young HA, Trinchieri G, Wink DA (2013). Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity. Clin Cancer Res  19, 1340-6.   https://doi.org/10.1158/1078-0432.CCR-12-0408|3. Ridnour LA, Dhanapal S, Hoos M, Wilson J, Lee J, Cheng RY, Brueggemann EE, Hines HB, Wilcock DM, Vitek MP, Wink DA, Colton CA (2012). Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1. J Neurochem  123, 736-49.   https://doi.org/10.1111/jnc.12028|4. Schoenfeld MP, Ansari RR, Nakao A, Wink D (2012). A hypothesis on biological protection from space radiation through the use of new therapeutic gases as medical counter measures. Med Gas Res  2, 8.   https://doi.org/10.1186/2045-9912-2-8|5. Soto-Pantoja DR, Miller TW, Pendrak ML, DeGraff WG, Sullivan C, Ridnour LA, Abu-Asab M, Wink DA, Tsokos M, Roberts DD (2012). CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy  8, 1628-42.   https://doi.org/10.4161/auto.21562|6. Soto-Pantoja DR, Ridnour LA, Wink DA, Roberts DD (2013). Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci Rep  3, 1038.   https://doi.org/10.1038/srep01038",https://intramural.nih.gov/search/searchview.taf?ipid=78629
289,BC010899-06,"October 01, 2012 -  September 30, 2013",Properties of redox modified NSAIDs in cancer prevention and treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Wilmarie  Flores-santana|Julie Lynn Heinecke; PhD|Lisa Ann Ridnour|Christopher H Switzer|James B Mitchell; PhD|Show all 7,NULL,Larry K Keefer; PhD (Chemical Biology Laboratory)|Grace  Yeh; PhD (Office of the Director)|David D Roberts; PhD (Laboratory of Pathology),NULL,"1. Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA (2012). Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol  25, 769-93.   https://doi.org/10.1021/tx2005234|2. Horváth B, Mukhopadhyay P, Kechrid M, Patel V, Tanchian G, Wink DA, Gertsch J, Pacher P (2012). β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radic Biol Med  52, 1325-33.   https://doi.org/10.1016/j.freeradbiomed.2012.01.014|3. Schoenfeld MP, Ansari RR, Nakao A, Wink D (2012). A hypothesis on biological protection from space radiation through the use of new therapeutic gases as medical counter measures. Med Gas Res  2, 8.   https://doi.org/10.1186/2045-9912-2-8|4. Switzer CH, Cheng RY, Ridnour LA, Murray MC, Tazzari V, Sparatore A, Del Soldato P, Hines HB, Glynn SA, Ambs S, Wink DA (2012). Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Res  72, 2394-404.   https://doi.org/10.1158/0008-5472.CAN-11-3115",https://intramural.nih.gov/search/searchview.taf?ipid=78630
290,BC010910-06,"October 01, 2012 -  September 30, 2013",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Yulia  Demchenko|Peter D Aplan; MD,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|Jonathan  Keats (TGen (Translational Genomics Research Institute))",NULL,NULL,"1. Bergsagel PL, Kuehl WM (2013). Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity. Leukemia  27, 2067-8.   https://doi.org/10.1038/leu.2013.139|2. Kuehl WM, Bergsagel PL (2012). Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest  122, 3456-63.   https://doi.org/10.1172/JCI61188",https://intramural.nih.gov/search/searchview.taf?ipid=78656
291,BC010914-06,"October 01, 2012 -  September 30, 2013",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78651
292,BC010932-06,"October 01, 2012 -  September 30, 2013",Functional and developmental T cell subsets,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Kuka M, Munitic I, Ashwell JD (2012). Identification and characterization of polyclonal αβ-T cells with dendritic cell properties. Nat Commun  3, 1223.   https://doi.org/10.1038/ncomms2223|2. Munitic I, Kuka M, Allam A, Scoville JP, Ashwell JD (2013). CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. J Immunol  190, 1169-79.   https://doi.org/10.4049/jimmunol.1202353",https://intramural.nih.gov/search/searchview.taf?ipid=78513
293,BC010938-06,"October 01, 2012 -  September 30, 2013",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Martin  Glatz; MD|Sheila E Phang|Amynah  Pradhan,NULL,NULL,Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID) |Robert A Sokolic (NHGRI) |Alexandra  Freeman (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Steven M Holland; MD (NIAID),"1. Conlan S, Kong HH, Segre JA (2012). Species-level analysis of DNA sequence data from the NIH Human Microbiome Project. PLoS One  7, e47075.   https://doi.org/10.1371/journal.pone.0047075|2. Conlan S, Mijares LA, NISC Comparative Sequencing Program, Becker J, Blakesley RW, Bouffard GG, Brooks S, Coleman H, Gupta J, Gurson N, Park M, Schmidt B, Thomas PJ, Otto M, Kong HH, Murray PR, Segre JA (2012). Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol  13, R64.   https://doi.org/10.1186/gb-2012-13-7-r64|3. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD, NISC Comparative Sequence Program, Murray PR, Turner ML, Segre JA (2012). Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res  22, 850-9.   https://doi.org/10.1101/gr.131029.111|4. Larson D, Cooper PJ, Hübner MP, Reyes J, Vaca M, Chico M, Kong HH, Mitre E (2012). Helminth infection is associated with decreased basophil responsiveness in human beings. J Allergy Clin Immunol  130, 270-2.   https://doi.org/10.1016/j.jaci.2012.04.017|5. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA, Belkaid Y (2012). Compartmentalized control of skin immunity by resident commensals. Science  337, 1115-9.   https://doi.org/10.1126/science.1225152|6. Oh J, Conlan S, Polley EC, Segre JA, Kong HH (2012). Shifts in human skin and nares microbiota of healthy children and adults. Genome Med  4, 77.   https://doi.org/10.1186/gm378",https://intramural.nih.gov/search/searchview.taf?ipid=78652
294,BC010939-06,"October 01, 2012 -  September 30, 2013",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Sirisha  Chakka|Tamara L Jones,John  Weinstein (MD Anderson)|Philip L Lorenzi|Patrick  Grohar,"Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)","Christopher P Austin; AB, MD (NCATS) |Scott E Martin (NCATS)","1. Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE (2012). Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Res  14, R109.   https://doi.org/10.1186/bcr3230",https://intramural.nih.gov/search/searchview.taf?ipid=78530
295,BC010940-06,"October 01, 2012 -  September 30, 2013",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Amynah  Pradhan,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78650
296,BC010944-06,"October 01, 2012 -  September 30, 2013",Strategies for Cancer Vaccine Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Joseph Raymond Cohen; PhD|Romaine Ingrid Fernando|Sofia Ribeiro Gameiro|Bertina L Gibbs|Peter Sungwhan Kim; PhD|Show all 12,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|Helen B Sabzevari|James  Breitmeyer (BN ImmunoTherapeutics)",NULL,NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors, in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation. Lattime E, Gerson SL, eds., in press.|3. Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J (2012). Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood  120, 3030-8.   https://doi.org/10.1182/blood-2012-05-427799|4. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, Palena C (2012). Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res  18, 3868-79.   https://doi.org/10.1158/1078-0432.CCR-11-3211|5. Schlom J (2012). Recent advances in therapeutic cancer vaccines. Cancer Biother Radiopharm  27, 2-5.   https://doi.org/10.1089/cbr.2012.1200|6. Schlom J (2012). Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst  104, 599-613.   https://doi.org/10.1093/jnci/djs033|7. Schlom J, Hodge JW (2012). Introduction: Therapeutic cancer vaccines. Semin Oncol  39, 243-4.   https://doi.org/10.1053/j.seminoncol.2012.02.009|8. Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW (2012). Distinct effects of saracatinib on memory CD8+ T cell differentiation. J Immunol  188, 4323-33.   https://doi.org/10.4049/jimmunol.1101439",https://intramural.nih.gov/search/searchview.taf?ipid=78578
297,BC010945-06,"October 01, 2012 -  September 30, 2013",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",Philip M Arlen; MD|Bonnie L Casey|Christopher Ryan Heery; MD|Joseph Woong Kim; MD|Jennifer L Marte|Sheri A Mcmahon|Show all 12,"Robert  DiPaola (The Cancer Institute of New Jersey)|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)|Carsten Goessl  Goessl (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Ravi  Madan (Medical Oncology Branch),NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Heery C, Hodge J, Gulley J (2012) Combining radiation and therapeutic cancer vaccines: a synergistic approach. Breast Cancer Management 1:325-335|3. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|4. Kim JW, Gulley JL (2012). Poxviral vectors for cancer immunotherapy. Expert Opin Biol Ther  12, 463-78.   https://doi.org/10.1517/14712598.2012.668516|5. Madan R, Gulley J, Kantoff P (2013) Demystifying immunotherapy in prostate cancer: Understanding current and future treatment strategies. Cancer Journal (United States) 19(1):50-58|6. Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL (2012). Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol  39, 296-304.   https://doi.org/10.1053/j.seminoncol.2012.02.010|7. Madan RA, Heery CR, Gulley JL (2012). Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity. Oncoimmunology  1, 1167-1168.   https://doi.org/10.4161/onci.20591|8. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2",https://intramural.nih.gov/search/searchview.taf?ipid=78558
298,BC010946-06,"October 01, 2012 -  September 30, 2013",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Kristin  Askin|Anastasia L Sowers|Angela  Thetford|Show all 7,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,"1. Mitchell JB, Anver MR, Sowers AL, Rosenberg PS, Figueroa M, Thetford A, Krishna MC, Albert PS, Cook JA (2012). The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation. Cancer Res  72, 4846-55.   https://doi.org/10.1158/0008-5472.CAN-12-1879",https://intramural.nih.gov/search/searchview.taf?ipid=78679
299,BC010954-06,"October 01, 2012 -  September 30, 2013",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Jennifer Lynne Shoe|Katherine  Stagliano|Ashley Simone Triplett; PhD|Joost J Oppenheim; MD,NULL,Stefan  Ambs (Laboratory of Human Carcinogenesis)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology),NULL,"1. Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S (2013). MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene  32, 4139-47.   https://doi.org/10.1038/onc.2012.424|2. Hurwitz AA, Watkins SK (2012). Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother  61, 289-293.   https://doi.org/10.1007/s00262-011-1181-5|3. Watkins SK, Hurwitz AA (2012). FOXO3: A master switch for regulating tolerance and immunity in dendritic cells. Oncoimmunology  1, 252-254.   https://doi.org/10.4161/onci.1.2.18241|4. Watkins SK, Zhu Z, Watkins KE, Hurwitz AA (2012). Isolation of immune cells from primary tumors. J Vis Exp   e3952  https://doi.org/10.3791/3952",https://intramural.nih.gov/search/searchview.taf?ipid=78640
300,BC010955-06,"October 01, 2012 -  September 30, 2013",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Steven Martin Cuss|Jennifer Lynne Shoe|Katherine  Stagliano|Ziqiang  Zhu,Vincenzo  Bronte|Mary Jo  Turk (Dartmouth Medical School)|Viktor  Umansky (DKFZ),Lionel  Feigenbaum (Office Of The Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Nicholas Phillip Restifo; MD (Surgery Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology),NULL,"1. Watkins SK, Zhu Z, Watkins KE, Hurwitz AA (2012). Isolation of immune cells from primary tumors. J Vis Exp   e3952  https://doi.org/10.3791/3952|2. Zhu Z, Singh V, Watkins SK, Bronte V, Shoe JL, Feigenbaum L, Hurwitz AA (2013). High-avidity T cells are preferentially tolerized in the tumor microenvironment. Cancer Res  73, 595-604.   https://doi.org/10.1158/0008-5472.CAN-12-1123",https://intramural.nih.gov/search/searchview.taf?ipid=78639
301,BC010956-06,"October 01, 2012 -  September 30, 2013",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Xu  Feng; PhD|Michael C Lu|Yoichi  Ogawa|Takeshi  Ouchi; MD|Chuanjin  Wu,"Daniel M Kaplan|Frank  Costanti (Columbia University Medical Center)|Nicholas  Greene (Institute of Child Health, UCL)",Lino  Tessarollo (Mouse Cancer Genetics Program)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),"Ronald N Germain; MD, PhD (NIAID) |Maria Irene Morasso; PhD (NIAMS)","1. Gaiser MR, Lämmermann T, Feng X, Igyarto BZ, Kaplan DH, Tessarollo L, Germain RN, Udey MC (2012). Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc Natl Acad Sci U S A  109, E889-97.   https://doi.org/10.1073/pnas.1117674109",https://intramural.nih.gov/search/searchview.taf?ipid=78614
302,BC010957-06,"October 01, 2012 -  September 30, 2013",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Nataliya Prokopenko Buxbaum|Kevin  Chua|Don Eugene Farthing|Francis  Flomerfelt; PhD|Philip J Lucas; PhD|Show all 8,NULL,NULL,Michael  Eckhaus; DVM (OD),"1. El-Kassar N, Flomerfelt FA, Choudhury B, Hugar LA, Chua KS, Kapoor V, Lucas PJ, Gress RE (2012). High levels of IL-7 cause dysregulation of thymocyte development. Int Immunol  24, 661-71.   https://doi.org/10.1093/intimm/dxs067|2. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH (2012). An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol  188, 5859-66.   https://doi.org/10.4049/jimmunol.1102328",https://intramural.nih.gov/search/searchview.taf?ipid=78556
303,BC010958-06,"October 01, 2012 -  September 30, 2013","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Hee Jun  Cho; PhD|Julien J Homble|Yoo-Seok  Hwang|Yon Ju  Ji|Kathleen T Soria|Emily Frances Winterbottom,Herbert  Steinbeisser (University of Heidelberg)|Colin  Stewart (Institute of medical biology)|Sally  Moody (George Washington University Medical Center),"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Lee HS, Sokol SY, Moody SA, Daar IO (2012). Using 32-cell stage Xenopus embryos to probe PCP signaling. Methods Mol Biol  839, 91-104.   https://doi.org/10.1007/978-1-61779-510-7_8",https://intramural.nih.gov/search/searchview.taf?ipid=78531
304,BC010959-06,"October 01, 2012 -  September 30, 2013",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Jacqueline H Barlow|Maria Elsa  Callen Moreu|Arnab  Ray Chaudhuri|Hua Tang  Chen|Aysegul  Ergen|Babak  Faryabi|Show all 13,NULL,NULL,NULL,"1. Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A (2013). Identification of early replicating fragile sites that contribute to genome instability. Cell  152, 620-32.   https://doi.org/10.1016/j.cell.2013.01.006|2. Bothmer A, Rommel PC, Gazumyan A, Polato F, Reczek CR, Muellenbeck MF, Schaetzlein S, Edelmann W, Chen PL, Brosh RM, Casellas R, Ludwig T, Baer R, Nussenzweig A, Nussenzweig MC, Robbiani DF (2013). Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J Exp Med  210, 115-23.   https://doi.org/10.1084/jem.20121975|3. Bowman-Colin C, Xia B, Bunting S, Klijn C, Drost R, Bouwman P, Fineman L, Chen X, Culhane AC, Cai H, Rodig SJ, Bronson RT, Jonkers J, Nussenzweig A, Kanellopoulou C, Livingston DM (2013). Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer. Proc Natl Acad Sci U S A  110, 8632-7.   https://doi.org/10.1073/pnas.1305362110|4. Bunting SF, Callén E, Kozak ML, Kim JM, Wong N, López-Contreras AJ, Ludwig T, Baer R, Faryabi RB, Malhowski A, Chen HT, Fernandez-Capetillo O, D'Andrea A, Nussenzweig A (2012). BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell  46, 125-35.   https://doi.org/10.1016/j.molcel.2012.02.015|5. Bunting SF, Nussenzweig A (2013). End-joining, translocations and cancer. Nat Rev Cancer  13, 443-54.   https://doi.org/10.1038/nrc3537|6. Callen E, Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen HT, Faryabi RB, Polato F, Santos M, Starnes LM, Wesemann DR, Lee JE, Tubbs A, Sleckman BP, Daniel JA, Ge K, Alt FW, Fernandez-Capetillo O, Nussenzweig MC, Nussenzweig A (2013). 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell  153, 1266-80.   https://doi.org/10.1016/j.cell.2013.05.023|7. Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A (2012). The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration. Immunity  37, 971-85.   https://doi.org/10.1016/j.immuni.2012.10.007|8. Daniel JA, Nussenzweig A (2012). Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination. Biochim Biophys Acta  1819, 733-8.   https://doi.org/10.1016/j.bbagrm.2012.01.019|9. Daniel JA, Nussenzweig A (2013). The AID-induced DNA damage response in chromatin. Mol Cell  50, 309-21.   https://doi.org/10.1016/j.molcel.2013.04.017|10. Daniel JA, Pellegrini M, Lee BS, Guo Z, Filsuf D, Belkina NV, You Z, Paull TT, Sleckman BP, Feigenbaum L, Nussenzweig A (2012). Loss of ATM kinase activity leads to embryonic lethality in mice. J Cell Biol  198, 295-304.   https://doi.org/10.1083/jcb.201204035|11. Di Virgilio M, Callen E, Yamane A, Zhang W, Jankovic M, Gitlin AD, Feldhahn N, Resch W, Oliveira TY, Chait BT, Nussenzweig A, Casellas R, Robbiani DF, Nussenzweig MC (2013). Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science  339, 711-5.   https://doi.org/10.1126/science.1230624|12. Feldhahn N, Ferretti E, Robbiani DF, Callen E, Deroubaix S, Selleri L, Nussenzweig A, Nussenzweig MC (2012). The hSSB1 orthologue Obfc2b is essential for skeletogenesis but dispensable for the DNA damage response in vivo. EMBO J  31, 4045-56.   https://doi.org/10.1038/emboj.2012.247|13. Hakim O, Resch W, Yamane A, Klein I, Kieffer-Kwon KR, Jankovic M, Oliveira T, Bothmer A, Voss TC, Ansarah-Sobrinho C, Mathe E, Liang G, Cobell J, Nakahashi H, Robbiani DF, Nussenzweig A, Hager GL, Nussenzweig MC, Casellas R (2012). DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature  484, 69-74.   https://doi.org/10.1038/nature10909|14. Lee BS, Gapud EJ, Zhang S, Dorsett Y, Bredemeyer A, George R, Callen E, Daniel JA, Osipovich O, Oltz EM, Bassing CH, Nussenzweig A, Lees-Miller S, Hammel M, Chen BP, Sleckman BP (2013). Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination. Mol Cell Biol  33, 3568-79.   https://doi.org/10.1128/MCB.00308-13|15. Muñoz MC, Laulier C, Gunn A, Cheng A, Robbiani DF, Nussenzweig A, Stark JM (2012). RING finger nuclear factor RNF168 is important for defects in homologous recombination caused by loss of the breast cancer susceptibility factor BRCA1. J Biol Chem  287, 40618-28.   https://doi.org/10.1074/jbc.M112.410951|16. Sin HS, Barski A, Zhang F, Kartashov AV, Nussenzweig A, Chen J, Andreassen PR, Namekawa SH (2012). RNF8 regulates active epigenetic modifications and escape gene activation from inactive sex chromosomes in post-meiotic spermatids. Genes Dev  26, 2737-48.   https://doi.org/10.1101/gad.202713.112|17. Yamane A, Robbiani DF, Resch W, Bothmer A, Nakahashi H, Oliveira T, Rommel PC, Brown EJ, Nussenzweig A, Nussenzweig MC, Casellas R (2013). RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle. Cell Rep  3, 138-47.   https://doi.org/10.1016/j.celrep.2012.12.006",https://intramural.nih.gov/search/searchview.taf?ipid=78686
305,BC010960-06,"October 01, 2012 -  September 30, 2013",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Lee Alderman; PA-C|Daniele N Avila|Judy Liliana Baruffaldi|Juan Carlos Gea-Banacloche; MD|Nancy M Hardy|Jennifer Amy Mann|Show all 12,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA, Williams KM, Datiles MB, Bishop R, Bassim CW, Mays JW, Edwards D, Cole K, Avila DN, Taylor T, Urban A, Joe GO, Comis LE, Berger A, Stratton P, Zhang D, Shelhamer JH, Gea-Banacloche JC, Sportes C, Fowler DH, et al. [2 more authors] (2013). National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant  19, 632-9.   https://doi.org/10.1016/j.bbmt.2013.01.013|2. Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, Taylor T, Avila D, Zhang D, Grkovic L, Datiles M, Gress RE, Pavletic SZ (2012). Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res  91, 45S-51S.   https://doi.org/10.1177/0022034512450881|3. Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood  121, 2864-74.   https://doi.org/10.1182/blood-2012-08-446872|4. Hardy NM, Fellowes V, Rose JJ, Odom J, Pittaluga S, Steinberg SM, Blacklock-Schuver B, Avila DN, Memon S, Kurlander RJ, Khuu HM, Stetler-Stevenson M, Mena E, Dwyer AJ, Levine BL, June CH, Reshef R, Vonderheide RH, Gress RE, Fowler DH, Hakim FT, Bishop MR (2012). Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. Blood  119, 2956-9.   https://doi.org/10.1182/blood-2011-09-378398|5. Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR (2012). Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol  30, 830-6.   https://doi.org/10.1200/JCO.2011.37.0296|6. Tomblyn M, Chen M, Kukreja M, Aljurf MD, Al Mohareb F, Bolwell BJ, Cahn JY, Carabasi MH, Gale RP, Gress RE, Gupta V, Hale GA, Ljungman P, Maziarz RT, Storek J, Wingard JR, Young JA, Horowitz MM, Ballen KK (2012) No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Transpl Infect Dis 14:468-78",https://intramural.nih.gov/search/searchview.taf?ipid=78557
306,BC010970-06,"October 01, 2012 -  September 30, 2013",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Garland M Davis|Jonathan Kroemer Fallon; PhD|Amanda Jayne Lyon; PhD|James W Hodge; PhD,Helen B Sabzevari|James  Breitmeyer (BN ImmunoTherapeutics),NULL,NULL,"1. Takai S, Sabzevari H, Farsaci B, Schlom J, Greiner JW (2012). Distinct effects of saracatinib on memory CD8+ T cell differentiation. J Immunol  188, 4323-33.   https://doi.org/10.4049/jimmunol.1101439",https://intramural.nih.gov/search/searchview.taf?ipid=78554
307,BC010972-06,"October 01, 2012 -  September 30, 2013",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Benjamin  Boyerinas|Caroline Mikaela Maria Jochems; PhD|Claudia Mercedes Palena|James L Gulley; MD, PhD|James W Hodge; PhD|Christopher Ryan Heery; MD","David  Apelian (GlobeImmune, Inc.)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|James  Breitmeyer (BN ImmunoTherapeutics)",Ira H Pastan; MD (Molecular Biology Section)|William Laurence Dahut; MD (Medical Oncology Branch)|Ravi  Madan (Medical Oncology Branch),NULL,"1. Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J (2012). Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood  120, 3030-8.   https://doi.org/10.1182/blood-2012-05-427799|2. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|3. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2|4. Mazor R, Vassall AN, Eberle JA, Beers R, Weldon JE, Venzon DJ, Tsang KY, Benhar I, Pastan I (2012). Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A. Proc Natl Acad Sci U S A  109, E3597-603.   https://doi.org/10.1073/pnas.1218138109|5. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, Palena C (2012). Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res  18, 3868-79.   https://doi.org/10.1158/1078-0432.CCR-11-3211|6. Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW (2013). Inhibition of TGF-β1 signaling promotes central memory T cell differentiation. J Immunol  191, 2299-307.   https://doi.org/10.4049/jimmunol.1300472|7. Schlom J, Tsang K (submitted in 2012) Native And Agonist Ctl Epitopes Of The Muc1 Tumor Antigen. Patents issued: 2013206896 (AU in 2017); 602013031592 (EP in 2018). Patents pending: 551304/2014 (JP application); PCT/US2013/020058 (PC application); 14/370,595 (US application); 2860599 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=78612
308,BC010973-06,"October 01, 2012 -  September 30, 2013",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI","Benjamin  Boyerinas|Caroline Mikaela Maria Jochems; PhD|James L Gulley; MD, PhD|James W Hodge; PhD|Claudia Mercedes Palena|Christopher Ryan Heery; MD","David  Apelian (GlobeImmune, Inc.)|James  Breitmeyer (BN ImmunoTherapeutics)",William Laurence Dahut; MD (Medical Oncology Branch)|Ravi  Madan (Medical Oncology Branch),NULL,"1. Tucker J, Jochems C, Gulley J, Schlom J, Tsang K (2012) Shifting the balance of cell-mediated immunity and suppression in human prostate cancer [review]. Cancers 4:1333-1348",https://intramural.nih.gov/search/searchview.taf?ipid=78613
309,BC010975-06,"October 01, 2012 -  September 30, 2013",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Anna Ruth Kwilas; PhD|Andressa  Ardiani|Marion G Taylor|Jeffrey  Schlom; PhD,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),Bradford J Wood; MD (CC),"1. Heery C, Hodge J, Gulley J (2012) Combining radiation and therapeutic cancer vaccines: a synergistic approach. Breast Cancer Management 1:325-335|2. Hodge JW, Sharp HJ, Gameiro SR (2012). Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation. Cancer Biother Radiopharm  27, 12-22.   https://doi.org/10.1089/cbr.2012.1202|3. Kwilas AR, Donahue RN, Bernstein MB, Hodge JW (2012). In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer. Front Oncol  2, 104.   https://doi.org/10.3389/fonc.2012.00104",https://intramural.nih.gov/search/searchview.taf?ipid=78637
310,BC010976-06,"October 01, 2012 -  September 30, 2013",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu,Nicholas  MarshArmstrong (Johns Hopkins University)|George  Hajishengallis (University of Pennsylvanis School of Dental Medicine)|Seiichiro  Motegi (Gunma University School of Medicine)|Harvey  Florman (Universty of Massachusetts Medical School),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78615
311,BC010977-06,"October 01, 2012 -  September 30, 2013",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Juan Manuel Crespo-Barreto; PhD|Stephen Charles Kales|Mariya Sergeyevna Liyasova; PhD|Ke  Ma|Marion M Nau|Donna M Voeller|Show all 7,Marcus Ramsay Clark|Jian  Zhang (University of Chicago),"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Udayan  Guha (Medical Oncology Branch)",Anna  Panchenko; PhD (NLM),"1. Guo H, Qiao G, Ying H, Li Z, Zhao Y, Liang Y, Yang L, Lipkowitz S, Penninger JM, Langdon WY, Zhang J (2012). E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell Rep  1, 472-82.   https://doi.org/10.1016/j.celrep.2012.04.008|2. Kales SC, Ryan PE, Lipkowitz S (2012). Cbl exposes its RING finger. Nat Struct Mol Biol  19, 131-3.   https://doi.org/10.1038/nsmb.2241|3. Ryan PE, Kales SC, Yadavalli R, Nau MM, Zhang H, Lipkowitz S (2012). Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5. PLoS One  7, e49428.   https://doi.org/10.1371/journal.pone.0049428",https://intramural.nih.gov/search/searchview.taf?ipid=78667
312,BC010982-06,"October 01, 2012 -  September 30, 2013",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Liat Hava Goldberg-Cooks|Sheryl Maxine Gough|Masahiro  Onozawa|Paul S Meltzer; MD, PhD",Donald  Small (Johns Hopkins University School of Medicine)|Steven  Nimer (MSKCC),Lino  Tessarollo (Mouse Cancer Genetics Program)|Linda  Wolff; PhD (Laboratory of Cellular Oncology),NULL,"1. Greenblatt S, Li L, Slape C, Nguyen B, Novak R, Duffield A, Huso D, Desiderio S, Borowitz MJ, Aplan P, Small D (2012). Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood  119, 2883-94.   https://doi.org/10.1182/blood-2011-10-382283|2. Levens D, Aplan PD (2013). Notching up MYC gives a LIC. Cell Stem Cell  13, 8-9.   https://doi.org/10.1016/j.stem.2013.06.008|3. Novak RL, Harper DP, Caudell D, Slape C, Beachy SH, Aplan PD (2012). Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol  40, 1016-27.   https://doi.org/10.1016/j.exphem.2012.08.001|4. Slape CI, Saw J, Jowett JB, Aplan PD, Strasser A, Jane SM, Curtis DJ (2012). Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood  120, 2475-83.   https://doi.org/10.1182/blood-2012-05-430736|5. Xu H, Menendez S, Schlegelberger B, Bae N, Aplan PD, Göhring G, Deblasio TR, Nimer SD (2012). Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model. Blood  120, 3089-97.   https://doi.org/10.1182/blood-2012-01-405332",https://intramural.nih.gov/search/searchview.taf?ipid=78511
313,BC010983-06,"October 01, 2012 -  September 30, 2013",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Sheryl Maxine Gough,Steven  Nimer (MSKCC)|JP  Issa (MD Anderson)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,"1. Gough SM, Chung YJ, Aplan PD (2012). Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect. PLoS One  7, e36876.   https://doi.org/10.1371/journal.pone.0036876",https://intramural.nih.gov/search/searchview.taf?ipid=78512
314,BC010984-06,"October 01, 2012 -  September 30, 2013",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Alena - Gros; PhD|Joyce G Landry|Richard A Morgan; PhD|Kathleen E Morton-cooper|Lien T Ngo|Mary Ann  Toomey|Show all 12,NULL,NULL,Yardena Rachel Samuels; PhD (NHGRI),"1. Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US (2012). Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol  10, 113.   https://doi.org/10.1186/1477-7819-10-113|2. Bergamaschi C, Bear J, Rosati M, Beach RK, Alicea C, Sowder R, Chertova E, Rosenberg SA, Felber BK, Pavlakis GN (2012). Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum. Blood  120, e1-8.   https://doi.org/10.1182/blood-2011-10-384362|3. Casati A, Varghaei-Nahvi A, Feldman SA, Assenmacher M, Rosenberg SA, Dudley ME, Scheffold A (2013). Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients. Cancer Immunol Immunother  62, 1563-73.   https://doi.org/10.1007/s00262-013-1459-x|4. DeVita VT, Rosenberg SA (2012). Two hundred years of cancer research. N Engl J Med  366, 2207-14.   https://doi.org/10.1056/NEJMra1204479|5. Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013). Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol  31, 2152-9.   https://doi.org/10.1200/JCO.2012.46.6441|6. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME, Rosenberg SA (2012). Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res  18, 5212-23.   https://doi.org/10.1158/1078-0432.CCR-12-1108|7. Jin J, Sabatino M, Somerville R, Wilson JR, Dudley ME, Stroncek DF, Rosenberg SA (2012). Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. J Immunother  35, 283-92.   https://doi.org/10.1097/CJI.0b013e31824e801f|8. Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP (2013). Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther  21, 1369-77.   https://doi.org/10.1038/mt.2013.58|9. Kochenderfer JN, Rosenberg SA (2013). Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol  10, 267-76.   https://doi.org/10.1038/nrclinonc.2013.46|10. Kvistborg P, Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, van Rooij N, Linnemann C, van Buuren MM, Urbanus JH, Beltman JB, Thor Straten P, Li YF, Robbins PF, Besser MJ, Schachter J, Kenter GG, Dudley ME, Rosenberg SA, Haanen JB, Hadrup SR, Schumacher TN (2012). TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology  1, 409-418.   https://doi.org/10.4161/onci.18851|11. Lu YC, Yao X, Li YF, El-Gamil M, Dudley ME, Yang JC, Almeida JR, Douek DC, Samuels Y, Rosenberg SA, Robbins PF (2013). Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression. J Immunol  190, 6034-42.   https://doi.org/10.4049/jimmunol.1202830|12. Morgan RA, Johnson LA, Davis JL, Zheng Z, Woolard KD, Reap EA, Feldman SA, Chinnasamy N, Kuan CT, Song H, Zhang W, Fine HA, Rosenberg SA (2012). Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Hum Gene Ther  23, 1043-53.   https://doi.org/10.1089/hum.2012.041|13. Prieto PA, Yang JC, Sherry RM, Hughes MS, Kammula US, White DE, Levy CL, Rosenberg SA, Phan GQ (2012). CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin Cancer Res  18, 2039-47.   https://doi.org/10.1158/1078-0432.CCR-11-1823|14. Restifo NP, Dudley ME, Rosenberg SA (2012). Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol  12, 269-81.   https://doi.org/10.1038/nri3191|15. Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, Samuels Y, Rosenberg SA (2013). Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med  19, 747-52.   https://doi.org/10.1038/nm.3161|16. Rosenberg SA (2012). Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med  4, 127ps8.   https://doi.org/10.1126/scitranslmed.3003634|17. Somerville RP, Devillier L, Parkhurst MR, Rosenberg SA, Dudley ME (2012). Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor. J Transl Med  10, 69.   https://doi.org/10.1186/1479-5876-10-69|18. Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, Gattinoni L, Heath JR, Kalos M, Marincola FM, Miller JS, Mostoslavsky G, Powell DJ, Rao M, Restifo NP, Rosenberg SA, O'Shea J, Melief CJ (2012). New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med  10, 48.   https://doi.org/10.1186/1479-5876-10-48|19. Tran E, Chinnasamy D, Yu Z, Morgan RA, Lee CC, Restifo NP, Rosenberg SA (2013). Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia. J Exp Med  210, 1125-35.   https://doi.org/10.1084/jem.20130110|20. Uccellini L, De Giorgi V, Zhao Y, Tumaini B, Erdenebileg N, Dudley ME, Tomei S, Bedognetti D, Ascierto ML, Liu Q, Simon R, Kottyan L, Kaufman KM, Harley JB, Wang E, Rosenberg SA, Marincola FM (2012). IRF5 gene polymorphisms in melanoma. J Transl Med  10, 170.   https://doi.org/10.1186/1479-5876-10-170|21. Wang A, Chandran S, Shah SA, Chiu Y, Paria BC, Aghamolla T, Alvarez-Downing MM, Lee CC, Singh S, Li T, Dudley ME, Restifo NP, Rosenberg SA, Kammula US (2012). The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci Transl Med  4, 149ra120.   https://doi.org/10.1126/scitranslmed.3004306|22. Yang S, Ji Y, Gattinoni L, Zhang L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA (2013). Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol Immunother  62, 727-36.   https://doi.org/10.1007/s00262-012-1378-2|23. Yao X, Ahmadzadeh M, Lu YC, Liewehr DJ, Dudley ME, Liu F, Schrump DS, Steinberg SM, Rosenberg SA, Robbins PF (2012). Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood  119, 5688-96.   https://doi.org/10.1182/blood-2011-10-386482|24. Zhang L, Yu Z, Muranski P, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2013). Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy. Gene Ther  20, 575-80.   https://doi.org/10.1038/gt.2012.75",https://intramural.nih.gov/search/searchview.taf?ipid=78576
315,BC010985-06,"October 01, 2012 -  September 30, 2013",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Joyce G Landry|Richard A Morgan; PhD|Kathleen E Morton-cooper|Lien T Ngo|Mary Ann  Toomey|Jessica  Fankhauser|Show all 11,NULL,NULL,NULL,"1. Aung PP, Liu YC, Ballester LY, Robbins PF, Rosenberg SA, Lee CC (2014). Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol  45, 259-67.   https://doi.org/10.1016/j.humpath.2013.05.029|2. Parkhurst M, Morgan R, Rosati S, Rosenberg S (submitted in 2012) Murine Anti-ny-eso-1 T Cell Receptors. Patents issued: 9,487,573 (US in 2017); 2013266421 (AU in 2017); ZL 201380038 (CN in 2018). Patents pending: 201711136635.4 (CN application); 13726389.3 (EP application); 235720 (IL application); 514144/2015 (JP application); PCT/US2013/042162 (PC application); 15/267,285 (US application); 2874486 (CA application).|3. Robbins P, Rosenberg S, Yao X (submitted in 2012) T Cell Receptors Recognizing Mhc Class Ii-restricted Mage-a3. Patents issued: 2013315391 (AU in 2017); 9,879,065 (US in 2018). Patents pending: 2884743 (CA application); 201380059102.4 (CN application); 13767200.2 (EP application); 237560 (IL application); 532065/2015 (JP application); 10-2015-7006543 (KR application); MX/A/2015/003061 (MX application); PCT/US2013/059608 (PC application); 15/848,344 (US application); 2017219019 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=78575
316,BC010992-06,"October 01, 2012 -  September 30, 2013",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",Charlotte Park Choi|Mary K Ernst|Deanna R Gotte|Alison J Rattray|Brenda K Shafer,"Zachory  Burton (Biochemistry and Molecular Biology, Michigan State University)|Maria  Kilfoil (U Mass Amherst)|Marc  Vermulst (GENOME RECOMBINATION & REGULATION SECTION)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Strathern J, Malagon F, Irvin J, Gotte D, Shafer B, Kireeva M, Lubkowska L, Jin DJ, Kashlev M (2013). The fidelity of transcription: RPB1 (RPO21) mutations that increase transcriptional slippage in S. cerevisiae. J Biol Chem  288, 2689-99.   https://doi.org/10.1074/jbc.M112.429506|2. Walmacq C, Cheung AC, Kireeva ML, Lubkowska L, Ye C, Gotte D, Strathern JN, Carell T, Cramer P, Kashlev M (2012). Mechanism of translesion transcription by RNA polymerase II and its role in cellular resistance to DNA damage. Mol Cell  46, 18-29.   https://doi.org/10.1016/j.molcel.2012.02.006|3. Zhou YN, Lubkowska L, Hui M, Court C, Chen S, Court DL, Strathern J, Jin DJ, Kashlev M (2013). Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J Biol Chem  288, 2700-10.   https://doi.org/10.1074/jbc.M112.429464",https://intramural.nih.gov/search/searchview.taf?ipid=78607
317,BC010998-06,"October 01, 2012 -  September 30, 2013",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Chand  Khanna; MD|Lee Jay Helman; MD|Carol J Thiele,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|David  Azorsa (NHGRI)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Show all 7","Malcolm A Smith (Clinical Investigations Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",James G Taylor; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78646
318,BC010999-06,"October 01, 2012 -  September 30, 2013",Characterization of FGFR4 mutations in Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Chand  Khanna; MD,NULL,"Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",James G Taylor; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78647
319,BC011001-06,"October 01, 2012 -  September 30, 2013",Micro RNA  Profiling in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Malcolm A Smith (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78648
320,BC011002-06,"October 01, 2012 -  September 30, 2013",BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78645
321,BC011006-06,"October 01, 2012 -  September 30, 2013",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Weihong  Xu|Yandan  Yang; PhD|Wyndham H Wilson; MD, PhD|Wenming  Xiao; PhD",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Biometrics Research Branch),John I Powell (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78599
322,BC011007-06,"October 01, 2012 -  September 30, 2013",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Arthur L Shaffer|Yandan  Yang; PhD|Hong  Zhao|Wenming  Xiao; PhD,NULL,George W Wright (Biometrics Research Branch),John I Powell (CIT),"1. Kentsis A, Reed C, Rice KL, Sanda T, Rodig SJ, Tholouli E, Christie A, Valk PJ, Delwel R, Ngo V, Kutok JL, Dahlberg SE, Moreau LA, Byers RJ, Christensen JG, Vande Woude G, Licht JD, Kung AL, Staudt LM, Look AT (2012). Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nat Med  18, 1118-22.   https://doi.org/10.1038/nm.2819|2. Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, Neuberg DS, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CH, Weng AP, Staudt LM, Druker BJ, Look AT (2013). TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov  3, 564-77.   https://doi.org/10.1158/2159-8290.CD-12-0504|3. Yang Y, Shaffer AL, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, Young RM, Zhao H, Yang Y, Xu W, Buggy JJ, Balasubramanian S, Mathews LA, Shinn P, Guha R, Ferrer M, Thomas C, Waldmann TA, Staudt LM (2012). Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell  21, 723-37.   https://doi.org/10.1016/j.ccr.2012.05.024|4. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene  32, 5429-38.   https://doi.org/10.1038/onc.2012.590",https://intramural.nih.gov/search/searchview.taf?ipid=78600
323,BC011008-06,"October 01, 2012 -  September 30, 2013",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Michele  Ceribelli; PhD|Daniel James Hodson|Priscilla Ninette Kelly; PhD|Lim Huat Kian; MD|John Harrison Platig|Lixin  Rui|Show all 15,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Richard  Fisher (University of Rochester School of Medicine)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|T. Andrew  Lister (St. Bartholomew Hospital)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology),John I Powell (CIT),"1. Lim KH, Staudt LM (2013). Toll-like receptor signaling. Cold Spring Harb Perspect Biol  5, a011247.   https://doi.org/10.1101/cshperspect.a011247|2. Lim KH, Yang Y, Staudt LM (2012). Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol Rev  246, 359-78.   https://doi.org/10.1111/j.1600-065X.2012.01105.x|3. Yang Y, Shaffer AL, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, Young RM, Zhao H, Yang Y, Xu W, Buggy JJ, Balasubramanian S, Mathews LA, Shinn P, Guha R, Ferrer M, Thomas C, Waldmann TA, Staudt LM (2012). Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell  21, 723-37.   https://doi.org/10.1016/j.ccr.2012.05.024",https://intramural.nih.gov/search/searchview.taf?ipid=78597
324,BC011010-06,"October 01, 2012 -  September 30, 2013",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Laurence  Lamy|Ryan Matthew Young|Ola Anders Landgren,NULL,"Walter M Kuehl; MD, PhD (Cancer Genetics Branch)|Christina M Annunziata (Medical Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78598
325,BC011011-06,"October 01, 2012 -  September 30, 2013",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Laura  Baranello|Fedor Edmundovich Kouzine|Suzanne Laurie Sanford,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Baranello L, Levens D, Gupta A, Kouzine F (2012). The importance of being supercoiled: how DNA mechanics regulate dynamic processes. Biochim Biophys Acta  1819, 632-8.   https://doi.org/10.1016/j.bbagrm.2011.12.007|2. Kouzine F, Gupta A, Baranello L, Wojtowicz D, Ben-Aissa K, Liu J, Przytycka TM, Levens D (2013). Transcription-dependent dynamic supercoiling is a short-range genomic force. Nat Struct Mol Biol  20, 396-403.   https://doi.org/10.1038/nsmb.2517",https://intramural.nih.gov/search/searchview.taf?ipid=78661
326,BC011012-06,"October 01, 2012 -  September 30, 2013",Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,"Gary  Siskin (Albany Medical Center)|Eric  Whitman (Morristown Memorial Hospital)|H. Denis Alexander; PhD (Department of Hematology, Belfast City Hospital)|Charles  Nutting (Sweedish Medical Center)|Sanjiv  Agarwla (St. Luke's Hospital and Health System)|Mark  Faries (John Wayne Cancer Institute)|Show all 8",William D Figg; PharmD (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78638
327,BC011017-06,"October 01, 2012 -  September 30, 2013",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Leroy E Hood|David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78617
328,BC011018-06,"October 01, 2012 -  September 30, 2013",Differential Gene Expression and Targeting of Gliomas Using Radiation,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),Russell R Lonser; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78625
329,BC011019-06,"October 01, 2012 -  September 30, 2013",Diffuse Intrinsic Pontine Glioma Genomic Study,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Javad  Nazarian (Children's National Medical Center)|Eric H Raabe","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Jonathan Keith Killian (Cancer Genetics Branch)|Leomar Y Ballester; MD, PhD (Laboratory of Pathology)",NULL,"1. Ballester L, Wang Z, Shandilya S, Miettinen M, Burger P, Eberhart C, Rodriguez F, Raabe E, Warren K, Quezado M (2013) Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol, in press.|2. Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS (2012). Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol  14, 326-32.   https://doi.org/10.1093/neuonc/nor190",https://intramural.nih.gov/search/searchview.taf?ipid=78624
330,BC011024-06,"October 01, 2012 -  September 30, 2013",Tumor and Metastasis Therapy,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Allyson E Koyen|Michael Mark Lizardo; PhD|Ling  Ren|Lee Jay Helman; MD,"Aykut  Uren (Georgetown University Medical Center)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Timothy  Green (AstraZeneca)|Stephen  Lesnick (Huntsman Cancer Center)|Eugenie  Kleinerman (Pediatric Oncology, MD Anderson Cancer Center)|Show all 8","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|David Anderson Wink (Radiation Biology Branch)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Briggs JW, Ren L, Nguyen R, Chakrabarti K, Cassavaugh J, Rahim S, Bulut G, Zhou M, Veenstra TD, Chen Q, Wei JS, Khan J, Uren A, Khanna C (2012). The ezrin metastatic phenotype is associated with the initiation of protein translation. Neoplasia  14, 297-310.   https://doi.org/10.1593/neo.11518|2. Hong SH, Ren L, Mendoza A, Eleswarapu A, Khanna C (2012). Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells. Neoplasia  14, 249-58.   https://doi.org/10.1593/neo.111498|3. Ren L, Hong SH, Chen QR, Briggs J, Cassavaugh J, Srinivasan S, Lizardo MM, Mendoza A, Xia AY, Avadhani N, Khan J, Khanna C (2012). Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma. Cancer Res  72, 1001-12.   https://doi.org/10.1158/0008-5472.CAN-11-0210",https://intramural.nih.gov/search/searchview.taf?ipid=78649
331,BC011027-06,"October 01, 2012 -  September 30, 2013",Animal models to study the role of INK4b loss in human acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Juraj  Bies|Joanna  Fares|Rita  Humeniuk|Richard P Koller,NULL,NULL,NULL,"1. Humeniuk R, Rosu-Myles M, Fares J, Koller R, Bies J, Wolff L (2013). The role of tumor suppressor p15Ink4b in the regulation of hematopoietic progenitor cell fate. Blood Cancer J  3, e99.   https://doi.org/10.1038/bcj.2012.44",https://intramural.nih.gov/search/searchview.taf?ipid=78632
332,BC011028-06,"October 01, 2012 -  September 30, 2013",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Gennady  Bratslavsky|Kristin K Shouck|Donna  Drake|Sarah M Fowler; RN|Julia C Friend; PA|Rabindra  Gautam|Show all 24,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)","1. Srinivasan R, Linehan W (2012) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology., pp. 1475-1491.|2. Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G (2012). Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol  188, 1695-700.   https://doi.org/10.1016/j.juro.2012.07.029|3. Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, Hasumi H, Hasumi Y, Kieffer-Kwon KR, Gonzalez CG, Hughes RM, Klein ME, Oh HF, Bible P, Southon E, Tessarollo L, Schmidt LS, Linehan WM, Casellas R (2012). The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development. Blood  120, 1254-61.   https://doi.org/10.1182/blood-2012-02-410407|4. Ballester L, Aung P, Lai J, DiGiovanna J, Abdullaev Z, Pack S, Linehan W, Stern J, Pinto P, Lee C (2013) An Unusual Presentation of Glomeruloid Mehangioma in a Patient With VHL Syndrome: A Case Report and Review of Literature. Open J Clin Diagnostics 3:June 1-4|5. Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013). Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol  27, 196-201.   https://doi.org/10.1089/end.2012.0483|6. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|7. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|8. Chow WH, Shuch B, Linehan WM, Devesa SS (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer  119, 388-94.   https://doi.org/10.1002/cncr.27690|9. Eisenhofer G, Vocke CD, Elkahloun A, Huynh TT, Prodanov T, Lenders JW, Timmers HJ, Benhammou JN, Linehan WM, Pacak K (2012). Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution. Horm Metab Res  44, 343-8.   https://doi.org/10.1055/s-0032-1304662|10. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J (2013). A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res  11, 1061-1071.   https://doi.org/10.1158/1541-7786.MCR-13-0111|11. Filson CP, Schwartz K, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Miller DC (2014). Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. Urol Oncol  32, 27.e15-21.   https://doi.org/10.1016/j.urolonc.2012.09.014|12. Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM (2012). Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl Cancer Inst  104, 1750-64.   https://doi.org/10.1093/jnci/djs418|13. Linehan W, Vocke C, Peterson J, Merino M, Schmidt L, Ricketts C (2013) The Cancer Genome Atlas Research Network: Comprehensive Molecular Characterization of Clear Cell Renal Cell Carcinoma. Nature 499:43-49|14. Linehan WM (2012). Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res  22, 2089-100.   https://doi.org/10.1101/gr.131110.111|15. Linehan WM (2012). The genetic basis of kidney cancer: implications for management and use of targeted therapeutic approaches. Eur Urol  61, 896-8.   https://doi.org/10.1016/j.eururo.2012.02.022|16. Linehan WM, Rathmell WK (2012). Kidney cancer. Urol Oncol  30, 948-51.   https://doi.org/10.1016/j.urolonc.2012.08.021|17. Linehan WM, Ricketts CJ (2013). The metabolic basis of kidney cancer. Semin Cancer Biol  23, 46-55.   https://doi.org/10.1016/j.semcancer.2012.06.002|18. Linehan WM, Rouault TA (2013). Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. Clin Cancer Res  19, 3345-52.   https://doi.org/10.1158/1078-0432.CCR-13-0304|19. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|20. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x|21. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM (2012). Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis  1, e14.   https://doi.org/10.1038/oncsis.2012.14|22. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ (2011). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature  481, 385-8.   https://doi.org/10.1038/nature10642|23. Neckers L, Ricketts CJ, Marston Linehan W (2013). New insights into von Hippel-Lindau function highlighted by investigation of the trichloroethylene-induced p.P81S hotspot mutation. J Natl Cancer Inst  105, 1339-40.   https://doi.org/10.1093/jnci/djt240|24. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013). An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer  132, 2640-7.   https://doi.org/10.1002/ijc.27934|25. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|26. Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013). Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol  37, 74-80.   https://doi.org/10.1097/PAS.0b013e31825ec16f|27. Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K (2013). Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas. Neoplasia  15, 435-47.   https://doi.org/10.1593/neo.122132|28. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R (2012). Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist  17, 46-54.   https://doi.org/10.1634/theoncologist.2011-0227|29. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012). Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int  109, 1600-6.   https://doi.org/10.1111/j.1464-410X.2011.10785.x|30. Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH (2014). Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol  32, 23.e9-13.   https://doi.org/10.1016/j.urolonc.2012.08.011|31. Shuch B, Linehan WM, Srinivasan R (2013). Aerobic glycolysis: a novel target in kidney cancer. Expert Rev Anticancer Ther  13, 711-9.   https://doi.org/10.1586/era.13.57|32. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|33. Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM (2013). Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol  189, 430-5.   https://doi.org/10.1016/j.juro.2012.07.139|34. Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R (2012). Targeting the mTOR pathway in Chromophobe Kidney Cancer. J Cancer  3, 152-7.   https://doi.org/10.7150/jca.4378|35. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G (2012). Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol  188, 2084-8.   https://doi.org/10.1016/j.juro.2012.08.038|36. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007|37. Sourbier C, Srivastava G, Ghosh MC, Ghosh S, Yang Y, Gupta G, Degraff W, Krishna MC, Mitchell JB, Rouault TA, Linehan WM (2012). Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma. Oncotarget  3, 1472-82.   https://doi.org/10.18632/oncotarget.561|38. Stamatakis L, Metwalli AR, Middelton LA, Marston Linehan W (2013). Diagnosis and management of BHD-associated kidney cancer. Fam Cancer  12, 397-402.   https://doi.org/10.1007/s10689-013-9657-4|39. Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM (2013) Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol 63:244-51|40. Teicher BA, Linehan WM, Helman LJ (2012). Targeting cancer metabolism. Clin Cancer Res  18, 5537-45.   https://doi.org/10.1158/1078-0432.CCR-12-2587|41. Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Gesuwan K, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ (2012). von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. Surgery  152, 1106-17.   https://doi.org/10.1016/j.surg.2012.08.010|42. Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, Hoang A, Nix J, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto PA (2012). Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg  47, 2077-82.   https://doi.org/10.1016/j.jpedsurg.2012.07.003|43. Weisbrod AB, Kitano M, Gesuwan K, Millo C, Herscovitch P, Nilubol N, Linehan WM, Kebebew E (2012). Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. J Clin Endocrinol Metab  97, E613-7.   https://doi.org/10.1210/jc.2011-2626|44. Woldemichael GM, Turbyville TJ, Vasselli JR, Linehan WM, McMahon JB (2012). Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A. Neoplasia  14, 771-7.   https://doi.org/10.1593/neo.12852|45. Yang Y, Lane AN, Ricketts CJ, Sourbier C, Wei MH, Shuch B, Pike L, Wu M, Rouault TA, Boros LG, Fan TW, Linehan WM (2013). Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One  8, e72179.   https://doi.org/10.1371/journal.pone.0072179|46. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001|47. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D (2012). Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol  36, 654-62.   https://doi.org/10.1097/PAS.0b013e31824f24a6",https://intramural.nih.gov/search/searchview.taf?ipid=78665
333,BC011031-06,"October 01, 2012 -  September 30, 2013",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI","Valentina  Factor|Tanya N Hoang|Akira  Tomokuni; MD, PhD|Phuongnga  Ton|Jesper B Andersen; PhD|Jens Uwe Marquardt|Show all 9","Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)","Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Xin HW, Hari DM, Mullinax JE, Ambe CM, Koizumi T, Ray S, Anderson AJ, Wiegand GW, Garfield SH, Thorgeirsson SS, Avital I (2012). Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division. Stem Cells  30, 591-8.   https://doi.org/10.1002/stem.1061",https://intramural.nih.gov/search/searchview.taf?ipid=78610
334,BC011032-06,"October 01, 2012 -  September 30, 2013",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Alok  Mishra|Mehdi  Mollapour|Thomas L Prince|Harvey Grant Schwartz|Manabu  Tatokoro|Show all 10,"Brian  Blagg (Chemistry, University of Kansas)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Nicolas  Winssinger (University of Strassbourg)|Gabriela X Chiosis|Show all 11",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)|Jane Beth Trepel (Medical Oncology Branch),NULL,"1. Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB (2012). Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy. Curr Mol Med  12, 1125-41.   https://doi.org/10.2174/156652412803306729|2. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L (2012). Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle  11, 3649-55.   https://doi.org/10.4161/cc.21926|3. Kim YS, Kumar V, Lee S, Iwai A, Neckers L, Malhotra SV, Trepel JB (2012). Methoxychalcone inhibitors of androgen receptor translocation and function. Bioorg Med Chem Lett  22, 2105-9.   https://doi.org/10.1016/j.bmcl.2011.12.141|4. Neckers L, Workman P (2012). Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res  18, 64-76.   https://doi.org/10.1158/1078-0432.CCR-11-1000|5. Solier S, Kohn KW, Scroggins B, Xu W, Trepel J, Neckers L, Pommier Y (2012). Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A  109, 12866-72.   https://doi.org/10.1073/pnas.1203617109|6. Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L (2012). Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol Cell  47, 434-43.   https://doi.org/10.1016/j.molcel.2012.05.015|7. Xu W, Neckers L (2012). The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity. Future Oncol  8, 939-42.   https://doi.org/10.2217/fon.12.80",https://intramural.nih.gov/search/searchview.taf?ipid=78685
335,BC011033-06,"October 01, 2012 -  September 30, 2013",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Berta  Bosch Pages|Karis  Faust|Sanjay  Khandelwal,Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI),Lionel  Feigenbaum (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78573
336,BC011035-06,"October 01, 2012 -  September 30, 2013",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Sunil  Kaul,NULL,Lionel  Feigenbaum (Office Of The Director),Katherine Walton Roche; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78572
337,BC011037-06,"October 01, 2012 -  September 30, 2013",Developing new immunotherapies based of CD4+ T cells,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,NULL,NULL,Robert L Danner; MD (CC),"1. Kerkar SP, Restifo NP (2012). Cellular constituents of immune escape within the tumor microenvironment. Cancer Res  72, 3125-30.   https://doi.org/10.1158/0008-5472.CAN-11-4094|2. Muranski P, Restifo NP (2013). Essentials of Th17 cell commitment and plasticity. Blood  121, 2402-14.   https://doi.org/10.1182/blood-2012-09-378653|3. Zou W, Restifo NP (2012). Nine lives for TH9s? Nat Med  18, 1177-8.   https://doi.org/10.1038/nm.2868",https://intramural.nih.gov/search/searchview.taf?ipid=78567
338,BC011038-06,"October 01, 2012 -  September 30, 2013",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Gennady  Bratslavsky|Kristin K Shouck|Donna  Drake|Sarah M Fowler; RN|Julia C Friend; PA|Rabindra  Gautam|Show all 25,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|James  McMahon; PhD (Molecular Targets Laboratory),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)","1. Schmidt L, Srinivasan R, Linehan W (2014) The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies, in Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets. Figlin R, ed., pp. 3-25.|2. Srinivasan R, Linehan W (2012) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology., pp. 1475-1491.|3. Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G (2012). Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol  188, 1695-700.   https://doi.org/10.1016/j.juro.2012.07.029|4. Ballester L, Aung P, Lai J, DiGiovanna J, Abdullaev Z, Pack S, Linehan W, Stern J, Pinto P, Lee C (2013) An Unusual Presentation of Glomeruloid Mehangioma in a Patient With VHL Syndrome: A Case Report and Review of Literature. Open J Clin Diagnostics 3:June 1-4|5. Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013). Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol  27, 196-201.   https://doi.org/10.1089/end.2012.0483|6. Chow WH, Shuch B, Linehan WM, Devesa SS (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer  119, 388-94.   https://doi.org/10.1002/cncr.27690|7. Eisenhofer G, Vocke CD, Elkahloun A, Huynh TT, Prodanov T, Lenders JW, Timmers HJ, Benhammou JN, Linehan WM, Pacak K (2012). Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution. Horm Metab Res  44, 343-8.   https://doi.org/10.1055/s-0032-1304662|8. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J (2013). A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res  11, 1061-1071.   https://doi.org/10.1158/1541-7786.MCR-13-0111|9. Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM (2012). Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl Cancer Inst  104, 1750-64.   https://doi.org/10.1093/jnci/djs418|10. Linehan W, Vocke C, Peterson J, Merino M, Schmidt L, Ricketts C (2013) The Cancer Genome Atlas Research Network: Comprehensive Molecular Characterization of Clear Cell Renal Cell Carcinoma. Nature 499:43-49|11. Linehan WM (2012). Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res  22, 2089-100.   https://doi.org/10.1101/gr.131110.111|12. Linehan WM (2012). The genetic basis of kidney cancer: implications for management and use of targeted therapeutic approaches. Eur Urol  61, 896-8.   https://doi.org/10.1016/j.eururo.2012.02.022|13. Linehan WM, Rathmell WK (2012). Kidney cancer. Urol Oncol  30, 948-51.   https://doi.org/10.1016/j.urolonc.2012.08.021|14. Linehan WM, Ricketts CJ (2013). The metabolic basis of kidney cancer. Semin Cancer Biol  23, 46-55.   https://doi.org/10.1016/j.semcancer.2012.06.002|15. Linehan WM, Rouault TA (2013). Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. Clin Cancer Res  19, 3345-52.   https://doi.org/10.1158/1078-0432.CCR-13-0304|16. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|17. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x|18. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM (2012). Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis  1, e14.   https://doi.org/10.1038/oncsis.2012.14|19. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ (2011). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature  481, 385-8.   https://doi.org/10.1038/nature10642|20. Neckers L, Ricketts CJ, Marston Linehan W (2013). New insights into von Hippel-Lindau function highlighted by investigation of the trichloroethylene-induced p.P81S hotspot mutation. J Natl Cancer Inst  105, 1339-40.   https://doi.org/10.1093/jnci/djt240|21. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013). An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer  132, 2640-7.   https://doi.org/10.1002/ijc.27934|22. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|23. Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013). Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol  37, 74-80.   https://doi.org/10.1097/PAS.0b013e31825ec16f|24. Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K (2013). Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas. Neoplasia  15, 435-47.   https://doi.org/10.1593/neo.122132|25. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R (2012). Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist  17, 46-54.   https://doi.org/10.1634/theoncologist.2011-0227|26. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012). Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int  109, 1600-6.   https://doi.org/10.1111/j.1464-410X.2011.10785.x|27. Shuch B, Linehan WM, Srinivasan R (2013). Aerobic glycolysis: a novel target in kidney cancer. Expert Rev Anticancer Ther  13, 711-9.   https://doi.org/10.1586/era.13.57|28. Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM (2013). Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol  189, 430-5.   https://doi.org/10.1016/j.juro.2012.07.139|29. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G (2012). Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol  188, 2084-8.   https://doi.org/10.1016/j.juro.2012.08.038|30. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007|31. Sourbier C, Srivastava G, Ghosh MC, Ghosh S, Yang Y, Gupta G, Degraff W, Krishna MC, Mitchell JB, Rouault TA, Linehan WM (2012). Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma. Oncotarget  3, 1472-82.   https://doi.org/10.18632/oncotarget.561|32. Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM (2013) Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol 63:244-51|33. Teicher BA, Linehan WM, Helman LJ (2012). Targeting cancer metabolism. Clin Cancer Res  18, 5537-45.   https://doi.org/10.1158/1078-0432.CCR-12-2587|34. Turcotte S, Turkbey B, Barak S, Libutti SK, Alexander HR, Linehan WM, Hughes MS, Nilubol N, Gesuwan K, Millo C, Quezado M, Choyke PL, Kebebew E, Phan GQ (2012). von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. Surgery  152, 1106-17.   https://doi.org/10.1016/j.surg.2012.08.010|35. Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, Hoang A, Nix J, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto PA (2012). Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg  47, 2077-82.   https://doi.org/10.1016/j.jpedsurg.2012.07.003|36. Weisbrod AB, Kitano M, Gesuwan K, Millo C, Herscovitch P, Nilubol N, Linehan WM, Kebebew E (2012). Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. J Clin Endocrinol Metab  97, E613-7.   https://doi.org/10.1210/jc.2011-2626|37. Woldemichael GM, Turbyville TJ, Vasselli JR, Linehan WM, McMahon JB (2012). Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A. Neoplasia  14, 771-7.   https://doi.org/10.1593/neo.12852|38. Yang Y, Lane AN, Ricketts CJ, Sourbier C, Wei MH, Shuch B, Pike L, Wu M, Rouault TA, Boros LG, Fan TW, Linehan WM (2013). Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One  8, e72179.   https://doi.org/10.1371/journal.pone.0072179|39. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001",https://intramural.nih.gov/search/searchview.taf?ipid=78666
339,BC011039-06,"October 01, 2012 -  September 30, 2013",Long distant regulation of c-myb in normal cells and acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Richard P Koller|Junfang  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78631
340,BC011043-06,"October 01, 2012 -  September 30, 2013",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Masaya  Baba|Hisashi  Hasumi|Yukiko  Hasumi|Kristin K Shouck|Donna  Drake|Sarah M Fowler; RN|Show all 24,Masahiro  Yao MD (Yokohama City University Medical School)|Mutsuo  Furihata|Yoshihiko  Kakinuma (Kochi Medical School)|Alessio  Nencioni (University of Genoa)|Junichi  Sadoshima (UMDNJ)|Eric  Miska (Gurdon Institute),Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,"1. Srinivasan R, Linehan W (2012) Treatment of Advanced Renal Cell Carcinoma, in Campbell-Walsh Urology., pp. 1475-1491.|2. Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G (2012). Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol  188, 1695-700.   https://doi.org/10.1016/j.juro.2012.07.029|3. Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, Hasumi H, Hasumi Y, Kieffer-Kwon KR, Gonzalez CG, Hughes RM, Klein ME, Oh HF, Bible P, Southon E, Tessarollo L, Schmidt LS, Linehan WM, Casellas R (2012). The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development. Blood  120, 1254-61.   https://doi.org/10.1182/blood-2012-02-410407|4. Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013). Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol  27, 196-201.   https://doi.org/10.1089/end.2012.0483|5. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|6. Chow WH, Shuch B, Linehan WM, Devesa SS (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer  119, 388-94.   https://doi.org/10.1002/cncr.27690|7. Filson CP, Schwartz K, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Miller DC (2014). Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. Urol Oncol  32, 27.e15-21.   https://doi.org/10.1016/j.urolonc.2012.09.014|8. Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM (2012). Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN. J Natl Cancer Inst  104, 1750-64.   https://doi.org/10.1093/jnci/djs418|9. Linehan WM (2012). Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res  22, 2089-100.   https://doi.org/10.1101/gr.131110.111|10. Linehan WM (2012). The genetic basis of kidney cancer: implications for management and use of targeted therapeutic approaches. Eur Urol  61, 896-8.   https://doi.org/10.1016/j.eururo.2012.02.022|11. Linehan WM, Rathmell WK (2012). Kidney cancer. Urol Oncol  30, 948-51.   https://doi.org/10.1016/j.urolonc.2012.08.021|12. Linehan WM, Ricketts CJ (2013). The metabolic basis of kidney cancer. Semin Cancer Biol  23, 46-55.   https://doi.org/10.1016/j.semcancer.2012.06.002|13. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|14. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013). An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer  132, 2640-7.   https://doi.org/10.1002/ijc.27934|15. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R (2012). Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist  17, 46-54.   https://doi.org/10.1634/theoncologist.2011-0227|16. Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012). Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int  109, 1600-6.   https://doi.org/10.1111/j.1464-410X.2011.10785.x|17. Shuch B, Linehan WM, Srinivasan R (2013). Aerobic glycolysis: a novel target in kidney cancer. Expert Rev Anticancer Ther  13, 711-9.   https://doi.org/10.1586/era.13.57|18. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|19. Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R (2012). Targeting the mTOR pathway in Chromophobe Kidney Cancer. J Cancer  3, 152-7.   https://doi.org/10.7150/jca.4378|20. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G (2012). Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol  188, 2084-8.   https://doi.org/10.1016/j.juro.2012.08.038|21. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007|22. Stamatakis L, Metwalli AR, Middelton LA, Marston Linehan W (2013). Diagnosis and management of BHD-associated kidney cancer. Fam Cancer  12, 397-402.   https://doi.org/10.1007/s10689-013-9657-4|23. Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM (2013) Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol 63:244-51|24. Teicher BA, Linehan WM, Helman LJ (2012). Targeting cancer metabolism. Clin Cancer Res  18, 5537-45.   https://doi.org/10.1158/1078-0432.CCR-12-2587|25. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D (2012). Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol  36, 654-62.   https://doi.org/10.1097/PAS.0b013e31824f24a6",https://intramural.nih.gov/search/searchview.taf?ipid=78662
341,BC011046-06,"October 01, 2012 -  September 30, 2013",Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Lisa Ann Tobin|Yili  Xie|John R Wunderlich,NULL,NULL,NULL,"1. Xie Y, Tobin LA, Camps J, Wangsa D, Yang J, Rao M, Witasp E, Awad KS, Yoo N, Ried T, Kwong KF (2013). MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene  32, 2442-51.   https://doi.org/10.1038/onc.2012.258",https://intramural.nih.gov/search/searchview.taf?ipid=78657
342,BC011049-06,"October 01, 2012 -  September 30, 2013",Development and evaluation of apoptosis targeted therapies in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Lisa Ann Tobin|Yili  Xie|John R Wunderlich,NULL,NULL,Harry Lewis Malech; MD (NIAID),"1. Tobin LA, Xie Y, Tsokos M, Chung SI, Merz AA, Arnold MA, Li G, Malech HL, Kwong KF (2013). Pegylated siRNA-loaded calcium phosphate nanoparticle-driven amplification of cancer cell internalization in vivo. Biomaterials  34, 2980-90.   https://doi.org/10.1016/j.biomaterials.2013.01.046",https://intramural.nih.gov/search/searchview.taf?ipid=78658
343,BC011053-06,"October 01, 2012 -  September 30, 2013",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Orla Majella Casey|Paul Gerard Hynes|Heather  Sheppard,NULL,NULL,NULL,"1. Casey OM, Fang L, Hynes PG, Abou-Kheir WG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K (2012). TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. PLoS One  7, e41668.   https://doi.org/10.1371/journal.pone.0041668",https://intramural.nih.gov/search/searchview.taf?ipid=78644
344,BC011054-06,"October 01, 2012 -  September 30, 2013",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Anna Maartje Aalbers|Marianne K-H Kim|Elise C Kohn; MD,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Natasha  Caplen (Cancer Genetics Branch),Craig Joseph Thomas (NCATS),"1. Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM (2012). IKK-ε coordinates invasion and metastasis of ovarian cancer. Cancer Res  72, 5494-504.   https://doi.org/10.1158/0008-5472.CAN-11-3993",https://intramural.nih.gov/search/searchview.taf?ipid=78510
345,BC011055-06,"October 01, 2012 -  September 30, 2013",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI","Christopher Thomas Campbell; MD, PhD|Sudipa  Chowdhury|Saddam Musleh Muthana; PhD|Whitney Shea Wright|Yalong  Zhang",Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases),"Lisa  Mcshane (Biometrics Research Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Yin Z, Nguyen HG, Chowdhury S, Bentley P, Bruckman MA, Miermont A, Gildersleeve JC, Wang Q, Huang X (2012). Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens. Bioconjug Chem  23, 1694-703.   https://doi.org/10.1021/bc300244a",https://intramural.nih.gov/search/searchview.taf?ipid=78552
346,BC011056-06,"October 01, 2012 -  September 30, 2013",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Alan  Brooks,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Avi  Ashkenazi (Genentech, Inc.)|Noako  Seki (Kurume University)|Neil  Cross (Sheffield Hallam University)","Stanley  Lipkowitz; MD, PhD (Laboratory of Cellular and Molecular Biology)|James  McMahon; PhD (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)",NULL,"1. Henrich CJ, Thomas CL, Brooks AD, Booth NL, Lowery EM, Pompei RJ, McMahon JB, Sayers TJ (2012). Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis. Apoptosis  17, 79-89.   https://doi.org/10.1007/s10495-011-0652-7|2. Whitson EL, Sun H, Thomas CL, Henrich CJ, Sayers TJ, McMahon JB, Griesinger C, McKee TC (2012). Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima. J Nat Prod  75, 394-9.   https://doi.org/10.1021/np200805z",https://intramural.nih.gov/search/searchview.taf?ipid=78577
347,BC011058-06,"October 01, 2012 -  September 30, 2013",Development of a Vaccine for HIVAIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Janet M Dipasquale|Venkatramanan  Mohanram; PhD|Thomas Anthony Musich; PhD|Michael Anthony Thomas; PhD|Iskra  Tuero; PhD|Show all 11,"Susan  Barnett (Chiron Corporation)|Ruth  Ruprecht (Dana Farber Cancer Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Timothy  Fouts (Profectus BioSciences, Inc.)|David C Montefiori; PhD (Department of Surgery, NIAID)|Susan  ZollaPazner (New York University School of Medicine)|Show all 8",David J Venzon; PhD (Biostatistics and Data Management Section)|Jeffrey  Gildersleeve (Chemical Biology Laboratory)|Brandon Frank Keele (Office Of The Director),"Terence Martyn Phillips; PhD, DSc (NIBIB) |Vanessa  Hirsch (NIAID)","1. Campbell C, Llewellyn S, Demberg T, Morgan I, Robert-Guroff M, Gildersleeve J (2013) High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge. PLOS One, in press.|2. Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, Lee EM, Kalisz I, Kalyanaraman VS, Dipasquale J, McKinnon K, Robert-Guroff M (2012). Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J Virol  86, 12591-604.   https://doi.org/10.1128/JVI.00298-12|3. Demberg T, Robert-Guroff M (2012). Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol  3, 250.   https://doi.org/10.3389/fimmu.2012.00250|4. Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M (2012). Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route. Clin Vaccine Immunol  19, 629-37.   https://doi.org/10.1128/CVI.00010-12|5. Rasmussen RA, Siddappa NB, Lakhashe SK, Watkins J, Villinger F, Ibegbu C, Florese RH, Robert-Guroff M, Montefiori DC, Forthal DN, O'Connor D, Ruprecht RM, Clade C Program Project Group (2012). High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure:  prevention of viremia. AIDS  26, 149-55.   https://doi.org/10.1097/QAD.0b013e32834d3c4f|6. Vargas-Inchaustegui DA, Xiao P, Tuero I, Patterson LJ, Robert-Guroff M (2012). NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model. J Immunol  189, 1878-85.   https://doi.org/10.4049/jimmunol.1201026|7. VargasInchaustegui D, Robert-Guroff M (2013) Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention. Curr HIV Res, in press.|8. Xiao P, Patterson LJ, Kuate S, Brocca-Cofano E, Thomas MA, Venzon D, Zhao J, DiPasquale J, Fenizia C, Lee EM, Kalisz I, Kalyanaraman VS, Pal R, Montefiori D, Keele BF, Robert-Guroff M (2012). Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge. J Virol  86, 4644-57.   https://doi.org/10.1128/JVI.06812-11",https://intramural.nih.gov/search/searchview.taf?ipid=78570
348,BC011061-06,"October 01, 2012 -  September 30, 2013",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kirill Andreevich Afonin|Eckart  Bindewald|Anish A Dalal|Adrian K Davey|Ravi Vrajesh Desai|Kshitij  Gupta|Show all 16,"Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luc  Jaeger (University of California Santa Barbara)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)|Robert L Jernigan; PhD (NCI)|Hanan  Samet (University of Maryland)|Show all 9",Yun Xing M Wang (Structural Biophysics Laboratory)|Marina A Dobrovolskaia (Office Cancer Nanotechnology Research)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Peter F Johnson; PhD (Laboratory of Cancer Prevention),Jakob  Reiser (OD),"1. Grabow W, Afonin K, Zakrevsky P, Walker F, Calkins E, Geary C, Kasprzak W, Bindewald E, Shapiro B, Jaeger L (2012) RNA Nanotechnology in Nanomedicine, in Nanomedicine and Drug Delivery (Recent Advances in Nanoscience and Nanotechnology). Sebastian M, Ninan N, Haghi A, eds., pp. 208-220.|2. Afonin K, Linsay B, Shapiro B (2013) Engineered RNA nanodesigns for applications in RNA nanotechnology. RNA Nanotechnology 1:1-15|3. Afonin KA, Kireeva M, Grabow WW, Kashlev M, Jaeger L, Shapiro BA (2012). Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs. Nano Lett  12, 5192-5.   https://doi.org/10.1021/nl302302e|4. Kim T, Shapiro BA (2013). The role of salt concentration and magnesium binding in HIV-1 subtype-A and subtype-B kissing loop monomer structures. J Biomol Struct Dyn  31, 495-510.   https://doi.org/10.1080/07391102.2012.706072|5. Wolfe KC, Hastings WA, Dutta S, Long A, Shapiro BA, Woolf TB, Guthold M, Chirikjian GS (2012). Multiscale modeling of double-helical DNA and RNA: a unification through Lie groups. J Phys Chem B  116, 8556-72.   https://doi.org/10.1021/jp2126015|6. Shapiro BA, Afonin KA, Bindewald EA, Jaeger LA, Santhanam AA, Viard MA (submitted in 2012) Auto-recognizing Therapeutic R/dna Chimeric Nanoparticles (np). Patents issued: 2780455 (EP in 2017); 2780455 (GB in 2017); 6093775 (JP in 2017); 9,631,192 (US in 2017). Patents pending: PCT/US2012/065945 (PC application); 2012340094 (AU application); 2856117 (CA application).|7. Shapiro BA, Afonin KA, Grabow WA, Jaeger LA, Kashlev MA, Kireeva MA (submitted in 2012) Co-transcriptional Assembly Of Modified Rna Nanoparticles. Patent issued: 9,719,084 (US in 2017). Patents pending: 15/666,326 (US application); PCT/US2013/058492 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=78582
349,BC011062-06,"October 01, 2012 -  September 30, 2013",Development of a Vaccine for HIVAIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Janet M Dipasquale|Sergio  Lavilla-Alonso; PhD|Tinashe Edward Nyanhete|Michael Anthony Thomas; PhD|Iskra  Tuero; PhD|Show all 8,Sol  Langermann (Amplimmune)|Ashley  Haase (University of Minnesota)|Qingsheng  Li (University of Nebraska Lincoln),David J Venzon; PhD (Biostatistics and Data Management Section),"Terence Martyn Phillips; PhD, DSc (NIBIB)","1. Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M (2012). Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route. Clin Vaccine Immunol  19, 629-37.   https://doi.org/10.1128/CVI.00010-12|2. Vargas-Inchaustegui DA, Xiao P, Tuero I, Patterson LJ, Robert-Guroff M (2012). NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model. J Immunol  189, 1878-85.   https://doi.org/10.4049/jimmunol.1201026|3. VargasInchaustegui D, Robert-Guroff M (2013) Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention. Curr HIV Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78571
350,BC011063-06,"October 01, 2012 -  September 30, 2013",Development of a Vaccine for HIVAIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Janet M Dipasquale|Sergio  Lavilla-Alonso; PhD|Tinashe Edward Nyanhete|Michael Anthony Thomas; PhD,"Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Christopher  Miller (University of California, Davis)|Timothy  Fouts (Profectus BioSciences, Inc.)",NULL,Mark  Connors; MD (NIAID),"1. Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, DeSilva V, Fritts L, Bett AJ, Casimiro DR, Shiver JW, Robert-Guroff M, Robertson MN, McChesney MB, Gilbert PB, Miller CJ (2012). Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J Virol  86, 2239-50.   https://doi.org/10.1128/JVI.06175-11|2. Thomas M, Song R, Demberg T, VargasInchaustegui D, Robert-Guroff M (2013) Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3, and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors. PLOS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78569
351,BC011064-06,"October 01, 2012 -  September 30, 2013",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","John K Simmons|Shuling  Zhang; MD, PhD|Ke  Zhang",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78682
352,BC011065-06,"October 01, 2012 -  September 30, 2013",Preclinical Testing of HDAC and mTOR Inhibitors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kenneth Michael Felsenstein|Benjamin John Gamache|Joy Michelle Gary|John K Simmons|Shuling  Zhang; MD, PhD|Ke  Zhang|Show all 7",NULL,Ola Anders Landgren (Lymphoid Malignancies Branch),NULL,"1. Simmons JK, Amlin-Van Schaick JC, Geiger TR, Reilly K, Hunter K, Mock BA (2012). Mouse genetics 2011: meeting report. Mamm Genome  23, 225-31.   https://doi.org/10.1007/s00335-012-9390-6",https://intramural.nih.gov/search/searchview.taf?ipid=78683
353,BC011069-06,"October 01, 2012 -  September 30, 2013",Biology and Therapy of Lymphopenia,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Hua  Zhang,NULL,Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Claude  Sportes (Experimental Transplantation and Immunology Branch),NULL,"1. Lundström W, Fewkes NM, Mackall CL (2012). IL-7 in human health and disease. Semin Immunol  24, 218-24.   https://doi.org/10.1016/j.smim.2012.02.005",https://intramural.nih.gov/search/searchview.taf?ipid=78670
354,BC011070-06,"October 01, 2012 -  September 30, 2013",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Shahed  Abdullah|Theresa M Davies Hill|Nancy Ellen Diener|Moses Osemwingie Evbuomwan|Karthik Ayyappankave Ganapathi|Shunyou  Gong|Show all 14,NULL,NULL,NULL,"1. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57|2. Menon MP, Pittaluga S, Jaffe ES (2012). The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification. Cancer J  18, 411-20.   https://doi.org/10.1097/PPO.0b013e31826aee97|3. Venkataraman G, Song JY, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Traverse-Glehen A, Eberle FC, Hanson JC, Raffeld MA, Pittaluga S, Jaffe ES (2013). Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood  121, 1795-804.   https://doi.org/10.1182/blood-2012-06-439455",https://intramural.nih.gov/search/searchview.taf?ipid=78641
355,BC011073-06,"October 01, 2012 -  September 30, 2013",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Yongzhi  Cui; MD|Steven Lorenz Highfill|Daniel W Lee|Adrienne Hart Smith|Rimas Jonas Orentas|Javed  Khan; MD|Show all 7,Malcolm  Brenner (Baylor College of Medicine)|Laurence  Cooper (MD Anderson Cancer Center)|Carl  June (University of Pennsylvania)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Delores  Schendel (Max-Delbruck-Center for Molecular Medicine),"Peter D Aplan; MD (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA (2012). The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. Clin Cancer Res  18, 2780-90.   https://doi.org/10.1158/1078-0432.CCR-11-1920|2. Orentas RJ, Lee DW, Mackall C (2012). Immunotherapy targets in pediatric cancer. Front Oncol  2, 3.   https://doi.org/10.3389/fonc.2012.00003|3. Orentas RJ, Yang JJ, Wen X, Wei JS, Mackall CL, Khan J (2012). Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol  2, 194.   https://doi.org/10.3389/fonc.2012.00194",https://intramural.nih.gov/search/searchview.taf?ipid=78668
356,BC011076-06,"October 01, 2012 -  September 30, 2013",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Smitha  Antony|Guojian  Jiang; MD|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler|Yongzhong  Wu",NULL,Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,"1. Doroshow JH, Juhasz A, Ge Y, Holbeck S, Lu J, Antony S, Wu Y, Jiang G, Roy K (2012). Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel. Biochem Pharmacol  83, 1195-207.   https://doi.org/10.1016/j.bcp.2012.01.022|2. Esworthy RS, Kim BW, Rivas GE, Leto TL, Doroshow JH, Chu FF (2012). Analysis of candidate colitis genes in the Gdac1 locus of mice deficient in glutathione peroxidase-1 and -2. PLoS One  7, e44262.   https://doi.org/10.1371/journal.pone.0044262",https://intramural.nih.gov/search/searchview.taf?ipid=78532
357,BC011078-06,"October 01, 2012 -  September 30, 2013",Phase 01 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Agnes  Juhasz|Yves  Pommier; PhD|William M Bonner; PhD,NULL,Joseph E Tomaszewski (Office of the Director)|Ralph  Parchment (Toxicology and Pharmacology Branch),NULL,"1. Kummar S, Doroshow J (2012) Phase 0 Trials in Oncology, in Handbook of Anticancer Pharmacokinetics and Pharmacodynamics., in press.|2. Weil M, Kummar S, Doroshow J, Chen A (2012) BRCA Mtations and PARP Inhibitors, in Handbook of Therapeutic Biomarkers in Cancer. Yang S, ed., in press.|3. Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, Doroshow JH (2012). Advances in using PARP inhibitors to treat cancer. BMC Med  10, 25.   https://doi.org/10.1186/1741-7015-10-25|4. Kummar S, Ji J, Morgan R, Lenz HJ, Puhalla SL, Belani CP, Gandara DR, Allen D, Kiesel B, Beumer JH, Newman EM, Rubinstein L, Chen A, Zhang Y, Wang L, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH (2012). A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clin Cancer Res  18, 1726-34.   https://doi.org/10.1158/1078-0432.CCR-11-2821|5. Morgan RJ, Leong L, Chow W, Gandara D, Frankel P, Garcia A, Lenz HJ, Doroshow JH (2012). Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study. Invest New Drugs  30, 723-8.   https://doi.org/10.1007/s10637-010-9557-5|6. Murai J, Huang SY, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y (2012). Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res  72, 5588-99.   https://doi.org/10.1158/0008-5472.CAN-12-2753|7. Pfister TD, Hollingshead M, Kinders RJ, Zhang Y, Evrard YA, Ji J, Khin SA, Borgel S, Stotler H, Carter J, Divelbiss R, Kummar S, Pommier Y, Parchment RE, Tomaszewski JE, Doroshow JH (2012). Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues. PLoS One  7, e50494.   https://doi.org/10.1371/journal.pone.0050494|8. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012). CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res  72, 3499-511.   https://doi.org/10.1158/0008-5472.CAN-12-1370|9. Schilsky RL, Doroshow JH, Leblanc M, Conley BA (2012). Development and use of integral assays in clinical trials. Clin Cancer Res  18, 1540-6.   https://doi.org/10.1158/1078-0432.CCR-11-2202|10. VanderWalde A, Ye W, Frankel P, Asuncion D, Leong L, Luu T, Morgan R, Twardowski P, Koczywas M, Pezner R, Paz IB, Margolin K, Wong J, Doroshow JH, Forman S, Shibata S, Somlo G (2012). Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer. Biol Blood Marrow Transplant  18, 1273-80.   https://doi.org/10.1016/j.bbmt.2012.01.021|11. Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, Ballestrero A, Doroshow JH, Pommier Y (2012). Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc Natl Acad Sci U S A  109, 15030-5.   https://doi.org/10.1073/pnas.1205943109",https://intramural.nih.gov/search/searchview.taf?ipid=78533
358,BC011081-06,"October 01, 2012 -  September 30, 2013",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Arvin Koruthu George|Soroush  Rais-Bahrami|Jason Todd Rothwax|Mohummad Minhaj Siddiqui|Lambros  Stamatakis|Srinivas  Vourganti|Show all 8,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|William Laurence Dahut; MD (Medical Oncology Branch)",Bradford J Wood; MD (CC),"1. Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G (2012). Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol  188, 1695-700.   https://doi.org/10.1016/j.juro.2012.07.029|2. Agochukwu NQ, Rastinehad AR, Richter LA, Barak S, Zerbe CS, Holland SM, Pinto PA (2012). Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature. J Pediatr Surg  47, 400-3.   https://doi.org/10.1016/j.jpedsurg.2011.11.003|3. Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013). Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol  27, 196-201.   https://doi.org/10.1089/end.2012.0483|4. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|5. Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA (2012). Image guidance in the focal treatment of prostate cancer. Curr Opin Urol  22, 328-35.   https://doi.org/10.1097/MOU.0b013e32835482cc|6. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|7. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|8. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA (2012). Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int  110, E694-700.   https://doi.org/10.1111/j.1464-410X.2012.11503.x|9. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|10. Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M (2012). Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys  39, 4093-103.   https://doi.org/10.1118/1.4722753|11. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G (2012). Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol  188, 2084-8.   https://doi.org/10.1016/j.juro.2012.08.038|12. Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2012). MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol  18, 34-45.   https://doi.org/10.4261/1305-3825.DIR.4478-11.1|13. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|14. Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL (2012). Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int  110, 1642-7.   https://doi.org/10.1111/j.1464-410X.2012.11469.x|15. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA (2012). Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol  188, 1157-1163.   https://doi.org/10.1016/j.juro.2012.06.011|16. Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, Hoang A, Nix J, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto PA (2012). Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg  47, 2077-82.   https://doi.org/10.1016/j.jpedsurg.2012.07.003|17. Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol  188, 2152-2157.   https://doi.org/10.1016/j.juro.2012.08.025|18. Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int  110, E783-8.   https://doi.org/10.1111/j.1464-410X.2012.11646.x",https://intramural.nih.gov/search/searchview.taf?ipid=78690
359,BC011084-06,"October 01, 2012 -  February 01, 2010",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Keisuke  Hasegawa|Sung Jin  Ryu|Pavol  Cekan; PhD,Mirek  Dundr (Rosalin Franklin University)|Jan  Motlik (Institute of Animal Physiology and Genetics)|Kristen  Verhey (University of Michigan),NULL,NULL,"1. Hasegawa K, Ryu SJ, Kaláb P (2013). Chromosomal gain promotes formation of a steep RanGTP gradient that drives mitosis in aneuploid cells. J Cell Biol  200, 151-61.   https://doi.org/10.1083/jcb.201206142",https://intramural.nih.gov/search/searchview.taf?ipid=78642
360,BC011090-06,"October 01, 2012 -  September 30, 2013",Merkel Cell Carcinoma Polyomavirus,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Rachel  Schowalter; PhD,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School),Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Alison Anne McBride; PhD (NIAID),"1. Li J, Wang X, Diaz J, Tsang SH, Buck CB, You J (2013). Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J Virol  87, 9173-88.   https://doi.org/10.1128/JVI.01216-13|2. Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, Gilbert M, Wakarchuk WW, Imamura A, Ando H, Kiso M, Arnberg N, Garcea RL, Peters T, Buck CB, Stehle T (2012). Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog  8, e1002738.   https://doi.org/10.1371/journal.ppat.1002738|3. Schowalter RM, Reinhold WC, Buck CB (2012). Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One  7, e42181.   https://doi.org/10.1371/journal.pone.0042181",https://intramural.nih.gov/search/searchview.taf?ipid=78522
361,BC011091-06,"October 01, 2012 -  September 30, 2013",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Yuan  Jiang; MD|Chyau Yueh Christopher Lau|Show all 16",NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Elaine S Jaffe; MD (Laboratory of Pathology)|Kenneth H Kraemer; MD (Dermatology Branch),Jeffery L Miller; MD (NIDDK) |Leslie Glenn Biesecker; MD (NHGRI),"1. Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013). Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics  12, 1621-31.   https://doi.org/10.1074/mcp.M112.026427|2. Baysan M, Bozdag S, Cam MC, Kotliarova S, Ahn S, Walling J, Killian JK, Stevenson H, Meltzer P, Fine HA (2012). G-cimp status prediction of glioblastoma samples using mRNA expression data. PLoS One  7, e47839.   https://doi.org/10.1371/journal.pone.0047839|3. Beachy SH, Onozawa M, Chung YJ, Slape C, Bilke S, Francis P, Pineda M, Walker RL, Meltzer P, Aplan PD (2012). Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma. Blood  120, 1048-59.   https://doi.org/10.1182/blood-2012-01-401760|4. Chatterjee R, Zhao J, He X, Shlyakhtenko A, Mann I, Waterfall JJ, Meltzer P, Sathyanarayana BK, FitzGerald PC, Vinson C (2012). Overlapping ETS and CRE Motifs ((G/C)CGGAAGTGACGTCA) preferentially bound by GABPα and CREB proteins. G3 (Bethesda)  2, 1243-56.   https://doi.org/10.1534/g3.112.004002|5. Debbache J, Zaidi MR, Davis S, Guo T, Bismuth K, Wang X, Skuntz S, Maric D, Pickel J, Meltzer P, Merlino G, Arnheiter H (2012). In vivo role of alternative splicing and serine phosphorylation of the microphthalmia-associated transcription factor. Genetics  191, 133-44.   https://doi.org/10.1534/genetics.111.135996|6. Gao Y, Killian K, Zhang H, Yu K, Li QZ, Weinstein S, Virtamo J, Tucker M, Taylor P, Albanes D, Meltzer P, Caporaso N (2012). Leukocyte DNA methylation and colorectal cancer among male smokers. World J Gastrointest Oncol  4, 193-201.   https://doi.org/10.4251/wjgo.v4.i8.193|7. Gartner JJ, Davis S, Wei X, Lin JC, Trivedi NS, Teer JK, NISC Comparative Sequencing Program, Meltzer PS, Rosenberg SA, Samuels Y (2012). Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma. BMC Genomics  13, 505.   https://doi.org/10.1186/1471-2164-13-505|8. Hirsch D, Kemmerling R, Davis S, Camps J, Meltzer PS, Ried T, Gaiser T (2013). Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res  73, 1454-60.   https://doi.org/10.1158/0008-5472.CAN-12-0928|9. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS (2012). Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res  18, 77-90.   https://doi.org/10.1158/1078-0432.CCR-11-0962|10. Killian JK, Walker RL, Bilke S, Chen Y, Davis S, Cornelison R, Smith WI, Meltzer PS (2012). Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples. Methods Mol Biol  823, 107-18.   https://doi.org/10.1007/978-1-60327-216-2_8|11. Kouprina N, Lee NC, Pavlicek A, Samoshkin A, Kim JH, Lee HS, Varma S, Reinhold WC, Otstot J, Solomon G, Davis S, Meltzer PS, Schleutker J, Larionov V (2012). Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families. Genes Chromosomes Cancer  51, 933-48.   https://doi.org/10.1002/gcc.21977|12. O'Shea PJ, Kim DW, Logan JG, Davis S, Walker RL, Meltzer PS, Cheng SY, Williams GR (2012). Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling. J Biol Chem  287, 17812-22.   https://doi.org/10.1074/jbc.M111.311464|13. Parker SC, Gartner J, Cardenas-Navia I, Wei X, Ozel Abaan H, Ajay SS, Hansen NF, Song L, Bhanot UK, Killian JK, Gindin Y, Walker RL, Meltzer PS, Mullikin JC, Furey TS, Crawford GE, Rosenberg SA, Samuels Y, Margulies EH (2012). Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomes. PLoS Genet  8, e1002871.   https://doi.org/10.1371/journal.pgen.1002871|14. Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, Lee HS, Killian KJ, Wang Y, Tsokos M, Roncalli M, Steinberg SM, Wang Y, Giaccone G (2012). Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis  3, e351.   https://doi.org/10.1038/cddis.2012.92|15. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E (2012). DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab  97, E1004-13.   https://doi.org/10.1210/jc.2011-3298|16. Valenzuela MS, Hu L, Lueders J, Walker R, Meltzer PS (2012). Broader utilization of origins of DNA replication in cancer cell lines along a 78 kb region of human chromosome 2q34. J Cell Biochem  113, 132-40.   https://doi.org/10.1002/jcb.23336|17. Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS (2012). Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol  14, 326-32.   https://doi.org/10.1093/neuonc/nor190|18. Kebebew E, Meltzer P, Rechache N, Wang Y (submitted in 2012) Dna Methylation For The Diagnosis, Prognosis And Treatmemt Of Adrenal Neoplasms. Patent issued: 9,428,813 (US in 2016). Patent pending: PCT/US2013/030347 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=78677
362,BC011095-06,"October 01, 2012 -  September 30, 2013",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi|Young Hwan Lee|Joseph V Reilly|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Peter A Pinto; MD",NULL,"Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,"1. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x",https://intramural.nih.gov/search/searchview.taf?ipid=78519
363,BC011101-06,"October 01, 2012 -  September 30, 2013",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Baltazar D Aguda|Susie  Ahn|Rolanda  Bailey|Mehmet  Baysan|Galina Ivanovna Belova|Margaret  Cam; PhD|Show all 19,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78544
364,BC011105-06,"October 01, 2012 -  September 30, 2013",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Ravikiran S Yedidi|David A Davis; MD|Robert  Yarchoan; MD|Kenji  Maeda,"Arun  Ghosh|Masayuki  Amano (Kumamoto University School of Medicine)|Hiromi  OgataAoki (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)|Hiroanori  Hayashi (Kumamoto University School of Medicine)",NULL,NULL,"1. Aoki M, Danish ML, Aoki-Ogata H, Amano M, Ide K, Das D, Koh Y, Mitsuya H (2012). Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1. J Virol  86, 13384-96.   https://doi.org/10.1128/JVI.07234-11|2. Ghosh AK, Chapsal BD, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2012). Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. Bioorg Med Chem Lett  22, 2308-11.   https://doi.org/10.1016/j.bmcl.2012.01.061",https://intramural.nih.gov/search/searchview.taf?ipid=78680
365,BC011106-06,"October 01, 2012 -  September 30, 2013",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office Of The Director)","Paul E Love; MD, PhD (NICHD)","1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78595
366,BC011107-06,"October 01, 2012 -  September 30, 2013",Function and Regulation of Protein Scaffolds and Signal Modulators in Signaling,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Pradeep  Kota|Junghwa  Lim|Daniel A Ritt|Elizabeth Mclean Terrell|Ira  Daar; PhD,John  Scott (Oregon Health and Science University)|Robert  Rottapel (University of Toronto)|Rueben  Shaw (Salk Institute),Peter F Johnson; PhD (Laboratory of Cancer Prevention),NULL,"1. Koveal D, Schuh-Nuhfer N, Ritt D, Page R, Morrison DK, Peti W (2012). A CC-SAM, for coiled coil-sterile α motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane. Sci Signal  5, ra94.   https://doi.org/10.1126/scisignal.2003289|2. Logue JS, Morrison DK (2012). Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev  26, 641-50.   https://doi.org/10.1101/gad.186965.112|3. Morrison DK (2012). MAP kinase pathways. Cold Spring Harb Perspect Biol  4.   https://doi.org/10.1101/cshperspect.a011254|4. Rouquette-Jazdanian AK, Sommers CL, Kortum RL, Morrison DK, Samelson LE (2012). LAT-independent Erk activation via Bam32-PLC-γ1-Pak1 complexes: GTPase-independent Pak1 activation. Mol Cell  48, 298-312.   https://doi.org/10.1016/j.molcel.2012.08.011",https://intramural.nih.gov/search/searchview.taf?ipid=78684
367,BC011108-06,"October 01, 2012 -  September 30, 2013",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathleen L Decicco|Monika  Deshpande|J Curtis Gwilliam|Zhihong  Shan,NULL,NULL,NULL,"1. DeCicco-Skinner KL, Nolan SJ, Deshpande MM, Trovato EL, Dempsey TA, Wiest JS (2013). Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice. PLoS One  8, e56212.   https://doi.org/10.1371/journal.pone.0056212",https://intramural.nih.gov/search/searchview.taf?ipid=78626
368,BC011109-06,"October 01, 2012 -  September 30, 2013",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Kenji  Maeda,Arun  Ghosh|Yoshikazu  Takaoka (Ono Pharmaceutical Co. Ltd.)|Hiromi  OgataAoki (Kumamoto University School of Medicine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78681
369,BC011111-06,"October 01, 2012 -  September 30, 2013",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,NULL,Lionel  Feigenbaum (Office Of The Director)|Jung-Hyun  Park (Experimental Immunology Branch),Lothar  Hennighausen; PhD (NIDDK),"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78596
370,BC011112-06,"October 01, 2012 -  September 30, 2013",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,"Arlene  Sharpe (Dept of Pathology, Harvard Medical School)|Naomi  Taylor",Lionel  Feigenbaum (Office Of The Director)|Dinah  Singer; PhD (Molecular Regulation Section),NULL,"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78592
371,BC011113-06,"October 01, 2012 -  September 30, 2013",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78593
372,BC011114-06,"October 01, 2012 -  September 30, 2013",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,NULL,Lionel  Feigenbaum (Office Of The Director),"Paul E Love; MD, PhD (NICHD)","1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78594
373,BC011115-06,"October 01, 2012 -  September 30, 2013",Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,"Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)",Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78579
374,BC011116-06,"October 01, 2012 -  September 30, 2013",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,NULL,Lionel  Feigenbaum (Office Of The Director)|Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|8. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|9. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|10. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78590
375,BC011117-06,"October 01, 2012 -  September 30, 2013",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 11,NULL,NULL,NULL,"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|7. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|8. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918|9. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|10. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013) Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell 154:1326-1341|11. Van Laethem F, Tikhonova AN, Singer A (2012). MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. Trends Immunol  33, 437-41.   https://doi.org/10.1016/j.it.2012.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=78591
376,BC011118-06,"October 01, 2012 -  September 30, 2013",Role of Shh in developmental patterning and proliferation of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,"Gerard  Evan (UCSF)|Licia  Selleri (Cornell Univ Weill Medical College)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)",Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Bowers M, Eng L, Lao Z, Turnbull RK, Bao X, Riedel E, Mackem S, Joyner AL (2012). Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol  370, 110-24.   https://doi.org/10.1016/j.ydbio.2012.07.017",https://intramural.nih.gov/search/searchview.taf?ipid=78673
377,BC011119-06,"October 01, 2012 -  September 30, 2013",Hoxd gene functions in digit morphogenesis and role of Gli3-Hoxd interaction,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,"Denis  Duboule (Zoology and Animal Biology, Univ. of Geneva)|John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Steve  Vokes (U. Texas, Austin)",Stephen J Lockett; PhD (Office Of The Director)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),"Yingzi  Yang; PhD (NHGRI) |Richa  Agarwala; BTech, MS, PhD (NLM) |Ivan  Ovcharenko; PhD (NLM)","1. Bowers M, Eng L, Lao Z, Turnbull RK, Bao X, Riedel E, Mackem S, Joyner AL (2012). Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol  370, 110-24.   https://doi.org/10.1016/j.ydbio.2012.07.017",https://intramural.nih.gov/search/searchview.taf?ipid=78674
378,BC011120-06,"October 01, 2012 -  September 30, 2013",Genome-wide identification of target promoters of developmental regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,"Benoit  Bruneau (UCSF)|Steve  Vokes (U. Texas, Austin)",NULL,"Ivan  Ovcharenko; PhD (NLM) |Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78671
379,BC011121-06,"October 01, 2012 -  September 30, 2013",RNA interference approach to dissect roles of notochord regulators,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,NULL,Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78672
380,BC011122-06,"October 01, 2012 -  September 30, 2013",Epigenetic Alterations Induced by Tobacco Smoke,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Victor  Marquez; PhD (Chemical Biology Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78580
381,BC011123-06,"October 01, 2012 -  September 30, 2013",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Fabiola  Cecchi|Young Hwan Lee|Joseph V Reilly|Peter A Pinto; MD,NULL,Jane Beth Trepel (Medical Oncology Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Ettore  Appella; MD (Chemical Immunology Section)|Melinda  Hollingshead (Biological Testing Branch)|Lawrence R Phillips (Developmental Therapeutics Program)|Robert J Fisher (Office Of The Director),NULL,"1. Cecchi F, Rabe DC, Bottaro DP (2012). Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets  16, 553-72.   https://doi.org/10.1517/14728222.2012.680957|2. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x",https://intramural.nih.gov/search/searchview.taf?ipid=78520
382,BC011124-06,"October 01, 2012 -  September 30, 2013",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi|Young Hwan Lee|Joseph V Reilly|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Laura  Schmidt","Stuart  Aaronson (Research, Mount Sinai Medical Center)|Ascoli  Carl (Clinical Development Oncology, Rockland Immunologicals, Inc)|Teresa  Burgess (Preclinical Development, Amgen)|Isabelle  Desault (Research Oncology, Amgen)|Angela  Coxon (Amgen)|James  Christensen (Oncology Research, Pfizer)|Show all 24","Maria  Merino; PhD (Laboratory of Pathology)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Terrence R Burke; PhD (Chemical Biology Laboratory)",NULL,"1. Cecchi F, Bottaro DP (2012). Novel antagonists of heparin binding growth factors. Oncotarget  3, 911-2.   https://doi.org/10.18632/oncotarget.645|2. Cecchi F, Pajalunga D, Fowler CA, Uren A, Rabe DC, Peruzzi B, Macdonald NJ, Blackman DK, Stahl SJ, Byrd RA, Bottaro DP (2012). Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell  22, 250-62.   https://doi.org/10.1016/j.ccr.2012.06.029|3. Jagoda EM, Lang L, Bhadrasetty V, Histed S, Williams M, Kramer-Marek G, Mena E, Rosenblum L, Marik J, Tinianow JN, Merchant M, Szajek L, Paik C, Cecchi F, Raffensperger K, Jose-Dizon JM, Bottaro DP, Choyke P (2012). Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. J Nucl Med  53, 1592-600.   https://doi.org/10.2967/jnumed.111.102293|4. Ozen E, Gozukizil A, Erdal E, Uren A, Bottaro DP, Atabey N (2012). Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1. PLoS One  7, e42717.   https://doi.org/10.1371/journal.pone.0042717",https://intramural.nih.gov/search/searchview.taf?ipid=78521
383,BC011126-06,"October 01, 2012 -  September 30, 2013",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Melvin Nelson Doster|Shari  Gordon; PhD|Namal Prasanna Malimbada-Liyanage|Poonam  Poonam|Monica  Vaccari|Marjorie  Robert-Guroff; PhD,"Donald  Forthal (School of Medicine, Univ of CA)|Eckhard  Podack (Department of Microbiology, University of Miami)|Chris  Miller; MS|David C Montefiori; PhD (Department of Surgery, NIAID)|Guido  Ferrari (Duke University)|Savita  Pahwa (Miller School of Medicine, University of Miami)|Show all 9",John  Schiller; PhD (Laboratory of Cellular Oncology)|Jeffrey  Roberts (Laboratory of Cellular Oncology)|Christopher  Buck (Laboratory of Cellular Oncology)|Francis W Ruscetti; PhD (Laboratory of Experimental Immunology)|Gene  Shearer; PhD (Cell Mediated Immunity Section),Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |Daniel C Douek; MD (NIAID),"1. Vaccari M, Boasso A, Fenizia C, Fuchs D, Hryniewicz A, Morgan T, Weiss D, Doster MN, Heraud JM, Shearer GM, Franchini G (2012). Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockade. J Virol  86, 108-13.   https://doi.org/10.1128/JVI.05609-11",https://intramural.nih.gov/search/searchview.taf?ipid=78549
384,BC011131-06,"October 01, 2012 -  September 30, 2013",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Kalyan Sundar Chakrabarti; PhD|Ranabir  Das|Tao  Huang|Jess R Li,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Liu S, Chen Y, Li J, Huang T, Tarasov S, King A, Weissman AM, Byrd RA, Das R (2012). Promiscuous interactions of gp78 E3 ligase CUE domain with polyubiquitin chains. Structure  20, 2138-50.   https://doi.org/10.1016/j.str.2012.09.020",https://intramural.nih.gov/search/searchview.taf?ipid=78525
385,BC011132-06,"October 01, 2012 -  September 30, 2013",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Ranabir  Das|Jess R Li|Shangjin  Sun|Yun Xing M Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78524
386,BC011150-05,"October 01, 2012 -  September 30, 2013",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Miranda L Hanson|Julie  Hixon|Wenqing  Li,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78708
387,BC011152-05,"October 01, 2012 -  September 30, 2013",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Marco  Cardone|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Anna T Mason|Loretta R Smith|Robin T Winkler Pickett|Show all 7,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Franca  Gerosa (Pathology/Immunology, University of Verona)",NULL,Francesco M. Marincola; MD (CC) |Alan  Sher; PhD (NIAID),"1. Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW (2013). LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells. PLoS Pathog  9, e1003357.   https://doi.org/10.1371/journal.ppat.1003357|2. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S, Hieny S, Caspar P, Yamasaki S, Lin X, Ting JP, Trinchieri G, Besra GS, Cerundolo V, Sher A (2013). Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome. J Immunol  190, 5722-30.   https://doi.org/10.4049/jimmunol.1203343",https://intramural.nih.gov/search/searchview.taf?ipid=78756
388,BC011153-05,"October 01, 2012 -  September 30, 2013",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Sarah Delia Cramer|Ren Ming  Dai|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Hiu  Kiu|Rosalba  Salcedo|Show all 9,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)",NULL,"Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC)","1. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA, Belkaid Y (2012). Compartmentalized control of skin immunity by resident commensals. Science  337, 1115-9.   https://doi.org/10.1126/science.1225152",https://intramural.nih.gov/search/searchview.taf?ipid=78755
389,BC011154-05,"October 01, 2012 -  September 30, 2013",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Eric Dante Ciappio|Tao  Deng|Takashi  Furusawa|Jamie Elyse Kugler|Shaofei  Zhang,"Joseph  Orly (Hebrew University)|Eran  Meshorer (Hebrew University)|Sanjoy  Das (Pediatrics and Cancer Biology, Vanderbilt University Medical Center)|David  Weinstock (Harvard medical School)",Kenneth H Kraemer; MD (Dermatology Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Jing  Huang (Laboratory of Cancer Biology and Genetics),NULL,"1. Melcer S, Hezroni H, Rand E, Nissim-Rafinia M, Skoultchi A, Stewart CL, Bustin M, Meshorer E (2012). Histone modifications and lamin A regulate chromatin protein dynamics in early embryonic stem cell differentiation. Nat Commun  3, 910.   https://doi.org/10.1038/ncomms1915",https://intramural.nih.gov/search/searchview.taf?ipid=78699
390,BC011155-05,"October 01, 2012 -  September 30, 2013",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Weizao  Chen|Yang  Feng|Dontcho Videv Jelev; PhD|John  Owens|Prabakaran  Ponraj|Yanping  Wang|Show all 9,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Barton  Haynes (Duke University)|Gerald  Quinnan (Uniformed Services University of the Health Sciences)|MeiYun  Zhang (University of Hong Kong)|Rui  Gong; PhD|Show all 7",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Peter D Kwong; PhD (NIAID),"1. Chen W, Feng Y, Wang Y, Zhu Z, Dimitrov DS (2012). Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies. Biochem Biophys Res Commun  425, 931-7.   https://doi.org/10.1016/j.bbrc.2012.08.013|2. Gong R, Chen W, Dimitrov DS (2012). Candidate antibody-based therapeutics against HIV-1. BioDrugs  26, 143-62.   https://doi.org/10.2165/11631400-000000000-00000|3. Gong R, Chen W, Dimitrov DS (2012). Expression, purification, and characterization of engineered antibody CH2 and VH domains. Methods Mol Biol  899, 85-102.   https://doi.org/10.1007/978-1-61779-921-1_6|4. Gong R, Wang Y, Ying T, Dimitrov DS (2012). Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn. PLoS One  7, e42288.   https://doi.org/10.1371/journal.pone.0042288|5. Prabakaran P, Zhu Z, Chen W, Gong R, Feng Y, Streaker E, Dimitrov DS (2012). Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing. Front Microbiol  3, 277.   https://doi.org/10.3389/fmicb.2012.00277|6. Zhang MY, Yuan T, Li J, Rosa Borges A, Watkins JD, Guenaga J, Yang Z, Wang Y, Wilson R, Li Y, Polonis VR, Pincus SH, Ruprecht RM, Dimitrov DS (2012). Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41. PLoS One  7, e44241.   https://doi.org/10.1371/journal.pone.0044241",https://intramural.nih.gov/search/searchview.taf?ipid=78707
391,BC011156-05,"October 01, 2012 -  September 30, 2013",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Weizao  Chen|Yang  Feng|Dontcho Videv Jelev; PhD|Jinyu  Li|John  Owens|Prabakaran  Ponraj|Show all 9,Christopher  Broder (Uniformed Services University of the Health Sciences)|Linfa  Wang (Duke-NUS Graduate Medical School),NULL,NULL,"1. Zhao Q, Zhu Z, Dimitrov DS (2012). Yeast display of engineered antibody domains. Methods Mol Biol  899, 73-84.   https://doi.org/10.1007/978-1-61779-921-1_5",https://intramural.nih.gov/search/searchview.taf?ipid=78706
392,BC011158-05,"October 01, 2012 -  September 30, 2013",Study the role(s) of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mangmang  Li|Shunlin  Jiang,NULL,Jianxin  Shi (Biostatistics Branch)|Michael  Bustin; PhD (Protein Section)|Lino  Tessarollo (Mouse Cancer Genetics Program),Guokai  Chen (NHLBI),"1. He Y, Korboukh I, Jin J, Huang J (2012). Targeting protein lysine methylation and demethylation in cancers. Acta Biochim Biophys Sin (Shanghai)  44, 70-9.   https://doi.org/10.1093/abbs/gmr109|2. Li M, He Y, Dubois W, Wu X, Shi J, Huang J (2012). Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell  46, 30-42.   https://doi.org/10.1016/j.molcel.2012.01.020|3. Li M, He Y, Feng X, Huang J (2012). Genome-wide studies of the transcriptional regulation by p53. Biochim Biophys Acta  1819, 684-7.   https://doi.org/10.1016/j.bbagrm.2012.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=78718
393,BC011159-05,"October 01, 2012 -  September 30, 2013",Identification of Biomarkers for Response to Chemoprevention of Colon Cancer,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Prevention, NCI",Weidong  Li|Shakir M Saud|Matthew R Young; PhD,Robert  Chapkin (Texas A&M)|Terry  Hartman (Penn State Univ)|Gerd  Bobe,Amanda  Cross (Nutritional Epidemiology Branch),NULL,"1. Kim YS, Farrar W, Colburn NH, Milner JA (2012). Cancer stem cells: potential target for bioactive food components. J Nutr Biochem  23, 691-8.   https://doi.org/10.1016/j.jnutbio.2012.03.002|2. Mentor-Marcel RA, Bobe G, Sardo C, Wang LS, Kuo CT, Stoner G, Colburn NH (2012). Plasma cytokines as potential response indicators to dietary freeze-dried black raspberries in colorectal cancer patients. Nutr Cancer  64, 820-5.   https://doi.org/10.1080/01635581.2012.697597|3. Mitsunaga M, Kosaka N, Choyke PL, Young MR, Dextras CR, Saud SM, Colburn NH, Sakabe M, Nagano T, Asanuma D, Urano Y, Kobayashi H (2013). Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe. Gut  62, 1179-86.   https://doi.org/10.1136/gutjnl-2011-301795|4. Saud SM, Young MR, Jones-Hall YL, Ileva L, Evbuomwan MO, Wise J, Colburn NH, Kim YS, Bobe G (2013). Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Res  73, 5473-84.   https://doi.org/10.1158/0008-5472.CAN-13-0525",https://intramural.nih.gov/search/searchview.taf?ipid=78702
394,BC011160-05,"October 01, 2012 -  September 30, 2013",Mechanisms in development and regulation of metastasis in lung cancer,King F Kwong,NULL,"Surgery Branch, NCI",Lisa Ann Tobin|Yili  Xie|John R Wunderlich,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78734
395,BC011162-05,"October 01, 2012 -  September 30, 2013",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Jian  Wang|Shouhui  Yang; PhD,Jochen  Gaedcke|Anirban  Maitra (Johns Hopkins University School of Medicine),Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Zhang G, He P, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Hanna N, Alexander HR, Hussain SP (2013). FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Cancer Res  73, 5416-25.   https://doi.org/10.1158/0008-5472.CAN-13-0362|2. Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi B, Ried T, Yfantis H, Lee D, Maitra A, Hanna N, Alexander H, Hussain S (2013) Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Can Res, in press.|3. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SP (2012). DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One  7, e31507.   https://doi.org/10.1371/journal.pone.0031507",https://intramural.nih.gov/search/searchview.taf?ipid=78720
396,BC011163-05,"October 01, 2012 -  September 30, 2013",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mary  Hollander|Nicolas  Skrypek|Suman Kumar Vodnala,NULL,Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78761
397,BC011165-05,"October 01, 2012 -  September 30, 2013",Role of immature myeloid cells in premetastatic lung,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hangyi  Yan|Jianchao  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78762
398,BC011167-05,"October 01, 2012 -  September 30, 2013",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Jennifer D Rieker,Martin  McMahon (University of Californial at San Francisco)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School),Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78739
399,BC011168-05,"October 01, 2012 -  September 30, 2013",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yi  Tang|Xuan  Xu,Beth  Levine; MD (UT Southwestern Medical Center)|MarieDominique  Filippi (Cincinnati Children's Research Foundation)|Steven  Cheng (Nanjing Medical University),Miriam R Anver (Office Of The Director)|Ming  Zhou (Nucleic Acids Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),Chuxia  Deng; PhD (NIDDK),"1. Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE (2012). A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat Med  18, 227-34.   https://doi.org/10.1038/nm.2596",https://intramural.nih.gov/search/searchview.taf?ipid=78764
400,BC011173-05,"October 01, 2012 -  September 30, 2013",Genomic Classification of Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI",Jesper B Andersen; PhD|Valentina  Factor|Tanya N Hoang|Phuongnga  Ton|Marian E Durkin,"Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)|Peter  Galle|Derek  Chiang (University of North Carolina)|Jens Uwe Marquardt|Young  Park (Yonsei University College of Medicine)|Show all 7",Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,"1. Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, Conner EA, Gillen MC, Roskams T, Roberts LR, Factor VM, Thorgeirsson SS (2012). Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology  142, 1021-1031.e15.   https://doi.org/10.1053/j.gastro.2011.12.005|2. Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, Park ES, Lim JY, Heo J, Kim YJ, Kim DG, Kaseb A, Park YN, Wang XW, Thorgeirsson SS, Lee JS (2012). Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology  55, 1443-52.   https://doi.org/10.1002/hep.24813|3. Marquardt JU, Fischer K, Baus K, Kashyap A, Ma S, Krupp M, Linke M, Teufel A, Zechner U, Strand D, Thorgeirsson SS, Galle PR, Strand S (2013). Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients. Hepatology  58, 1054-64.   https://doi.org/10.1002/hep.26413",https://intramural.nih.gov/search/searchview.taf?ipid=78752
401,BC011175-05,"October 01, 2012 -  September 30, 2013",Validation of Therapeutic Target Genes in Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI",Thomas Michel Herve Decaens|Marian E Durkin|Tanya N Hoang|Phuongnga  Ton|Jesper B Andersen; PhD|Valentina  Factor,"Ian  MacLachlan (Protiva, Protiva Biotherapeutics, Inc)|Lars  Zender (University of Tubingen)","Udai S Kammula (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, Conner EA, Gillen MC, Roskams T, Roberts LR, Factor VM, Thorgeirsson SS (2012). Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology  142, 1021-1031.e15.   https://doi.org/10.1053/j.gastro.2011.12.005|2. Andersen JB, Thorgeirsson SS (2012). Genetic profiling of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol  28, 266-72.   https://doi.org/10.1097/MOG.0b013e3283523c7e|3. Andersen JB, Thorgeirsson SS (2013). Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities. Gastroenterology  144, 687-90.   https://doi.org/10.1053/j.gastro.2013.02.018|4. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, Qin LX, Yamashita T, Woo HG, Kim YJ, Kaneko S, Tang ZY, Thorgeirsson SS, Wang XW (2012). Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology  56, 1792-803.   https://doi.org/10.1002/hep.25890|5. Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, Jeck WR, Andersen JB, Jiang W, Savich GL, Tan TX, Auman JT, Hoskins JM, Misher AD, Moser CD, Yourstone SM, Kim JW, Cibulskis K, Getz G, Hunt HV, Thorgeirsson SS, Roberts LR, Ye D, Guan KL, Xiong Y, Qin LX, et al. [1 more author] (2013). Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene  32, 3091-100.   https://doi.org/10.1038/onc.2012.315",https://intramural.nih.gov/search/searchview.taf?ipid=78753
402,BC011176-05,"October 01, 2012 -  September 30, 2013",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Christine  Happel; PhD|Dhivya  Ramalingam|Anna  Serquina|Thomas S Uldrick,NULL,NULL,NULL,"1. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM (2012). Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression. J Virol  86, 11663-74.   https://doi.org/10.1128/JVI.01147-12|2. Ramalingam D, Kieffer-Kwon P, Ziegelbauer JM (2012). Emerging themes from EBV and KSHV microRNA targets. Viruses  4, 1687-710.   https://doi.org/10.3390/v4091687",https://intramural.nih.gov/search/searchview.taf?ipid=78765
403,BC011177-05,"October 01, 2012 -  September 30, 2013",Botulinum Toxin for Painful Cutaneous Leiomyomas,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Edward W Cowen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78733
404,BC011181-05,"October 01, 2012 -  September 30, 2013",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Kajal  Biswas|Susan L North|Stacey S Stauffer|Thirthagiri  Eswary,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)|Stephen  Byers (Georgetown University)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, Burkett SS, Martin BK, Southon E, Sizemore SC, Pruss D, Bowles KR, Roa BB, Hunter N, Tessarollo L, Wenstrup RJ, Byrd RA, Sharan SK (2012). Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet  21, 3993-4006.   https://doi.org/10.1093/hmg/dds222|2. Biswas K, Stauffer S, Sharan SK (2012). Using recombineering to generate point mutations:galK-based positive-negative selection method. Methods Mol Biol  852, 121-31.   https://doi.org/10.1007/978-1-61779-564-0_10|3. Chang S, Sharan SK (2012). BRCA1 and microRNAs: emerging networks and potential therapeutic targets. Mol Cells  34, 425-32.   https://doi.org/10.1007/s10059-012-0118-y|4. Chang S, Sharan SK (2012). Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1. Oncotarget  3, 5-6.   https://doi.org/10.18632/oncotarget.433|5. Chang S, Sharan SK (2013). The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription  4, 24-8.   https://doi.org/10.4161/trns.22600|6. Chang S, Stauffer S, Sharan SK (2012). Using recombineering to generate point mutations: the oligonucleotide-based ""hit and fix"" method. Methods Mol Biol  852, 111-20.   https://doi.org/10.1007/978-1-61779-564-0_9",https://intramural.nih.gov/search/searchview.taf?ipid=78747
405,BC011185-05,"October 01, 2012 -  September 30, 2013",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Jian  Wang|Shouhui  Yang; PhD,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Anirban  Maitra (Johns Hopkins University School of Medicine)|Richard  Bucala (Yale University),David Anderson Wink (Radiation Biology Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,"1. Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T, Yfantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back TC, Yanaga K, Hanna N, Alexander HR, Maitra A, Hussain SP (2013). Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer  132, 785-94.   https://doi.org/10.1002/ijc.27736",https://intramural.nih.gov/search/searchview.taf?ipid=78721
406,BC011187-05,"October 01, 2012 -  September 30, 2013",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Zachary Thomas Daar|Teresa  Kosakowska Cholo|Jing  Lin|Katherine M Nyswaner|Srideshikan  Sargur Madabushi|Rishabh  Sharan,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program)|Shyam K Sharan (Mouse Cancer Genetics Program)|Sarangan  Ravichandran (Office Of The Director)|Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78695
407,BC011188-05,"October 01, 2012 -  September 30, 2013",Diazeniumdiolates as Broad-Spectrum Anticancer Agents,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",Zhao  Cao|Kenyatta Meticeo Cosby; MD|Ryan John Holland; PhD|Joseph A. Hrabie; PhD|Youseung  Kim|Anna E Maciag|Show all 8,"Paul  Shami (Medical Oncology, U of Utah)|Astrid  Weyerbrock (UNIVERSITÃTSKLINIKUM FREIBURG)",Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology),NULL,"1. Holland RJ, Maciag AE, Kumar V, Shi L, Saavedra JE, Prud'homme RK, Chakrapani H, Keefer LK (2012). Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate ""Double JS-K"". Chem Res Toxicol  25, 2670-7.   https://doi.org/10.1021/tx3003142|2. Maciag A, Holland R, Saavedra J, Chakrapani H, Shami P, Keefer L (2012) Thiol Modification By Pharmacologically Active Agents of the Diazeniumdiolate Class. Forum on Immunopathol Dis Ther 3:91-95",https://intramural.nih.gov/search/searchview.taf?ipid=78728
408,BC011189-05,"October 01, 2012 -  September 30, 2013",Molecular Pathogenic Mechanism of Rhabdomyosarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78700
409,BC011190-05,"October 01, 2012 -  September 30, 2013",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Wilmarie  Flores-santana|Julie Lynn Heinecke; PhD|James B Mitchell; PhD|Murali  Krishna; PhD,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA (2012). Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol  25, 769-93.   https://doi.org/10.1021/tx2005234|2. Gao WD, Murray CI, Tian Y, Zhong X, DuMond JF, Shen X, Stanley BA, Foster DB, Wink DA, King SB, Van Eyk JE, Paolocci N (2012). Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res  111, 1002-11.   https://doi.org/10.1161/CIRCRESAHA.112.270827",https://intramural.nih.gov/search/searchview.taf?ipid=78760
410,BC011191-05,"October 01, 2012 -  September 30, 2013",Preclinical Mouse Model of Thyroid Carcinogenesis,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Dong Wook  Kim; PhD|Jeong-Won  Park|Mark Cauthen Willingham|Li  Zhao|Xuguang  Zhu,"Young  Jo (Chungnam national University Hospital)|THOMAS  KLONISCH (University of Manitoba)|Matthew D Ringel; MD (Lab. of Molec. Endocrinol., Washington Hospital Center)|Mark  Willingham (Wake Forest University School of Medicine)","Electron  Kebebew; MD (Endocrine Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Kim DW, Zhao L, Hanover J, Willingham M, Cheng SY (2012). Thyroid hormone receptor β suppresses SV40-mediated tumorigenesis via novel nongenomic actions. Am J Cancer Res  2, 606-19.|2. Kim WG, Cheng SY (2013). Thyroid hormone receptors and cancer. Biochim Biophys Acta  1830, 3928-36.   https://doi.org/10.1016/j.bbagen.2012.04.002|3. Kim WG, Guigon CJ, Fozzatti L, Park JW, Lu C, Willingham MC, Cheng SY (2012). SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clin Cancer Res  18, 1281-90.   https://doi.org/10.1158/1078-0432.CCR-11-2892|4. Lu C, Zhu X, Willingham MC, Cheng SY (2012). Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma. Oncogene  31, 2007-16.   https://doi.org/10.1038/onc.2011.390|5. Zhao L, Zhu X, Won Park J, Fozzatti L, Willingham M, Cheng SY (2012). Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor. Endocrinology  153, 5090-100.   https://doi.org/10.1210/en.2012-1600|6. Zhu X, Cheng SY (2012). Modeling follicular thyroid cancer for future therapies. Am J Cancer Res  2, 130-40.",https://intramural.nih.gov/search/searchview.taf?ipid=78701
411,BC011192-05,"October 01, 2012 -  September 30, 2013",The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78759
412,BC011197-05,"October 01, 2012 -  September 30, 2013",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI","Pramita  Chatterjee|Subrata  Debnath; PhD|Sharlyn  Mazur; PhD|Hiroyasu  Sakai; MD, PhD|Harichandra Dnyaneshwar Tagad; PhD",NULL,Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Daniel  Appella; PhD (NIDDK),"1. Goloudina AR, Mazur SJ, Appella E, Garrido C, Demidov ON (2012). Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio. Cell Cycle  11, 1883-7.   https://doi.org/10.4161/cc.19901|2. Goloudina AR, Tanoue K, Hammann A, Fourmaux E, Le Guezennec X, Bulavin DV, Mazur SJ, Appella E, Garrido C, Demidov ON (2012). Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Proc Natl Acad Sci U S A  109, E68-75.   https://doi.org/10.1073/pnas.1107017108|3. Lowe J, Cha H, Lee MO, Mazur SJ, Appella E, Fornace AJ (2012). Regulation of the Wip1 phosphatase and its effects on the stress response. Front Biosci (Landmark Ed)  17, 1480-98.   https://doi.org/10.2741/3999",https://intramural.nih.gov/search/searchview.taf?ipid=78696
413,BC011199-05,"October 01, 2012 -  September 30, 2013",Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,John M Jessup,NULL,"Cellular and Molecular Biology Section, NCI","Abid Rasheed Mattoo; PhD|Snorri S. Thorgeirsson; MD, PhD",Dean  Tang (UT M D Anderson Cancer Center)|Karine  Breckpot (Vrije Universiteit Brussel)|Jakob  Reiser (FDA),"Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Robert  Kinders (Toxicology and Pharmacology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Meshinchi S, Hunger SP, Aplenc R, Adamson PC, Jessup JM (2012). Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031. Clin Cancer Res  18, 1547-54.   https://doi.org/10.1158/1078-0432.CCR-11-2205|2. Poste G, Carbone DP, Parkinson DR, Verweij J, Hewitt SM, Jessup JM (2012). Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res  18, 1515-23.   https://doi.org/10.1158/1078-0432.CCR-11-2206|3. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS (2012) Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 30:2327-33|4. Williams PM, Lively TG, Jessup JM, Conley BA (2012). Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res  18, 1531-9.   https://doi.org/10.1158/1078-0432.CCR-11-2203|5. Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M, Veenstra TD, Thorgeirsson SS, Jessup JM (2013). NANOG modulates stemness in human colorectal cancer. Oncogene  32, 4397-405.   https://doi.org/10.1038/onc.2012.461|6. Zwart SR, Jessup JM, Ji J, Smith SM (2012). Saturation diving alters folate status and biomarkers of DNA damage and repair. PLoS One  7, e31058.   https://doi.org/10.1371/journal.pone.0031058",https://intramural.nih.gov/search/searchview.taf?ipid=78724
414,BC011202-05,"October 01, 2012 -  September 30, 2013",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Maria L Kireeva|Lucyna E Lubkowska|Celine Marguerite Paulette Walmacq,Michelle  Wang (Cornell University)|Patrick  Cramer (LM University),Jeffrey N Strathern (Genome Recombination and Regulation Section)|Thomas Dana Schneider; PhD (Gene Regulation and Chromosome Biology Laboratory),Philip John Brooks; PhD (NIAAA),"1. Walmacq C, Cheung AC, Kireeva ML, Lubkowska L, Ye C, Gotte D, Strathern JN, Carell T, Cramer P, Kashlev M (2012). Mechanism of translesion transcription by RNA polymerase II and its role in cellular resistance to DNA damage. Mol Cell  46, 18-29.   https://doi.org/10.1016/j.molcel.2012.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=78727
415,BC011203-05,"October 01, 2012 -  September 30, 2013",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Aurelia  Battesti|Tingting  Liu; PhD|Song  Tong,NULL,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Battesti A, Tsegaye YM, Packer DG, Majdalani N, Gottesman S (2012). H-NS regulation of IraD and IraM antiadaptors for control of RpoS degradation. J Bacteriol  194, 2470-8.   https://doi.org/10.1128/JB.00132-12",https://intramural.nih.gov/search/searchview.taf?ipid=78712
416,BC011204-05,"October 01, 2012 -  September 30, 2013",Preclinical development of Ala+TIMP-2 as an cancer therapeutic,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Huiying  Han|Sandra  Jensen-Taubman|Laurie Ann  Shuman Moss|Beiyang  Wei,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,"1. Guedez L, Jensen-Taubman S, Bourboulia D, Kwityn CJ, Wei B, Caterina J, Stetler-Stevenson WG (2012). TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J Immunother  35, 502-12.   https://doi.org/10.1097/CJI.0b013e3182619c8e|2. Han H, Bourboulia D, Jensen-Taubman S, Isaac B, Wei B, Stetler-Stevenson WG (2014). An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells. Oncogene  33, 1198-206.   https://doi.org/10.1038/onc.2013.61|3. Kim SH, Cho YR, Kim HJ, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, Stetler-Stevenson WG, Seo DW (2012). Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway. Blood  120, 4892-902.   https://doi.org/10.1182/blood-2012-05-428243|4. Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG (2012). Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol  181, 1895-9.   https://doi.org/10.1016/j.ajpath.2012.08.044",https://intramural.nih.gov/search/searchview.taf?ipid=78751
417,BC011205-05,"October 01, 2012 -  September 30, 2013",Population based studies,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",Rene A Costello; MT|Sham  Mailankody|Shengyang  Wu|Mary Ann M Yancey|Adriana  Zingone; MD,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Magnus  Bjorkholm (Karolinska)|Sigurdur  Kristinsson (Karolinska),"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee IM, Purdue MP, Rothman N, Severi G, Yuan JM, Anderson KC, Pollak M, Rifai N, Hartge P, Landgren O, Lessin L, Virtamo J, Wallace RB, Manson JE, Colditz GA (2012). Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood  120, 4929-37.   https://doi.org/10.1182/blood-2012-03-417253|2. Chang CM, Landgren O, Koshiol J, Björkholm M, Löve TJ, Kristinsson SY (2012). Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden. Int J Cancer  131, 2208-9.   https://doi.org/10.1002/ijc.27483|3. Drahos J, Vanwormer JJ, Greenlee RT, Landgren O, Koshiol J (2013). Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data. Ann Epidemiol  23, 291-3.   https://doi.org/10.1016/j.annepidem.2013.02.005|4. Engels EA, Savoldo B, Pfeiffer RM, Costello R, Zingone A, Heslop HE, Landgren O (2013). Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients. Transplantation  95, 519-26.   https://doi.org/10.1097/TP.0b013e318274ab63|5. Hultcrantz M, Kristinsson SY, Andersson TM, Landgren O, Eloranta S, Derolf AR, Dickman PW, Björkholm M (2012). Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol  30, 2995-3001.   https://doi.org/10.1200/JCO.2012.42.1925|6. Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ, Benson JT, Colby CL, Dispenzieri A, Landgren O, Kumar S, Bradwell AR, Cerhan JR, Rajkumar SV (2013) Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS. Leukemia 27:208-12|7. Kristinsson SY, Goldin LR, Turesson I, Björkholm M, Landgren O (2012). Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies. Acta Haematol  127, 173-7.   https://doi.org/10.1159/000335618|8. Wu SP, Minter A, Costello R, Zingone A, Lee CK, Au WY, Landgren O (2013). MGUS prevalence in an ethnically Chinese population in Hong Kong. Blood  121, 2363-4.   https://doi.org/10.1182/blood-2012-11-466011",https://intramural.nih.gov/search/searchview.taf?ipid=78735
418,BC011206-05,"October 01, 2012 -  September 30, 2013",Genome wide profiling of histone variants in colorectal cancer cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Rajbir K Gill|Marcin Piotr Walkiewicz|Song  Fu,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),Emilios K Dimitriadis; PhD (NIBIB),"1. Quenet D, Walkiewicz M, Dalal Y (2012) Chromatin at the Intersection of Disease and Therapy, in Toxicology and Epigenetics., pp. 51-72.|2. Quénet D, Dalal Y (2012). The CENP-A nucleosome: a dynamic structure and role at the centromere. Chromosome Res  20, 465-79.   https://doi.org/10.1007/s10577-012-9301-4",https://intramural.nih.gov/search/searchview.taf?ipid=78703
419,BC011207-05,"October 01, 2012 -  September 30, 2013",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Delphine Chantal Anne Marie Quenet; PhD,Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)|Jennifer  Otteson (Ohio State University),NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Quenet DC, Dimitriadis EK, Dalal Y (2012) Atomic Force Microscopy of Chromatin, in Atomic Force Microscopy Investigations into Biology - From Cell to Protein. Ferwin CL, ed, InTech (New York, NY), pp. 195-218.|2. Bui M, Dimitriadis EK, Hoischen C, An E, Quénet D, Giebe S, Nita-Lazar A, Diekmann S, Dalal Y (2012). Cell-cycle-dependent structural transitions in the human CENP-A nucleosome in vivo. Cell  150, 317-26.   https://doi.org/10.1016/j.cell.2012.05.035",https://intramural.nih.gov/search/searchview.taf?ipid=78704
420,BC011208-05,"October 01, 2012 -  September 30, 2013",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jothy  Dhakshnamoorthy|Hernan Diego Folco|Namhoon  Lee|Sameet Satish Mehta; PhD|Takeshi  Mizuguchi|Nitika  Taneja; PhD|Show all 7,Ee Sin  Chen|Job  Dekker; PhD (University of Massachusetts)|Leonid  Mirny (Massachusetts Institute of Technology),Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),Henry L Levin; PhD (NICHD),"1. Aygün O, Mehta S, Grewal SI (2013). HDAC-mediated suppression of histone turnover promotes epigenetic stability of heterochromatin. Nat Struct Mol Biol  20, 547-54.   https://doi.org/10.1038/nsmb.2565|2. Lorenz DR, Mikheyeva IV, Johansen P, Meyer L, Berg A, Grewal SI, Cam HP (2012). CENP-B cooperates with Set1 in bidirectional transcriptional silencing and genome organization of retrotransposons. Mol Cell Biol  32, 4215-25.   https://doi.org/10.1128/MCB.00395-12|3. Shim YS, Choi Y, Kang K, Cho K, Oh S, Lee J, Grewal SI, Lee D (2012). Hrp3 controls nucleosome positioning to suppress non-coding transcription in eu- and heterochromatin. EMBO J  31, 4375-87.   https://doi.org/10.1038/emboj.2012.267|4. Yamanaka S, Mehta S, Reyes-Turcu FE, Zhuang F, Fuchs RT, Rong Y, Robb GB, Grewal SI (2013). RNAi triggered by specialized machinery silences developmental genes and retrotransposons. Nature  493, 557-60.   https://doi.org/10.1038/nature11716",https://intramural.nih.gov/search/searchview.taf?ipid=78714
421,BC011209-05,"October 01, 2012 -  September 30, 2013",Kinetochore Interaction with Centromere Chromatin in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Marcin Piotr Walkiewicz|Delphine Chantal Anne Marie Quenet; PhD,Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)|Jennifer  Otteson (Ohio State University)|Garegin  Papaoin (University of Maryland)|Michael  Poirier (Ohio State University)|Sean  Taverna (Johns Hopkins University),NULL,NULL,"1. Bui M, Dimitriadis EK, Hoischen C, An E, Quénet D, Giebe S, Nita-Lazar A, Diekmann S, Dalal Y (2012). Cell-cycle-dependent structural transitions in the human CENP-A nucleosome in vivo. Cell  150, 317-26.   https://doi.org/10.1016/j.cell.2012.05.035|2. Quénet D, Dalal Y (2012). The CENP-A nucleosome: a dynamic structure and role at the centromere. Chromosome Res  20, 465-79.   https://doi.org/10.1007/s10577-012-9301-4|3. Quénet D, McNally JG, Dalal Y (2012). Through thick and thin: the conundrum of chromatin fibre folding in vivo. EMBO Rep  13, 943-4.   https://doi.org/10.1038/embor.2012.143",https://intramural.nih.gov/search/searchview.taf?ipid=78705
422,BC011210-05,"October 01, 2012 -  September 30, 2013",Magnetic Drug Delivery for Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78709
423,BC011211-05,"October 01, 2012 -  September 30, 2013",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Jean-Philippe  Castaing|Prahathees  Eswara Moorthy|Scarlett  Lee|Irene S Tan|Cordelia Anne Weiss,"Douglas  Weibel (University of Wisconsin-Madison)|Fang  Tian (Penn State University, College of Medicine)|Kerwyn  Huang (Stanford University)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Aravind L Iyer; PhD (NLM) |Hari  Shroff; PhD (NIBIB),"1. Ebmeier SE, Tan IS, Clapham KR, Ramamurthi KS (2012). Small proteins link coat and cortex assembly during sporulation in Bacillus subtilis. Mol Microbiol  84, 682-96.   https://doi.org/10.1111/j.1365-2958.2012.08052.x|2. Yepes A, Schneider J, Mielich B, Koch G, García-Betancur JC, Ramamurthi KS, Vlamakis H, López D (2012). The biofilm formation defect of a Bacillus subtilis flotillin-defective mutant involves the protease FtsH. Mol Microbiol  86, 457-71.   https://doi.org/10.1111/j.1365-2958.2012.08205.x",https://intramural.nih.gov/search/searchview.taf?ipid=78745
424,BC011212-05,"October 01, 2012 -  September 30, 2013",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Na-Young  Song; PhD|Jami D Willette brown|Feng  Zhu; PhD|Howard A Young; PhD|Robert  Wiltrout; PhD|Giorgio  Trinchieri,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,"1. Liu S, Chen Z, Zhu F, Hu Y (2012). IκB kinase alpha and cancer. J Interferon Cytokine Res  32, 152-8.   https://doi.org/10.1089/jir.2011.0107|2. Xia X, Park E, Fishcher S, Hu Y (2013) Mouse genetic models reveal surprising functions of IkappaB alpha in skin development and skin carcinogenesis. Cancers 5:170-83",https://intramural.nih.gov/search/searchview.taf?ipid=78717
425,BC011214-05,"October 01, 2012 -  September 30, 2013",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Changwan  Hong|Davinna Lachelle Ligons|Megan A Luckey|Joo Young  Park,Thomas  Hunig (University of Wuerzburg)|Scott  Walsh (University of Maryland)|Batu M Erman,NULL,Marta Liliana Catalfamo; PhD (NIAID) |Bibiana  Bielekova; MD (NINDS),"1. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park JH, Tai X, Kimura M, Wang L, Grinberg A, Kubo M, Bosselut R, Love P, Singer A (2012). Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J  31, 366-77.   https://doi.org/10.1038/emboj.2011.388|2. Adoro S, Park JH, Singer A (2012). Coreceptor gene ""imprinting:"" a genetic solution to a developmental dilemma in T cells. Cell Cycle  11, 833-4.   https://doi.org/10.4161/cc.11.5.19596|3. Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A (2012). The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration. Immunity  37, 971-85.   https://doi.org/10.1016/j.immuni.2012.10.007|4. Hong C, Luckey MA, Park JH (2012). Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin Immunol  24, 151-8.   https://doi.org/10.1016/j.smim.2012.02.002|5. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|6. Ligons DL, Tuncer C, Linowes BA, Akcay IM, Kurtulus S, Deniz E, Atasever Arslan B, Cevik SI, Keller HR, Luckey MA, Feigenbaum L, Möröy T, Ersahin T, Atalay R, Erman B, Park JH (2012). CD8 lineage-specific regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1. J Biol Chem  287, 34386-99.   https://doi.org/10.1074/jbc.M112.378687|7. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|8. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A (2012). Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol  13, 569-78.   https://doi.org/10.1038/ni.2292|9. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A (2012). αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity  36, 79-91.   https://doi.org/10.1016/j.immuni.2011.11.013|10. Tinsley KW, Hong C, Luckey MA, Park JY, Kim GY, Yoon HW, Keller HR, Sacks AJ, Feigenbaum L, Park JH (2013). Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus. Blood  122, 2358-68.   https://doi.org/10.1182/blood-2012-12-472076",https://intramural.nih.gov/search/searchview.taf?ipid=78743
426,BC011215-05,"October 01, 2012 -  September 30, 2013",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Changwan  Hong|Davinna Lachelle Ligons|Megan A Luckey|Joo Young  Park,NULL,Alfred  Singer; MD (Lymphocyte Development Section)|James Stephen Shaw; PhD (Human Immunology Section),NULL,"1. Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A (2012). The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration. Immunity  37, 971-85.   https://doi.org/10.1016/j.immuni.2012.10.007|2. Hong C, Nam AS, Keller HR, Ligons DL, Park JY, Yoon HW, Park JJ, Luckey MA, Park JH (2013). Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine  64, 532-40.   https://doi.org/10.1016/j.cyto.2013.08.001|3. Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH (2012). An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis. J Immunol  188, 5859-66.   https://doi.org/10.4049/jimmunol.1102328|4. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|5. McCaughtry TM, Etzensperger R, Alag A, Tai X, Kurtulus S, Park JH, Grinberg A, Love P, Feigenbaum L, Erman B, Singer A (2012). Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus. J Exp Med  209, 2263-76.   https://doi.org/10.1084/jem.20121505|6. Um JH, Brown AL, Singh SK, Chen Y, Gucek M, Lee BS, Luckey MA, Kim MK, Park JH, Sleckman BP, Gellert M, Chung JH (2013). Metabolic sensor AMPK directly phosphorylates RAG1 protein and regulates V(D)J recombination. Proc Natl Acad Sci U S A  110, 9873-8.   https://doi.org/10.1073/pnas.1307928110",https://intramural.nih.gov/search/searchview.taf?ipid=78744
427,BC011216-05,"October 01, 2012 -  September 30, 2013",CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Satarupa  Das|Paul W Kriebel|Rachel Mary Lee|Lunhua  Liu|Wolfgang  Losert; PhD|Ritankar  Majumdar|Show all 10,Wolfgang  Losert (University of Maryland)|Marcus  Cicerone (NIST)|Alessio  Fasano (MassGeneral Hospital),Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),Robert Simon Adelstein; MD (NHLBI) |James Robert Sellers; PhD (NHLBI),"1. Afonso PV, Janka-Junttila M, Lee YJ, McCann CP, Oliver CM, Aamer KA, Losert W, Cicerone MT, Parent CA (2012). LTB4 is a signal-relay molecule during neutrophil chemotaxis. Dev Cell  22, 1079-91.   https://doi.org/10.1016/j.devcel.2012.02.003|2. Afonso PV, Parent CA (2012). Neutrophils under tension. Dev Cell  22, 236-8.   https://doi.org/10.1016/j.devcel.2012.01.017|3. Liu L, Aerbajinai W, Ahmed SM, Rodgers GP, Angers S, Parent CA (2012). Radil controls neutrophil adhesion and motility through β2-integrin activation. Mol Biol Cell  23, 4751-65.   https://doi.org/10.1091/mbc.E12-05-0408|4. Parent CA, Weiner OD (2013). The symphony of cell movement: how cells orchestrate diverse signals and forces to control migration. Curr Opin Cell Biol  25, 523-5.   https://doi.org/10.1016/j.ceb.2013.07.011|5. Weiger MC, Parent CA (2012). Phosphoinositides in chemotaxis. Subcell Biochem  59, 217-54.   https://doi.org/10.1007/978-94-007-3015-1_7",https://intramural.nih.gov/search/searchview.taf?ipid=78742
428,BC011217-05,"October 01, 2012 -  September 30, 2013",Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",N Keith Collins|Deborah B Householder|Serguei V Kozlov|Zoe W Ohler,"David  Gandara (University of Califormia at Davis)|Colin  Hill (GNS Healthcare, Inc.)|Annette  Walter (Clovis Oncology, Inc.)",NULL,NULL,"1. Weaver Z, Difilippantonio S, Carretero J, Martin P, El Meskini R, Iacovelli A, Gumprecht M, Kulaga A, Guerin T, Schlomer J, Baran M, Kozlov S, McCann T, Mena S, Alshahrour F, Alexander D, Wong K, Van Dyke T (2012) Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78757
429,BC011219-05,"October 01, 2012 -  September 30, 2013",Combination Gene Therapy and Th1Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",Shoba M Amarnath|Tania Cristina Felizardo|J  Foley|Miriam E Mossoba,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)",NULL,David F Stroncek; MD (CC),"1. Neschadim A, Wang JC, Sato T, Fowler DH, Lavie A, Medin JA (2012). Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase. Mol Ther  20, 1002-13.   https://doi.org/10.1038/mt.2011.298",https://intramural.nih.gov/search/searchview.taf?ipid=78710
430,BC011220-05,"October 01, 2012 -  September 30, 2013",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",Shoba M Amarnath|Tania Cristina Felizardo|J  Foley,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),"1. Amarnath S, Fowler DH (2012). Harnessing autophagy for adoptive T-cell therapy. Immunotherapy  4, 1-4.   https://doi.org/10.2217/imt.11.144|2. Castiello L, Mossoba M, Viterbo A, Sabatino M, Fellowes V, Foley JE, Winterton M, Halverson DC, Civini S, Jin P, Fowler DH, Stroncek DF (2013). Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells. Cytotherapy  15, 598-609.   https://doi.org/10.1016/j.jcyt.2012.12.008|3. Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood  121, 2864-74.   https://doi.org/10.1182/blood-2012-08-446872",https://intramural.nih.gov/search/searchview.taf?ipid=78711
431,BC011222-05,"October 01, 2012 -  September 30, 2013",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin|Sadhanshu  Shukla; PhD,NULL,Jane Beth Trepel (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78750
432,BC011223-05,"October 01, 2012 -  September 30, 2013",Function of O-GlcNAc-modified Human RNA Polymerase II in Transcription,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Alfonso  Fernandez; PhD|Jason Alexander Piotrowski; BA, MS",Gerald  Hart (Johns Hopkins University School of Medicine)|Alma  Burlingame (UCSF),Pradman  Qasba; PhD (Center for Cancer Research Nanobiology Program),John Allan Hanover; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI),"1. Ranuncolo SM, Ghosh S, Hanover JA, Hart GW, Lewis BA (2012). Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem  287, 23549-61.   https://doi.org/10.1074/jbc.M111.330910",https://intramural.nih.gov/search/searchview.taf?ipid=78738
433,BC011224-05,"October 01, 2012 -  September 30, 2013",Casein Kinase 1 Delta in Wnt Signaling and Beyond,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yoshimi Endo Greer|Charles Peter Xavier,Anthony  Brown (Weill Cornell Medical College)|Gregory  Pazour (University of Massachusetts Medical School),Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),Kapil  Bharti; PhD (NEI) |Yingzi  Yang; PhD (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78746
434,BC011229-05,"October 01, 2012 -  September 30, 2013",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Lara Helmi el Touny|Laura  Vera Ramirez|Aleksandra M Michalowska,NULL,Chand  Khanna; MD (Pediatric Oncology Branch),"Mark  Hoenerhoff; DVM, PhD (NIEHS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78713
435,BC011232-05,"October 01, 2012 -  September 30, 2013",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",M A Siddiqui,"Susan  Keay|Alex  Mackerell Jr (University of Maryland)|Inka  Brockhausen (Queen's University, Human Mobility Research Centre)|Myriam Louise Cotten",NULL,Daron  Freedberg (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78698
436,BC011233-05,"October 01, 2012 -  September 30, 2013",Structural Bioinformatics,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Hongjun  Bai|Bangalore K Sathyanarayana|Chin-Hsien  Tai|Todd J Taylor,"Andriy  Kryshtafovych (University of California, Davis)|Gaetano  Montelione (Northeast Structural Genomics Consortium, CABM, Rutgers University)|John  Moult (University of Maryland Biotechnology Institute)|Jean  Garnier; PhD|JeanFrancois  Gibrat (INRA)|Ron  Unger; PhD",Ira H Pastan; MD (Molecular Biology Section),"Peter Jonathan Munson; BA, MA, PhD (CIT) |Warren J Leonard; MD (NHLBI)","1. Feiglin A, Moult J, Lee B, Ofran Y, Unger R (2012). Neighbor overlap is enriched in the yeast interaction network: analysis and implications. PLoS One  7, e39662.   https://doi.org/10.1371/journal.pone.0039662|2. Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I (2012). A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity. Protein Eng Des Sel  25, 1-6.   https://doi.org/10.1093/protein/gzr053|3. Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I (2012). Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci U S A  109, 11782-7.   https://doi.org/10.1073/pnas.1209292109|4. Samson F, Shrager R, Tai CH, Sam V, Lee B, Munson PJ, Gibrat JF, Garnier J (2012). DOMIRE: a web server for identifying structural domains and their neighbors in proteins. Bioinformatics  28, 1040-1.   https://doi.org/10.1093/bioinformatics/bts076",https://intramural.nih.gov/search/searchview.taf?ipid=78737
437,BC011238-05,"October 01, 2012 -  September 30, 2013",Computational Biology,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Youngshang  Pak,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,"1. Pak Y, Zhang Y, Pastan I, Lee B (2012). Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors. Cancer Res  72, 3143-52.   https://doi.org/10.1158/0008-5472.CAN-11-3925",https://intramural.nih.gov/search/searchview.taf?ipid=78736
438,BC011240-05,"October 01, 2012 -  September 30, 2013",Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Deborah B Householder|Zoe W Ohler,Leroy E Hood|KuoChen  Wei (Chang Gung Memorial Hospital),"Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Scott E McNeil (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78758
439,BC011255-04,"October 01, 2012 -  September 30, 2013",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jude  Alsarraj|Ling  Bai|Farhoud  Faraji|Thomas Rudolf Geiger|Ngoc-Han  Ha|Renard Cerrell Walker|Show all 7,"Pier Paolo  Pandolfi (Harvard University)|Fernando  PardoManuel de la Villena (UNC)|David  Threadgill; PhD (Department of Genetics, University of North Carolina School of Medicine)|Eisaku  Kondo (Aichi Cancer Center Research Institute)|Nicholas  Smithers (GlaxoSmithKline)","Kevin  Gardner; MD, PhD (Cancer Genetics Branch)",Keiko  Ozato; PhD (NICHD),"1. Alsarraj J, Hunter KW (2012). Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix. Int J Breast Cancer  2012, 670632.   https://doi.org/10.1155/2012/670632|2. Faraji F, Pang Y, Walker RC, Nieves Borges R, Yang L, Hunter KW (2012). Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity. PLoS Genet  8, e1002926.   https://doi.org/10.1371/journal.pgen.1002926|3. Hu Y, Wu G, Rusch M, Lukes L, Buetow KH, Zhang J, Hunter KW (2012). Integrated cross-species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci U S A  109, 3184-9.   https://doi.org/10.1073/pnas.1117872109|4. Hunter KW (2012). Mouse models of cancer: does the strain matter? Nat Rev Cancer  12, 144-9.   https://doi.org/10.1038/nrc3206|5. Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW (2012). Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet  8, e1002735.   https://doi.org/10.1371/journal.pgen.1002735",https://intramural.nih.gov/search/searchview.taf?ipid=78771
440,BC011258-04,"October 01, 2012 -  September 30, 2013",Analysis of tumor cell death on antigen-specific immune responses,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Miaojun  Han,"Lothar  Jntsch (Helmholtz Centre for Infection Research)|Michael Peter Manns; MD (epartment of Gastroenterology and Hepatology, edizinische Hochschule Hannover)",NULL,NULL,"1. Gamrekelashvili J, Ormandy LA, Heimesaat MM, Kirschning CJ, Manns MP, Korangy F, Greten TF (2012). Primary sterile necrotic cells fail to cross-prime CD8(+) T cells. Oncoimmunology  1, 1017-1026.   https://doi.org/10.4161/onci.21098",https://intramural.nih.gov/search/searchview.taf?ipid=78773
441,BC011261-04,"October 01, 2012 -  September 30, 2013",Biological Implications and Translational Applications of HDMX Inhibition,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD|Amanda Lee Whiting,Jean-Christophe  Marine (KU Leuven)|Paul  Neilsen (University of Adelaide)|Aart  Jochemsen (Leiden University Medical Center),NULL,Craig Joseph Thomas (NCATS),"1. de Lange J, Teunisse AF, Vries MV, Lodder K, Lam S, Luyten GP, Bernal F, Jager MJ, Jochemsen AG (2012). High levels of Hdmx promote cell growth in a subset of uveal melanomas. Am J Cancer Res  2, 492-507.|2. Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC (2012). MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med  18, 1239-47.   https://doi.org/10.1038/nm.2863",https://intramural.nih.gov/search/searchview.taf?ipid=78775
442,BC011262-04,"October 01, 2012 -  September 30, 2013",Broadening the Utility of Stapled Peptides through Chemical Optimization,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD|Amanda Lee Whiting,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78776
443,BC011264-04,"October 01, 2012 -  September 30, 2013",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Caiyi  Li|Paul  Mittelstadt; PhD,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section),Dragana  Jankovic; PhD (NIAID),"1. Mittelstadt PR, Monteiro JP, Ashwell JD (2012). Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J Clin Invest  122, 2384-94.   https://doi.org/10.1172/JCI63067",https://intramural.nih.gov/search/searchview.taf?ipid=78777
444,BC011267-04,"October 01, 2012 -  September 30, 2013",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Anne Michele Miermont-Eltejaye|Pflicke  Holger|Nicholas Paul Schaub|Yaroslav  Teper,Umesh  Bhanot (Memorial Sloan-Kettering Cancer Center)|Duncan  Jodrell (CRUK Cambridge Research Institute),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Scott E Martin (NCATS) |Yardena Rachel Samuels; PhD (NHGRI) |Craig Joseph Thomas (NCATS),"1. Jaiswal KR, Xin HW, Anderson A, Wiegand G, Kim B, Miller T, Hari D, Ray S, Koizumi T, Rudloff U, Thorgeirsson SS, Avital I (2012). Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Stem Cell Res  9, 249-60.   https://doi.org/10.1016/j.scr.2012.08.001|2. Langan RC, Gill F, Raiji MT, Mullinax JE, Pittaluga S, Pandalai P, Davis J, Perkins K, Avital I, Rudloff U (2013). Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing? Pancreas  42, 363-6.   https://doi.org/10.1097/MPA.0b013e3182648778|3. Langan RC, Lagisetty KH, Atay S, Pandalai P, Stojadinovic A, Rudloff U, Avital I (2015). Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology. Am J Clin Oncol  38, 98-102.   https://doi.org/10.1097/COC.0b013e3182880bc5|4. Langan RC, Mullinax JE, Ray S, Raiji MT, Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G, Butcher D, Anver M, Bilchik AJ, Stojadinovic A, Rudloff U, Avital I (2012). A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers. J Cancer  3, 231-40.   https://doi.org/10.7150/jca.4542|5. Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A, Avital I (2012). Liver directed therapy for renal cell carcinoma. J Cancer  3, 184-90.   https://doi.org/10.7150/jca.4456|6. Ray S, Langan RC, Mullinax JE, Koizumi T, Xin HW, Wiegand GW, Anderson AJ, Stojadinovic A, Thorgeirsson S, Rudloff U, Avital I (2012). Establishment of human ultra-low passage colorectal cancer cell lines using spheroids from fresh surgical specimens suitable for in vitro and in vivo studies. J Cancer  3, 196-206.   https://doi.org/10.7150/jca.4484|7. Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK, Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital I (2013). A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol  20, 555-61.   https://doi.org/10.1245/s10434-012-2651-5",https://intramural.nih.gov/search/searchview.taf?ipid=78779
445,BC011269-04,"October 01, 2012 -  September 30, 2013",Thoracic Cancer Research Laboratory,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78780
446,BC011275-04,"October 01, 2012 -  September 30, 2013",Gene expression and regulation in endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Myriem  Boufraqech; PhD|Neelam  Gulati|Mei  He|Brandi La'Shae Howard|Meenu  Jain|Yi  Liu-Chittenden; PhD|Show all 13,NULL,NULL,"Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78782
447,BC011277-04,"October 01, 2012 -  September 30, 2013",Procaspase 3 activator compounds combined with X-ray irradiation,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Naga Venkata Gopal  Abbineni|Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78783
448,BC011278-04,"October 01, 2012 -  September 30, 2013",Mechanisms of Early Stage Mammary Tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78784
449,BC011280-04,"October 01, 2012 -  September 30, 2013",Cancer Therapy Trials using novel vaccine platforms,Ravi  Madan|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Antonio  Fojo; MD, PhD",NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Ann Wild Gramza (Endocrine Oncology Branch)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Huang J, Jochems C, Talaie T, Anderson A, Jales A, Tsang KY, Madan RA, Gulley JL, Schlom J (2012). Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood  120, 3030-8.   https://doi.org/10.1182/blood-2012-05-427799|2. Madan RA, Gulley JL, Kantoff PW (2013). Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies. Cancer J  19, 50-8.   https://doi.org/10.1097/PPO.0b013e31828160a9|3. Madan RA, Schwaab T, Gulley JL (2012). Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer. J Natl Compr Canc Netw  10, 1505-12.   https://doi.org/10.6004/jnccn.2012.0156",https://intramural.nih.gov/search/searchview.taf?ipid=78785
450,BC011281-04,"October 01, 2012 -  September 30, 2013",Combination therapies involving novel cancer vaccines,Ravi  Madan|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD|Andrea Borghese Apolo|Antonio  Fojo; MD, PhD",Robert  DiPaola (Cancer Center of New Jersey)|Mark  Stein (The Cancer Institute of New Jersey)|Marijo  Bilusic,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Aradhana  Kaushal (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Karen A Kurdziel; MD (Molecular Imaging Program)|Christopher Ryan Heery; MD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Huen NY, Pang AL, Tucker JA, Lee TL, Vergati M, Jochems C, Intrivici C, Cereda V, Chan WY, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY (2013). Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer  133, 373-82.   https://doi.org/10.1002/ijc.28026|2. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|3. Madan RA, Bilusic M, Heery C, Schlom J, Gulley JL (2012). Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol  39, 296-304.   https://doi.org/10.1053/j.seminoncol.2012.02.010|4. Madan RA, Gulley JL, Kantoff PW (2013). Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies. Cancer J  19, 50-8.   https://doi.org/10.1097/PPO.0b013e31828160a9|5. Madan RA, Heery CR, Gulley JL (2012). Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity. Oncoimmunology  1, 1167-1168.   https://doi.org/10.4161/onci.20591|6. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2|7. Madan RA, Schwaab T, Gulley JL (2012). Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer. J Natl Compr Canc Netw  10, 1505-12.   https://doi.org/10.6004/jnccn.2012.0156|8. Singh N, Madan RA, Gulley JL (2013). Ipilimumab  in prostate cancer. Expert Opin Biol Ther  13, 303-13.   https://doi.org/10.1517/14712598.2012.754421",https://intramural.nih.gov/search/searchview.taf?ipid=78786
451,BC011282-04,"October 01, 2012 -  September 30, 2013",RNAi screen for chromatin modifiers in DNA repair and aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Simran  Khurana|Jeongkyu  Kim; PhD|Jinping  Liu|Andy Dong-Anh Tran; PhD|Ofir  Hakim,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78787
452,BC011283-04,"October 01, 2012 -  September 30, 2013",Investigating the role of DNA breaks in mammalian aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jeongkyu  Kim; PhD|Andy Dong-Anh Tran; PhD,NULL,NULL,NULL,"1. Singh SK, Williams CA, Klarmann K, Burkett SS, Keller JR, Oberdoerffer P (2013). Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med  210, 987-1001.   https://doi.org/10.1084/jem.20121608",https://intramural.nih.gov/search/searchview.taf?ipid=78788
453,BC011286-04,"October 01, 2012 -  September 30, 2013",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78790
454,BC011287-04,"October 01, 2012 -  September 30, 2013",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78791
455,BC011293-04,"October 01, 2012 -  September 30, 2013",Impact of chromatin structure on alternative splicing of CD45 pre-mRNA,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Marc Andre Bailly; PhD|Satyajeet Pramod Khare|Maria Fernanda Prigge|Ryan Jared Marina,NULL,Mikhail V Kashlev (Molecular Mechanisms of Transcription Section),NULL,"1. Oberdoerffer S (2012). A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing. Transcription  3, 106-9.   https://doi.org/10.4161/trns.19816|2. Shukla S, Oberdoerffer S (2012). Co-transcriptional regulation of alternative pre-mRNA splicing. Biochim Biophys Acta  1819, 673-83.   https://doi.org/10.1016/j.bbagrm.2012.01.014",https://intramural.nih.gov/search/searchview.taf?ipid=78794
456,BC011294-04,"October 01, 2012 -  September 30, 2013",Conditional manipulation of hnRNPLL expression in murine models,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Maria Fernanda Prigge|Ryan Jared Marina,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78795
457,BC011295-04,"October 01, 2012 -  September 30, 2013",Optimizing the graft versus leukemia effect for pediatric ALL,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Waleed M Haso|Haiying  Qin|Yinmeng  Yang|Crystal L. Mackall; MD|Alan S Wayne; MD,"Janetta  Bijl (HÃ´pital Maisonneuve-Rosemont)|Boro  Dropulic|SYD  JOHNSON (MacroGenics, Inc.)",NULL,NULL,"1. Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ (2013). Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. J Immunol  190, 1351-9.   https://doi.org/10.4049/jimmunol.1200391|2. Duncan BB, Highfill SL, Qin H, Bouchkouj N, Larabee S, Zhao P, Woznica I, Liu Y, Li Y, Wu W, Lai JH, Jones B, Mackall CL, Bachovchin WW, Fry TJ (2013). A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy. J Immunother  36, 400-11.   https://doi.org/10.1097/CJI.0b013e3182a80213|3. Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR (2012). Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol  30, 830-6.   https://doi.org/10.1200/JCO.2011.37.0296|4. Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS (2012). Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. Am J Hematol  87, 916-22.   https://doi.org/10.1002/ajh.23174|5. Walsh MP, Duncan B, Larabee S, Krauss A, Davis JP, Cui Y, Kim SY, Guimond M, Bachovchin W, Fry TJ (2013) Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS One 8:e58860",https://intramural.nih.gov/search/searchview.taf?ipid=78796
458,BC011298-04,"October 01, 2012 -  September 30, 2013",Ph I Radiation and Lenalidomide in pediatric malignant glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78798
459,BC011299-04,"October 01, 2012 -  September 30, 2013",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Laurie  Steffen,NULL,NULL,Peter  Herscovitch; MD (CC) |Nicholas  Patronas; MD (CC),"1. Hipp SJ, Steffen-Smith EA, Patronas N, Herscovitch P, Solomon JM, Bent RS, Steinberg SM, Warren KE (2012). Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI. J Neurooncol  109, 521-7.   https://doi.org/10.1007/s11060-012-0918-0",https://intramural.nih.gov/search/searchview.taf?ipid=78799
460,BC011300-04,"October 01, 2012 -  September 30, 2013",CANCER AND INFLAMMATION GENETICS,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Michal Marcin Dyba|Alana Rachael Ebert-Zavos|Lisa  Maslan|Albert M Gold|Kate M McGee|Michael L Nickerson|Show all 14,Lorena  Orozco (INMEGEN)|Federico  Antillon (UNOP)|Ana  Ortiz (University of Puerto Rico Comprehensive Cancer Center)|Walter  Guerra (Instituto Cancerologia)|Taras K Oleksyk|Dan  Theodorescu (University of Colorado)|Show all 12,"Nadya I Tarasova; PhD (Cancer Inflammation Program)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,"1. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, et al. [164 more authors] (2012). Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet  44, 651-8.   https://doi.org/10.1038/ng.2270|2. Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF, Chanock SJ, Anderson SK, Dean M (2012). Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts. Hum Genet  131, 1453-1466.   https://doi.org/10.1007/s00439-012-1182-2|3. Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, Brandt W, Esposito D, Kinoshita S, Wessjohann L, Morham SG, Andresson T, Kruth HS, Okano T, Dean M (2013). The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum Mutat  34, 317-29.   https://doi.org/10.1002/humu.22230|4. Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ (2012). ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol  30, 751-7.   https://doi.org/10.1200/JCO.2011.38.0345",https://intramural.nih.gov/search/searchview.taf?ipid=78800
461,BC011301-04,"October 01, 2012 -  September 30, 2013",CANCER AND INFLAMMATION: FUNCTION AND THERAPY,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Lisa  Maslan|Albert M Gold|Kate M McGee|Karobi  Moitra|Julie  Sawitzke|Michael L Nickerson|Show all 8,"Ken  Offitt (Medicine, Sloan Kettering Cancer Center)|Rando  Allikmets (Columbia University)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Susan  Bates; MD (Medical Oncology Branch)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Baas DC, Ho L, Tanck MW, Fritsche LG, Merriam JE, van het Slot R, Koeleman BP, Gorgels TG, van Duijn CM, Uitterlinden AG, de Jong PT, Hofman A, ten Brink JB, Vingerling JR, Klaver CC, Dean M, Weber BH, Allikmets R, Hageman GS, Bergen AA (2012). Multicenter cohort association study of SLC2A1 single nucleotide polymorphisms and age-related macular degeneration. Mol Vis  18, 657-74.|2. Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF, Chanock SJ, Anderson SK, Dean M (2012). Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts. Hum Genet  131, 1453-1466.   https://doi.org/10.1007/s00439-012-1182-2|3. Moitra K, Im K, Limpert K, Borsa A, Sawitzke J, Robey R, Yuhki N, Savan R, Huang da W, Lempicki RA, Bates S, Dean M (2012). Differential gene and microRNA expression between etoposide resistant and etoposide sensitive MCF7 breast cancer cell lines. PLoS One  7, e45268.   https://doi.org/10.1371/journal.pone.0045268",https://intramural.nih.gov/search/searchview.taf?ipid=78801
462,BC011302-04,"October 01, 2012 -  September 30, 2013",Screen for Ras inhibitors,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Joseph Orion Carver,NULL,NULL,Anton  Simeonov (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78802
463,BC011303-04,"October 01, 2012 -  September 30, 2013",Ras oncogene induced protein SUMOylation changes,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Bing  Yu,NULL,NULL,Marjan  Gucek; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78803
464,BC011304-04,"October 01, 2012 -  September 30, 2013",New shRNA vectors for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78804
465,BC011306-04,"October 01, 2012 -  September 30, 2013",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Lyuba Aleksandrovna Khavrutskii,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  GonzalezJuarrero (Colorado State University),Michael  Dean; PhD (Laboratory of Experimental Immunology)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Joseph John Barchi (Chemical Biology Laboratory)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Susan  Bates; MD (Medical Oncology Branch),NULL,"1. Timofeeva O, Tarasova N (2012) Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation. JAK-STAT 1(4):1-11|2. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L, Dakshanamurthy S, Brown ML, Dritschilo A (2012). Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem  287, 14192-200.   https://doi.org/10.1074/jbc.M111.323899",https://intramural.nih.gov/search/searchview.taf?ipid=78805
466,BC011307-04,"October 01, 2012 -  September 30, 2013",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Yuhong  Chen; PhD,Joseph R Kates|Vadim  Gaponenko,Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78806
467,BC011311-04,"October 01, 2012 -  September 30, 2013",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Kajal  Biswas|Xia  Ding,Stephen  Byers (Georgetown University)|William  Foulkes (McGill University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78809
468,BC011313-04,"October 01, 2012 -  September 30, 2013",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gaia  Bisaccioni|Michael Christopher Giano|Scott Hammond Medina; PhD|Katelyn Jean Nagy|Daniel James Smith|Cem  Sonmez|Show all 7,Darrin  Pochan (University of Delaware)|Norm  Wagner (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Yifat  Miller|Scott  Walsh (University of Maryland),Ruth  Nussinov; PhD (Center for Cancer Research Nanobiology Program)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation),Robert  Tycko; PhD (NIDDK),"1. Geisler I, Schneider J (2012) Evolution Based Design of an Injectable Hydrogel. Adv Funct Mater 22:259|2. Knerr P, Branco M, Nagarkar R, Pochan D, Schneider J (2012) Heavy Metal Ion Hydrogelation of a Self-Assembling Peptide via Cysteinyl Chelation. J Mater Chem 22:1352|3. Yan C, Mackay ME, Czymmek K, Nagarkar RP, Schneider JP, Pochan DJ (2012). Injectable solid peptide hydrogel as a cell carrier: effects of shear flow on hydrogels and cell payload. Langmuir  28, 6076-87.   https://doi.org/10.1021/la2041746",https://intramural.nih.gov/search/searchview.taf?ipid=78811
469,BC011314-04,"October 01, 2012 -  September 30, 2013",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Michael Christopher Giano|Allison Irene Keim|Scott Hammond Medina; PhD,NULL,Robert  Blumenthal; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Gaspar D, Veiga AS, Sinthuvanich C, Schneider JP, Castanho MA (2012). Anticancer peptide SVS-1: efficacy precedes membrane neutralization. Biochemistry  51, 6263-5.   https://doi.org/10.1021/bi300836r|2. Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP (2012). Anticancer β-hairpin peptides: membrane-induced folding triggers activity. J Am Chem Soc  134, 6210-7.   https://doi.org/10.1021/ja210569f|3. Veiga AS, Sinthuvanich C, Gaspar D, Franquelim HG, Castanho MA, Schneider JP (2012). Arginine-rich self-assembling peptides as potent antibacterial gels. Biomaterials  33, 8907-16.   https://doi.org/10.1016/j.biomaterials.2012.08.046",https://intramural.nih.gov/search/searchview.taf?ipid=78812
470,BC011315-04,"October 01, 2012 -  September 30, 2013",Molecular characterization of endometrial cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Anne Mary Noonan; MD|Elise C Kohn; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78813
471,BC011316-04,"October 01, 2012 -  September 30, 2013",Role of the human transcription factor T in chordoma growth,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78814
472,BC011319-04,"October 01, 2012 -  September 30, 2013",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78816
473,BC011320-04,"October 01, 2012 -  September 30, 2013",Targeting dendritic cells for selective  modulation of Graft-versus-Host Disease,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiying  Qin|Crystal L. Mackall; MD,NULL,NULL,NULL,"1. Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ (2013). Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. J Immunol  190, 1351-9.   https://doi.org/10.4049/jimmunol.1200391",https://intramural.nih.gov/search/searchview.taf?ipid=78817
474,BC011321-04,"October 01, 2012 -  September 30, 2013",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder|Ying  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78818
475,BC011324-04,"October 01, 2012 -  September 30, 2013",Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Lingjun  Meng,Kunsoo  Rhee (Seoul National University)|Raymond L Erikson|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology),NULL,NULL,"1. Lee KH, Johmura Y, Yu LR, Park JE, Gao Y, Bang JK, Zhou M, Veenstra TD, Yeon Kim B, Lee KS (2012). Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway. EMBO J  31, 3104-17.   https://doi.org/10.1038/emboj.2012.144",https://intramural.nih.gov/search/searchview.taf?ipid=78820
476,BC011325-04,"October 01, 2012 -  September 30, 2013",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro|Gisela H Fanning-Heidecker,Kenneth  Cornetta (Indiana University)|Edward  Gabrielson (Johns Hopkins Medical Institution)|John W Mellors,Robert  Shoemaker (Screening Technologies Branch),NULL,"1. Aloia AL, Duffy L, Pak V, Lee KE, Sanchez-Martinez S, Derse D, Heidecker G, Cornetta K, Rein A (2013). A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay. Gene Ther  20, 169-76.   https://doi.org/10.1038/gt.2012.18|2. Sfanos KS, Aloia AL, De Marzo AM, Rein A (2012). XMRV and prostate cancer--a 'final' perspective. Nat Rev Urol  9, 111-8.   https://doi.org/10.1038/nrurol.2011.225",https://intramural.nih.gov/search/searchview.taf?ipid=78821
477,BC011326-04,"October 01, 2012 -  September 30, 2013",Sensitization of chordoma cell lines to ionizing radiation,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Kheem Singh Bisht,NULL,NULL,"Menghang  Xia (NCATS) |Christopher P Austin; AB, MD (NCATS) |Ruili  Huang (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78822
478,BC011328-04,"October 01, 2012 -  September 30, 2013",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Yevgeniy  Gindin|Arthur A Glatfelter; MS|Yuan  Jiang; MD|Chyau Yueh Christopher Lau|Show all 13",NULL,Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78823
479,BC011330-04,"October 01, 2012 -  September 30, 2013",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alejandra  Garcia-Glaessner,NULL,Patricia  Steeg; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78824
480,BC011332-04,"October 01, 2012 -  September 30, 2013",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Amber Jin Giles|Miki B Kasai|Yorleny M Vicioso|Javed  Khan; MD|Carol J Thiele|Chand  Khanna; MD|Show all 9,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)",NULL,NULL,"1. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med  18, 883-91.   https://doi.org/10.1038/nm.2753|2. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL (2013). Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood  122, 1105-13.   https://doi.org/10.1182/blood-2012-08-449413",https://intramural.nih.gov/search/searchview.taf?ipid=78826
481,BC011333-04,"October 01, 2012 -  September 30, 2013",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78827
482,BC011334-04,"October 01, 2012 -  September 30, 2013",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Amber Jin Giles|Miki B Kasai|Yorleny M Vicioso|Javed  Khan; MD|Chand  Khanna; MD|Crystal L. Mackall; MD|Show all 10,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 7",Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, et al. [1 more author] (2013). The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia  15, 848-62.   https://doi.org/10.1593/neo.13706|2. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med  18, 883-91.   https://doi.org/10.1038/nm.2753",https://intramural.nih.gov/search/searchview.taf?ipid=78828
483,BC011336-04,"October 01, 2012 -  September 30, 2013",Tools for Prediction of Drug Metabolism and Metabolites,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Markus  Sitzmann|Alexey Vladimirovich Zakharov; PhD,Anders  Wallqvist (Department of Defense)|Layton  Smith (Sanford Burnham Medical Research Institute),NULL,"Christopher P Austin; AB, MD (NCATS)","1. Peach ML, Zakharov AV, Liu R, Pugliese A, Tawa G, Wallqvist A, Nicklaus MC (2012). Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software. Future Med Chem  4, 1907-32.   https://doi.org/10.4155/fmc.12.150|2. Zakharov AV, Peach ML, Sitzmann M, Filippov IV, McCartney HJ, Smith LH, Pugliese A, Nicklaus MC (2012). Computational tools and resources for metabolism-related property predictions. 2. Application to prediction of half-life time in human liver microsomes. Future Med Chem  4, 1933-44.   https://doi.org/10.4155/fmc.12.152",https://intramural.nih.gov/search/searchview.taf?ipid=78829
484,BC011337-04,"October 01, 2012 -  September 30, 2013",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Qiong J Wang,NULL,NULL,NULL,"1. Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC (2012). Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma. Cancer Res  72, 6119-29.   https://doi.org/10.1158/0008-5472.CAN-12-0588",https://intramural.nih.gov/search/searchview.taf?ipid=78830
485,BC011340-04,"October 01, 2012 -  September 30, 2013",Preclinical development of new therapeutics for children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully|Laurie  Steffen|Brigitte  Widemann; MD|Nalini M Jayaprakash|Srivandana  Akshintala|Diane  Cole|Show all 7,NULL,NULL,"John D. Bacher; BS, DVM, MS (OD)","1. McCully C, Pastakia D, Bacher J, Thomas M, SteffenSmith E, Saleem K, Walbridge S, Brinster L, Warren K (2013) Development of an animal model for microdialysis sampling of the pons and cerebral cortex in rhesus monkeys. Comparative Medicine 63:1-6",https://intramural.nih.gov/search/searchview.taf?ipid=78832
486,BC011343-04,"October 01, 2012 -  September 30, 2013",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Austin Gerard Duffy|Stefanie Rae Carey|Suzanne E Fioravanti|Osama Entoun Rahma; MD|Susanna Varkey Ulahannan|Tobias  Eggert|Show all 9,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Liang  Cao (Cancer Genetics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC) |Nadine  Abi Jaoudeh (CC),"1. Duffy A, Wilkerson J, Greten TF (2013). Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. Hepatology  57, 1068-77.   https://doi.org/10.1002/hep.26120|2. Rahma OE, Greten TF, Duffy A (2012). Locally advanced cancer of the esophagus, current treatment strategies, and future directions. Front Oncol  2, 52.   https://doi.org/10.3389/fonc.2012.00052",https://intramural.nih.gov/search/searchview.taf?ipid=78835
487,BC011344-04,"October 01, 2012 -  September 30, 2013",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Austin Gerard Duffy|Suzanne E Fioravanti,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Greten TF, Zhao F, Gamrekelashvili J, Korangy F (2012). Human Th17 cells in patients with cancer: Friends or foe? Oncoimmunology  1, 1438-1439.   https://doi.org/10.4161/onci.21245|2. Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, Greten TF, Korangy F (2012). S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology  136, 176-83.   https://doi.org/10.1111/j.1365-2567.2012.03566.x|3. Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigtländer T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, Korangy F, Greten TF (2012). Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. J Immunol  188, 6055-62.   https://doi.org/10.4049/jimmunol.1102918|4. Zhao F, Korangy F, Greten TF (2012). Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma. Dig Dis  30, 477-82.   https://doi.org/10.1159/000341695",https://intramural.nih.gov/search/searchview.taf?ipid=78836
488,BC011345-04,"October 01, 2012 -  September 30, 2013",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tobias  Eggert|Miaojun  Han|Chi  Ma|Jose  Medina Echeverz,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Silvana Romina Goldszmid (Laboratory of Experimental Immunology)|Nicholas Phillip Restifo; MD (Surgery Branch)|Jimmy  Stauffer (Mouse Cancer Genetics Program)|William G Telford (Experimental Transplantation and Immunology Branch)|Masaki  Terabe (Vaccine Branch)",Cynthia E Dunbar; MD (NHLBI) |Francesco M. Marincola; MD (CC) |Ena  Wang (CC),"1. Haile LA, Greten TF, Korangy F (2012). Immune suppression: the hallmark of myeloid derived suppressor cells. Immunol Invest  41, 581-94.   https://doi.org/10.3109/08820139.2012.680635|2. Ma C, Kapanadze T, Gamrekelashvili J, Manns MP, Korangy F, Greten TF (2012). Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol  92, 1199-206.   https://doi.org/10.1189/jlb.0212059",https://intramural.nih.gov/search/searchview.taf?ipid=78837
489,BC011346-04,"October 01, 2012 -  September 30, 2013",Immune suppressor mechanism in a murine model of hepatitis and liver cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Chi  Ma|Jose  Medina Echeverz,NULL,"Masaki  Terabe (Vaccine Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Silvana Romina Goldszmid (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",Francesco M. Marincola; MD (CC) |Ena  Wang (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78838
490,BC011350-04,"October 01, 2012 -  September 30, 2013",Molecular Discovery Program,Jeffrey N Strathern,NULL,"Molecular Discovery Program, NCI",Claudia A Lipschultz,NULL,James  McMahon; PhD (Molecular Targets Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78842
491,BC011351-04,"October 01, 2012 -  September 30, 2013",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Ravi  Madan|William D Figg; PharmD|William Laurence Dahut; MD|Jane Beth Trepel,Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Jean  HoffmanCensits (Jefferson University Hospital)|Dan  Theodorescu (University of Colorado),"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Mark  Raffeld; MD (Laboratory of Pathology)",NULL,"1. Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB (2012). Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy. Curr Mol Med  12, 1125-41.   https://doi.org/10.2174/156652412803306729|2. Balar AV, Apolo AB, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF (2013). Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer. J Clin Oncol  31, 724-30.   https://doi.org/10.1200/JCO.2012.42.5215|3. Kohaar I, Porter-Gill P, Lenz P, Fu YP, Mumy A, Tang W, Apolo AB, Rothman N, Baris D, Schned AR, Ylaya K, Schwenn M, Johnson A, Jones M, Kida M, Silverman DT, Hewitt SM, Moore LE, Prokunina-Olsson L (2013). Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst  105, 69-73.   https://doi.org/10.1093/jnci/djs458|4. Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL (2012). The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med  53, 1175-84.   https://doi.org/10.2967/jnumed.111.100883|5. Svatek RS, Rosenberg JE, Galsky MD, Lee CT, Latini DM, Bochner BH, Weizer AZ, Apolo AB, Sridhar SS, Kamat AM, Hansel D, Flaig TW, Smith ND, Lotan Y (2013). Summary of the 6th Annual Bladder Cancer Think Tank: new directions in urologic research. Urol Oncol  31, 968-73.   https://doi.org/10.1016/j.urolonc.2011.12.017",https://intramural.nih.gov/search/searchview.taf?ipid=78843
492,BC011352-04,"October 01, 2012 -  September 30, 2013",Molecular and clinical profiling,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",Rene A Costello; MT|Sham  Mailankody|Shengyang  Wu|Mary Ann M Yancey|Adriana  Zingone; MD,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Sigurdur  Kristinsson (Karolinska),Peter L Choyke; MD (Molecular Imaging Program)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Richard  Childs; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78844
493,BC011353-04,"October 01, 2012 -  September 30, 2013",Development and validation of preclinical mouse model for serous ovarian cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Deborah B Householder|Zoe W Ohler,"Leroy E Hood|Colin  Hill (GNS Healthcare, Inc.)",Christina M Annunziata (Medical Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch),NULL,"1. Serber DW, Rogala A, Makarem M, Rosson GB, Simin K, Godfrey V, Van Dyke T, Eaves CJ, Bultman SJ (2012). The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner. PLoS One  7, e31346.   https://doi.org/10.1371/journal.pone.0031346|2. Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, Householder DB, Baran ML, Yi M, Song Y, Sun W, McDunn JE, Martin PL, Van Dyke T, Difilippantonio S (2012). Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res  72, 4141-53.   https://doi.org/10.1158/0008-5472.CAN-11-3834",https://intramural.nih.gov/search/searchview.taf?ipid=78845
494,BC011354-04,"October 01, 2012 -  September 30, 2013",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78846
495,BC011372-03,"October 01, 2012 -  September 30, 2013",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Muhammad  Jamal|Barbara Helen Rath|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ (2012). The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells. Neoplasia  14, 150-8.   https://doi.org/10.1593/neo.111794|2. Kahn J, Hayman T, Jamal M, Rath B, Kramp T, Camphausen K, Tofilon P (2013) The mTORC1mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity of Glioblastoma Stem-like Cells. Neuro-Oncology, in press.|3. Kahn J, Tofilon PJ, Camphausen K (2012). Preclinical models in radiation oncology. Radiat Oncol  7, 223.   https://doi.org/10.1186/1748-717X-7-223|4. Kil WJ, Tofilon PJ, Camphausen K (2012). Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol  7, 25.   https://doi.org/10.1186/1748-717X-7-25|5. Rath BH, Fair JM, Jamal M, Camphausen K, Tofilon PJ (2013). Astrocytes enhance the invasion potential of glioblastoma stem-like cells. PLoS One  8, e54752.   https://doi.org/10.1371/journal.pone.0054752|6. Tandle A, Shankavaram U, Brown M, Ho J, Graves C, Lita E, Pfohl J, Mohney R, Tofilon P, Camphausen K (2013) Urinary metabolomic profiling of patients with glioblastoma multiforme. Journal of Proteomics and Bioinformatics, in press.|7. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013). Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer  49, 3020-8.   https://doi.org/10.1016/j.ejca.2013.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=78852
496,BC011373-03,"October 01, 2012 -  September 30, 2013",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Heekyong  Bae|Marwa Wahba Foreman|Thomas John Hayman|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Hayman TJ, Kramp T, Kahn J, Jamal M, Camphausen K, Tofilon PJ (2013). Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity. Transl Oncol  6, 355-62.   https://doi.org/10.1593/tlo.13163|2. Hayman TJ, Wahba A, Rath BH, Bae H, Kramp T, Shankavaram UT, Camphausen K, Tofilon PJ (2014). The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells. Clin Cancer Res  20, 110-9.   https://doi.org/10.1158/1078-0432.CCR-13-2136|3. Hayman TJ, Williams ES, Jamal M, Shankavaram UT, Camphausen K, Tofilon PJ (2012). Translation initiation factor eIF4E is a target for tumor cell radiosensitization. Cancer Res  72, 2362-72.   https://doi.org/10.1158/0008-5472.CAN-12-0329|4. Kahn J, Hayman T, Jamal M, Rath B, Kramp T, Camphausen K, Tofilon P (2013) The mTORC1mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity of Glioblastoma Stem-like Cells. Neuro-Oncology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78853
497,BC011374-03,"October 01, 2012 -  September 30, 2013",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Jeanelle M Spencer|Laura M Tuschong,NULL,NULL,"Steven M Holland; MD (NIAID) |Harry Lewis Malech; MD (NIAID) |Helen C Su; MD, PhD (NIAID)","1. Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC, Hickstein DD, Pavletic S, Fahle G, Nath A (2013). Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology  80, 1494-500.   https://doi.org/10.1212/WNL.0b013e31828cf8a2",https://intramural.nih.gov/search/searchview.taf?ipid=78854
498,BC011376-03,"October 01, 2012 -  September 30, 2013",Structural and Biochemical Studies of p53 Family Function,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78856
499,BC011378-03,"October 01, 2012 -  September 30, 2013",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Mary Elizabeth Olanich|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Ji  Luo (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Javed  Khan; MD (Pediatric Oncology Branch),NULL,"1. Barr FG (2012). New Treatments for Rhabdomyosarcoma: the Importance of Target Practice. Clin Cancer Res  18, 595-597.   https://doi.org/10.1158/1078-0432.CCR-11-2832|2. Duan F, Smith LM, Gustafson DM, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG (2012). Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group. Genes Chromosomes Cancer  51, 662-74.   https://doi.org/10.1002/gcc.21953|3. Hinson AR, Jones R, Crose LE, Belyea BC, Barr FG, Linardic CM (2013). Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls. Front Oncol  3, 183.   https://doi.org/10.3389/fonc.2013.00183|4. Olanich ME, Barr FG (2013). A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opin Ther Targets  17, 607-23.   https://doi.org/10.1517/14728222.2013.772136",https://intramural.nih.gov/search/searchview.taf?ipid=78857
500,BC011379-03,"October 01, 2012 -  September 30, 2013",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78858
501,BC011381-03,"October 01, 2012 -  September 30, 2013",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Devaiah Nanjappa Ballachanda|Chanelle Monet Case Borden|Anne G M Gegonne Bosselut|Jie  Mu|Petria-George S Thompson|Jocelyn D Weissman,Brian  Albrecht (Constellation Pharmaceuticals)|Michael S Hewitt|Robert  Sims (Constellation Pharmaceuticals),Brian  Lewis (Lymphoid Malignancies Branch)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),Keiko  Ozato; PhD (NICHD) |Pamela Gehron Robey; PhD (NIDCR) |Jinfang  Zhu; PhD (NIAID) |S Stoney  Simons; PhD (NIDDK),"1. Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, Ozato K, Sims RJ, Singer DS (2012). BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A  109, 6927-32.   https://doi.org/10.1073/pnas.1120422109|2. Devaiah BN, Singer DS (2012). Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation. J Biol Chem  287, 38755-66.   https://doi.org/10.1074/jbc.M112.412015",https://intramural.nih.gov/search/searchview.taf?ipid=78860
502,BC011382-03,"October 01, 2012 -  September 30, 2013",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian Eric Fisher|Moody D Amie; PhD|Joshua R Porter|Maria  Merino; PhD|Mark  Raffeld; MD,Jue  Shi (Hong Kong Baptist University)|Klaus  Hahn (UNC-Chapel Hill),Piyush Kumar Agarwal; MD (Urologic Oncology Branch),NULL,"1. Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, Lahav G (2012). p53 dynamics control cell fate. Science  336, 1440-4.   https://doi.org/10.1126/science.1218351",https://intramural.nih.gov/search/searchview.taf?ipid=78861
503,BC011383-03,"October 01, 2012 -  September 30, 2013",Transcription Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Matthew L Ferguson|Tineke Laura Lenstra|Murali  Palangat; PhD|Simona Saiprasad Patange|Joseph  Rodriguez,Eric  Drier (Mad City Labs)|Robert  Singer (Albert Einstein College of Medicine),Dinah  Singer; PhD (Molecular Regulation Section),"Carson C Chow; BASc, PhD (NIDDK) |S Stoney  Simons; PhD (NIDDK)","1. Palangat M, Larson DR (2012). Complexity of RNA polymerase II elongation dynamics. Biochim Biophys Acta  1819, 667-72.   https://doi.org/10.1016/j.bbagrm.2012.02.024",https://intramural.nih.gov/search/searchview.taf?ipid=78862
504,BC011385-03,"October 01, 2012 -  September 30, 2013",Detection of Specific Glycan Moieties on the Cell Surface,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,"1. Mercer N, Ramakrishnan B, Boeggeman E, Verdi L, Qasba PK (2013). Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface. Bioconjug Chem  24, 144-52.   https://doi.org/10.1021/bc300542z",https://intramural.nih.gov/search/searchview.taf?ipid=78864
505,BC011387-03,"October 01, 2012 -  September 30, 2013",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Puspa Raj Pandey; PhD,"James  Anderson (University of Nebraska Medical Center)|Julia  Bridge (University of Nebraska Medical Center)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|David  Parham (University of Oklahoma Health Sciences Center)|Erin  Rudzinski (Oregon Health and Science University)|Stephen  Skapek (The University of Chicago)|Show all 9",Javed  Khan; MD (Pediatric Oncology Branch)|Ji  Luo (Medical Oncology Branch),NULL,"1. Tarnowski M, Schneider G, Amann G, Clark G, Houghton P, Barr FG, Kenner L, Ratajczak MZ, Kucia M (2012). RasGRF1 regulates proliferation and metastatic behavior of human alveolar             rhabdomyosarcomas. Int J Oncol  41, 995-1004.   https://doi.org/10.3892/ijo.2012.1536|2. Wilson R, Teng L, Bachmeyer K, Bissonette M, Husain A, Parham D, Triche T, Wing M, GastierFoster J, Barr F, Hawkins D, Anderson J, Skapek S, Volchenboum S (2013) Rhabdomyosarcoma class can be discriminated by a two-gene signature using routine pathology material. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78865
506,BC011390-03,"October 01, 2012 -  September 30, 2013",Vascular Biology in Cancer,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Shyam K Sharan,Xiaolin  He (Northwestern University)|Deyu  Li (Vanderbilt University)|Kevin  Peters (Akebia Therapeutics),Jonathan  Keller; PhD (Laboratory of Cancer Prevention)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78868
507,BC011391-03,"October 01, 2012 -  September 30, 2013",Role of IKK alpha in lung squamous cell carcinoma development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Maheshvarma Rvs Datla|Zane N Gray|Na-Young  Song; PhD|Jami D Willette brown|Feng  Zhu; PhD|Robert  Wiltrout; PhD|Show all 8,Ellen  Richie (MD Anderson Cancer Center)|Nancy  Jenkins (Houston Methodist Research Institute),"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)|David  Schrump; MD (Surgery Branch)",NULL,"1. Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y (2013). The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell  23, 527-40.   https://doi.org/10.1016/j.ccr.2013.03.009|2. Xiao Z, Jiang Q, WilletteBrown J, Hu Y (2013) Mouse modeling resembling human lung cancer. Oncotarget 5:1-2",https://intramural.nih.gov/search/searchview.taf?ipid=78869
508,BC011393-03,"October 01, 2012 -  September 30, 2013",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Jonathan Stephen Williams|Ying  Xiao|Mark  Udey; MD,Anthony  Oro (Stanford University School of Medicine)|Keisuke  Nagao (Keio University),NULL,Yosuke  Mukoyama; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78871
509,BC011394-03,"October 01, 2012 -  September 30, 2013",Molecular pathogenesis of Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Amy B Coxon|Kenneth Michael Daily|Jonathan Stephen Williams,"Boris  Bastian (UCSF)|Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)|Show all 7","Eric Alan Stahlberg (Biostatistics and Data Management Section)|Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Mark  Raffeld; MD (Laboratory of Pathology)",Amir Hossein Gandjbakhche; PhD (NICHD) |Jay Robert Knutson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78872
510,BC011397-03,"October 01, 2012 -  September 30, 2013",Alternative splicing in Ras transformed cells,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Valentin  Giroux,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78873
511,BC011398-03,"October 01, 2012 -  September 30, 2013",Membrane trafficking function in primary cilium assembly and signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI","Adrian Alejandro Cuenca; MHS, PhD|Christine Antoinette Kettenhofen; PhD|Quanlong  Lu; PhD|Vijay  Walia|Matthew Allen Weiss|Peter Alex John|Show all 7",NULL,Ulrich  Baxa; PhD (Office Of The Director)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),Jennifer A Lippincott Schwartz; PhD (NICHD),"1. Asante D, Maccarthy-Morrogh L, Townley AK, Weiss MA, Katayama K, Palmer KJ, Suzuki H, Westlake CJ, Stephens DJ (2013). A role for the Golgi matrix protein giantin in ciliogenesis through control of the localization of dynein-2. J Cell Sci  126, 5189-97.   https://doi.org/10.1242/jcs.131664",https://intramural.nih.gov/search/searchview.taf?ipid=78874
512,BC011399-03,"October 01, 2012 -  September 30, 2013",Regulation of microRNA expression by Mutant p53,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Toshifumi  Hara|Xiao Ling  Li|Murugan  Subramanian|Sven  Bilke|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78875
513,BC011400-03,"October 01, 2012 -  September 30, 2013",Function of Mutant p53-regulated microRNAs in cancer cells,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Toshifumi  Hara|Matthew Fletcher Jones|Xiao Ling  Li|Murugan  Subramanian|Sven  Bilke|Paul S Meltzer; MD, PhD",NULL,Stefan  Ambs (Laboratory of Human Carcinogenesis)|Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78876
514,BC011401-03,"October 01, 2012 -  September 30, 2013",Mechanisms regulating the context-dependant function of microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sven  Bilke|Paul S Meltzer; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78877
515,BC011402-03,"October 01, 2012 -  September 30, 2013",MicroRNA phenotypic screening for the discovery of novel anti-cancer microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Toshifumi  Hara|Xiao Ling  Li|Natasha  Caplen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78878
516,BC011403-03,"October 01, 2012 -  September 30, 2013",Mechanistic investigation of the RTK cooperation paradigm in vitro and in vivo,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra Gesine Cauer|Andrew L Smith|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Udayan  Guha (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78879
517,BC011405-03,"October 01, 2012 -  September 30, 2013",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|2. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001|3. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D (2012). Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol  36, 654-62.   https://doi.org/10.1097/PAS.0b013e31824f24a6",https://intramural.nih.gov/search/searchview.taf?ipid=78881
518,BC011406-03,"October 01, 2012 -  September 30, 2013",miRNA profiling  of prostate cancer.,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|2. Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M (2012). Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys  39, 4093-103.   https://doi.org/10.1118/1.4722753|3. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|4. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA (2012). Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol  188, 1157-1163.   https://doi.org/10.1016/j.juro.2012.06.011",https://intramural.nih.gov/search/searchview.taf?ipid=78882
519,BC011407-03,"October 01, 2012 -  September 30, 2013",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Jacques  Grill (Gustave Roussy Institute)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Dannis  van Vuurden (VU University medical Center)|Gilbert  Vezina (Children's National Medical Center)|Show all 7,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78883
520,BC011408-03,"October 01, 2012 -  September 30, 2013",Compare substrate specificities of wild type and mutant EGFR kinases.,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity,Heng  Zhu (Johns Hopkins Medical Institute)|Ileana  Cristea (Princeton University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78884
521,BC011409-03,"October 01, 2012 -  September 30, 2013",Gene Expression Profiling and RNA visualization with Single-Molecule FISH,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Tineke Laura Lenstra|Murali  Palangat; PhD|Joseph  Rodriguez,NULL,David  Levens; PhD (Laboratory of Pathology)|Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology)|Dinah  Singer; PhD (Molecular Regulation Section),"Elissa P Lei; BS, PhD (NIDDK)","1. Coulon A, Chow CC, Singer RH, Larson DR (2013). Eukaryotic transcriptional dynamics: from single molecules to cell populations. Nat Rev Genet  14, 572-84.   https://doi.org/10.1038/nrg3484|2. Trcek T, Chao JA, Larson DR, Park HY, Zenklusen D, Shenoy SM, Singer RH (2012). Single-mRNA counting using fluorescent in situ hybridization in budding yeast. Nat Protoc  7, 408-19.   https://doi.org/10.1038/nprot.2011.451",https://intramural.nih.gov/search/searchview.taf?ipid=78885
522,BC011410-03,"October 01, 2012 -  September 30, 2013",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity|Xu  Zhang,Akhilesh  Pandey (Johns Hopkins University)|Andrea  Califano; PhD,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78886
523,BC011411-03,"October 01, 2012 -  September 30, 2013",Development of ESiPSC approach for non-germline GEM modeling,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",N Keith Collins|Serguei V Kozlov,NULL,Luis Manuel Alvarez; PhD (Cancer and Developmental Biology Laboratory),"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78887
524,BC011412-03,"October 01, 2012 -  September 30, 2013",Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan,NULL,"Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)|Harold  Varmus; MD (Office Of The Director)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78888
525,BC011413-03,"October 01, 2012 -  September 30, 2013",Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C, Rosenberg SA (2012). B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood  119, 2709-20.   https://doi.org/10.1182/blood-2011-10-384388",https://intramural.nih.gov/search/searchview.taf?ipid=78889
526,BC011414-03,"October 01, 2012 -  September 30, 2013",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Tapan Kumar Maity,Todd  Golub (Broad Institute of MIT and Harvard)|Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center),"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78890
527,BC011415-03,"October 01, 2012 -  September 30, 2013",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,"Mark E Dudley (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78891
528,BC011416-03,"October 01, 2012 -  September 30, 2013",Investigation of Rabs and trafficking regulators roles in tumorigenesis,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Matthew Allen Weiss|Peter Alex John,NULL,Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78892
529,BC011417-03,"October 01, 2012 -  September 30, 2013",New Chimeric Antigen Receptors for Treating Hematologic Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Ronald E Gress; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78893
530,BC011418-03,"October 01, 2012 -  September 30, 2013",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,NULL,"Susan  Bates; MD (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78894
531,BC011419-03,"October 01, 2012 -  September 30, 2013",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Shangjin  Sun,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78895
532,BC011422-02,"October 01, 2012 -  September 30, 2013",Role of IKKalpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Jami D Willette brown|Zuoxiang  Xiao|Feng  Zhu; PhD|Dennis M Klinman; MD, PhD|Giorgio  Trinchieri|Robert  Wiltrout; PhD",Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences)|Denis  Guttridge (Ohio State University)|Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Ellen  Richie (MD Anderson Cancer Center),Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Balkhi MY, Willette-Brown J, Zhu F, Chen Z, Liu S, Guttridge DC, Karin M, Hu Y (2012). IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis. Blood  119, 5467-77.   https://doi.org/10.1182/blood-2012-01-401547",https://intramural.nih.gov/search/searchview.taf?ipid=78925
533,BC011423-02,"October 01, 2012 -  September 30, 2013",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD,NULL,NULL,NULL,"1. Hinson AR, Jones R, Crose LE, Belyea BC, Barr FG, Linardic CM (2013). Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls. Front Oncol  3, 183.   https://doi.org/10.3389/fonc.2013.00183|2. Wilson R, Teng L, Bachmeyer K, Bissonette M, Husain A, Parham D, Triche T, Wing M, GastierFoster J, Barr F, Hawkins D, Anderson J, Skapek S, Volchenboum S (2013) Rhabdomyosarcoma class can be discriminated by a two-gene signature using routine pathology material. Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=78934
534,BC011424-02,"October 01, 2012 -  September 30, 2013",Bone Marrow Stromal Cells as Mitigators of Radiation Injury,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jason Andrew Horton; PhD|Kathryn Elizabeth Hudak|Bradley T Scroggins|Ayla Oksuz White,NULL,NULL,Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78919
535,BC011425-02,"October 01, 2012 -  September 30, 2013",Expression of class I in Treg cells,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Jie  Mu,NULL,Susan  Sharrow (Experimental Immunology Branch)|Alfred  Singer; MD (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section),NULL,"1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022",https://intramural.nih.gov/search/searchview.taf?ipid=78901
536,BC011426-02,"October 01, 2012 -  September 30, 2013",Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Carolyn Ana Crisp|Andrea L Ferris|Barry  Johnson|Mary J McWilliams|Steven J Smith|Janani  Varadarajan|Show all 7,"Zandrea  Ambrose (University of Pittsburgh)|Peter  Cherepanov (Imperial College London)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Milne (Oxford University)|Robert  Roeder (Rockefeller University)|Alex  Ruthenburg (University of Chicago)|Show all 7",William Gregory Alvord (Office Of The Director)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Xiaolin  Wu; PhD (Office Of The Director),Henry L Levin; PhD (NICHD),"1. Ambrose Z, Lee K, Ndjomou J, Xu H, Oztop I, Matous J, Takemura T, Unutmaz D, Engelman A, Hughes SH, KewalRamani VN (2012). Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J Virol  86, 4708-14.   https://doi.org/10.1128/JVI.05887-11|2. Johnson BC, Métifiot M, Pommier Y, Hughes SH (2012). Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity. Antimicrob Agents Chemother  56, 411-9.   https://doi.org/10.1128/AAC.05292-11|3. Métifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y (2013). Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem Biol  8, 209-17.   https://doi.org/10.1021/cb300471n|4. Wang H, Jurado KA, Wu X, Shun MC, Li X, Ferris AL, Smith SJ, Patel PA, Fuchs JR, Cherepanov P, Kvaratskhelia M, Hughes SH, Engelman A (2012). HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor. Nucleic Acids Res  40, 11518-30.   https://doi.org/10.1093/nar/gks913|5. Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. Chem Biol Drug Des  79, 157-65.   https://doi.org/10.1111/j.1747-0285.2011.01270.x|6. Zhao XZ, Maddali K, Smith SJ, Métifiot M, Johnson BC, Marchand C, Hughes SH, Pommier Y, Burke TR (2012). 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett  22, 7309-13.   https://doi.org/10.1016/j.bmcl.2012.10.088",https://intramural.nih.gov/search/searchview.taf?ipid=78896
537,BC011427-02,"October 01, 2012 -  September 30, 2013",Immunohistochemical analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jerzy P Lasota|Zengfeng  Wang; PhD,NULL,NULL,NULL,"1. Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M (2012). A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Ann Oncol  23, 1335-40.   https://doi.org/10.1093/annonc/mdr442|2. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|3. Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol  25, 854-8.   https://doi.org/10.1038/modpathol.2012.31|4. Lai JP, Rosenberg AZ, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target. Oncoimmunology  1, 1409-1410.   https://doi.org/10.4161/onci.21059|5. Lasota J, Wang Z, Kim SY, Helman L, Miettinen M (2013). Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications. Am J Surg Pathol  37, 114-9.   https://doi.org/10.1097/PAS.0b013e3182613c86|6. Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P (2013). Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol  37, 234-40.   https://doi.org/10.1097/PAS.0b013e3182671178|7. Miettinen M, Lasota J (2013). Gastrointestinal stromal tumors. Gastroenterol Clin North Am  42, 399-415.   https://doi.org/10.1016/j.gtc.2013.01.001|8. Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z (2014). GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol  38, 13-22.   https://doi.org/10.1097/PAS.0b013e3182a0218f|9. Miettinen M, Rikala MS, Rys J, Lasota J, Wang ZF (2012). Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma:  an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Am J Surg Pathol  36, 629-39.   https://doi.org/10.1097/PAS.0b013e318243555b|10. Miettinen M, Sarlomo-Rikala M, McCue P, Czapiewski P, Langfort R, Waloszczyk P, Wazny K, Biernat W, Lasota J, Wang Z (2014). Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms. Appl Immunohistochem Mol Morphol  22, 31-6.   https://doi.org/10.1097/PAI.0b013e31828bfdd3",https://intramural.nih.gov/search/searchview.taf?ipid=78935
538,BC011429-02,"October 01, 2012 -  September 30, 2013",Zbtb family members in lymphocyte differentiation and function,Damian  Kovalovsky; PhD,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78942
539,BC011431-02,"October 01, 2012 -  September 30, 2013",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Brandon Wai-Sing Kwong|Yan  Wang,NULL,NULL,Dorian  McGavern (NINDS) |Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78940
540,BC011432-02,"October 01, 2012 -  September 30, 2013",Regulation of T-bet expression in TH17 cells by microRNAs,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Brandon Wai-Sing Kwong|Yan  Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78941
541,BC011433-02,"October 01, 2012 -  September 30, 2013",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Anna  Afasizheva|Benjamin Henry Blehm|Nancy Ziyan Jiang|Yorihisa  Kotobuki; MD, PhD|Deborah  Hemingway",NULL,NULL,NULL,"1. Tanner K (2012). Regulation of the basement membrane by epithelia generated forces. Phys Biol  9, 065003.   https://doi.org/10.1088/1478-3975/9/6/065003|2. Tanner K, Mori H, Mroue R, Bruni-Cardoso A, Bissell MJ (2012). Coherent angular motion in the establishment of multicellular architecture of glandular tissues. Proc Natl Acad Sci U S A  109, 1973-8.   https://doi.org/10.1073/pnas.1119578109",https://intramural.nih.gov/search/searchview.taf?ipid=78944
542,BC011435-02,"October 01, 2012 -  September 30, 2013",Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Belete Ayele Desimmie|Taisuke  Izumi; PhD|Krista A Delviks-Frankenberry|Maria Ashley Hamscher,Yoshio  Koyanagi|Kei  Sato (Kyoto University)|Yong  Xiong (Yale University),Terrence R Burke; PhD (Chemical Biology Laboratory),James  Inglese (NCATS) |Scott E Martin (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78899
543,BC011436-02,"October 01, 2012 -  September 30, 2013","Mechanisms of Antiviral Drug Resistance, Host Factors and Retroviral Replication",Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Krista A Delviks-Frankenberry|Taisuke  Izumi; PhD|Wei-Shau  Hu; PhD|Stephen H Hughes; PhD|John Miller Coffin; PhD,"Jean L Mbisa (NCI)|Julie  Overbaugh (Fred Hutchinson Cancer Research Center)|Marcelo  Soares; PhD (Instituto Nacional de Cancer do Brasil)|Dalton  Wamalwa (University of Nairobi)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Mary  Kearney (Host Virus Interaction Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,"1. Cingöz O, Paprotka T, Delviks-Frankenberry KA, Wildt S, Hu WS, Pathak VK, Coffin JM (2012). Characterization, mapping, and distribution of the two XMRV parental proviruses. J Virol  86, 328-38.   https://doi.org/10.1128/JVI.06022-11|2. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, Roser JD, Estes JD, Hao XP, Trubey CM, Lara A, Lee K, Chaipan C, Bess JW, Nagashima K, Keele BF, Macallister R, Smedley J, Pathak VK, Kewalramani VN, Coffin JM, Lifson JD (2012). Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques. J Virol  86, 3152-66.   https://doi.org/10.1128/JVI.06886-11|3. Delviks-Frankenberry K, Cingöz O, Coffin JM, Pathak VK (2012). Recombinant origin, contamination, and de-discovery of XMRV. Curr Opin Virol  2, 499-507.   https://doi.org/10.1016/j.coviro.2012.06.009|4. Delviks-Frankenberry KA, Lengruber RB, Santos AF, Silveira JM, Soares MA, Kearney MF, Maldarelli F, Pathak VK (2013). Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology  435, 433-41.   https://doi.org/10.1016/j.virol.2012.09.021|5. Ndongwe TP, Adedeji AO, Michailidis E, Ong YT, Hachiya A, Marchand B, Ryan EM, Rai DK, Kirby KA, Whatley AS, Burke DH, Johnson M, Ding S, Zheng YM, Liu SL, Kodama E, Delviks-Frankenberry KA, Pathak VK, Mitsuya H, Parniak MA, Singh K, Sarafianos SG (2012). Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase. Nucleic Acids Res  40, 345-59.   https://doi.org/10.1093/nar/gkr694",https://intramural.nih.gov/search/searchview.taf?ipid=78900
544,BC011437-02,"October 01, 2012 -  September 30, 2013",Focused siRNA screening using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Chih-Shia  Lee,Scott  Lowe (Cold Spring Harbor Laboratory)|Frank  McCormick (UCSF School of Medicine),Natasha  Caplen (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78929
545,BC011438-02,"October 01, 2012 -  September 30, 2013",Pooled shRNA screens for target discoveries in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Changwoo Liam Lee,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch)|Jayne M Stommel (Radiation Oncology Branch),J Silvio  Gutkind; PhD (NIDCR),"1. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012). Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A  109, 5322-7.   https://doi.org/10.1073/pnas.1200012109",https://intramural.nih.gov/search/searchview.taf?ipid=78930
546,BC011439-02,"October 01, 2012 -  September 30, 2013",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert Olds Carpenter; PhD|Ronald E Gress; MD|Frances  Hakim; PhD,NULL,Stefania  Pittaluga (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology)|Steven A Feldman (Surgery Branch),NULL,"1. Kochenderfer JN (submitted in 2012) Chimeric Antigen Receptors Targeting B-cell Maturation Antigen. Patents issued: 234870 (IL in 2014); 2013246443 (AU in 2017); 700362 (NZ in 2017); 11201406414W (SG in 2017); 9,765,342 (US in 2017). Patents pending: 2017208279 (AU application); BR112014024893-1 (BR application); 2,869,562 (CA application); 201380027676.3 (CN application); 201491837 (EA application); 13714125.5 (EP application); 15104056.6 (HK application); P-00201406162 (ID application); 7407/CHENP/2014 (IN application); EU9056 (IS application); 2015-505765 (JP application); 2014-7031520 (KR application); MX/A/2014/012222 (MX application); PCT/US2013/032029 (PC application); 2014144143 (RU application); 1401006159 (TH application); 15/692,473 (US application); 2014/07014 (SA application). Tracking numbers: E-040-2012-0-AR-03 (AR application); E-040-2012-0-RU-26 (RU application).",https://intramural.nih.gov/search/searchview.taf?ipid=78920
547,BC011441-02,"October 01, 2012 -  September 30, 2013",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra Gesine Cauer|Diane Marie Kambach|Andrew L Smith|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78931
548,BC011443-02,"October 01, 2012 -  September 30, 2013",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jennifer T Miller,Ram  Savan|Nicolas  SluisCremer (University of Pittsburgh),NULL,NULL,"1. Legrice S (2013) Conformational dynamics of reverse transcription, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. (Le Grice S, Goette M, eds., in press.|2. Legrice S, Nowotny M (2013) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., in press.|3. Chung S, Miller JT, Lapkouski M, Tian L, Yang W, Le Grice SF (2013). Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybrids. J Biol Chem  288, 16177-84.   https://doi.org/10.1074/jbc.M113.465641|4. Le Grice SF (2012). Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise. J Biol Chem  287, 40850-7.   https://doi.org/10.1074/jbc.R112.389056",https://intramural.nih.gov/search/searchview.taf?ipid=78898
549,BC011446-02,"October 01, 2012 -  September 30, 2013",The ClpP protease as a therapeutic target in bacterial and mammalian cells,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Germaine Yeku Noukelak|Serhiy Volodymirovych Surkov; PhD,NULL,NULL,Anton  Simeonov (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78903
550,BC011447-02,"October 01, 2012 -  September 30, 2013",Clinical Development of New Agents for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Linda L Ellison Dejewski|Jennifer D Rabb|Laurie  Steffen|Brigitte  Widemann; MD,"Susan  Blaney (Baylor University/TCCC)|James  Boyett (St Jude Children's Research Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Mark  Kieran (Children's Hospital)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Show all 7",Kevin A Camphausen; MD (Radiation Oncology Branch),Russell R Lonser; MD (NINDS) |Joelle  Sarlls; PhD (NINDS),"1. Fangusaro J, Gururangan S, Young Poussaint T, McLendon R, OnarThomas A, Warren K, Wu S, Packer R, Banerjee A, Gilbertson R, Jakacki R, Gajjar A, Goldman S, Pollack I, Friedman H, Boyett J, Kun L, Fouladi M (2013) Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study-022 (PBTC-022). Cancer, in press.|2. Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE (2012). A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. J Neurooncol  106, 643-9.   https://doi.org/10.1007/s11060-011-0709-z",https://intramural.nih.gov/search/searchview.taf?ipid=78915
551,BC011449-02,"October 01, 2012 -  September 30, 2013",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,Ji  Luo (Medical Oncology Branch)|Barry R O'Keefe (Molecular Targets Laboratory)|David S Waugh; PhD (Protein Engineering Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78936
552,BC011450-02,"October 01, 2012 -  September 30, 2013",Ipilimumab for treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Jedd  Wolchok (Memorial Sloan-Kettering),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I (2013). The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys  85, 293-5.   https://doi.org/10.1016/j.ijrobp.2012.03.017",https://intramural.nih.gov/search/searchview.taf?ipid=78933
553,BC011451-02,"October 01, 2012 -  September 30, 2013",Synthesis and Study of Inhibitors of Ubiquitin Ligases,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78937
554,BC011454-02,"October 01, 2012 -  September 30, 2013",RGB-286638 as a radiation sensitizer,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Naga Venkata Gopal  Abbineni|Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78927
555,BC011455-02,"October 01, 2012 -  September 30, 2013",Therapeutic use of immunomodulators and ionizining radiation,Karl Erick Haglund,NULL,"Radiation Oncology Branch, NCI",Naga Venkata Gopal  Abbineni|Kheem Singh Bisht,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78928
556,BC011456-02,"October 01, 2012 -  September 30, 2013",Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78921
557,BC011458-02,"October 01, 2012 -  September 30, 2013",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Sam Joseph Brancato|Qingdi Q Li,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Hisataka  Kobayashi (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78943
558,BC011459-02,"October 01, 2012 -  September 30, 2013",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Veronica Jeanne Farmer|Dong  Kong; PhD|Meena  Sharma|Anil Kumar Shukla|Allan M Weissman; MD,NULL,Kyung  Lee; PhD (Chemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78939
559,BC011460-02,"October 01, 2012 -  September 30, 2013",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Upasana  Ray,NULL,NULL,NULL,"1. Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB (2012). Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog  8, e1002650.   https://doi.org/10.1371/journal.ppat.1002650|2. Schowalter RM, Reinhold WC, Buck CB (2012). Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One  7, e42181.   https://doi.org/10.1371/journal.pone.0042181",https://intramural.nih.gov/search/searchview.taf?ipid=78905
560,BC011461-02,"October 01, 2012 -  September 30, 2013",The Role of RISC Proteins in HIV-1 Replication,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Laura Minji Choi|Ioannis N Kagiampakis|Kyeongeun  Lee|Hyun Jae  Yu|Wendy  Yuen|Eric O Freed; PhD|Show all 7,"Sara  Sawyer (University of Texas, Austin)|Derya  Unutmaz (New York University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78897
561,BC011462-02,"October 01, 2012 -  September 30, 2013",Establishing the Preclinical Model for Metastatic Melanoma,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Deborah B Householder|Zoe W Ohler,Marcus  Bosenberg (Yale University)|Martin  McMahon (University of Californial at San Francisco),Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),NULL,"1. Van Dyke T, Merlino G (2012). β-catenin in metastatic melanoma--the smoking gun reloaded. Pigment Cell Melanoma Res  25, 125-6.   https://doi.org/10.1111/j.1755-148X.2011.00964.x",https://intramural.nih.gov/search/searchview.taf?ipid=78923
562,BC011463-02,"October 01, 2012 -  September 30, 2013",Adoption and Retooling of GEM model for Pancreatic Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Serguei V Kozlov|Zoe W Ohler,"Ross  Cagan (Mount Sinai School of Medicine)|Neal  Goodwin (Jackson Laboratory, West)",Scott E McNeil (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78924
563,BC011464-02,"October 01, 2012 -  September 30, 2013",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Gabriella Marie Diaz|Junko  Hattori|Shawn A Hill|Francesco Roberto Simonetti; MD,Anuradha  Ganesan (Henry M. Jackson Foundation)|Deborah  McMahon (University of Pittsburgh)|John W Mellors|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Lisa  Demeter (University of Washington)|Show all 8,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Richard T Davey; MD (NIAID) |Michael  Proschan; PhD (NIAID) |H. Clifford  Lane; MD (NIAID) |Henry  Masur; MD (CC) |Irini  Sereti; MD (NIAID),"1. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, Pinyakorn S, Phanuphak N, Trichavaroj R, Rutvisuttinunt W, Chomchey N, Paris R, Peel S, Valcour V, Maldarelli F, Chomont N, Michael N, Phanuphak P, Kim JH, RV254/SEARCH 010 Study Group (2012). Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One  7, e33948.   https://doi.org/10.1371/journal.pone.0033948|2. Besson GJ, McMahon D, Maldarelli F, Mellors JW (2012). Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy. Clin Infect Dis  54, 451-3.   https://doi.org/10.1093/cid/cir721",https://intramural.nih.gov/search/searchview.taf?ipid=78906
564,BC011465-02,"October 01, 2012 -  September 30, 2013",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Yeung  Ho|Zuqin  Nie; PhD|Ying  Zheng|Weixin  Zhou; PhD|Lipeng  Wu,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Rafael Cristian Casellas; PhD (NIAMS) |Keji  Zhao; PhD (NHLBI),"1. Lovén J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, Lee TI, Young RA (2012). Revisiting global gene expression analysis. Cell  151, 476-82.   https://doi.org/10.1016/j.cell.2012.10.012|2. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (2012). c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell  151, 68-79.   https://doi.org/10.1016/j.cell.2012.08.033",https://intramural.nih.gov/search/searchview.taf?ipid=78904
565,BC011466-02,"October 01, 2012 -  September 30, 2013",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Gabriella Marie Diaz|Junko  Hattori|Shawn A Hill|Francesco Roberto Simonetti; MD,Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Anuradha  Ganesan (Henry M. Jackson Foundation)|Deborah  McMahon (University of Pittsburgh)|John W Mellors|Helene  Mens (Copenhagen University)|Show all 7,Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Joseph P Casazza (NIAID) |Richard T Davey; MD (NIAID) |Michele  Di Mascio; PhD (NIAID) |Dean  Follmann; PhD (NIAID) |Joseph A Kovacs; MD (CC) |Mark  Connors; MD (NIAID),"1. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, Pinyakorn S, Phanuphak N, Trichavaroj R, Rutvisuttinunt W, Chomchey N, Paris R, Peel S, Valcour V, Maldarelli F, Chomont N, Michael N, Phanuphak P, Kim JH, RV254/SEARCH 010 Study Group (2012). Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One  7, e33948.   https://doi.org/10.1371/journal.pone.0033948|2. Besson GJ, McMahon D, Maldarelli F, Mellors JW (2012). Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy. Clin Infect Dis  54, 451-3.   https://doi.org/10.1093/cid/cir721",https://intramural.nih.gov/search/searchview.taf?ipid=78907
566,BC011467-02,"October 01, 2012 -  September 30, 2013",Molecularly targeted natural products discovery from diverse natural sources,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",Heidi  Bokesch|Laura  Cartner|Amaya  Castro-Ruiz|Susanna Tsz Shan Chan|Richard W Fuller|Suthananda Naidu Sunassee,NULL,Susan  Bates; MD (Medical Oncology Branch)|Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|William Marston Linehan; MD (Urologic Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology),NULL,"1. Blees JS, Bokesch HR, Rübsamen D, Schulz K, Milke L, Bajer MM, Gustafson KR, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B (2012). Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1. PLoS One  7, e46567.   https://doi.org/10.1371/journal.pone.0046567|2. Diyabalanage T, Ratnayake R, Bokesch HR, Ransom TT, Henrich CJ, Beutler JA, McMahon JB, Gustafson KR (2012). Flabelliferins A and B, sesterterpenoids from the South Pacific sponge Carteriospongia flabellifera. J Nat Prod  75, 1490-4.   https://doi.org/10.1021/np3003518|3. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x",https://intramural.nih.gov/search/searchview.taf?ipid=78909
567,BC011468-02,"October 01, 2012 -  September 30, 2013",Adaptations and methodologies for enhanced identification of lead compounds,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",NULL,NULL,Susan  Bates; MD (Medical Oncology Branch)|Nancy H Colburn; PhD (Laboratory of Cancer Prevention)|William Marston Linehan; MD (Urologic Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78910
568,BC011469-02,"October 01, 2012 -  September 30, 2013",Building Libraries with Chemical Diversity for Screening,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Jason R Evans|Ekaterina  Goncharo|Cheryl L Thomas,Sergazy  Adekenov (International Research and Production Holding Phytochemistry)|Jeff  Aube (University of Kansas)|Darkan  Balpanaov (Biomedpreparat)|Young Ho  Kim|Sergei  Kozmin (University of Chicago)|John  Porco (Boston University)|Show all 8,NULL,NULL,"1. Dong S, Qin T, Hamel E, Beutler JA, Porco JA (2012). Synthesis of chamaecypanone C analogues from in situ-generated cyclopentadienones and their biological evaluation. J Am Chem Soc  134, 19782-7.   https://doi.org/10.1021/ja3084708",https://intramural.nih.gov/search/searchview.taf?ipid=78911
569,BC011470-02,"October 01, 2012 -  September 30, 2013",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"William  Chain (University of Hawaii)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Kathlyn  Parker (Stony Brook University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)","William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)",NULL,"1. Akee RK, Ransom T, Ratnayake R, McMahon JB, Beutler JA (2012). Chlorinated englerins with selective inhibition of renal cancer cell growth. J Nat Prod  75, 459-63.   https://doi.org/10.1021/np200905u|2. Devkota KP, Wilson J, Henrich CJ, McMahon JB, Reilly KM, Beutler JA (2013). Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth. J Nat Prod  76, 59-63.   https://doi.org/10.1021/np300696g",https://intramural.nih.gov/search/searchview.taf?ipid=78912
570,BC011471-02,"October 01, 2012 -  September 30, 2013",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Kirk R Gustafson; PhD,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78913
571,BC011472-02,"October 01, 2012 -  September 30, 2013",Isolation of antiviral proteins from natural product extracts.,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"Paul  Christou (Universitat de Lleida)|Edward  Karamov (Ivanovsky Institute of Virology)|Lynn  Morris (National Institute for Communicable Diseases)|Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Melissa  Robbiani (The Population Council)",Alexander  Wlodawer; PhD (Protein Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78914
572,BC011476-01,"October 01, 2012 -  September 30, 2013",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Sherry Jones Coulter; BS|Gabriel Arther Knudsen|Abdella Mohammed Sadik|J Michael Sanders; PhD,Marian  Pavuk (CDC)|Hoang  Quynh (University of Hanoi)|Arnold  Schecter (NIEHS)|Steven T Szabo,NULL,Stavros  Garantziotis; MD (NIEHS) |Gaylia Jean Harry; PhD (NIEHS) |Kristina Thayer Chialton; PhD (NIEHS),"1. Bergman A, Rydén A, Law RJ, de Boer J, Covaci A, Alaee M, Birnbaum L, Petreas M, Rose M, Sakai S, Van den Eede N, van der Veen I (2012). A novel abbreviation standard for organobromine, organochlorine and organophosphorus flame retardants and some characteristics of the chemicals. Environ Int  49, 57-82.   https://doi.org/10.1016/j.envint.2012.08.003|2. Birnbaum LS (2013). Designing safer chemicals. Environ Health Perspect  121, A9.   https://doi.org/10.1289/ehp.121-a13|3. Birnbaum LS (2013). State of the science of endocrine disruptors. Environ Health Perspect  121, A107.   https://doi.org/10.1289/ehp.1306695|4. Birnbaum LS (2013). When environmental chemicals act like uncontrolled medicine. Trends Endocrinol Metab  24, 321-3.   https://doi.org/10.1016/j.tem.2012.12.005|5. Cote I, Anastas PT, Birnbaum LS, Clark RM, Dix DJ, Edwards SW, Preuss PW (2012). Advancing the next generation of health risk assessment. Environ Health Perspect  120, 1499-502.   https://doi.org/10.1289/ehp.1104870|6. Gosavi RA, Knudsen GA, Birnbaum LS, Pedersen LC (2013). Mimicking of estradiol binding by flame retardants and their metabolites: a crystallographic analysis. Environ Health Perspect  121, 1194-9.   https://doi.org/10.1289/ehp.1306902|7. Hakk H, Szabo DT, Huwe J, Diliberto J, Birnbaum LS (2012). Novel and distinct metabolites identified following a single oral dose of α- or γ-hexabromocyclododecane in mice. Environ Sci Technol  46, 13494-503.   https://doi.org/10.1021/es303209g|8. Humblet O, Korrick SA, Williams PL, Sergeyev O, Emond C, Birnbaum LS, Burns JS, Altshul LM, Patterson DG, Turner WE, Lee MM, Revich B, Hauser R (2013). Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys. Environ Health Perspect  121, 111-7.   https://doi.org/10.1289/ehp.1205278|9. La Merrill M, Emond C, Kim MJ, Antignac JP, Le Bizec B, Clément K, Birnbaum LS, Barouki R (2013). Toxicological function of adipose tissue: focus on persistent organic pollutants. Environ Health Perspect  121, 162-9.   https://doi.org/10.1289/ehp.1205485|10. Lam T, Williams PL, Burns JS, Sergeyev O, Korrick SA, Lee MM, Birnbaum LS, Revich B, Altshul LM, Patterson DG, Turner WE, Hauser R (2013). Predictors of serum chlorinated pesticide concentrations among prepubertal Russian boys. Environ Health Perspect  121, 1372-7.   https://doi.org/10.1289/ehp.1306480|11. Sanders JM, Knudsen GA, Birnbaum LS (2013). The fate of β-hexabromocyclododecane in female C57BL/6 mice. Toxicol Sci  134, 251-7.   https://doi.org/10.1093/toxsci/kft121|12. Schecter A, Lorber M, Guo Y, Wu Q, Yun SH, Kannan K, Hommel M, Imran N, Hynan LS, Cheng D, Colacino JA, Birnbaum LS (2013). Phthalate concentrations and dietary exposure from food purchased in New York State. Environ Health Perspect  121, 473-94.   https://doi.org/10.1289/ehp.1206367|13. Schecter A, Szabo DT, Miller J, Gent TL, Malik-Bass N, Petersen M, Paepke O, Colacino JA, Hynan LS, Harris TR, Malla S, Birnbaum LS (2012). Hexabromocyclododecane (HBCD) stereoisomers in U.S. food from Dallas, Texas. Environ Health Perspect  120, 1260-4.   https://doi.org/10.1289/ehp.1204993|14. van den Berg M, Denison MS, Birnbaum LS, Devito MJ, Fiedler H, Falandysz J, Rose M, Schrenk D, Safe S, Tohyama C, Tritscher A, Tysklind M, Peterson RE (2013). Polybrominated dibenzo-p-dioxins, dibenzofurans, and biphenyls: inclusion in the toxicity equivalency factor concept for dioxin-like compounds. Toxicol Sci  133, 197-208.   https://doi.org/10.1093/toxsci/kft070",https://intramural.nih.gov/search/searchview.taf?ipid=83089
573,BC011478-01,"October 01, 2012 -  September 30, 2013",Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Lindsey Meredith Draper|Sanja  Stevanovic; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83068
574,BC011479-01,"October 01, 2012 -  September 30, 2013",T-cell receptor gene therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Lindsey Meredith Draper,NULL,NULL,NULL,"1. Hinrichs CS, Restifo NP (2013). Reassessing target antigens for adoptive T-cell therapy. Nat Biotechnol  31, 999-1008.   https://doi.org/10.1038/nbt.2725",https://intramural.nih.gov/search/searchview.taf?ipid=83069
575,BC011480-01,"October 01, 2012 -  September 30, 2013",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Yun  Ji|James N Kochenderfer,"Carl  June (University of Pennsylavnia)|Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Dietmar  Zehn (Swiss Vaccine Research Institute)",Nicholas Phillip Restifo; MD (Surgery Branch),"Toren  Finkel; MD, PhD (NHLBI) |Stefan Adi Muljo; PhD (NIAID) |Mario  Roederer; PhD (NIAID) |David F Stroncek; MD (CC) |John S Tsang; PhD (NIAID) |Ena  Wang (CC)","1. Gattinoni L, Klebanoff CA, Restifo NP (2012). Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer  12, 671-84.   https://doi.org/10.1038/nrc3322|2. Klebanoff CA, Gattinoni L, Restifo NP (2012). Sorting through subsets:  which T-cell populations mediate highly effective adoptive immunotherapy? J Immunother  35, 651-60.   https://doi.org/10.1097/CJI.0b013e31827806e6",https://intramural.nih.gov/search/searchview.taf?ipid=83042
576,BC011482-01,"October 01, 2012 -  September 30, 2013",Evaluation of the Natural History of Patients withTumors of the Central Nervous,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),"John Anthony Butman; MD, PhD (CC) |John Keenam Park (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83056
577,BC011484-01,"October 01, 2012 -  September 30, 2013",Develop novel therapeutics for patients with treatment resistant glioma,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",Carlos A Salgado,NULL,"William D Figg; PharmD (Medical Oncology Branch)|Cody John Peer (Office of the Director)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Kreisl TN, McNeill KA, Sul J, Iwamoto FM, Shih J, Fine HA (2012). A phase I/II trial of vandetanib for patients with recurrent malignant glioma. Neuro Oncol  14, 1519-26.   https://doi.org/10.1093/neuonc/nos265",https://intramural.nih.gov/search/searchview.taf?ipid=83057
578,BC011485-01,"October 01, 2012 -  September 30, 2013",Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Geng  Zhang,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83041
579,BC011486-01,"October 01, 2012 -  September 30, 2013",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Kenji  Maeda|Yuki  Takamatsu; MD,Masayuki  Amano (Kumamoto University School of Medicine)|Manabu  Aoki (Kumamoto Health Science University)|Hiroyuki  Hayakawa (Yamasa Corporation)|Hiromi  OgataAoki (Kumamoto University School of Medicine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83017
580,BC011487-01,"October 01, 2012 -  September 30, 2013",Systems-level analysis of the regulation and function of c-Myc,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian Eric Fisher|David  Levens; PhD|David D Roberts; PhD,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83071
581,BC011488-01,"October 01, 2012 -  September 30, 2013",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David Church Montgomery|Allison Marie Roberts|Alexander William Sorum,NULL,NULL,Ajit  Jadhav (NCATS) |David J Maloney (NCATS) |Anton  Simeonov (NCATS),"1. Meier JL, Yu AS, Korf I, Segal DJ, Dervan PB (2012). Guiding the design of synthetic DNA-binding molecules with massively parallel sequencing. J Am Chem Soc  134, 17814-22.   https://doi.org/10.1021/ja308888c",https://intramural.nih.gov/search/searchview.taf?ipid=83085
582,BC011490-01,"October 01, 2012 -  September 30, 2013",Ubiquitin signaling,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Xiang  Chen|Fahu  He|Fen  Liu; PhD|Leah Ann Randles; PhD|Yan-Hong  Shi,Aaron  Ehlinger (University of Minnesota)|Daniel  Finley (Harvard Medical School)|Simona  Polo (University of Milan)|Maria  Sunnerhagen (Linkoping University),NULL,NULL,"1. Chen X, Walters KJ (2012). Identifying and studying ubiquitin receptors by NMR. Methods Mol Biol  832, 279-303.   https://doi.org/10.1007/978-1-61779-474-2_20|2. Hennig J, de Vries SJ, Hennig KD, Randles L, Walters KJ, Sunnerhagen M, Bonvin AM (2012). MTMDAT-HADDOCK: high-throughput, protein complex structure modeling based on limited proteolysis and mass spectrometry. BMC Struct Biol  12, 29.   https://doi.org/10.1186/1472-6807-12-29|3. Randles L, Walters KJ (2012). Ubiquitin and its binding domains. Front Biosci (Landmark Ed)  17, 2140-57.   https://doi.org/10.2741/4042",https://intramural.nih.gov/search/searchview.taf?ipid=83086
583,BC011491-01,"October 01, 2012 -  September 30, 2013",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Maria C Dolbec-Oliveras|Ramesh  Govindan; BS|Hyunmi Kim Halas; PhD,NULL,NULL,NULL,"1. Du J, Kelly AE, Funabiki H, Patel DJ (2012). Structural basis for recognition of H3T3ph and Smac/DIABLO N-terminal peptides by human Survivin. Structure  20, 185-95.   https://doi.org/10.1016/j.str.2011.12.001",https://intramural.nih.gov/search/searchview.taf?ipid=83084
584,BC011492-01,"October 01, 2012 -  September 30, 2013","Biomarkers in Cancer Diagnosis,Prognosis, and Therapuetic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Katsuhiro  Anami; MD, PhD|Matthew J Blackburn|Elise Dawn Bowman|Tomer  Cooks|Kristen Leigh Greathouse|Majda  Haznadar|Show all 22",William J Blot|Markus  Mohler (University of Mainz)|Bert R Vogelstein|Wataru  Yasui (Hiroshima University)|Jun  Yokota (National Cancer Center Research Institute),"Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)",Julia A Segre; PhD (NHGRI),"1. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, Park JY, Harris CC, Yang P, Jen J (2012). Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res  18, 3658-67.   https://doi.org/10.1158/1078-0432.CCR-11-2857|2. Okayama H, Schetter AJ, Harris CC (2012). MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis  30 Suppl 2, 9-15.   https://doi.org/10.1159/000341882|3. Ryan BM, McClary AC, Valeri N, Robinson D, Paone A, Bowman ED, Robles AI, Croce C, Harris CC (2012). rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One  7, e36306.   https://doi.org/10.1371/journal.pone.0036306|4. Ryan BM, Robles AI, Harris CC (2012). KRAS-LCS6 genotype as a prognostic marker in early-stage CRC--letter. Clin Cancer Res  18, 3487-8; author reply 3489.   https://doi.org/10.1158/1078-0432.CCR-12-0250|5. Schetter AJ, Okayama H, Harris CC (2012). The role of microRNAs in colorectal cancer. Cancer J  18, 244-52.   https://doi.org/10.1097/PPO.0b013e318258b78f|6. Zhao Y, Schetter AJ, Yang GB, Nguyen G, Mathé EA, Li P, Cai H, Yu L, Liu F, Hang D, Yang H, Wang XW, Ke Y, Harris CC (2013). microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int J Cancer  132, 2901-9.   https://doi.org/10.1002/ijc.27954",https://intramural.nih.gov/search/searchview.taf?ipid=83036
585,BC011493-01,"October 01, 2012 -  September 30, 2013","Molecular Oncology of Pediatric, Adolescent and Young Adult Sarcomas",Fernanda  Arnaldez,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD,NULL,"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83058
586,BC011494-01,"October 01, 2012 -  September 30, 2013",Development of Therapeutic Approaches for Wild-Type GIST,Fernanda  Arnaldez,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD|Brigitte  Widemann; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83059
587,BC011495-01,"October 01, 2012 -  September 30, 2013",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Kristen Leigh Greathouse|Majda  Haznadar|Mohammed A. Khan; PhD|Hirokazu  Okayama; PhD|Brid Mairead Ryan|Aaron Joseph Schetter|Show all 13,"William J Blot|Ann  Schwartz (Karmanos Cancer Institute)|Ping  Yang; MD, PhD (Mayo Clinic)|Jun  Yokota (National Cancer Center Research Institute)","Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Stephen J Chanock; MD, PhD (Laboratory Translational Genomics)",NULL,"1. Coté ML, Liu M, Bonassi S, Neri M, Schwartz AG, Christiani DC, Spitz MR, Muscat JE, Rennert G, Aben KK, Andrew AS, Bencko V, Bickeböller H, Boffetta P, Brennan P, Brenner H, Duell EJ, Fabianova E, Field JK, Foretova L, Friis S, Harris CC, Holcatova I, Hong YC, Isla D, et al. [34 more authors] (2012). Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer  48, 1957-68.   https://doi.org/10.1016/j.ejca.2012.01.038|2. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, Park CH, Rakhshan F, Schultz DA, Kolbert CP, Lupu R, Park JY, Harris CC, Yang P, Jen J (2012). Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res  18, 3658-67.   https://doi.org/10.1158/1078-0432.CCR-11-2857|3. Ryan BM, Calhoun KM, Pine SR, Bowman ED, Robles AI, Ambs S, Harris CC (2012). MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer  131, 2710-6.   https://doi.org/10.1002/ijc.27573|4. Ryan BM, McClary AC, Valeri N, Robinson D, Paone A, Bowman ED, Robles AI, Croce C, Harris CC (2012). rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One  7, e36306.   https://doi.org/10.1371/journal.pone.0036306|5. Ryan BM, Robles AI, Harris CC (2012). KRAS-LCS6 genotype as a prognostic marker in early-stage CRC--letter. Clin Cancer Res  18, 3487-8; author reply 3489.   https://doi.org/10.1158/1078-0432.CCR-12-0250|6. Taga M, Mechanic LE, Hagiwara N, Vähäkangas KH, Bennett WP, Alavanja MC, Welsh JA, Khan MA, Lee A, Diasio R, Edell E, Bungum A, Jang JS, Yang P, Jen J, Harris CC (2012). EGFR somatic mutations in lung tumors: radon exposure and passive smoking in former- and never-smoking U.S. women. Cancer Epidemiol Biomarkers Prev  21, 988-92.   https://doi.org/10.1158/1055-9965.EPI-12-0166|7. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, McClary AC, Bowman ED, Goodman JE, Bernig T, Chanock SJ, Harris CC (2012). 3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res  72, 1467-77.   https://doi.org/10.1158/0008-5472.CAN-11-3073",https://intramural.nih.gov/search/searchview.taf?ipid=83037
588,BC011496-01,"October 01, 2012 -  September 30, 2013","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Krist Michael Aploks|Izumi  Horikawa|Abdul Matin Mondal|Elisa A Spillare|Casmir Elyse Turnquist-Held,NULL,Ettore  Appella; MD (Chemical Immunology Section),NULL,"1. Schetter AJ, Harris CC (2012). Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome. Proc Natl Acad Sci U S A  109, 7955-6.   https://doi.org/10.1073/pnas.1205457109|2. Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM, Stauffer JK, Zheng ZM, Harris CC (2013). Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene  32, 2792-8.   https://doi.org/10.1038/onc.2012.288",https://intramural.nih.gov/search/searchview.taf?ipid=83038
589,BC011498-01,"October 01, 2012 -  September 30, 2013",Clinical Trials of Immunotherapies for Childhood Cancer,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Donna B Bernstein|Daniel W Lee|Hua  Zhang,"Malcolm  Brenner (Baylor College of Medicine)|NaiKong  Cheung (Memorial Sloan Kettering Cancer Center)|Laurence  Cooper (MD Anderson Cancer Center)|Steven  Grupp (Children's Hospital of Philadelphia)|Carl  June (University of Pennsylvania)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Show all 7","Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",David F Stroncek; MD (CC),"1. Lee DW, Barrett DM, Mackall C, Orentas R, Grupp SA (2012). The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer. Clin Cancer Res  18, 2780-90.   https://doi.org/10.1158/1078-0432.CCR-11-1920|2. Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL (2012). Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. J Clin Oncol  30, 4141-7.   https://doi.org/10.1200/JCO.2012.44.1055",https://intramural.nih.gov/search/searchview.taf?ipid=83018
590,BC011500-01,"October 01, 2012 -  September 30, 2013",Pathogenesis and therapy of KSHV-associated Malignancies,Mark Niccolo Polizzotto; MD,NULL,"HIV and AIDS Malignancy Branch, NCI",Karen O Aleman|Joseph M Ziegelbauer,Christina  Chang (Alfred Hospital)|Merrole  ColeSinclair (University of Melbourne)|Vikram  Khetani (Celgene Corporation)|Peter  Medveczky (University of South Florida)|Lisa  Pugliese (Celgene Corporation)|Harold  Tjalsma (Radboud University Nijmegen Medical Center)|Show all 8,"William D Figg; PharmD (Medical Oncology Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Denise  Whitby (Office Of The Director)|Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)","Amir Hossein Gandjbakhche; PhD (NICHD) |Peter  Herscovitch; MD (CC) |Vojtech  Huser; MD, PhD (CC) |Corina M Millo; MD (CC) |Irini  Sereti; MD (NIAID)","1. Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G (2012). Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res  72, 1157-69.   https://doi.org/10.1158/0008-5472.CAN-11-3067|2. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R (2012). Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Front Microbiol  3, 73.   https://doi.org/10.3389/fmicb.2012.00073|3. Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Whitby D (2012). Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. J Infect Dis  205, 1665-76.   https://doi.org/10.1093/infdis/jis249|4. Uldrick TS, Polizzotto MN, Yarchoan R (2012). Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol  24, 495-505.   https://doi.org/10.1097/CCO.0b013e328355e0f3|5. Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R (2012). Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol  30, 1476-83.   https://doi.org/10.1200/JCO.2011.39.6853",https://intramural.nih.gov/search/searchview.taf?ipid=83064
591,BC011501-01,"October 01, 2012 -  September 30, 2013",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sarah Faith Clatterbuck Soper; PhD|Tianhong  Wang|Kyota  Yasuda; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83081
592,BC011502-01,"October 01, 2012 -  September 30, 2013",Development and use of nanoFACS for analysis and sorting of nanoparticles,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD|Marjorie  Robert-Guroff; PhD|Katherine M McKinnon","Marty  Bigos (Stanford)|Sally Penny  Chisholm (MIT)|Tigges  John (BIDMC)|Susan  Knox (Stanford)|Roy  Overton (Partec, North America)|David  Park (Stanford)|Show all 7",Kevin A Camphausen; MD (Radiation Oncology Branch)|Norman Norman Coleman; MD (Radiation Research Program)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jane Beth Trepel (Medical Oncology Branch)|Anu  Puri; PhD (Membrane Structure and Function Section)|William G Telford (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83082
593,BC011503-01,"October 01, 2012 -  September 30, 2013",Novel Combinations of Radiation and Immunotherapy,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jay Arthur Berzofsky; MD, PhD",Rosemarie  DeKruyff (Children's Hospital Boston)|Gordon  Freeman (Harvard)|Susan  Knox (Stanford)|Dale  Umetsu (Children's Hospital Boston),Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Hiniker SM, Chen DS, Reddy S, Chang DT, Jones JC, Mollick JA, Swetter SM, Knox SJ (2012). A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Transl Oncol  5, 404-7.   https://doi.org/10.1593/tlo.12280",https://intramural.nih.gov/search/searchview.taf?ipid=83083
594,BC011504-01,"October 01, 2012 -  September 30, 2013",Study the roles of p53 and p53 mutants in mesenchymal stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hongfeng  Gou|Min Hwa  Shin|Shunlin  Jiang,NULL,Chand  Khanna; MD (Pediatric Oncology Branch)|Jianxin  Shi (Biostatistics Branch),NULL,"1. He Y, Korboukh I, Jin J, Huang J (2012). Targeting protein lysine methylation and demethylation in cancers. Acta Biochim Biophys Sin (Shanghai)  44, 70-9.   https://doi.org/10.1093/abbs/gmr109|2. Li M, He Y, Dubois W, Wu X, Shi J, Huang J (2012). Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell  46, 30-42.   https://doi.org/10.1016/j.molcel.2012.01.020|3. Li M, He Y, Feng X, Huang J (2012). Genome-wide studies of the transcriptional regulation by p53. Biochim Biophys Acta  1819, 684-7.   https://doi.org/10.1016/j.bbagrm.2012.02.002|4. Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J (2013). Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle  12, 1279-91.   https://doi.org/10.4161/cc.24364",https://intramural.nih.gov/search/searchview.taf?ipid=83060
595,BC011505-01,"October 01, 2012 -  September 30, 2013",Characterization of the hematopoietic stem cell lineage,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Naiche L Adler|Cynthia M Elder,NULL,Jonathan  Keller; PhD (Laboratory of Cancer Prevention),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83016
596,BC011506-01,"October 01, 2012 -  September 30, 2013",Synthesis and evaluation of small-molecule imaging agents,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Alexander Patrick Gorka|Rachel Wolff Jung|Piotr  Kaczmarek|Andrew James Lee|Roger Rauhauser Nani,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|David Anderson Wink (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83080
597,BC011511-01,"October 01, 2012 -  September 30, 2013",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Amanda Lee Whiting,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83066
598,BC011512-01,"October 01, 2012 -  September 30, 2013",Activatable molecular cancer imaging probe,Hisataka  Kobayashi,Peter L Choyke; MD,"Molecular Imaging Program, NCI",Vinita Marie Alexander|Kohei  Sano,Neil  Bander (Cornell Univ)|Derek  Bartlett (ImaginAb)|Yu  Chen (Univ of Maryland)|Marcin  Ptaszek (UMBC)|Yasuteru  Urano,Terry Anne Van Dyke (Mouse Cancer Genetics Program)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Matthew R Young; PhD (Laboratory of Cancer Prevention),NULL,"1. Alexander VM, Sano K, Yu Z, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H (2012). Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases. Bioconjug Chem  23, 1671-9.   https://doi.org/10.1021/bc3002419|2. McCann TE, Kosaka N, Choyke PL, Kobayashi H (2012). The use of fluorescent proteins for developing cancer-specific target imaging probes. Methods Mol Biol  872, 191-204.   https://doi.org/10.1007/978-1-61779-797-2_13|3. Mitsunaga M, Kosaka N, Choyke PL, Young MR, Dextras CR, Saud SM, Colburn NH, Sakabe M, Nagano T, Asanuma D, Urano Y, Kobayashi H (2013). Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe. Gut  62, 1179-86.   https://doi.org/10.1136/gutjnl-2011-301795|4. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2012). In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Cancer Res  14, R61.   https://doi.org/10.1186/bcr3167",https://intramural.nih.gov/search/searchview.taf?ipid=83048
599,BC011513-01,"October 01, 2012 -  September 30, 2013",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi,Peter L Choyke; MD,"Molecular Imaging Program, NCI",Vinita Marie Alexander|Kohei  Sano,Zaver  Bhujwalla (Johns Hopkins)|Yu  Chen (Univ of Maryland)|Toshiyoshi  Fujiwara (Okayama Univ)|Peter  Marinkovich (Stnford Univ)|Mikako  Ogawa,"Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H (2012). Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem  23, 604-9.   https://doi.org/10.1021/bc200648m|2. Mitsunaga M, Nakajima T, Sano K, Kramer-Marek G, Choyke PL, Kobayashi H (2012). Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer  12, 345.   https://doi.org/10.1186/1471-2407-12-345|3. Nakajima T, Sano K, Choyke P, Kobayashi H (2013) Dual targeted photoimmunotherapy can synergistically enhance the therapeutic effects. Theranostics 3:357-65|4. Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H (2012). Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Cancer Res  72, 4622-8.   https://doi.org/10.1158/0008-5472.CAN-12-1298|5. Sano K, Nakajima T, Choyke PL, Kobayashi H (2013). Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano  7, 717-24.   https://doi.org/10.1021/nn305011p",https://intramural.nih.gov/search/searchview.taf?ipid=83049
600,BC011514-01,"October 01, 2012 -  September 30, 2013",Investigating the biology of pediatric gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Nada  Jabado (McGill University)|Javad  Nazarian (Children's National Medical Center)|Eric H Raabe,"Leomar Y Ballester; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83047
601,BC011518-01,"October 01, 2012 -  September 30, 2013",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Tae Sung  Kim|Jin Hyup Lee|Jung Eun  Park,Jeong Kyu Bang|Raymond L Erikson|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Kunsoo  Rhee (Seoul National University),Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),Wei  Yang; PhD (NIDDK),"1. Chang J, Seo SG, Lee KH, Nagashima K, Bang JK, Kim BY, Erikson RL, Lee KW, Lee HJ, Park JE, Lee KS (2013). Essential role of Cenexin1, but not Odf2, in ciliogenesis. Cell Cycle  12, 655-62.   https://doi.org/10.4161/cc.23585",https://intramural.nih.gov/search/searchview.taf?ipid=83039
602,BC011519-01,"October 01, 2012 -  September 30, 2013",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,"1. Cooper JP, Youle RJ (2012). Balancing cell growth and death. Curr Opin Cell Biol  24, 802-3.   https://doi.org/10.1016/j.ceb.2012.11.003|2. Greenwood J, Cooper JP (2012). Non-coding telomeric and subtelomeric transcripts are differentially regulated by telomeric and heterochromatin assembly factors in fission yeast. Nucleic Acids Res  40, 2956-63.   https://doi.org/10.1093/nar/gkr1155",https://intramural.nih.gov/search/searchview.taf?ipid=83087
603,BC011520-01,"October 01, 2012 -  September 30, 2013",Phase II Trial of Cytoreductive Surgery and HIPEC for ACC,Marybeth S Hughes,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83040
604,BC011521-01,"October 01, 2012 -  September 30, 2013",Combination Studies in Prostat Cancer,Ravi  Madan|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Andrea Borghese Apolo|Philip M Arlen; MD|William Laurence Dahut; MD|William D Figg; PharmD,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Madan RA, Shah AA, Dahut WL (2013). Is it time to reevaluate definitive therapy in prostate cancer? J Natl Cancer Inst  105, 683-5.   https://doi.org/10.1093/jnci/djt094",https://intramural.nih.gov/search/searchview.taf?ipid=83050
605,BC011522-01,"October 01, 2012 -  September 30, 2013",Discovery of kinase targets in chromosome 10 deleted glioma cells,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane Marie Kambach|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Ji  Luo (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83067
606,BC011524-01,"October 01, 2012 -  September 30, 2013",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Nancy Ziyan Jiang|Yorihisa  Kotobuki; MD, PhD|Anna  Afasizheva|Benjamin Henry Blehm",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83079
607,BC011525-01,"October 01, 2012 -  September 30, 2013",Targeting DNA damage repair and related pathways in HRD-womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Nicolas M Gordon|Alyssa  Stacy|Christina M Annunziata|William D Figg; PharmD,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Brigitte  Widemann; MD (Pediatric Oncology Branch),Bradford J Wood; MD (CC),"1. Lee JM, Hays JL, Noonan AM, Squires J, Minasian L, Annunziata C, Wood BJ, Yu M, Calvo KR, Houston N, Azad N, Kohn EC (2013). Feasibility and safety of sequential research-related tumor core biopsies in clinical trials. Cancer  119, 1357-64.   https://doi.org/10.1002/cncr.27916",https://intramural.nih.gov/search/searchview.taf?ipid=83063
608,BC011526-01,"October 01, 2012 -  September 30, 2013",Therapeutic evaluation in GEM pancreatic model,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Serguei V Kozlov,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83052
609,BC011527-01,"October 01, 2012 -  September 30, 2013",Androgen Receptor in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Sam Joseph Brancato,NULL,Jane Beth Trepel (Medical Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83076
610,BC011528-01,"October 01, 2012 -  September 30, 2013","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Lambros  Stamatakis|Sam Joseph Brancato,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83077
611,BC011529-01,"October 01, 2012 -  September 30, 2013",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83070
612,BC011530-01,"October 01, 2012 -  September 30, 2013",Investigate the role of EGFR mutation and amplification in GBM tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83051
613,CO020003-05,"October 01, 2012 -  September 30, 2013",Office of Cancer Genomics,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Daniela S Gerhard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78948
614,CP000101-09,"October 01, 2012 -  September 30, 2013",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch)|Blossom  Patterson (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78990
615,CP000112-09,"October 01, 2012 -  September 30, 2013",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Guo-Qing  Wang (CICAMS)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",NULL,NULL,"1. Li WQ, Hu N, Hyland PL, Gao Y, Wang ZM, Yu K, Su H, Wang CY, Wang LM, Chanock SJ, Burdett L, Ding T, Qiao YL, Fan JH, Wang Y, Xu Y, Shi JX, Gu F, Wheeler W, Xiong XQ, Giffen C, Tucker MA, Dawsey SM, Freedman ND, Abnet CC, et al. [2 more authors] (2013). Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population. Carcinogenesis  34, 1536-42.   https://doi.org/10.1093/carcin/bgt094|2. Lin SW, Chen W, Fan JH, Dawsey SM, Taylor PR, Qiao YL, Abnet CC (2012). Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol  176, 1043-50.   https://doi.org/10.1093/aje/kws285",https://intramural.nih.gov/search/searchview.taf?ipid=78989
616,CP000176-09,"October 01, 2012 -  September 30, 2013",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wendy  Wang (NCI/DCP),Ping  Hu; MS (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78991
617,CP000185-09,"October 01, 2012 -  September 30, 2013",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Show all 12",NULL,NULL,"1. Boffetta P, Islami F, Vedanthan R, Pourshams A, Kamangar F, Khademi H, Etemadi A, Salahi R, Semnani S, Emadi A, Abnet CC, Brennan P, Pharoah PD, Dawsey SM, Malekzadeh R (2013). A U-shaped relationship between haematocrit and mortality in a large prospective cohort study. Int J Epidemiol  42, 601-15.   https://doi.org/10.1093/ije/dyt013|2. Boreiri M, Samadi F, Etemadi A, Babaei M, Ahmadi E, Sharifi AH, Nikmanesh A, Houshiar A, Pourfarzai F, Yazdanbod A, Alimohammadian M, Sotoudeh M (2013). Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Arch Iran Med  16, 343-7.   https://doi.org/013166/AIM.007|3. Dar NA, Islami F, Bhat GA, Shah IA, Makhdoomi MA, Iqbal B, Rafiq R, Lone MM, Abnet CC, Boffetta P (2013). Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir. Br J Cancer  109, 1367-72.   https://doi.org/10.1038/bjc.2013.437|4. Etemadi A, Islami F, Phillips DH, Godschalk R, Golozar A, Kamangar F, Malekshah AF, Pourshams A, Elahi S, Ghojaghi F, Strickland PT, Taylor PR, Boffetta P, Abnet CC, Dawsey SM, Malekzadeh R, van Schooten FJ (2013). Variation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotype. Int J Cancer  132, 2738-47.   https://doi.org/10.1002/ijc.27953|5. Islami F, Cao Y, Kamangar F, Nasrollahzadeh D, Marjani HA, Shakeri R, Fahimi S, Sotoudeh M, Dawsey SM, Abnet CC, Boffetta P, Malekzadeh R (2013). Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case-control study in a high-risk area and literature review. Eur J Cancer Prev  22, 461-6.   https://doi.org/10.1097/CEJ.0b013e32835c7f87|6. Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, Abaie B, Islami F, Nasseri-Moghaddam S, Etemadi A, Byrnes G, Abnet CC, Dawsey SM, Day NE, Pharoah PD, Boffetta P, Brennan P, Kamangar F (2012). Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ  344, e2502.   https://doi.org/10.1136/bmj.e2502|7. Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, Pourshams A, Poustchi H, Navabakhsh B, Naemi M, Pharoah PD, Abnet CC, Brennan P, Boffetta P, Dawsey SM, Esteghamati A, Malekzadeh R (2013). Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens  31, 1364-71; discussion 1371.   https://doi.org/10.1097/HJH.0b013e3283613053|8. Nieminen MT, Novak-Frazer L, Collins R, Dawsey SP, Dawsey SM, Abnet CC, White RE, Freedman ND, Mwachiro M, Bowyer P, Salaspuro M, Rautemaa R (2013). Alcohol and acetaldehyde in African fermented milk mursik--a possible etiologic factor for high incidence of esophageal cancer in western Kenya. Cancer Epidemiol Biomarkers Prev  22, 69-75.   https://doi.org/10.1158/1055-9965.EPI-12-0908|9. Roshandel G, Semnani S, Malekzadeh R, Dawsey SM (2012). Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med  15, 713-22.   https://doi.org/0121511/AIM.0013|10. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Abedi-Ardekani B, Khoshnia M, Islami F, Pourshams A, Pawlita M, Boffetta P, Dawsey SM, Kamangar F, Abnet CC (2013). Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. Cancer Prev Res (Phila)  6, 477-82.   https://doi.org/10.1158/1940-6207.CAPR-12-0491|11. Wang JB, Fan JH, Liang H, Li J, Xiao HJ, Wei WQ, Dawsey SM, Qiao YL, Boffetta P (2012). Attributable causes of esophageal cancer incidence and mortality in China. PLoS One  7, e42281.   https://doi.org/10.1371/journal.pone.0042281",https://intramural.nih.gov/search/searchview.taf?ipid=78992
618,CP004410-37,"October 01, 2012 -  September 30, 2013",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,"Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (Dermatology Branch)","Jeffery P Struewing; MS, MD (NHGRI)","1. Caporaso NE (2013). Why precursors matter. Cancer Epidemiol Biomarkers Prev  22, 518-20.   https://doi.org/10.1158/1055-9965.EPI-13-0135|2. Goldin LR, McMaster ML, Caporaso NE (2013). Precursors to lymphoproliferative malignancies. Cancer Epidemiol Biomarkers Prev  22, 533-9.   https://doi.org/10.1158/1055-9965.EPI-12-1348|3. Goldstein AM, Tucker MA (2013). Dysplastic nevi and melanoma. Cancer Epidemiol Biomarkers Prev  22, 528-32.   https://doi.org/10.1158/1055-9965.EPI-12-1346|4. Iles MM, Law MH, Stacey SN, Han J, Fang S, Pfeiffer R, Harland M, Macgregor S, Taylor JC, Aben KK, Akslen LA, Avril MF, Azizi E, Bakker B, Benediktsdottir KR, Bergman W, Scarrà GB, Brown KM, Calista D, Chaudru V, Fargnoli MC, Cust AE, Demenais F, de Waal AC, Dębniak T, GenoMEL Consortium, Q-MEGA and AMFS Investigators, et al. [65 more authors] (2013). A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet  45, 428-32, 432e1.   https://doi.org/10.1038/ng.2571|5. Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu HH, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, et al. [8 more authors] (2013). Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet  50, 264-70.   https://doi.org/10.1136/jmedgenet-2012-101455",https://intramural.nih.gov/search/searchview.taf?ipid=78964
619,CP005782-19,"October 01, 2012 -  September 30, 2013",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Nutritional Epidemiology Branch),Barbara  Rehermann; MD (NIDDK) |Raymond  Donnelly (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78963
620,CP005803-19,"October 01, 2012 -  September 30, 2013",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD|Dilys  Parry; PhD|Thomas  Fears; PhD|Jorge R Toro,"Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|Naoko  Ishibe; ScD (Clinical & Translational Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)","David  Ng; AB, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78962
621,CP005804-19,"October 01, 2012 -  September 30, 2013",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Andrea  Baccarelli|Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Office of the Director)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. Gu F, Caporaso NE, Schairer C, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG (2013). Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev  22, 58-68.   https://doi.org/10.1158/1055-9965.EPI-12-0909",https://intramural.nih.gov/search/searchview.taf?ipid=78961
622,CP010119-18,"October 01, 2012 -  September 30, 2013",Studies of Occupational Cancer (Pesticides),"Laura Elizabeth Beane Freeman|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Gabriella  Andreotti|Stella  Koutros|Jonathan Nicholas Hofmann|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Dalsu  Baris|Show all 7",Lisbeth  LopezCarrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center),"Jay  Lubin; PhD (Biostatistics Branch)|Ola Anders Landgren (Medical Oncology Branch)|Shelia K Zahm; ScM, ScD (Office of the Director)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Hou L, Andreotti G, Baccarelli AA, Savage S, Hoppin JA, Sandler DP, Barker J, Zhu ZZ, Hoxha M, Dioni L, Zhang X, Koutros S, Freeman LE, Alavanja MC (2013). Lifetime pesticide use and telomere shortening among male pesticide applicators in the Agricultural Health Study. Environ Health Perspect  121, 919-24.   https://doi.org/10.1289/ehp.1206432|2. Karami S, Andreotti G, Koutros S, Barry KH, Moore LE, Han S, Hoppin JA, Sandler DP, Lubin JH, Burdette LA, Yuenger J, Yeager M, Freeman LE, Blair A, Alavanja MC (2013). Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer. Cancer Epidemiol Biomarkers Prev  22, 1557-66.   https://doi.org/10.1158/1055-9965.EPI-12-1454|3. Koutros S, Beane Freeman LE, Lubin JH, Heltshe SL, Andreotti G, Barry KH, DellaValle CT, Hoppin JA, Sandler DP, Lynch CF, Blair A, Alavanja MC (2013). Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study. Am J Epidemiol  177, 59-74.   https://doi.org/10.1093/aje/kws225",https://intramural.nih.gov/search/searchview.taf?ipid=78956
623,CP010120-18,"October 01, 2012 -  September 30, 2013",Studies of Occupational Cancer,"Michael  Alavanja; PhD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Show all 13",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)","Dale  Sandler; PhD (NIEHS) |Jane  Hoppin; ScD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Hu W, Bassig BA, Xu J, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD, Leaderer B, Yeager M, Menashe I, Boyle P, Zou K, Zhu Y, Chanock S, Lan Q, Rothman N (2013). Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma. Environ Mol Mutagen  54, 72-7.   https://doi.org/10.1002/em.21739",https://intramural.nih.gov/search/searchview.taf?ipid=78958
624,CP010121-18,"October 01, 2012 -  September 30, 2013",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Mustafa  Dosemeci; PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Show all 15","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13","Shelia K Zahm; ScM, ScD (Office of the Director)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, Kogevinas M, Lloreta J, Rothman N, Carrato A, Rivas del Fresno M, Real FX, Malats N, Spanish Bladder Cancer/EPICURO Study investigators (2012). Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst  104, 1897-904.   https://doi.org/10.1093/jnci/djs444|2. Barone-Adesi F, Chapman RS, Silverman DT, He X, Hu W, Vermeulen R, Ning B, Fraumeni JF, Rothman N, Lan Q (2012). Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ  345, e5414.   https://doi.org/10.1136/bmj.e5414|3. Bassig BA, Zhang L, Tang X, Vermeulen R, Shen M, Smith MT, Qiu C, Ge Y, Ji Z, Reiss B, Hosgood HD, Liu S, Bagni R, Guo W, Purdue M, Hu W, Yue F, Li L, Huang H, Rothman N, Lan Q (2013). Occupational exposure to trichloroethylene and serum concentrations of IL-6, IL-10, and TNF-alpha. Environ Mol Mutagen  54, 450-4.   https://doi.org/10.1002/em.21789|4. Zhang L, Bassig BA, Mora JL, Vermeulen R, Ge Y, Curry JD, Hu W, Shen M, Qiu C, Ji Z, Reiss B, McHale CM, Liu S, Guo W, Purdue MP, Yue F, Li L, Smith MT, Huang H, Tang X, Rothman N, Lan Q (2013). Alterations in serum immunoglobulin levels in workers occupationally exposed to trichloroethylene. Carcinogenesis  34, 799-802.   https://doi.org/10.1093/carcin/bgs403",https://intramural.nih.gov/search/searchview.taf?ipid=78959
625,CP010122-18,"October 01, 2012 -  September 30, 2013",Occupational Exposure Assessment,Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Joanne S Colt|Show all 19",Tye  Arbuckle (Health Canada)|Susan  Shortreed (McGill University)|Berit  Bakke (National Institute of Occupational Health)|Igor  Burstyn (Drexel University)|Paolo  Boffetta (International Agency for Research on Cancer)|Jerome  Lavoue (University of Montreal)|Show all 59,Nilanjan  Chatterjee (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Jay  Lubin; PhD (Biostatistics Branch)|Preetha  Rajaraman (Center For Global Health),NULL,"1. Wheeler DC, Burstyn I, Vermeulen R, Yu K, Shortreed SM, Pronk A, Stewart PA, Colt JS, Baris D, Karagas MR, Schwenn M, Johnson A, Silverman DT, Friesen MC (2013). Inside the black box: starting to uncover the underlying decision rules used in a one-by-one expert assessment of occupational exposure in case-control studies. Occup Environ Med  70, 203-10.   https://doi.org/10.1136/oemed-2012-100918",https://intramural.nih.gov/search/searchview.taf?ipid=78957
626,CP010123-18,"October 01, 2012 -  September 30, 2013",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| | |Melissa Charmaine Friesen|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt|Nicole Cardello Deziel",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Shelia K Zahm; ScM, ScD (Office of the Director)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Lan Q, Cawthon R, Gao Y, Hu W, Hosgood HD, Barone-Adesi F, Ji BT, Bassig B, Chow WH, Shu X, Cai Q, Xiang Y, Berndt S, Kim C, Chanock S, Zheng W, Rothman N (2013). Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One  8, e59230.   https://doi.org/10.1371/journal.pone.0059230|2. Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q, Xiang YB, Li C, Ji BT, Zheng Y, Ali S, Shu XO, Zheng W (2013). A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst  105, 573-9.   https://doi.org/10.1093/jnci/djt018|3. Wu SH, Shu XO, Chow WH, Xiang YB, Zhang X, Cai Q, Li HL, Milne G, Wen W, Ji BT, Rothman N, Gao YT, Zheng W, Yang G (2013). Adiposity and fat distribution in relation to inflammation and oxidative stress in a relatively lean population of Chinese women. Dis Markers  34, 279-93.   https://doi.org/10.3233/DMA-130969|4. Zhang X, Gao YT, Yang G, Li H, Cai Q, Xiang YB, Ji BT, Franke AA, Zheng W, Shu XO (2012). Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol  41, 1367-75.   https://doi.org/10.1093/ije/dys130|5. Zhang X, Shu XO, Li H, Yang G, Xiang YB, Cai Q, Ji BT, Gao YT, Zheng W (2013). Visceral adiposity and risk of coronary heart disease in relatively lean Chinese adults. Int J Cardiol  168, 2141-5.   https://doi.org/10.1016/j.ijcard.2013.01.275",https://intramural.nih.gov/search/searchview.taf?ipid=78960
627,CP010124-18,"October 01, 2012 -  September 30, 2013",Cervical cancer and human papillomavirus (HPV) infection,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD|Vikrant Vasant Sahasrabuddhe|Hannah  Yang,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Sholom  Wacholder; PhD (Biostatistics Branch)|Julia  Gage (Clinical Genetics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)|Joshua Neil Sampson (Biostatistics Branch)|Patricia  Luhn (Cancer Prevention Fellowship Program),NULL,"1. Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere B, Gage JC, Fetterman B, Darragh TM, Rodriguez AC, Wentzensen N (2013). A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. Cancer Epidemiol Biomarkers Prev  22, 42-9.   https://doi.org/10.1158/1055-9965.EPI-12-0984|2. Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, LaMere BJ, Schwartz L, Gage JC, Fetterman B, Lorey T, Wentzensen N (2013). Interrater agreement of anal cytology. Cancer Cytopathol  121, 72-8.   https://doi.org/10.1002/cncy.21218|3. Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2013). Cervical histopathology variability among laboratories: a population-based statewide investigation. Am J Clin Pathol  139, 330-5.   https://doi.org/10.1309/AJCPSD3ZXJXP7NNB|4. Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N (2013). Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiol Biomarkers Prev  22, 1095-101.   https://doi.org/10.1158/1055-9965.EPI-12-1455|5. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, et al. [12 more authors] (2013). TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A  110, 6021-6.   https://doi.org/10.1073/pnas.1303607110|6. Lahrmann B, Valous NA, Eisenmann U, Wentzensen N, Grabe N (2013). Semantic focusing allows fully automated single-layer slide scanning of cervical cytology slides. PLoS One  8, e61441.   https://doi.org/10.1371/journal.pone.0061441|7. Luhn P, Houldsworth J, Cahill L, Schiffman M, Castle PE, Zuna RE, Dunn ST, Gold MA, Walker J, Wentzensen N (2013). Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol  130, 595-600.   https://doi.org/10.1016/j.ygyno.2013.06.005|8. Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N (2013). The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol  128, 265-70.   https://doi.org/10.1016/j.ygyno.2012.11.003|9. Luhn P, Wentzensen N (2013). HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease. Curr Obstet Gynecol Rep  2, 76-85.   https://doi.org/10.1007/s13669-013-0040-0|10. Mathews CA, Stoner JA, Wentzensen N, Moxley KM, Tenney ME, Tuller ER, Myers T, Landrum LM, Lanneau G, Zuna RE, Gold MA, Wang SS, Walker JL (2012). Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol  127, 278-82.   https://doi.org/10.1016/j.ygyno.2012.07.119|11. Wentzensen N (2013). Triage of HPV-positive women in cervical cancer screening. Lancet Oncol  14, 107-9.   https://doi.org/10.1016/S1470-2045(12)70568-5|12. Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2013). Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer  133, 2172-81.   https://doi.org/10.1002/ijc.28215",https://intramural.nih.gov/search/searchview.taf?ipid=78952
628,CP010125-18,"October 01, 2012 -  September 30, 2013",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Debra  Silverman; ScD, ScM|Michael  Alavanja; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Show all 12",James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John  Reif (Colorado State University)|John W Brock (CDC)|Show all 27,"Shelia K Zahm; ScM, ScD (Office of the Director)|Jay  Lubin; PhD (Biostatistics Branch)",NULL,"1. Dellavalle CT, Daniel CR, Aschebrook-Kilfoy B, Hollenbeck AR, Cross AJ, Sinha R, Ward MH (2013). Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer  108, 205-12.   https://doi.org/10.1038/bjc.2012.522|2. Deziel NC, Ward MH, Bell EM, Whitehead TP, Gunier RB, Friesen MC, Nuckols JR (2013). Temporal variability of pesticide concentrations in homes and implications for attenuation bias in epidemiologic studies. Environ Health Perspect  121, 565-71.   https://doi.org/10.1289/ehp.1205811|3. Friesen MC, Pronk A, Wheeler DC, Chen YC, Locke SJ, Zaebst DD, Schwenn M, Johnson A, Waddell R, Baris D, Colt JS, Silverman DT, Stewart PA, Katki HA (2013). Comparison of algorithm-based estimates of occupational diesel exhaust exposure to those of multiple independent raters in a population-based case-control study. Ann Occup Hyg  57, 470-81.   https://doi.org/10.1093/annhyg/mes082|4. Guha N, Ward MH, Gunier R, Colt JS, Lea CS, Buffler PA, Metayer C (2013). Characterization of residential pesticide use and chemical formulations through self-report and household inventory: the Northern California Childhood Leukemia study. Environ Health Perspect  121, 276-82.   https://doi.org/10.1289/ehp.1204926|5. Koutros S, Baris D, Fischer A, Tang W, Garcia-Closas M, Karagas MR, Schwenn M, Johnson A, Figueroa J, Waddell R, Prokunina-Olsson L, Rothman N, Silverman DT (2013). Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer  133, 3008-13.   https://doi.org/10.1002/ijc.28325|6. Metayer C, Colt JS, Buffler PA, Reed HD, Selvin S, Crouse V, Ward MH (2013). Exposure to herbicides in house dust and risk of childhood acute lymphoblastic leukemia. J Expo Sci Environ Epidemiol  23, 363-70.   https://doi.org/10.1038/jes.2012.115|7. Whitehead TP, Ward MH, Colt JS, Nishioka MG, Buffler PA, Rappaport SM, Metayer C (2013). Determinants of polychlorinated biphenyls in dust from homes in California, USA. Environ Sci Process Impacts  15, 339-46.   https://doi.org/10.1039/c2em30721a",https://intramural.nih.gov/search/searchview.taf?ipid=78965
629,CP010126-18,"October 01, 2012 -  September 30, 2013",Hormone-Related Cancers,Michael Blaise Cook|IRP Faculty Profile  |Jonine Danya Figueroa| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD|Roni T Falk|Britton Lindsay Trabert|Hannah  Yang|Barbara J Fuhrman|Sarah Jane Nyante,David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA (2013). Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause  20, 354-8.   https://doi.org/10.1097/GME.0b013e318268ca46|2. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, et al. [420 more authors] (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45:371-84, 384e1-2|3. Brinton LA, Felix AS (2014). Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol  142, 83-9.   https://doi.org/10.1016/j.jsbmb.2013.05.001|4. Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R (2013). Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol  129, 277-84.   https://doi.org/10.1016/j.ygyno.2013.02.023|5. Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Ovarian Cancer Association Consortium, et al. [33 more authors] (2013). Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control  24, 989-1004.   https://doi.org/10.1007/s10552-013-0174-4|6. Falk RT, Brinton LA, Dorgan JF, Fuhrman BJ, Veenstra TD, Xu X, Gierach GL (2013). Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res  15, R34.   https://doi.org/10.1186/bcr3416|7. Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME (2013). Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst  105, 166-74.   https://doi.org/10.1093/jnci/djs505|8. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, Tyrer J, Maia AT, Beck A, Knoblauch NW, Chen C, Kraft P, Barnes D, González-Neira A, Alonso MR, Herrero D, GENICA Network, kConFab Investigators, et al. [186 more authors] (2013). Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet  92, 489-503.   https://doi.org/10.1016/j.ajhg.2013.01.002|9. Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012). Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst  104, 1218-27.   https://doi.org/10.1093/jnci/djs327|10. Goode EL, DeRycke M, Kalli KR, Oberg AL, Cunningham JM, Maurer MJ, Fridley BL, Armasu SM, Serie DJ, Ramar P, Goergen K, Vierkant RA, Rider DN, Sicotte H, Wang C, Winterhoff B, Phelan CM, Schildkraut JM, Weber RP, Iversen E, Berchuck A, Sutphen R, Birrer MJ, Hampras S, Preus L, et al. [16 more authors] (2013). Inherited variants in regulatory T cell genes and outcome of ovarian cancer. PLoS One  8, e53903.   https://doi.org/10.1371/journal.pone.0053903|11. Jamshidi M, Schmidt MK, Dörk T, Garcia-Closas M, Heikkinen T, Cornelissen S, van den Broek AJ, Schürmann P, Meyer A, Park-Simon TW, Figueroa J, Sherman M, Lissowska J, Keong GT, Irwanto A, Laakso M, Hautaniemi S, Aittomäki K, Blomqvist C, Liu J, Nevanlinna H (2013). Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome. Int J Cancer  132, 2044-55.   https://doi.org/10.1002/ijc.27884|12. Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Köbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Høgdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Australian Ovarian Cancer Study Group and Australian Cancer Study (Ovarian Cancer), Ovarian Cancer Association Consortium, et al. [5 more authors] (2013). Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium. BMC Cancer  13, 28.   https://doi.org/10.1186/1471-2407-13-28|13. Larson NB, Jenkins GD, Larson MC, Vierkant RA, Sellers TA, Phelan CM, Schildkraut JM, Sutphen R, Pharoah PP, Gayther SA, Wentzensen N, Ovarian Cancer Association Consortium, Goode EL, Fridley BL (2014). Kernel canonical correlation analysis for assessing gene-gene interactions and application to ovarian cancer. Eur J Hum Genet  22, 126-31.   https://doi.org/10.1038/ejhg.2013.69|14. Li J, Foo JN, Schoof N, Varghese JS, Fernandez-Navarro P, Gierach GL, Quek ST, Hartman M, Nord S, Kristensen VN, Pollán M, Figueroa JD, Thompson DJ, Li Y, Khor CC, Humphreys K, Liu J, Czene K, Hall P (2013). Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size. J Med Genet  50, 666-73.   https://doi.org/10.1136/jmedgenet-2013-101708|15. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Peto J, Genica Network, kConFab, AOCS Management Group, et al. [67 more authors] (2013). Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet  9, e1003284.   https://doi.org/10.1371/journal.pgen.1003284|16. Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Ovarian Cancer Association Consortium, et al. [23 more authors] (2013). Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer  20, 251-62.   https://doi.org/10.1530/ERC-12-0395|17. Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, for Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber RP, Ziogas A, Anton-Culver H, Ovarian Cancer Association Consortium, et al. [26 more authors] (2013). Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev  22, 880-90.   https://doi.org/10.1158/1055-9965.EPI-12-1030-T|18. Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM, Australian Cancer Study, Australian Ovarian Cancer Study, Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Consortium of Investigators of Modifiers of BRCA1/2, et al. [153 more authors] (2013). Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun  4, 1627.   https://doi.org/10.1038/ncomms2613|19. Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J, Dicks E, Australian Cancer Study, Australian Ovarian Cancer Study Group, Aben KK, Anton-Culver H, Antonenkova N, Armasu SM, Baglietto L, et al. [143 more authors] (2013). GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet  45, 362-70, 370e1-2.   https://doi.org/10.1038/ng.2564|20. Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS (2012). ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control  23, 1805-10.   https://doi.org/10.1007/s10552-012-0059-y|21. Poole EM, Merritt MA, Jordan SJ, Yang HP, Hankinson SE, Park Y, Rosner B, Webb PM, Cramer DW, Wentzensen N, Terry KL, Tworoger SS (2013). Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev  22, 429-37.   https://doi.org/10.1158/1055-9965.EPI-12-1183-T|22. Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC (2012) Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat 135:571-80|23. Rudolph A, Hein R, Lindström S, Beckmann L, Behrens S, Liu J, Aschard H, Bolla MK, Wang J, Truong T, Cordina-Duverger E, Menegaux F, Brüning T, Harth V, GENICA Network, Severi G, Baglietto L, Southey M, Chanock SJ, Lissowska J, Figueroa JD, Eriksson M, Humpreys K, Darabi H, Olson JE, Stevens KN, kConFab Investigators, AOCS Management Group, Breast Cancer Association Consortium, et al. [24 more authors] (2013). Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer  20, 875-87.   https://doi.org/10.1530/ERC-13-0349|24. Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries (GEKID) (2013). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol  37, 370-3.   https://doi.org/10.1016/j.canep.2013.04.003|25. Sak M, Duric N, Littrup P, Li C, Bey-Knight L, Sherman M, Boyd N, Gierach G (2013). Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment. Proc SPIE Int Soc Opt Eng  8675, 86751E.   https://doi.org/10.1117/12.2007146|26. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Australian National Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, et al. [36 more authors] (2013). Type I and II endometrial cancers: have they different risk factors? J Clin Oncol  31, 2607-18.   https://doi.org/10.1200/JCO.2012.48.2596|27. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Australian Ovarian Cancer Study Group, Australian Cancer Study, et al. [143 more authors] (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun  4, 1628.   https://doi.org/10.1038/ncomms2629|28. Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, Australian Breast Cancer Tissue Bank Investigators, Baglietto L, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H, Brinton L, Bui QM, Buring JE, Buys SS, Familial Breast Cancer Study, GENICA Consortium, et al. [115 more authors] (2012). A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet  21, 5373-84.   https://doi.org/10.1093/hmg/dds381|29. Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, et al. [42 more authors] (2013). Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol  14, 853-62.   https://doi.org/10.1016/S1470-2045(13)70253-5|30. Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group (2013). Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol  37, 492-7.   https://doi.org/10.1016/j.canep.2013.03.017|31. Trabert B, Graubard BI, Erickson RL, Zhang Y, McGlynn KA (2013). Second to fourth digit ratio, handedness and testicular germ cell tumors. Early Hum Dev  89, 463-6.   https://doi.org/10.1016/j.earlhumdev.2013.04.001|32. Trabert B, Graubard BI, Nyante SJ, Rifai N, Bradwin G, Platz EA, McQuillan GM, McGlynn KA (2012). Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control  23, 1881-91.   https://doi.org/10.1007/s10552-012-0024-9|33. Trabert B, Zugna D, Richiardi L, McGlynn KA, Akre O (2013). Congenital malformations and testicular germ cell tumors. Int J Cancer  133, 1900-4.   https://doi.org/10.1002/ijc.28207|34. Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Newcomb PA (2013). The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Breast Cancer Res Treat  140, 427-34.   https://doi.org/10.1007/s10549-013-2646-3|35. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B (2013). Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol  37, 374-7.   https://doi.org/10.1016/j.canep.2013.03.008|36. White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, for AOCS/ACS group;, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, Gronwald J, Culver HA, Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk J, Chang-Claude J, Bandera EV, Hogdall E, Heitz F, et al. [63 more authors] (2013). Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev  22, 987-92.   https://doi.org/10.1158/1055-9965.EPI-13-0028|37. Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2013). Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol  31, 2146-51.   https://doi.org/10.1200/JCO.2012.45.5758",https://intramural.nih.gov/search/searchview.taf?ipid=78966
630,CP010127-18,"October 01, 2012 -  September 30, 2013",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78984
631,CP010128-18,"October 01, 2012 -  September 30, 2013",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  KrugerKjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Show all 8,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Catherine G Schairer (Biostatistics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Jay  Lubin; PhD (Biostatistics Branch)|Michael Fred Leitzmann (Nutritional Epidemiology Branch)",NULL,"1. Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G (2013). In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril  99, 1189-96.   https://doi.org/10.1016/j.fertnstert.2012.12.029|2. Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV, B~FIT Research Group (2013). Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer  20, 151-60.   https://doi.org/10.1530/ERC-12-0229|3. Hargreave M, Jensen A, Deltour I, Brinton LA, Andersen KK, Kjaer SK (2013). Increased risk for cancer among offspring of women with fertility problems. Int J Cancer  133, 1180-6.   https://doi.org/10.1002/ijc.28110",https://intramural.nih.gov/search/searchview.taf?ipid=78967
632,CP010131-18,"October 01, 2012 -  September 30, 2013",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 13",David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, Rajaraman P, Little MP (2013). Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys  86, 224-33.   https://doi.org/10.1016/j.ijrobp.2012.09.001|2. Berrington de Gonzalez A, Kutsenko A, Rajaraman P (2012). Sarcoma risk after radiation exposure. Clin Sarcoma Res  2, 18.   https://doi.org/10.1186/2045-3329-2-18|3. Boukheris H, Stovall M, Gilbert ES, Stratton KL, Smith SA, Weathers R, Hammond S, Mertens AC, Donaldson SS, Armstrong GT, Robison LL, Neglia JP, Inskip PD (2013). Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys  85, 776-83.   https://doi.org/10.1016/j.ijrobp.2012.06.006|4. Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA (2013). The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control  24, 55-60.   https://doi.org/10.1007/s10552-012-0089-5|5. Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, Mertens A, Meadows A, Neglia JP, Hammond S, Whitton J, Inskip PD, Robison LL, Diller L (2012). Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys  84, 224-30.   https://doi.org/10.1016/j.ijrobp.2011.11.022|6. Kleinerman R, Yu C, Little M, Li Y, Abramson D, Seddon J, Tucker M (2012) Reply to A Moll, et al. Journal of Cancer Oncology 30:3028-3034|7. Kleinerman RA, Schonfeld SJ, Tucker MA (2012). Sarcomas in hereditary retinoblastoma. Clin Sarcoma Res  2, 15.   https://doi.org/10.1186/2045-3329-2-15|8. Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE (2013). Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer. Int J Radiat Oncol Biol Phys  86, 922-9.   https://doi.org/10.1016/j.ijrobp.2013.04.010|9. Little MP, Kleinerman RA, Stovall M, Smith SA, Mabuchi K (2012). Analysis of dose response for circulatory disease after radiotherapy for benign disease. Int J Radiat Oncol Biol Phys  84, 1101-9.   https://doi.org/10.1016/j.ijrobp.2012.01.053|10. Little MP, Stovall M, Smith SA, Kleinerman RA (2013). A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiation therapy for benign disease. Int J Radiat Oncol Biol Phys  85, 451-9.   https://doi.org/10.1016/j.ijrobp.2012.04.029|11. Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, et al. [3 more authors] (2012). Risk of treatment-related esophageal cancer among breast cancer survivors. Ann Oncol  23, 3081-91.   https://doi.org/10.1093/annonc/mds144|12. Sakata R, Kleinerman RA, Mabuchi K, Stovall M, Smith SA, Weathers R, Wactawski-Wende J, Cookfair DL, Boice JD, Inskip PD (2012). Cancer mortality following radiotherapy for benign gynecologic disorders. Radiat Res  178, 266-79.   https://doi.org/10.1667/rr2845.1|13. Schonfeld SJ, Curtis RE, Anderson WF, Berrington de González A (2012). The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status. Cancer Causes Control  23, 1721-8.   https://doi.org/10.1007/s10552-012-0054-3|14. Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, Stovall M, Leisenring W, Robison LL, Mertens AC (2012). Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst  104, 1240-50.   https://doi.org/10.1093/jnci/djs298|15. Wu LC, Kleinerman RA, Curtis RE, Savage SA, de González AB (2012). Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type. Cancer Epidemiol Biomarkers Prev  21, 1993-9.   https://doi.org/10.1158/1055-9965.EPI-12-0810",https://intramural.nih.gov/search/searchview.taf?ipid=78968
633,CP010132-18,"October 01, 2012 -  September 30, 2013",Studies of Populations Exposed to Environmental Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Steven L Simon|Alina V Brenner|Maureen Cusack Hatch; MD|Daryl  Freedman|Alice  Sigurdson; PhD|Amy  de Gonzalez,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Abend M, Pfeiffer R, Ruf C, Hatch M, Bogdanova T, Tronko M, Riecke A, Hartmann J, Meineke V, Boukheris H, Sigurdson A, Mabuchi K, Brenner A (2012) Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident. PLoS One 7:e39103|2. Abend M, Pfeiffer RM, Ruf C, Hatch M, Bogdanova TI, Tronko MD, Riecke A, Hartmann J, Meineke V, Boukheris H, Sigurdson AJ, Mabuchi K, Brenner AV (2012). Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident. PLoS One  7, e39103.   https://doi.org/10.1371/journal.pone.0039103|3. Braganza MZ, Kitahara CM, Berrington de González A, Inskip PD, Johnson KJ, Rajaraman P (2012). Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol  14, 1316-24.   https://doi.org/10.1093/neuonc/nos208|4. Cahoon EK, Rozhko A, Hatch M, Polyanskaya O, Ostroumova E, Tang M, Nadirov E, Yauseyenka V, Savasteeva I, McConnell RJ, Pfeiffer RM, Brenner AV (2013). Factors associated with serum thyroglobulin levels in a population living in Belarus. Clin Endocrinol (Oxf)  79, 120-7.   https://doi.org/10.1111/cen.12107|5. Kitahara CM, Wang SS, Melin BS, Wang Z, Braganza M, Inskip PD, Albanes D, Andersson U, Beane Freeman LE, Buring JE, Carreón T, Feychting M, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Henriksson R, Hsing AW, Johansen C, Linet MS, McKean-Cowdin R, Michaud DS, Peters U, Purdue MP, et al. [19 more authors] (2012). Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol  41, 1075-85.   https://doi.org/10.1093/ije/dys114|6. Lee C, Lamart S, Moroz B (2013) EVALUATION OF THE USE OF SURROGATE TISSUES FOR CALCULATING RADIATION DOSE TO LYMPHATIC NODES FROM EXTERNAL PHOTON BEAMS. Radiation Protection Dosimetry epub:1-10|7. Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, Mabuchi K, Tronko MD, Nikiforov YE (2013). RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer  119, 1792-9.   https://doi.org/10.1002/cncr.27893|8. Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, Nadyrov E, Petrenko S, Romanov G, Yauseyenka V, Drozdovitch V, Minenko V, Prokopovich A, Savasteeva I, Zablotska LB, Mabuchi K, Brenner AV (2013). Measures of thyroid function among Belarusian children and adolescents exposed to iodine-131 from the accident at the Chernobyl nuclear plant. Environ Health Perspect  121, 865-71.   https://doi.org/10.1289/ehp.1205783",https://intramural.nih.gov/search/searchview.taf?ipid=78953
634,CP010133-18,"October 01, 2012 -  September 30, 2013",Studies of Populations Exposed to Occupational Sources of Radiation,"Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Peter D Inskip; ScD|Alice  Sigurdson; PhD|Steven L Simon|Show all 8,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Aschebrook-Kilfoy B, Neta G, Brenner AV, Hutchinson A, Pfeiffer RM, Sturgis EM, Xu L, Wheeler W, Doody MM, Chanock SJ, Sigurdson AJ (2012). Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer. Endocr Relat Cancer  19, 333-44.   https://doi.org/10.1530/ERC-11-0372|2. Brenner AV, Neta G, Sturgis EM, Pfeiffer RM, Hutchinson A, Yeager M, Xu L, Zhou C, Wheeler W, Tucker MA, Chanock SJ, Sigurdson AJ (2013). Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer. PLoS One  8, e57243.   https://doi.org/10.1371/journal.pone.0057243|3. Freedman DM, Cahoon EK, Rajaraman P, Major JM, Doody MM, Alexander BH, Hoffbeck RW, Kimlin MG, Graubard BI, Linet MS (2013). Sunlight and other determinants of circulating 25-hydroxyvitamin D levels in black and white participants in a nationwide U.S. study. Am J Epidemiol  177, 180-92.   https://doi.org/10.1093/aje/kws223|4. Gilbert ES, Sokolnikov ME, Preston DL, Schonfeld SJ, Schadilov AE, Vasilenko EK, Koshurnikova NA (2013). Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort. Radiat Res  179, 332-42.   https://doi.org/10.1667/RR3054.1|5. Kitahara CM, Neta G, Pfeiffer RM, Kwon D, Xu L, Freedman ND, Hutchinson AA, Chanock SJ, Sturgis EM, Sigurdson AJ, Brenner AV (2012). Common obesity-related genetic variants and papillary thyroid cancer risk. Cancer Epidemiol Biomarkers Prev  21, 2268-71.   https://doi.org/10.1158/1055-9965.EPI-12-0790|6. Major JM, Graubard BI, Dodd KW, Iwan A, Alexander BH, Linet MS, Freedman DM (2013). Variability and reproducibility of circulating vitamin D in a nationwide U.S. population. J Clin Endocrinol Metab  98, 97-104.   https://doi.org/10.1210/jc.2012-2643|7. Neta G, Rajaraman P, Berrington de Gonzalez A, Doody MM, Alexander BH, Preston D, Simon SL, Melo D, Miller J, Freedman DM, Linet MS, Sigurdson AJ (2013). A prospective study of medical diagnostic radiography and risk of thyroid cancer. Am J Epidemiol  177, 800-9.   https://doi.org/10.1093/aje/kws315|8. Rahu K, Auvinen A, Hakulinen T, Tekkel M, Inskip PD, Bromet EJ, Boice JD, Rahu M (2013). Chernobyl cleanup workers from Estonia: follow-up for cancer incidence and mortality. J Radiol Prot  33, 395-411.   https://doi.org/10.1088/0952-4746/33/2/395|9. Rahu K, Hakulinen T, Smailyte G, Stengrevics A, Auvinen A, Inskip PD, Boice JD, Rahu M (2013). Site-specific cancer risk in the Baltic cohort of Chernobyl cleanup workers, 1986-2007. Eur J Cancer  49, 2926-33.   https://doi.org/10.1016/j.ejca.2013.04.014|10. Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV (2013). An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer  119, 1393-401.   https://doi.org/10.1002/cncr.27909|11. Schonfeld SJ, Neta G, Sturgis EM, Pfeiffer RM, Hutchinson AA, Xu L, Wheeler W, Guénel P, Rajaraman P, de Vathaire F, Ron E, Tucker MA, Chanock SJ, Sigurdson AJ, Brenner AV (2012). Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid  22, 151-6.   https://doi.org/10.1089/thy.2011.0309|12. Schonfeld SJ, Tsareva YV, Preston DL, Okatenko PV, Gilbert ES, Ron E, Sokolnikov ME, Koshurnikova NA (2012). Cancer mortality following in utero exposure among offspring of female Mayak Worker Cohort members. Radiat Res  178, 160-5.   https://doi.org/10.1667/rr2848.1|13. Zablotska LB, Bazyka D, Lubin JH, Gudzenko N, Little MP, Hatch M, Finch S, Dyagil I, Reiss RF, Chumak VV, Bouville A, Drozdovitch V, Kryuchkov VP, Golovanov I, Bakhanova E, Babkina N, Lubarets T, Bebeshko V, Romanenko A, Mabuchi K (2013). Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Environ Health Perspect  121, 59-65.   https://doi.org/10.1289/ehp.1204996",https://intramural.nih.gov/search/searchview.taf?ipid=78969
635,CP010134-18,"October 01, 2012 -  September 30, 2013",Studies of Atomic Bomb Survivors,"Alina V Brenner| | |Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",NULL,"Dale  Preston (Hirosoft)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Kyoji  Furukawa; PhD|Kotaro  Ozasa (Radiation Effects Research Foundation)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Nori  Nakamwa (Radiation Effects Research Foundation)|Show all 9",NULL,NULL,"1. Egawa H, Furukawa K, Preston D, Funamoto S, Yonehara S, Matsuo T, Tokuoka S, Suyama A, Ozasa K, Kodama K, Mabuchi K (2012). Radiation and smoking effects on lung cancer incidence by histological types among atomic bomb survivors. Radiat Res  178, 191-201.   https://doi.org/10.1667/rr2819.1|2. Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, Sugiyama H, Soda M, Ozasa K, Mabuchi K (2013). Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer  132, 1222-6.   https://doi.org/10.1002/ijc.27749|3. Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, Iwanaga M, Miyazaki Y, Cullings HM, Suyama A, Ozasa K, Shore RE, Mabuchi K (2013). The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res  179, 361-82.   https://doi.org/10.1667/RR2892.1",https://intramural.nih.gov/search/searchview.taf?ipid=78994
636,CP010135-18,"October 01, 2012 -  September 30, 2013",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile  |Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Daryl  Freedman|Alice  Sigurdson; PhD|Mark Peter Little|Rochelle E Curtis,"Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Robert  Selker (Division of Neurosurgery, Western Pennsylvania Hospital)|Show all 12",Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Preetha  Rajaraman (Center For Global Health)|Gila I Neta (Office of the Director)|Susan Shaw Devesa (Biostatistics Branch),NULL,"1. Little MP, Rajaraman P, Curtis RE, Devesa SS, Inskip PD, Check DP, Linet MS (2012). Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ  344, e1147.   https://doi.org/10.1136/bmj.e1147|2. Neta G, Stewart PA, Rajaraman P, Hein MJ, Waters MA, Purdue MP, Samanic C, Coble JB, Linet MS, Inskip PD (2012). Occupational exposure to chlorinated solvents and risks of glioma and meningioma in adults. Occup Environ Med  69, 793-801.   https://doi.org/10.1136/oemed-2012-100742|3. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, et al. [45 more authors] (2012). Genome-wide association study of glioma and meta-analysis. Hum Genet  131, 1877-88.   https://doi.org/10.1007/s00439-012-1212-0",https://intramural.nih.gov/search/searchview.taf?ipid=78970
637,CP010136-18,"October 01, 2012 -  September 30, 2013",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Dalsu  Baris|Joanne S Colt|Mary Helen Ward; MS, PhD|Joseph B Coble|Claudine M Samanic|Show all 12",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)|Mark  Schiffman; MD (Clinical Genetics Branch)",NULL,"1. Chow WH, Shuch B, Linehan WM, Devesa SS (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer  119, 388-94.   https://doi.org/10.1002/cncr.27690|2. Hofmann JN, Schwartz K, Chow WH, Ruterbusch JJ, Shuch BM, Karami S, Rothman N, Wacholder S, Graubard BI, Colt JS, Purdue MP (2013). The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control  24, 167-74.   https://doi.org/10.1007/s10552-012-0102-z|3. Karami S, Daugherty SE, Schonfeld SJ, Park Y, Hollenbeck AR, Grubb RL, Hofmann JN, Chow WH, Purdue MP (2013). Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol  177, 1368-77.   https://doi.org/10.1093/aje/kws406|4. Olson SH, Hsu M, Satagopan JM, Maisonneuve P, Silverman DT, Lucenteforte E, Anderson KE, Borgida A, Bracci PM, Bueno-de-Mesquita HB, Cotterchio M, Dai Q, Duell EJ, Fontham EH, Gallinger S, Holly EA, Ji BT, Kurtz RC, La Vecchia C, Lowenfels AB, Luckett B, Ludwig E, Petersen GM, Polesel J, Seminara D, Pancreatic Cancer Case-Control Consortium, et al. [2 more authors] (2013). Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Am J Epidemiol  178, 691-700.   https://doi.org/10.1093/aje/kwt052|5. Purdue MP, Ye Y, Wang Z, Colt JS, Schwartz KL, Davis FG, Rothman N, Chow WH, Wu X, Chanock SJ (2014). A genome-wide association study of renal cell carcinoma among African Americans. Cancer Epidemiol Biomarkers Prev  23, 209-14.   https://doi.org/10.1158/1055-9965.EPI-13-0818|6. Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH (2014). Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol  32, 23.e9-13.   https://doi.org/10.1016/j.urolonc.2012.08.011",https://intramural.nih.gov/search/searchview.taf?ipid=78971
638,CP010142-15,"October 01, 2012 -  September 30, 2013",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI",Rebecca  Troisi|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Michael  Pollak (McGill University)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Chester  Douglass (Harvard School of Dentistry),Lisa  Mirabello (Genetic Epidemiology Branch)|Ying  Gao (Genetic Epidemiology Branch)|Kenneth  Buetow; PhD (Center For Biomedical Informatics & Information Technology),NULL,"1. Hirt C, Weitmann K, Schüler F, Kiefer T, Rabkin CS, Hoffmann W, Dölken G (2013). Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking. Leuk Lymphoma  54, 2678-84.   https://doi.org/10.3109/10428194.2013.788177|2. Savage S, Mirabello L, Wacholder S, Fraumeni J, Yeager M, Hoover R, Chanock S, Landi M, Tucker M, Purdue M, Caporaso N, Rothman N, Silverman D, Troisi R, Helman L, Wang Z, GastierFoster J, Gorlick R, Khanna C, Flanagan A, Tirabosco R, Andrulis I, Wunder J, Gokgoz N, PatioGarcia A, et al. [21 more authors] (2013) Genome-wide Association Study Identifies Novel Loci Associated with Osteosarcoma. Nature Genetics 45:799-803|3. Thomas DM, Savage SA, Bond GL (2012). Hereditary and environmental epidemiology of sarcomas. Clin Sarcoma Res  2, 13.   https://doi.org/10.1186/2045-3329-2-13",https://intramural.nih.gov/search/searchview.taf?ipid=78972
639,CP010144-15,"October 01, 2012 -  September 30, 2013",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  |Neelam K Giri; MD| |Christian Peter Kratz| |Phuong L Mai| | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Sholom  Wacholder; PhD|Alexander  Pemov|Renee C Bremer|Gladys M. Glenn; MD, PhD|Hormuzdiar Aspandiar Katki; MS|Show all 9",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|Lawrence  Einhorn (Indiana University Medical Center)|Show all 58,"Thomas  Fears; PhD (Genetic Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Margaret Anne Tucker (Human Genetics Program)","Jeffery P Struewing; MS, MD (NHGRI) |Pamela  Stratton; MD (NICHD)","1. Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M (2013). Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer  133, 1513-5.   https://doi.org/10.1002/ijc.28157|2. Alter BP, Rosenberg PS (2013). VACTERL-H Association and Fanconi Anemia. Mol Syndromol  4, 87-93.   https://doi.org/10.1159/000346035|3. Alter BP, Rosenberg PS, Day T, Menzel S, Giri N, Savage SA, Thein SL (2013). Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes. Br J Haematol  162, 542-6.   https://doi.org/10.1111/bjh.12399|4. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, et al. [420 more authors] (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45:371-84, 384e1-2|5. Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR, et al. [5 more authors] (2013). Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet  45, 680-5.   https://doi.org/10.1038/ng.2634|6. Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, SWE-BRCA, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, HEBON, EMBRACE, GEMO Study Collaborators, KConFab Investigators, OCGN, Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), et al. [136 more authors] (2012). A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev  21, 1362-70.   https://doi.org/10.1158/1055-9965.EPI-12-0229|7. Fargo JH, Kratz CP, Giri N, Savage SA, Wong C, Backer K, Alter BP, Glader B (2013). Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol  160, 547-54.   https://doi.org/10.1111/bjh.12167|8. Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, Wang X, Eldridge RC, Tessier DC, Vincent D, Bacot F, Hogervorst FB, Peock S, Stoppa-Lyonnet D, KConFab Investigators, Peterlongo P, Schmutzler RK, Ontario Cancer Genetics Network, HEBON, EMBRACE, GEMO Study Collaborators, GENICA Network, et al. [101 more authors] (2013). Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet  9, e1003173.   https://doi.org/10.1371/journal.pgen.1003173|9. Gu F, Pfeiffer RM, Bhattacharjee S, Han SS, Taylor PR, Berndt S, Yang H, Sigurdson AJ, Toro J, Mirabello L, Greene MH, Freedman ND, Abnet CC, Dawsey SM, Hu N, Qiao YL, Ding T, Brenner AV, Garcia-Closas M, Hayes R, Brinton LA, Lissowska J, Wentzensen N, Kratz C, Moore LE, et al. [10 more authors] (2013). Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer  108, 1378-86.   https://doi.org/10.1038/bjc.2013.7|10. Hutson SP, Han PK, Hamilton JG, Rife SC, Al-Rahawan MM, Moser RP, Duty SP, Anand S, Alter BP (2015). The use of haematopoietic stem cell transplantation in Fanconi anaemia patients: a survey of decision making among families in the US and Canada. Health Expect  18, 929-41.   https://doi.org/10.1111/hex.12066|11. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, OCGN, Thomassen M, Paligo M, Aretini P, SWE-BRCA, Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, HEBON, EMBRACE, GEMO Study Collaborators, KConFab, CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer, et al. [91 more authors] (2012). Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer  106, 2016-24.   https://doi.org/10.1038/bjc.2012.160|12. Khincha PP, Savage SA (2013). Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol  50, 333-47.   https://doi.org/10.1053/j.seminhematol.2013.09.002|13. Mai PL, Malkin D, Garber JE, Schiffman JD, Weitzel JN, Strong LC, Wyss O, Locke L, Means V, Achatz MI, Hainaut P, Frebourg T, Evans DG, Bleiker E, Patenaude A, Schneider K, Wilfond B, Peters JA, Hwang PM, Ford J, Tabori U, Ognjanovic S, Dennis PA, Wentzensen IM, Greene MH, et al. [2 more authors] (2012). Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet  205, 479-87.   https://doi.org/10.1016/j.cancergen.2012.06.008|14. Matsui K, Giri N, Alter BP, Pinto LA (2013). Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes. Br J Haematol  163, 81-92.   https://doi.org/10.1111/bjh.12475|15. Mirabello L, Kratz CP, Savage SA, Greene MH (2012). Promoter methylation of candidate genes associated with familial testicular cancer. Int J Mol Epidemiol Genet  3, 213-27.|16. Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM, et al. [10 more authors] (2013). Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet  22, 2748-53.   https://doi.org/10.1093/hmg/ddt109|17. Sherman ME, Guido R, Wentzensen N, Yang HP, Mai PL, Greene MH (2012). New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research. Gynecol Oncol  127, 645-50.   https://doi.org/10.1016/j.ygyno.2012.08.023|18. Stewart DR, Pemov A, Van Loo P, Beert E, Brems H, Sciot R, Claes K, Pak E, Dutra A, Lee CC, Legius E (2012). Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors. Genes Chromosomes Cancer  51, 429-37.   https://doi.org/10.1002/gcc.21928",https://intramural.nih.gov/search/searchview.taf?ipid=78973
640,CP010145-14,"October 01, 2012 -  September 30, 2013",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  |Phuong L Mai| |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",June  Peters|Jennifer T Loud,"David  Alberts (University of Arizona Cancer Center)|Deborah A. Bell; MD (Department of Laboratory Medicine and Pathology, Mayo Clinic)|Molly  Brewer (Arizona Cancer Center)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|M  Constenino (BioTech Laboratories)|Show all 17",Margaret Anne Tucker (Human Genetics Program)|Richard P Moser (Science Of Research & Technology Branch)|Sheila Ann Prindiville (Office Of The Director),Paul Kj Han (NHGRI),"1. Hoskins L, Greene M (2012) Anticipatory Loss and Early Mastectomy for Young Female BRCA12 Mutation Carriers. Qualitative Health Research 22:1633-1646",https://intramural.nih.gov/search/searchview.taf?ipid=78974
641,CP010150-14,"October 01, 2012 -  September 30, 2013","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol|James Jerome Goedert; MD,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Neal David Freedman (Nutritional Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Castro FA, Koshiol J, Hsing AW, Devesa SS (2013). Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer  133, 1664-71.   https://doi.org/10.1002/ijc.28161|2. Chaturvedi AK, Moore SC, Hildesheim A (2013). Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. Am J Epidemiol  177, 14-9.   https://doi.org/10.1093/aje/kws357|3. Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM (2013). Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant  13, 1523-32.   https://doi.org/10.1111/ajt.12234|4. Hall EC, Engels EA, Montgomery RA, Segev DL (2013). Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation  96, 476-9.   https://doi.org/10.1097/TP.0b013e318299dc0e|5. Hall EC, Pfeiffer RM, Segev DL, Engels EA (2013). Cumulative incidence of cancer after solid organ transplantation. Cancer  119, 2300-8.   https://doi.org/10.1002/cncr.28043|6. Hall EC, Segev DL, Engels EA (2013). Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant  13, 714-20.   https://doi.org/10.1111/ajt.12066|7. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA (2013). HPV-related cancers after solid organ transplantation in the United States. Am J Transplant  13, 3202-9.   https://doi.org/10.1111/ajt.12472|8. Morton LM, Kim CJ, Weiss LM, Bhatia K, Cockburn M, Hawes D, Wang SS, Chang C, Altekruse SF, Engels EA, Cozen W (2014). Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. Leuk Lymphoma  55, 551-7.   https://doi.org/10.3109/10428194.2013.813499|9. Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS (2013). Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer  133, 1271-85.   https://doi.org/10.1002/ijc.27828|10. Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, Hartge P, Morton LM (2013). The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev  22, 1069-78.   https://doi.org/10.1158/1055-9965.EPI-13-0040|11. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM (2013). HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst  105, 350-60.   https://doi.org/10.1093/jnci/djs529|12. Suneja G, Shiels MS, Melville SK, Williams MA, Rengan R, Engels EA (2013). Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals. AIDS  27, 459-68.   https://doi.org/10.1097/QAD.0b013e32835ad56e",https://intramural.nih.gov/search/searchview.taf?ipid=78975
642,CP010152-14,"October 01, 2012 -  September 30, 2013",PLCO Trial Etiologic and Early Marker Study,"Mark  Purdue|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Wen-Yi  Huang|Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Christine Dorothy Berg (Early Detection Research Group),NULL,"1. Hendrickson SJ, Lindström S, Eliassen AH, Rosner BA, Chen C, Barrdahl M, Brinton L, Buring J, Canzian F, Chanock S, Clavel-Chapelon F, Figueroa JD, Gapstur SM, Garcia-Closas M, Gaudet MM, Haiman CA, Hazra A, Henderson B, Hoover R, Hüsing A, Johansson M, Kaaks R, Khaw KT, Kolonel LN, Le Marchand L, et al. [15 more authors] (2013). Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev  22, 927-36.   https://doi.org/10.1158/1055-9965.EPI-13-0017|2. Hofmann JN, Liao LM, Pollak MN, Wang Y, Pfeiffer RM, Baris D, Andreotti G, Lan Q, Landgren O, Rothman N, Purdue MP (2012). A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood  120, 4418-20.   https://doi.org/10.1182/blood-2012-06-438606|3. Jiang J, Ahn J, Huang WY, Hayes RB (2013). Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med  57, 60-4.   https://doi.org/10.1016/j.ypmed.2013.04.014|4. Kitahara CM, Berndt SI, de González AB, Coleman HG, Schoen RE, Hayes RB, Huang WY (2013). Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol  31, 2450-9.   https://doi.org/10.1200/JCO.2012.48.4691|5. Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV, Hayes RB, Stanczyk FZ, Wentzensen N, Brinton LA (2013). Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  22, 1304-12.   https://doi.org/10.1158/1055-9965.EPI-13-0258|6. Purdue MP, Hofmann JN, Kemp TJ, Chaturvedi AK, Lan Q, Park JH, Pfeiffer RM, Hildesheim A, Pinto LA, Rothman N (2013). A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. Blood  122, 951-7.   https://doi.org/10.1182/blood-2013-01-481077",https://intramural.nih.gov/search/searchview.taf?ipid=78976
643,CP010158-13,"October 01, 2012 -  September 30, 2013",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",Vikrant Vasant Sahasrabuddhe|Elna Christina Marianne Persson,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",Kelly Jen-Yi Yu (Early Detection Research Group),NULL,"1. Aarestrup J, Gamborg M, Cook MB, Sørensen TI, Baker JL (2014). Childhood body mass index and the risk of prostate cancer in adult men. Br J Cancer  111, 207-12.   https://doi.org/10.1038/bjc.2014.266|2. Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K (2013). Race and colon cancer survival in an equal-access health care system. Cancer Epidemiol Biomarkers Prev  22, 1030-6.   https://doi.org/10.1158/1055-9965.EPI-13-0143|3. Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere B, Gage JC, Fetterman B, Darragh TM, Rodriguez AC, Wentzensen N (2013). A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. Cancer Epidemiol Biomarkers Prev  22, 42-9.   https://doi.org/10.1158/1055-9965.EPI-12-0984|4. Cook MB, Gamborg M, Aarestrup J, Sørensen TI, Baker JL (2013). Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register. Cancer Epidemiol Biomarkers Prev  22, 2232-40.   https://doi.org/10.1158/1055-9965.EPI-13-0712|5. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF (2013). Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10. Gut  62, 1667-8.   https://doi.org/10.1136/gutjnl-2013-305164|6. Enewold L, McGlynn KA, Shriver CD, Zhu K (2012). Mammography screening by race/ethnicity among U.S. servicewomen, 2009-2010. Mil Med  177, 1513-8.   https://doi.org/10.7205/milmed-d-12-00247|7. Hernandez BY, Zhu X, Kwee S, Chan OT, Tsai N, Okimoto G, Horio D, McGlynn KA, Altekruse S, Wong LL (2013). Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev  22, 2016-23.   https://doi.org/10.1158/1055-9965.EPI-13-0397|8. London WT, McGlynn KA (2012). Can propranalol prevent hepatocellular carcinoma? Cancer Prev Res (Phila)  5, 989-91.   https://doi.org/10.1158/1940-6207.CAPR-12-0247|9. Sahasrabuddhe VV, Castle PE, Follansbee S, Borgonovo S, Tokugawa D, Schwartz LM, Lorey TS, LaMere BJ, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Wentzensen N (2013). Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men. J Infect Dis  207, 392-401.   https://doi.org/10.1093/infdis/jis694|10. Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA (2013). Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol  108, 1314-21.   https://doi.org/10.1038/ajg.2013.160|11. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE (2012). Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS  26, 2185-92.   https://doi.org/10.1097/QAD.0b013e328359f255|12. Zheng L, Enewold L, Zahm SH, Shriver CD, Zhou J, Marrogi A, McGlynn KA, Zhu K (2012). Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev  21, 1841-7.   https://doi.org/10.1158/1055-9965.EPI-12-0560|13. Zhou J, Enewold L, Zahm SH, Jatoi I, Shriver C, Anderson WF, Jeffery DD, Andaya A, Potter JF, McGlynn KA, Zhu K (2013) Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care system. Am J Surg 206:393-9",https://intramural.nih.gov/search/searchview.taf?ipid=78977
644,CP010167-13,"October 01, 2012 -  September 30, 2013",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi|Patricia  Hartge; ScD,NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78978
645,CP010168-13,"October 01, 2012 -  September 30, 2013",Early Life Exposures and Subsequent Cancer Risk,"Rebecca  Troisi| | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 12",NULL,NULL,"1. Bjørge T, Sørensen HT, Grotmol T, Engeland A, Stephansson O, Gissler M, Tretli S, Troisi R (2013). Fetal growth and childhood cancer: a population-based study. Pediatrics  132, e1265-75.   https://doi.org/10.1542/peds.2013-1317|2. Ganmaa D, Rich-Edwards JW, Frazier LA, Davaalkham D, Oyunbileg G, Janes C, Potischman N, Hoover R, Troisi R (2013). A comparison of migrants to, and women born in, urban Mongolia: demographic, reproductive, anthropometric and lifestyle characteristics. Int Health  5, 244-50.   https://doi.org/10.1093/inthealth/iht020|3. Troisi R, Doody DR, Mueller BA (2013). A linked-registry study of gestational factors and subsequent breast cancer risk in the mother. Cancer Epidemiol Biomarkers Prev  22, 835-47.   https://doi.org/10.1158/1055-9965.EPI-12-1375",https://intramural.nih.gov/search/searchview.taf?ipid=78979
646,CP010169-12,"October 01, 2012 -  September 30, 2013","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Patricia  Hartge; ScD|Hormuzdiar Aspandiar Katki; MS|Catherine G Schairer","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch),NULL,"1. Bertrand KA, Eliassen AH, Hankinson SE, Gierach GL, Xu X, Rosner B, Ziegler RG, Tamimi RM (2012). Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat  136, 277-87.   https://doi.org/10.1007/s10549-012-2240-0|2. Fuhrman BJ, Pfeiffer RM, Wu AH, Xu X, Keefer LK, Veenstra TD, Ziegler RG (2013). Green tea intake is associated with urinary estrogen profiles in Japanese-American women. Nutr J  12, 25.   https://doi.org/10.1186/1475-2891-12-25|3. Ziegler RG (2012). Following up folate and its function in colorectal carcinogenesis. J Natl Cancer Inst  104, 1525-7.   https://doi.org/10.1093/jnci/djs412",https://intramural.nih.gov/search/searchview.taf?ipid=78982
647,CP010170-13,"October 01, 2012 -  September 30, 2013",Multidisciplinary Studies of Hematopoietic Malignancies,Patricia  Hartge; ScD| | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Martha S Linet; PhD,"Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Shelia K Zahm; ScM, ScD (Office of the Director)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)|Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, et al. [105 more authors] (2013). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet  45, 868-76.   https://doi.org/10.1038/ng.2652|2. Deziel NC, Nuckols JR, Colt JS, De Roos AJ, Pronk A, Gourley C, Severson RK, Cozen W, Cerhan JR, Hartge P, Ward MH (2012). Determinants of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in house dust samples from four areas of the United States. Sci Total Environ  433, 516-22.   https://doi.org/10.1016/j.scitotenv.2012.06.098|3. Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM (2012). Inherited genetic variation and overall survival following follicular lymphoma. Am J Hematol  87, 724-6.   https://doi.org/10.1002/ajh.23184|4. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA (2013). Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol  88, 245-50.   https://doi.org/10.1002/ajh.23385|5. Nieters A, Conde L, Slager SL, Brooks-Wilson A, Morton L, Skibola DR, Novak AJ, Riby J, Ansell SM, Halperin E, Shanafelt TD, Agana L, Wang AH, De Roos AJ, Severson RK, Cozen W, Spinelli J, Butterbach K, Becker N, de Sanjose S, Benavente Y, Cocco P, Staines A, Maynadié M, Foretova L, et al. [18 more authors] (2012). PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood  120, 4645-8.   https://doi.org/10.1182/blood-2012-05-427989",https://intramural.nih.gov/search/searchview.taf?ipid=78980
648,CP010176-13,"October 01, 2012 -  September 30, 2013",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Office of the Director)|Denise  Whitby (Office Of The Director)",NULL,"1. Buonaguro FM, Gueye SN, Wabinga HR, Ngoma TA, Vermorken JB, Mbulaiteye SM (2013). Clinical oncology in resource-limited settings. Infect Agent Cancer  8, 39.   https://doi.org/10.1186/1750-9378-8-39|2. Chang JT, Shebl FM, Pfeiffer RM, Biryahwaho B, Graubard BI, Mbulaiteye SM (2013). A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis. Infect Agent Cancer  8, 3.   https://doi.org/10.1186/1750-9378-8-3|3. Mbulaiteye SM, Kemp T, Gage JC, Ajenifuja KO, Kiruthu C, Wentzensen NA, Adepiti C, Wacholder S, Burk RD, Schiffman M, Pinto L (2013). Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women. Cytokine  64, 146-51.   https://doi.org/10.1016/j.cyto.2013.07.028|4. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, et al. [17 more authors] (2012). Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature  490, 116-20.   https://doi.org/10.1038/nature11378",https://intramural.nih.gov/search/searchview.taf?ipid=78981
649,CP010180-12,"October 01, 2012 -  September 30, 2013",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi|Lisa Wey-Lan Chu,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78995
650,CP010181-11,"October 01, 2012 -  September 30, 2013",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Junmo  Nam,"Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Laure  El Ghormli (GW Biostat)|Show all 12","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"1. Blackwelder WC, Biswas K, Wu Y, Kotloff KL, Farag TH, Nasrin D, Graubard BI, Sommerfelt H, Levine MM (2012). Statistical methods in the Global Enteric Multicenter Study (GEMS). Clin Infect Dis  55 Suppl 4, S246-53.   https://doi.org/10.1093/cid/cis788|2. Breslow RA, Chen CM, Graubard BI, Jacobovits T, Kant AK (2013). Diets of drinkers on drinking and nondrinking days: NHANES 2003-2008. Am J Clin Nutr  97, 1068-75.   https://doi.org/10.3945/ajcn.112.050161|3. Chen YH, Chatterjee N, Carroll RJ (2013). Using shared genetic controls in studies of gene-environment interactions. Biometrika  100, 319-338.   https://doi.org/10.1093/biomet/ass078|4. Davies JL, Cazier JB, Dunlop MG, Houlston RS, Tomlinson IP, Holmes CC (2012) A novel test for gene-ancestry interactions in genome-wide association data. PLoS One 7:e48687|5. Flegal KM, Kit BK, Orpana H, Graubard BI (2013). Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA  309, 71-82.   https://doi.org/10.1001/jama.2012.113905|6. Gail MH, Sheehy T, Cosentino M, Pee D, Diaz-Mayoral NA, Garcia-Closas M, Caporaso NE, Pitt K, Ziegler RG (2013). Maximizing DNA yield for epidemiologic studies: no more buffy coats? Am J Epidemiol  178, 1170-6.   https://doi.org/10.1093/aje/kwt079|7. Garcia-Closas M, Rothman N, Figueroa JD, Prokunina-Olsson L, Han SS, Baris D, Jacobs EJ, Malats N, De Vivo I, Albanes D, Purdue MP, Sharma S, Fu YP, Kogevinas M, Wang Z, Tang W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, et al. [19 more authors] (2013). Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res  73, 2211-20.   https://doi.org/10.1158/0008-5472.CAN-12-2388|8. Han SS, Rosenberg PS, Garcia-Closas M, Figueroa JD, Silverman D, Chanock SJ, Rothman N, Chatterjee N (2012). Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. Am J Epidemiol  176, 1060-7.   https://doi.org/10.1093/aje/kws166|9. Kant AK, Graubard BI (2012). Race-ethnic, family income, and education differentials in nutritional and lipid biomarkers in US children and adolescents: NHANES 2003-2006. Am J Clin Nutr  96, 601-12.   https://doi.org/10.3945/ajcn.112.035535|10. Katki HA, Li Y, Edelstein DW, Castle PE (2012). Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimens. Stat Med  31, 436-48.   https://doi.org/10.1002/sim.4422|11. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK (2013). Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis  17, S28-35.   https://doi.org/10.1097/LGT.0b013e318285423c|12. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK (2013). Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis  17, S36-42.   https://doi.org/10.1097/LGT.0b013e3182854253|13. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA (2013). Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med  369, 245-254.   https://doi.org/10.1056/NEJMoa1301851|14. Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, Tan YT, Ji BT, Chow WH, Cai Q, Liu DK, Yang G, Xiang YB, Zheng W, Sinha R, Cross AJ, Moore SC (2013). Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev  22, 631-40.   https://doi.org/10.1158/1055-9965.EPI-12-1109|15. Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, Lu P, Hsia CC, Wang N, Xu L, Lu L, Huang F, Zhu Y, Lu J, Ni Z, Zhang Q, Wu Y, Liu G, Wu Z, Qu C, Gail MH (2013). Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis  34, 1800-5.   https://doi.org/10.1093/carcin/bgt007|16. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD (2013). Selection criteria for lung-cancer screening. N Engl J Med  368, 728-36.   https://doi.org/10.1056/NEJMoa1211776|17. Wacholder S (2012). Clinical utility in evaluation of risk models. Am J Epidemiol  176, 495-6.   https://doi.org/10.1093/aje/kws255|18. Wacholder S (2013). Precursors in cancer epidemiology: aligning definition and function. Cancer Epidemiol Biomarkers Prev  22, 521-7.   https://doi.org/10.1158/1055-9965.EPI-13-0084|19. Wang YC, Graubard BI, Rosenberg MA, Kuntz KM, Zauber AG, Kahle L, Schechter CB, Feuer EJ (2013). Derivation of background mortality by smoking and obesity in cancer simulation models. Med Decis Making  33, 176-97.   https://doi.org/10.1177/0272989X12458725|20. Wei J, Carroll RJ, Müller UU, Van Keilegom I, Chatterjee N (2013). Robust estimation for homoscedastic regression in the secondary analysis of case-control data. J R Stat Soc Series B Stat Methodol  75, 185-206.   https://doi.org/10.1111/j.1467-9868.2012.01052.x|21. Wentzensen N, Wacholder S (2013). From differences in means between cases and controls to risk stratification: a business plan for biomarker development. Cancer Discov  3, 148-57.   https://doi.org/10.1158/2159-8290.CD-12-0196",https://intramural.nih.gov/search/searchview.taf?ipid=78955
651,CP010182-11,"October 01, 2012 -  September 30, 2013",Epidemiologic Field Studies,"Nilanjan  Chatterjee| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Wenqing  Li (Genetic Epidemiology Branch)",NULL,"1. Gierach GL, Pfeiffer RM, Patel DA, Black A, Schairer C, Gill A, Brinton LA, Sherman ME (2014). Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause  21, 592-601.   https://doi.org/10.1097/GME.0000000000000118|2. Riedl R, Engels EA, Warren JL, Berghold A, Ricker W, Pfeiffer RM (2013). Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion  53, 2198-206.   https://doi.org/10.1111/trf.12071|3. Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL (2013). Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst  105, 1373-84.   https://doi.org/10.1093/jnci/djt206|4. Schairer C, Soliman AS, Omar S, Khaled H, Eissa S, Ayed FB, Khalafallah S, Ayoub WB, Kantor ED, Merajver S, Swain SM, Gail M, Brown LM (2013). Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Med  2, 178-84.   https://doi.org/10.1002/cam4.48|5. Soliman AS, Schairer C (2012). Considerations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years. Cancer Med  1, 338-49.   https://doi.org/10.1002/cam4.36",https://intramural.nih.gov/search/searchview.taf?ipid=78985
652,CP010183-11,"October 01, 2012 -  September 30, 2013",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Catherine G Schairer|Philip Samuel Rosenberg; PhD|Jay  Lubin; PhD|Sholom  Wacholder; PhD|Mitchell Henry Gail; PhD, MD|Show all 7",Susan Shaw Devesa (NCI)|Jorgen  Olsen (Danish Cancer Society)|Dennis  Weisenburger (University of Nebraska Medical Center)|Ismail  Jatoi (US Army)|Kangmin  Zhu|Briseis  AschebrookKilfoy (University of Chicago)|Show all 24,"Lynn Rachel Goldin; PhD (Genetic Epidemiology Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Dalsu  Baris (Occupational and Environmental Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Charles  Rabkin (Infection & Immunoepidemiology Branch)",NULL,"1. Anderson WF, Rosenberg PS, Petito L, Katki HA, Ejlertsen B, Ewertz M, Rasmussen BB, Jensen MB, Kroman N (2013). Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer  133, 2201-6.   https://doi.org/10.1002/ijc.28222|2. Daugherty SE, Lacey JV, Pfeiffer RM, Park Y, Hoover RN, Silverman DT (2013). Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer  133, 462-72.   https://doi.org/10.1002/ijc.28022|3. Drahos J, Wu M, Anderson WF, Trivers KF, King J, Rosenberg PS, Eheman C, Cook MB (2013). Regional variations in esophageal cancer rates by census region in the United States, 1999-2008. PLoS One  8, e67913.   https://doi.org/10.1371/journal.pone.0067913|4. Gail MH, Sheehy T, Cosentino M, Pee D, Diaz-Mayoral NA, Garcia-Closas M, Caporaso NE, Pitt K, Ziegler RG (2013). Maximizing DNA yield for epidemiologic studies: no more buffy coats? Am J Epidemiol  178, 1170-6.   https://doi.org/10.1093/aje/kwt079|5. Matsuno RK, Sherman ME, Visvanathan K, Goodman MT, Hernandez BY, Lynch CF, Ioffe OB, Horio D, Platz C, Altekruse SF, Pfeiffer RM, Anderson WF (2013). Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Cancer Causes Control  24, 749-57.   https://doi.org/10.1007/s10552-013-0157-5|6. Rosenberg PS, Wilson KL, Anderson WF (2012). Are incidence rates of adult leukemia in the United States significantly associated with birth cohort? Cancer Epidemiol Biomarkers Prev  21, 2159-66.   https://doi.org/10.1158/1055-9965.EPI-12-0910|7. Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF (2012). Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Epigenetics  7, 1258-67.   https://doi.org/10.4161/epi.22220",https://intramural.nih.gov/search/searchview.taf?ipid=78954
653,CP010184-11,"October 01, 2012 -  September 30, 2013",Consultation and Collaboration,Sholom  Wacholder; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Junmo  Nam|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD",Eleuterio  BravoOtero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Show all 78,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Claudine M Samanic (Occupational and Environmental Epidemiology Branch)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)","Harvey J Alter; MD (CC) |Jane  Hoppin; ScD (NIEHS) |Joni L Rutter (NIDA) |Dale  Sandler; PhD (NIEHS) |Jeffery P Struewing; MS, MD (NHGRI) |Clarice  Weinberg; PhD (NIEHS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78987
654,CP010185-11,"October 01, 2012 -  September 30, 2013",Biodefense Project,Martha S Linet; PhD|IRP Faculty Profile  |Steven L Simon,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Choonsik  Lee|Amy  de Gonzalez|Andre  Bouville,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",NULL,NULL,"1. Coleman C, Blumenthal D, Casto C, Alfant M, Simon S, Remick A, Gepford H, Bowman T, Telfer J, Blumenthal P, Noska M (2013) Recovery and Resilience after a Nuclear Power Plant Disaster: A Medical-Decision Model for Managing an Effective, Timely, and Balanced Response. Disaster Medicine and Public Health Preparedness 7:136-145|2. Coleman C, Blumenthal D, Casto C, Alfant M, Simon S, Remick A, Gepford H, Bowman T, Telfer J, Blumenthal P, Noska M (2013) Recovery and Resilience after a Nuclear Power Plant Disaster: A Medical-Decision Model for Managing an Effective, Timely, and Balanced Response. Disaster Medicine and Public Health Preparedness 7:136-145|3. Simon S (2012) RESPONSE OF THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES IN PROTECTING AMERICANS IN JAPAN DURING THE FUKUSHIMA NUCLEAR CRISIS. Health Physics 102:570-579",https://intramural.nih.gov/search/searchview.taf?ipid=78986
655,CP010187-09,"October 01, 2012 -  September 30, 2013",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,"1. Salas LA, Cantor KP, Tardon A, Serra C, Carrato A, Garcia-Closas R, Rothman N, Malats N, Silverman D, Kogevinas M, Villanueva CM (2013). Biological and statistical approaches for modeling exposure to specific trihalomethanes and bladder cancer risk. Am J Epidemiol  178, 652-60.   https://doi.org/10.1093/aje/kwt009",https://intramural.nih.gov/search/searchview.taf?ipid=78993
656,CP010188-09,"October 01, 2012 -  September 30, 2013",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Catherine G Schairer|Ju-Hyun  Park|Stephanie Ann Kovalchik|Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington),"Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Yikyung  Park (Nutritional Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,"1. Kovalchik SA, Pfeiffer RM (2014). Population-based absolute risk estimation with survey data. Lifetime Data Anal  20, 252-75.   https://doi.org/10.1007/s10985-013-9258-4|2. Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, Sklar CA, Donaldson SS, Anderson H, Bhatti P, Hammond S, Leisenring WM, Mertens AC, Smith SA, Stovall M, Tucker MA, Weathers RE, Robison LL, Pfeiffer RM (2013). Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol  31, 119-27.   https://doi.org/10.1200/JCO.2012.41.8996|3. Pfeiffer RM (2013). Extensions of criteria for evaluating risk prediction models for public health applications. Biostatistics  14, 366-81.   https://doi.org/10.1093/biostatistics/kxs037|4. Pfeiffer RM, Park Y, Kreimer AR, Lacey JV, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P (2013). Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med  10, e1001492.   https://doi.org/10.1371/journal.pmed.1001492|5. Riedl R, Engels EA, Warren JL, Berghold A, Ricker W, Pfeiffer RM (2013). Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion  53, 2198-206.   https://doi.org/10.1111/trf.12071",https://intramural.nih.gov/search/searchview.taf?ipid=78988
657,CP010190-08,"October 01, 2012 -  September 30, 2013",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Mark H Greene; MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Shahinaz M Gadalla|Bari Jane Ballew,"Immaculata  DeVivo (Harvard Medical School)|David  Hunter (Harvard School of Public Health)|Richard  Cawthon (University of Utah)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Show all 10",Lisa  Mirabello (Genetic Epidemiology Branch),NULL,"1. Ballew BJ, Yeager M, Jacobs K, Giri N, Boland J, Burdett L, Alter BP, Savage SA (2013). Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet  132, 473-80.   https://doi.org/10.1007/s00439-013-1265-8|2. Bellodi C, McMahon M, Contreras A, Juliano D, Kopmar N, Nakamura T, Maltby D, Burlingame A, Savage SA, Shimamura A, Ruggero D (2013). H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep  3, 1493-502.   https://doi.org/10.1016/j.celrep.2013.04.030|3. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, et al. [6 more authors] (2013). Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant  19, 1238-43.   https://doi.org/10.1016/j.bbmt.2013.05.021|4. Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, Savage SA (2012). Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? Psychosomatics  53, 230-5.   https://doi.org/10.1016/j.psym.2011.09.003",https://intramural.nih.gov/search/searchview.taf?ipid=78996
658,CP010192-06,"October 01, 2012 -  September 30, 2013","Biorepository Processing, Storage, and Research",Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,Karen E Berliner (Human Genetics Program)|Marianne  Henderson (Office of Division Operations and Analysis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79003
659,CP010193-07,"October 01, 2012 -  September 30, 2013",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Office of the Director, NCI",Julie  Mendelsohn|Amy  Hutchinson,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|H  BuenodeMesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Show all 17",Geoffrey Scott Tobias (Human Genetics Program)|Kai  Yu (Biostatistics Branch),NULL,"1. Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, et al. [25 more authors] (2013). Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control  24, 13-25.   https://doi.org/10.1007/s10552-012-0078-8|2. Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault MC, et al. [37 more authors] (2013). An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One  8, e72311.   https://doi.org/10.1371/journal.pone.0072311|3. Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, et al. [40 more authors] (2013). Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control  24, 595-602.   https://doi.org/10.1007/s10552-012-0138-0|4. Parikh H, Jia J, Zhang X, Chung CC, Jacobs KB, Yeager M, Boland J, Hutchinson A, Burdett L, Hoskins J, Risch HA, Stolzenberg-Solomon RZ, Chanock SJ, Wolpin BM, Petersen GM, Fuchs CS, Hartge P, Amundadottir L (2013). A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. Pancreas  42, 209-15.   https://doi.org/10.1097/MPA.0b013e318264cea5",https://intramural.nih.gov/search/searchview.taf?ipid=78997
660,CP010194-07,"October 01, 2012 -  September 30, 2013",Diet and Cancer in India,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,NULL,Barry Ira Graubard; PhD (Biostatistics Branch),NULL,"1. Daniel CR, Kapur K, McAdams MJ, Dixit-Joshi S, Devasenapathy N, Shetty H, Hariharan S, George PS, Mathew A, Sinha R (2014). Development of a field-friendly automated dietary assessment tool and nutrient database for India. Br J Nutr  111, 160-71.   https://doi.org/10.1017/S0007114513001864",https://intramural.nih.gov/search/searchview.taf?ipid=78998
661,CP010195-07,"October 01, 2012 -  September 30, 2013","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein|Rashmi P Sinha; PhD|Amanda  Cross|Christian Cormac Abnet; PhD, MPH|Neal David Freedman|Alison Marian Mondul|Show all 7",David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Cook MB, Kamangar F, Weinstein SJ, Albanes D, Virtamo J, Taylor PR, Abnet CC, Wood RJ, Petty G, Cross AJ, Dawsey SM (2012). Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev  21, 2033-42.   https://doi.org/10.1158/1055-9965.EPI-12-0799|2. Lynch SM, Major JM, Cawthon R, Weinstein SJ, Virtamo J, Lan Q, Rothman N, Albanes D, Stolzenberg-Solomon RZ (2013). A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. Int J Cancer  133, 2672-80.   https://doi.org/10.1002/ijc.28272|3. Michal Freedman D, Kuncl RW, Weinstein SJ, Malila N, Virtamo J, Albanes D (2013). Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener  14, 246-51.   https://doi.org/10.3109/21678421.2012.745570|4. Mondul AM, Sampson JN, Moore SC, Weinstein SJ, Evans AM, Karoly ED, Virtamo J, Albanes D (2013). Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr  98, 488-93.   https://doi.org/10.3945/ajcn.113.062778|5. Mondul AM, Weinstein SJ, Virtamo J, Albanes D (2012). Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer  107, 1589-94.   https://doi.org/10.1038/bjc.2012.417|6. Weinstein SJ, Mondul AM, Kopp W, Rager H, Virtamo J, Albanes D (2013). Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer  132, 2940-7.   https://doi.org/10.1002/ijc.27969",https://intramural.nih.gov/search/searchview.taf?ipid=78999
662,CP010196-07,"October 01, 2012 -  September 30, 2013",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Yikyung  Park|Amanda  Cross|Rachael Zoe Solomon|Neal David Freedman|Jacqueline M Major; MS|Steven  Moore,NULL,NULL,NULL,"1. Arem H, Park Y, Pelser C, Ballard-Barbash R, Irwin ML, Hollenbeck A, Gierach GL, Brinton LA, Pfeiffer RM, Matthews CE (2013). Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst  105, 342-9.   https://doi.org/10.1093/jnci/djs530|2. Behrens G, Matthews CE, Moore SC, Freedman ND, McGlynn KA, Everhart JE, Hollenbeck AR, Leitzmann MF (2013). The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study. Eur J Epidemiol  28, 55-66.   https://doi.org/10.1007/s10654-013-9767-1|3. Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM (2013). Hormonal risk factors and invasive epithelial ovarian cancer risk by parity. Br J Cancer  109, 769-76.   https://doi.org/10.1038/bjc.2013.344|4. Bosire C, Stampfer MJ, Subar AF, Park Y, Kirkpatrick SI, Chiuve SE, Hollenbeck AR, Reedy J (2013). Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol  177, 504-13.   https://doi.org/10.1093/aje/kws261|5. Cross AJ, Hollenbeck AR, Park Y (2013). A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine. Cancer Causes Control  24, 1737-46.   https://doi.org/10.1007/s10552-013-0251-8|6. Daniel CR, Park Y, Chow WH, Graubard BI, Hollenbeck AR, Sinha R (2013). Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort. Am J Clin Nutr  97, 1036-43.   https://doi.org/10.3945/ajcn.112.045351|7. Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, et al. [14 more authors] (2013). The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer  108, 727-34.   https://doi.org/10.1038/bjc.2013.2|8. Hofmann JN, Moore SC, Lim U, Park Y, Baris D, Hollenbeck AR, Matthews CE, Gibson TM, Hartge P, Purdue MP (2013). Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. Am J Epidemiol  177, 776-86.   https://doi.org/10.1093/aje/kws295|9. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, et al. [15 more authors] (2013). Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst  105, 219-36.   https://doi.org/10.1093/jnci/djs635|10. Kabat GC, Wu JW, Moore SC, Morton LM, Park Y, Hollenbeck AR, Rohan TE (2013). Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev  22, 848-54.   https://doi.org/10.1158/1055-9965.EPI-13-0093|11. Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND (2013). The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study. J Clin Endocrinol Metab  98, E497-502.   https://doi.org/10.1210/jc.2012-3335|12. Liu W, Park Y, Purdue MP, Giovannucci E, Cho E (2013). A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study. Cancer Causes Control  24, 1865-73.   https://doi.org/10.1007/s10552-013-0263-4|13. Llewellyn Smith , Brinton L, Freedman N, Benson G (2012) Response Re: Body Mass Index and Risk of Lung Cancer Among Never, Former, and Current Smokers. J Natl Cancer Inst 104:1681|14. Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N (2012). Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review. Cancer Causes Control  23, 1839-52.   https://doi.org/10.1007/s10552-012-0063-2|15. Pelser C, Mondul AM, Hollenbeck AR, Park Y (2013). Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev  22, 697-707.   https://doi.org/10.1158/1055-9965.EPI-12-1196-T|16. Persson EC, Schwartz LM, Park Y, Trabert B, Hollenbeck AR, Graubard BI, Freedman ND, McGlynn KA (2013). Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev  22, 415-21.   https://doi.org/10.1158/1055-9965.EPI-12-1169|17. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2012). Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst  104, 1808-14.   https://doi.org/10.1093/jnci/djs452|18. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2013). Response. J Natl Cancer Inst  105, 668- 71.   https://doi.org/10.1093/jnci/djt063|19. Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT (2013). Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort. Am J Clin Nutr  98, 1057-65.   https://doi.org/10.3945/ajcn.113.058123|20. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM (2013). 50-year trends in smoking-related mortality in the United States. N Engl J Med  368, 351-64.   https://doi.org/10.1056/NEJMsa1211127|21. Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck A, Danforth KN, Park Y, Brinton LA (2012). Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer  107, 1181-7.   https://doi.org/10.1038/bjc.2012.397|22. Xue X, Kim MY, Gaudet MM, Park Y, Heo M, Hollenbeck AR, Strickler HD, Gunter MJ (2013). A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies. Cancer Epidemiol Biomarkers Prev  22, 275-85.   https://doi.org/10.1158/1055-9965.EPI-12-1050|23. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, Hollenbeck A, Park Y, Sherman ME, Brinton LA (2013). Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol  177, 142-51.   https://doi.org/10.1093/aje/kws200",https://intramural.nih.gov/search/searchview.taf?ipid=79005
663,CP010197-07,"October 01, 2012 -  September 30, 2013","Physical Activity, Energy Balance, and Cancer",Demetrius  Albanes; MD|IRP Faculty Profile  |Amanda  Cross| | |Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Cross AJ, Boca S, Freedman ND, Caporaso NE, Huang WY, Sinha R, Sampson JN, Moore SC (2014). Metabolites of tobacco smoking and colorectal cancer risk. Carcinogenesis  35, 1516-22.   https://doi.org/10.1093/carcin/bgu071|2. Matthews CE, Keadle SK, Sampson J, Lyden K, Bowles HR, Moore SC, Libertine A, Freedson PS, Fowke JH (2013). Validation of a previous-day recall measure of active and sedentary behaviors. Med Sci Sports Exerc  45, 1629-38.   https://doi.org/10.1249/MSS.0b013e3182897690",https://intramural.nih.gov/search/searchview.taf?ipid=79000
664,CP010198-07,"October 01, 2012 -  September 30, 2013",Lower Gastrointestinal Cancer Studies,Amanda  Cross,NULL,"Nutritional Epidemiology Branch, NCI",Rashmi P Sinha; PhD,Philip  Schoenfeld (University of Michigan School of Medicine)|Andrew P Flood,Elaine L Lanza (Laboratory of Cancer Prevention),NULL,"1. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ (2013). Factors associated with the risk of adenoma recurrence in distal and proximal colon. Digestion  87, 141-6.   https://doi.org/10.1159/000346281|2. Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME (2014). Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut  63, 949-56.   https://doi.org/10.1136/gutjnl-2012-303796",https://intramural.nih.gov/search/searchview.taf?ipid=79001
665,CP010199-07,"October 01, 2012 -  September 30, 2013",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Amanda  Cross|Yikyung  Park|Charles E Matthews,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Laurence  Freedman (Biometry Research Group)|Richard P Troiano (Risk Factor Monitoring and Methods Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79002
666,CP010200-06,"October 01, 2012 -  September 30, 2013",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,"1. Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, Bézieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hazra A, Henderson B, Hoffmeister M, Hopper JL, Hudson TJ, Jenkins MA, Küry S, et al. [19 more authors] (2013). Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev  22, 2037-46.   https://doi.org/10.1158/1055-9965.EPI-13-0209",https://intramural.nih.gov/search/searchview.taf?ipid=79004
667,CP010201-04,"October 01, 2012 -  September 30, 2013",Laboratory of Translational Genomics,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,Laufey Thora Amundadottir (Laboratory Translational Genomics)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Kevin Michael Brown (Laboratory Translational Genomics),NULL,"1. Balbás-Martínez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Márquez M, Vazquez M, Lapi E, Castro-Giner F, Beltran S, Bayés M, Carrato A, Cigudosa JC, Domínguez O, Gut M, Herranz J, Juanpere N, Kogevinas M, Langa X, López-Knowles E, Lorente JA, Lloreta J, Pisano DG, Richart L, Rico D, Salgado RN, et al. [8 more authors] (2013). Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet  45, 1464-9.   https://doi.org/10.1038/ng.2799|2. Bassig BA, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD, Hu W, Leaderer B, Yeager M, Menashe I, Boyle P, Xu J, Zou K, Zhu Y, Chanock S, Rothman N, Lan Q (2012). Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma. Environ Mol Mutagen  53, 145-51.   https://doi.org/10.1002/em.21675|3. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, et al. [420 more authors] (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45:371-84, 384e1-2|4. Chung CC, Hsing AW, Edward Yeboah, Biritwum R, Tettey Y, Adjei A, Cook MB, De Marzo A, Netto G, Tay E, Boland JF, Yeager M, Chanock SJ (2014). A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry. Prostate  74, 579-89.   https://doi.org/10.1002/pros.22726|5. Deng Q, Zheng T, Lan Q, Lan Y, Holford T, Chen Y, Dai M, Leaderer B, Boyle P, Chanock SJ, Rothman N, Zhang Y (2013). Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma. Eur J Cancer Prev  22, 77-82.   https://doi.org/10.1097/CEJ.0b013e328354d2c1|6. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative, Australian Prostate Cancer Bioresource, UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons'' Section of Oncology, UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators, PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, et al. [119 more authors] (2013). Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet  45, 385-91, 391e1-2.   https://doi.org/10.1038/ng.2560|7. French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, Tyrer J, Maia AT, Beck A, Knoblauch NW, Chen C, Kraft P, Barnes D, González-Neira A, Alonso MR, Herrero D, GENICA Network, kConFab Investigators, et al. [186 more authors] (2013). Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet  92, 489-503.   https://doi.org/10.1016/j.ajhg.2013.01.002|8. Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kaplan R, Meade A, McKay J, Johansson M, Lathrop M, Larkin J, Rothman N, Wang Z, Chow WH, Stevens VL, Ryan Diver W, Gapstur SM, Albanes D, Virtamo J, Wu X, Brennan P, Chanock S, Eisen T, et al. [1 more author] (2013). Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Hum Mol Genet  22, 825-31.   https://doi.org/10.1093/hmg/dds489|9. Iyer S, Perera F, Zhang B, Chanock S, Wang S, Tang D (2014). Significant interactions between maternal PAH exposure and haplotypes in candidate genes on B[a]P-DNA adducts in a NYC cohort of non-smoking African-American and Dominican mothers and newborns. Carcinogenesis  35, 69-75.   https://doi.org/10.1093/carcin/bgt339|10. Jiao J, Zheng T, Lan Q, Chen Y, Deng Q, Bi X, Kim C, Holford T, Leaderer B, Boyle P, Ba Y, Xia Z, Chanock SJ, Rothman N, Zhang Y (2012). Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma. Eur J Cancer Prev  21, 580-4.   https://doi.org/10.1097/CEJ.0b013e328351c762|11. Kim C, Zheng T, Lan Q, Chen Y, Foss F, Chen X, Holford T, Leaderer B, Boyle P, Chanock SJ, Rothman N, Zhang Y (2012). Genetic polymorphisms in oxidative stress pathway genes and modification of BMI and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  21, 866-8.   https://doi.org/10.1158/1055-9965.EPI-12-0010|12. Koster R, Mitra N, D'Andrea K, Vardhanabhuti S, Chung CC, Wang Z, Loren Erickson R, Vaughn DJ, Litchfield K, Rahman N, Greene MH, McGlynn KA, Turnbull C, Chanock SJ, Nathanson KL, Kanetsky PA (2014). Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors. Hum Mol Genet  23, 6061-8.   https://doi.org/10.1093/hmg/ddu305|13. Lee PS, Fang J, Jessop L, Myers T, Raj P, Hu N, Wang C, Taylor PR, Wang J, Khan J, Jasin M, Chanock SJ (2014). RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines. Breast Cancer (Auckl)  8, 135-44.   https://doi.org/10.4137/BCBCR.S17766|14. Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF, Chanock SJ, Anderson SK, Dean M (2012). Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts. Hum Genet  131, 1453-1466.   https://doi.org/10.1007/s00439-012-1182-2|15. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, et al. [194 more authors] (2013). Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet  45, 353-61, 361e1-2.   https://doi.org/10.1038/ng.2563|16. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Peto J, Genica Network, kConFab, AOCS Management Group, et al. [67 more authors] (2013). Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet  9, e1003284.   https://doi.org/10.1371/journal.pgen.1003284|17. Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM, Australian Cancer Study, Australian Ovarian Cancer Study, Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Consortium of Investigators of Modifiers of BRCA1/2, et al. [153 more authors] (2013). Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun  4, 1627.   https://doi.org/10.1038/ncomms2613|18. Perry JR, Corre T, Esko T, Chasman DI, Fischer K, Franceschini N, He C, Kutalik Z, Mangino M, Rose LM, Vernon Smith A, Stolk L, Sulem P, Weedon MN, Zhuang WV, Arnold A, Ashworth A, Bergmann S, Buring JE, Burri A, Chen C, Cornelis MC, Couper DJ, Goodarzi MO, Gudnason V, ReproGen Consortium, et al. [41 more authors] (2013). A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet  22, 1465-72.   https://doi.org/10.1093/hmg/dds551|19. Savage SA, Gadalla SM, Chanock SJ (2013). The long and short of telomeres and cancer association studies. J Natl Cancer Inst  105, 448-9.   https://doi.org/10.1093/jnci/djt041|20. Wilson Sayres MA, Brookes AJ, Chanock SJ, Cheung VG, Goldstein DB, Jin L, Kwok PY (2012). HGV2011: personalized genomic medicine meets the incidentalome. Hum Mutat  33, 582-5.   https://doi.org/10.1002/humu.22008",https://intramural.nih.gov/search/searchview.taf?ipid=79009
668,CP010202-05,"October 01, 2012 -  September 30, 2013","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Arem H, Bobe G, Sampson J, Subar AF, Park Y, Risch H, Hollenbeck A, Mayne ST, Stolzenberg-Solomon RZ (2013). Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. Br J Cancer  108, 1168-72.   https://doi.org/10.1038/bjc.2012.584",https://intramural.nih.gov/search/searchview.taf?ipid=78951
669,CP010206-04,"October 01, 2012 -  September 30, 2013","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Julia  Gage,"Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Karen  Canfell (U New South Wales)|Philip E Castle; PhD, MPH (NCI)|Jane  Kim (Harvard School of Public Health)|Show all 10",Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Lisa  Mirabello (Genetic Epidemiology Branch),NULL,"1. Ajenifuja KO, Gage JC, Adepiti AC, Wentzensen N, Eklund C, Reilly M, Hutchinson M, Burk RD, Schiffman M (2013). A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. Int J Gynecol Cancer  23, 507-12.   https://doi.org/10.1097/IGC.0b013e318280f395|2. Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S (2012). Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J Clin Oncol  30, 3044-50.   https://doi.org/10.1200/JCO.2011.38.8389|3. Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD (2012). Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiol Biomarkers Prev  21, 2125-37.   https://doi.org/10.1158/1055-9965.EPI-12-0905|4. Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM (2013). A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry. Hum Pathol  44, 2542-8.   https://doi.org/10.1016/j.humpath.2013.06.015|5. Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2013). Cervical histopathology variability among laboratories: a population-based statewide investigation. Am J Clin Pathol  139, 330-5.   https://doi.org/10.1309/AJCPSD3ZXJXP7NNB|6. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK (2013). Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst  105, 175-201.   https://doi.org/10.1093/jnci/djs491|7. Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, Lorincz A, Burk RD (2012). Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Cancer Inst  104, 556-65.   https://doi.org/10.1093/jnci/djs135|8. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J (2012). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis  16, 175-204.   https://doi.org/10.1097/LGT.0b013e31824ca9d5|9. Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD (2012). Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst  104, 1738-49.   https://doi.org/10.1093/jnci/djs425",https://intramural.nih.gov/search/searchview.taf?ipid=79010
670,CP010207-04,"October 01, 2012 -  September 30, 2013",PLCO EEMS and Extended Follow Up,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Christine Dorothy Berg (Early Detection Research Group)|Philip  Prorok (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79011
671,CP010209-04,"October 01, 2012 -  September 30, 2013",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR, CVT Vaccine Group (2013). Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One  8, e68329.   https://doi.org/10.1371/journal.pone.0068329|2. Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, Tjønneland A, Overvad K, Quirós JR, González CA, Sánchez MJ, Larrañaga N, Navarro C, Barricarte A, Travis RC, Khaw KT, Wareham N, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Panico S, Masala G, Grioni S, Tumino R, et al. [17 more authors] (2013). Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol  31, 2708-15.   https://doi.org/10.1200/JCO.2012.47.2738|3. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR (2013). Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet  382, 877-87.   https://doi.org/10.1016/S0140-6736(13)60809-0",https://intramural.nih.gov/search/searchview.taf?ipid=79013
672,CP010210-04,"October 01, 2012 -  September 30, 2013","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,"1. Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA (2014). Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. Int J Cancer  134, 411-25.   https://doi.org/10.1002/ijc.28354",https://intramural.nih.gov/search/searchview.taf?ipid=79014
673,CP010211-04,"October 01, 2012 -  September 30, 2013",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Cindy M Chang,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Kelly Jen-Yi Yu (Early Detection Research Group)",NULL,"1. Hildesheim A (2013). Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier. Am J Epidemiol  177, 251-3.   https://doi.org/10.1093/aje/kws403",https://intramural.nih.gov/search/searchview.taf?ipid=79015
674,CP010212-04,"October 01, 2012 -  September 30, 2013",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Bonequi P, Meneses-González F, Correa P, Rabkin CS, Camargo MC (2013). Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control  24, 217-31.   https://doi.org/10.1007/s10552-012-0110-z|2. Hirt C, Weitmann K, Schüler F, Kiefer T, Rabkin CS, Hoffmann W, Dölken G (2013). Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking. Leuk Lymphoma  54, 2678-84.   https://doi.org/10.3109/10428194.2013.788177",https://intramural.nih.gov/search/searchview.taf?ipid=79016
675,CP010213-04,"October 01, 2012 -  September 30, 2013",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Chaturvedi AK (2012). Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol  6 Suppl 1, S16-24.   https://doi.org/10.1007/s12105-012-0377-0|2. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK (2012). Prevalence of oral HPV infection in the United States, 2009-2010. JAMA  307, 693-703.   https://doi.org/10.1001/jama.2012.101|3. Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS (2013). Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer  119, 2291-9.   https://doi.org/10.1002/cncr.27989",https://intramural.nih.gov/search/searchview.taf?ipid=79017
676,CP010214-04,"October 01, 2012 -  September 30, 2013",Microbes and Human Malignancies,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Barbara J Fuhrman (Hormonal and Reproductive Epidemiology Branch)|Roberto  Flores (Nutritional Science Research Group),NULL,"1. Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, North American AIDS Cohort Collaboration on Research and Design of IeDEA, et al. [1 more author] (2013). Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr  62, 405-13.   https://doi.org/10.1097/QAI.0b013e31828177d7|2. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L (2013). Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst  105, 1907-11.   https://doi.org/10.1093/jnci/djt300|3. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, Yuki Y, Del Prete GQ, Goulder P, Brumme ZL, Brumme CJ, John M, Mallal S, Nelson G, Bosch R, Heckerman D, Stein JL, Soderberg KA, Moody MA, Denny TN, Zeng X, Fang J, Moffett A, Lifson JD, Goedert JJ, et al. [12 more authors] (2013). Influence of HLA-C expression level on HIV control. Science  340, 87-91.   https://doi.org/10.1126/science.1232685|4. Cozen W, Yu G, Gail MH, Ridaura VK, Nathwani BN, Hwang AE, Hamilton AS, Mack TM, Gordon JI, Goedert JJ (2013). Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins. Br J Cancer  108, 1163-7.   https://doi.org/10.1038/bjc.2013.60|5. Goedert JJ (2013). The microbiota and human health: beyond exploration. Eur J Clin Invest  43, 657-9.   https://doi.org/10.1111/eci.12100|6. Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ (2013). Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS  27, 635-43.   https://doi.org/10.1097/QAD.0b013e32835cba6c|7. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, et al. [21 more authors] (2013). Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog  9, e1003515.   https://doi.org/10.1371/journal.ppat.1003515|8. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA, et al. [1 more author] (2013). Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One  8, e81355.   https://doi.org/10.1371/journal.pone.0081355|9. Shiels MS, Landgren O, Costello R, Zingone A, Goedert JJ, Engels EA (2012). Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis  55, e103-8.   https://doi.org/10.1093/cid/cis692",https://intramural.nih.gov/search/searchview.taf?ipid=79018
677,CP010215-04,"October 01, 2012 -  September 30, 2013",Human microbiome and cancer,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79019
678,CP010216-04,"October 01, 2012 -  September 30, 2013",Immune responses to HPV infection and HPV vaccination,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Safaeian M, Costa Rican Vaccine Trial Group (2013). HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. PLoS One  8, e53067.   https://doi.org/10.1371/journal.pone.0053067|2. Safaeian M, Rajaraman P, Hartge P, Yeager M, Linet M, Butler MA, Ruder AM, Purdue MP, Hsing A, Beane-Freeman L, Hoppin JA, Albanes D, Weinstein SJ, Inskip PD, Brenner A, Rothman N, Chatterjee N, Gillanders EM, Chanock SJ, Wang SS (2013). Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control  24, 1885-91.   https://doi.org/10.1007/s10552-013-0244-7",https://intramural.nih.gov/search/searchview.taf?ipid=79020
679,CP010217-03,"October 01, 2012 -  September 30, 2013",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Anil Kumar Chaturvedi|Felipe A Castro,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, Boggino H, Codas R, Xavier Bosch F, de Sanjose S, Muñoz N, Hildesheim A, Cubilla AL (2013). Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol  31, 861-7.   https://doi.org/10.1007/s00345-011-0802-0|2. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR (2013). Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet  382, 877-87.   https://doi.org/10.1016/S0140-6736(13)60809-0",https://intramural.nih.gov/search/searchview.taf?ipid=79021
680,CP010218-03,"October 01, 2012 -  September 30, 2013",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Felipe A Castro,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79022
681,CP010219-03,"October 01, 2012 -  September 30, 2013",Studies of other risk factors for radiosensitive tumors,Martha S Linet; PhD|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y, Purdue MP, Schairer C, Berrington de González A (2012). Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control  23, 1615-24.   https://doi.org/10.1007/s10552-012-0039-2|2. Potischman N, Linet MS (2013). Invited commentary: are dietary intakes and other exposures in childhood and adolescence important for adult cancers? Am J Epidemiol  178, 184-9.   https://doi.org/10.1093/aje/kwt101",https://intramural.nih.gov/search/searchview.taf?ipid=79023
682,CP010220-03,"October 01, 2012 -  September 30, 2013",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kubo A, Cook MB, Shaheen NJ, Vaughan TL, Whiteman DC, Murray L, Corley DA (2013). Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut  62, 1684-91.   https://doi.org/10.1136/gutjnl-2012-303753|2. Speaks C, McGlynn KA, Cook MB (2012). Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant. Cancer Causes Control  23, 1593-8.   https://doi.org/10.1007/s10552-012-0036-5",https://intramural.nih.gov/search/searchview.taf?ipid=79024
683,CP010221-03,"October 01, 2012 -  September 30, 2013",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Office of the Director, NCI",Alison Marian Mondul|Jacqueline M Major; MS|Mark  Purdue|Stephanie Joan Weinstein|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Kevin  Jacobs (Laboratory Translational Genomics)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79025
684,CP010222-03,"October 01, 2012 -  September 30, 2013",Studies of Populations Exposed to Diagnostic Medical Radiation,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 13",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Berrington A, Apostoaei A, Veiga L, Rajaraman P, Thomas B, Hoffman F, Gilbert E, Land C (2012) RadRAT: a radiation risk assessment tool for lifetime cancer risk projection. J Radiol Prot 32:205-22|2. Kim KP, Berrington de González A, Pearce MS, Salotti JA, Parker L, McHugh K, Craft AW, Lee C (2012). Development of a database of organ doses for paediatric and young adult CT scans in the United Kingdom. Radiat Prot Dosimetry  150, 415-26.   https://doi.org/10.1093/rpd/ncr429|3. Lee C, Lamart S, Moroz BE (2013). Computational lymphatic node models in pediatric and adult hybrid phantoms for radiation dosimetry. Phys Med Biol  58, N59-82.   https://doi.org/10.1088/0031-9155/58/5/N59|4. Linet MS, Slovis TL, Miller DL, Kleinerman R, Lee C, Rajaraman P, Berrington de Gonzalez A (2012). Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin  62, 75-100.   https://doi.org/10.3322/caac.21132|5. Pearce MS, Salotti JA, Howe NL, McHugh K, Kim KP, Lee C, Craft AW, Berrington de Gonzaléz A, Parker L (2012). CT Scans in Young People in Great Britain: Temporal and Descriptive Patterns, 1993-2002. Radiol Res Pract  2012, 594278.   https://doi.org/10.1155/2012/594278|6. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Sir Craft AW, Parker L, Berrington de González A (2012). Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet  380, 499-505.   https://doi.org/10.1016/S0140-6736(12)60815-0|7. Thierry-Chef I, Dabin J, Friberg EG, Hermen J, Istad TS, Jahnen A, Krille L, Lee C, Maccia C, Nordenskjöld A, Olerud HM, Rani K, Rehel JL, Simon SL, Struelens L, Kesminiene A (2013). Assessing organ doses from paediatric CT scans--a novel approach for an epidemiology study (the EPI-CT study). Int J Environ Res Public Health  10, 717-28.   https://doi.org/10.3390/ijerph10020717|8. Veiga LH, Lubin JH, Anderson H, de Vathaire F, Tucker M, Bhatti P, Schneider A, Johansson R, Inskip P, Kleinerman R, Shore R, Pottern L, Holmberg E, Hawkins MM, Adams MJ, Sadetzki S, Lundell M, Sakata R, Damber L, Neta G, Ron E (2012). A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res  178, 365-76.   https://doi.org/10.1667/rr2889.1",https://intramural.nih.gov/search/searchview.taf?ipid=79026
685,CP010224-02,"October 01, 2012 -  September 30, 2013",Esophageal cancer genetic project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Chaoyu C Wang|Alisa  Goldstein; PhD,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|DongXin  Lin (CICAMS)|XiaoOu  Shu (Vanderbilt University)|LiDong  Wang (Zhengzhou Medical University)|JianMin  Yuan (University of Pittsburgh)|Wei  Zheng (Vanderbilt University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79028
686,CP010225-02,"October 01, 2012 -  September 30, 2013",Barretts esophagus early detection project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Paula L Hyland|Melissa  Rotunno,NULL,"Ruth  Pfeiffer; PhD (Biostatistics Branch)|Sanford Martin Dawsey; MD (Nutritional Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79029
687,SC000167-22,"October 01, 2012 -  September 30, 2013",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,Shioko  Kimura; PhD (Endocrinology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79040
688,SC000550-33,"October 01, 2012 -  September 30, 2013",Lymphoma Disease Discovery and Defintion,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Karthik Ayyappankave Ganapathi|Alina  Nicolae|Xiangrong  Zhao|Shahed  Abdullah|Moses Osemwingie Evbuomwan|Show all 10,"Wing  Chan (Pathology, University of Nebraska)|Andreas  Chott (Pathology, University of Vienna)|Elias  Campo (University of Barcelona)|Nancy  Harris|Steven  Swerdlow (University of Pittsburgh Med Center)|Randy  Gascoyne (British Columbia Cancer Center)|Show all 10","Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|George W Wright (Biometrics Research Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)","Jeffrey  Cohen; MD (NIAID) |Vemulkonda Koneti Rao; MD, FRCPA (NIAID)","1. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|2. Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, Liu Z, Lachel CM, Deffenbacher K, Greiner TC, Vose JM, Bhagavathi S, Staudt LM, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, McKeithan TW, et al. [1 more author] (2012). Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood  119, 4939-48.   https://doi.org/10.1182/blood-2011-07-370122|3. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57|4. Menon MP, Pittaluga S, Jaffe ES (2012). The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification. Cancer J  18, 411-20.   https://doi.org/10.1097/PPO.0b013e31826aee97|5. Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD (2012). The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. Am J Hematol  87, 790-4.   https://doi.org/10.1002/ajh.23205|6. Ranuncolo SM, Pittaluga S, Evbuomwan MO, Jaffe ES, Lewis BA (2012). Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival. Blood  120, 3756-63.   https://doi.org/10.1182/blood-2012-01-405951|7. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, et al. [17 more authors] (2012). Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature  490, 116-20.   https://doi.org/10.1038/nature11378",https://intramural.nih.gov/search/searchview.taf?ipid=79041
689,SC000892-30,"October 01, 2012 -  September 30, 2013",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Joshua Wade Collins|Emily  Hua|Natascia  Marino,Maximillian  Murone (Debio Pharmaceuticals)|George  Sledge Jr (Indiana University)|Fernando  VidalVanaclocha (CEU-San Pablo University School of Medicine),Maria  Merino; PhD (Laboratory of Pathology)|Natasha  Caplen (Cancer Genetics Branch),NULL,"1. Marshall JC, Collins JW, Nakayama J, Horak CE, Liewehr DJ, Steinberg SM, Albaugh M, Vidal-Vanaclocha F, Palmieri D, Barbier M, Murone M, Steeg PS (2012). Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer. J Natl Cancer Inst  104, 1306-19.   https://doi.org/10.1093/jnci/djs319|2. Steeg PS (2012). Perspective: The right trials. Nature  485, S58-9.   https://doi.org/10.1038/485S58a",https://intramural.nih.gov/search/searchview.taf?ipid=79043
690,SC003657-39,"October 01, 2012 -  September 30, 2013",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI",NULL,NULL,"Howard A Young; PhD (Laboratory of Experimental Immunology)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",Keiko  Ozato; PhD (NICHD),"1. Miyagawa F, Zhang H, Terunuma A, Ozato K, Tagaya Y, Katz SI (2012). Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells. Proc Natl Acad Sci U S A  109, 12123-8.   https://doi.org/10.1073/pnas.1201453109|2. Paek SY, Miyagawa F, Zhang H, Linton JT, Hoover SB, Simpson RM, Katz SI (2012). Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity. J Invest Dermatol  132, 677-86.   https://doi.org/10.1038/jid.2011.347",https://intramural.nih.gov/search/searchview.taf?ipid=79044
691,SC003669-24,"October 01, 2012 -  September 30, 2013",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Yoichi  Ogawa|Takeshi  Ouchi; MD,Keisuke  Nagao (Keio University Schiool of Medicine)|Adam  Glick; PhD (NCI),NULL,Maria Irene Morasso; PhD (NIAMS) |Ulrich K Siebenlist; PhD (NIAID),"1. Gaiser MR, Lämmermann T, Feng X, Igyarto BZ, Kaplan DH, Tessarollo L, Germain RN, Udey MC (2012). Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc Natl Acad Sci U S A  109, E889-97.   https://doi.org/10.1073/pnas.1117674109|2. Mohammed J, Gunderson AJ, Khong HH, Koubek RD, Udey MC, Glick AB (2013). TGFβ1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity. J Invest Dermatol  133, 135-43.   https://doi.org/10.1038/jid.2012.241|3. Nagao K, Kobayashi T, Moro K, Ohyama M, Adachi T, Kitashima DY, Ueha S, Horiuchi K, Tanizaki H, Kabashima K, Kubo A, Cho YH, Clausen BE, Matsushima K, Suematsu M, Furtado GC, Lira SA, Farber JM, Udey MC, Amagai M (2012). Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol  13, 744-52.   https://doi.org/10.1038/ni.2353|4. Udey MC (2012). Epidermal Langerhans cells tune skin reactivity to contact allergens. J Clin Invest  122, 1602-5.   https://doi.org/10.1172/JCI63190",https://intramural.nih.gov/search/searchview.taf?ipid=79045
692,SC004002-44,"October 01, 2012 -  September 30, 2013",IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Jing  Chen|Sigrid Priscilla Dubois|Wei  Ju|Juergen R Mueller; PhD|Masao  Nakagawa|Liyanage P Perera; PhD|Show all 9,"Nicole  Urquhart (Dept of, University of the West Indies)|Sandor  Damjanovich MD (University of Debrecen)|Bana  Jabri (University of Chicago)|Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)","Martin W Brechbiel; PhD (Radiation Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Steven J Jacobson; PhD (NINDS) |Bibiana  Bielekova; MD (NINDS),"1. Müller JR, Waldmann TA, Kruhlak MJ, Dubois S (2012). Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells. J Biol Chem  287, 40328-38.   https://doi.org/10.1074/jbc.M112.378612|2. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, et al. [17 more authors] (2012). Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature  490, 116-20.   https://doi.org/10.1038/nature11378|3. Yang Y, Shaffer AL, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, Young RM, Zhao H, Yang Y, Xu W, Buggy JJ, Balasubramanian S, Mathews LA, Shinn P, Guha R, Ferrer M, Thomas C, Waldmann TA, Staudt LM (2012). Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell  21, 723-37.   https://doi.org/10.1016/j.ccr.2012.05.024|4. Yu P, Steel JC, Zhang M, Morris JC, Waitz R, Fasso M, Allison JP, Waldmann TA (2012). Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Proc Natl Acad Sci U S A  109, 6187-92.   https://doi.org/10.1073/pnas.1203479109",https://intramural.nih.gov/search/searchview.taf?ipid=79047
693,SC004020-36,"October 01, 2012 -  September 30, 2013","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Blake Francis Frey|Alison Elizabeth Hogg|Meghan  Hughes|Liat  Izhak|Shingo  Kato; MD, PhD|Laurel  Lagenaur; PhD|Show all 19","Charles  Delisi|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Mark  Smyth (University of Melbourne)|Show all 33","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|William Marston Linehan; MD (Urologic Oncology Branch)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Ira H Pastan; MD (Molecular Biology Section)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Raj K Puri (OD) |Warren J Leonard; MD (NHLBI)","1. Berzofsky JA (2012). Improving immunotherapy: revisiting the immunologist's little secret. Sci Transl Med  4, 120fs4.   https://doi.org/10.1126/scitranslmed.3003658|2. Berzofsky JA, Terabe M, Wood LV (2012). Strategies to use immune modulators in therapeutic vaccines against cancer. Semin Oncol  39, 348-57.   https://doi.org/10.1053/j.seminoncol.2012.02.002|3. Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN (2012). A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunol Immunother  61, 373-84.   https://doi.org/10.1007/s00262-011-1100-9|4. Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters RC, Kirk J, Eppler B, Klinman DM, Sui Y, Gagnon S, Belyakov IM, Mumper RJ, Berzofsky JA (2012). Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med  18, 1291-6.   https://doi.org/10.1038/nm.2866",https://intramural.nih.gov/search/searchview.taf?ipid=79048
694,SC006321-34,"October 01, 2012 -  September 30, 2013",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Kristin  Askin|Janet W Gamson|Askale Y Mathias|Show all 9,NULL,Deborah E Citrin (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD)","1. Baum BJ, Alevizos I, Zheng C, Cotrim AP, Liu S, McCullagh L, Goldsmith CM, Burbelo PD, Citrin DE, Mitchell JB, Nottingham LK, Rudy SF, Van Waes C, Whatley MA, Brahim JS, Chiorini JA, Danielides S, Turner RJ, Patronas NJ, Chen CC, Nikolov NP, Illei GG (2012). Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A  109, 19403-7.   https://doi.org/10.1073/pnas.1210662109|2. Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB, Gutkind JS (2012). mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell  11, 401-14.   https://doi.org/10.1016/j.stem.2012.06.007|3. Sourbier C, Srivastava G, Ghosh MC, Ghosh S, Yang Y, Gupta G, Degraff W, Krishna MC, Mitchell JB, Rouault TA, Linehan WM (2012). Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma. Oncotarget  3, 1472-82.   https://doi.org/10.18632/oncotarget.561",https://intramural.nih.gov/search/searchview.taf?ipid=79049
695,SC006330-33,"October 01, 2012 -  September 30, 2013",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|Hu-Chen  Xie|Ying  Zhuge,"Thomas  Fearon (Radiology, Children's National Medical Center)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79035
696,SC006353-31,"October 01, 2012 -  September 30, 2013",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Francois  Guerard; PhD|Young-Seung  Kim|Diane E Milenic|Kwon Joong  Yong|Kevin A Camphausen; MD|Show all 7,"Andrew  Scott (Ludwig Institute for Cancer Research)|Ruby  Meredith (UAB)|Silvia  Jurisson (University of Missouri, Columbia)|Tom  Quinn (U. Missouri, Co.)|Marty  Pomper (Johns Hopkins)","Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|James B Mitchell; PhD (Radiation Biology Branch)",Peter  Herscovitch; MD (CC),"1. Baidoo KE, Yong K, Brechbiel MW (2013). Molecular pathways: targeted α-particle radiation therapy. Clin Cancer Res  19, 530-7.   https://doi.org/10.1158/1078-0432.CCR-12-0298|2. Guérard F, Lee YS, Tripier R, Szajek LP, Deschamps JR, Brechbiel MW (2013). Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging. Chem Commun (Camb)  49, 1002-4.   https://doi.org/10.1039/c2cc37549d|3. Nayak TK, Garmestani K, Milenic DE, Brechbiel MW (2012). PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab. J Nucl Med  53, 113-20.   https://doi.org/10.2967/jnumed.111.094169|4. Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW (2012). (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease. Mol Cancer Ther  11, 639-48.   https://doi.org/10.1158/1535-7163.MCT-11-0671|5. Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW (2013). Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51. Int J Radiat Oncol Biol Phys  85, 1119-26.   https://doi.org/10.1016/j.ijrobp.2012.09.015|6. Zhou Y, Baidoo KE, Brechbiel MW (2013). Mapping biological behaviors by application of longer-lived positron emitting radionuclides. Adv Drug Deliv Rev  65, 1098-111.   https://doi.org/10.1016/j.addr.2012.10.012",https://intramural.nih.gov/search/searchview.taf?ipid=79050
697,SC006387-26,"October 01, 2012 -  September 30, 2013",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Kristin  Askin|Janet W Gamson|Askale Y Mathias|Show all 9,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section),Tracey Ann Rouault; MD (NICHD),"1. Hyodo F, Davis RM, Hyodo E, Matsumoto S, Krishna MC, Mitchell JB (2012). The relationship between tissue oxygenation and redox status using magnetic             resonance imaging. Int J Oncol  41, 2103-8.   https://doi.org/10.3892/ijo.2012.1638",https://intramural.nih.gov/search/searchview.taf?ipid=79051
698,SC006538-20,"October 01, 2012 -  September 30, 2013",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI",Cindy Huong-Bich Chau|Elena Valerie Fernandez|Douglas K Price|Kelie M Reece; PhD|William Laurence Dahut; MD|Andrea Borghese Apolo|Show all 7,"Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Edward  Goetzl (University of California, San Francisco)","Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|John J Wright (Investigational Drug Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)",NULL,"1. Chau CH, Figg WD (2012). Aflibercept in pediatric solid tumors: moving beyond the trap. Clin Cancer Res  18, 4868-71.   https://doi.org/10.1158/1078-0432.CCR-12-2212|2. Chau CH, Figg WD (2012). Angiogenesis inhibitors increase tumor stem cells. Cancer Biol Ther  13, 586-7.   https://doi.org/10.4161/cbt.19852",https://intramural.nih.gov/search/searchview.taf?ipid=79052
699,SC006581-30,"October 01, 2012 -  September 30, 2013",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Yulia  Demchenko,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch),NULL,"1. Kuehl WM, Bergsagel PL (2012). Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest  122, 3456-63.   https://doi.org/10.1172/JCI61188",https://intramural.nih.gov/search/searchview.taf?ipid=79053
700,SC006663-24,"October 01, 2012 -  September 30, 2013",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Marybeth S Hughes,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Joanna H Shih (Biometrics Research Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79054
701,SC006732-25,"October 01, 2012 -  September 30, 2013","Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance","Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Marianne  Poruchynsky|Wilfred D Stein|Julia  Wilkerson|Susan  Bates; MD|William D Figg; PharmD|Douglas K Price|Show all 8,NULL,"James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)",Robert  Innis; MD (NIMH),"1. Blagoev KB, Wilkerson J, Stein WD, Motzer RJ, Bates SE, Fojo AT (2013). Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma. Cell Rep  3, 277-81.   https://doi.org/10.1016/j.celrep.2013.01.015|2. Stein WD, Wilkerson J, Kim ST, Huang X, Motzer RJ, Fojo AT, Bates SE (2012). Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth. Clin Cancer Res  18, 2374-81.   https://doi.org/10.1158/1078-0432.CCR-11-2275",https://intramural.nih.gov/search/searchview.taf?ipid=79055
702,SC006737-22,"October 01, 2012 -  September 30, 2013",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Suraj  Mishra|Hiroaki  Mitsuya,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Frank  Maldarelli (Host Virus Interaction Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)",Paul T Wingfield; PhD (NIAMS) |John Grant Bernbaum (NIAID) |Stephen J Stahl; PhD (NIAMS),"1. Davis DA, Soule EE, Davidoff KS, Daniels SI, Naiman NE, Yarchoan R (2012). Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing. Antimicrob Agents Chemother  56, 3620-8.   https://doi.org/10.1128/AAC.00055-12",https://intramural.nih.gov/search/searchview.taf?ipid=79056
703,SC006738-22,"October 01, 2012 -  September 30, 2013",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Kenji  Maeda|Yuki  Takamatsu; MD|Ravikiran S Yedidi|Robert  Yarchoan; MD,"Arun  Ghosh|Masao 		  Matsuoka (Institute for Virus Research, Kyoto University)|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Hiroyuki  Hayakawa (Yamasa Corporation)|Hiromi  OgataAoki (Kumamoto University School of Medicine)|Show all 11",NULL,Paul T Wingfield; PhD (NIAMS),"1. Ghosh AK, Chapsal BD, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2012). Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. Bioorg Med Chem Lett  22, 2308-11.   https://doi.org/10.1016/j.bmcl.2012.01.061|2. Michailidis E, Singh K, Ryan EM, Hachiya A, Ong YT, Kirby KA, Marchand B, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG (2012). Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant. Cell Mol Biol (Noisy-le-grand)  58, 187-95.|3. Murphey-Corb M, Rajakumar P, Michael H, Nyaundi J, Didier PJ, Reeve AB, Mitsuya H, Sarafianos SG, Parniak MA (2012). Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo. Antimicrob Agents Chemother  56, 4707-12.   https://doi.org/10.1128/AAC.00723-12|4. Sohl CD, Kasiviswanathan R, Kim J, Pradere U, Schinazi RF, Copeland WC, Mitsuya H, Baba M, Anderson KS (2012). Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Mol Pharmacol  82, 125-33.   https://doi.org/10.1124/mol.112.078758|5. Sohl CD, Singh K, Kasiviswanathan R, Copeland WC, Mitsuya H, Sarafianos SG, Anderson KS (2012). Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicity. Antimicrob Agents Chemother  56, 1630-4.   https://doi.org/10.1128/AAC.05729-11",https://intramural.nih.gov/search/searchview.taf?ipid=79036
704,SC006741-21,"October 01, 2012 -  September 30, 2013",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH (2013). Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med  369, 1915-25.   https://doi.org/10.1056/NEJMoa1308392",https://intramural.nih.gov/search/searchview.taf?ipid=79037
705,SC006891-25,"October 01, 2012 -  September 30, 2013",Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Lauren M Long|Eyal Mordechai Ramu|Crystal L. Mackall; MD|Brigitte  Widemann; MD,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Arnaldez FI, Helman LJ (2012). Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am  26, 527-42, vii-viii.   https://doi.org/10.1016/j.hoc.2012.01.004|2. Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ (2012). Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist  17, 321.   https://doi.org/10.1634/theoncologist.2010-0265|3. Grohar PJ, Segars LE, Yeung C, Pommier Y, D'Incalci M, Mendoza A, Helman LJ (2014). Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. Clin Cancer Res  20, 1190-203.   https://doi.org/10.1158/1078-0432.CCR-13-0901|4. Teicher BA, Linehan WM, Helman LJ (2012). Targeting cancer metabolism. Clin Cancer Res  18, 5537-45.   https://doi.org/10.1158/1078-0432.CCR-12-2587|5. Wiener L, Battles H, Zadeh S, Smith CJ, Helman LJ, Kim SY (2012). Gastrointestinal stromal tumor: psychosocial characteristics and considerations. Support Care Cancer  20, 1343-9.   https://doi.org/10.1007/s00520-012-1426-7",https://intramural.nih.gov/search/searchview.taf?ipid=79057
706,SC006892-25,"October 01, 2012 -  September 30, 2013",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Amy Claire McCalla-Martin|Arnulfo G Mendoza|Xiaolin  Wan|Choh L Yeung,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)","Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Arnaldez FI, Helman LJ (2012). Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am  26, 527-42, vii-viii.   https://doi.org/10.1016/j.hoc.2012.01.004|2. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|3. Wan X, Yeung C, Kim SY, Dolan JG, Ngo VN, Burkett S, Khan J, Staudt LM, Helman LJ (2012). Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Res  72, 5889-99.   https://doi.org/10.1158/0008-5472.CAN-12-1991",https://intramural.nih.gov/search/searchview.taf?ipid=79058
707,SC007263-21,"October 01, 2012 -  September 30, 2013",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Jennifer Lynn Dine|Donna M Voeller,Mauricio A Cuello|Sandra M Swain; MD|David  Tice (MedImmune),"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Christina M Annunziata (Medical Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79059
708,SC007281-20,"October 01, 2012 -  September 30, 2013",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Julie Lynn Heinecke; PhD|Lisa Ann Ridnour|Christopher H Switzer|James B Mitchell; PhD,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Larry K Keefer; PhD (Chemical Biology Laboratory)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office of the Director),NULL,"1. Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA (2012). Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol  25, 769-93.   https://doi.org/10.1021/tx2005234|2. Heinrich TA, da Silva RS, Miranda KM, Switzer CH, Wink DA, Fukuto JM (2013). Biological nitric oxide signalling: chemistry and terminology. Br J Pharmacol  169, 1417-29.   https://doi.org/10.1111/bph.12217|3. Moody TW, Osefo N, Nuche-Berenguer B, Ridnour L, Wink D, Jensen RT (2012). Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. J Pharmacol Exp Ther  341, 873-81.   https://doi.org/10.1124/jpet.111.190033|4. Ridnour LA, Cheng RY, Switzer CH, Heinecke JL, Ambs S, Glynn S, Young HA, Trinchieri G, Wink DA (2013). Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity. Clin Cancer Res  19, 1340-6.   https://doi.org/10.1158/1078-0432.CCR-12-0408|5. Switzer CH, Cheng RY, Ridnour LA, Glynn SA, Ambs S, Wink DA (2012). Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. Breast Cancer Res  14, R125.   https://doi.org/10.1186/bcr3319|6. Switzer CH, Glynn SA, Cheng RY, Ridnour LA, Green JE, Ambs S, Wink DA (2012). S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol Cancer Res  10, 1203-15.   https://doi.org/10.1158/1541-7786.MCR-12-0124|7. Switzer CH, Ridnour LA, Cheng R, Heinecke J, Burke A, Glynn S, Ambs S, Wink DA (2012). S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer. For Immunopathol Dis Therap  3, 117-124.   https://doi.org/10.1615/ForumImmunDisTher.2012006108",https://intramural.nih.gov/search/searchview.taf?ipid=79060
709,SC009144-29,"October 01, 2012 -  September 30, 2013",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Laura  Baranello|Hye-Jung  Chung|Fedor Edmundovich Kouzine|Zuqin  Nie; PhD|Suzanne Laurie Sanford|Show all 9,NULL,"Lino  Tessarollo (Mouse Cancer Genetics Program)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),"1. Grøntved L, Bandle R, John S, Baek S, Chung HJ, Liu Y, Aguilera G, Oberholtzer C, Hager GL, Levens D (2012). Rapid genome-scale mapping of chromatin accessibility in tissue. Epigenetics Chromatin  5, 10.   https://doi.org/10.1186/1756-8935-5-10",https://intramural.nih.gov/search/searchview.taf?ipid=79061
710,SC009163-26,"October 01, 2012 -  September 30, 2013",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Alexandre  Buckley de Meritens|Giovanna  Casagrande|Andrea  Fischone|Marco  Mineo|Sharon Ann Romano|Victoria M Virador|Show all 8,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Riccardo  Alessandro (U-Palermo)|Thomas  Conrads (USUHS),"David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Robert  Callahan; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)",NULL,"1. Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC (2012). L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med  16, 2369-78.   https://doi.org/10.1111/j.1582-4934.2012.01547.x",https://intramural.nih.gov/search/searchview.taf?ipid=79062
711,SC009172-25,"October 01, 2012 -  September 30, 2013",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|Gema  Martin-Manso|Michael L Pendrak|John M Sipes|David Ricardo Soto Pantoja; PhD|Erica  Stein|Show all 7,"Willaim  Frazier (Biochemistry and Molecular Biophysics, Washington University)|Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)",David Anderson Wink (Radiation Biology Branch),Abdel G Elkahloun; PhD (NHGRI) |Chengyu  Liu; PhD (NHLBI),"1. Roberts D, Frazier W (2013) Thrombospondins and Their Receptors: Evolving Functions, in Evolution of Extracellular Matrix. Keeley F, Mecham R, eds., pp. 221-242.|2. Roberts D, SotoPantoja D, Isenberg J (2012) CD47, in Encyclopedia of Signaling Molecules., pp. 335-343.|3. Rogers N, Yao M, Zimmerman M, Roberts D, Isenberg J (2012) Ex vivo and In vivo Assessments of Angiogenesis, Blood Flow and Vasoactive Capability, in The Textbook of Angiogenesis and Lymphangiogenesis: Methods and Applications. Zudaire E, Cuttitta F, eds., pp. 349-374.|4. SotoPantoja D, Roberts D (2012) Thrombospondin-1, in Encyclopedia of Signaling Molecules. Choi S, ed., pp. 1846-1852.|5. Kaur S, Soto-Pantoja DR, Stein EV, Liu C, Elkahloun AG, Pendrak ML, Nicolae A, Singh SP, Nie Z, Levens D, Isenberg JS, Roberts DD (2013). Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci Rep  3, 1673.   https://doi.org/10.1038/srep01673|6. Martin-Manso G, Navarathna DH, Galli S, Soto-Pantoja DR, Kuznetsova SA, Tsokos M, Roberts DD (2012). Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis. PLoS One  7, e48775.   https://doi.org/10.1371/journal.pone.0048775|7. Roberts DD, Miller TW, Rogers NM, Yao M, Isenberg JS (2012). The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol  31, 162-9.   https://doi.org/10.1016/j.matbio.2012.01.005|8. Rogers NM, Roberts DD, Isenberg JS (2013). Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow. Ann Surg  258, 184-91.   https://doi.org/10.1097/SLA.0b013e31827e52e1|9. Rogers NM, Yao M, Novelli EM, Thomson AW, Roberts DD, Isenberg JS (2012). Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management. Am J Physiol Renal Physiol  303, F1117-25.   https://doi.org/10.1152/ajprenal.00359.2012|10. Soto-Pantoja DR, Miller TW, Frazier WA, Roberts DD (2012). Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies. Proc Natl Acad Sci U S A  109, E2842; author reply E2844-5.   https://doi.org/10.1073/pnas.1205441109|11. Soto-Pantoja DR, Miller TW, Pendrak ML, DeGraff WG, Sullivan C, Ridnour LA, Abu-Asab M, Wink DA, Tsokos M, Roberts DD (2012). CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy  8, 1628-42.   https://doi.org/10.4161/auto.21562|12. Soto-Pantoja DR, Ridnour LA, Wink DA, Roberts DD (2013). Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci Rep  3, 1038.   https://doi.org/10.1038/srep01038|13. Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD (2013). Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47. Expert Opin Ther Targets  17, 89-103.   https://doi.org/10.1517/14728222.2013.733699|14. SotoPantoja D, Kaur S, Miller T, Isenberg J, Roberts D (2013) Leukocyte surface antigen CD47. Signaling Gateway, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=79032
712,SC009173-25,"October 01, 2012 -  September 30, 2013",Host Colonization and Vascular Dissemination of Candida albicans,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Gema  Martin-Manso|Michael L Pendrak|John M Sipes|Erica  Stein,NULL,NULL,Martin J Lizak; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Michail S Lionakis (NIAID) |Dorian  McGavern (NINDS),"1. Martin-Manso G, Navarathna DH, Galli S, Soto-Pantoja DR, Kuznetsova SA, Tsokos M, Roberts DD (2012). Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis. PLoS One  7, e48775.   https://doi.org/10.1371/journal.pone.0048775|2. Navarathna DH, Lionakis MS, Lizak MJ, Munasinghe J, Nickerson KW, Roberts DD (2012). Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans. PLoS One  7, e48475.   https://doi.org/10.1371/journal.pone.0048475",https://intramural.nih.gov/search/searchview.taf?ipid=79033
713,SC009174-25,"October 01, 2012 -  September 30, 2013",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|John M Sipes,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University),David Anderson Wink (Radiation Biology Branch),NULL,"1. Roberts D, SotoPantoja D, Isenberg J (2012) CD47, in Encyclopedia of Signaling Molecules., pp. 335-343.|2. Miller TW, Kaur S, Ivins-O'Keefe K, Roberts DD (2013). Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biol  32, 316-24.   https://doi.org/10.1016/j.matbio.2013.02.009|3. Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD (2012). Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem  287, 4211-21.   https://doi.org/10.1074/jbc.M111.307819|4. Roberts DD, Miller TW, Rogers NM, Yao M, Isenberg JS (2012). The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol  31, 162-9.   https://doi.org/10.1016/j.matbio.2012.01.005|5. Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD (2013). Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47. Expert Opin Ther Targets  17, 89-103.   https://doi.org/10.1517/14728222.2013.733699|6. SotoPantoja D, Kaur S, Miller T, Isenberg J, Roberts D (2013) Leukocyte surface antigen CD47. Signaling Gateway, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=79031
714,SC009179-25,"October 01, 2012 -  September 30, 2013",The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Huiying  Han|Sandra  Jensen-Taubman|Laurie Ann  Shuman Moss|Beiyang  Wei,"Dong-Wan  Seo (Laboratory of Molecular Biochemistry, Kangwon National University)|Junseo  Oh (Korea University Graduate School Of Medicine)","Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-Stevenson WG (2013). TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells. Oncotarget  4, 166-76.   https://doi.org/10.18632/oncotarget.801|2. Bourboulia D, JensenTaubman S, Stetler-Stevenson W (2012) TIMP-2 An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties. Treat Strategies Hematol 2:31-35|3. Guedez L, Jensen-Taubman S, Bourboulia D, Kwityn CJ, Wei B, Caterina J, Stetler-Stevenson WG (2012). TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J Immunother  35, 502-12.   https://doi.org/10.1097/CJI.0b013e3182619c8e|4. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L (2012). Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle  11, 3649-55.   https://doi.org/10.4161/cc.21926|5. Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG (2012). Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol  181, 1895-9.   https://doi.org/10.1016/j.ajpath.2012.08.044|6. Stetler-Stevenson W, Bourboulia D, Guedex L, JensenTaubman S (2012) Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development. Curr Angiogenesis 1:148-56",https://intramural.nih.gov/search/searchview.taf?ipid=79063
715,SC009374-22,"October 01, 2012 -  September 30, 2013",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",John Lawrence Hays|Saawan C Mehta|Marco  Mineo|Minshu R Yu|William D Figg; PharmD|Christina M Annunziata,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Riccardo  Alessandro (U-Palermo)|Yiling  Lu (MD Anderson Cancer Center),David Jay Goldstein (Office of the Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Eric Christopher Polley (Biometrics Research Branch),NULL,"1. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, Kohn EC (2012). Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis  15, 33-45.   https://doi.org/10.1007/s10456-011-9241-1|2. Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC (2012). L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer. J Cell Mol Med  16, 2369-78.   https://doi.org/10.1111/j.1582-4934.2012.01547.x",https://intramural.nih.gov/search/searchview.taf?ipid=79064
716,SC009375-21,"October 01, 2012 -  September 30, 2013",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Alexandre  Buckley de Meritens|Andrea  Fischone|Jasmine  Han; MD|John Lawrence Hays|Jessica Kent-Glover Hearn|Nicole Dupas Houston|Show all 13,Ben  Davidson (Norwegian Radium Hospital)|Gordon  Mills (MD Anderson Cancer Center)|Joyce  Liu (DFCI)|Ursula  Matulonis (DFCI)|Thomas  Conrads (USUHS)|Laura  Havriletsky (Duke University)|Show all 9,Chad Andrew Hamilton (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|James Halpern Doroshow (Developmental Therapeutics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert F Murphy (Pediatric Oncology Branch),Bradford J Wood; MD (CC),"1. Annunziata CM, Kohn EC, LoRusso P, Houston ND, Coleman RL, Buzoianu M, Robbie G, Lechleider R (2013). Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors. Invest New Drugs  31, 77-84.   https://doi.org/10.1007/s10637-012-9801-2|2. Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013). Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics  12, 1621-31.   https://doi.org/10.1074/mcp.M112.026427|3. Kohn EC, Hurteau J (2013). Ovarian cancer : making its own rules-again. Cancer  119, 474-6.   https://doi.org/10.1002/cncr.27833|4. Lee JM, Hays JL, Noonan AM, Squires J, Minasian L, Annunziata C, Wood BJ, Yu M, Calvo KR, Houston N, Azad N, Kohn EC (2013). Feasibility and safety of sequential research-related tumor core biopsies in clinical trials. Cancer  119, 1357-64.   https://doi.org/10.1002/cncr.27916|5. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484",https://intramural.nih.gov/search/searchview.taf?ipid=79065
717,SC009389-20,"October 01, 2012 -  September 30, 2013",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Juanjuan  Yin,Ginesa  GarciaRostan (University of Valladolid)|Massimo  Santoro,"Sheueyann  Cheng; PhD (Gene Regulation Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79066
718,SC010051-18,"October 01, 2012 -  September 30, 2013",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Young-Seung  Kim|Diane E Milenic|Yang  Zhou,NULL,NULL,Lacy Henry Bryant (CC) |Daniel  Appella; PhD (NIDDK),"1. Huang CH, Nwe K, Al Zaki A, Brechbiel MW, Tsourkas A (2012). Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents. ACS Nano  6, 9416-24.   https://doi.org/10.1021/nn304160p|2. Kim YS, Nwe K, Milenic DE, Brechbiel MW, Satz S, Baidoo KE (2012). Synthesis and characterization of αvβ₃-targeting peptidomimetic chelate conjugates for PET and SPECT imaging. Bioorg Med Chem Lett  22, 5517-22.   https://doi.org/10.1016/j.bmcl.2012.07.024|3. Nwe K, Kim YS, Milenic DE, Baidoo KE, Brechbiel MW (2012). (111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an α(v)β(3) Integrin-Binding Radiotracer. J Labelled Comp Radiopharm  55, 423-426.   https://doi.org/10.1002/jlcr.2965",https://intramural.nih.gov/search/searchview.taf?ipid=79069
719,SC010074-18,"October 01, 2012 -  September 30, 2013",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Alok  Mishra|Mehdi  Mollapour|Thomas L Prince|Harvey Grant Schwartz|Manabu  Tatokoro|Show all 10,"YunJin  Jung (Pusan National University)|Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Show all 12",Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Jane Beth Trepel (Medical Oncology Branch)|James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Cheng Q, Chang JT, Geradts J, Neckers LM, Haystead T, Spector NL, Lyerly HK (2012). Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res  14, R62.   https://doi.org/10.1186/bcr3168|2. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L (2012). Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle  11, 3649-55.   https://doi.org/10.4161/cc.21926|3. Kim YS, Kumar V, Lee S, Iwai A, Neckers L, Malhotra SV, Trepel JB (2012). Methoxychalcone inhibitors of androgen receptor translocation and function. Bioorg Med Chem Lett  22, 2105-9.   https://doi.org/10.1016/j.bmcl.2011.12.141|4. Shim JS, Rao R, Beebe K, Neckers L, Han I, Nahta R, Liu JO (2012). Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. J Natl Cancer Inst  104, 1576-90.   https://doi.org/10.1093/jnci/djs396|5. Solier S, Kohn KW, Scroggins B, Xu W, Trepel J, Neckers L, Pommier Y (2012). Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A  109, 12866-72.   https://doi.org/10.1073/pnas.1203617109|6. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007|7. Tsutsumi S, Mollapour M, Prodromou C, Lee CT, Panaretou B, Yoshida S, Mayer MP, Neckers LM (2012). Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proc Natl Acad Sci U S A  109, 2937-42.   https://doi.org/10.1073/pnas.1114414109|8. Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L (2012). Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol Cell  47, 434-43.   https://doi.org/10.1016/j.molcel.2012.05.015|9. Xu W, Neckers L (2012). The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity. Future Oncol  8, 939-42.   https://doi.org/10.2217/fon.12.80",https://intramural.nih.gov/search/searchview.taf?ipid=79071
720,SC010093-17,"October 01, 2012 -  September 30, 2013",Targeting the Epigenome for Lung Cancer Therapy,David  Schrump; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Medical Oncology Branch)|Victor  Marquez; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79039
721,SC010098-11,"October 01, 2012 -  September 30, 2013",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Medical Oncology Branch, NCI","Anna C Couvillon; NP|Nancy A Harold|Guinevere Joy Ng Chun|Philip M Arlen; MD|William D Figg; PharmD|Antonio  Fojo; MD, PhD","Anthony  D'Amico (Radiation Oncology, Harvard Medical School)|Phil  Kantoff (DFCI)","James L Gulley; MD, PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Figg WD, Chau CH, Madan RA, Gulley JL, Gao R, Sissung TM, Spencer S, Beatson M, Aragon-Ching J, Steinberg SM, Dahut WL (2013). Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity. Clin Genitourin Cancer  11, 229-37.   https://doi.org/10.1016/j.clgc.2013.04.007|3. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|4. Gulley JL, Leitman SF, Dahut W, Schlom J (2012). Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J Natl Cancer Inst  104, 1106; author reply 1109-12.   https://doi.org/10.1093/jnci/djs280|5. Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL (2012). Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis  15, 289-95.   https://doi.org/10.1038/pcan.2012.7|6. Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, Adler SS, Turkbey B, Dahut W, Gulley JL, Madan RA, Landgren O, Choyke PL (2012). The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med  53, 1175-84.   https://doi.org/10.2967/jnumed.111.100883|7. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol  13, 501-8.   https://doi.org/10.1016/S1470-2045(12)70006-2|8. Madan RA, Shah AA, Dahut WL (2013). Is it time to reevaluate definitive therapy in prostate cancer? J Natl Cancer Inst  105, 683-5.   https://doi.org/10.1093/jnci/djt094|9. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484",https://intramural.nih.gov/search/searchview.taf?ipid=79093
722,SC010282-16,"October 01, 2012 -  September 30, 2013",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Shannon I Skarshaug|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Mohammed Zulfiqar Farooqui; DO (NHLBI)","1. Degheidy HA, Gadalla SM, Farooqui MZ, Abbasi F, Arthur DC, Bauer SR, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2013). Bcl-2 level as a biomarker for 13q14 deletion in CLL. Cytometry B Clin Cytom  84, 237-47.   https://doi.org/10.1002/cyto.b.21090",https://intramural.nih.gov/search/searchview.taf?ipid=79073
723,SC010288-16,"October 01, 2012 -  September 30, 2013",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","J  Foley|David Charles Halverson; MD|Miriam E Mossoba|Ronald E Gress; MD|Steven  Pavletic; MD, MS|Frances  Hakim; PhD","Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Robert  Korngold (Cancer Center, Hackensack University)","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)",David F Stroncek; MD (CC) |Susan  Leitman; MD (CC) |Hanh M Khuu; MD (CC),"1. Fowler DH (2012). Editorial: protean effects of IL-10 include skin self-defense. J Leukoc Biol  92, 247-8.   https://doi.org/10.1189/jlb.0312156|2. Hardy NM, Fellowes V, Rose JJ, Odom J, Pittaluga S, Steinberg SM, Blacklock-Schuver B, Avila DN, Memon S, Kurlander RJ, Khuu HM, Stetler-Stevenson M, Mena E, Dwyer AJ, Levine BL, June CH, Reshef R, Vonderheide RH, Gress RE, Fowler DH, Hakim FT, Bishop MR (2012). Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. Blood  119, 2956-9.   https://doi.org/10.1182/blood-2011-09-378398|3. Laurence A, Amarnath S, Mariotti J, Kim YC, Foley J, Eckhaus M, O'Shea JJ, Fowler DH (2012). STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity  37, 209-22.   https://doi.org/10.1016/j.immuni.2012.05.027|4. Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD (2012). Hydrogen sulfide is an endogenous potentiator of T cell activation. J Biol Chem  287, 4211-21.   https://doi.org/10.1074/jbc.M111.307819|5. Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR (2012). Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol  30, 830-6.   https://doi.org/10.1200/JCO.2011.37.0296",https://intramural.nih.gov/search/searchview.taf?ipid=79074
724,SC010354-14,"October 01, 2012 -  September 30, 2013",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Srivandana  Akshintala|Andrea Maria Baldwin|Diane  Cole|Eva  Dombi|Nalini M Jayaprakash|Robert F Murphy|Show all 10,"Gregory  Reaman (Children's National Medical Center)|David  Viskochil (University of Utah)|John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Larry  Baker (SARC)|Peter Charles Adamson; MD|Susan  Blaney (Texas Children's Cancer Center)|Show all 7","Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)","Jeffrey M Solomon; BS, MS, PhD (CC)","1. Chuk MK, Aikin A, Whitcomb T, Widemann BC, Zannikos P, Bayever E, Balis FM, Fox E (2012). A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors. Pediatr Blood Cancer  59, 865-9.   https://doi.org/10.1002/pbc.24201|2. Lodish M, Dagalakis U, Chen CC, Sinaii N, Whitcomb P, Aikin A, Dombi E, Marcus L, Widemann B, Fox E, Chuk M, Balis F, Wells S, Stratakis CA (2012). (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab  97, E207-12.   https://doi.org/10.1210/jc.2011-2766|3. Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL (2012). Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. J Clin Oncol  30, 4141-7.   https://doi.org/10.1200/JCO.2012.44.1055|4. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484|5. Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, Glade Bender J, Burke M, Weigel B, Stempak D, Balis FM, Blaney SM (2012). A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res  18, 6011-22.   https://doi.org/10.1158/1078-0432.CCR-11-3284|6. Widemann BC, Schwartz S, Jayaprakash N, Christensen R, Pui CH, Chauhan N, Daugherty C, King TR, Rush JE, Howard SC (2014). Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Pharmacotherapy  34, 427-39.   https://doi.org/10.1002/phar.1360",https://intramural.nih.gov/search/searchview.taf?ipid=79077
725,SC010355-14,"October 01, 2012 -  September 30, 2013",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Inn-Inn  Chen|Michael Joseph Diprima|Hyeong Il  Kwak|Arianna  Caprioli|Nicole Sarah Mills|Hidetaka  Ohnuki|Show all 8,Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Amparo  AcherPalmer (University of Frankfurt)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling),Dragan  Maric; PhD (NINDS) |Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI) |Jinfang  Zhu; PhD (NIAID),"1. Oksenhendler E, Boutboul D, Beldjord K, Meignin V, de Labarthe A, Fieschi C, Dossier A, Agbalika F, Parravicini C, Tosato G, Gérard L, Galicier L (2013). Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients. Eur J Haematol  91, 497-503.   https://doi.org/10.1111/ejh.12191|2. Salvucci O, Tosato G (2012). Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res  114, 21-57.   https://doi.org/10.1016/B978-0-12-386503-8.00002-8|3. Segarra M, Ohnuki H, Maric D, Salvucci O, Hou X, Kumar A, Li X, Tosato G (2012). Semaphorin 6A regulates angiogenesis by modulating VEGF signaling. Blood  120, 4104-15.   https://doi.org/10.1182/blood-2012-02-410076",https://intramural.nih.gov/search/searchview.taf?ipid=79078
726,SC010356-14,"October 01, 2012 -  September 30, 2013",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Arianna  Caprioli|Nicole Sarah Mills|Ombretta  Salvucci,Frederick  Wang (Harvard Univ)|Stefan  RoseJohn (Univ. of Kiel),"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David A Davis; MD (HIV and AIDS Malignancy Branch)",Joshua  Farber; MD (NIAID) |Dragan  Maric; PhD (NINDS) |Manfred  Boehm; MD (NHLBI),"1. Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G (2012). Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res  72, 1157-69.   https://doi.org/10.1158/0008-5472.CAN-11-3067|2. Sakakibara S, Espigol-Frigole G, Gasperini P, Uldrick TS, Yarchoan R, Tosato G (2013). A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein. Oncogene  32, 1223-32.   https://doi.org/10.1038/onc.2012.145|3. Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J, Rose-John S (2012). HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood  119, 5173-81.   https://doi.org/10.1182/blood-2011-09-377705",https://intramural.nih.gov/search/searchview.taf?ipid=79079
727,SC010357-14,"October 01, 2012 -  September 30, 2013",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Masahiko  Ajiro; PhD|Xiaofan  Li; PhD|Vladimir  Majerciak|Nishi Raj Sharma; PhD|Xiaohong  Wang,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)","Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Michael John Kruhlak; PhD (Experimental Immunology Branch)|Barbara K Felber (Vaccine Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|George N Pavlakis; MD, PhD (Vaccine Branch)",John Philip McCoy (NHLBI) |Chuxia  Deng; PhD (NIDDK) |Jun  Zhu; PhD (NHLBI),"1. Majerciak V, Zheng Z (2013) Detection of Viral RNA Splicing in Diagnostic Virology, in Advanced Techniques in Diagnostic Microbiology. Tang Y, Stratton C, eds., pp. 693-748.|2. Ajiro M, Jia R, Zhang L, Liu X, Zheng ZM (2012). Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression. PLoS One  7, e46412.   https://doi.org/10.1371/journal.pone.0046412|3. Jia R, Zheng Z (2012) SRSF3 (serinearginine-rich splicing factor 3). Atlas Genet Cytogenet Oncol Haematol 16:838-840|4. Massimelli MJ, Majerciak V, Kruhlak M, Zheng ZM (2013). Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J Virol  87, 243-56.   https://doi.org/10.1128/JVI.01693-12|5. Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, Felber BK (2012). Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol  86, 13089-94.   https://doi.org/10.1128/JVI.00606-12|6. Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM, Stauffer JK, Zheng ZM, Harris CC (2013). Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene  32, 2792-8.   https://doi.org/10.1038/onc.2012.288",https://intramural.nih.gov/search/searchview.taf?ipid=79080
728,SC010366-13,"October 01, 2012 -  September 30, 2013",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Dominik  Bogen|Andrew Scott Brohl|Li  Chen|Jianbin Na He|Laura Beth Hurd|Samuel  Li|Show all 15,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Peter  Ambros (Children’s Cancer Research Institute)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, et al. [35 more authors] (2013). The genetic landscape of high-risk neuroblastoma. Nat Genet  45, 279-84.   https://doi.org/10.1038/ng.2529|2. Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD (2012). Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer  107, 1418-22.   https://doi.org/10.1038/bjc.2012.375|3. Wan X, Yeung C, Kim SY, Dolan JG, Ngo VN, Burkett S, Khan J, Staudt LM, Helman LJ (2012). Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Res  72, 5889-99.   https://doi.org/10.1158/0008-5472.CAN-12-1991",https://intramural.nih.gov/search/searchview.taf?ipid=79081
729,SC010372-13,"October 01, 2012 -  September 30, 2013",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79082
730,SC010373-13,"October 01, 2012 -  September 30, 2013",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,"1. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013). Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer  49, 3020-8.   https://doi.org/10.1016/j.ejca.2013.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=79083
731,SC010375-13,"October 01, 2012 -  September 30, 2013",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Anne G M Gegonne Bosselut|Kevin Patrick Semmens,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Daoud M Meerzaman (Center For Biomedical Informatics & Information Technology)|Alfred  Singer; MD (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section)|Lino  Tessarollo (Mouse Cancer Genetics Program),Pamela Gehron Robey; PhD (NIDCR),"1. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11",https://intramural.nih.gov/search/searchview.taf?ipid=79084
732,SC010376-13,"October 01, 2012 -  September 30, 2013",TNF Signaling and Cell Death,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Zhenyu  Cai|Swati Suresh Choksi|Huijuan  Cui|Siriporn  Jitkaew|Elena  Pobezinskaya|Yan  Zhang|Show all 7,Xuemin  Zhang|Anning  Lin (Shanghai Institute of Biochemistry and Cell Biology),NULL,Chuxia  Deng; PhD (NIDDK) |Richard James Youle; PhD (NINDS),"1. Pobezinskaya YL, Liu Z (2012). The role of TRADD in death receptor signaling. Cell Cycle  11, 871-6.   https://doi.org/10.4161/cc.11.5.19300|2. Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012). Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A  109, 5322-7.   https://doi.org/10.1073/pnas.1200012109",https://intramural.nih.gov/search/searchview.taf?ipid=79085
733,SC010378-13,"October 01, 2012 -  September 30, 2013",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Yang-Jo  Chung|Liat Hava Goldberg-Cooks|Sheryl Maxine Gough|Masahiro  Onozawa|Zhenhua  Zhang|Paul S Meltzer; MD, PhD","Trang  Hoang (U. Montreal)|Adolfo  Ferrando (Genetics, Columbia U.)",David  Levens; PhD (Laboratory of Pathology)|Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Beachy SH, Onozawa M, Chung YJ, Slape C, Bilke S, Francis P, Pineda M, Walker RL, Meltzer P, Aplan PD (2012). Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma. Blood  120, 1048-59.   https://doi.org/10.1182/blood-2012-01-401760|2. Gough SM, Chung YJ, Aplan PD (2012). Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect. PLoS One  7, e36876.   https://doi.org/10.1371/journal.pone.0036876|3. Lacombe J, Krosl G, Tremblay M, Gerby B, Martin R, Aplan PD, Lemieux S, Hoang T (2013). Genetic interaction between Kit and Scl. Blood  122, 1150-61.   https://doi.org/10.1182/blood-2011-01-331819|4. Métais JY, Winkler T, Geyer JT, Calado RT, Aplan PD, Eckhaus MA, Dunbar CE (2012). BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation. PLoS One  7, e48267.   https://doi.org/10.1371/journal.pone.0048267",https://intramural.nih.gov/search/searchview.taf?ipid=79086
734,SC010379-13,"October 01, 2012 -  September 30, 2013",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Liat Hava Goldberg-Cooks|Masahiro  Onozawa|Zhenhua  Zhang,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,"1. Onozawa M, Aplan PD (2012). Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy. Genes Chromosomes Cancer  51, 525-35.   https://doi.org/10.1002/gcc.21942",https://intramural.nih.gov/search/searchview.taf?ipid=79087
735,SC010384-13,"October 01, 2012 -  September 30, 2013",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer|Laura M Tuschong,David  Russell (University of Washington)|Derek  Persons (St. Jude's Cancer Research Center)|Punam  Malik,NULL,Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79088
736,SC010437-13,"October 01, 2012 -  September 30, 2013",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Adele R Blackler; PhD|Qiang  Du; PhD|Jeffrey C Hanson|Michael  Tangrea|Maria  Merino; PhD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Rodriguez-Canales J, Hanson JC, Hipp JD, Balis UJ, Tangrea MA, Emmert-Buck MR, Bova GS (2013). Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications. Methods Mol Biol  980, 61-120.   https://doi.org/10.1007/978-1-62703-287-2_5|2. Yan W, Shih J, Rodriguez-Canales J, Tangrea MA, Player A, Diao L, Hu N, Goldstein AM, Wang J, Taylor PR, Lippman SM, Wistuba II, Emmert-Buck MR, Erickson HS (2013). Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma. Am J Pathol  182, 529-39.   https://doi.org/10.1016/j.ajpath.2012.10.028|3. Yan W, Shih JH, Rodriguez-Canales J, Tangrea MA, Ylaya K, Hipp J, Player A, Hu N, Goldstein AM, Taylor PR, Emmert-Buck MR, Erickson HS (2012). Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma. BMC Res Notes  5, 73.   https://doi.org/10.1186/1756-0500-5-73",https://intramural.nih.gov/search/searchview.taf?ipid=79089
737,BC010906-06,"October 01, 2012 -  September 30, 2013",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Jing  Chen|Sigrid Priscilla Dubois|Wei  Ju|Juergen R Mueller; PhD|Liyanage P Perera; PhD|Michael N Petrus|Show all 9,NULL,"Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Simone CB, Morris JC, Stewart DM, Urquhart NE, Janik JE, Kreitman RJ, Lita E, Conlon K, Wharfe G, Waldmann TA, Kaushal A (2012). Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma. Blood  120, 1816-9.   https://doi.org/10.1182/blood-2012-01-401349",https://intramural.nih.gov/search/searchview.taf?ipid=78620
738,BC009255-39,"October 01, 2012 -  September 30, 2013",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,"1. Kimura MY, Pobezinsky LA, Guinter TI, Thomas J, Adams A, Park JH, Tai X, Singer A (2013). IL-7 signaling must be intermittent, not continuous, during CD8⁺ T cell homeostasis to promote cell survival instead of cell death. Nat Immunol  14, 143-51.   https://doi.org/10.1038/ni.2494|2. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918",https://intramural.nih.gov/search/searchview.taf?ipid=78191
739,BC010469-11,"October 01, 2012 -  September 30, 2013",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",Curtis  Henrich|Tanya R Johnson|Anthony  Wamiru|Jennifer A Wilson|Girma M Woldemichael,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Donald  Smee (Animal, Dairy and Veterinary Sciences Dept, Utah State University)|Peter  Wipf (Univ. of Pittsburgh)|John  Porco (Boston University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|Show all 22",Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|William Marston Linehan; MD (Urologic Oncology Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Joseph John Barchi (Chemical Biology Laboratory),Michael P Bray (NIAID),"1. Akee RK, Ransom T, Ratnayake R, McMahon JB, Beutler JA (2012). Chlorinated englerins with selective inhibition of renal cancer cell growth. J Nat Prod  75, 459-63.   https://doi.org/10.1021/np200905u|2. Alexandre KB, Gray ES, Mufhandu H, McMahon JB, Chakauya E, O'Keefe BR, Chikwamba R, Morris L (2012). The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. Virology  423, 175-86.   https://doi.org/10.1016/j.virol.2011.12.001|3. Blees JS, Bokesch HR, Rübsamen D, Schulz K, Milke L, Bajer MM, Gustafson KR, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B (2012). Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1. PLoS One  7, e46567.   https://doi.org/10.1371/journal.pone.0046567|4. Devkota KP, Wilson J, Henrich CJ, McMahon JB, Reilly KM, Beutler JA (2013). Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth. J Nat Prod  76, 59-63.   https://doi.org/10.1021/np300696g|5. Diyabalanage T, Ratnayake R, Bokesch HR, Ransom TT, Henrich CJ, Beutler JA, McMahon JB, Gustafson KR (2012). Flabelliferins A and B, sesterterpenoids from the South Pacific sponge Carteriospongia flabellifera. J Nat Prod  75, 1490-4.   https://doi.org/10.1021/np3003518|6. Henrich CJ, Budhu A, Yu Z, Evans JR, Goncharova EI, Ransom TT, Wang XW, McMahon JB (2013). High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells. Chem Biol Drug Des  82, 131-9.   https://doi.org/10.1111/cbdd.12146|7. Henrich CJ, Thomas CL, Brooks AD, Booth NL, Lowery EM, Pompei RJ, McMahon JB, Sayers TJ (2012). Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis. Apoptosis  17, 79-89.   https://doi.org/10.1007/s10495-011-0652-7|8. McKee TC, Rabe D, Bokesch HR, Grkovic T, Whitson EL, Diyabalanage T, Van Wyk AW, Marcum SR, Gardella RS, Gustafson KR, Linehan WM, McMahon JB, Bottaro DP (2012). Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges. J Nat Prod  75, 1632-6.   https://doi.org/10.1021/np300211x|9. Whitson EL, Sun H, Thomas CL, Henrich CJ, Sayers TJ, McMahon JB, Griesinger C, McKee TC (2012). Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima. J Nat Prod  75, 394-9.   https://doi.org/10.1021/np200805z|10. Woldemichael GM, Turbyville TJ, Vasselli JR, Linehan WM, McMahon JB (2012). Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin A. Neoplasia  14, 771-7.   https://doi.org/10.1593/neo.12852",https://intramural.nih.gov/search/searchview.taf?ipid=78355
740,BC010517-11,"October 01, 2012 -  September 30, 2013",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Megan L Peach|Markus  Sitzmann|Alexey Vladimirovich Zakharov; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 13,NULL,"Christopher P Austin; AB, MD (NCATS) |Evan  Bolton; PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78358
741,BC010548-11,"October 01, 2012 -  September 30, 2013",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kathryn  Compton|Cody John Peer,"Alex  Sparreboom|Steve  Grant (Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)","Andrea Borghese Apolo (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|Austin Gerard Duffy (Medical Oncology Branch)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)",NULL,"1. Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL (2013). Phase I trial of a new schedule of romidepsin in patients with advanced cancers. Clin Cancer Res  19, 4499-507.   https://doi.org/10.1158/1078-0432.CCR-13-0095|2. Gordon MS, Rosen LS, Mendelson D, Ramanathan RK, Goldman J, Liu L, Xu Y, Gerson SL, Anthony SP, Figg WD, Spencer S, Adams BJ, Theuer CP, Leigh BR, Weiss GJ (2013) A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Invest New Drugs 31:714-23|3. Peer CJ, Sissung TM, Kim A, Jain L, Woo S, Gardner ER, Kirkland CT, Troutman SM, English BC, Richardson ED, Federspiel J, Venzon D, Dahut W, Kohn E, Kummar S, Yarchoan R, Giaccone G, Widemann B, Figg WD (2012). Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia. Clin Cancer Res  18, 2099-107.   https://doi.org/10.1158/1078-0432.CCR-11-2484|4. Rajan A, Carter CA, Kelly RJ, Gutierrez M, Kummar S, Szabo E, Yancey MA, Ji J, Mannargudi B, Woo S, Spencer S, Figg WD, Giaccone G (2012). A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors. Clin Cancer Res  18, 2344-51.   https://doi.org/10.1158/1078-0432.CCR-11-2425|5. Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS (2012). A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin Cancer Res  18, 4820-9.   https://doi.org/10.1158/1078-0432.CCR-12-0098",https://intramural.nih.gov/search/searchview.taf?ipid=78492
742,BC010571-10,"October 01, 2012 -  September 30, 2013",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,"Alexander  Erkine (Butler University)|Keith  Wilkinson; PhD (Biochemistry, Emory University)","Munira A Basrai; PhD (Cancer Genetics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)",Marta Liliana Catalfamo; PhD (NIAID),"1. Case CM, Sackett DL, Wangsa D, Karpova T, McNally JG, Ried T, Camps J (2013). CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites. PLoS One  8, e64575.   https://doi.org/10.1371/journal.pone.0064575|2. Choy JS, O'Toole E, Schuster BM, Crisp MJ, Karpova TS, McNally JG, Winey M, Gardner MK, Basrai MA (2013). Genome-wide haploinsufficiency screen reveals a novel role for γ-TuSC in spindle organization and genome stability. Mol Biol Cell  24, 2753-63.   https://doi.org/10.1091/mbc.E12-12-0902|3. Mazza D, Abernathy A, Golob N, Morisaki T, McNally JG (2012). A benchmark for chromatin binding measurements in live cells. Nucleic Acids Res  40, e119.   https://doi.org/10.1093/nar/gks701|4. Mueller F, Morisaki T, Mazza D, McNally JG (2012). Minimizing the impact of photoswitching of fluorescent proteins on FRAP analysis. Biophys J  102, 1656-65.   https://doi.org/10.1016/j.bpj.2012.02.029",https://intramural.nih.gov/search/searchview.taf?ipid=78380
743,BC010639-10,"October 01, 2012 -  September 30, 2013",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Megan L Peach|Iwona Elzbieta Weidlich|Terrence R Burke; PhD|John Stephen Schneekloth,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|David D Roberts; PhD (Laboratory of Pathology),"Paul P. Liu; MD, PhD (NHGRI)","1. Geczy T, Peach ML, El Kazzouli S, Sigano DM, Kang JH, Valle CJ, Selezneva J, Woo W, Kedei N, Lewin NE, Garfield SH, Lim L, Mannan P, Marquez VE, Blumberg PM (2012). Molecular basis for failure of ""atypical"" C1 domain of Vav1 to bind diacylglycerol/phorbol ester. J Biol Chem  287, 13137-58.   https://doi.org/10.1074/jbc.M111.320010",https://intramural.nih.gov/search/searchview.taf?ipid=78382
744,BC010685-09,"October 01, 2012 -  September 30, 2013",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Jeannette Marie McNulty|Michael Kanwolo Newford|Sarah Paige Young|Willie J Young,NULL,Udayan  Guha (Medical Oncology Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NIAID)","1. O'Connell ML, Birkenkamp KE, Kleiner DE, Folio LR, Holland SM, Olivier KN (2012). Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest  141, 1203-1209.   https://doi.org/10.1378/chest.11-0425",https://intramural.nih.gov/search/searchview.taf?ipid=78402
745,BC010687-09,"October 01, 2012 -  September 30, 2013",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Helen G Lynch|Jeannette Marie McNulty|Catherine R Neely|Michael Kanwolo Newford|Claire D Roque|Maryann Elisabeth Williamson|Show all 7,"Elizabeth  Brunt (Pathology, St. Louis University)|Arthur  Mccullough (Gastroenterology/Hepatology, Cleveland Clinic Foundation)|Joel  Lavine (Pediatrics, University of California San Diego Medical Center)|Arun  Sanyal (Hepatology, Virginia Commonwealth University Medical Center)|James  Tonascia (n/a, Johns Hopkins Center for Clinical Trials)|Hari  Conjeevaram (Gastroenterology, The University of Michigan)|Show all 12","Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Udayan  Guha (Medical Oncology Branch)","Jay  Hoofnagle; MD (NIDDK) |Marc Gregory Ghany; MD (NIDDK) |Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Michael  Polis; MD (NIAID) |Shyamasundaran  Kottilil; MD, PhD (NIAID)","1. Allison RD, Conry-Cantilena C, Koziol D, Schechterly C, Ness P, Gibble J, Kleiner DE, Ghany MG, Alter HJ (2012). A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis  206, 654-61.   https://doi.org/10.1093/infdis/jis410|2. Chalasani N, Vuppalanchi R, Navarro V, Fontana R, Bonkovsky H, Barnhart H, Kleiner DE, Hoofnagle JH (2012). Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Ann Intern Med  156, 857-60, W297-300.   https://doi.org/10.7326/0003-4819-156-12-201206190-00006|3. Diaz G, Melis M, Tice A, Kleiner DE, Mishra L, Zamboni F, Farci P (2013). Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma. Int J Cancer  133, 816-24.   https://doi.org/10.1002/ijc.28075|4. Fan X, Upadhyaya B, Wu L, Koh C, Santín-Durán M, Pittaluga S, Uzel G, Kleiner D, Williams E, Ma CA, Bodansky A, Oliveira JB, Edmonds P, Hornung R, Wong DW, Fayer R, Fleisher T, Heller T, Prussin C, Jain A (2012). CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clin Immunol  143, 152-61.   https://doi.org/10.1016/j.clim.2012.01.014|5. Gara N, Zhao X, Collins MT, Chong WH, Kleiner DE, Jake Liang T, Ghany MG, Hoofnagle JH (2012). Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther  35, 1317-25.   https://doi.org/10.1111/j.1365-2036.2012.05093.x|6. Gara N, Zhao X, Kleiner DE, Liang TJ, Hoofnagle JH, Ghany MG (2013). Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol  11, 303-8.e1.   https://doi.org/10.1016/j.cgh.2012.10.044|7. Georgoff P, Thomasson D, Louie A, Fleischman E, Dutcher L, Mani H, Kottilil S, Morse C, Dodd L, Kleiner D, Hadigan C (2012). Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis. AJR Am J Roentgenol  199, 2-7.   https://doi.org/10.2214/AJR.11.7384|8. Kleiner DE, Berman D (2012). Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma. Dig Dis Sci  57, 2233-40.   https://doi.org/10.1007/s10620-012-2140-5|9. Nissim O, Melis M, Diaz G, Kleiner DE, Tice A, Fantola G, Zamboni F, Mishra L, Farci P (2012). Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PLoS One  7, e49611.   https://doi.org/10.1371/journal.pone.0049611|10. Noureddin M, Wright EC, Alter HJ, Clark S, Thomas E, Chen R, Zhao X, Conry-Cantilena C, Kleiner DE, Liang TJ, Ghany MG (2013). Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology  58, 1548-57.   https://doi.org/10.1002/hep.26506|11. Oppenheimer AP, Koh C, McLaughlin M, Williamson JC, Norton TD, Laudadio J, Heller T, Kleiner DE, High KP, Morse CG (2013). Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases. World J Gastroenterol  19, 115-21.   https://doi.org/10.3748/wjg.v19.i1.115",https://intramural.nih.gov/search/searchview.taf?ipid=78404
746,BC010858-07,"October 01, 2012 -  September 30, 2013",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Langston  Lim|Poonam  Mannan,NULL,Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Sukhbir  Kaur (Laboratory of Pathology),Chava  Kimchi-Sarfaty (OD) |Kevin G Chen; MD (NINDS) |Zuben  Sauna; PhD (OD),"1. Geczy T, Peach ML, El Kazzouli S, Sigano DM, Kang JH, Valle CJ, Selezneva J, Woo W, Kedei N, Lewin NE, Garfield SH, Lim L, Mannan P, Marquez VE, Blumberg PM (2012). Molecular basis for failure of ""atypical"" C1 domain of Vav1 to bind diacylglycerol/phorbol ester. J Biol Chem  287, 13137-58.   https://doi.org/10.1074/jbc.M111.320010|2. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, Kohn EC (2012). Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis  15, 33-45.   https://doi.org/10.1007/s10456-011-9241-1|3. Weng MT, Lee JH, Wei SC, Li Q, Shahamatdar S, Hsu D, Schetter AJ, Swatkoski S, Mannan P, Garfield S, Gucek M, Kim MK, Annunziata CM, Creighton CJ, Emanuele MJ, Harris CC, Sheu JC, Giaccone G, Luo J (2012). Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci U S A  109, E3659-67.   https://doi.org/10.1073/pnas.1207673110|4. Xin HW, Hari DM, Mullinax JE, Ambe CM, Koizumi T, Ray S, Anderson AJ, Wiegand GW, Garfield SH, Thorgeirsson SS, Avital I (2012). Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division. Stem Cells  30, 591-8.   https://doi.org/10.1002/stem.1061",https://intramural.nih.gov/search/searchview.taf?ipid=78499
747,BC010859-07,"October 01, 2012 -  September 30, 2013",DNA Sequencing and Digital Gene Expression Core,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Patricia  Johnson|Steven W Shema,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78501
748,BC010903-06,"October 01, 2012 -  September 30, 2013",Transgenic Core Facility,Deborah A Swing,Terry Anne Van Dyke,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,"1. Li J, Akagi K, Hu Y, Trivett AL, Hlynialuk CJ, Swing DA, Volfovsky N, Morgan TC, Golubeva Y, Stephens RM, Smith DE, Symer DE (2012). Mouse endogenous retroviruses can trigger premature transcriptional termination at a distance. Genome Res  22, 870-84.   https://doi.org/10.1101/gr.130740.111|2. Waldron-Roby E, Ratovitski T, Wang X, Jiang M, Watkin E, Arbez N, Graham RK, Hayden MR, Hou Z, Mori S, Swing D, Pletnikov M, Duan W, Tessarollo L, Ross CA (2012). Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci  32, 183-93.   https://doi.org/10.1523/JNEUROSCI.1305-11.2012",https://intramural.nih.gov/search/searchview.taf?ipid=78608
749,BC010905-06,"October 01, 2012 -  September 30, 2013",Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mark E Dudley|Steven A Feldman|Kenichi  Hanada|Marybeth S Hughes|Udai S Kammula|King F Kwong|Show all 17,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section),Yardena Rachel Samuels; PhD (NHGRI),"1. Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US (2012). Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol  10, 113.   https://doi.org/10.1186/1477-7819-10-113|2. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME, Rosenberg SA (2012). Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res  18, 5212-23.   https://doi.org/10.1158/1078-0432.CCR-12-1108",https://intramural.nih.gov/search/searchview.taf?ipid=78633
750,BC010915-06,"October 01, 2012 -  September 30, 2013",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Damian  Kovalovsky; PhD|Vanja  Lazarevic|Jung-Hyun  Park,NULL,"Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|James Stephen Shaw; PhD (Human Immunology Section)|David M Segal; PhD (Immune Targeting Section)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Philip Jeffrey Tofilon (Radiation Oncology Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Jeffrey Burnett Kopp; MD (NIDDK) |Myung Hee  Park; PhD (NIDCR) |David Barry Sacks (CC)","1. Ben-Aissa K, Patino-Lopez G, Belkina NV, Maniti O, Rosales T, Hao JJ, Kruhlak MJ, Knutson JR, Picart C, Shaw S (2012). Activation of moesin, a protein that links actin cytoskeleton to the plasma membrane, occurs by phosphatidylinositol 4,5-bisphosphate (PIP2) binding sequentially to two sites and releasing an autoinhibitory linker. J Biol Chem  287, 16311-23.   https://doi.org/10.1074/jbc.M111.304881|2. Callen E, Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen HT, Faryabi RB, Polato F, Santos M, Starnes LM, Wesemann DR, Lee JE, Tubbs A, Sleckman BP, Daniel JA, Ge K, Alt FW, Fernandez-Capetillo O, Nussenzweig MC, Nussenzweig A (2013). 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell  153, 1266-80.   https://doi.org/10.1016/j.cell.2013.05.023|3. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Göbel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S, Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, et al. [2 more authors] (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res  110, 1202-10.   https://doi.org/10.1161/CIRCRESAHA.111.256370|4. Liu Y, Belkina NV, Park C, Nambiar R, Loughhead SM, Patino-Lopez G, Ben-Aissa K, Hao JJ, Kruhlak MJ, Qi H, von Andrian UH, Kehrl JH, Tyska MJ, Shaw S (2012). Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice. Blood  119, 445-53.   https://doi.org/10.1182/blood-2011-07-368860|5. Lonsdorf AS, Krämer BF, Fahrleitner M, Schönberger T, Gnerlich S, Ring S, Gehring S, Schneider SW, Kruhlak MJ, Meuth SG, Nieswandt B, Gawaz M, Enk AH, Langer HF (2012). Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J Biol Chem  287, 2168-78.   https://doi.org/10.1074/jbc.M111.269811|6. Müller JR, Waldmann TA, Kruhlak MJ, Dubois S (2012). Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15Rα in human monocytes and dendritic cells. J Biol Chem  287, 40328-38.   https://doi.org/10.1074/jbc.M112.378612|7. Sousa AA, Morgan JT, Brown PH, Adams A, Jayasekara MP, Zhang G, Ackerson CJ, Kruhlak MJ, Leapman RD (2012). Synthesis, characterization, and direct intracellular imaging of ultrasmall and uniform glutathione-coated gold nanoparticles. Small  8, 2277-86.   https://doi.org/10.1002/smll.201200071|8. Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A (2012). Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood  119, 5155-63.   https://doi.org/10.1182/blood-2011-11-388918",https://intramural.nih.gov/search/searchview.taf?ipid=78655
751,BC010923-06,"October 01, 2012 -  September 30, 2013",Tissue Array Research Program,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI","Joon Yong Chung|Catherine Margaret Conway; PhD|Haruhisa  Kitano; MD, PhD|Kristofferson R Ylaya|Elaine S Jaffe; MD|Frederic Glenn Barr",NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Tim Friedrich Greten (Medical Oncology Branch)","Yoke Peng  Loh; PhD (NICHD) |Alfredo A Molinolo; MD, PhD (NIDCR)","1. Chung JY, Kitano H, Takikita M, Cho H, Noh KH, Kim TW, Ylaya K, Hanaoka J, Fukuoka J, Hewitt SM (2013). Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer. Hum Pathol  44, 472-9.   https://doi.org/10.1016/j.humpath.2012.06.018|2. Chung JY, Yi JM, Xie R, Brown V, Lee O, Ahuja N, Braunschweig T, Hewitt SM (2012). A pressure cooking-based DNA extraction from archival formalin-fixed, paraffin-embedded tissue. Anal Biochem  425, 128-34.   https://doi.org/10.1016/j.ab.2012.03.012|3. Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Molinolo A, Hewitt SM, Curino AC, Coso OA, Facchinetti MM (2012). Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer  77, 168-75.   https://doi.org/10.1016/j.lungcan.2012.02.016|4. Hewitt SM, Badve SS, True LD (2012). Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy. Clin Cancer Res  18, 1524-30.   https://doi.org/10.1158/1078-0432.CCR-11-2204|5. Hipp J, Monaco J, Kunju LP, Cheng J, Yagi Y, Rodriguez-Canales J, Emmert-Buck MR, Hewitt S, Feldman MD, Tomaszewski JE, Toner M, Tompkins RG, Flotte T, Lucas D, Gilbertson JR, Madabhushi A, Balis U (2012). Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification. Anal Cell Pathol (Amst)  35, 251-65.   https://doi.org/10.3233/ACP-2012-0054|6. Hipp JA, Hipp JD, Lim M, Sharma G, Smith LB, Hewitt SM, Balis UG (2012). Image microarrays derived from tissue microarrays (IMA-TMA): New resource for computer-aided diagnostic algorithm development. J Pathol Inform  3, 24.   https://doi.org/10.4103/2153-3539.98168|7. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57|8. Molinolo AA, Marsh C, El Dinali M, Gangane N, Jennison K, Hewitt S, Patel V, Seiwert TY, Gutkind JS (2012). mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res  18, 2558-68.   https://doi.org/10.1158/1078-0432.CCR-11-2824|9. Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, Mao CP, Wu TC, Kim TW (2012). Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest  122, 4077-93.   https://doi.org/10.1172/JCI64057|10. Orlov NV, Weeraratna AT, Hewitt SM, Coletta CE, Delaney JD, Mark Eckley D, Shamir L, Goldberg IG (2012). Automatic detection of melanoma progression by histological analysis of secondary sites. Cytometry A  81, 364-73.   https://doi.org/10.1002/cyto.a.22044|11. Poste G, Carbone DP, Parkinson DR, Verweij J, Hewitt SM, Jessup JM (2012). Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res  18, 1515-23.   https://doi.org/10.1158/1078-0432.CCR-11-2206|12. Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigtländer T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, Korangy F, Greten TF (2012). Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. J Immunol  188, 6055-62.   https://doi.org/10.4049/jimmunol.1102918",https://intramural.nih.gov/search/searchview.taf?ipid=78564
752,BC010930-06,"October 01, 2012 -  September 30, 2013",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Peter D Aplan; MD|Walter M Kuehl; MD, PhD|Ester K Rozenblum",Geula  Klorin (Rambam: Human Health Care Campus)|Frederic  Kaye; MD (NCI),Ola Anders Landgren (Lymphoid Malignancies Branch)|Adriana  Zingone; MD (Medical Oncology Branch),NULL,"1. Klorin G, Rozenblum E, Glebov O, Walker RL, Park Y, Meltzer PS, Kirsch IR, Kaye FJ, Roschke AV (2013). Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines. Cancer Genet  206, 191-205.   https://doi.org/10.1016/j.cancergen.2013.04.006",https://intramural.nih.gov/search/searchview.taf?ipid=78574
753,BC010934-06,"October 01, 2012 -  September 30, 2013",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Susan  Dhamala|Matin M Imanguli|Jeremy J Rose|Xiao Y Yan|Steven  Pavletic; MD, MS|Claude  Sportes|Show all 11",NULL,Kristin  Baird (Pediatric Oncology Branch)|Edward W Cowen (Dermatology Branch),Ping  Jin (CC) |David F Stroncek; MD (CC),"1. Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN (2013). B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res  19, 2048-60.   https://doi.org/10.1158/1078-0432.CCR-12-2422|2. Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, Taylor T, Avila D, Zhang D, Grkovic L, Datiles M, Gress RE, Pavletic SZ (2012). Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res  91, 45S-51S.   https://doi.org/10.1177/0022034512450881|3. Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR (2012). Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol  30, 830-6.   https://doi.org/10.1200/JCO.2011.37.0296",https://intramural.nih.gov/search/searchview.taf?ipid=78559
754,BC010936-06,"October 01, 2012 -  September 30, 2013",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Masaki  Terabe,Cliburn  Chan (Duke University)|Marcin  Moniuszko|Kent  Weinhold (DUMC),"Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Myong-Hee  Sung (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)",Lois Jean Patterson (OD),"1. Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, Lee EM, Kalisz I, Kalyanaraman VS, Dipasquale J, McKinnon K, Robert-Guroff M (2012). Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J Virol  86, 12591-604.   https://doi.org/10.1128/JVI.00298-12|2. Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M (2012). Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route. Clin Vaccine Immunol  19, 629-37.   https://doi.org/10.1128/CVI.00010-12|3. Zhao J, Stagno JR, Varticovski L, Nimako E, Rishi V, McKinnon K, Akee R, Shoemaker RH, Ji X, Vinson C (2012). P6981, an arylstibonic acid, is a novel low nanomolar inhibitor of cAMP response element-binding protein binding to DNA. Mol Pharmacol  82, 814-23.   https://doi.org/10.1124/mol.112.080820",https://intramural.nih.gov/search/searchview.taf?ipid=78675
755,BC010937-06,"October 01, 2012 -  September 30, 2013",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Marjorie P Duberstein|Duane Howard Hamilton|Bruce K Huang|Jeffrey  Schlom; PhD|Kwong Yok Tsang|James L Gulley; MD, PhD|Show all 7","Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)",NULL,NULL,"1. Hamilton DH, Litzinger MT, Fernando RI, Huang B, Palena C (2012). Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas. Semin Oncol  39, 358-66.   https://doi.org/10.1053/j.seminoncol.2012.02.005|2. Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang KY, Ferrone S, Gameiro SR (2013). Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Int J Cancer  133, 624-36.   https://doi.org/10.1002/ijc.28070|3. Palena C, Hamilton DH, Fernando RI (2012). Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol  8, 713-22.   https://doi.org/10.2217/fon.12.59|4. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M, Hamilton D, Huang B, Tucker J, Tsang KY, Schlom J, Palena C (2012). Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin Cancer Res  18, 3868-79.   https://doi.org/10.1158/1078-0432.CCR-11-3211",https://intramural.nih.gov/search/searchview.taf?ipid=78687
756,BC010947-06,"October 01, 2012 -  September 30, 2013",Cell and Cancer Biology Branch Confocal Microscopy Core,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Ross G Lake|Zhenggang  Liu; PhD|Juanjuan  Yin|Orla Majella Casey,Massimo  Santoro|Ginesa  GarciaRostan (University of Valladolid),"Susan  Bates; MD (Medical Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Marianne  Poruchynsky (Medical Oncology Branch)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics)|Olga  Aprelikova; PhD (Laboratory of Cancer Biology and Genetics)|Philip L Martin (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78623
757,BC010948-06,"October 01, 2012 -  September 30, 2013",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Mona E El gamil|Shahram S Farid|Yili  Li|Yong-Chen  Lu; PhD|Arnold L Mixon|Xin  Yao,NULL,NULL,NULL,"1. Chou J, Voong LN, Mortales CL, Towlerton AM, Pollack SM, Chen X, Yee C, Robbins PF, Warren EH (2012). Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. J Immunother  35, 131-41.   https://doi.org/10.1097/CJI.0b013e31824300c7|2. Kvistborg P, Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, van Rooij N, Linnemann C, van Buuren MM, Urbanus JH, Beltman JB, Thor Straten P, Li YF, Robbins PF, Besser MJ, Schachter J, Kenter GG, Dudley ME, Rosenberg SA, Haanen JB, Hadrup SR, Schumacher TN (2012). TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology  1, 409-418.   https://doi.org/10.4161/onci.18851|3. Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol  25, 854-8.   https://doi.org/10.1038/modpathol.2012.31|4. Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC (2012). Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma. Cancer Res  72, 6119-29.   https://doi.org/10.1158/0008-5472.CAN-12-0588|5. Yao X, Ahmadzadeh M, Lu YC, Liewehr DJ, Dudley ME, Liu F, Schrump DS, Steinberg SM, Rosenberg SA, Robbins PF (2012). Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood  119, 5688-96.   https://doi.org/10.1182/blood-2011-10-386482|6. Zhu S, Van den Eynde BJ, Coulie PG, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2012). Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12. J Immunother  35, 680-8.   https://doi.org/10.1097/CJI.0b013e31827338ea|7. Robbins P, Rosenberg S, Yao X (submitted in 2012) T Cell Receptors Recognizing Mhc Class Ii-restricted Mage-a3. Patents issued: 2013315391 (AU in 2017); 9,879,065 (US in 2018). Patents pending: 2884743 (CA application); 201380059102.4 (CN application); 13767200.2 (EP application); 237560 (IL application); 532065/2015 (JP application); 10-2015-7006543 (KR application); MX/A/2015/003061 (MX application); PCT/US2013/059608 (PC application); 15/848,344 (US application); 2017219019 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=78568
758,BC010953-06,"October 01, 2012 -  September 30, 2013",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Bih-Rong  Wei|Beverly  Mock; PhD|Lalage  Wakefield; PhD|Show all 8,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Udayan  Guha (Medical Oncology Branch)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Mark  Raffeld; MD (Laboratory of Pathology)|Harold  Varmus; MD (Office Of The Director),NULL,"1. Paek SY, Miyagawa F, Zhang H, Linton JT, Hoover SB, Simpson RM, Katz SI (2012). Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity. J Invest Dermatol  132, 677-86.   https://doi.org/10.1038/jid.2011.347|2. Suh KS, Malik M, Shukla A, Ryscavage A, Wright L, Jividen K, Crutchley JM, Dumont RA, Fernandez-Salas E, Webster JD, Simpson RM, Yuspa SH (2012). CLIC4 is a tumor suppressor for cutaneous squamous cell cancer. Carcinogenesis  33, 986-95.   https://doi.org/10.1093/carcin/bgs115|3. Webster JD, Michalowski AM, Dwyer JE, Corps KN, Wei BR, Juopperi T, Hoover SB, Simpson RM (2012). Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis. J Pathol Inform  3, 18.   https://doi.org/10.4103/2153-3539.95130",https://intramural.nih.gov/search/searchview.taf?ipid=78589
759,BC010965-06,"October 01, 2012 -  September 30, 2013",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",Marzeena  Dyba,Marzena E Pazgier|Vadim  Gaponenko,Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Anil K Patri (Office Cancer Nanotechnology Research)|Anu  Puri; PhD (Membrane Structure and Function Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Liu S, Chen Y, Li J, Huang T, Tarasov S, King A, Weissman AM, Byrd RA, Das R (2012). Promiscuous interactions of gp78 E3 ligase CUE domain with polyubiquitin chains. Structure  20, 2138-50.   https://doi.org/10.1016/j.str.2012.09.020|2. Tewary P, de la Rosa G, Sharma N, Rodriguez LG, Tarasov SG, Howard OM, Shirota H, Steinhagen F, Klinman DM, Yang D, Oppenheim JJ (2013). β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation. J Immunol  191, 865-74.   https://doi.org/10.4049/jimmunol.1201648|3. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L, Dakshanamurthy S, Brown ML, Dritschilo A (2012). Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem  287, 14192-200.   https://doi.org/10.1074/jbc.M111.323899",https://intramural.nih.gov/search/searchview.taf?ipid=78609
760,BC010978-06,"October 01, 2012 -  September 30, 2013",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Carole A Parent; PhD|Stanley  Lipkowitz; MD, PhD|Ying  Zhang|Jeffrey S Rubin; MD, PhD",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine),NULL,"Paul E Love; MD, PhD (NICHD) |Justin W Taraska (NHLBI)","1. Clayberger C, Finn MW, Wang T, Saini R, Wilson C, Barr VA, Sabatino M, Castiello L, Stroncek D, Krensky AM (2012). 15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity. J Immunol  188, 6119-26.   https://doi.org/10.4049/jimmunol.1200570|2. Lesourne R, Zvezdova E, Song KD, El-Khoury D, Uehara S, Barr VA, Samelson LE, Love PE (2012). Interchangeability of Themis1 and Themis2 in thymocyte development reveals two related proteins with conserved molecular function. J Immunol  189, 1154-61.   https://doi.org/10.4049/jimmunol.1200123|3. Luo R, Akpan IO, Hayashi R, Sramko M, Barr V, Shiba Y, Randazzo PA (2012). GTP-binding protein-like domain of AGAP1 is protein binding site that allosterically regulates ArfGAP protein catalytic activity. J Biol Chem  287, 17176-85.   https://doi.org/10.1074/jbc.M111.334458|4. Sherman E, Barr VA, Samelson LE (2013). Resolving multi-molecular protein interactions by photoactivated localization microscopy. Methods  59, 261-9.   https://doi.org/10.1016/j.ymeth.2012.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=78518
761,BC010981-06,"October 01, 2012 -  September 30, 2013","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,Chwee Teck  Lim (National University of Singapore)|Siyang  Zheng (Penn State University),Lee Jay Helman; MD (Pediatric Oncology Branch)|William Laurence Dahut; MD (Medical Oncology Branch)|William D Figg; PharmD (Medical Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,"1. Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R (2012). Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell. Int J Cancer  131, 2143-52.   https://doi.org/10.1002/ijc.27471",https://intramural.nih.gov/search/searchview.taf?ipid=78528
762,BC010989-06,"October 01, 2012 -  September 30, 2013",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Yasmine  Assadipour|Mary Alexandra Black|Hui  Xu|Richard A Morgan; PhD|James Chung-Yin Yang; MD, PhD|Maria  Parkhurst|Show all 10",Dirk  Jager (University Medical Center Heidelberg)|Andrew  Quong (Thomas Jefferson University),James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Ling  Zhang (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch),Dhana  Chinnasamy; PhD (NHLBI),"1. Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G (2012). Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther  20, 246-9.   https://doi.org/10.1038/mt.2011.288|2. Yang S, Karne NK, Goff SL, Black MA, Xu H, Bischof D, Cornetta K, Rosenberg SA, Morgan RA, Feldman SA (2012). A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes. Hum Gene Ther Methods  23, 73-83.   https://doi.org/10.1089/hgtb.2011.199|3. Zhang L, Feldman SA, Zheng Z, Chinnasamy N, Xu H, Nahvi AV, Dudley ME, Rosenberg SA, Morgan RA (2012). Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. J Immunother  35, 430-9.   https://doi.org/10.1097/CJI.0b013e31825898e8",https://intramural.nih.gov/search/searchview.taf?ipid=78541
763,BC010991-06,"October 01, 2012 -  September 30, 2013",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",May H Garcia|Aradhana  Kaushal,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78526
764,BC011016-06,"October 01, 2012 -  September 30, 2013",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Scott R Cherry; BS|Janet R Fields|Jacek Tadeusz Lubkowski,"TOZSER  JOZSEF (University of Debrecen)|Robert  Ulrich (Molecular Immunology, USAMRIID)|Gregory  Plano; PhD (Microbiology and Immunology, University of Miami School of Medicine)|Honggao  Yan",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Robert  Shoemaker (Screening Technologies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,"1. Hogan M, Bahta M, Cherry S, Lountos GT, Tropea JE, Zhao BM, Burke TR, Waugh DS, Ulrich RG (2013). Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase. Chem Biol Drug Des  81, 323-33.   https://doi.org/10.1111/cbdd.12097|2. Lountos GT, Tropea JE, Waugh DS (2012). Structure of the cytoplasmic domain of Yersinia pestis YscD, an essential component of the type III secretion system. Acta Crystallogr D Biol Crystallogr  68, 201-9.   https://doi.org/10.1107/S0907444911054308|3. Lountos GT, Tropea JE, Waugh DS (2013). Structure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas' disease. Mol Biochem Parasitol  187, 1-8.   https://doi.org/10.1016/j.molbiopara.2012.10.006|4. Raran-Kurussi S, Tözsér J, Cherry S, Tropea JE, Waugh DS (2013). Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases. Anal Biochem  436, 142-4.   https://doi.org/10.1016/j.ab.2013.01.031",https://intramural.nih.gov/search/searchview.taf?ipid=78611
765,BC011020-06,"October 01, 2012 -  September 30, 2013",Cell Production Facility Core,Mark E Dudley,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,NULL,NULL,"1. Alvarez-Downing MM, Inchauste SM, Dudley ME, White DE, Wunderlich JR, Rosenberg SA, Kammula US (2012). Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol  10, 113.   https://doi.org/10.1186/1477-7819-10-113|2. Bear AS, Morgan RA, Cornetta K, June CH, Binder-Scholl G, Dudley ME, Feldman SA, Rosenberg SA, Shurtleff SA, Rooney CM, Heslop HE, Dotti G (2012). Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? Mol Ther  20, 246-9.   https://doi.org/10.1038/mt.2011.288|3. Dudley ME (2012). A major player ""gets in the act"". J Immunother  35, 595-7.   https://doi.org/10.1097/CJI.0b013e3182725602|4. Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013). Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol  31, 2152-9.   https://doi.org/10.1200/JCO.2012.46.6441|5. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME, Rosenberg SA (2012). Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res  18, 5212-23.   https://doi.org/10.1158/1078-0432.CCR-12-1108|6. Jin J, Sabatino M, Somerville R, Wilson JR, Dudley ME, Stroncek DF, Rosenberg SA (2012). Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. J Immunother  35, 283-92.   https://doi.org/10.1097/CJI.0b013e31824e801f|7. Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C, Rosenberg SA (2012). B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood  119, 2709-20.   https://doi.org/10.1182/blood-2011-10-384388|8. Kvistborg P, Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, van Rooij N, Linnemann C, van Buuren MM, Urbanus JH, Beltman JB, Thor Straten P, Li YF, Robbins PF, Besser MJ, Schachter J, Kenter GG, Dudley ME, Rosenberg SA, Haanen JB, Hadrup SR, Schumacher TN (2012). TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology  1, 409-418.   https://doi.org/10.4161/onci.18851|9. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath A, Wang T, Bielekova B, Wuest SC, Akula N, et al. [6 more authors] (2013). Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother  36, 133-51.   https://doi.org/10.1097/CJI.0b013e3182829903|10. Restifo NP, Dudley ME, Rosenberg SA (2012). Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol  12, 269-81.   https://doi.org/10.1038/nri3191|11. Seaman BJ, Guardiani EA, Brewer CC, Zalewski CK, King KA, Rudy S, Van Waes C, Morgan RA, Dudley ME, Yang JC, Rosenberg SA, Kim HJ (2012). Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma. Otolaryngol Head Neck Surg  147, 744-9.   https://doi.org/10.1177/0194599812448356|12. Somerville RP, Devillier L, Parkhurst MR, Rosenberg SA, Dudley ME (2012). Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor. J Transl Med  10, 69.   https://doi.org/10.1186/1479-5876-10-69|13. Somerville RP, Dudley ME (2012). Bioreactors get personal. Oncoimmunology  1, 1435-1437.   https://doi.org/10.4161/onci.21206|14. Uccellini L, De Giorgi V, Zhao Y, Tumaini B, Erdenebileg N, Dudley ME, Tomei S, Bedognetti D, Ascierto ML, Liu Q, Simon R, Kottyan L, Kaufman KM, Harley JB, Wang E, Rosenberg SA, Marincola FM (2012). IRF5 gene polymorphisms in melanoma. J Transl Med  10, 170.   https://doi.org/10.1186/1479-5876-10-170|15. Wang A, Chandran S, Shah SA, Chiu Y, Paria BC, Aghamolla T, Alvarez-Downing MM, Lee CC, Singh S, Li T, Dudley ME, Restifo NP, Rosenberg SA, Kammula US (2012). The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans. Sci Transl Med  4, 149ra120.   https://doi.org/10.1126/scitranslmed.3004306|16. Yao X, Ahmadzadeh M, Lu YC, Liewehr DJ, Dudley ME, Liu F, Schrump DS, Steinberg SM, Rosenberg SA, Robbins PF (2012). Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood  119, 5688-96.   https://doi.org/10.1182/blood-2011-10-386482|17. Zhang L, Feldman SA, Zheng Z, Chinnasamy N, Xu H, Nahvi AV, Dudley ME, Rosenberg SA, Morgan RA (2012). Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. J Immunother  35, 430-9.   https://doi.org/10.1097/CJI.0b013e31825898e8",https://intramural.nih.gov/search/searchview.taf?ipid=78535
766,BC011021-05,"October 01, 2012 -  September 30, 2013",Basic Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78177
767,BC011029-06,"October 01, 2012 -  September 30, 2013",Preclinical development and clinical monitoring of adoptive immune therapy,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Vicki  Fellowes|Jeremy J Rose|Daniel H Fowler|Nancy M Hardy|Claude  Sportes|James N Kochenderfer,NULL,NULL,NULL,"1. Hardy NM, Fellowes V, Rose JJ, Odom J, Pittaluga S, Steinberg SM, Blacklock-Schuver B, Avila DN, Memon S, Kurlander RJ, Khuu HM, Stetler-Stevenson M, Mena E, Dwyer AJ, Levine BL, June CH, Reshef R, Vonderheide RH, Gress RE, Fowler DH, Hakim FT, Bishop MR (2012). Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. Blood  119, 2956-9.   https://doi.org/10.1182/blood-2011-09-378398",https://intramural.nih.gov/search/searchview.taf?ipid=78560
768,BC011030-06,"October 01, 2012 -  September 30, 2013",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Richard A Morgan; PhD|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78688
769,BC011040-06,"October 01, 2012 -  September 30, 2013",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Allison  Gomez|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Holly S Stevenson|Show all 10,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Kenneth H Kraemer; MD (Dermatology Branch)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)",NULL,"1. Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P (2013). Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol  37, 234-40.   https://doi.org/10.1097/PAS.0b013e3182671178|2. Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, Lee HS, Killian KJ, Wang Y, Tsokos M, Roncalli M, Steinberg SM, Wang Y, Giaccone G (2012). Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis  3, e351.   https://doi.org/10.1038/cddis.2012.92|3. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E (2012). DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab  97, E1004-13.   https://doi.org/10.1210/jc.2011-3298|4. Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS (2012). Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol  14, 326-32.   https://doi.org/10.1093/neuonc/nor190",https://intramural.nih.gov/search/searchview.taf?ipid=78538
770,BC011041-06,"October 01, 2012 -  September 30, 2013",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Allison  Gomez|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Holly S Stevenson|Show all 9,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Kenneth H Kraemer; MD (Dermatology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Ene CI, Edwards L, Riddick G, Baysan M, Woolard K, Kotliarova S, Lai C, Belova G, Cam M, Walling J, Zhou M, Stevenson H, Kim HS, Killian K, Veenstra T, Bailey R, Song H, Zhang W, Fine HA (2012). Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PLoS One  7, e51407.   https://doi.org/10.1371/journal.pone.0051407|2. Killian JK, Walker RL, Bilke S, Chen Y, Davis S, Cornelison R, Smith WI, Meltzer PS (2012). Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples. Methods Mol Biol  823, 107-18.   https://doi.org/10.1007/978-1-60327-216-2_8|3. Nader N, Ng SS, Wang Y, Abel BS, Chrousos GP, Kino T (2012). Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. PLoS One  7, e26751.   https://doi.org/10.1371/journal.pone.0026751",https://intramural.nih.gov/search/searchview.taf?ipid=78539
771,BC011042-06,"October 01, 2012 -  September 30, 2013",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),"1. Grøntved L, Bandle R, John S, Baek S, Chung HJ, Liu Y, Aguilera G, Oberholtzer C, Hager GL, Levens D (2012). Rapid genome-scale mapping of chromatin accessibility in tissue. Epigenetics Chromatin  5, 10.   https://doi.org/10.1186/1756-8935-5-10|2. Levens D (2013). Cellular MYCro economics: Balancing MYC function with MYC expression. Cold Spring Harb Perspect Med  3.   https://doi.org/10.1101/cshperspect.a014233",https://intramural.nih.gov/search/searchview.taf?ipid=78660
772,BC011044-06,"October 01, 2012 -  September 30, 2013",Tissue ProcessingSequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Catherine  Wells|Robert A Worrell,Catherine  Stolle (Childrenâ€™s Hospital of Philadelphia)|William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Joel  Moss; MD, PhD (NHLBI)","1. Eisenhofer G, Vocke CD, Elkahloun A, Huynh TT, Prodanov T, Lenders JW, Timmers HJ, Benhammou JN, Linehan WM, Pacak K (2012). Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution. Horm Metab Res  44, 343-8.   https://doi.org/10.1055/s-0032-1304662|2. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|3. Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013). Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol  37, 74-80.   https://doi.org/10.1097/PAS.0b013e31825ec16f|4. Shuch B, Agochukwu N, Ricketts C, Vocke C, Gautam R, Merino M, Linehan W, Srinivasan R (2013) Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer. Journal of Clinical Oncology, in press.|5. Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM (2013). Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol  189, 430-5.   https://doi.org/10.1016/j.juro.2012.07.139|6. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001",https://intramural.nih.gov/search/searchview.taf?ipid=78618
773,BC011047-06,"October 01, 2012 -  September 30, 2013",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Mario A Anzano|Valery  Bliskovsky; PhD|Marta  Custer|Maudeline  Etienne|Anthony W Vieira|Susan  Walters|Show all 15,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Alasdair M Gilfillan; PhD (NIAID) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID)","1. Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC, Potter M, Nussenzweig MC, Casellas R (2012). Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. Proc Natl Acad Sci U S A  109, 10972-7.   https://doi.org/10.1073/pnas.1200106109|2. LeGrand J, Park ES, Wang H, Gupta S, Owens JD, Nelson PJ, DuBois W, Bair T, Janz S, Mushinski JF (2012). Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia. Blood  119, 1018-28.   https://doi.org/10.1182/blood-2011-06-363887|3. Li M, He Y, Dubois W, Wu X, Shi J, Huang J (2012). Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell  46, 30-42.   https://doi.org/10.1016/j.molcel.2012.01.020",https://intramural.nih.gov/search/searchview.taf?ipid=78534
774,BC011048-06,"October 01, 2012 -  September 30, 2013",Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Chand  Khanna; MD (Pediatric Oncology Branch),Baolin  Zhang (OD),"1. Kang Z, Sun SY, Cao L (2012). Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma. ISRN Oncol  2012, 395952.   https://doi.org/10.5402/2012/395952",https://intramural.nih.gov/search/searchview.taf?ipid=78529
775,BC011052-06,"October 01, 2012 -  September 30, 2013",Cytopathology Core,Armando  Filie,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Keith R Brosky|Tangi Y Howard|Dana K Erickson|Patricia A Fetsch|May Ester Owens|Mark J Roth,NULL,NULL,NULL,"1. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS (2012). Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res  18, 77-90.   https://doi.org/10.1158/1078-0432.CCR-11-0962|2. Khozin S, Roth MJ, Rajan A, Smith K, Thomas A, Berman A, Giaccone G (2012). Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement. J Thorac Oncol  7, e29-31.   https://doi.org/10.1097/JTO.0b013e3182697a23|3. Song JY, Filie AC, Venzon D, Stetler-Stevenson M, Yuan CM (2012). Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens. Cytometry B Clin Cytom  82, 305-12.   https://doi.org/10.1002/cyto.b.21033|4. Zhang J, Qiu S, Zhang Y, Merino M, Fetsch P, Avital I, Filie A, Pastan I, Hassan R (2012). Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P. Anticancer Res  32, 5151-8.|5. Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, Wiegand G, Avital I, Fetsch P, Mani H, Zlott D, Robey R, Bates SE, Li X, Rao M, Schrump DS (2012). Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res  72, 4178-92.   https://doi.org/10.1158/0008-5472.CAN-11-3983",https://intramural.nih.gov/search/searchview.taf?ipid=78542
776,BC011068-06,"October 01, 2012 -  September 30, 2013",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"1. Hipp J, Monaco J, Kunju LP, Cheng J, Yagi Y, Rodriguez-Canales J, Emmert-Buck MR, Hewitt S, Feldman MD, Tomaszewski JE, Toner M, Tompkins RG, Flotte T, Lucas D, Gilbertson JR, Madabhushi A, Balis U (2012). Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification. Anal Cell Pathol (Amst)  35, 251-65.   https://doi.org/10.3233/ACP-2012-0054",https://intramural.nih.gov/search/searchview.taf?ipid=78540
777,BC011075-06,"October 01, 2012 -  September 30, 2013",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78536
778,BC011077-06,"October 01, 2012 -  September 30, 2013",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78537
779,BC011079-06,"October 01, 2012 -  September 30, 2013",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Winnifred Theresa Navarro|Thu A Pham|Trinh  Pham|Liqiang  Xi; MD|Elaine S Jaffe; MD|Michael R Emmert-Buck; MD, PhD|Show all 9",NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Samuel A Wells (Medical Oncology Branch)|Raffit  Hassan (Laboratory of Molecular Biology)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)",Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID),"1. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|2. Kalra N, Ashai A, Xi L, Zhang J, Avital I, Raffeld M, Hassan R (2012). Patients with peritoneal mesothelioma lack epidermal growth factor receptor             tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep  27, 1794-800.   https://doi.org/10.3892/or.2012.1725|3. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|4. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57|5. Slotta-Huspenina J, Koch I, de Leval L, Keller G, Klier M, Bink K, Kremer M, Raffeld M, Fend F, Quintanilla-Martinez L (2012). The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index. Haematologica  97, 1422-30.   https://doi.org/10.3324/haematol.2011.055715|6. Snow AL, Xiao W, Stinson JR, Lu W, Chaigne-Delalande B, Zheng L, Pittaluga S, Matthews HF, Schmitz R, Jhavar S, Kuchen S, Kardava L, Wang W, Lamborn IT, Jing H, Raffeld M, Moir S, Fleisher TA, Staudt LM, Su HC, Lenardo MJ (2012). Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med  209, 2247-61.   https://doi.org/10.1084/jem.20120831|7. Tamburrino A, Molinolo AA, Salerno P, Chernock RD, Raffeld M, Xi L, Gutkind JS, Moley JF, Wells SA, Santoro M (2012). Activation of the mTOR pathway in primary medullary thyroid carcinoma and lymph node metastases. Clin Cancer Res  18, 3532-40.   https://doi.org/10.1158/1078-0432.CCR-11-2700|8. Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ (2012). Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood  119, 3330-2.   https://doi.org/10.1182/blood-2011-09-379339",https://intramural.nih.gov/search/searchview.taf?ipid=78694
780,BC011086-06,"October 01, 2012 -  September 30, 2013",Brain Tumor Animal Therapeutics Core,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Hua  Song|Wei  Zhang|Rolanda  Bailey|Dionne  Davis|Lincoln A Edwards|Kevin D Woolard,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",John Keenam Park (NINDS) |Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78546
781,BC011087-06,"October 01, 2012 -  September 30, 2013",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Cynthia A Harris|Hong  Jin|Charisma D Roque|Elaine S Jaffe; MD|Stefania  Pittaluga|Markku Martti Miettinen,NULL,"James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Laboratory of Molecular Biology)",NULL,"1. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|2. Herman SE, Sun X, McAuley EM, Hsieh MM, Pittaluga S, Raffeld M, Liu D, Keyvanfar K, Chapman CM, Chen J, Buggy JJ, Aue G, Tisdale JF, Pérez-Galán P, Wiestner A (2013). Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia  27, 2311-21.   https://doi.org/10.1038/leu.2013.131|3. Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC (2012). NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol  25, 854-8.   https://doi.org/10.1038/modpathol.2012.31|4. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57",https://intramural.nih.gov/search/searchview.taf?ipid=78691
782,BC011093-06,"October 01, 2012 -  September 30, 2013",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Constance M Yuan,NULL,"Richard  Little; MD, PhD (Clinical Investigations Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Nancy M Hardy (Experimental Transplantation and Immunology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Song JY, Filie AC, Venzon D, Stetler-Stevenson M, Yuan CM (2012). Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens. Cytometry B Clin Cytom  82, 305-12.   https://doi.org/10.1002/cyto.b.21033",https://intramural.nih.gov/search/searchview.taf?ipid=78605
783,BC011104-06,"October 01, 2012 -  September 30, 2013",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)|Terry J Fry (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Hardy NM, Fellowes V, Rose JJ, Odom J, Pittaluga S, Steinberg SM, Blacklock-Schuver B, Avila DN, Memon S, Kurlander RJ, Khuu HM, Stetler-Stevenson M, Mena E, Dwyer AJ, Levine BL, June CH, Reshef R, Vonderheide RH, Gress RE, Fowler DH, Hakim FT, Bishop MR (2012). Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. Blood  119, 2956-9.   https://doi.org/10.1182/blood-2011-09-378398|2. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, Fitzgerald DJ, Lechleider R, Pastan I (2012). Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. J Clin Oncol  30, 1822-8.   https://doi.org/10.1200/JCO.2011.38.1756|3. Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ (2012). Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood  119, 3330-2.   https://doi.org/10.1182/blood-2011-09-379339",https://intramural.nih.gov/search/searchview.taf?ipid=78604
784,BC011137-05,"October 01, 2012 -  September 30, 2013",Center for Applied Preclinical Research (CAPR),Terry Anne Van Dyke,NULL,"Office of the Director, NCI",NULL,"David  Gandara (University of Califormia at Davis)|Neal  Goodwin (Jackson Laboratory, West)|Marcus  Bosenberg (Yale University)|Martin  McMahon (University of Californial at San Francisco)|Annette  Walter (Clovis Oncology, Inc.)|Ross  Cagan (Mount Sinai School of Medicine)|Show all 7","Karlyne M Reilly; BS, PhD (Mouse Cancer Genetics Program)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Nancy H Colburn; PhD (Laboratory of Cancer Prevention)","Christopher P Austin; AB, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78181
785,BC011138-06,"October 01, 2012 -  September 30, 2013",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78692
786,BC011139-06,"October 01, 2012 -  September 30, 2013",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78693
787,BC011236-05,"October 01, 2012 -  September 30, 2013",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78740
788,BC011237-05,"October 01, 2012 -  September 30, 2013",CIP Genomics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",NULL,Robert  Lanford (Texas Biomedical Research Institute)|Effie  Petersdorf (Fred Hutchinson),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Michael  Dean; PhD (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78741
789,BC011257-04,"October 01, 2012 -  September 30, 2013",Applied Molecular Pathology Laboratory,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Joon Yong Chung|Jennifer  Martinez,NULL,"Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Kohaar I, Porter-Gill P, Lenz P, Fu YP, Mumy A, Tang W, Apolo AB, Rothman N, Baris D, Schned AR, Ylaya K, Schwenn M, Johnson A, Jones M, Kida M, Silverman DT, Hewitt SM, Moore LE, Prokunina-Olsson L (2013). Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst  105, 69-73.   https://doi.org/10.1093/jnci/djs458|2. Lenz P, Pfeiffer R, Baris D, Schned AR, Takikita M, Poscablo MC, Schwenn M, Johnson A, Jones M, Kida M, Cantor KP, Rothman N, Silverman DT, Hewitt SM, Moore LE (2012). Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev  21, 1555-64.   https://doi.org/10.1158/1055-9965.EPI-12-0261|3. Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, Lissowska J, Peplonska B, Brinton L, Garcia-Closas M, Sherman ME (2012). Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res  14, R64.   https://doi.org/10.1186/bcr3170",https://intramural.nih.gov/search/searchview.taf?ipid=78772
790,BC011265-04,"October 01, 2012 -  September 30, 2013",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Mary Ellen  Palko|Susan W Reid|Bradley D St Croix,NULL,"Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Dolph Lee Hatfield; PhD (Laboratory of Cancer Prevention)|Mark  Udey; MD (Dermatology Branch)|Teizo  Yoshimura; PhD (Laboratory of Molecular Immunoregulation)|Jairaj K Acharya; MBBS, PhD (Laboratory of Cell and Developmental Signaling)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, Hasumi H, Hasumi Y, Kieffer-Kwon KR, Gonzalez CG, Hughes RM, Klein ME, Oh HF, Bible P, Southon E, Tessarollo L, Schmidt LS, Linehan WM, Casellas R (2012). The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development. Blood  120, 1254-61.   https://doi.org/10.1182/blood-2012-02-410407|2. Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, Burkett SS, Martin BK, Southon E, Sizemore SC, Pruss D, Bowles KR, Roa BB, Hunter N, Tessarollo L, Wenstrup RJ, Byrd RA, Sharan SK (2012). Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay. Hum Mol Genet  21, 3993-4006.   https://doi.org/10.1093/hmg/dds222|3. Chiang YJ, Difilippantonio MJ, Tessarollo L, Morse HC, Hodes RJ (2012). Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas. PLoS One  7, e49305.   https://doi.org/10.1371/journal.pone.0049305|4. Diril MK, Ratnacaram CK, Padmakumar VC, Du T, Wasser M, Coppola V, Tessarollo L, Kaldis P (2012). Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci U S A  109, 3826-31.   https://doi.org/10.1073/pnas.1115201109|5. Gaiser MR, Lämmermann T, Feng X, Igyarto BZ, Kaplan DH, Tessarollo L, Germain RN, Udey MC (2012). Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc Natl Acad Sci U S A  109, E889-97.   https://doi.org/10.1073/pnas.1117674109|6. Gegonne A, Tai X, Zhang J, Wu G, Zhu J, Yoshimoto A, Hanson J, Cultraro C, Chen QR, Guinter T, Yang Z, Hathcock K, Singer A, Rodriguez-Canales J, Tessarollo L, Mackem S, Meerzaman D, Buetow K, Singer DS (2012). The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells. Mol Cell Biol  32, 1984-97.   https://doi.org/10.1128/MCB.06305-11|7. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012). Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature  491, 254-8.   https://doi.org/10.1038/nature11465|8. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (2012). c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell  151, 68-79.   https://doi.org/10.1016/j.cell.2012.08.033|9. Padmakumar VC, Speer K, Pal-Ghosh S, Masiuk KE, Ryscavage A, Dengler SL, Hwang S, Edwards JC, Coppola V, Tessarollo L, Stepp MA, Yuspa SH (2012). Spontaneous skin erosions and reduced skin and corneal wound healing characterize CLIC4(NULL) mice. Am J Pathol  181, 74-84.   https://doi.org/10.1016/j.ajpath.2012.03.025|10. Takeda H, Koso H, Tessarollo L, Copeland NG, Jenkins NA (2013). Musashi1-CreER(T2) : a new cre line for conditional mutagenesis in neural stem cells. Genesis  51, 128-34.   https://doi.org/10.1002/dvg.22357|11. Unnisa Z, Clark JP, Roychoudhury J, Thomas E, Tessarollo L, Copeland NG, Jenkins NA, Grimes HL, Kumar AR (2012). Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress. Blood  120, 4973-81.   https://doi.org/10.1182/blood-2012-06-435800",https://intramural.nih.gov/search/searchview.taf?ipid=78778
791,BC011309-04,"October 01, 2012 -  September 30, 2013",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Jung-Hyun  Park|Damian  Kovalovsky; PhD|Vanja  Lazarevic,NULL,Dinah  Singer; PhD (Molecular Regulation Section)|Richard J Hodes; MD (Immune Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78807
792,BC011310-04,"October 01, 2012 -  September 30, 2013",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Jung-Hyun  Park,NULL,Dinah  Singer; PhD (Molecular Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78808
793,BC011331-04,"October 01, 2012 -  September 30, 2013",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Yuliya  Kriga|Yelena  Levin|John Castle Raley; MS|Shashikala Dilhani Ratnayake|Jyoti Umesha Shetty|Tatyana Yulyevna Smirnova|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78825
794,BC011380-03,"October 01, 2012 -  September 30, 2013",Multivalent Inhibition of Integrin alphaVbeta3,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),"1. Englund EA, Wang D, Fujigaki H, Sakai H, Micklitsch CM, Ghirlando R, Martin-Manso G, Pendrak ML, Roberts DD, Durell SR, Appella DH (2012). Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds. Nat Commun  3, 614.   https://doi.org/10.1038/ncomms1629",https://intramural.nih.gov/search/searchview.taf?ipid=78859
795,BC011392-03,"October 01, 2012 -  September 30, 2013",LGD Core,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78870
796,BC011428-02,"October 01, 2012 -  September 30, 2013",CCR FACS Core Laboratory,Karen Marie Wolcott,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Subhadra  Banerjee|Ludmila  Krymskaya,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78945
797,BC011430-02,"October 01, 2012 -  September 30, 2013",CPTR - Mass Spectrometry,Lisa Marie Jenkins,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",Kandice Danielle Tanner; PhD|Yang  Zhang,NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)",Rafael Cristian Casellas; PhD (NIAMS) |Willy Albrecht Flegel; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78918
798,BC011434-02,"October 01, 2012 -  September 30, 2013",Collaborative Protein Technology Resource: Automated Capillary Immunoassays,Jinqiu  Chen,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",Michelle Anne Herrmann,NULL,Christina M Annunziata (Medical Oncology Branch)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Liang  Cao (Cancer Genetics Branch)|Natasha  Caplen (Cancer Genetics Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics),"Adrian U Wiestner; MD, PhD (NHLBI)","1. Kohn EA, Yang YA, Du Z, Nagano Y, Van Schyndle CM, Herrmann MA, Heldman M, Chen JQ, Stuelten CH, Flanders KC, Wakefield LM (2012). Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. Mol Cancer Res  10, 1389-99.   https://doi.org/10.1158/1541-7786.MCR-12-0136-T",https://intramural.nih.gov/search/searchview.taf?ipid=78926
799,BC011453-02,"October 01, 2012 -  September 30, 2013",Development and Excecution of Collaborative High-Throughput Microscopy Assays,Ty Cole Voss,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78917
800,BC011475-01,"October 01, 2012 -  September 30, 2013",Genomics and Systems Pharmacology Core,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,"1. Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012). CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res  72, 3499-511.   https://doi.org/10.1158/0008-5472.CAN-12-1370",https://intramural.nih.gov/search/searchview.taf?ipid=83046
801,BC011497-01,"October 01, 2012 -  September 30, 2013",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83044
802,BC011499-01,"October 01, 2012 -  September 30, 2013",Comparative genomic hybridization data and web-based tool for the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83043
803,BC011509-01,"October 01, 2012 -  September 30, 2013",Clustering of the drug activities of the NCI-60 cancerous cell lines,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Vinodh  Rajapakse|James Halpern Doroshow,NULL,Joel  Morris (Drug Synthesis and Chemistry Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83045
804,BC011515-01,"October 01, 2012 -  September 30, 2013",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Paresma Rasiklal Patel; PhD|Gary T Pauly|Dina M Sigano,NULL,NULL,NULL,"1. Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH (2012). A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology  9, 99.   https://doi.org/10.1186/1742-4690-9-99",https://intramural.nih.gov/search/searchview.taf?ipid=83065
805,BC011531-01,"October 01, 2012 -  September 30, 2013",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Sam Joseph Brancato,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83078
806,BC011532-01,"October 01, 2012 -  September 30, 2013",CCR Bioinformatics Core,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83088
807,CO020007-05,"October 01, 2012 -  September 30, 2013",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Craig W Reynolds,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78950
808,CP010178-12,"October 01, 2012 -  September 30, 2013",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Tabassum  Bandey|Ian K Barrow|Michael  Beerman|Merideth  Brown|Laura Ann Burdett|Show all 26,NULL,Gilles F Thomas (Laboratory Translational Genomics)|Kashif  Haque (Office Of The Director)|Kevin  Jacobs (Laboratory Translational Genomics)|Calvin  Ott (Office Of The Director)|Liqun  Qi (Biorepositories & Biospecimen Research Branch),Jun  Lu (NIEHS),"1. Machiela MJ, Chanock SJ (2013). Detectable clonal mosaicism in the human genome. Semin Hematol  50, 348-59.   https://doi.org/10.1053/j.seminhematol.2013.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=78983
809,CP010203-05,"October 01, 2012 -  September 30, 2013",Applied Molecular Pathology Laboratory,Mark E Sherman; MD| | |Margaret Anne Tucker|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Human Genetics Program, NCI",Karen E Berliner,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79006
810,CP010223-02,"October 01, 2012 -  September 30, 2013",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Louise  Brinton; PhD| |Marianne  Henderson| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Joseph  Fraumeni; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of Division Operations and Analysis, NCI

Office of the Director, NCI","Regina Gale Ziegler; PhD, MPH",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79027
811,SC006536-20,"October 01, 2012 -  September 30, 2013",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Paula A Carter|Kathryn  Compton|Merrill E Goldsmith|Cody John Peer|Gareth  Peters|Diana  Roame|Show all 7,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Steve  Grant (Virginia Commonwealth University)|Mark  Ratain (University of Chicago)",William Laurence Dahut; MD (Medical Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Heidi H Kong (Dermatology Branch)|Giuseppe  Giaccone; MD (Medical Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch),NULL,"1. Chen X, Peer CJ, Alfaro R, Tian T, Spencer SD, Figg WD (2012). Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization. J Pharm Biomed Anal  62, 140-8.   https://doi.org/10.1016/j.jpba.2012.01.008",https://intramural.nih.gov/search/searchview.taf?ipid=79091
812,SC006537-20,"October 01, 2012 -  September 30, 2013",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kathryn  Compton|Alesia J Holly|Cody John Peer|Tristan  Sissung,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Alex  Sparreboom|Steve  Grant (Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)","William Laurence Dahut; MD (Medical Oncology Branch)|Howard A Fine; MD, PhD (Neuro-Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Susan  Bates; MD (Medical Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)",NULL,"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Gordon MS, Rosen LS, Mendelson D, Ramanathan RK, Goldman J, Liu L, Xu Y, Gerson SL, Anthony SP, Figg WD, Spencer S, Adams BJ, Theuer CP, Leigh BR, Weiss GJ (2013) A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors. Invest New Drugs 31:714-23|3. Lewis JP, Stephens SH, Horenstein RB, O'Connell JR, Ryan K, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Mitchell BD, Shuldiner AR (2013). The CYP2C19*17 variant is not independently associated with clopidogrel response. J Thromb Haemost  11, 1640-6.   https://doi.org/10.1111/jth.12342|4. Noonan AM, Eisch RA, Liewehr DJ, Sissung TM, Venzon DJ, Flagg TP, Haigney MC, Steinberg SM, Figg WD, Piekarz RL, Bates SE (2013). Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel. Clin Cancer Res  19, 3095-104.   https://doi.org/10.1158/1078-0432.CCR-13-0109|5. Rajan A, Carter CA, Kelly RJ, Gutierrez M, Kummar S, Szabo E, Yancey MA, Ji J, Mannargudi B, Woo S, Spencer S, Figg WD, Giaccone G (2012). A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors. Clin Cancer Res  18, 2344-51.   https://doi.org/10.1158/1078-0432.CCR-11-2425|6. Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS (2012). A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer. Clin Cancer Res  18, 4820-9.   https://doi.org/10.1158/1078-0432.CCR-12-0098",https://intramural.nih.gov/search/searchview.taf?ipid=79092
813,SC006743-20,"October 01, 2012 -  September 30, 2013",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Giuseppe  Giaccone; MD,"Medical Oncology Branch, NCI",Sylvia Vania  Alarcon Velasco|Min Jung Lee|Sunmin T Lee|Reid Phillip Schlesinger|Andrea Borghese Apolo|William Laurence Dahut; MD|Show all 7,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Marc  Cox (University of Texas at El Paso)|Christophe  Nicot (-, University of Kansas Medical Center)|Shiv  Srivastava (Urology, CPDR, USUHS)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Gennady  Bratslavsky (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Alarcon SV, Mollapour M, Lee MJ, Tsutsumi S, Lee S, Kim YS, Prince T, Apolo AB, Giaccone G, Xu W, Neckers LM, Trepel JB (2012). Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy. Curr Mol Med  12, 1125-41.   https://doi.org/10.2174/156652412803306729|2. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L (2012). Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle  11, 3649-55.   https://doi.org/10.4161/cc.21926|3. Kim YS, Kumar V, Lee S, Iwai A, Neckers L, Malhotra SV, Trepel JB (2012). Methoxychalcone inhibitors of androgen receptor translocation and function. Bioorg Med Chem Lett  22, 2105-9.   https://doi.org/10.1016/j.bmcl.2011.12.141|4. Solier S, Kohn KW, Scroggins B, Xu W, Trepel J, Neckers L, Pommier Y (2012). Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A  109, 12866-72.   https://doi.org/10.1073/pnas.1203617109|5. Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z, Beebe K, Siderius M, Lee MJ, Couvillon A, Trepel JB, Miyata Y, Matts R, Neckers L (2012). Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol Cell  47, 434-43.   https://doi.org/10.1016/j.molcel.2012.05.015",https://intramural.nih.gov/search/searchview.taf?ipid=79090
814,SC009372-22,"October 01, 2012 -  September 30, 2013",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Prashant Ramesh  Tembhare|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Alan S Wayne; MD (Pediatric Oncology Branch)|Susan  Bates; MD (Medical Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)","Adrian U Wiestner; MD, PhD (NHLBI) |Steven M Holland; MD (NIAID)","1. Hardy NM, Fellowes V, Rose JJ, Odom J, Pittaluga S, Steinberg SM, Blacklock-Schuver B, Avila DN, Memon S, Kurlander RJ, Khuu HM, Stetler-Stevenson M, Mena E, Dwyer AJ, Levine BL, June CH, Reshef R, Vonderheide RH, Gress RE, Fowler DH, Hakim FT, Bishop MR (2012). Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation. Blood  119, 2956-9.   https://doi.org/10.1182/blood-2011-09-378398|2. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|3. Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C, Rosenberg SA (2012). B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood  119, 2709-20.   https://doi.org/10.1182/blood-2011-10-384388|4. Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O (2014). Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. Leuk Lymphoma  55, 1402-3.   https://doi.org/10.3109/10428194.2013.831091|5. Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS (2012). Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. Am J Hematol  87, 916-22.   https://doi.org/10.1002/ajh.23174",https://intramural.nih.gov/search/searchview.taf?ipid=79038
815,SC010353-14,"October 01, 2012 -  September 30, 2013",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI",Cynthia P Love|Kelly D Richards|Vicki  Richmond|Nirali Niranjan Shah|Sivasubramanian  Baskar|Brigitte  Widemann; MD|Show all 11,"David  Loeb (Pediatric Hematology-Oncology, Johns Hopkins University)|Civin  Curt (Pediatric Oncology, Johns Hopkins University)|Ching-Hon  Pui (St Jude Children's Research Hospital)|Deepa  Bhowjani (St Jude Children's Research Hospital)|Sima  Jeha (Pediatric Oncology, St Jude Children's Cancer Research Hospital)|Lewis  Silverman (Dana Farber/Children's Hospital)|Show all 22","Ira H Pastan; MD (Molecular Biology Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Frances  Hakim; PhD (Experimental Transplantation and Immunology Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)",Austin John Barrett; MD (NHLBI) |Susan  Leitman; MD (CC) |Roger  Kurlander; MD (CC) |Hanh M Khuu; MD (CC) |David F Stroncek; MD (CC) |Minocher  Battiwalla; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79076
816,BC010686-09,"October 01, 2012 -  September 30, 2013",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Earle J Barnes|Joseph  Chinquee|Jeannette Marie McNulty|Silke  Williams|Sarah Paige Young,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78403
817,BC010694-09,"October 01, 2012 -  September 30, 2013",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Veronica  Krevinko|Shannon I Skarshaug|Valerie M Zgonc|Elaine S Jaffe; MD|Stefania  Pittaluga|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Blanche P Alter (Clinical Genetics Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Alan S Wayne; MD (Pediatric Oncology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Mohammed Zulfiqar Farooqui; DO (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78389
818,BC010882-06,"October 01, 2012 -  September 30, 2013",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78601
819,BC010950-06,"October 01, 2012 -  September 30, 2013",Research Nursing,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,Paulo  Zucali (IRCCS)|Martin  Gutierrez (Micheal and Dianne Bienes Cancer Center),James Halpern Doroshow (Developmental Therapeutics Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78551
820,BC010951-06,"October 01, 2012 -  September 30, 2013",Medical Directors Office,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78550
821,BC010963-06,"October 01, 2012 -  September 30, 2013",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Steven  Pavletic; MD, MS|Robert Lee Alderman; PA-C|Daniele N Avila|Judy Liliana Baruffaldi|Juan Carlos Gea-Banacloche; MD|Nancy M Hardy|Show all 12","Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78555
822,BC010987-06,"October 01, 2012 -  September 30, 2013",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78602
823,BC010988-06,"October 01, 2012 -  September 30, 2013",Center for Cancer Research Clinical Trials Data Management Service,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78603
824,BC010990-06,"October 01, 2012 -  September 30, 2013",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",May H Garcia|Aradhana  Kaushal,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78527
825,BC011022-05,"October 01, 2012 -  September 30, 2013",Clinical Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78178
826,BC011089-06,"October 01, 2012 -  September 30, 2013",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin K Shouck|Celene  Chua|Donna  Drake|Sarah M Fowler; RN|Julia C Friend; PA|Rabindra  Gautam|Show all 17,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Medical Oncology Branch),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78663
827,BC011092-06,"October 01, 2012 -  September 30, 2013",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Sarah M Fowler; RN|Julia C Friend; PA|Rabindra  Gautam|Geri L Hawks|An Ngoc Hoang|Cristiane  Leite|Show all 14,NULL,Maria  Merino; PhD (Laboratory of Pathology)|William Laurence Dahut; MD (Medical Oncology Branch),"Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78664
828,BC011098-06,"October 01, 2012 -  September 30, 2013",Brain Tumor Clinical and Clinical Research Program,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",Zina Hasan Alyoussif|Tracy D Ani|Dawit  Aregawi; MD|Tracy L Cropper|Nancy B Garren|Mireya Aurora Gomez|Show all 15,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"John Keenam Park (NINDS) |John Anthony Butman; MD, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78547
829,BC011242-05,"October 01, 2012 -  September 30, 2013",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 25,Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Udai S Kammula (Surgery Branch),"Elliot Brian Levy (CC) |Nadine  Abi Jaoudeh (CC) |Aradhana M Venkatesan (CC) |Karel  Pacak; MD, PhD (NICHD) |Karen T Adams (NICHD) |Karun  Sharma (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78766
830,BC011291-04,"October 01, 2012 -  September 30, 2013",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78793
831,BC011317-04,"October 01, 2012 -  September 30, 2013",Dermatology Consultation Service,Edward W Cowen,Mark  Udey; MD,"Dermatology Branch, NCI",Olanda M Hathaway|Haley Bharat Naik,Francesco  DelGaldo (University of Leeds)|Michelle  Lowes; MD (Rockefeller University),"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Kristin  Baird (Pediatric Oncology Branch)","Raphaela  Goldbach-Mansky; MD, MHS (NIAMS) |Alison Anne McBride; PhD (NIAID) |Nehal N Mehta (NHLBI) |Maria Irene Morasso; PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78815
832,BC011349-04,"October 01, 2012 -  September 30, 2013",Development of FISH Molecular  Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Elaine S Jaffe; MD|Maria  Merino; PhD|Markku Martti Miettinen,NULL,Giuseppe  Giaccone; MD (Medical Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78841
833,BC011517-01,"October 01, 2012 -  September 30, 2013",Pediatric Oncology Branch Behvioral Science Core,Melinda S Merchant,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Cristina Regina Maria Abel|Stacia Martin Peron; PhD|Lori  Wiener; PhD, LCSW-C|Pamela  Wolters|Sima Lehimgar Zadeh|Kristin  Baird|Show all 7",Jimmie  Holland (MSKCC)|David  Jacobson (CNMC)|Wendy  Lichtenthal (MSKCC)|Aziza  Shad (Georgetown)|Leonard  Wexler (Memorial Sloan Kettering Cancer Center),NULL,Maryland  Pao; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83062
834,SC003800-43,"October 01, 2012 -  September 30, 2013",Surgical Consultants  Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI","Giao Q Phan|Richard  Sherry; MD|Marybeth S Hughes|Udai S Kammula|James Chung-Yin Yang; MD, PhD|Udo  Rudloff|Show all 8",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79046
835,SC006329-33,"October 01, 2012 -  September 30, 2013",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|John  Ondos|Hu-Chen  Xie|Show all 12,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79034
836,SC007202-30,"October 01, 2012 -  September 30, 2013",Biostatistics and Data Management Section,Seth M Steinberg; PhD,William Laurence Dahut; MD,"Biostatistics and Data Management Section, NCI",David J Liewehr|David J Venzon; PhD,NULL,"Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|Susan  Bates; MD (Medical Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Elise C Kohn; MD (Medical Oncology Branch)",Zenaide Maria Quezado; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79030
837,BC010843-07,"October 01, 2012 -  September 30, 2013",Medical Oncology Fellowship Program,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Nicolas  Acquavella Pesantes|Christine Campo Alewine|Sanjeeve  Balasubramaniam|Mauricio Emanuel Burotto Pichun|Lauren Mary Curtis|Jan Kenneth Davidson-Moncada|Show all 12,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78456
838,BC011023-06,"October 01, 2012 -  September 30, 2013",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",NULL,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology),Bradford J Wood; MD (CC),"1. Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G (2012). Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol  188, 1695-700.   https://doi.org/10.1016/j.juro.2012.07.029|2. Agochukwu NQ, Rastinehad AR, Richter LA, Barak S, Zerbe CS, Holland SM, Pinto PA (2012). Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature. J Pediatr Surg  47, 400-3.   https://doi.org/10.1016/j.jpedsurg.2011.11.003|3. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|4. Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA (2012). Image guidance in the focal treatment of prostate cancer. Curr Opin Urol  22, 328-35.   https://doi.org/10.1097/MOU.0b013e32835482cc|5. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|6. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA (2012). Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int  110, E694-700.   https://doi.org/10.1111/j.1464-410X.2012.11503.x|7. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|8. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|9. Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M (2012). Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys  39, 4093-103.   https://doi.org/10.1118/1.4722753|10. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G (2012). Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol  188, 2084-8.   https://doi.org/10.1016/j.juro.2012.08.038|11. Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2012). MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol  18, 34-45.   https://doi.org/10.4261/1305-3825.DIR.4478-11.1|12. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|13. Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL (2012). Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int  110, 1642-7.   https://doi.org/10.1111/j.1464-410X.2012.11469.x|14. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA (2012). Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol  188, 1157-1163.   https://doi.org/10.1016/j.juro.2012.06.011|15. Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, Hoang A, Nix J, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto PA (2012). Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg  47, 2077-82.   https://doi.org/10.1016/j.jpedsurg.2012.07.003|16. Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol  188, 2152-2157.   https://doi.org/10.1016/j.juro.2012.08.025|17. Xu H, Lasso A, Guion P, Krieger A, Kaushal A, Singh AK, Pinto PA, Coleman J, Grubb RL, Lattouf JB, Menard C, Whitcomb LL, Fichtinger G (2013). Accuracy analysis in MRI-guided robotic prostate biopsy. Int J Comput Assist Radiol Surg  8, 937-44.   https://doi.org/10.1007/s11548-013-0831-9|18. Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA (2012). Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int  110, E783-8.   https://doi.org/10.1111/j.1464-410X.2012.11646.x",https://intramural.nih.gov/search/searchview.taf?ipid=78689
839,BC011136-05,"October 01, 2012 -  September 30, 2013",The CCRWalter Reed Army Medical Center Gynecologic Cancer Program Research Lab,Elise C Kohn; MD,NULL,"Medical Oncology Branch, NCI",Jasmine  Han; MD|Tracy J Litzi|Sharon Ann Romano|Michael P Stany|Christina M Annunziata,"Gustavo  Rodriguez (Gynecologic Oncology, Evanston Northwestern Hospital)|Andrew  Berchuck (Gyn Oncology, Duke Univ)|Robert  Bast (Medicine, MD Anderson Cancer Center)|Anna  Lockshin (University of Pittsburgh Cancer Institute)|John I Risinger; PhD (NCI)|Carl  Morrison (Roswell Park Cancer Institute)|Show all 10",Chad Andrew Hamilton (Medical Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78180
840,BC011241-05,"October 01, 2012 -  September 30, 2013",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Karthik Ayyappankave Ganapathi|Shunyou  Gong|Alina  Nicolae|Stefania  Pittaluga|Yi  Xie|Show all 11,NULL,"Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012). Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol  36, 716-25.   https://doi.org/10.1097/PAS.0b013e3182487158|2. Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013). Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol  37, 333-43.   https://doi.org/10.1097/PAS.0b013e31826b9b57|3. Menon MP, Pittaluga S, Jaffe ES (2012). The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification. Cancer J  18, 411-20.   https://doi.org/10.1097/PPO.0b013e31826aee97",https://intramural.nih.gov/search/searchview.taf?ipid=78723
841,BC011271-04,"October 01, 2012 -  September 30, 2013",Developmental Therapeutics Clinic,Giuseppe  Giaccone; MD,NULL,"Medical Oncology Branch, NCI",William D Figg; PharmD|Jane Beth Trepel,NULL,James Halpern Doroshow (Developmental Therapeutics Branch)|Shivaani  Kummar; PhD (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78781
842,BC011384-03,"October 01, 2012 -  September 30, 2013",Anatomic Pathology Residency Program,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","Meghna  Alimchandani; MD|Leomar Y Ballester; MD, PhD|Jennifer Lynne Dreiling; MD|Yi-Shan  Lee; MD, PhD|Gregory Michael Riedlinger; MD, PhD|Avi Z Rosenberg",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78863
843,BC011516-01,"October 01, 2012 -  September 30, 2013",Pediatric Oncology Branch Clinical Care and Education,Melinda S Merchant,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Catherine Michelle Albert|Sherri L Depollar|Ruchika  Goel|Christine Marie Heske|Kyle William Jackson; MD, MPH|Elad  Jacoby; MD|Show all 16",Jeffry  Keefer (Johns Hopkins University School of Medicine)|Ido  PazPriel (Johns Hopkins University),NULL,NULL,"1. Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL (2012). Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. J Clin Oncol  30, 4141-7.   https://doi.org/10.1200/JCO.2012.44.1055|2. van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM (2013). Enhancing immune reconstitution: from bench to bedside. Biol Blood Marrow Transplant  19, S79-83.   https://doi.org/10.1016/j.bbmt.2012.09.016",https://intramural.nih.gov/search/searchview.taf?ipid=83061
844,SC000853-60,"October 01, 2012 -  September 30, 2013",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","David D Roberts; PhD|Michael R Emmert-Buck; MD, PhD|Mark  Raffeld; MD",NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Antonio  Fojo; MD, PhD (Medical Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Medical Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT (2012). Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab  97, E1782-90.   https://doi.org/10.1210/jc.2012-1791|2. Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R (2012). Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell. Int J Cancer  131, 2143-52.   https://doi.org/10.1002/ijc.27471|3. Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, O'Neil NJ, Price JC, Zhang S, England BM, Godwin AK, Sgroi DC, NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Hieter P, Mullikin JC, Merino MJ, Bell DW (2012). Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet  44, 1310-5.   https://doi.org/10.1038/ng.2455|4. Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA (2012). 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med  53, 538-45.   https://doi.org/10.2967/jnumed.111.096032|5. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM (2012). Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis  1, e14.   https://doi.org/10.1038/oncsis.2012.14|6. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|7. Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN (2012). A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunol Immunother  61, 373-84.   https://doi.org/10.1007/s00262-011-1100-9|8. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E (2012). DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab  97, E1004-13.   https://doi.org/10.1210/jc.2011-3298|9. Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM (2012). Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol  188, 2063-71.   https://doi.org/10.1016/j.juro.2012.08.030|10. Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M (2012). Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys  39, 4093-103.   https://doi.org/10.1118/1.4722753|11. Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA (2012). Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology  79, 233-9.   https://doi.org/10.1016/j.urology.2011.10.002|12. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA (2012). Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol  188, 1157-1163.   https://doi.org/10.1016/j.juro.2012.06.011|13. Venkatesan AM, Partanen A, Pulanic TK, Dreher MR, Fischer J, Zurawin RK, Muthupillai R, Sokka S, Nieminen HJ, Sinaii N, Merino M, Wood BJ, Stratton P (2012). Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. J Vasc Interv Radiol  23, 786-794.e4.   https://doi.org/10.1016/j.jvir.2012.02.015|14. Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM (2012). A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet  205, 377-90.   https://doi.org/10.1016/j.cancergen.2012.05.001|15. Zhang J, Qiu S, Zhang Y, Merino M, Fetsch P, Avital I, Filie A, Pastan I, Hassan R (2012). Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P. Anticancer Res  32, 5151-8.|16. Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K (2012). Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med  367, 922-30.   https://doi.org/10.1056/NEJMoa1205119|17. Ziadloo A, Burks SR, Gold EM, Lewis BK, Chaudhry A, Merino MJ, Frenkel V, Frank JA (2012). Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells  30, 1216-27.   https://doi.org/10.1002/stem.1099",https://intramural.nih.gov/search/searchview.taf?ipid=79042
845,BC010569-10,"October 01, 2012 -  September 30, 2013",Comparative Oncology Program,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Christina  Mazcko|Lee Jay Helman; MD,"Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Susan  Lana (Department of Clinical Sciences, Colorado State University)|Steven  Suter (Department of Clinical Sciences, North Carolina State University)|William  Kisseberth (Veterinary Medicine, Ohio State University)|Lisa  Barber (Veterinary Medicine, Tufts University)|Show all 35","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Caryn  Steakley; BA, BSN, MSW (Office of the Director)|Joseph E Tomaszewski (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|James Halpern Doroshow (Developmental Therapeutics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78378
846,BC010856-07,"October 01, 2012 -  September 30, 2013",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78498
847,BC010931-06,"October 01, 2012 -  September 30, 2013",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Caroline Elizabeth Salter|Jessica Ann Beck|Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Matti  Kiupel; PhD|Show all 10,"Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Boris  Bastian (UCSF)|Marcus  Bosenberg (Yale University)|Glen  Esplin (Univsity of Utah)|Michael  Goldschmidt (University of Pennsylvania)|Donald  Meuten (North Carolina State University)|Show all 10","Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Patricia  Steeg; PhD (Developmental Therapeutics Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)","Kanta  Subbarao; MD, MPH (NIAID) |Robert S Balaban; PhD (NHLBI)","1. Webster JD, Michalowski AM, Dwyer JE, Corps KN, Wei BR, Juopperi T, Hoover SB, Simpson RM (2012). Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis. J Pathol Inform  3, 18.   https://doi.org/10.4103/2153-3539.95130|2. Zhang S, Pruitt M, Tran D, Du Bois W, Zhang K, Patel R, Hoover S, Simpson RM, Simmons J, Gary J, Snapper CM, Casellas R, Mock BA (2013). B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol  191, 1692-703.   https://doi.org/10.4049/jimmunol.1201767",https://intramural.nih.gov/search/searchview.taf?ipid=78588
848,BC011161-05,"October 01, 2012 -  September 30, 2013",The automated measurement of foci in fluorescence microscopy,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78697
849,BC011235-05,"October 01, 2012 -  September 30, 2013",Support of NCI CCR Clinical Research and Bioinformatics,Jeffrey D Shilling,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78748
850,BC011445-02,"October 01, 2012 -  September 30, 2013","Coordination of DNA Replication, Transcription and Chromatin Assembly",Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,NULL,Mirit I Aladjem; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78908
851,CO020005-05,"October 01, 2012 -  September 30, 2013",National Cancer Informatics Program (NCIP),Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Dwayne D Forquer|George  Komatsoulis,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78949
852,CP010205-05,"October 01, 2012 -  September 30, 2013",Scientific Computing,Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI","Stephen J Chanock; MD, PhD",NULL,"Marianne  Henderson (Office of Division Operations and Analysis)|Karen E Berliner (Human Genetics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Nilanjan  Chatterjee (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79008
853,BC011234-05,"October 01, 2012 -  September 30, 2013",CCR New Space Activation,Darren W Henderson,Robert  Wiltrout; PhD,"Office of the Director, NCI",Debra L Borris|Monica I Gonzales,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78716
854,CO020002-05,"October 01, 2012 -  September 30, 2013",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Daryl E Paunil (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78947
855,BC011133-05,"October 01, 2012 -  September 30, 2013",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Viola D Black|Terry  Moody; PhD|Kathy  Augustin|Mary L Velthuis,NULL,"Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78182
856,BC011285-04,"October 01, 2012 -  September 30, 2013",CCR Education and Outreach,Kimberly R Martin,Robert  Wiltrout; PhD,"Office of the Director, NCI",Chris Russell Palmer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78789
857,CP010204-05,"October 01, 2012 -  September 30, 2013","Communications, Education and Outreach",Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Catherine B McClave|Jennifer K Loukissas|Alyssa Marie Voss|Wendy  Schneider-Levinson|Saloni  Nayar|Victoria Anne McCallum,NULL,Jackie Ann Lavigne (Office of Education)|Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79007
858,CP010208-04,"October 01, 2012 -  September 30, 2013",Special Studies Institutional Review Board Support,Catherine G Schairer| | |Joseph  Fraumeni; MD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI

Office of Division Operations and Analysis, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=79012
859,BC010857-07,"October 01, 2012 -  September 30, 2013",Science and Technology Partnerships,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",Davida Michelle Bilgrad|Mariam Q Malik,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78500
860,BC011193-05,"October 01, 2012 -  September 30, 2013",Office of Policy and Intellectual Property,Eric A Hale,Robert  Wiltrout; PhD,"Office of the Director, NCI",Grace  Yeh; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78715
861,CO020001-05,"October 01, 2012 -  September 30, 2013",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,Karen M Maurey  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=78946
